-------------
sentence: Concomitant use with other calcium-containing medicines (including antacids) may cause too much calcium in the blood or urine, which may increase the chance of side effects.
entities: calcium / calcium
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: Concomitant use with other calcium-containing medicines (including antacids) may cause too much calcium in the blood or urine, which may increase the chance of side effects.
entities: antacids / calcium
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: Using calcium acetate with digitalis glycosides (heart medicine) may cause hypercalcemia (too much calcium in the blood), which could increase the chance of developing an irregular heartbeat.
entities: calcium acetate / calcium
ddi: null
>>> match: cause_nsubj_dep
-------------
sentence: Using calcium acetate with digitalis glycosides (heart medicine) may cause hypercalcemia (too much calcium in the blood), which could increase the chance of developing an irregular heartbeat.
entities: digitalis glycosides / calcium
ddi: null
>>> match: cause_nsubj_dep
-------------
sentence: Ocupress should be used with caution in patients who are receiving a beta-adrenergic blocking agent orally because of the potential for additive effects on systemic beta-blockade.
entities: Ocupress / beta-adrenergic blocking agent
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Close observation of the patient is recommended when a beta-blocker is administered to patients receiving catecholamine-depleting drugs such as reserpine, because of possible additive effects and the production of hypotension and/or marked bradycardia, which may produce vertigo, syncope, or postural hypotension.
entities: beta-blocker / reserpine
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Laboratory Tests Response to Plenaxis should be monitored by measuring serum total testosterone concentrations just prior to administration on Day 29 and every 8 weeks thereafter.
entities: Plenaxis / testosterone
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: International Normalized Ratio (INR) elevations and/or bleeding events have been reported in some patients taking warfarin while on IRESSA therapy.
entities: warfarin / IRESSA
ddi: effect
>>> match: take_obj_advcl
-------------
sentence: Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as ranitidine or cimetidine) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.
entities: histamine H2-receptor antagonists / IRESSA
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as ranitidine or cimetidine) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.
entities: ranitidine / IRESSA
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Drugs that cause significant sustained elevation in gastric pH (histamine H2-receptor antagonists such as ranitidine or cimetidine) may reduce plasma concentrations of IRESSA and therefore potentially may reduce efficacy.
entities: cimetidine / IRESSA
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Phase II clinical trial data, where IRESSA and vinorelbine have been used concomitantly, indicate that IRESSA may exacerbate the neutropenic effect of vinorelbine.
entities: IRESSA / IRESSA
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: Phase II clinical trial data, where IRESSA and vinorelbine have been used concomitantly, indicate that IRESSA may exacerbate the neutropenic effect of vinorelbine.
entities: IRESSA / vinorelbine
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: Phase II clinical trial data, where IRESSA and vinorelbine have been used concomitantly, indicate that IRESSA may exacerbate the neutropenic effect of vinorelbine.
entities: vinorelbine / IRESSA
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: Phase II clinical trial data, where IRESSA and vinorelbine have been used concomitantly, indicate that IRESSA may exacerbate the neutropenic effect of vinorelbine.
entities: vinorelbine / vinorelbine
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: Phase II clinical trial data, where IRESSA and vinorelbine have been used concomitantly, indicate that IRESSA may exacerbate the neutropenic effect of vinorelbine.
entities: IRESSA / vinorelbine
ddi: effect
>>> match: exacerbate_nsubj_obj
-------------
sentence: The adverse experience profile seen with KEMSTROTM was similar to that seen with baclofen tablets.
entities: KEMSTROTM / baclofen
ddi: null
>>> match: see_obl_dep
-------------
sentence: Our data suggest that TAM significantly potentiates the reduction in cell number induced by 1,25(OH)2D3 alone. 
entities: TAM / 1,25(OH)2D3
ddi: effect
>>> match: potentiate_nsubj_dep
-------------
sentence: Apraclonidine should not be used in patients receiving MAO inhibitors..
entities: Apraclonidine / MAO inhibitors
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Tricyclic antidepressants have been reported to blunt the hypotensive effect of systemic clonidine.
entities: Tricyclic antidepressants / clonidine
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: FLUOTHANE augments the action of non-depolarising muscle relaxants and the muscle relaxant effects of aminoglycosides.
entities: FLUOTHANE / non-depolarising muscle relaxants
ddi: effect
>>> match: augment_nsubj_obj
-------------
sentence: FLUOTHANE augments the action of non-depolarising muscle relaxants and the muscle relaxant effects of aminoglycosides.
entities: FLUOTHANE / aminoglycosides
ddi: effect
>>> match: augment_nsubj_obj
-------------
sentence: FLUOTHANE may augment the hypotension caused by the ganglionic-blocking effect of tubocurarine.
entities: FLUOTHANE / tubocurarine
ddi: effect
>>> match: augment_nsubj_dep
-------------
sentence: Caution should be exercised during the administration of adrenaline to patients anaesthetised with FLUOTHANE as arrhythmias may be precipitated.
entities: adrenaline / FLUOTHANE
ddi: advise
>>> match: exercise_obl_obl
-------------
sentence: For this reason the dose of adrenaline should be restricted and an antiarrhythmic agent administered as appropriate.
entities: adrenaline / antiarrhythmic agent
ddi: null
>>> match: restrict_nsubj:pass_conj
-------------
sentence: Caution should also be applied for other sympathomimetics, and for aminophylline and theophylline and tricyclic antidepressants, which may also precipitate arrhythmias.
entities: sympathomimetics / aminophylline
ddi: null
>>> match: apply_obl_conj
-------------
sentence: Caution should also be applied for other sympathomimetics, and for aminophylline and theophylline and tricyclic antidepressants, which may also precipitate arrhythmias.
entities: sympathomimetics / theophylline
ddi: null
>>> match: apply_obl_conj
-------------
sentence: Caution should also be applied for other sympathomimetics, and for aminophylline and theophylline and tricyclic antidepressants, which may also precipitate arrhythmias.
entities: sympathomimetics / tricyclic antidepressants
ddi: null
>>> match: apply_obl_conj
-------------
sentence: In the first double-blind comparative study (28-week) of olanzapine and risperidone, olanzapine 10 to 20 mg/day proved to be significantly more effective than risperidone 4 to 12 mg/day in the treatment of negative and depressive symptoms but not on overall psychopathology symptoms. 
entities: olanzapine / olanzapine
ddi: null
>>> match: prove_obl_dep
-------------
sentence: In the first double-blind comparative study (28-week) of olanzapine and risperidone, olanzapine 10 to 20 mg/day proved to be significantly more effective than risperidone 4 to 12 mg/day in the treatment of negative and depressive symptoms but not on overall psychopathology symptoms. 
entities: olanzapine / risperidone
ddi: null
>>> match: prove_obl_xcomp
-------------
sentence: In the first double-blind comparative study (28-week) of olanzapine and risperidone, olanzapine 10 to 20 mg/day proved to be significantly more effective than risperidone 4 to 12 mg/day in the treatment of negative and depressive symptoms but not on overall psychopathology symptoms. 
entities: risperidone / olanzapine
ddi: null
>>> match: prove_obl_dep
-------------
sentence: In the first double-blind comparative study (28-week) of olanzapine and risperidone, olanzapine 10 to 20 mg/day proved to be significantly more effective than risperidone 4 to 12 mg/day in the treatment of negative and depressive symptoms but not on overall psychopathology symptoms. 
entities: risperidone / risperidone
ddi: null
>>> match: prove_obl_xcomp
-------------
sentence: In the first double-blind comparative study (28-week) of olanzapine and risperidone, olanzapine 10 to 20 mg/day proved to be significantly more effective than risperidone 4 to 12 mg/day in the treatment of negative and depressive symptoms but not on overall psychopathology symptoms. 
entities: olanzapine / risperidone
ddi: null
>>> match: prove_dep_xcomp
-------------
sentence: In contrast, preliminary results from an 8-week controlled study suggested risperidone 2 to 6 mg/day was superior to olanzapine 5 to 20 mg/day against positive and anxiety/depressive symptoms (p < 0.05), although consistent with the first study, both agents demonstrated similar efficacy on measures of overall psychopathology. 
entities: risperidone / olanzapine
ddi: null
>>> match: suggest_obj_dep
-------------
sentence: Improvements in general cognitive function seen with olanzapine treatment in a 1-year controlled study of patients with early-phase schizophrenia, were significantly greater than changes seen with either risperidone or haloperidol. 
entities: olanzapine / risperidone
ddi: null
>>> match: see_obl_dep
-------------
sentence: Improvements in general cognitive function seen with olanzapine treatment in a 1-year controlled study of patients with early-phase schizophrenia, were significantly greater than changes seen with either risperidone or haloperidol. 
entities: olanzapine / haloperidol
ddi: null
>>> match: see_obl_dep
-------------
sentence: Several studies indicate that olanzapine has benefits against symptoms of aggression and agitation, while other studies strongly support the effectiveness of olanzapine in the treatment of depressive symptomatology. 
entities: olanzapine / olanzapine
ddi: null
>>> match: have_nsubj_advcl
-------------
sentence: Olanzapine is associated with significantly fewer extrapyramidal symptoms than haloperidol and risperidone. 
entities: Olanzapine / haloperidol
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: Olanzapine is associated with significantly fewer extrapyramidal symptoms than haloperidol and risperidone. 
entities: Olanzapine / risperidone
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: In comparison with haloperidol, the adverse events reported significantly more frequently with olanzapine in > or = 3.5% of patients were dry mouth, bodyweight gain and increased appetite and compared with risperidone, only bodyweight gain occurred significantly more frequently with olanzapine. 
entities: haloperidol / olanzapine
ddi: null
>>> match: report_obl_obl
-------------
sentence: In comparison with haloperidol, the adverse events reported significantly more frequently with olanzapine in > or = 3.5% of patients were dry mouth, bodyweight gain and increased appetite and compared with risperidone, only bodyweight gain occurred significantly more frequently with olanzapine. 
entities: haloperidol / risperidone
ddi: null
>>> match: report_obl_obl
-------------
sentence: In comparison with haloperidol, the adverse events reported significantly more frequently with olanzapine in > or = 3.5% of patients were dry mouth, bodyweight gain and increased appetite and compared with risperidone, only bodyweight gain occurred significantly more frequently with olanzapine. 
entities: haloperidol / olanzapine
ddi: null
>>> match: report_obl_obl
-------------
sentence: Pharmacoeconomic analyses indicate that olanzapine does not significantly increase, and may even decrease, the overall direct treatment costs of schizophrenia, compared with haloperidol. 
entities: olanzapine / haloperidol
ddi: null
>>> match: increase_nsubj_advcl
-------------
sentence: Compared with risperidone, olanzapine has also been reported to decrease overall treatment costs, despite the several-fold higher daily acquisition cost of the drug. 
entities: risperidone / olanzapine
ddi: null
>>> match: report_advcl_nsubj:pass
-------------
sentence: Olanzapine treatment improves quality of life in patients with schizophrenia and related psychoses to a greater extent than haloperidol, and to broadly the same extent as risperidone. 
entities: Olanzapine / haloperidol
ddi: null
>>> match: improve_nsubj_obl
-------------
sentence: Olanzapine treatment improves quality of life in patients with schizophrenia and related psychoses to a greater extent than haloperidol, and to broadly the same extent as risperidone. 
entities: Olanzapine / risperidone
ddi: null
>>> match: improve_nsubj_obl
-------------
sentence: CONCLUSIONS: Olanzapine demonstrated superior antipsychotic efficacy compared with haloperidol in the treatment of acute phase schizophrenia, and in the treatment of some patients with first-episode or treatment-resistant schizophrenia. 
entities: Olanzapine / haloperidol
ddi: null
>>> match: demonstrate_nsubj_advcl
-------------
sentence: The reduced risk of adverse events and therapeutic superiority compared with haloperidol and risperidone in the treatment of negative and depressive symptoms support the choice of olanzapine as a first-line option in the management of schizophrenia in the acute phase and for the maintenance of treatment response.
entities: haloperidol / olanzapine
ddi: null
>>> match: compare_obl_dep
-------------
sentence: The reduced risk of adverse events and therapeutic superiority compared with haloperidol and risperidone in the treatment of negative and depressive symptoms support the choice of olanzapine as a first-line option in the management of schizophrenia in the acute phase and for the maintenance of treatment response.
entities: risperidone / olanzapine
ddi: null
>>> match: compare_obl_dep
-------------
sentence: Netilmicin should not be administered concomitantly with potent loop diuretics such as furosemide and ethacrynic acid as the potential for ototoxicity is enhanced by the combination.
entities: Netilmicin / loop diuretics
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Netilmicin should not be administered concomitantly with potent loop diuretics such as furosemide and ethacrynic acid as the potential for ototoxicity is enhanced by the combination.
entities: Netilmicin / furosemide
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Netilmicin should not be administered concomitantly with potent loop diuretics such as furosemide and ethacrynic acid as the potential for ototoxicity is enhanced by the combination.
entities: Netilmicin / ethacrynic acid
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Terbinafine decreases the clearance of caffeine by 19%. 
entities: Terbinafine / caffeine
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Terbinafine increases the clearance of cyclosporine by 15%. 
entities: Terbinafine / cyclosporine
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Terbinafine clearance is increased 100% by rifampin, a CyP450 enzyme inducer, and decreased 33% by cimetidine, a CyP450 enzyme inhibitor. 
entities: Terbinafine / rifampin
ddi: mechanism
>>> match: increase_nsubj:pass_obl
-------------
sentence: Terbinafine clearance is increased 100% by rifampin, a CyP450 enzyme inducer, and decreased 33% by cimetidine, a CyP450 enzyme inhibitor. 
entities: Terbinafine / cimetidine
ddi: mechanism
>>> match: increase_nsubj:pass_conj
-------------
sentence: Terbinafine clearance is increased 100% by rifampin, a CyP450 enzyme inducer, and decreased 33% by cimetidine, a CyP450 enzyme inhibitor. 
entities: rifampin / cimetidine
ddi: null
>>> match: increase_obl_conj
-------------
sentence: Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, calcium channel antagonists, and macrolide antibiotics). 
entities: midazolam / azole antimycotics
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, calcium channel antagonists, and macrolide antibiotics). 
entities: midazolam / protease inhibitors
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, calcium channel antagonists, and macrolide antibiotics). 
entities: midazolam / calcium channel antagonists
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, calcium channel antagonists, and macrolide antibiotics). 
entities: midazolam / macrolide antibiotics
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Drugs such as erythromycin, diltiazem, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. 
entities: erythromycin / midazolam
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Drugs such as erythromycin, diltiazem, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. 
entities: diltiazem / midazolam
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Drugs such as erythromycin, diltiazem, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. 
entities: verapamil / midazolam
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Drugs such as erythromycin, diltiazem, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. 
entities: ketoconazole / midazolam
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Drugs such as erythromycin, diltiazem, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. 
entities: fluconazole / midazolam
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Drugs such as erythromycin, diltiazem, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam. 
entities: itraconazole / midazolam
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Although not studied, the potent cytochrome P450 3A4 inhibitors ritonavir and nelfinavir may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of midazolam. 
entities: ritonavir / midazolam
ddi: mechanism
>>> match: cause_nsubj_obl
-------------
sentence: Although not studied, the potent cytochrome P450 3A4 inhibitors ritonavir and nelfinavir may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of midazolam. 
entities: nelfinavir / midazolam
ddi: mechanism
>>> match: cause_nsubj_obl
-------------
sentence: The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. 
entities: VERSED Syrup / narcotics
ddi: effect
>>> match: accentuate_nsubj:pass_obl
-------------
sentence: The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. 
entities: VERSED Syrup / morphine
ddi: effect
>>> match: accentuate_nsubj:pass_obl
-------------
sentence: The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. 
entities: VERSED Syrup / meperidine
ddi: effect
>>> match: accentuate_nsubj:pass_obl
-------------
sentence: The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. 
entities: VERSED Syrup / fentanyl
ddi: effect
>>> match: accentuate_nsubj:pass_obl
-------------
sentence: The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. 
entities: VERSED Syrup / propofol
ddi: effect
>>> match: accentuate_nsubj:pass_obl
-------------
sentence: The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. 
entities: VERSED Syrup / ketamine
ddi: effect
>>> match: accentuate_nsubj:pass_obl
-------------
sentence: The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. 
entities: VERSED Syrup / nitrous oxide
ddi: effect
>>> match: accentuate_nsubj:pass_obl
-------------
sentence: The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. 
entities: VERSED Syrup / secobarbital
ddi: effect
>>> match: accentuate_nsubj:pass_obl
-------------
sentence: The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol. 
entities: VERSED Syrup / droperidol
ddi: effect
>>> match: accentuate_nsubj:pass_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / theophylline
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / cisapride
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / antipyrine
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / caffeine
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / carbamazepine
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / diazepam
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / desmethyldiazepam
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / diclofenac
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / naproxen
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / piroxicam
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / digoxin
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / ethanol
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / glyburide
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / contraceptive
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / levonorgestrel
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / ethinyl estradiol
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / metoprolol
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / nifedipine
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / phenytoin
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / warfarin
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / midazolam
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / clarithromycin
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / metronidazole
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin. 
entities: pantoprazole / amoxicillin
ddi: null
>>> match: need_advcl_obl
-------------
sentence: Because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, ketoconazole, ampicillin esters, and iron salts). 
entities: pantoprazole / ketoconazole
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, ketoconazole, ampicillin esters, and iron salts). 
entities: pantoprazole / ampicillin
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, ketoconazole, ampicillin esters, and iron salts). 
entities: pantoprazole / iron
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Resveratrol (5-35 micromol/l) induced concentration-dependent relaxation of mesenteric arteries preconstricted with noradrenaline (8 micromol/l) or KCl (125 mmol/l) from both lean and dietary-obese rats. 
entities: Resveratrol / noradrenaline
ddi: null
>>> match: induce_nsubj_dep
-------------
sentence: Resveratrol (5-35 micromol/l) induced concentration-dependent relaxation of mesenteric arteries preconstricted with noradrenaline (8 micromol/l) or KCl (125 mmol/l) from both lean and dietary-obese rats. 
entities: Resveratrol / KCl
ddi: null
>>> match: induce_nsubj_dep
-------------
sentence: Resveratrol (5-35 micromol/l) induced concentration-dependent relaxation of mesenteric arteries preconstricted with noradrenaline (8 micromol/l) or KCl (125 mmol/l) from both lean and dietary-obese rats. 
entities: noradrenaline / KCl
ddi: null
>>> match: preconstrict_obl_conj
-------------
sentence: It is possible that the cardiovascular action of other calcium channel blockers could be enhanced by the addition of Nimotop .
entities: calcium channel blockers / Nimotop
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: In Europe, Nimotop  was observed to occasionally intensify the effect of antihypertensive compounds taken concomitantly by patients suffering from hypertension;
entities: Nimotop / antihypertensive compounds
ddi: effect
>>> match: observe_nsubj:pass_obl
-------------
sentence: A study in eight healthy volunteers has shown a 50% increase in mean peak nimodipine plasma concentrations and a 90% increase in mean area under the curve, after a one week course of cimetidine at 1,000 mg/day and nimodipine at 90 mg/day.
entities: nimodipine / cimetidine
ddi: null
>>> match: show_obj_obl
-------------
sentence: A study in eight healthy volunteers has shown a 50% increase in mean peak nimodipine plasma concentrations and a 90% increase in mean area under the curve, after a one week course of cimetidine at 1,000 mg/day and nimodipine at 90 mg/day.
entities: nimodipine / nimodipine
ddi: null
>>> match: show_obj_obl
-------------
sentence: Concurrent administration of dyphylline and probenecid, which competes for tubular secretion, has been shown to increase the plasma half-life of dyphylline .
entities: dyphylline / dyphylline
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Concurrent administration of dyphylline and probenecid, which competes for tubular secretion, has been shown to increase the plasma half-life of dyphylline .
entities: probenecid / dyphylline
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Oral metronidazole has been reported to potentiate the anticoagulant effect of coumarin and warfarin, resulting in a prolongation of prothrombin time. 
entities: metronidazole / coumarin
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Oral metronidazole has been reported to potentiate the anticoagulant effect of coumarin and warfarin, resulting in a prolongation of prothrombin time. 
entities: metronidazole / warfarin
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / beta-blockers
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / propranolol
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / sparfloxacin
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / grepafloxacin
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / guanethidine
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / guanadrel
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / metrizamide
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / cabergoline
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / lithium
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / narcotic
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / codeine
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / antihistamines
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-depressants / diphenhydramine
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / beta-blockers
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / propranolol
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / sparfloxacin
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / grepafloxacin
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / guanethidine
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / guanadrel
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / metrizamide
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / cabergoline
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / lithium
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / narcotic
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / codeine
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / antihistamines
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: Interactions may also occur with the following: anti-depressants/anti-anxiety drugs, drugs used to treat an overactive thyroid, beta-blockers (e.g., propranolol), sparfloxacin, grepafloxacin, guanethidine, guanadrel, metrizamide, cabergoline, lithium, narcotic pain medication (e.g., codeine), drugs used to aid sleep, drowsiness-causing antihistamines (e.g., diphenhydramine), any other drugs that may make you drowsy.
entities: anti-anxiety drugs / diphenhydramine
ddi: null
>>> match: use_dep_xcomp
-------------
sentence: An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of rosiglitazone. 
entities: gemfibrozil / rosiglitazone
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of rosiglitazone. 
entities: gemfibrozil / rifampin
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of rosiglitazone. 
entities: gemfibrozil / rosiglitazone
ddi: null
>>> match: decrease_csubj_obj
-------------
sentence: An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of rosiglitazone. 
entities: rosiglitazone / rosiglitazone
ddi: null
>>> match: decrease_csubj_obj
-------------
sentence: An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of rosiglitazone. 
entities: rifampin / rosiglitazone
ddi: mechanism
>>> match: decrease_csubj_obj
-------------
sentence: GABITRIL is considered to be a non-enzyme inducing AED.
entities: GABITRIL / AED
ddi: null
>>> match: consider_nsubj:pass_xcomp
-------------
sentence: Effects of GABITRIL on other Antiepilepsy Drugs (AEDs) : Phenytoin: Tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy.
entities: Tiagabine / phenytoin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Carbamazepine: Tiagabine had no effect on the steady-state plasma concentrations of carbamazepine or its epoxide metabolite in patients with epilepsy.
entities: Tiagabine / carbamazepine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Valproate: Tiagabine causes a slight decrease (about 10%) in steady-state valproate concentrations.
entities: Tiagabine / valproate
ddi: mechanism
>>> match: cause_nsubj_obj
-------------
sentence: The addition of tiagabine in a limited number of patients in three well-controlled studies caused no systematic changes in phenobarbital or primidone concentrations when compared to placebo.
entities: tiagabine / phenobarbital
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: The addition of tiagabine in a limited number of patients in three well-controlled studies caused no systematic changes in phenobarbital or primidone concentrations when compared to placebo.
entities: tiagabine / primidone
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: Effects of other Antiepilepsy Drugs (AEDs) on GABITRIL : Carbamazepine: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking carbamazepine with or without other enzyme- inducing AEDs.
entities: carbamazepine / AEDs
ddi: null
>>> match: take_obj_obl
-------------
sentence: Phenytoin: Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking phenytoin with or without other enzyme- inducing AEDs.
entities: phenytoin / AEDs
ddi: null
>>> match: take_obj_obl
-------------
sentence: Phenobarbital (Primidone): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking phenobarbital (primidone) with or without other enzyme-inducing AEDs.
entities: phenobarbital / AEDs
ddi: null
>>> match: take_obj_obl
-------------
sentence: Phenobarbital (Primidone): Population pharmacokinetic analyses indicate that tiagabine clearance is 60% greater in patients taking phenobarbital (primidone) with or without other enzyme-inducing AEDs.
entities: primidone / AEDs
ddi: null
>>> match: take_obj_obl
-------------
sentence: Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.
entities: tiagabine / tiagabine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.
entities: tiagabine / valproate
ddi: null
>>> match: have_nsubj_conj
-------------
sentence: Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.
entities: tiagabine / tiagabine
ddi: null
>>> match: have_nsubj_conj
-------------
sentence: Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.
entities: valproate / tiagabine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.
entities: valproate / valproate
ddi: null
>>> match: have_nsubj_conj
-------------
sentence: Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.
entities: valproate / tiagabine
ddi: null
>>> match: have_nsubj_conj
-------------
sentence: Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.
entities: tiagabine / valproate
ddi: null
>>> match: have_obj_conj
-------------
sentence: Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.
entities: tiagabine / tiagabine
ddi: null
>>> match: have_obj_conj
-------------
sentence: Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.
entities: valproate / tiagabine
ddi: mechanism
>>> match: decrease_nsubj_dep
-------------
sentence: Interaction of GABITRIL with Other Drugs : Cimetidine : Co-administration of cimetidine (800 mg/day) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics.
entities: Cimetidine / tiagabine
ddi: null
>>> match: have_nsubj_obl
-------------
sentence: Interaction of GABITRIL with Other Drugs : Cimetidine : Co-administration of cimetidine (800 mg/day) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics.
entities: Cimetidine / tiagabine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Interaction of GABITRIL with Other Drugs : Cimetidine : Co-administration of cimetidine (800 mg/day) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics.
entities: cimetidine / tiagabine
ddi: null
>>> match: have_nsubj_obl
-------------
sentence: Interaction of GABITRIL with Other Drugs : Cimetidine : Co-administration of cimetidine (800 mg/day) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics.
entities: cimetidine / tiagabine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Interaction of GABITRIL with Other Drugs : Cimetidine : Co-administration of cimetidine (800 mg/day) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics.
entities: tiagabine / tiagabine
ddi: null
>>> match: have_obl_obj
-------------
sentence: Ethanol or Triazolam: No significant differences were observed in the pharmacokinetics of triazolam (0.125 mg) and tiagabine (10 mg) when given together as a single dose.
entities: triazolam / tiagabine
ddi: null
>>> match: observe_obl_dep
-------------
sentence: Tiagabine has shown no clinically important potentiation of the pharmacodynamic effects of triazo lam or alcohol.
entities: Tiagabine / alcohol
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: Because of the possible additive effects of drugs that may depress the nervous system, ethanol or triazolam should be used cautiously in combination with tiagabine.
entities: ethanol / tiagabine
ddi: advise
>>> match: use_obl_obl
-------------
sentence: Because of the possible additive effects of drugs that may depress the nervous system, ethanol or triazolam should be used cautiously in combination with tiagabine.
entities: triazolam / tiagabine
ddi: advise
>>> match: use_obl_obl
-------------
sentence: PROSTIN E2 may augment the activity of other oxytocic drugs.
entities: PROSTIN E2 / oxytocic drugs
ddi: effect
>>> match: augment_nsubj_obj
-------------
sentence: The duration of the period following treatment with AMEVIVE  before one should consider starting other immunosuppressive therapy has not been evaluated.
entities: AMEVIVE / immunosuppressive
ddi: null
>>> match: consider_nsubj_xcomp
-------------
sentence: Since the effect of AMEVIVE on pregnancy and fetal development, including immune system development, is not known, health care providers are encouraged to enroll patients currently taking AMEVIVE who become pregnant into the Biogen Pregnancy Registry by calling 1-866-AMEVIVE (1-866-263-8483).
entities: AMEVIVE / AMEVIVE
ddi: null
>>> match: encourage_advcl_xcomp
-------------
sentence: Since the effect of AMEVIVE on pregnancy and fetal development, including immune system development, is not known, health care providers are encouraged to enroll patients currently taking AMEVIVE who become pregnant into the Biogen Pregnancy Registry by calling 1-866-AMEVIVE (1-866-263-8483).
entities: AMEVIVE / AMEVIVE
ddi: null
>>> match: encourage_advcl_xcomp
-------------
sentence: CNS-Active Drugs Ethanol An additive effect on psychomotor performance was seen with coadministration of eszopiclone and ethanol 0.70 g/kg for up to 4 hours after ethanol administration.
entities: Ethanol / eszopiclone
ddi: null
>>> match: see_nsubj:pass_obl
-------------
sentence: CNS-Active Drugs Ethanol An additive effect on psychomotor performance was seen with coadministration of eszopiclone and ethanol 0.70 g/kg for up to 4 hours after ethanol administration.
entities: Ethanol / ethanol
ddi: null
>>> match: see_nsubj:pass_obl
-------------
sentence: CNS-Active Drugs Ethanol An additive effect on psychomotor performance was seen with coadministration of eszopiclone and ethanol 0.70 g/kg for up to 4 hours after ethanol administration.
entities: Ethanol / ethanol
ddi: null
>>> match: see_nsubj:pass_obl
-------------
sentence: The AUC of eszopiclone was increased 2.2-fold by coadministration of ketoconazole, a potent inhibitor of CYP3A4, 400 mg daily for 5 days.
entities: eszopiclone / ketoconazole
ddi: mechanism
>>> match: increase_nsubj:pass_parataxis
-------------
sentence: Drugs That Induce CYP3A4 (Rifampicin) Racemic zopiclone exposure was decreased 80% by concomitant useof rifampicin, a potent inducer of CYP3A4.
entities: Rifampicin / rifampicin
ddi: null
>>> match: decrease_nsubj:pass_obl
-------------
sentence: Drugs That Induce CYP3A4 (Rifampicin) Racemic zopiclone exposure was decreased 80% by concomitant useof rifampicin, a potent inducer of CYP3A4.
entities: zopiclone / rifampicin
ddi: mechanism
>>> match: decrease_nsubj:pass_obl
-------------
sentence: WelChol  was found to have no significant effect on the bioavailability of digoxin, lovastatin, metoprolol, quinidine, valproic acid, and warfarin.
entities: WelChol / digoxin
ddi: null
>>> match: find_nsubj:pass_xcomp
-------------
sentence: WelChol  was found to have no significant effect on the bioavailability of digoxin, lovastatin, metoprolol, quinidine, valproic acid, and warfarin.
entities: WelChol / lovastatin
ddi: null
>>> match: find_nsubj:pass_xcomp
-------------
sentence: WelChol  was found to have no significant effect on the bioavailability of digoxin, lovastatin, metoprolol, quinidine, valproic acid, and warfarin.
entities: WelChol / metoprolol
ddi: null
>>> match: find_nsubj:pass_xcomp
-------------
sentence: WelChol  was found to have no significant effect on the bioavailability of digoxin, lovastatin, metoprolol, quinidine, valproic acid, and warfarin.
entities: WelChol / quinidine
ddi: null
>>> match: find_nsubj:pass_xcomp
-------------
sentence: WelChol  was found to have no significant effect on the bioavailability of digoxin, lovastatin, metoprolol, quinidine, valproic acid, and warfarin.
entities: WelChol / valproic acid
ddi: null
>>> match: find_nsubj:pass_xcomp
-------------
sentence: WelChol  was found to have no significant effect on the bioavailability of digoxin, lovastatin, metoprolol, quinidine, valproic acid, and warfarin.
entities: WelChol / warfarin
ddi: null
>>> match: find_nsubj:pass_xcomp
-------------
sentence: WelChol  decreased the Cmax and AUC of sustained-release verapamil (Calan SR ) by approximately 31% and 11%, respectively.
entities: WelChol / verapamil
ddi: mechanism
>>> match: decrease_nsubj_iobj
-------------
sentence: WelChol  decreased the Cmax and AUC of sustained-release verapamil (Calan SR ) by approximately 31% and 11%, respectively.
entities: WelChol / Calan SR
ddi: mechanism
>>> match: decrease_nsubj_iobj
-------------
sentence: METHODS: Clinical studies, case reports, and commentaries and editorials concerning sildenafil published in the international literature between January 1999 and August 2000 were identified through searches of MEDLINE, PREMEDLINE, and International Pharmaceutical Abstracts, using the terms sildenafil, Viagra, and erectile dysfunction. 
entities: sildenafil / sildenafil
ddi: null
>>> match: identify_nsubj:pass_obl
-------------
sentence: METHODS: Clinical studies, case reports, and commentaries and editorials concerning sildenafil published in the international literature between January 1999 and August 2000 were identified through searches of MEDLINE, PREMEDLINE, and International Pharmaceutical Abstracts, using the terms sildenafil, Viagra, and erectile dysfunction. 
entities: sildenafil / Viagra
ddi: null
>>> match: identify_nsubj:pass_obl
-------------
sentence: RESULTS: Sildenafil has demonstrated effectiveness in men with erectile dysfunction associated with prostatectomy, radiation therapy, diabetes mellitus, certain neurologic disorders, and drug therapy (eg, selective serotonin reuptake inhibitors [SSRIs]). 
entities: Sildenafil / selective serotonin reuptake inhibitors
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: RESULTS: Sildenafil has demonstrated effectiveness in men with erectile dysfunction associated with prostatectomy, radiation therapy, diabetes mellitus, certain neurologic disorders, and drug therapy (eg, selective serotonin reuptake inhibitors [SSRIs]). 
entities: Sildenafil / SSRIs
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In addition, patients taking drugs that inhibit the cytochrome P450 3A4 isozyme, which metabolizes sildenafil, may experience increased drug concentrations and possible toxicity from normal doses of sildenafil. 
entities: sildenafil / sildenafil
ddi: null
>>> match: inhibit_obj_dep
-------------
sentence: Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.
entities: Selective serotonin reuptake inhibitors / 5-HT1 agonists
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.
entities: SSRIs / 5-HT1 agonists
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.
entities: fluoxetine / 5-HT1 agonists
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.
entities: fluvoxamine / 5-HT1 agonists
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.
entities: paroxetine / 5-HT1 agonists
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.
entities: sertraline / 5-HT1 agonists
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Co-treatment with the potent CYP3A4 inhibitor ketoconazole increases erlotinib AUC by 2/3.
entities: ketoconazole / erlotinib
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Pre-treatment with the CYP3A4 inducer rifampicin decreased erlotinib AUC by about 2/3.
entities: rifampicin / erlotinib
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: If the TARCEVA dose is adjusted upward, the dose will need to be reduced upon discontinuation of rifampicin or other inducers.
entities: TARCEVA / rifampicin
ddi: advise
>>> match: need_advcl_xcomp
-------------
sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.
entities: narcotic analgesics / hydrocodone
ddi: effect
>>> match: receive_obj_advcl
-------------
sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.
entities: narcotic analgesics / acetaminophen
ddi: null
>>> match: receive_obj_advcl
-------------
sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.
entities: antipsychotics / hydrocodone
ddi: effect
>>> match: receive_obj_advcl
-------------
sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.
entities: antipsychotics / acetaminophen
ddi: null
>>> match: receive_obj_advcl
-------------
sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.
entities: antianxiety agents / hydrocodone
ddi: effect
>>> match: receive_obj_advcl
-------------
sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.
entities: antianxiety agents / acetaminophen
ddi: null
>>> match: receive_obj_advcl
-------------
sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.
entities: CNS depressants / hydrocodone
ddi: effect
>>> match: receive_obj_advcl
-------------
sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.
entities: CNS depressants / acetaminophen
ddi: null
>>> match: receive_obj_advcl
-------------
sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.
entities: alcohol / hydrocodone
ddi: effect
>>> match: receive_obj_advcl
-------------
sentence: Patients receiving other narcotic analgesics, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive CNS depression.
entities: alcohol / acetaminophen
ddi: null
>>> match: receive_obj_advcl
-------------
sentence: The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
entities: MAO inhibitors / antidepressant
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
entities: MAO inhibitors / hydrocodone
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
entities: tricyclic antidepressants / antidepressant
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
entities: tricyclic antidepressants / hydrocodone
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
entities: hydrocodone / antidepressant
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.
entities: hydrocodone / hydrocodone
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: The absorption of lymecycline may be affected by the simultaneous administration of indigestion remedies, iron or zinc supplements.
entities: lymecycline / iron
ddi: mechanism
>>> match: affect_nsubj:pass_obl
-------------
sentence: The absorption of lymecycline may be affected by the simultaneous administration of indigestion remedies, iron or zinc supplements.
entities: lymecycline / zinc
ddi: mechanism
>>> match: affect_nsubj:pass_obl
-------------
sentence: After multiple dosing, interferon beta-1a (AVONEX  30 mcg IM once weekly) reduced TYSABRI  clearance by approximately 30%.
entities: interferon beta-1a / TYSABRI
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: After multiple dosing, interferon beta-1a (AVONEX  30 mcg IM once weekly) reduced TYSABRI  clearance by approximately 30%.
entities: AVONEX / TYSABRI
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).
entities: TYSABRI / TYSABRI
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).
entities: AVONEX / TYSABRI
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: The similarity of the TYSABRI -associated adverse event profile between Study 1 (without co-administered AVONEX ) and Study 2 (with co-administered AVONEX ) indicates that this alteration in clearance does not necessitate reduction of the TYSABRI  dose to maintain safety, General).
entities: AVONEX / TYSABRI
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: An intravenous injection of perchlorate given later also produces a complete and immediately beginning depletion of pertechnetate already accumulated in the thyroid, within a period of 195 min after 99m-TcO-4-injection with a corresponding increase in blood levels. 
entities: perchlorate / pertechnetate
ddi: mechanism
>>> match: produce_nsubj_conj
-------------
sentence: CYP3A4 Inhibitors: Ketoconazole, an inhibitor of the drug metabolizing enzyme CYP3A4, significantly increased plasma concentrations of tolterodine when coadministered to subjects who were poor metabolizers (see CLINICAL PHARMACOLOGY, Variability in Metabolism and Drug-Drug Interactions). 
entities: Ketoconazole / tolterodine
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Special consideration should be given to the administration of ETHYOL in patients receiving antihypertensive medications or other drugs that could cause or potentiate hypotension.
entities: ETHYOL / antihypertensive medications
ddi: advise
>>> match: give_obl_obl
-------------
sentence: Because dexfenfluramine is a serotonin releaser and reuptake inhibitor, dexfenfluramine should not be used concomitantly with a MAO inhibitor.
entities: dexfenfluramine / dexfenfluramine
ddi: null
>>> match: use_advcl_nsubj:pass
-------------
sentence: Because dexfenfluramine is a serotonin releaser and reuptake inhibitor, dexfenfluramine should not be used concomitantly with a MAO inhibitor.
entities: dexfenfluramine / MAO inhibitor
ddi: null
>>> match: use_advcl_obl
-------------
sentence: Because dexfenfluramine is a serotonin releaser and reuptake inhibitor, dexfenfluramine should not be used concomitantly with a MAO inhibitor.
entities: dexfenfluramine / MAO inhibitor
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Dexfenfluramine should not be administered with other serotoninergic agents.
entities: Dexfenfluramine / serotoninergic agents
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: quinolones / theophylline
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: quinolones / caffeine
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: quinolones / anticoagulant
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: quinolones / warfarin
ddi: effect
>>> match: show_nsubj:pass_xcomp
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: quinolones / cyclosporine
ddi: effect
>>> match: show_nsubj:pass_xcomp
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: theophylline / caffeine
ddi: null
>>> match: elevate_obj_conj
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: theophylline / anticoagulant
ddi: null
>>> match: elevate_obj_conj
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: theophylline / warfarin
ddi: null
>>> match: elevate_obj_conj
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: theophylline / cyclosporine
ddi: null
>>> match: elevate_obj_conj
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: caffeine / anticoagulant
ddi: null
>>> match: elevate_conj_conj
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: caffeine / warfarin
ddi: null
>>> match: elevate_conj_conj
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: caffeine / cyclosporine
ddi: null
>>> match: elevate_conj_conj
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: anticoagulant / cyclosporine
ddi: null
>>> match: elevate_conj_conj
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: warfarin / cyclosporine
ddi: null
>>> match: elevate_conj_conj
-------------
sentence: Gemfibrozil Other fibrates Niacin (nicotinic acid) (=1 g/day)
entities: Gemfibrozil / Niacin
ddi: null
>>> match: fibrate_nsubj_obj
-------------
sentence: Gemfibrozil Other fibrates Niacin (nicotinic acid) (=1 g/day)
entities: Gemfibrozil / nicotinic acid
ddi: null
>>> match: fibrate_nsubj_obj
-------------
sentence: Danazol: The risk of myopathy/rhabdomyolysis is increased by concomitant administration of danazol particularly with higher doses of lovastatin (see WARNINGS, Myopathy/Rhabdomyolysis).
entities: danazol / lovastatin
ddi: effect
>>> match: increase_obl_obl
-------------
sentence: Amiodarone or Verapamil: The risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the HMG-CoA reductase inhibitor class (see WARNINGS, Myopathy/Rhabdomyolysis).
entities: amiodarone / HMG-CoA reductase inhibitor class
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: Amiodarone or Verapamil: The risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the HMG-CoA reductase inhibitor class (see WARNINGS, Myopathy/Rhabdomyolysis).
entities: verapamil / HMG-CoA reductase inhibitor class
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: Coumarin Anticoagulants: In a small clinical trial in which lovastatin was administered to warfarin treated patients, no effect on prothrombin time was detected.
entities: lovastatin / warfarin
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: However, another HMG-CoA reductase inhibitor has been found to produce a less than two-second increase in prothrombin time in healthy volunteers receiving low doses of warfarin.
entities: HMG-CoA reductase inhibitor / warfarin
ddi: effect
>>> match: find_nsubj:pass_xcomp
-------------
sentence: Also, bleeding and/or increased prothrombin time have been reported in a few patients taking coumarin anticoagulants concomitantly with lovastatin.
entities: coumarin anticoagulants / lovastatin
ddi: effect
>>> match: take_obj_obl
-------------
sentence: It is recommended that in patients taking anticoagulants, prothrombin time be determined before starting lovastatin and frequently enough during early therapy to insure that no significant alteration of prothrombin time occurs.
entities: anticoagulants / lovastatin
ddi: advise
>>> match: determine_obl_obl
-------------
sentence: Lovastatin therapy has not been associated with bleeding or with changes in prothrombin time in patients not taking anticoagulants.
entities: Lovastatin / anticoagulants
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: Digoxin: In patients with hypercholesterolemia, concomitant administration of lovastatin and digoxin resulted in no effect on digoxin plasma concentrations.
entities: lovastatin / digoxin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Digoxin: In patients with hypercholesterolemia, concomitant administration of lovastatin and digoxin resulted in no effect on digoxin plasma concentrations.
entities: digoxin / digoxin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Oral Hypoglycemic Agents: In pharmacokinetic studies of MEVACOR in hypercholesterolemic noninsulin dependent diabetic patients, there was no drug interaction with glipizide or with chlorpropamide
entities: MEVACOR / glipizide
ddi: null
>>> match: be_obl_nsubj
-------------
sentence: Oral Hypoglycemic Agents: In pharmacokinetic studies of MEVACOR in hypercholesterolemic noninsulin dependent diabetic patients, there was no drug interaction with glipizide or with chlorpropamide
entities: MEVACOR / chlorpropamide
ddi: null
>>> match: be_obl_nsubj
-------------
sentence: Two studies were conducted in HIV-infected subjects to assess the potential for azithromycin to interact with zidovudine and dideoxyinosine. 
entities: azithromycin / zidovudine
ddi: null
>>> match: interact_nsubj_obl
-------------
sentence: Two studies were conducted in HIV-infected subjects to assess the potential for azithromycin to interact with zidovudine and dideoxyinosine. 
entities: azithromycin / dideoxyinosine
ddi: null
>>> match: interact_nsubj_obl
-------------
sentence: The zidovudine study dosed subjects with 1200 mg/day of azithromycin (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of zidovudine. 
entities: zidovudine / azithromycin
ddi: null
>>> match: dose_nsubj_obl
-------------
sentence: The zidovudine study dosed subjects with 1200 mg/day of azithromycin (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of zidovudine. 
entities: zidovudine / zidovudine
ddi: null
>>> match: dose_nsubj_obj
-------------
sentence: The zidovudine study dosed subjects with 1200 mg/day of azithromycin (n = 7) (later changed to 600 mg/day [n = 5]) for Days 8 to 21 of a 21-day course of 100 mg, five times/day of zidovudine. 
entities: azithromycin / zidovudine
ddi: null
>>> match: dose_obl_obj
-------------
sentence: Subjects treated with 200 mg of dideoxyinosine twice daily for 21 days received 1200 mg of azithromycin or an equivalent amount of placebo/day for Days 8 to 21. 
entities: dideoxyinosine / azithromycin
ddi: null
>>> match: treat_obl_parataxis
-------------
sentence: Antiretroviral plasma and urine sampling were conducted on Days 1, 7, and 21 for zidovudine and on Days 7 and 21 for dideoxyinosine. 
entities: Antiretroviral / zidovudine
ddi: null
>>> match: conduct_nsubj:pass_obl
-------------
sentence: Antiretroviral plasma and urine sampling were conducted on Days 1, 7, and 21 for zidovudine and on Days 7 and 21 for dideoxyinosine. 
entities: Antiretroviral / dideoxyinosine
ddi: null
>>> match: conduct_nsubj:pass_obl
-------------
sentence: Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%. 
entities: Azithromycin / zidovudine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%. 
entities: Azithromycin / zidovudine
ddi: mechanism
>>> match: have_nsubj_advcl
-------------
sentence: Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%. 
entities: Azithromycin / zidovudine
ddi: mechanism
>>> match: have_nsubj_advcl
-------------
sentence: Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%. 
entities: zidovudine / zidovudine
ddi: null
>>> match: have_obj_advcl
-------------
sentence: Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%. 
entities: zidovudine / zidovudine
ddi: null
>>> match: have_obj_advcl
-------------
sentence: Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%. 
entities: zidovudine / zidovudine
ddi: null
>>> match: decrease_obj_conj
-------------
sentence: Azithromycin had no significant effect on dideoxyinosine pharmacokinetics. 
entities: Azithromycin / dideoxyinosine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Based on the results of these studies, it is concluded that azithromycin may be safely coadministered with both zidovudine and dideoxyinosine.
entities: azithromycin / zidovudine
ddi: null
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Based on the results of these studies, it is concluded that azithromycin may be safely coadministered with both zidovudine and dideoxyinosine.
entities: azithromycin / dideoxyinosine
ddi: null
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Because tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage.
entities: tetracyclines / anticoagulant
ddi: null
>>> match: require_csubj_obj
-------------
sentence: Because tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage.
entities: anticoagulant / anticoagulant
ddi: null
>>> match: require_csubj_obj
-------------
sentence: Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracyclines in conjunction with penicillin.
entities: tetracyclines / penicillin
ddi: advise
>>> match: give_obj_obl
-------------
sentence: Absorption of tetracyclines is impaired by antacids containing aluminum, calcium, or magnesium, and iron-containing preparations.
entities: tetracyclines / antacids
ddi: null
>>> match: impair_nsubj:pass_obl
-------------
sentence: Absorption of tetracyclines is impaired by antacids containing aluminum, calcium, or magnesium, and iron-containing preparations.
entities: tetracyclines / aluminum
ddi: mechanism
>>> match: impair_nsubj:pass_obl
-------------
sentence: Absorption of tetracyclines is impaired by antacids containing aluminum, calcium, or magnesium, and iron-containing preparations.
entities: tetracyclines / calcium
ddi: mechanism
>>> match: impair_nsubj:pass_obl
-------------
sentence: Absorption of tetracyclines is impaired by antacids containing aluminum, calcium, or magnesium, and iron-containing preparations.
entities: tetracyclines / magnesium
ddi: mechanism
>>> match: impair_nsubj:pass_obl
-------------
sentence: Absorption of tetracyclines is impaired by antacids containing aluminum, calcium, or magnesium, and iron-containing preparations.
entities: tetracyclines / iron
ddi: mechanism
>>> match: impair_nsubj:pass_obl
-------------
sentence: Absorption of tetracycline is impaired by bismuth subsalicylate.
entities: tetracycline / bismuth subsalicylate
ddi: mechanism
>>> match: impair_nsubj:pass_obl
-------------
sentence: Barbiturates, carbamazepine, and phenytoin decrease the half-life of doxycycline.
entities: Barbiturates / doxycycline
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates, carbamazepine, and phenytoin decrease the half-life of doxycycline.
entities: carbamazepine / doxycycline
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates, carbamazepine, and phenytoin decrease the half-life of doxycycline.
entities: phenytoin / doxycycline
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Concurrent use of tetracycline may render oral contraceptives less effective.
entities: tetracycline / contraceptives
ddi: effect
>>> match: render_nsubj_xcomp
-------------
sentence: Ritalin may decrease the hypotensive effect of guanethidine. 
entities: Ritalin / guanethidine
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / coumarin anticoagulants
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / anticonvulsants
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / phenobarbital
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / diphenylhydantoin
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / primidone
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / phenylbutazone
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / tricyclic drugs
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / imipramine
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / clomipramine
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine). 
entities: Ritalin / desipramine
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: INOmax has been administered with tolazoline, dopamine, dobutamine, steroids, surfactant, and high-frequency ventilation.
entities: INOmax / tolazoline
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: INOmax has been administered with tolazoline, dopamine, dobutamine, steroids, surfactant, and high-frequency ventilation.
entities: INOmax / dopamine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: INOmax has been administered with tolazoline, dopamine, dobutamine, steroids, surfactant, and high-frequency ventilation.
entities: INOmax / dobutamine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: INOmax has been administered with tolazoline, dopamine, dobutamine, steroids, surfactant, and high-frequency ventilation.
entities: INOmax / steroids
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: INOmax has been administered with tolazoline, dopamine, dobutamine, steroids, surfactant, and high-frequency ventilation.
entities: INOmax / surfactant
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including sodium nitroprusside and nitroglycerin, may have an additive effect with INOmax on the risk of developing methemoglobinemia.
entities: nitric oxide donor compounds / INOmax
ddi: effect
>>> match: evaluate_obj_dep
-------------
sentence: Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including sodium nitroprusside and nitroglycerin, may have an additive effect with INOmax on the risk of developing methemoglobinemia.
entities: sodium nitroprusside / INOmax
ddi: effect
>>> match: evaluate_obj_dep
-------------
sentence: Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including sodium nitroprusside and nitroglycerin, may have an additive effect with INOmax on the risk of developing methemoglobinemia.
entities: nitroglycerin / INOmax
ddi: effect
>>> match: evaluate_obj_dep
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / acetaminophen
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Tylenol
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / antibiotics
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / ampicillin
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / tetracycline
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / anticonvulsants
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Dilantin
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Phenobarbital
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Tegretol
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Trileptal
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Topamax
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Felbatol
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / antifungals
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Gris-PEG
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Nizoral
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Sporanox
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / atorvastatin
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Lipitor
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / clofibrate
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Atromid-S
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / cyclosporine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Neoral
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Sandimmune
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / protease inhibitors
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Agenerase
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Crixivan
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Fortovase
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Invirase
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Kaletra
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Norvir
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Viracept
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / morphine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Astramorph
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Kadian
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / MS Contin
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / phenylbutazone
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / prednisolone
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Prelone
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / rifadin
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / rifampin
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / temazepam
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / theophylline
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / Theo-Dur
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Etonogestrel may interact with the following medications: acetaminophen (Tylenol), antibiotics such as ampicillin and tetracycline, anticonvulsants (Dilantin, Phenobarbital, Tegretol, Trileptal, Topamax, Felbatol), antifungals (Gris-PEG, Nizoral, Sporanox), atorvastatin (Lipitor), clofibrate (Atromid-S), cyclosporine (Neoral, Sandimmune), HIV drugs classified as protease inhibitors (Agenerase, Crixivan, Fortovase, Invirase, Kaletra, Norvir, Viracept), morphine (Astramorph, Kadian, MS Contin), phenylbutazone, prednisolone (Prelone), rifadin (rifampin), St. Johns wort, temazepam, theophylline (Theo-Dur), and vitamin C.
entities: Etonogestrel / vitamin C
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: The authors examined the effect of the cyclooxygenase-2 (COX-2) inhibitor, rofecoxib, at steady state on the pharmacokinetics of digoxin following a single dose in healthy subjects. 
entities: rofecoxib / digoxin
ddi: null
>>> match: examine_obj_obl
-------------
sentence: Samples for plasma and urine immunoreactive digoxin concentrations were collected through 120 hours following the digoxin dose. 
entities: digoxin / digoxin
ddi: null
>>> match: collect_nsubj:pass_obl
-------------
sentence: Scopolamine should be used with care in patients taking other drugs that are capable of causing CNS effects such as sedatives, tranquilizers, or alcohol. 
entities: Scopolamine / sedatives
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Scopolamine should be used with care in patients taking other drugs that are capable of causing CNS effects such as sedatives, tranquilizers, or alcohol. 
entities: Scopolamine / tranquilizers
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Scopolamine should be used with care in patients taking other drugs that are capable of causing CNS effects such as sedatives, tranquilizers, or alcohol. 
entities: Scopolamine / alcohol
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: CONCLUSIONS: In contrast to the effects of glucocorticoids in rodent studies, these results indicate that an acute increase in cortisol does not enhance the psychostimulant effects of d-amphetamine in humans.
entities: glucocorticoids / d-amphetamine
ddi: null
>>> match: indicate_obl_ccomp
-------------
sentence: Metformin: In healthy subjects given single 500 mg doses of cephalexin and metformin, plasma metformin mean cmax and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%.
entities: cephalexin / metformin
ddi: null
>>> match: mean_obl_nsubj
-------------
sentence: Metformin: In healthy subjects given single 500 mg doses of cephalexin and metformin, plasma metformin mean cmax and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%.
entities: cephalexin / metformin
ddi: null
>>> match: mean_obl_ccomp
-------------
sentence: Metformin: In healthy subjects given single 500 mg doses of cephalexin and metformin, plasma metformin mean cmax and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%.
entities: metformin / metformin
ddi: null
>>> match: mean_obl_nsubj
-------------
sentence: Metformin: In healthy subjects given single 500 mg doses of cephalexin and metformin, plasma metformin mean cmax and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%.
entities: metformin / metformin
ddi: null
>>> match: mean_obl_ccomp
-------------
sentence: Metformin: In healthy subjects given single 500 mg doses of cephalexin and metformin, plasma metformin mean cmax and AUC increased by an average of 34% and 24%, respectively, and metformin mean renal clearance decreased by 14%.
entities: metformin / metformin
ddi: null
>>> match: mean_nsubj_ccomp
-------------
sentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.
entities: metformin / cephalexin
ddi: null
>>> match: recommend_nsubj:pass_obl
-------------
sentence: Accordingly, careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin.
entities: metformin / metformin
ddi: null
>>> match: recommend_nsubj:pass_obl
-------------
sentence: Probenecid: As with other b-lactams, the renal excretion of cephalexin is inhibited by probenecid.
entities: b-lactams / cephalexin
ddi: null
>>> match: inhibit_obl_nsubj:pass
-------------
sentence: Probenecid: As with other b-lactams, the renal excretion of cephalexin is inhibited by probenecid.
entities: b-lactams / probenecid
ddi: null
>>> match: inhibit_obl_obl
-------------
sentence: Probenecid: As with other b-lactams, the renal excretion of cephalexin is inhibited by probenecid.
entities: cephalexin / probenecid
ddi: mechanism
>>> match: inhibit_nsubj:pass_obl
-------------
sentence: Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity.
entities: Lithium / diuretics
ddi: mechanism
>>> match: give_nsubj:pass_obl
-------------
sentence: Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity.
entities: Lithium / lithium
ddi: null
>>> match: give_nsubj:pass_advcl
-------------
sentence: Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity.
entities: diuretics / lithium
ddi: null
>>> match: give_obl_advcl
-------------
sentence: EDECRIN may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics.
entities: EDECRIN / aminoglycoside
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: EDECRIN may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics.
entities: EDECRIN / cephalosporin antibiotics
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: A number of drugs, including ethacrynic acid, have been shown to displace warfarin from plasma protein;
entities: ethacrynic acid / warfarin
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: In some patients, the administration of a non- steroidal antiinflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium- sparing and thiazide diuretics.
entities: non- steroidal antiinflammatory agent / potassium- sparing diuretics
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: In some patients, the administration of a non- steroidal antiinflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium- sparing and thiazide diuretics.
entities: non- steroidal antiinflammatory agent / thiazide diuretics
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Therefore, when EDECRIN and non- steroidal anti- inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.
entities: EDECRIN / diuretic
ddi: null
>>> match: observe_advcl_xcomp
-------------
sentence: Therefore, when EDECRIN and non- steroidal anti- inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.
entities: non- steroidal anti- inflammatory agents / diuretic
ddi: null
>>> match: observe_advcl_xcomp
-------------
sentence: Chlorthalidone may add to or potentiate the action of other antihypertensive drugs.
entities: Chlorthalidone / antihypertensive drugs
ddi: effect
>>> match: add_nsubj_obl
-------------
sentence: Chlorthalidone and related drugs may increase the responsiveness to tubocurarine.
entities: Chlorthalidone / tubocurarine
ddi: effect
>>> match: increase_nsubj_obl
-------------
sentence: Chlorthalidone and related drugs may decrease arterial responsiveness to norepinephrine.
entities: Chlorthalidone / norepinephrine
ddi: effect
>>> match: decrease_nsubj_obl
-------------
sentence: The hypotensive effect of sodium nitroprusside is augmented by that of most other hypotensive drugs, including ganglionic blocking agents, negative inotropic agents, and inhaled anesthetics.
entities: sodium nitroprusside / hypotensive drugs
ddi: effect
>>> match: augment_nsubj:pass_obl
-------------
sentence: The hypotensive effect of sodium nitroprusside is augmented by that of most other hypotensive drugs, including ganglionic blocking agents, negative inotropic agents, and inhaled anesthetics.
entities: sodium nitroprusside / ganglionic blocking agents
ddi: effect
>>> match: augment_nsubj:pass_obl
-------------
sentence: The hypotensive effect of sodium nitroprusside is augmented by that of most other hypotensive drugs, including ganglionic blocking agents, negative inotropic agents, and inhaled anesthetics.
entities: sodium nitroprusside / anesthetics
ddi: effect
>>> match: augment_nsubj:pass_obl
-------------
sentence: Anticoagulants Anabolic steroids may increase sensitivity to oral anticoagulants. 
entities: Anticoagulants / anticoagulants
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Anticoagulants Anabolic steroids may increase sensitivity to oral anticoagulants. 
entities: Anabolic steroids / anticoagulants
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Warfarin: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected. 
entities: oxandrolone / S-warfarin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Warfarin: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected. 
entities: oxandrolone / R-warfarin
ddi: null
>>> match: result_nsubj_parataxis
-------------
sentence: Warfarin: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected. 
entities: warfarin / S-warfarin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Warfarin: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected. 
entities: warfarin / R-warfarin
ddi: null
>>> match: result_nsubj_parataxis
-------------
sentence: Warfarin: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected. 
entities: S-warfarin / R-warfarin
ddi: null
>>> match: result_obl_parataxis
-------------
sentence: When oxandrolone therapy is initiated in a patient already receiving treatment with warfarin, the INR or prothrombin time (PT) should be monitored closely and the dose of warfarin adjusted as necessary until a stable target INR or PT has been achieved. 
entities: oxandrolone / warfarin
ddi: advise
>>> match: initiate_nsubj:pass_obl
-------------
sentence: When oxandrolone therapy is initiated in a patient already receiving treatment with warfarin, the INR or prothrombin time (PT) should be monitored closely and the dose of warfarin adjusted as necessary until a stable target INR or PT has been achieved. 
entities: oxandrolone / warfarin
ddi: null
>>> match: monitor_advcl_conj
-------------
sentence: When oxandrolone therapy is initiated in a patient already receiving treatment with warfarin, the INR or prothrombin time (PT) should be monitored closely and the dose of warfarin adjusted as necessary until a stable target INR or PT has been achieved. 
entities: warfarin / warfarin
ddi: null
>>> match: monitor_advcl_conj
-------------
sentence: Oral hypoglycemic agents Oxandrolone may inhibit the metabolism of oral hypoglycemic agents. 
entities: hypoglycemic agents / hypoglycemic agents
ddi: null
>>> match: inhibit_nsubj_obj
-------------
sentence: Oral hypoglycemic agents Oxandrolone may inhibit the metabolism of oral hypoglycemic agents. 
entities: Oxandrolone / hypoglycemic agents
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / alcohol
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / CNS depressants
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / antihistamines
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / anticholinergics
ddi: int
>>> match: interact_nsubj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / antihistamines
ddi: null
>>> match: interact_nsubj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / monoamine oxidase (MAO) inhibitors
ddi: int
>>> match: interact_nsubj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / antihistamines
ddi: null
>>> match: interact_nsubj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / antihistamines
ddi: null
>>> match: interact_nsubj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / antihistamines
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / anticholinergics
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / antihistamines
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / anticholinergics
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / anticholinergics
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: anticholinergics / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_conj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: anticholinergics / antihistamines
ddi: null
>>> match: interact_conj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: anticholinergics / antihistamines
ddi: null
>>> match: interact_conj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_conj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_conj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_conj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: prolong_nsubj_obj
-------------
sentence: MAO inhibitors prolong and intensify the anticholinergic effects of antihistamines.
entities: MAO inhibitors / antihistamines
ddi: effect
>>> match: prolong_nsubj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: Antihistamines / alcohol
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: Antihistamines / CNS depressants
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: Antihistamines / hypnotics
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: Antihistamines / sedatives
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: Antihistamines / tranquilizers
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: Antihistamines / antianxiety agents
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: alcohol / hypnotics
ddi: null
>>> match: have_obj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: alcohol / sedatives
ddi: null
>>> match: have_obj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: alcohol / tranquilizers
ddi: null
>>> match: have_obj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: alcohol / antianxiety agents
ddi: null
>>> match: have_obj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: CNS depressants / hypnotics
ddi: null
>>> match: have_obj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: CNS depressants / sedatives
ddi: null
>>> match: have_obj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: CNS depressants / tranquilizers
ddi: null
>>> match: have_obj_obj
-------------
sentence: Antihistamines may have additive effects with alcohol and other CNS depressants, e.g., hypnotics, sedatives, tranquilizers, antianxiety agents.
entities: CNS depressants / antianxiety agents
ddi: null
>>> match: have_obj_obj
-------------
sentence: Administration of valproic acid decreases oral clearance of temozolomide by about 5%. 
entities: valproic acid / temozolomide
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Diuretics: Patients on diuretics, and especially those started recently, may occasionally experience an excessive reduction of blood pressure after initiation of ACEON    Tablets therapy. 
entities: diuretics / ACEON
ddi: effect
>>> match: experience_nsubj_obl
-------------
sentence: The possibility of hypotensive effects can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with perindopril. 
entities: diuretic / perindopril
ddi: effect
>>> match: discontinue_obj_conj
-------------
sentence: If diuretics cannot be interrupted, close medical supervision should be provided with the first dose of ACEON    Tablets, for at least two hours and until blood pressure has stabilized for another hour. 
entities: diuretics / ACEON
ddi: advise
>>> match: provide_advcl_obl
-------------
sentence: The bioavailability of perindoprilat was reduced by diuretics, however, and this was associated with a decrease in plasma ACE inhibition. 
entities: perindoprilat / diuretics
ddi: null
>>> match: reduce_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy. 
entities: lithium / lithium
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy. 
entities: lithium / lithium
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Use of a diuretic may further increase the risk of lithium toxicity. 
entities: diuretic / lithium
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded. 
entities: digoxin / ACEON
ddi: null
>>> match: show_obj_advcl
-------------
sentence: Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded. 
entities: digoxin / digoxin
ddi: null
>>> match: show_obj_advcl
-------------
sentence: Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded. 
entities: digoxin / perindopril
ddi: null
>>> match: show_obj_advcl
-------------
sentence: Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded. 
entities: digoxin / perindoprilat
ddi: null
>>> match: show_obj_advcl
-------------
sentence: Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded. 
entities: ACEON / digoxin
ddi: null
>>> match: coadminister_obl_conj
-------------
sentence: Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded. 
entities: ACEON / perindopril
ddi: null
>>> match: coadminister_obl_conj
-------------
sentence: Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded. 
entities: ACEON / perindoprilat
ddi: null
>>> match: coadminister_obl_conj
-------------
sentence: Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of zidovudine or rifabutin to warrant dosage adjustment when megestrol acetate is administered with these drugs. 
entities: zidovudine / megestrol acetate
ddi: null
>>> match: warrant_nsubj_advcl
-------------
sentence: Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of zidovudine or rifabutin to warrant dosage adjustment when megestrol acetate is administered with these drugs. 
entities: rifabutin / megestrol acetate
ddi: null
>>> match: warrant_nsubj_advcl
-------------
sentence: Administration of a higher dose of indinavir should be considered when coadministering with megestrol acetate. 
entities: indinavir / megestrol acetate
ddi: advise
>>> match: consider_nsubj:pass_xcomp
-------------
sentence: Taking amyl nitrite after drinking alcohol may worsen side effects and may cause severe hypotension and cardiovascular collapse.
entities: amyl nitrite / alcohol
ddi: effect
>>> match: take_obj_advcl
-------------
sentence: Sulfamethizole may increase the effects of barbiturates, tolbutamide, and uricosurics. 
entities: Sulfamethizole / barbiturates
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Sulfamethizole may increase the effects of barbiturates, tolbutamide, and uricosurics. 
entities: Sulfamethizole / tolbutamide
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Sulfamethizole may increase the effects of barbiturates, tolbutamide, and uricosurics. 
entities: Sulfamethizole / uricosurics
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: When warfarin is co-administered with nevirapine, anticoagulation levels should be monitored frequently.
entities: warfarin / nevirapine
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Clarithromycin exposure was significantly decreased by nevirapine;
entities: Clarithromycin / nevirapine
ddi: mechanism
>>> match: decrease_nsubj:pass_obl
-------------
sentence: Oral contraceptives and other hormonalmethods of birth control should not be usedas the sole method of contraception inwomen taking nevirapine, since nevirapinemay lower the plasma levels of thesemedications.
entities: contraceptives / nevirapine
ddi: advise
>>> match: useda_nsubj_obj
-------------
sentence: A dose increase of lopinavir/ritonavir to 533/133 mg twice daily with food isrecommended in combination with nevirapine.
entities: lopinavir / nevirapine
ddi: advise
>>> match: isrecommend_nsubj_obl
-------------
sentence: A dose increase of lopinavir/ritonavir to 533/133 mg twice daily with food isrecommended in combination with nevirapine.
entities: ritonavir / nevirapine
ddi: advise
>>> match: isrecommend_nsubj_obl
-------------
sentence: Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.
entities: Methadone / opiate
ddi: null
>>> match: decrease_nsubj:pass_parataxis
-------------
sentence: Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.
entities: Methadone / Methadone
ddi: null
>>> match: decrease_nsubj:pass_parataxis
-------------
sentence: Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.
entities: Methadone / nevirapine
ddi: null
>>> match: decrease_nsubj:pass_parataxis
-------------
sentence: Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.
entities: Methadone / methadone
ddi: null
>>> match: decrease_nsubj:pass_parataxis
-------------
sentence: Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.
entities: opiate / Methadone
ddi: null
>>> match: decrease_parataxis_parataxis
-------------
sentence: Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.
entities: opiate / nevirapine
ddi: null
>>> match: decrease_parataxis_parataxis
-------------
sentence: Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.
entities: opiate / methadone
ddi: null
>>> match: decrease_parataxis_parataxis
-------------
sentence: Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.
entities: Methadone / nevirapine
ddi: advise
>>> match: maintain_nsubj_obj
-------------
sentence: Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.
entities: Methadone / methadone
ddi: null
>>> match: decrease_parataxis_parataxis
-------------
sentence: Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.
entities: nevirapine / methadone
ddi: null
>>> match: decrease_parataxis_parataxis
-------------
sentence: aBased on reports of narcotic withdrawal syndrome in patients treated with nevirapine and methadone concurrently, and evidence of decreased plasma concentrations of methadone.
entities: nevirapine / methadone
ddi: null
>>> match: abase_obl_conj
-------------
sentence: aBased on reports of narcotic withdrawal syndrome in patients treated with nevirapine and methadone concurrently, and evidence of decreased plasma concentrations of methadone.
entities: methadone / methadone
ddi: null
>>> match: abase_obl_conj
-------------
sentence: SKELAXIN may enhance the effects of alcohol, barbiturates and other CNS depressants.
entities: SKELAXIN / alcohol
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: SKELAXIN may enhance the effects of alcohol, barbiturates and other CNS depressants.
entities: SKELAXIN / barbiturates
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: SKELAXIN may enhance the effects of alcohol, barbiturates and other CNS depressants.
entities: SKELAXIN / CNS depressants
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: In vitro studies have shown CASODEX can displace coumarin anticoagulants, such as warfarin, from their protein-binding sites.
entities: CASODEX / coumarin anticoagulants
ddi: mechanism
>>> match: show_obj_dep
-------------
sentence: In vitro studies have shown CASODEX can displace coumarin anticoagulants, such as warfarin, from their protein-binding sites.
entities: CASODEX / warfarin
ddi: mechanism
>>> match: show_obj_dep
-------------
sentence: It is recommended that if CASODEX is started in patients already receiving coumarin anticoagulants, prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary.
entities: CASODEX / coumarin anticoagulants
ddi: advise
>>> match: start_nsubj:pass_obl
-------------
sentence: It is recommended that if CASODEX is started in patients already receiving coumarin anticoagulants, prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary.
entities: CASODEX / anticoagulant
ddi: advise
>>> match: monitor_advcl_conj
-------------
sentence: It is recommended that if CASODEX is started in patients already receiving coumarin anticoagulants, prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary.
entities: coumarin anticoagulants / anticoagulant
ddi: null
>>> match: monitor_advcl_conj
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: anticholinergic / AKINETON
ddi: null
>>> match: occur_nsubj_advcl
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: anticholinergic / narcotic analgesics
ddi: effect
>>> match: occur_nsubj_advcl
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: anticholinergic / meperidine
ddi: effect
>>> match: occur_nsubj_advcl
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: anticholinergic / phenothiazines
ddi: effect
>>> match: occur_nsubj_advcl
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: anticholinergic / antipsychotics
ddi: effect
>>> match: occur_nsubj_advcl
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: anticholinergic / tricyclic antidepressants
ddi: effect
>>> match: occur_nsubj_advcl
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: anticholinergic / antiarrhythmics
ddi: effect
>>> match: occur_nsubj_advcl
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: anticholinergic / quinidine
ddi: effect
>>> match: occur_nsubj_advcl
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: anticholinergic / antihistamines
ddi: effect
>>> match: occur_nsubj_advcl
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / narcotic analgesics
ddi: effect
>>> match: administer_nsubj:pass_dep
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / meperidine
ddi: effect
>>> match: administer_nsubj:pass_dep
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / phenothiazines
ddi: effect
>>> match: administer_nsubj:pass_dep
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / antipsychotics
ddi: effect
>>> match: administer_nsubj:pass_dep
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / tricyclic antidepressants
ddi: effect
>>> match: administer_nsubj:pass_dep
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / antiarrhythmics
ddi: effect
>>> match: administer_nsubj:pass_dep
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / quinidine
ddi: effect
>>> match: administer_nsubj:pass_dep
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / antihistamines
ddi: effect
>>> match: administer_nsubj:pass_dep
-------------
sentence: Coumarin-Derivative Anticoagulants: Prolongation of prothrombin time (PT) and International Normalized Ratio (INR) were observed in patients receiving ZOLINZA concomitantly with coumarin-derivative anticoagulants. 
entities: Coumarin-Derivative Anticoagulants / ZOLINZA
ddi: null
>>> match: observe_nsubj:pass_obl
-------------
sentence: Coumarin-Derivative Anticoagulants: Prolongation of prothrombin time (PT) and International Normalized Ratio (INR) were observed in patients receiving ZOLINZA concomitantly with coumarin-derivative anticoagulants. 
entities: Coumarin-Derivative Anticoagulants / coumarin-derivative anticoagulants
ddi: null
>>> match: observe_nsubj:pass_obl
-------------
sentence: Coumarin-Derivative Anticoagulants: Prolongation of prothrombin time (PT) and International Normalized Ratio (INR) were observed in patients receiving ZOLINZA concomitantly with coumarin-derivative anticoagulants. 
entities: ZOLINZA / coumarin-derivative anticoagulants
ddi: effect
>>> match: receive_obj_obl
-------------
sentence: Other HDAC Inhibitors Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ZOLINZA and other HDAC inhibitors (e.g., valproic acid). 
entities: HDAC Inhibitors / ZOLINZA
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Other HDAC Inhibitors Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ZOLINZA and other HDAC inhibitors (e.g., valproic acid). 
entities: HDAC Inhibitors / HDAC inhibitors
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Other HDAC Inhibitors Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ZOLINZA and other HDAC inhibitors (e.g., valproic acid). 
entities: HDAC Inhibitors / valproic acid
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.
entities: CNS depressant drugs / INAPSINE
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.
entities: barbiturates / INAPSINE
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.
entities: tranquilizers / INAPSINE
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.
entities: opioids / INAPSINE
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Other CNS depressant drugs (e.g. barbiturates, tranquilizers, opioids and general anesthetics) have additive or potentiating effects with INAPSINE.
entities: anesthetics / INAPSINE
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Following the administration of INAPSINE, the dose of other CNS depressant drugs should be reduced.
entities: INAPSINE / CNS depressant drugs
ddi: advise
>>> match: reduce_obl_nsubj:pass
-------------
sentence: Coadministration of terfenadine with Itraconazole has led to elevated plasma concentrations of terfenadine, resulting in rare instances of life- threatening cardiac dysrhythmias and one death.
entities: terfenadine / terfenadine
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: Coadministration of terfenadine with Itraconazole has led to elevated plasma concentrations of terfenadine, resulting in rare instances of life- threatening cardiac dysrhythmias and one death.
entities: Itraconazole / terfenadine
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: In vitro data suggest that itraconazole, when compared to ketoconazole, has a less pronounced effect on the biotransformation system responsible for the metabolism of astemizole.
entities: ketoconazole / astemizole
ddi: null
>>> match: have_advcl_obj
-------------
sentence: Based on the chemical resemblance of itraconazole and ketoconazole, coadministration of astemizole with itraconazole is contraindicated.
entities: itraconazole / astemizole
ddi: null
>>> match: contraindicate_advcl_nsubj:pass
-------------
sentence: Based on the chemical resemblance of itraconazole and ketoconazole, coadministration of astemizole with itraconazole is contraindicated.
entities: itraconazole / itraconazole
ddi: null
>>> match: contraindicate_advcl_nsubj:pass
-------------
sentence: Based on the chemical resemblance of itraconazole and ketoconazole, coadministration of astemizole with itraconazole is contraindicated.
entities: ketoconazole / astemizole
ddi: null
>>> match: contraindicate_advcl_nsubj:pass
-------------
sentence: Based on the chemical resemblance of itraconazole and ketoconazole, coadministration of astemizole with itraconazole is contraindicated.
entities: ketoconazole / itraconazole
ddi: null
>>> match: contraindicate_advcl_nsubj:pass
-------------
sentence: Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in an eight-fold increase in the mean AUC of cisapride.
entities: ketoconazole / cisapride
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in an eight-fold increase in the mean AUC of cisapride.
entities: ketoconazole / cisapride
ddi: null
>>> match: inhibit_nsubj_obj
-------------
sentence: In vitro data suggest that itraconazole also markedly inhibits the biotransformation system mainly responsible for the metabolism of cisapride;
entities: itraconazole / cisapride
ddi: mechanism
>>> match: inhibit_nsubj_xcomp
-------------
sentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.
entities: Cyclosporine / Itraconazole
ddi: advise
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.
entities: tacrolimus / Itraconazole
ddi: advise
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Cyclosporine, tacrolimus and digoxin concentrations should be monitored at the initiation of Itraconazole therapy and frequently thereafter, and the dose of these three drug products adjusted appropriately.
entities: digoxin / Itraconazole
ddi: advise
>>> match: monitor_nsubj:pass_obl
-------------
sentence: When Itraconazole was coadministered with phenytoin, rifampin, or H2antagonists, reduced plasma concentrations of itraconazole were reported.
entities: Itraconazole / phenytoin
ddi: mechanism
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: When Itraconazole was coadministered with phenytoin, rifampin, or H2antagonists, reduced plasma concentrations of itraconazole were reported.
entities: Itraconazole / rifampin
ddi: mechanism
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: When Itraconazole was coadministered with phenytoin, rifampin, or H2antagonists, reduced plasma concentrations of itraconazole were reported.
entities: Itraconazole / itraconazole
ddi: null
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: The physician is advised to monitor the plasma concentrations of itraconazole when any of these drugs is taken concurrently, and to increase the dose of Itraconazole if necessary.
entities: itraconazole / Itraconazole
ddi: null
>>> match: monitor_obj_advcl
-------------
sentence: Although no studies have been conducted, concomitant administration of Itraconazole and phenytoin may alter the metabolism of phenytoin;
entities: Itraconazole / phenytoin
ddi: null
>>> match: alter_nsubj_obj
-------------
sentence: Although no studies have been conducted, concomitant administration of Itraconazole and phenytoin may alter the metabolism of phenytoin;
entities: phenytoin / phenytoin
ddi: null
>>> match: alter_nsubj_obj
-------------
sentence: therefore, plasma concentrations of phenytoin should also be monitored when it is given concurrently with Itraconazole.
entities: phenytoin / Itraconazole
ddi: advise
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: It has been reported that Itraconazole enhances the anticoagulant effect of coumarin-like drugs.
entities: Itraconazole / coumarin
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Plasma concentrations of azole antifungal agents are reduced when given concurrently with isoniazid.
entities: azole antifungal agents / isoniazid
ddi: mechanism
>>> match: reduce_nsubj:pass_advcl
-------------
sentence: Itraconazole plasma concentrations should be monitored when Itraconazole and isoniazid are coadministered.
entities: Itraconazole / Itraconazole
ddi: null
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: Itraconazole plasma concentrations should be monitored when Itraconazole and isoniazid are coadministered.
entities: Itraconazole / isoniazid
ddi: null
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: The results from a study in which eight HIV-infected individuals were treated with zidovudine, 8 +/- 0.4 mg/kg/day, showed that the pharmacokinetics of zidovudine were not affected during concomitant administration of Itraconazole, 100 mg b.i.d.
entities: zidovudine / zidovudine
ddi: null
>>> match: show_nsubj_ccomp
-------------
sentence: The results from a study in which eight HIV-infected individuals were treated with zidovudine, 8 +/- 0.4 mg/kg/day, showed that the pharmacokinetics of zidovudine were not affected during concomitant administration of Itraconazole, 100 mg b.i.d.
entities: zidovudine / Itraconazole
ddi: null
>>> match: show_nsubj_ccomp
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / alcohol
ddi: effect
>>> match: interact_nsubj_obl
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / CNS depressants
ddi: effect
>>> match: interact_nsubj_obl
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / antihistamines
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / anticholinergics
ddi: effect
>>> match: interact_nsubj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / antihistamines
ddi: null
>>> match: interact_nsubj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / monoamine oxidase (MAO) inhibitors
ddi: effect
>>> match: interact_nsubj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / antihistamines
ddi: null
>>> match: interact_nsubj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: Dexbrompheniramine / antihistamines
ddi: null
>>> match: interact_nsubj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / antihistamines
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / anticholinergics
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / antihistamines
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / anticholinergics
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / anticholinergics
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: anticholinergics / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_conj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: anticholinergics / antihistamines
ddi: null
>>> match: interact_conj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: anticholinergics / antihistamines
ddi: null
>>> match: interact_conj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_conj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_conj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_conj_conj
-------------
sentence: Dexbrompheniramine can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: prolong_nsubj_obj
-------------
sentence: Suppression by verapamil of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in wistar rats.

entities: verapamil / azoxymethane
ddi: null
>>> match: induce_nsubj_obl
-------------
sentence: Suppression by verapamil of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in wistar rats.

entities: bombesin / azoxymethane
ddi: null
>>> match: induce_nsubj_obl
-------------
sentence: METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of AOM (7.4 mg/kg body weight) and subcutaneous injections of bombesin (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of verapamil (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45. 
entities: AOM / verapamil
ddi: null
>>> match: give_obj_dep
-------------
sentence: METHODS: From the beginning of the experiment, rats were given 10 weekly subcutaneous injections of AOM (7.4 mg/kg body weight) and subcutaneous injections of bombesin (40 microg/kg body weight) every other day, and from week 16, intraperitoneal injections of verapamil (10 or 20 mg/kg body weight) every other day until the end fo the experiment in week 45. 
entities: bombesin / verapamil
ddi: null
>>> match: give_obj_dep
-------------
sentence: Although verapamil administered at either dose had little or no effect on the enhancement of intestinal carcinogenesis by bombesin or on the location, histologic type, depth of involvement, labeling index, apoptotic index or tumor vascularity of intestinal cancers, it significantly decreased the incidence of cancer metastasis. 
entities: verapamil / bombesin
ddi: null
>>> match: administer_nsubj_dep
-------------
sentence: Verapamil also significantly decreased the incidence of lymphatic invasion of adenocarcinomas, which was enhanced by bombesin. 
entities: Verapamil / bombesin
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of theophylline, digoxin or an ethinylestradiol/levonorgestrol oral contraceptive product in healthy subjects.
entities: FACTIVE / theophylline
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of theophylline, digoxin or an ethinylestradiol/levonorgestrol oral contraceptive product in healthy subjects.
entities: FACTIVE / digoxin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of theophylline, digoxin or an ethinylestradiol/levonorgestrol oral contraceptive product in healthy subjects.
entities: FACTIVE / ethinylestradiol
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Administration of repeat doses of FACTIVE had no effect on the repeat dose pharmacokinetics of theophylline, digoxin or an ethinylestradiol/levonorgestrol oral contraceptive product in healthy subjects.
entities: FACTIVE / contraceptive product
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: FACTIVE / gemifloxacin
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: calcium carbonate / gemifloxacin
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: cimetidine / gemifloxacin
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: omeprazole / gemifloxacin
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: estrogen / gemifloxacin
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: progesterone / gemifloxacin
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Concomitant administration of FACTIVE and calcium carbonate, cimetidine, omeprazole, or an estrogen/progesterone oral contraceptive produced minor changes in the pharmacokinetics of gemifloxacin, which were considered to be without clinical significance.
entities: contraceptive / gemifloxacin
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Concomitant administration of FACTIVE with probenecid resulted in a 45% increase in systemic exposure to gemifloxacin.
entities: FACTIVE / gemifloxacin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Concomitant administration of FACTIVE with probenecid resulted in a 45% increase in systemic exposure to gemifloxacin.
entities: probenecid / gemifloxacin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: FACTIVE had no significant effect on the anticoagulant effect of warfarin in healthy subjects on stable warfarin therapy.
entities: FACTIVE / warfarin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: FACTIVE had no significant effect on the anticoagulant effect of warfarin in healthy subjects on stable warfarin therapy.
entities: FACTIVE / warfarin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: However, because some quinolones have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with warfarin or its derivatives.
entities: quinolones / warfarin
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: However, because some quinolones have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with warfarin or its derivatives.
entities: quinolones / quinolone antimicrobial
ddi: null
>>> match: monitor_advcl_advcl
-------------
sentence: However, because some quinolones have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with warfarin or its derivatives.
entities: quinolones / warfarin
ddi: null
>>> match: monitor_advcl_advcl
-------------
sentence: However, because some quinolones have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with warfarin or its derivatives.
entities: warfarin / quinolone antimicrobial
ddi: null
>>> match: monitor_advcl_advcl
-------------
sentence: However, because some quinolones have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with warfarin or its derivatives.
entities: warfarin / warfarin
ddi: null
>>> match: monitor_advcl_advcl
-------------
sentence: However, because some quinolones have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with warfarin or its derivatives.
entities: quinolone antimicrobial / warfarin
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: The absorption of oral gemifloxacin is significantly reduced by the concomitant administration of an antacid containing aluminum and magnesium.
entities: gemifloxacin / antacid
ddi: null
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The absorption of oral gemifloxacin is significantly reduced by the concomitant administration of an antacid containing aluminum and magnesium.
entities: gemifloxacin / aluminum
ddi: mechanism
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The absorption of oral gemifloxacin is significantly reduced by the concomitant administration of an antacid containing aluminum and magnesium.
entities: gemifloxacin / magnesium
ddi: mechanism
>>> match: reduce_nsubj:pass_obl
-------------
sentence: Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.
entities: Magnesium / FACTIVE
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.
entities: aluminum / FACTIVE
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.
entities: antacids / FACTIVE
ddi: null
>>> match: take_nsubj:pass_obl
-------------
sentence: Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.
entities: ferrous sulfate / FACTIVE
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.
entities: iron / FACTIVE
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.
entities: multivitamin preparations / FACTIVE
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.
entities: zinc / FACTIVE
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.
entities: Videx / FACTIVE
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Magnesium- and/or aluminum-containing antacids, products containing ferrous sulfate (iron), multivitamin preparations containing zinc or other metal cations, or Videx (didanosine) chewable/buffered tablets or the pediatric powder for oral solution should not be taken within 3 hours before or 2 hours after FACTIVE.
entities: didanosine / FACTIVE
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Sucralfate should not be taken within 2 hours of FACTIVE.
entities: Sucralfate / FACTIVE
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Vasoconstrictors: D.H.E. 45  (dihydroergotamine mesylate) Injection, USP should not be used with peripheral vasoconstrictors because the combination may cause synergistic elevation of blood pressure.
entities: dihydroergotamine mesylate / peripheral vasoconstrictors
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: Sumatriptan: Sumatriptan has been reported to cause coronary artery vasospasm, and its effect could be additive with D.H.E. 45  (dihydroergotamine mesylate) Injection, USP.
entities: Sumatriptan / dihydroergotamine mesylate
ddi: effect
>>> match: report_nsubj:pass_conj
-------------
sentence: Beta Blockers: Although the results of a clinical study did not indicate a safe problem associated with the administration of D.H.E. 45  (dihydroergotamine mesylate) Injection, USP to subjects already receiving propranolol, there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine.
entities: propranolol / ergotamine
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Nicotine: Nicotine may provoke vasoconstriction in some patients, predisposing to a greater ischemic response to ergot therapy.
entities: Nicotine / ergot
ddi: effect
>>> match: provoke_nsubj_dep
-------------
sentence: Macrolide Antibiotics (e. g. erythromycin and troleandomycin): Agents of the ergot alkaloid class, of which D.H.E. 45  (dihydroergotamine mesylate) Injection, USP is a member, have been shown to interact with antibiotics of the macrolide class, resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction.
entities: Macrolide Antibiotics / antibiotics
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Macrolide Antibiotics (e. g. erythromycin and troleandomycin): Agents of the ergot alkaloid class, of which D.H.E. 45  (dihydroergotamine mesylate) Injection, USP is a member, have been shown to interact with antibiotics of the macrolide class, resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction.
entities: Macrolide Antibiotics / macrolide class
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Macrolide Antibiotics (e. g. erythromycin and troleandomycin): Agents of the ergot alkaloid class, of which D.H.E. 45  (dihydroergotamine mesylate) Injection, USP is a member, have been shown to interact with antibiotics of the macrolide class, resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction.
entities: erythromycin / antibiotics
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Macrolide Antibiotics (e. g. erythromycin and troleandomycin): Agents of the ergot alkaloid class, of which D.H.E. 45  (dihydroergotamine mesylate) Injection, USP is a member, have been shown to interact with antibiotics of the macrolide class, resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction.
entities: erythromycin / macrolide class
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Macrolide Antibiotics (e. g. erythromycin and troleandomycin): Agents of the ergot alkaloid class, of which D.H.E. 45  (dihydroergotamine mesylate) Injection, USP is a member, have been shown to interact with antibiotics of the macrolide class, resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction.
entities: troleandomycin / antibiotics
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Macrolide Antibiotics (e. g. erythromycin and troleandomycin): Agents of the ergot alkaloid class, of which D.H.E. 45  (dihydroergotamine mesylate) Injection, USP is a member, have been shown to interact with antibiotics of the macrolide class, resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction.
entities: troleandomycin / macrolide class
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Macrolide Antibiotics (e. g. erythromycin and troleandomycin): Agents of the ergot alkaloid class, of which D.H.E. 45  (dihydroergotamine mesylate) Injection, USP is a member, have been shown to interact with antibiotics of the macrolide class, resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction.
entities: ergot alkaloid class / antibiotics
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Macrolide Antibiotics (e. g. erythromycin and troleandomycin): Agents of the ergot alkaloid class, of which D.H.E. 45  (dihydroergotamine mesylate) Injection, USP is a member, have been shown to interact with antibiotics of the macrolide class, resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction.
entities: ergot alkaloid class / macrolide class
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Macrolide Antibiotics (e. g. erythromycin and troleandomycin): Agents of the ergot alkaloid class, of which D.H.E. 45  (dihydroergotamine mesylate) Injection, USP is a member, have been shown to interact with antibiotics of the macrolide class, resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction.
entities: dihydroergotamine mesylate / antibiotics
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Macrolide Antibiotics (e. g. erythromycin and troleandomycin): Agents of the ergot alkaloid class, of which D.H.E. 45  (dihydroergotamine mesylate) Injection, USP is a member, have been shown to interact with antibiotics of the macrolide class, resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction.
entities: dihydroergotamine mesylate / macrolide class
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Vasospastic reactions have been reported with therapeutic doses of ergotamine-containing drugs when co-administered with these antibiotics.
entities: ergotamine / antibiotics
ddi: effect
>>> match: report_obl_advcl
-------------
sentence: SSRIs: Weakness hyperreflexia, and incoordination have been reported rarely when 5-HT1 agonists have been co-administered with SSRIs (e. g.
entities: 5-HT1 agonists / SSRIs
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Concurrent administration of a TNF antagonist with ORENCIA has been associated with an increased risk of serious infections and no significant additional efficacy over use of the TNF antagonists alone.
entities: TNF antagonist / TNF antagonists
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: Concurrent administration of a TNF antagonist with ORENCIA has been associated with an increased risk of serious infections and no significant additional efficacy over use of the TNF antagonists alone.
entities: ORENCIA / TNF antagonists
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.
entities: ORENCIA / anakinra
ddi: advise
>>> match: administer_nsubj_obl
-------------
sentence: Ethoxzolamide may increase the action of tricyclics, amphetamines, procainamide, and quinidine.
entities: Ethoxzolamide / tricyclics
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Ethoxzolamide may increase the action of tricyclics, amphetamines, procainamide, and quinidine.
entities: Ethoxzolamide / amphetamines
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Ethoxzolamide may increase the action of tricyclics, amphetamines, procainamide, and quinidine.
entities: Ethoxzolamide / procainamide
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Ethoxzolamide may increase the action of tricyclics, amphetamines, procainamide, and quinidine.
entities: Ethoxzolamide / quinidine
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: It may increase excretion of barbiturates, lithium, and ASA and may also increase the toxicity of salicylates.
entities: barbiturates / salicylates
ddi: null
>>> match: increase_obj_conj
-------------
sentence: It may increase excretion of barbiturates, lithium, and ASA and may also increase the toxicity of salicylates.
entities: lithium / salicylates
ddi: null
>>> match: increase_obj_conj
-------------
sentence: It may increase excretion of barbiturates, lithium, and ASA and may also increase the toxicity of salicylates.
entities: ASA / salicylates
ddi: null
>>> match: increase_obj_conj
-------------
sentence: Interactions for Vitamin B2 (Riboflavin):  Alcohol - impairs the intestinal absorption of riboflavin
entities: Alcohol / riboflavin
ddi: mechanism
>>> match: impair_nsubj_obj
-------------
sentence: Probenecid - concurrent use decreases gastrointestinal absorption of riboflavin; 
entities: Probenecid / riboflavin
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: requirements for riboflavin may be increased in patients receiving probenecid.
entities: riboflavin / probenecid
ddi: effect
>>> match: increase_nsubj:pass_obl
-------------
sentence: Aminoglycosides: The mixing of piperacillin with an aminoglycoside in vitro can result in substantial inactivation of the aminoglycoside.
entities: piperacillin / aminoglycoside
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Aminoglycosides: The mixing of piperacillin with an aminoglycoside in vitro can result in substantial inactivation of the aminoglycoside.
entities: aminoglycoside / aminoglycoside
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Vecuronium: When used in the perioperative period, piperacillin has been implicated in the prolongation of the neuromuscular blockade of vecuronium.
entities: piperacillin / vecuronium
ddi: effect
>>> match: implicate_nsubj:pass_obl
-------------
sentence: In one controlled clinical study, the ureidopenicillins, including piperacillin, were reported to prolong the action of vecuronium.
entities: piperacillin / vecuronium
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Due to their similar mechanism of action, it is expected that the neuromuscular blockade produced by any of the non-depolarizing muscle relaxants could be prolonged in the presence of piperacillin.
entities: non-depolarizing muscle relaxants / piperacillin
ddi: effect
>>> match: expect_ccomp_dep
-------------
sentence: Probenecid: The oral combination of probenecid before intramuscular injection of PIPRACIL produces an increase in piperacillin peak serum level of about 30%.
entities: probenecid / piperacillin
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Probenecid: The oral combination of probenecid before intramuscular injection of PIPRACIL produces an increase in piperacillin peak serum level of about 30%.
entities: PIPRACIL / piperacillin
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Anticoagulants: Coagulation parameters should be tested more frequently and monitored regularly during simultaneous administration of high doses of heparin, oral anticoagulants, or other drugs that may affect the blood coagulation system or the thrombocyte function.
entities: heparin / anticoagulants
ddi: null
>>> match: test_conj_conj
-------------
sentence: Methotrexate: Piperacillin sodium may reduce the excretion of methotrexate.
entities: Piperacillin sodium / methotrexate
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Diuretics: Patients on diuretics, especially those with intravascular volume depletion, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with fosinopril sodium.
entities: diuretics / fosinopril sodium
ddi: effect
>>> match: experience_nsubj_obl
-------------
sentence: The possibility of hypotensive effects can be minimized by either discontinuing the diuretic or increasing salt intake prior to initiation of treatment with fosinopril sodium.
entities: diuretic / fosinopril sodium
ddi: effect
>>> match: discontinue_obj_conj
-------------
sentence: Potassium Supplements and Potassium-Sparing Diuretics: Fosinopril sodium can attenuate potassium loss caused by thiazide diuretics.
entities: Fosinopril sodium / thiazide diuretics
ddi: effect
>>> match: attenuate_nsubj_dep
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.
entities: lithium / ACE inhibitors
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.
entities: lithium / lithium
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.
entities: lithium / ACE inhibitors
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.
entities: lithium / lithium
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.
entities: ACE inhibitors / lithium
ddi: effect
>>> match: receive_obj_obl
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: antacid / antacids
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: antacid / fosinopril
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: aluminum hydroxide / antacids
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: aluminum hydroxide / fosinopril
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: magnesium hydroxide / antacids
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: magnesium hydroxide / fosinopril
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: simethicone / antacids
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: simethicone / fosinopril
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: fosinopril / antacids
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: fosinopril / fosinopril
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: fosinoprilat / antacids
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: fosinoprilat / fosinopril
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: fosinopril / antacids
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: fosinopril / fosinopril
ddi: null
>>> match: suggest_nsubj_ccomp
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: antacids / fosinopril
ddi: mechanism
>>> match: impair_nsubj_obj
-------------
sentence: In a pharmacokinetic interaction study with warfarin, bioavailability parameters, the degree of protein binding, and the anticoagulant effect (measured by prothrombin time) of warfarin were not significantly changed.
entities: warfarin / warfarin
ddi: null
>>> match: change_obl_nsubj:pass
-------------
sentence: Drug/Laboratory Test Interaction Fosinopril may cause a false low measurement of serum digoxin levels with the Digi- Tab  RIA Kit for Digoxin.
entities: Fosinopril / digoxin
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: Drug/Laboratory Test Interaction Fosinopril may cause a false low measurement of serum digoxin levels with the Digi- Tab  RIA Kit for Digoxin.
entities: Fosinopril / Digoxin
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: TAMBOCOR has been administered to patients receiving digitalis preparations or beta-adrenergic blocking agents without adverse effects.
entities: TAMBOCOR / digitalis preparations
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: TAMBOCOR has been administered to patients receiving digitalis preparations or beta-adrenergic blocking agents without adverse effects.
entities: TAMBOCOR / beta-adrenergic blocking agents
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: During administration of multiple oral doses of TAMBOCOR to healthy subjects stabilized on a maintenance dose of digoxin, a 13%-19% increase in plasma digoxin levels occurred at six hours postdose.
entities: TAMBOCOR / digoxin
ddi: mechanism
>>> match: stabilize_obl_obl
-------------
sentence: During administration of multiple oral doses of TAMBOCOR to healthy subjects stabilized on a maintenance dose of digoxin, a 13%-19% increase in plasma digoxin levels occurred at six hours postdose.
entities: TAMBOCOR / digoxin
ddi: null
>>> match: stabilize_obl_obl
-------------
sentence: In a study involving healthy subjects receiving TAMBOCOR and propranolol concurrently, plasma flecainide levels were increased about 20% and propranolol levels were increased about 30% compared to control values.
entities: TAMBOCOR / flecainide
ddi: null
>>> match: increase_obl_nsubj:pass
-------------
sentence: In a study involving healthy subjects receiving TAMBOCOR and propranolol concurrently, plasma flecainide levels were increased about 20% and propranolol levels were increased about 30% compared to control values.
entities: TAMBOCOR / propranolol
ddi: null
>>> match: increase_obl_conj
-------------
sentence: In a study involving healthy subjects receiving TAMBOCOR and propranolol concurrently, plasma flecainide levels were increased about 20% and propranolol levels were increased about 30% compared to control values.
entities: propranolol / flecainide
ddi: null
>>> match: increase_obl_nsubj:pass
-------------
sentence: In a study involving healthy subjects receiving TAMBOCOR and propranolol concurrently, plasma flecainide levels were increased about 20% and propranolol levels were increased about 30% compared to control values.
entities: propranolol / propranolol
ddi: null
>>> match: increase_obl_conj
-------------
sentence: In a study involving healthy subjects receiving TAMBOCOR and propranolol concurrently, plasma flecainide levels were increased about 20% and propranolol levels were increased about 30% compared to control values.
entities: flecainide / propranolol
ddi: null
>>> match: increase_nsubj:pass_conj
-------------
sentence: TAMBOCOR has been used in a large number of patients receiving diuretics without apparent interaction.
entities: TAMBOCOR / diuretics
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Limited data in patients receiving known enzyme inducers ( phenytoin, phenobarbital, carbamazepine ) indicate only a 30% increase in the rate of flecainide elimination.
entities: phenytoin / flecainide
ddi: mechanism
>>> match: indicate_nsubj_obj
-------------
sentence: Limited data in patients receiving known enzyme inducers ( phenytoin, phenobarbital, carbamazepine ) indicate only a 30% increase in the rate of flecainide elimination.
entities: phenobarbital / flecainide
ddi: mechanism
>>> match: indicate_nsubj_obj
-------------
sentence: Limited data in patients receiving known enzyme inducers ( phenytoin, phenobarbital, carbamazepine ) indicate only a 30% increase in the rate of flecainide elimination.
entities: carbamazepine / flecainide
ddi: mechanism
>>> match: indicate_nsubj_obj
-------------
sentence: In healthy subjects receiving cimetidine (1 gm daily) for one week, plasma flecainide levels increased by about 30% and half-life increased by about 10%.
entities: cimetidine / flecainide
ddi: mechanism
>>> match: increase_obl_nsubj
-------------
sentence: When amiodarone is added to flecainide therapy, plasma flecainide levels may increase two-fold or more in some patients, if flecainide dosage is not reduced.
entities: amiodarone / flecainide
ddi: mechanism
>>> match: add_nsubj:pass_obl
-------------
sentence: When amiodarone is added to flecainide therapy, plasma flecainide levels may increase two-fold or more in some patients, if flecainide dosage is not reduced.
entities: amiodarone / flecainide
ddi: null
>>> match: increase_advcl_nsubj
-------------
sentence: When amiodarone is added to flecainide therapy, plasma flecainide levels may increase two-fold or more in some patients, if flecainide dosage is not reduced.
entities: amiodarone / flecainide
ddi: null
>>> match: increase_advcl_advcl
-------------
sentence: When amiodarone is added to flecainide therapy, plasma flecainide levels may increase two-fold or more in some patients, if flecainide dosage is not reduced.
entities: flecainide / flecainide
ddi: null
>>> match: increase_advcl_nsubj
-------------
sentence: When amiodarone is added to flecainide therapy, plasma flecainide levels may increase two-fold or more in some patients, if flecainide dosage is not reduced.
entities: flecainide / flecainide
ddi: null
>>> match: increase_advcl_advcl
-------------
sentence: When amiodarone is added to flecainide therapy, plasma flecainide levels may increase two-fold or more in some patients, if flecainide dosage is not reduced.
entities: flecainide / flecainide
ddi: null
>>> match: increase_nsubj_advcl
-------------
sentence: Drugs that inhibit cytochrome P450IID6, such as quinidine , might increase the plasma concentrations of flecainide in patients that are on chronic flecainide therapy;
entities: quinidine / flecainide
ddi: mechanism
>>> match: inhibit_obj_dep
-------------
sentence: Drugs that inhibit cytochrome P450IID6, such as quinidine , might increase the plasma concentrations of flecainide in patients that are on chronic flecainide therapy;
entities: quinidine / flecainide
ddi: null
>>> match: inhibit_obj_dep
-------------
sentence: Drugs that inhibit cytochrome P450IID6, such as quinidine , might increase the plasma concentrations of flecainide in patients that are on chronic flecainide therapy;
entities: flecainide / flecainide
ddi: null
>>> match: increase_obj_obl
-------------
sentence: Because both of these drugs have negative inotropic properties and the effects of coadministration with TAMBOCOR are unknown, neither disopyramide nor verapamil should be administered concurrently with TAMBOCOR unless, in the judgment of the physician, the benefits of this combination outweigh the risks.
entities: disopyramide / TAMBOCOR
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Because both of these drugs have negative inotropic properties and the effects of coadministration with TAMBOCOR are unknown, neither disopyramide nor verapamil should be administered concurrently with TAMBOCOR unless, in the judgment of the physician, the benefits of this combination outweigh the risks.
entities: verapamil / TAMBOCOR
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / Sanctura
ddi: null
>>> match: conduct_csubj:pass_ccomp
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / digoxin
ddi: null
>>> match: conduct_csubj:pass_ccomp
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / procainamide
ddi: null
>>> match: conduct_csubj:pass_ccomp
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / pancuronium
ddi: null
>>> match: conduct_csubj:pass_ccomp
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / morphine
ddi: null
>>> match: conduct_csubj:pass_ccomp
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / vancomycin
ddi: null
>>> match: conduct_csubj:pass_ccomp
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / metformin
ddi: null
>>> match: conduct_csubj:pass_ccomp
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / tenofovir
ddi: null
>>> match: conduct_csubj:pass_ccomp
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / digoxin
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / procainamide
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / pancuronium
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / morphine
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / vancomycin
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / metformin
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir). 
entities: Sanctura / tenofovir
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: Coadministration of Sanctura with drugs that are eliminated by active renal tubular secretion may increase the serum concentration of Sanctura and/or the coadministered drug due to competition for this elimination pathway. 
entities: Sanctura / Sanctura
ddi: null
>>> match: increase_csubj_obj
-------------
sentence: Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, itraconazole, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone). 
entities: ketoconazole / mifepristone
ddi: mechanism
>>> match: inhibit_nsubj_dep
-------------
sentence: Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, itraconazole, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone). 
entities: itraconazole / mifepristone
ddi: mechanism
>>> match: inhibit_nsubj_dep
-------------
sentence: Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, itraconazole, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone). 
entities: erythromycin / mifepristone
ddi: mechanism
>>> match: inhibit_nsubj_dep
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: anticonvulsants / mifepristone
ddi: mechanism
>>> match: induce_nsubj_obj
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: anticonvulsants / mifepristone
ddi: null
>>> match: induce_nsubj_dep
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: phenytoin / mifepristone
ddi: mechanism
>>> match: induce_nsubj_obj
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: phenytoin / mifepristone
ddi: null
>>> match: induce_nsubj_dep
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: phenobarbital / mifepristone
ddi: mechanism
>>> match: induce_nsubj_obj
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: phenobarbital / mifepristone
ddi: null
>>> match: induce_nsubj_dep
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: carbamazepine / mifepristone
ddi: mechanism
>>> match: induce_nsubj_obj
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: carbamazepine / mifepristone
ddi: null
>>> match: induce_nsubj_dep
-------------
sentence: John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone). 
entities: mifepristone / mifepristone
ddi: null
>>> match: induce_obj_dep
-------------
sentence: All vasopressors should be used cautiously in patients taking monoamine oxidase (MAO) inhibitors.
entities: vasopressors / monoamine oxidase (MAO) inhibitors
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Epinephrine should not be administered concomitantly with other sympathomimetic drugs (such as isoproterenol) because of possible additive effects and increased toxicity.
entities: Epinephrine / sympathomimetic drugs
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Epinephrine should not be administered concomitantly with other sympathomimetic drugs (such as isoproterenol) because of possible additive effects and increased toxicity.
entities: Epinephrine / isoproterenol
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Epinephrine also should be used cautiously with other drugs (e.g., digitalis, glycosides) that sensitize the myocardium to the actions of sympathomimetic drugs.
entities: Epinephrine / digitalis
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Epinephrine also should be used cautiously with other drugs (e.g., digitalis, glycosides) that sensitize the myocardium to the actions of sympathomimetic drugs.
entities: Epinephrine / glycosides
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Epinephrine also should be used cautiously with other drugs (e.g., digitalis, glycosides) that sensitize the myocardium to the actions of sympathomimetic drugs.
entities: Epinephrine / sympathomimetic drugs
ddi: null
>>> match: use_nsubj:pass_dep
-------------
sentence: Epinephrine also should be used cautiously with other drugs (e.g., digitalis, glycosides) that sensitize the myocardium to the actions of sympathomimetic drugs.
entities: digitalis / sympathomimetic drugs
ddi: null
>>> match: use_obl_dep
-------------
sentence: Epinephrine also should be used cautiously with other drugs (e.g., digitalis, glycosides) that sensitize the myocardium to the actions of sympathomimetic drugs.
entities: glycosides / sympathomimetic drugs
ddi: null
>>> match: use_obl_dep
-------------
sentence: Diuretic agents may decrease vascular response to pressor drugs such as epinephrine.
entities: Diuretic agents / epinephrine
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Epinephrine may antagonize the neuron blockade produced by guanethidine resulting in decreased antihypertensive effect and requiring increased dosage of the latter.
entities: Epinephrine / guanethidine
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain. 
entities: GL / ampicillin
ddi: null
>>> match: investigate_obj_dep
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain. 
entities: GL / cefazolin
ddi: null
>>> match: investigate_obj_dep
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain. 
entities: GL / oxytetracycline
ddi: null
>>> match: investigate_obj_dep
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain. 
entities: GL / chloramphenicol
ddi: null
>>> match: investigate_obj_dep
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain. 
entities: antibiotics / ampicillin
ddi: null
>>> match: investigate_obj_dep
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain. 
entities: antibiotics / cefazolin
ddi: null
>>> match: investigate_obj_dep
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain. 
entities: antibiotics / oxytetracycline
ddi: null
>>> match: investigate_obj_dep
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain. 
entities: antibiotics / chloramphenicol
ddi: null
>>> match: investigate_obj_dep
-------------
sentence: Synergism was observed when GL was combined with cefazolin against Bacillus subtilis and Klebsiella oxytoca.
entities: GL / cefazolin
ddi: effect
>>> match: combine_nsubj:pass_obl
-------------
sentence: Addition or deletion of any drug from the therapeutic regimen of patients receiving oral anticoagulants may affect patient response to the anticoagulant.
entities: anticoagulants / anticoagulant
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: For example, since cholestyramine may reduce the gastrointestinal absorption of both the oral anticoagulants and vitamin K, the net effects are unpredictable.
entities: cholestyramine / anticoagulants
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: For example, since cholestyramine may reduce the gastrointestinal absorption of both the oral anticoagulants and vitamin K, the net effects are unpredictable.
entities: cholestyramine / vitamin K
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Chloral hydrate may cause an increased prothrombin response by displacing the anticoagulant from protein binding sites or a diminished prothrombin response through increased metabolism of the unbound drug by hepatic enzyme induction, thus leading to inter-patient variation in ultimate prothrombin effect.
entities: Chloral hydrate / anticoagulant
ddi: mechanism
>>> match: cause_nsubj_obj
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;
entities: anticoagulant / adrenocortical steroids
ddi: effect
>>> match: diminish_obj_dep
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / adrenocortical steroids
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / alcohol
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / antacids
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / antihistamines
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / barbiturates
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / carbamazepine
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / chloral hydrate
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / chlordiazepoxide
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / cholestyramine
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / vitamin K
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / diuretics
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / ethchlorvynol
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / glutethimide
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / griseofulvin
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / haloperidol
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / meprobamate
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / contraceptives
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / paraldehyde
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / primidone
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / ranitidine
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / rifampin
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / vitamin C
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / warfarin sodium
ddi: effect
>>> match: diminish_obj_advcl
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;
entities: anticoagulant / alcohol
ddi: effect
>>> match: increase_obj_dep
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / alcohol
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / allopurinol
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / aminosalicylic acid
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / amiodarone
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / anabolic steroids
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / antibiotics
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / bromelains
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / chloral hydrate
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / chlorpropamide
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / chymotrypsin
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / cimetidine
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / cinchophen
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / clofibrate
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / dextran
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / dextrothyroxine
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / diazoxide
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / diflunisal
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / disulfiram
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / ethacrynic acid
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / fenoprofen
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / glucagon
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / ibuprofen
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / indomethacin
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / influenza virus vaccine
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / anesthetics
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / mefenamic acid
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / methyldopa
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / methylphenidate
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / metronidazole
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / miconazole
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / monoamine oxidase inhibitors
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / nalidixic acid
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / naproxen
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / oxolinic acid
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / oxyphenbutazone
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / pentoxifylline
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / phenylbutazone
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / phenyramidol
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / phenytoin
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / prolonged narcotics
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / pyrazolones
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / quinidine
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / quinine
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / ranitidine
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / salicylates
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / sulfinpyrazone
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / sulfonamides
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / sulindac
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / thyroid drugs
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / tolbutamide
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / triclofos sodium
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / trimethoprim
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Drugs that reportedly may increase oral anticoagulant response, ie, increased prothrombin response, in man include:alcohol*;allopurinol;aminosalicylic acid;amiodarone;anabolic steroids;antibiotics;bromelains;chloral hydrate*;chlorpropamide;chymotrypsin;cimetidine;cinchophen;clofibrate;dextran;dextrothyroxine;diazoxide;dietary deficiencies;diflunisal;disulfiram;drugs affecting blood elements;ethacrynic acid;fenoprofen;glucagon;hepatotoxic drugs;ibuprofen;indomethacin;influenza virus vaccine;inhalation anesthetics;mefenamic acid;methyldopa;methylphenidate;metronidazole;miconazole;monoamine oxidase inhibitors;nalidixic acid;naproxen;oxolinic acid;oxyphenbutazone;pentoxifylline;phenylbutazone;phenyramidol;phenytoin;prolonged hot weather;prolonged narcotics;pyrazolones;quinidine;quinine;ranitidine*;salicylates;sulfinpyrazone;sulfonamides, long acting;sulindac;thyroid drugs;tolbutamide;triclofos sodium;trimethoprim/sulfamethoxazole;unreliable prothrombin time determinations;warfarin sodium overdosage.
entities: anticoagulant / sulfamethoxazole
ddi: effect
>>> match: increase_obj_parataxis
-------------
sentence: Oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents, eg, tolbutamide and chlorpropamide, by inhibiting their metabolism in the liver.
entities: anticoagulants / hypoglycemic agents
ddi: mechanism
>>> match: potentiate_nsubj_obj
-------------
sentence: Oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents, eg, tolbutamide and chlorpropamide, by inhibiting their metabolism in the liver.
entities: anticoagulants / tolbutamide
ddi: mechanism
>>> match: potentiate_nsubj_obj
-------------
sentence: Oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents, eg, tolbutamide and chlorpropamide, by inhibiting their metabolism in the liver.
entities: anticoagulants / chlorpropamide
ddi: mechanism
>>> match: potentiate_nsubj_obj
-------------
sentence: Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently.
entities: anticoagulants / phenytoin
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently.
entities: anticoagulants / anticonvulsant
ddi: null
>>> match: occur_advcl_nsubj
-------------
sentence: Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently.
entities: anticoagulants / anticoagulant
ddi: null
>>> match: occur_advcl_advcl
-------------
sentence: Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently.
entities: anticoagulants / phenytoin
ddi: null
>>> match: occur_advcl_advcl
-------------
sentence: Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently.
entities: phenytoin / anticonvulsant
ddi: null
>>> match: occur_advcl_nsubj
-------------
sentence: Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently.
entities: phenytoin / anticoagulant
ddi: null
>>> match: occur_advcl_advcl
-------------
sentence: Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently.
entities: phenytoin / phenytoin
ddi: null
>>> match: occur_advcl_advcl
-------------
sentence: Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently.
entities: anticonvulsant / anticoagulant
ddi: null
>>> match: occur_nsubj_advcl
-------------
sentence: Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently.
entities: anticonvulsant / phenytoin
ddi: null
>>> match: occur_nsubj_advcl
-------------
sentence: Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents) or drugs which inhibit platelet function (eg, aspirin and other non-steroidal anti-inflammatory drugs, dipyridamole, hydrochloroquine, clofibrate, dextran) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations.
entities: aspirin / anticoagulants
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents) or drugs which inhibit platelet function (eg, aspirin and other non-steroidal anti-inflammatory drugs, dipyridamole, hydrochloroquine, clofibrate, dextran) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations.
entities: non-steroidal anti-inflammatory drugs / anticoagulants
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents) or drugs which inhibit platelet function (eg, aspirin and other non-steroidal anti-inflammatory drugs, dipyridamole, hydrochloroquine, clofibrate, dextran) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations.
entities: dipyridamole / anticoagulants
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents) or drugs which inhibit platelet function (eg, aspirin and other non-steroidal anti-inflammatory drugs, dipyridamole, hydrochloroquine, clofibrate, dextran) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations.
entities: hydrochloroquine / anticoagulants
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents) or drugs which inhibit platelet function (eg, aspirin and other non-steroidal anti-inflammatory drugs, dipyridamole, hydrochloroquine, clofibrate, dextran) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations.
entities: clofibrate / anticoagulants
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Drugs that reduce the number of blood platelets by causing bone marrow depression (such as antineoplastic agents) or drugs which inhibit platelet function (eg, aspirin and other non-steroidal anti-inflammatory drugs, dipyridamole, hydrochloroquine, clofibrate, dextran) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations.
entities: dextran / anticoagulants
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / aspirin
ddi: int
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / NSAIDs
ddi: int
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / melatonin
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / fluvoxamine
ddi: int
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / melatonin
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / beta blockers
ddi: int
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / melatonin
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / fluoxetine
ddi: int
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / progestin
ddi: int
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / melatonin
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / progestin
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / benzodiazepenes
ddi: int
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / corticosteroids
ddi: int
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / melatonin
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / corticosteroids
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: Melatonin / corticosteroids
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: aspirin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: aspirin / melatonin
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: aspirin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: aspirin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: NSAIDs / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: NSAIDs / melatonin
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: NSAIDs / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: NSAIDs / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / melatonin
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluvoxamine / melatonin
ddi: null
>>> match: increase_dep_nsubj:pass
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluvoxamine / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluvoxamine / melatonin
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluvoxamine / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluvoxamine / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / melatonin
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: beta blockers / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: beta blockers / melatonin
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: beta blockers / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: beta blockers / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / melatonin
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluoxetine / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluoxetine / melatonin
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluoxetine / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluoxetine / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / melatonin
ddi: null
>>> match: inhibit_dep_nsubj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / progestin
ddi: null
>>> match: inhibit_dep_nsubj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / melatonin
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / melatonin
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / melatonin
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: benzodiazepenes / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: benzodiazepenes / melatonin
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: benzodiazepenes / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: benzodiazepenes / corticosteroids
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: corticosteroids / melatonin
ddi: null
>>> match: interfere_dep_nsubj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: corticosteroids / corticosteroids
ddi: null
>>> match: interfere_dep_nsubj
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: corticosteroids / corticosteroids
ddi: null
>>> match: interfere_dep_obl
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interfere_nsubj_obl
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: corticosteroids / corticosteroids
ddi: null
>>> match: interfere_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: sodium carboxymethylcellulose / sodium fluorescein
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: sodium carboxymethylcellulose / NaFlu
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: sodium carboxymethylcellulose / bacitracin
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: sodium carboxymethylcellulose / insulin
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: NaCMC / sodium fluorescein
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: NaCMC / NaFlu
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: NaCMC / bacitracin
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: NaCMC / insulin
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: carboxymethylcellulose-cysteine / sodium fluorescein
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: carboxymethylcellulose-cysteine / NaFlu
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: carboxymethylcellulose-cysteine / bacitracin
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: carboxymethylcellulose-cysteine / insulin
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: CMC-Cys / sodium fluorescein
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: CMC-Cys / NaFlu
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: CMC-Cys / bacitracin
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin. 
entities: CMC-Cys / insulin
ddi: null
>>> match: conjugate_nsubj_obl
-------------
sentence: Cysteine was covalently linked to carbodiimide activated NaCMC. 
entities: Cysteine / NaCMC
ddi: null
>>> match: link_nsubj:pass_obl
-------------
sentence: Unmodified NaCMC (1% m/v) significantly improved the transport ratio (R= P(app) polymer/ P(app) control) of NaFlu to 1.3 and 1% (m/v) NaCMC conjugated with cysteine further enhanced the permeation. 
entities: NaCMC / NaFlu
ddi: null
>>> match: improve_nsubj_iobj
-------------
sentence: Unmodified NaCMC (1% m/v) significantly improved the transport ratio (R= P(app) polymer/ P(app) control) of NaFlu to 1.3 and 1% (m/v) NaCMC conjugated with cysteine further enhanced the permeation. 
entities: NaCMC / NaCMC
ddi: null
>>> match: improve_nsubj_iobj
-------------
sentence: Unmodified NaCMC (1% m/v) significantly improved the transport ratio (R= P(app) polymer/ P(app) control) of NaFlu to 1.3 and 1% (m/v) NaCMC conjugated with cysteine further enhanced the permeation. 
entities: NaCMC / cysteine
ddi: null
>>> match: improve_nsubj_iobj
-------------
sentence: Decreasing the concentration of CMC-Cys, exhibiting 7.3% (m/m) of immobilised cysteine (CMC-Cys7.3) from 1% (m/v) to 0.5% (m/v) decreased the R-value of NaFlu from 1.8 to 1.2. 
entities: CMC-Cys / cysteine
ddi: null
>>> match: decrease_obj_dep
-------------
sentence: Decreasing the concentration of CMC-Cys, exhibiting 7.3% (m/m) of immobilised cysteine (CMC-Cys7.3) from 1% (m/v) to 0.5% (m/v) decreased the R-value of NaFlu from 1.8 to 1.2. 
entities: CMC-Cys / NaFlu
ddi: null
>>> match: decrease_obj_dep
-------------
sentence: NaCMC at 1% (m/v) in the presence of free cysteine had no significant effect on the R-value of NaFlu compared to NaCMC alone. 
entities: NaCMC / NaFlu
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: NaCMC at 1% (m/v) in the presence of free cysteine had no significant effect on the R-value of NaFlu compared to NaCMC alone. 
entities: NaCMC / NaCMC
ddi: null
>>> match: have_nsubj_advcl
-------------
sentence: NaCMC at 1% (m/v) in the presence of free cysteine had no significant effect on the R-value of NaFlu compared to NaCMC alone. 
entities: cysteine / NaFlu
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: NaCMC at 1% (m/v) in the presence of free cysteine had no significant effect on the R-value of NaFlu compared to NaCMC alone. 
entities: cysteine / NaCMC
ddi: null
>>> match: have_nsubj_advcl
-------------
sentence: NaCMC at 1% (m/v) in the presence of free cysteine had no significant effect on the R-value of NaFlu compared to NaCMC alone. 
entities: NaFlu / NaCMC
ddi: null
>>> match: have_obj_advcl
-------------
sentence: Formulation of fluorescence labelled bacitracin and insulin in unconjugated NaCMC (1% m/v) did not significantly improve the permeation, however in the presence of 1% (m/v) CMC-Cys7.3 a significantly improved permeation was observed (R= 1.3). 
entities: bacitracin / CMC-Cys
ddi: null
>>> match: improve_nsubj_obl
-------------
sentence: Formulation of fluorescence labelled bacitracin and insulin in unconjugated NaCMC (1% m/v) did not significantly improve the permeation, however in the presence of 1% (m/v) CMC-Cys7.3 a significantly improved permeation was observed (R= 1.3). 
entities: insulin / CMC-Cys
ddi: null
>>> match: improve_nsubj_obl
-------------
sentence: Formulation of fluorescence labelled bacitracin and insulin in unconjugated NaCMC (1% m/v) did not significantly improve the permeation, however in the presence of 1% (m/v) CMC-Cys7.3 a significantly improved permeation was observed (R= 1.3). 
entities: NaCMC / CMC-Cys
ddi: null
>>> match: improve_nsubj_obl
-------------
sentence: Conjugation at NaCMC with cysteine moieties significantly improves the intestinal permeation of the hydrophilic molecule NaFlu and the model peptide drugs bacitracin and insulin in vitro, therefore this conjugated system maybe useful for peroral administration of peptide drugs in the future.
entities: NaCMC / NaFlu
ddi: null
>>> match: improve_nsubj_obj
-------------
sentence: Conjugation at NaCMC with cysteine moieties significantly improves the intestinal permeation of the hydrophilic molecule NaFlu and the model peptide drugs bacitracin and insulin in vitro, therefore this conjugated system maybe useful for peroral administration of peptide drugs in the future.
entities: NaCMC / bacitracin
ddi: null
>>> match: improve_nsubj_obj
-------------
sentence: Conjugation at NaCMC with cysteine moieties significantly improves the intestinal permeation of the hydrophilic molecule NaFlu and the model peptide drugs bacitracin and insulin in vitro, therefore this conjugated system maybe useful for peroral administration of peptide drugs in the future.
entities: NaCMC / insulin
ddi: null
>>> match: improve_nsubj_obj
-------------
sentence: Conjugation at NaCMC with cysteine moieties significantly improves the intestinal permeation of the hydrophilic molecule NaFlu and the model peptide drugs bacitracin and insulin in vitro, therefore this conjugated system maybe useful for peroral administration of peptide drugs in the future.
entities: cysteine / NaFlu
ddi: null
>>> match: improve_nsubj_obj
-------------
sentence: Conjugation at NaCMC with cysteine moieties significantly improves the intestinal permeation of the hydrophilic molecule NaFlu and the model peptide drugs bacitracin and insulin in vitro, therefore this conjugated system maybe useful for peroral administration of peptide drugs in the future.
entities: cysteine / bacitracin
ddi: null
>>> match: improve_nsubj_obj
-------------
sentence: Conjugation at NaCMC with cysteine moieties significantly improves the intestinal permeation of the hydrophilic molecule NaFlu and the model peptide drugs bacitracin and insulin in vitro, therefore this conjugated system maybe useful for peroral administration of peptide drugs in the future.
entities: cysteine / insulin
ddi: null
>>> match: improve_nsubj_obj
-------------
sentence: Folic acid in large amounts may counteract the antiepileptic effect of phenobarbital, phenytoin and primidone, and increase the frequency of seizures in susceptible pediatric patients.
entities: Folic acid / phenobarbital
ddi: effect
>>> match: counteract_nsubj_obj
-------------
sentence: Folic acid in large amounts may counteract the antiepileptic effect of phenobarbital, phenytoin and primidone, and increase the frequency of seizures in susceptible pediatric patients.
entities: Folic acid / phenytoin
ddi: effect
>>> match: counteract_nsubj_obj
-------------
sentence: Folic acid in large amounts may counteract the antiepileptic effect of phenobarbital, phenytoin and primidone, and increase the frequency of seizures in susceptible pediatric patients.
entities: Folic acid / primidone
ddi: effect
>>> match: counteract_nsubj_obj
-------------
sentence: Preliminary animal and human studies have shown that small quantities of systemically administered leucovorin enter the CSF primarily as 5-methyltetrahydro-folate and, in humans, remain 1 to 3 orders of magnitude lower than the usual methotrexate concentrations following intrathecal administration.
entities: leucovorin / methotrexate
ddi: null
>>> match: enter_nsubj_obl
-------------
sentence: However, high doses of leucovorin may reduce the efficacy of intrathecally administered methotrexate.
entities: leucovorin / methotrexate
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Leucovorin may enhance the toxicity of 5-fluorouracil.
entities: Leucovorin / 5-fluorouracil
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: MAO inhibitors should be used with caution in patients receiving hydralazine.
entities: MAO inhibitors / hydralazine
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: When other potent parental antihypertensive drugs, such as diazoxide, are used in combination with hydralazine, patients should be continuously observed for several hours for any excessive fall in blood pressure.
entities: antihypertensive drugs / hydralazine
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: When other potent parental antihypertensive drugs, such as diazoxide, are used in combination with hydralazine, patients should be continuously observed for several hours for any excessive fall in blood pressure.
entities: diazoxide / hydralazine
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Propranolol increases hydralazine's serum concentrations.
entities: Propranolol / hydralazine
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: NSAIDs may decrease the hemodynamic effects of hydralazine;
entities: NSAIDs / hydralazine
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Urinary acidifying agents (ammonium chloride, sodium acid phosphate, etc.) increase the concentration of the ionized species of the amphetamine molecule, thereby increasing urinary excretion.
entities: Urinary acidifying agents / amphetamine
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Urinary acidifying agents (ammonium chloride, sodium acid phosphate, etc.) increase the concentration of the ionized species of the amphetamine molecule, thereby increasing urinary excretion.
entities: ammonium chloride / amphetamine
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Urinary acidifying agents (ammonium chloride, sodium acid phosphate, etc.) increase the concentration of the ionized species of the amphetamine molecule, thereby increasing urinary excretion.
entities: sodium acid phosphate / amphetamine
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Adrenergic blockers: Adrenergic blockers are inhibited by amphetamines.
entities: Adrenergic blockers / amphetamines
ddi: effect
>>> match: inhibit_nsubj:pass_obl
-------------
sentence: Urinary alkalinizing agents (acetazolamide, some thiazides) increase the concentration of the non-ionized species of the amphetamine molecule, thereby decreasing urinary excretion.
entities: acetazolamide / amphetamine
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Urinary alkalinizing agents (acetazolamide, some thiazides) increase the concentration of the non-ionized species of the amphetamine molecule, thereby decreasing urinary excretion.
entities: thiazides / amphetamine
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Antidepressants, tricyclic: Amphetamines may enhance the activity of tricyclic or sympathomimetic agents;
entities: Amphetamines / tricyclic
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Antidepressants, tricyclic: Amphetamines may enhance the activity of tricyclic or sympathomimetic agents;
entities: Amphetamines / sympathomimetic agents
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;
entities: d-amphetamine / d-amphetamine
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;
entities: desipramine / d-amphetamine
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;
entities: protriptyline / d-amphetamine
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain;
entities: tricyclics / d-amphetamine
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: Antihistamines: Amphetamines may counteract the sedative effect of antihistamines.
entities: Amphetamines / antihistamines
ddi: effect
>>> match: counteract_nsubj_obj
-------------
sentence: Antihypertensives: Amphetamines may antagonize the hypotensive effects of antihypertensives.
entities: Amphetamines / antihypertensives
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: Chlorpromazine: Chlorpromazine blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of amphetamines, and can be used to treat amphetamine poisoning.
entities: Chlorpromazine / amphetamines
ddi: effect
>>> match: block_nsubj_dep
-------------
sentence: Chlorpromazine: Chlorpromazine blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of amphetamines, and can be used to treat amphetamine poisoning.
entities: Chlorpromazine / amphetamine
ddi: null
>>> match: block_nsubj_conj
-------------
sentence: Chlorpromazine: Chlorpromazine blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of amphetamines, and can be used to treat amphetamine poisoning.
entities: amphetamines / amphetamine
ddi: null
>>> match: block_dep_conj
-------------
sentence: Ethosuximide: Amphetamines may delay intestinal absorption of ethosuximide.
entities: Amphetamines / ethosuximide
ddi: mechanism
>>> match: delay_nsubj_obj
-------------
sentence: Haloperidol: Haloperidol blocks dopamine and norepinephrine reuptake, thus inhibiting the central stimulant effects of amphetamines.
entities: Haloperidol / amphetamines
ddi: effect
>>> match: block_nsubj_dep
-------------
sentence: Lithium carbonate: The stimulatory effects of amphetamines may be inhibited by lithium carbonate.
entities: amphetamines / lithium carbonate
ddi: effect
>>> match: inhibit_nsubj:pass_obl
-------------
sentence: Meperidine: Amphetamines potentiate the analgesic effect of meperidine.
entities: Amphetamines / meperidine
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Methenamine therapy: Urinary excretion of amphetamines is increased, and efficacy is reduced, by acidifying agents used in methenamine therapy.
entities: amphetamines / acidifying agents
ddi: mechanism
>>> match: increase_nsubj:pass_obl
-------------
sentence: Methenamine therapy: Urinary excretion of amphetamines is increased, and efficacy is reduced, by acidifying agents used in methenamine therapy.
entities: amphetamines / methenamine
ddi: null
>>> match: increase_nsubj:pass_obl
-------------
sentence: Norepinephrine: Amphetamines enhance the adrenergic effect of norepinephrine.
entities: Amphetamines / norepinephrine
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Phenobarbital: Amphetamines may delay intestinal absorption of phenobarbital;
entities: Amphetamines / phenobarbital
ddi: mechanism
>>> match: delay_nsubj_obj
-------------
sentence: Phenytoin: Amphetamines may delay intestinal absorption of phenytoin;
entities: Amphetamines / phenytoin
ddi: mechanism
>>> match: delay_nsubj_obj
-------------
sentence: Propoxyphene: In cases of propoxyphene overdosage, amphetamine CNS stimulation is potentiated and fatal convulsions can occur.
entities: propoxyphene / amphetamine
ddi: effect
>>> match: potentiate_obl_nsubj:pass
-------------
sentence: Veratrum alkaloids: Amphetamines inhibit the hypotensive effect of veratrum alkaloids.
entities: Amphetamines / veratrum alkaloids
ddi: effect
>>> match: inhibit_nsubj_obj
-------------
sentence: Drug/Laboratory Test Interactions: Amphetamines can cause a significant elevation in plasma corticosteroid levels.
entities: Amphetamines / corticosteroid
ddi: effect
>>> match: cause_nsubj_obj
-------------
sentence: Anticholinesterases: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride. 
entities: procaine hydrochloride / anticholinesterases
ddi: null
>>> match: result_nsubj_advcl
-------------
sentence: Anticholinesterases: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride. 
entities: procaine hydrochloride / procaine hydrochloride
ddi: null
>>> match: result_nsubj_advcl
-------------
sentence: Anticholinesterases: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride. 
entities: anticholinesterase agents / anticholinesterases
ddi: null
>>> match: result_nsubj_advcl
-------------
sentence: Anticholinesterases: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride. 
entities: anticholinesterase agents / procaine hydrochloride
ddi: null
>>> match: result_nsubj_advcl
-------------
sentence: Anticholinesterases: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride. 
entities: anticholinesterases / procaine hydrochloride
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Hyaluronidase: Hyaluronidase may increase the diffusion rate of procaine hydrochloride, resulting in a decreased time of onset, but an increase in systemic toxicity. 
entities: Hyaluronidase / procaine hydrochloride
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Sulfonamides: Concurrent use of procaine hydrochloride and sulfonamides may result in a reduction of the antibacterial action of the sulfonamide. 
entities: procaine hydrochloride / sulfonamide
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Sulfonamides: Concurrent use of procaine hydrochloride and sulfonamides may result in a reduction of the antibacterial action of the sulfonamide. 
entities: sulfonamides / sulfonamide
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Acetazolamide: Concurrent use of acetazolamide and procaine hydrochloride may extend the plasma half-life of procaine.
entities: acetazolamide / procaine
ddi: null
>>> match: extend_nsubj_obj
-------------
sentence: Acetazolamide: Concurrent use of acetazolamide and procaine hydrochloride may extend the plasma half-life of procaine.
entities: procaine hydrochloride / procaine
ddi: null
>>> match: extend_nsubj_obj
-------------
sentence: The uptake inhibitors cocaine and desipramine (3 mumol/liter) potentiated the positive inotropic effects of norepinephrine in nonfailing myocardium (p < 0.05) but not in functional class IV myocardium. 
entities: cocaine / norepinephrine
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: The uptake inhibitors cocaine and desipramine (3 mumol/liter) potentiated the positive inotropic effects of norepinephrine in nonfailing myocardium (p < 0.05) but not in functional class IV myocardium. 
entities: desipramine / norepinephrine
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Radioligand binding experiments using the uptake inhibitor hydrogen-3 mazindol revealed a significant decrease by approximately 30% in norepinephrine uptake-1 carrier density in functional classes II to III and IV myocardium versus nonfailing myocardium (p < 0.05). 
entities: mazindol / norepinephrine
ddi: null
>>> match: reveal_nsubj_obj
-------------
sentence: Compromised norepinephrine uptake-1 in functional class IV cannot be further increased by cocaine and desipramine. 
entities: norepinephrine / cocaine
ddi: null
>>> match: increase_nsubj:pass_obl
-------------
sentence: Compromised norepinephrine uptake-1 in functional class IV cannot be further increased by cocaine and desipramine. 
entities: norepinephrine / desipramine
ddi: null
>>> match: increase_nsubj:pass_obl
-------------
sentence: Heparin: Since heparin is contraindicated in patients with heparin-induced thrombocytopenia, the co-administration of Argatroban and heparin is unlikely for this indication.
entities: heparin / heparin
ddi: null
>>> match: contraindicate_nsubj:pass_obl
-------------
sentence: However, if Argatroban is to be initiated after cessation of heparin therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of Argatroban therapy.
entities: Argatroban / heparin
ddi: null
>>> match: initiate_nsubj:pass_obl
-------------
sentence: However, if Argatroban is to be initiated after cessation of heparin therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of Argatroban therapy.
entities: Argatroban / Argatroban
ddi: null
>>> match: allow_advcl_xcomp
-------------
sentence: However, if Argatroban is to be initiated after cessation of heparin therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of Argatroban therapy.
entities: heparin / Argatroban
ddi: null
>>> match: allow_advcl_xcomp
-------------
sentence: Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid.
entities: triamterene / vitamin B12
ddi: null
>>> match: control_obj_obl
-------------
sentence: Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid.
entities: triamterene / folic acid
ddi: null
>>> match: control_obj_obl
-------------
sentence: Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid.
entities: diuretic / vitamin B12
ddi: null
>>> match: control_obj_obl
-------------
sentence: Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid.
entities: diuretic / folic acid
ddi: null
>>> match: control_obj_obl
-------------
sentence: Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid.
entities: Methotrexate / vitamin B12
ddi: null
>>> match: control_obj_obl
-------------
sentence: Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid.
entities: Methotrexate / folic acid
ddi: null
>>> match: control_obj_obl
-------------
sentence: Concurrent use of alcohol and other CNS depression-producing drugs may increase the CNS depressant effects of methyprylon or these other medications.
entities: alcohol / methyprylon
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Concurrent use of alcohol and other CNS depression-producing drugs may increase the CNS depressant effects of methyprylon or these other medications.
entities: CNS depression-producing drugs / methyprylon
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Paroxetine and fluoxetine reduce the plasma concentration of endoxifen by about 50%. 
entities: Paroxetine / endoxifen
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Paroxetine and fluoxetine reduce the plasma concentration of endoxifen by about 50%. 
entities: fluoxetine / endoxifen
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with tamoxifen for breast cancer, especially SSRI antidepressants such as paroxetine and fluoxetine. 
entities: tamoxifen / SSRI antidepressants
ddi: advise
>>> match: prescribe_obl_obl
-------------
sentence: It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with tamoxifen for breast cancer, especially SSRI antidepressants such as paroxetine and fluoxetine. 
entities: tamoxifen / paroxetine
ddi: advise
>>> match: prescribe_obl_obl
-------------
sentence: It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with tamoxifen for breast cancer, especially SSRI antidepressants such as paroxetine and fluoxetine. 
entities: tamoxifen / fluoxetine
ddi: advise
>>> match: prescribe_obl_obl
-------------
sentence: If in certain cases, an antidepressant is considered necessary, it may be advisable to replace tamoxifen with anastrozole.
entities: tamoxifen / anastrozole
ddi: null
>>> match: replace_obj_obl
-------------
sentence: The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.
entities: NIZORAL / Ketoconazole
ddi: null
>>> match: metabolize_nsubj_parataxis
-------------
sentence: The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.
entities: NIZORAL / terfenadine
ddi: null
>>> match: metabolize_nsubj_parataxis
-------------
sentence: The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.
entities: NIZORAL / terfenadine
ddi: null
>>> match: metabolize_nsubj_parataxis
-------------
sentence: The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.
entities: Ketoconazole / terfenadine
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.
entities: Ketoconazole / terfenadine
ddi: null
>>> match: inhibit_nsubj_obj
-------------
sentence: Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals.
entities: ketoconazole / astemizole
ddi: effect
>>> match: inhibit_nsubj_obj
-------------
sentence: Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals.
entities: ketoconazole / astemizole
ddi: null
>>> match: inhibit_nsubj_dep
-------------
sentence: Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals.
entities: ketoconazole / desmethylastemizole
ddi: null
>>> match: inhibit_nsubj_dep
-------------
sentence: Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals.
entities: astemizole / astemizole
ddi: null
>>> match: inhibit_obj_dep
-------------
sentence: Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals.
entities: astemizole / desmethylastemizole
ddi: null
>>> match: inhibit_obj_dep
-------------
sentence: Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in a mean eight-fold increase in AUC of cisapride.
entities: ketoconazole / cisapride
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in a mean eight-fold increase in AUC of cisapride.
entities: ketoconazole / cisapride
ddi: null
>>> match: inhibit_nsubj_obj
-------------
sentence: Ketoconazole tablets may alter the metabolism of cyclosporine, tacrolimus, and methylprednisolone, resulting in elevated plasma concentrations of the latter drugs.
entities: Ketoconazole / cyclosporine
ddi: mechanism
>>> match: alter_nsubj_obj
-------------
sentence: Ketoconazole tablets may alter the metabolism of cyclosporine, tacrolimus, and methylprednisolone, resulting in elevated plasma concentrations of the latter drugs.
entities: Ketoconazole / tacrolimus
ddi: mechanism
>>> match: alter_nsubj_obj
-------------
sentence: Ketoconazole tablets may alter the metabolism of cyclosporine, tacrolimus, and methylprednisolone, resulting in elevated plasma concentrations of the latter drugs.
entities: Ketoconazole / methylprednisolone
ddi: mechanism
>>> match: alter_nsubj_obj
-------------
sentence: Dosage adjustment may be required if cyclosporine, tacrolimus, or methylprednisolone are given concomitantly with NIZORAL  Tablets.
entities: cyclosporine / NIZORAL
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: Dosage adjustment may be required if cyclosporine, tacrolimus, or methylprednisolone are given concomitantly with NIZORAL  Tablets.
entities: tacrolimus / NIZORAL
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: Dosage adjustment may be required if cyclosporine, tacrolimus, or methylprednisolone are given concomitantly with NIZORAL  Tablets.
entities: methylprednisolone / NIZORAL
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: It is, therefore, advisable to monitor digoxin concentrations in patients receiving ketoconazole.
entities: digoxin / ketoconazole
ddi: advise
>>> match: monitor_obj_obl
-------------
sentence: When taken orally , imidazole compounds like ketoconazole may enhance the anticoagulant effect of coumarin-like drugs.
entities: imidazole compounds / coumarin
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: When taken orally , imidazole compounds like ketoconazole may enhance the anticoagulant effect of coumarin-like drugs.
entities: ketoconazole / coumarin
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: INH (Isoniazid) is also reported to affect ketoconazole concentrations adversely.
entities: INH / ketoconazole
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: INH (Isoniazid) is also reported to affect ketoconazole concentrations adversely.
entities: Isoniazid / ketoconazole
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: After the coadministration of 200 mg oral ketoconazole twice daily and one 20 mg dose of loratadine to 11 subjects, the AUC and Cmax of loratadine averaged 302% (  142 S.D.) and 251% (  68 S.D.), respectively, of those obtained after co-treatment with placebo.
entities: ketoconazole / loratadine
ddi: null
>>> match: average_obl_nsubj
-------------
sentence: After the coadministration of 200 mg oral ketoconazole twice daily and one 20 mg dose of loratadine to 11 subjects, the AUC and Cmax of loratadine averaged 302% (  142 S.D.) and 251% (  68 S.D.), respectively, of those obtained after co-treatment with placebo.
entities: loratadine / loratadine
ddi: null
>>> match: average_obl_nsubj
-------------
sentence: Also, there were no clinically significant differences in adverse events when loratadine was administered with or without ketoconazole.
entities: loratadine / ketoconazole
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs. 
entities: coumarin-type anticoagulants / coumarin-type anticoagulants
ddi: null
>>> match: report_advcl_nsubj:pass
-------------
sentence: Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs. 
entities: coumarin-type anticoagulants / FELDENE
ddi: null
>>> match: report_advcl_obl
-------------
sentence: Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs. 
entities: coumarin-type anticoagulants / FELDENE
ddi: null
>>> match: report_advcl_parataxis
-------------
sentence: Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs. 
entities: coumarin-type anticoagulants / coumarin-type anticoagulants
ddi: null
>>> match: report_advcl_parataxis
-------------
sentence: Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs. 
entities: coumarin-type anticoagulants / FELDENE
ddi: int
>>> match: report_nsubj:pass_obl
-------------
sentence: Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs. 
entities: coumarin-type anticoagulants / FELDENE
ddi: null
>>> match: report_nsubj:pass_parataxis
-------------
sentence: Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs. 
entities: coumarin-type anticoagulants / coumarin-type anticoagulants
ddi: null
>>> match: report_nsubj:pass_parataxis
-------------
sentence: Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs. 
entities: FELDENE / FELDENE
ddi: null
>>> match: report_obl_parataxis
-------------
sentence: Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs. 
entities: FELDENE / coumarin-type anticoagulants
ddi: null
>>> match: report_obl_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: FELDENE / aspirin
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: FELDENE / antacids
ddi: null
>>> match: administer_nsubj:pass_conj
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: FELDENE / piroxicam
ddi: null
>>> match: administer_nsubj:pass_conj
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: FELDENE / Nonsteroidal anti-inflammatory agents
ddi: null
>>> match: administer_nsubj:pass_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: FELDENE / FELDENE
ddi: null
>>> match: administer_nsubj:pass_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: FELDENE / lithium
ddi: null
>>> match: administer_nsubj:pass_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: aspirin / antacids
ddi: null
>>> match: administer_obl_conj
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: aspirin / piroxicam
ddi: null
>>> match: administer_obl_conj
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: aspirin / Nonsteroidal anti-inflammatory agents
ddi: null
>>> match: administer_obl_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: aspirin / FELDENE
ddi: null
>>> match: administer_obl_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: aspirin / lithium
ddi: null
>>> match: administer_obl_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: antacids / piroxicam
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: antacids / Nonsteroidal anti-inflammatory agents
ddi: null
>>> match: administer_conj_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: antacids / FELDENE
ddi: null
>>> match: administer_conj_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: antacids / lithium
ddi: null
>>> match: administer_conj_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: piroxicam / Nonsteroidal anti-inflammatory agents
ddi: null
>>> match: administer_conj_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: piroxicam / FELDENE
ddi: null
>>> match: administer_conj_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: piroxicam / lithium
ddi: null
>>> match: administer_conj_parataxis
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: Nonsteroidal anti-inflammatory agents / lithium
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels. 
entities: FELDENE / lithium
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: It is recommended that plasma lithium levels be monitored when initiating, adjusting and discontinuing FELDENE.
entities: lithium / FELDENE
ddi: advise
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / paricalcitol
ddi: mechanism
>>> match: double_nsubj_ccomp
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / paricalcitol
ddi: null
>>> match: double_nsubj_ccomp
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / ketoconazole
ddi: null
>>> match: double_nsubj_ccomp
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / paricalcitol
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / ketoconazole
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / atazanavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / clarithromycin
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / indinavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / itraconazole
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / nefazodone
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / nelfinavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / ritonavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / saquinavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / telithromycin
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / voriconazole
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / paricalcitol
ddi: null
>>> match: know_nsubj:pass_advcl
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / ketoconazole
ddi: null
>>> match: know_nsubj:pass_advcl
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / paricalcitol
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / ketoconazole
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / atazanavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / clarithromycin
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / indinavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / itraconazole
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / nefazodone
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / nelfinavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / ritonavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / saquinavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / telithromycin
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / voriconazole
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / ketoconazole
ddi: null
>>> match: metabolize_nsubj:pass_obl
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / paricalcitol
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / ketoconazole
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / atazanavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / clarithromycin
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / indinavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / itraconazole
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / nefazodone
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / nelfinavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / ritonavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / saquinavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / telithromycin
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: paricalcitol / voriconazole
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / paricalcitol
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / ketoconazole
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / atazanavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / clarithromycin
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / indinavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / itraconazole
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / nefazodone
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / nelfinavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / ritonavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / saquinavir
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / telithromycin
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole. 
entities: ketoconazole / voriconazole
ddi: null
>>> match: demonstrate_ccomp_dep
-------------
sentence: Dose adjustment of Zemplar Capsules may be required, and iPTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYP3A4 inhibitor such as ketoconazole. 
entities: Zemplar / ketoconazole
ddi: advise
>>> match: require_nsubj:pass_conj
-------------
sentence: Drugs that impair intestinal absorption of fat-soluble vitamins, such as cholestyramine, may interfere with the absorption of Zemplar Capsules.
entities: fat-soluble vitamins / Zemplar
ddi: null
>>> match: interfere_dep_obl
-------------
sentence: Drugs that impair intestinal absorption of fat-soluble vitamins, such as cholestyramine, may interfere with the absorption of Zemplar Capsules.
entities: cholestyramine / Zemplar
ddi: mechanism
>>> match: interfere_dep_obl
-------------
sentence: In elderly patients concurrently receiving certain diuretics, primarily thiazides, an increased incidence of thrombopenia with purpura has been reported. 
entities: diuretics / thiazides
ddi: null
>>> match: report_obl_obl
-------------
sentence: It has been reported that sulfamethoxazole may prolong the prothrombin time in patients who are receiving the anticoagulant warfarin. 
entities: sulfamethoxazole / anticoagulant
ddi: null
>>> match: prolong_nsubj_obj
-------------
sentence: It has been reported that sulfamethoxazole may prolong the prothrombin time in patients who are receiving the anticoagulant warfarin. 
entities: sulfamethoxazole / warfarin
ddi: effect
>>> match: prolong_nsubj_obj
-------------
sentence: Sulfamethoxazole may inhibit the hepatic metabolism of phenytoin. 
entities: Sulfamethoxazole / phenytoin
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: At a 1.6-g dose, sulfamethoxazole produced a slight but significant increase in the half-life of phenytoin but did not produce a corresponding decrease in the metabolic clearance rate. 
entities: sulfamethoxazole / phenytoin
ddi: mechanism
>>> match: produce_nsubj_obj
-------------
sentence: Sulfonamides can also displace methotrexate from plasma protein-binding sites, thus increasing free methotrexate concentrations. 
entities: Sulfonamides / methotrexate
ddi: mechanism
>>> match: displace_nsubj_obj
-------------
sentence: Sulfonamides can also displace methotrexate from plasma protein-binding sites, thus increasing free methotrexate concentrations. 
entities: Sulfonamides / methotrexate
ddi: null
>>> match: displace_nsubj_dep
-------------
sentence: Sulfonamides can also displace methotrexate from plasma protein-binding sites, thus increasing free methotrexate concentrations. 
entities: methotrexate / methotrexate
ddi: null
>>> match: displace_obj_dep
-------------
sentence: Beta-blockers, clonidine, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.
entities: Beta-blockers / insulin
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Beta-blockers, clonidine, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.
entities: clonidine / insulin
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Beta-blockers, clonidine, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.
entities: lithium / insulin
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Beta-blockers, clonidine, lithium salts, and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin.
entities: alcohol / insulin
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: A clinical study in healthy male volunteers (n=24) demonstrated that mixing NovoLog with NPH human insulin immediately before injection produced some attenuation in the peak concentration of NovoLog, but that the time to peak and the total bioavailability of NovoLog were not significantly affected.
entities: NovoLog / NPH human insulin
ddi: null
>>> match: mix_obj_obl
-------------
sentence: A clinical study in healthy male volunteers (n=24) demonstrated that mixing NovoLog with NPH human insulin immediately before injection produced some attenuation in the peak concentration of NovoLog, but that the time to peak and the total bioavailability of NovoLog were not significantly affected.
entities: NovoLog / NovoLog
ddi: null
>>> match: mix_obj_advcl
-------------
sentence: A clinical study in healthy male volunteers (n=24) demonstrated that mixing NovoLog with NPH human insulin immediately before injection produced some attenuation in the peak concentration of NovoLog, but that the time to peak and the total bioavailability of NovoLog were not significantly affected.
entities: NovoLog / NovoLog
ddi: null
>>> match: mix_obj_conj
-------------
sentence: A clinical study in healthy male volunteers (n=24) demonstrated that mixing NovoLog with NPH human insulin immediately before injection produced some attenuation in the peak concentration of NovoLog, but that the time to peak and the total bioavailability of NovoLog were not significantly affected.
entities: NPH human insulin / NovoLog
ddi: null
>>> match: mix_obl_advcl
-------------
sentence: A clinical study in healthy male volunteers (n=24) demonstrated that mixing NovoLog with NPH human insulin immediately before injection produced some attenuation in the peak concentration of NovoLog, but that the time to peak and the total bioavailability of NovoLog were not significantly affected.
entities: NPH human insulin / NovoLog
ddi: null
>>> match: mix_obl_conj
-------------
sentence: A clinical study in healthy male volunteers (n=24) demonstrated that mixing NovoLog with NPH human insulin immediately before injection produced some attenuation in the peak concentration of NovoLog, but that the time to peak and the total bioavailability of NovoLog were not significantly affected.
entities: NovoLog / NovoLog
ddi: null
>>> match: mix_advcl_conj
-------------
sentence: If NovoLog is mixed with NPH human insulin, NovoLog should be drawn into the syringe first.
entities: NovoLog / NPH human insulin
ddi: null
>>> match: mix_nsubj:pass_obl
-------------
sentence: If NovoLog is mixed with NPH human insulin, NovoLog should be drawn into the syringe first.
entities: NovoLog / NovoLog
ddi: null
>>> match: draw_advcl_nsubj:pass
-------------
sentence: If NovoLog is mixed with NPH human insulin, NovoLog should be drawn into the syringe first.
entities: NPH human insulin / NovoLog
ddi: null
>>> match: draw_advcl_nsubj:pass
-------------
sentence: Because there are no data on the compatibility of NovoLog and crystalline zinc insulin preparations, NovoLog should not be mixed with these preparations.
entities: NovoLog / NovoLog
ddi: null
>>> match: mix_advcl_nsubj:pass
-------------
sentence: Because there are no data on the compatibility of NovoLog and crystalline zinc insulin preparations, NovoLog should not be mixed with these preparations.
entities: zinc insulin / NovoLog
ddi: null
>>> match: mix_advcl_nsubj:pass
-------------
sentence: When used in external subcutaneous infusion pumps for insulin, NovoLog should not be mixed with any other insulins or diluent.
entities: insulin / NovoLog
ddi: null
>>> match: mix_advcl_nsubj:pass
-------------
sentence: When used in external subcutaneous infusion pumps for insulin, NovoLog should not be mixed with any other insulins or diluent.
entities: insulin / insulins
ddi: null
>>> match: mix_advcl_obl
-------------
sentence: When used in external subcutaneous infusion pumps for insulin, NovoLog should not be mixed with any other insulins or diluent.
entities: NovoLog / insulins
ddi: null
>>> match: mix_nsubj:pass_obl
-------------
sentence: Digoxin: Coadministration of digoxin, a P-glycoprotein substrate, with oral conivaptan resulted in a reduction in clearance and an increase in digoxin Cmax and AUC values.
entities: digoxin / digoxin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Digoxin: Coadministration of digoxin, a P-glycoprotein substrate, with oral conivaptan resulted in a reduction in clearance and an increase in digoxin Cmax and AUC values.
entities: conivaptan / digoxin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Therefore, if digoxin is administered with VAPRISOL, the clinician should be alert to the possibility of increases in digoxin levels.
entities: digoxin / VAPRISOL
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: Antiretroviral Agents: No drug interactions with other antiretroviral medications have been identified that would warrant alteration of either the enfuvirtide dose or the dose of the other antiretroviral medication.
entities: antiretroviral medications / enfuvirtide
ddi: null
>>> match: identify_nsubj:pass_ccomp
-------------
sentence: Antiretroviral Agents: No drug interactions with other antiretroviral medications have been identified that would warrant alteration of either the enfuvirtide dose or the dose of the other antiretroviral medication.
entities: antiretroviral medications / antiretroviral medication
ddi: null
>>> match: identify_nsubj:pass_ccomp
-------------
sentence: Hypotension   Patients on Diuretic Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril.
entities: diuretics / captopril
ddi: effect
>>> match: experience_nsubj_advcl
-------------
sentence: Hypotension   Patients on Diuretic Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, as well as those on severe dietary salt restriction or dialysis, may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril.
entities: diuretic / captopril
ddi: null
>>> match: experience_nsubj_advcl
-------------
sentence: The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).
entities: captopril / diuretic
ddi: effect
>>> match: minimize_nsubj:pass_obl
-------------
sentence: The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).
entities: captopril / captopril
ddi: null
>>> match: minimize_nsubj:pass_obl
-------------
sentence: The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).
entities: captopril / captopril
ddi: null
>>> match: minimize_nsubj:pass_obl
-------------
sentence: The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).
entities: diuretic / captopril
ddi: null
>>> match: discontinue_obj_conj
-------------
sentence: The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).
entities: diuretic / captopril
ddi: null
>>> match: discontinue_obj_dep
-------------
sentence: The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).
entities: captopril / captopril
ddi: null
>>> match: discontinue_conj_dep
-------------
sentence: Agents Causing Renin Release Captopril's effect will be augmented by antihypertensive agents that cause renin release.
entities: Captopril / antihypertensive agents
ddi: effect
>>> match: augment_nsubj:pass_obl
-------------
sentence: Beta-adrenergic blocking drugs add some further antihypertensive effect to captopril, but the overall response is less than additive.
entities: Beta-adrenergic blocking drugs / captopril
ddi: effect
>>> match: add_nsubj_obl
-------------
sentence: Inhibitors Of Endogenous Prostaglandin Synthesis It has been reported that indomethacin may reduce the antihypertensive effect of captopril, especially in cases of low renin hypertension.
entities: indomethacin / captopril
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.
entities: lithium / lithium
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.
entities: lithium / ACE inhibitor
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.
entities: lithium / lithium
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.
entities: lithium / ACE inhibitor
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: If a diuretic is also used, it may increase the risk of lithium toxicity.
entities: diuretic / lithium
ddi: effect
>>> match: increase_advcl_obj
-------------
sentence: Loop Diuretics: Furosemide administered concurrently with captopril does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients.
entities: Furosemide / captopril
ddi: null
>>> match: administer_nsubj_obl
-------------
sentence: The potential for drug interactions with EMTRIVA has been studied in combination with indinavir, stavudine, famciclovir, and tenofovir disoproxil fumarate.
entities: EMTRIVA / indinavir
ddi: null
>>> match: study_nsubj:pass_obl
-------------
sentence: The potential for drug interactions with EMTRIVA has been studied in combination with indinavir, stavudine, famciclovir, and tenofovir disoproxil fumarate.
entities: EMTRIVA / stavudine
ddi: null
>>> match: study_nsubj:pass_obl
-------------
sentence: The potential for drug interactions with EMTRIVA has been studied in combination with indinavir, stavudine, famciclovir, and tenofovir disoproxil fumarate.
entities: EMTRIVA / famciclovir
ddi: null
>>> match: study_nsubj:pass_obl
-------------
sentence: Concomitant administration of substances that are also tubularly secreted (e.g., probenecid) could potentially result in delayed clearance of ALIMTA. 
entities: probenecid / ALIMTA
ddi: mechanism
>>> match: result_nsubj_obl
-------------
sentence: Although ibuprofen (400 mg qid) can be administered with ALIMTA in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering ibuprofen concurrently with ALIMTA to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min). 
entities: ibuprofen / ALIMTA
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Although ibuprofen (400 mg qid) can be administered with ALIMTA in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering ibuprofen concurrently with ALIMTA to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min). 
entities: ibuprofen / ibuprofen
ddi: null
>>> match: use_advcl_advmod
-------------
sentence: Although ibuprofen (400 mg qid) can be administered with ALIMTA in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering ibuprofen concurrently with ALIMTA to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min). 
entities: ibuprofen / ALIMTA
ddi: null
>>> match: use_advcl_advmod
-------------
sentence: Although ibuprofen (400 mg qid) can be administered with ALIMTA in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering ibuprofen concurrently with ALIMTA to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min). 
entities: ALIMTA / ibuprofen
ddi: null
>>> match: use_advcl_advmod
-------------
sentence: Although ibuprofen (400 mg qid) can be administered with ALIMTA in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering ibuprofen concurrently with ALIMTA to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min). 
entities: ALIMTA / ALIMTA
ddi: null
>>> match: use_advcl_advmod
-------------
sentence: Patients with mild to moderate renal insufficiency should avoid taking NSAIDs with short elimination half-lives for a period of 2 days before, the day of, and 2 days following administration of ALIMTA. 
entities: NSAIDs / ALIMTA
ddi: advise
>>> match: take_obj_advmod
-------------
sentence: In the absence of data regarding potential interaction between ALIMTA and NSAIDs with longer half-lives, all patients taking these NSAIDs should interrupt dosing for at least 5 days before, the day of, and 2 days following ALIMTA administration. 
entities: ALIMTA / NSAIDs
ddi: null
>>> match: interrupt_obl_nsubj
-------------
sentence: In the absence of data regarding potential interaction between ALIMTA and NSAIDs with longer half-lives, all patients taking these NSAIDs should interrupt dosing for at least 5 days before, the day of, and 2 days following ALIMTA administration. 
entities: ALIMTA / ALIMTA
ddi: null
>>> match: interrupt_obl_obl:npmod
-------------
sentence: In the absence of data regarding potential interaction between ALIMTA and NSAIDs with longer half-lives, all patients taking these NSAIDs should interrupt dosing for at least 5 days before, the day of, and 2 days following ALIMTA administration. 
entities: NSAIDs / NSAIDs
ddi: null
>>> match: interrupt_obl_nsubj
-------------
sentence: In the absence of data regarding potential interaction between ALIMTA and NSAIDs with longer half-lives, all patients taking these NSAIDs should interrupt dosing for at least 5 days before, the day of, and 2 days following ALIMTA administration. 
entities: NSAIDs / ALIMTA
ddi: null
>>> match: interrupt_obl_obl:npmod
-------------
sentence: In the absence of data regarding potential interaction between ALIMTA and NSAIDs with longer half-lives, all patients taking these NSAIDs should interrupt dosing for at least 5 days before, the day of, and 2 days following ALIMTA administration. 
entities: NSAIDs / ALIMTA
ddi: advise
>>> match: interrupt_nsubj_obl:npmod
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / contraceptives
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / antibiotics
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / quinidine
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / theophylline
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / corticosteroids
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / anticoagulants
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / beta blockers
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: contraceptives / antibiotics
ddi: null
>>> match: decrease_obj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: contraceptives / quinidine
ddi: null
>>> match: decrease_obj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: contraceptives / theophylline
ddi: null
>>> match: decrease_obj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: contraceptives / corticosteroids
ddi: null
>>> match: decrease_obj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: contraceptives / anticoagulants
ddi: null
>>> match: decrease_obj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: contraceptives / beta blockers
ddi: null
>>> match: decrease_obj_obj
-------------
sentence: MAO inhibitors and beta adrenergic blockers increase the effects of pseudoephedrine. 
entities: MAO inhibitors / pseudoephedrine
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: MAO inhibitors and beta adrenergic blockers increase the effects of pseudoephedrine. 
entities: beta adrenergic blockers / pseudoephedrine
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Sympathomimetics may reduce the antihypertensive effects of methyldopa, mecamylamine, reserpine and veratrum alkaloids.
entities: Sympathomimetics / methyldopa
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Sympathomimetics may reduce the antihypertensive effects of methyldopa, mecamylamine, reserpine and veratrum alkaloids.
entities: Sympathomimetics / mecamylamine
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Sympathomimetics may reduce the antihypertensive effects of methyldopa, mecamylamine, reserpine and veratrum alkaloids.
entities: Sympathomimetics / reserpine
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Sympathomimetics may reduce the antihypertensive effects of methyldopa, mecamylamine, reserpine and veratrum alkaloids.
entities: Sympathomimetics / veratrum alkaloids
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Intravenous ranitidine was shown to double the bioavailability of oral alendronate.
entities: ranitidine / alendronate
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Products containing calcium and other multivalent cations likely will interfere with absorption of alendronate.
entities: calcium / alendronate
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Products containing calcium and other multivalent cations likely will interfere with absorption of alendronate.
entities: multivalent cations / alendronate
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Cholestyramine and colestipol resins: Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.
entities: hydrochlorothiazide / anionic exchange resins
ddi: mechanism
>>> match: impair_nsubj:pass_obl
-------------
sentence: Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.
entities: cholestyramine / hydrochlorothiazide
ddi: mechanism
>>> match: bind_nsubj_obj
-------------
sentence: Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.
entities: colestipol / hydrochlorothiazide
ddi: mechanism
>>> match: bind_nsubj_obj
-------------
sentence: Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively.
entities: resins / hydrochlorothiazide
ddi: null
>>> match: bind_nsubj_obj
-------------
sentence: Corticosteroids, ACTH: intensified electrolyte depletion, particularly hypokalemia.
entities: Corticosteroids / ACTH
ddi: null
>>> match: intensify_nsubj_nsubj
-------------
sentence: Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity.
entities: Diuretic agents / lithium
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity.
entities: Diuretic agents / lithium
ddi: effect
>>> match: reduce_nsubj_conj
-------------
sentence: Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity.
entities: lithium / lithium
ddi: null
>>> match: reduce_obj_conj
-------------
sentence: Refer to the package insert for lithium preparations before use of such preparations with Hydrochlorothiazide.
entities: lithium / Hydrochlorothiazide
ddi: advise
>>> match: refer_obl_obl
-------------
sentence: Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics.
entities: non-steroidal anti-inflammatory agent / potassium-sparing diuretics
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Non-steroidal Anti-inflammatory Drugs: In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics.
entities: non-steroidal anti-inflammatory agent / thiazide diuretics
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Therefore, when Hydrochlorothiazide and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.
entities: Hydrochlorothiazide / diuretic
ddi: null
>>> match: observe_advcl_xcomp
-------------
sentence: Therefore, when Hydrochlorothiazide and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.
entities: non-steroidal anti-inflammatory agents / diuretic
ddi: null
>>> match: observe_advcl_xcomp
-------------
sentence: As with other cephalosporins, high concentrations of cefotetan may interfere with measurement of serum and urine creatinine levels by Jaffe  reaction and produce false increases in the levels of creatinine reported.
entities: cephalosporins / cefotetan
ddi: null
>>> match: interfere_obl_nsubj
-------------
sentence: The anxiogenic effects of theophylline were reduced by pretreatment with CGS 21680, an A2-selective agonist, but not by N6-cyclopentyladenosine (CPA), an A1-selective agonist. 
entities: theophylline / CGS 21680
ddi: effect
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The anxiogenic effects of theophylline were reduced by pretreatment with CGS 21680, an A2-selective agonist, but not by N6-cyclopentyladenosine (CPA), an A1-selective agonist. 
entities: theophylline / N6-cyclopentyladenosine
ddi: null
>>> match: reduce_nsubj:pass_conj
-------------
sentence: The anxiogenic effects of theophylline were reduced by pretreatment with CGS 21680, an A2-selective agonist, but not by N6-cyclopentyladenosine (CPA), an A1-selective agonist. 
entities: theophylline / CPA
ddi: null
>>> match: reduce_nsubj:pass_conj
-------------
sentence: The anxiogenic effects of theophylline were reduced by pretreatment with CGS 21680, an A2-selective agonist, but not by N6-cyclopentyladenosine (CPA), an A1-selective agonist. 
entities: CGS 21680 / N6-cyclopentyladenosine
ddi: null
>>> match: reduce_obl_conj
-------------
sentence: The anxiogenic effects of theophylline were reduced by pretreatment with CGS 21680, an A2-selective agonist, but not by N6-cyclopentyladenosine (CPA), an A1-selective agonist. 
entities: CGS 21680 / CPA
ddi: null
>>> match: reduce_obl_conj
-------------
sentence: However, the antagonism of the theophylline-induced anxiogenic effects by CGS21680 was only observed in the time spent in the light zone, and DPCPX-induced anxiogenic effects were neither reversed by CGS 21680 nor by CPA. 
entities: theophylline / DPCPX
ddi: null
>>> match: observe_nsubj:pass_conj
-------------
sentence: However, the antagonism of the theophylline-induced anxiogenic effects by CGS21680 was only observed in the time spent in the light zone, and DPCPX-induced anxiogenic effects were neither reversed by CGS 21680 nor by CPA. 
entities: theophylline / CGS 21680
ddi: null
>>> match: observe_nsubj:pass_conj
-------------
sentence: However, the antagonism of the theophylline-induced anxiogenic effects by CGS21680 was only observed in the time spent in the light zone, and DPCPX-induced anxiogenic effects were neither reversed by CGS 21680 nor by CPA. 
entities: theophylline / CPA
ddi: null
>>> match: observe_nsubj:pass_conj
-------------
sentence: However, the antagonism of the theophylline-induced anxiogenic effects by CGS21680 was only observed in the time spent in the light zone, and DPCPX-induced anxiogenic effects were neither reversed by CGS 21680 nor by CPA. 
entities: CGS21680 / DPCPX
ddi: null
>>> match: observe_nsubj:pass_conj
-------------
sentence: However, the antagonism of the theophylline-induced anxiogenic effects by CGS21680 was only observed in the time spent in the light zone, and DPCPX-induced anxiogenic effects were neither reversed by CGS 21680 nor by CPA. 
entities: CGS21680 / CGS 21680
ddi: null
>>> match: observe_nsubj:pass_conj
-------------
sentence: However, the antagonism of the theophylline-induced anxiogenic effects by CGS21680 was only observed in the time spent in the light zone, and DPCPX-induced anxiogenic effects were neither reversed by CGS 21680 nor by CPA. 
entities: CGS21680 / CPA
ddi: null
>>> match: observe_nsubj:pass_conj
-------------
sentence: However, the antagonism of the theophylline-induced anxiogenic effects by CGS21680 was only observed in the time spent in the light zone, and DPCPX-induced anxiogenic effects were neither reversed by CGS 21680 nor by CPA. 
entities: DPCPX / CGS 21680
ddi: null
>>> match: reverse_nsubj:pass_obl
-------------
sentence: However, the antagonism of the theophylline-induced anxiogenic effects by CGS21680 was only observed in the time spent in the light zone, and DPCPX-induced anxiogenic effects were neither reversed by CGS 21680 nor by CPA. 
entities: DPCPX / CPA
ddi: null
>>> match: reverse_nsubj:pass_obl
-------------
sentence: Glyburide: In a randomized, multiple-dose crossover study, patients with Type 2 diabetes were administered 120 mg Starlix three times a day before meals for 1 day in combination with glyburide 10 mg daily.
entities: Starlix / glyburide
ddi: null
>>> match: administer_obj_obl
-------------
sentence: Digoxin: When Starlix 120 mg before meals was administered in combination with a single 1-mg dose of digoxin to healthy volunteers, there were no clinically relevant changes in the pharmacokinetics of either agent.
entities: Starlix / digoxin
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Warfarin: When healthy subjects were administered Starlix 120 mg three times daily before meals for four days in combination with a single dose of warfarin 30 mg on day 2, there were no alterations in the pharmacokinetics of either agent.
entities: Starlix / warfarin
ddi: null
>>> match: administer_obj_obl:npmod
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: furosemide / nateglinide
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: propranolol / nateglinide
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: captopril / nateglinide
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: nicardipine / nateglinide
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: pravastatin / nateglinide
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: glyburide / nateglinide
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: warfarin / nateglinide
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: phenytoin / nateglinide
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: acetylsalicylic acid / nateglinide
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: tolbutamide / nateglinide
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: In vitro displacement studies with highly protein-bound drugs such as furosemide, propranolol, captopril, nicardipine, pravastatin, glyburide, warfarin, phenytoin, acetylsalicylic acid, tolbutamide, and metformin showed no influence on the extent of nateglinide protein binding.
entities: metformin / nateglinide
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / propranolol
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / glyburide
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / nicardipine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / warfarin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / phenytoin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / acetylsalicylic acid
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Similarly, nateglinide had no influence on the serum protein binding of propranolol, glyburide, nicardipine, warfarin, phenytoin, acetylsalicylic acid, and tolbutamide in vitro .
entities: nateglinide / tolbutamide
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: nonsteroidal anti-inflammatory agents / Starlix
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: nonsteroidal anti-inflammatory agents / antidiabetic drugs
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: NSAIDs / Starlix
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: NSAIDs / antidiabetic drugs
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: salicylates / Starlix
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: salicylates / antidiabetic drugs
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: monoamine oxidase inhibitors / Starlix
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: monoamine oxidase inhibitors / antidiabetic drugs
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: non-selective beta-adrenergic-blocking agents / Starlix
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Certain drugs, including nonsteroidal anti-inflammatory agents (NSAIDs), salicylates, monoamine oxidase inhibitors, and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: non-selective beta-adrenergic-blocking agents / antidiabetic drugs
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: thiazides / Starlix
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: thiazides / antidiabetic drugs
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: corticosteroids / Starlix
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: corticosteroids / antidiabetic drugs
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: thyroid products / Starlix
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: thyroid products / antidiabetic drugs
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: sympathomimetics / Starlix
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Certain drugs including thiazides, corticosteroids, thyroid products, and sympathomimetics may reduce the hypoglycemic action of Starlix and other oral antidiabetic drugs.
entities: sympathomimetics / antidiabetic drugs
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.
entities: Chloramphenicol / penicillins
ddi: effect
>>> match: interfere_nsubj_obl
-------------
sentence: Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.
entities: erythromycins / penicillins
ddi: effect
>>> match: interfere_nsubj_obl
-------------
sentence: Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.
entities: sulfonamides / penicillins
ddi: effect
>>> match: interfere_nsubj_obl
-------------
sentence: Bacteriostatic Antibiotics: Chloramphenicol, erythromycins, sulfonamides, or tetracyclines may interfere with the bactericidal effect of penicillins.
entities: tetracyclines / penicillins
ddi: effect
>>> match: interfere_nsubj_obl
-------------
sentence: Drug/Laboratory Test Interaction After treatment with ampicillin, a false-positive reaction for glucose in the urine may occur with copper sulfate tests (Benedicts solution, Fehlings solution, or Clinitest tablets) but not with enzyme based tests such as Clinistix and Glucose Enzymatic Test Strip USP.
entities: ampicillin / copper sulfate
ddi: null
>>> match: occur_obl_obl
-------------
sentence: Concomitant administration of naproxen and aspirin is not recommended because naproxen is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations and peak plasma levels.
entities: naproxen / aspirin
ddi: advise
>>> match: displace_nsubj:pass_obl
-------------
sentence: Naproxen and other NSAIDs can reduce the antihypertensive effect of propranolol and other beta-blockers.
entities: Naproxen / propranolol
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Naproxen and other NSAIDs can reduce the antihypertensive effect of propranolol and other beta-blockers.
entities: Naproxen / beta-blockers
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Naproxen and other NSAIDs can reduce the antihypertensive effect of propranolol and other beta-blockers.
entities: NSAIDs / propranolol
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Naproxen and other NSAIDs can reduce the antihypertensive effect of propranolol and other beta-blockers.
entities: NSAIDs / beta-blockers
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Caution should be used if naproxen is administered concomitantly with methotrexate.
entities: naproxen / methotrexate
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Naproxen, naproxen sodium and other NSAIDs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly increasing the toxicity of methotrexate.
entities: Naproxen / methotrexate
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Naproxen, naproxen sodium and other NSAIDs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly increasing the toxicity of methotrexate.
entities: Naproxen / methotrexate
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Naproxen, naproxen sodium and other NSAIDs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly increasing the toxicity of methotrexate.
entities: naproxen sodium / methotrexate
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Naproxen, naproxen sodium and other NSAIDs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly increasing the toxicity of methotrexate.
entities: naproxen sodium / methotrexate
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Naproxen, naproxen sodium and other NSAIDs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly increasing the toxicity of methotrexate.
entities: NSAIDs / methotrexate
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Naproxen, naproxen sodium and other NSAIDs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly increasing the toxicity of methotrexate.
entities: NSAIDs / methotrexate
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Naproxen, naproxen sodium and other NSAIDs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly increasing the toxicity of methotrexate.
entities: methotrexate / methotrexate
ddi: null
>>> match: reduce_obj_dep
-------------
sentence: Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.
entities: Keppra / phenytoin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.
entities: Antiepileptic Drugs / phenytoin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.
entities: AEDs / phenytoin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.
entities: Phenytoin / phenytoin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Drug-Drug Interactions Between Keppra  And Other Antiepileptic Drugs (AEDs) Phenytoin Keppra  (3000 mg daily) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy.
entities: Keppra / phenytoin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: Keppra / levetiracetam
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: Keppra / AEDs
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: AEDs / levetiracetam
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: AEDs / AEDs
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: carbamazepine / levetiracetam
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: carbamazepine / AEDs
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: gabapentin / levetiracetam
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: gabapentin / AEDs
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: lamotrigine / levetiracetam
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: lamotrigine / AEDs
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: phenobarbital / levetiracetam
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: phenobarbital / AEDs
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: phenytoin / levetiracetam
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: phenytoin / AEDs
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: primidone / levetiracetam
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: primidone / AEDs
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: valproate / levetiracetam
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Potential drug interactions between Keppra  and other AEDs (carbamazepine, gabapentin, lamotrigine, phenobarbital, phenytoin, primidone and valproate) were also assessed by evaluating the serum concentrations of levetiracetam and these AEDs during placebo-controlled clinical studies.
entities: valproate / AEDs
ddi: null
>>> match: assess_nsubj:pass_advmod
-------------
sentence: Effect of AEDs in Pediatric Patients There was about a 22% increase of apparent total body clearance of levetiracetam when it was co-administered with enzyme-inducing AEDs.
entities: AEDs / levetiracetam
ddi: null
>>> match: be_nsubj_obl
-------------
sentence: Effect of AEDs in Pediatric Patients There was about a 22% increase of apparent total body clearance of levetiracetam when it was co-administered with enzyme-inducing AEDs.
entities: AEDs / AEDs
ddi: null
>>> match: be_nsubj_obl
-------------
sentence: Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or lamotrigine.
entities: Levetiracetam / carbamazepine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or lamotrigine.
entities: Levetiracetam / valproate
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or lamotrigine.
entities: Levetiracetam / topiramate
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or lamotrigine.
entities: Levetiracetam / lamotrigine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Probenecid: Probenecid, a renal tubular secretion blocking agent, administered at a dose of 500 mg four times a day, did not change the pharmacokinetics of levetiracetam 1000 mg twice daily.
entities: Probenecid / levetiracetam
ddi: null
>>> match: administer_nsubj_dep
-------------
sentence: If ZEMURON    is administered following administration of succinylcholine, it should not be given until recovery from succinylcholine has been observed. 
entities: ZEMURON / succinylcholine
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: If ZEMURON    is administered following administration of succinylcholine, it should not be given until recovery from succinylcholine has been observed. 
entities: ZEMURON / succinylcholine
ddi: null
>>> match: give_advcl_advcl
-------------
sentence: If ZEMURON    is administered following administration of succinylcholine, it should not be given until recovery from succinylcholine has been observed. 
entities: succinylcholine / succinylcholine
ddi: null
>>> match: give_advcl_advcl
-------------
sentence: There are no controlled studies documenting the use of ZEMURON    before or after other nondepolarizing muscle relaxants. 
entities: ZEMURON / nondepolarizing muscle relaxants
ddi: null
>>> match: document_obj_obl
-------------
sentence: The serum concentration of phenytoin increased dramatically from 16.6 to 49.1 microg/mL when fluvoxamine was coadministered, although the daily dosage of phenytoin and other drugs had not changed. 
entities: phenytoin / fluvoxamine
ddi: null
>>> match: increase_nsubj_obl
-------------
sentence: The serum concentration of phenytoin increased dramatically from 16.6 to 49.1 microg/mL when fluvoxamine was coadministered, although the daily dosage of phenytoin and other drugs had not changed. 
entities: phenytoin / phenytoin
ddi: null
>>> match: increase_nsubj_obl
-------------
sentence: The serum concentration of phenytoin increased dramatically from 16.6 to 49.1 microg/mL when fluvoxamine was coadministered, although the daily dosage of phenytoin and other drugs had not changed. 
entities: phenytoin / drugs
ddi: null
>>> match: increase_nsubj_obl
-------------
sentence: The serum concentration of phenytoin increased dramatically from 16.6 to 49.1 microg/mL when fluvoxamine was coadministered, although the daily dosage of phenytoin and other drugs had not changed. 
entities: fluvoxamine / phenytoin
ddi: null
>>> match: coadminister_nsubj:pass_advcl
-------------
sentence: The serum concentration of phenytoin increased dramatically from 16.6 to 49.1 microg/mL when fluvoxamine was coadministered, although the daily dosage of phenytoin and other drugs had not changed. 
entities: fluvoxamine / drugs
ddi: null
>>> match: coadminister_nsubj:pass_advcl
-------------
sentence: Therefore, caution should be used when administering nitazoxanide concurrently with other highly plasma protein-bound drugs with narrow therapeutic indices, as competition for binding sites may occur (e.g., warfarin).
entities: nitazoxanide / warfarin
ddi: mechanism
>>> match: occur_nsubj_punct
-------------
sentence: The 20% v/v solution of alcohol was prepared in water from a stock solution of 95% ethanol. 
entities: alcohol / ethanol
ddi: null
>>> match: prepare_nsubj:pass_obl
-------------
sentence: These results suggest that exposure to environmental lead may alter the biological and behavioral responsiveness of an animal to alcohol.
entities: lead / alcohol
ddi: effect
>>> match: alter_nsubj_obj
-------------
sentence: - Lithium: Lithium should generally not be given with diuretics (such as bumetanide) because they reduce its renal clearance and add a high risk of lithium toxicity.
entities: Lithium / diuretics
ddi: advise
>>> match: give_nsubj:pass_obl
-------------
sentence: - Lithium: Lithium should generally not be given with diuretics (such as bumetanide) because they reduce its renal clearance and add a high risk of lithium toxicity.
entities: Lithium / bumetanide
ddi: advise
>>> match: give_nsubj:pass_obl
-------------
sentence: - Lithium: Lithium should generally not be given with diuretics (such as bumetanide) because they reduce its renal clearance and add a high risk of lithium toxicity.
entities: Lithium / lithium
ddi: null
>>> match: give_nsubj:pass_advcl
-------------
sentence: - Lithium: Lithium should generally not be given with diuretics (such as bumetanide) because they reduce its renal clearance and add a high risk of lithium toxicity.
entities: diuretics / lithium
ddi: null
>>> match: give_obl_advcl
-------------
sentence: - Lithium: Lithium should generally not be given with diuretics (such as bumetanide) because they reduce its renal clearance and add a high risk of lithium toxicity.
entities: bumetanide / lithium
ddi: null
>>> match: give_obl_advcl
-------------
sentence: - Probenecid: Pretreatment with probenecid reduces both the natriuresis and hyperreninemia produced by bumetanide.
entities: probenecid / bumetanide
ddi: effect
>>> match: reduce_nsubj_dep
-------------
sentence: Thus, probenecid should not be administered concurrently with bumetanide.
entities: probenecid / bumetanide
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: - Indomethacin: Indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide-induced increase in plasma renin activity.
entities: Indomethacin / bumetanide
ddi: mechanism
>>> match: blunt_nsubj_dep
-------------
sentence: - Indomethacin: Indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide-induced increase in plasma renin activity.
entities: Indomethacin / bumetanide
ddi: effect
>>> match: blunt_nsubj_conj
-------------
sentence: - Indomethacin: Indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide-induced increase in plasma renin activity.
entities: bumetanide / bumetanide
ddi: null
>>> match: blunt_dep_conj
-------------
sentence: - Antihypertensives: Bumetanide may potentiate the effect of various antihypertensive drugs, necessitating a reduction in the dosage of these drugs.
entities: Bumetanide / antihypertensive drugs
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: - Anticoagulants: Interaction studies in humans have shown bumetanide to have no effect on warfarin metabolism or on plasma prothrombin activity.
entities: bumetanide / warfarin
ddi: null
>>> match: show_obj_xcomp
-------------
sentence: Dexamethasone and retinyl acetate similarly inhibit and stimulate EGF- or insulin-induced proliferation of prostatic epithelium.
entities: Dexamethasone / EGF
ddi: effect
>>> match: inhibit_nsubj_conj
-------------
sentence: Dexamethasone and retinyl acetate similarly inhibit and stimulate EGF- or insulin-induced proliferation of prostatic epithelium.
entities: Dexamethasone / insulin
ddi: effect
>>> match: inhibit_nsubj_conj
-------------
sentence: Dexamethasone and retinyl acetate similarly inhibit and stimulate EGF- or insulin-induced proliferation of prostatic epithelium.
entities: retinyl acetate / EGF
ddi: effect
>>> match: inhibit_nsubj_conj
-------------
sentence: Dexamethasone and retinyl acetate similarly inhibit and stimulate EGF- or insulin-induced proliferation of prostatic epithelium.
entities: retinyl acetate / insulin
ddi: effect
>>> match: inhibit_nsubj_conj
-------------
sentence: Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin. 
entities: dexamethasone / transferrin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin. 
entities: dexamethasone / EGF
ddi: effect
>>> match: modify_advcl_obj
-------------
sentence: Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin. 
entities: dexamethasone / insulin
ddi: effect
>>> match: modify_advcl_obj
-------------
sentence: Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin. 
entities: retinyl acetate / transferrin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin. 
entities: retinyl acetate / EGF
ddi: effect
>>> match: modify_advcl_obj
-------------
sentence: Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin. 
entities: retinyl acetate / insulin
ddi: effect
>>> match: modify_advcl_obj
-------------
sentence: Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin. 
entities: transferrin / EGF
ddi: null
>>> match: modify_advcl_obj
-------------
sentence: Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin. 
entities: transferrin / insulin
ddi: null
>>> match: modify_advcl_obj
-------------
sentence: Higher concentrations of dexamethasone (10(-8) - 10(-6) M) or retinyl acetate (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of EGF. 
entities: dexamethasone / EGF
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Higher concentrations of dexamethasone (10(-8) - 10(-6) M) or retinyl acetate (3 X 10(-8) - 10(-7) M) enhance the mitogenic activity of EGF. 
entities: retinyl acetate / EGF
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Dexamethasone had a similar effect in the presence of insulin. 
entities: Dexamethasone / insulin
ddi: null
>>> match: have_nsubj_obl
-------------
sentence: However, retinyl acetate stimulated, but did not significantly inhibit, proliferation in the presence of insulin. 
entities: retinyl acetate / insulin
ddi: effect
>>> match: stimulate_nsubj_conj
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: dexamethasone / insulin
ddi: effect
>>> match: regulate_nsubj_obl
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: dexamethasone / EGF
ddi: effect
>>> match: regulate_nsubj_obl
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: retinyl acetate / insulin
ddi: effect
>>> match: regulate_nsubj_obl
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: retinyl acetate / EGF
ddi: effect
>>> match: regulate_nsubj_obl
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: glucocorticoids / insulin
ddi: effect
>>> match: regulate_nsubj_obl
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: glucocorticoids / EGF
ddi: effect
>>> match: regulate_nsubj_obl
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: retinoids / insulin
ddi: effect
>>> match: regulate_nsubj_obl
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: retinoids / EGF
ddi: effect
>>> match: regulate_nsubj_obl
-------------
sentence: Aminoglutethimide: Aminoglutethimide may diminish adrenal suppression by corticosteroids.
entities: Aminoglutethimide / corticosteroids
ddi: effect
>>> match: diminish_nsubj_obl
-------------
sentence: Amphotericin B injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents (e.g., amphotericin B, diuretics), patients should be observed closely for development of hypokalemia.
entities: corticosteroids / amphotericin B
ddi: advise
>>> match: administer_nsubj:pass_dep
-------------
sentence: Amphotericin B injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents (e.g., amphotericin B, diuretics), patients should be observed closely for development of hypokalemia.
entities: corticosteroids / diuretics
ddi: advise
>>> match: administer_nsubj:pass_dep
-------------
sentence: Antibiotics: Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance.
entities: Macrolide antibiotics / corticosteroid
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: If possible, anticholinesterase agents should be withdrawn at least 24 hours before initiating corticosteroid therapy.
entities: anticholinesterase agents / corticosteroid
ddi: advise
>>> match: withdraw_nsubj:pass_obl
-------------
sentence: Anticoagulants, oral: Co-administration of corticosteroids and warfarin usually results in inhibition of response to warfarin, although there have been some conflicting reports.
entities: Anticoagulants / warfarin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Anticoagulants, oral: Co-administration of corticosteroids and warfarin usually results in inhibition of response to warfarin, although there have been some conflicting reports.
entities: corticosteroids / warfarin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Anticoagulants, oral: Co-administration of corticosteroids and warfarin usually results in inhibition of response to warfarin, although there have been some conflicting reports.
entities: warfarin / warfarin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Antidiabetics: Because corticosteroids may increase blood glucose concentrations, dosage adjustments of antidiabetic agents may be required.
entities: corticosteroids / antidiabetic agents
ddi: effect
>>> match: require_advcl_nsubj:pass
-------------
sentence: Cholestyramine: Cholestyramine may increase the clearance of corticosteroids.
entities: Cholestyramine / corticosteroids
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Ephedrine: Ephedrine may enhance the metabolic clearance of corticosteroids, resulting in decreased blood levels and lessened physiologic activity, thus requiring an increase in corticosteroid dosage.
entities: Ephedrine / corticosteroids
ddi: mechanism
>>> match: enhance_nsubj_obj
-------------
sentence: Ephedrine: Ephedrine may enhance the metabolic clearance of corticosteroids, resulting in decreased blood levels and lessened physiologic activity, thus requiring an increase in corticosteroid dosage.
entities: Ephedrine / corticosteroid
ddi: null
>>> match: enhance_nsubj_dep
-------------
sentence: Ephedrine: Ephedrine may enhance the metabolic clearance of corticosteroids, resulting in decreased blood levels and lessened physiologic activity, thus requiring an increase in corticosteroid dosage.
entities: corticosteroids / corticosteroid
ddi: null
>>> match: enhance_obj_dep
-------------
sentence: Estrogens, including oral contraceptives: Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect.
entities: Estrogens / corticosteroids
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: barbiturates / corticosteroids
ddi: mechanism
>>> match: enhance_nsubj_obj
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: barbiturates / corticosteroid
ddi: null
>>> match: enhance_nsubj_conj
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: phenytoin / corticosteroids
ddi: mechanism
>>> match: enhance_nsubj_obj
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: phenytoin / corticosteroid
ddi: null
>>> match: enhance_nsubj_conj
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: carbamazepine / corticosteroids
ddi: mechanism
>>> match: enhance_nsubj_obj
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: carbamazepine / corticosteroid
ddi: null
>>> match: enhance_nsubj_conj
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: rifampin / corticosteroids
ddi: mechanism
>>> match: enhance_nsubj_obj
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: rifampin / corticosteroid
ddi: null
>>> match: enhance_nsubj_conj
-------------
sentence: Hepatic Enzyme Inducers, Inhibitors and Substrates: Drugs which induce cytochrome P450 3A4 (CYP 3A4) enzyme activity (e.g., barbiturates, phenytoin, carbamazepine, rifampin) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased.
entities: corticosteroids / corticosteroid
ddi: null
>>> match: enhance_obj_conj
-------------
sentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.
entities: ketoconazole / corticosteroids
ddi: mechanism
>>> match: have_nsubj_ccomp
-------------
sentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.
entities: macrolide antibiotics / corticosteroids
ddi: mechanism
>>> match: have_nsubj_ccomp
-------------
sentence: Drugs which inhibit CYP 3A4 (e.g., ketoconazole, macrolide antibiotics such as erythromycin) have the potential to result in increased plasma concentrations of corticosteroids.
entities: erythromycin / corticosteroids
ddi: mechanism
>>> match: have_nsubj_ccomp
-------------
sentence: Ketoconazole: Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60%, leading to increased risk of corticosteroid side effects.
entities: Ketoconazole / corticosteroids
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Ketoconazole: Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60%, leading to increased risk of corticosteroid side effects.
entities: Ketoconazole / corticosteroid
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Ketoconazole: Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60%, leading to increased risk of corticosteroid side effects.
entities: corticosteroids / corticosteroid
ddi: null
>>> match: decrease_obj_dep
-------------
sentence: In addition, ketoconazole alone can inhibit adrenal corticosteroid synthesis and may cause adrenal insufficiency during corticosteroid withdrawal.
entities: ketoconazole / corticosteroid
ddi: effect
>>> match: inhibit_nsubj_obj
-------------
sentence: Aspirin should be used cautiously in conjunction with corticosteroids in hypoprothrombinemia.
entities: Aspirin / corticosteroids
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: The clearance of salicylates may be increased with concurrent use of corticosteroids.
entities: salicylates / corticosteroids
ddi: mechanism
>>> match: increase_nsubj:pass_obl
-------------
sentence: Vaccines: Patients on corticosteroid therapy may exhibit a diminished response to toxoids and live or inactivated vaccines due to inhibition of antibody response.
entities: corticosteroid / live vaccines
ddi: effect
>>> match: exhibit_nsubj_obj
-------------
sentence: Vaccines: Patients on corticosteroid therapy may exhibit a diminished response to toxoids and live or inactivated vaccines due to inhibition of antibody response.
entities: corticosteroid / inactivated vaccines
ddi: effect
>>> match: exhibit_nsubj_obj
-------------
sentence: Corticosteroids may also potentiate the replication of some organisms contained in live attenuated vaccines.
entities: Corticosteroids / live attenuated vaccines
ddi: effect
>>> match: potentiate_nsubj_ccomp
-------------
sentence: Routine administration of vaccines or toxoids should be deferred until corticosteroid therapy is discontinued if possible.
entities: vaccines / corticosteroid
ddi: advise
>>> match: defer_nsubj:pass_advcl
-------------
sentence: Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with DIFFERIN Gel.
entities: sulfur / DIFFERIN
ddi: null
>>> match: use_obj_obl
-------------
sentence: Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with DIFFERIN Gel.
entities: resorcinol / DIFFERIN
ddi: null
>>> match: use_obj_obl
-------------
sentence: Particular caution should be exercised in using preparations containing sulfur, resorcinol, or salicylic acid in combination with DIFFERIN Gel.
entities: salicylic acid / DIFFERIN
ddi: null
>>> match: use_obj_obl
-------------
sentence: Boric acid may interact with the idoxuridine preparation causing a gritty substance to form or may interact with the preservative in the idoxuridine preparation causing a toxic effect in the eye.
entities: Boric acid / idoxuridine
ddi: mechanism
>>> match: interact_nsubj_obl
-------------
sentence: Boric acid may interact with the idoxuridine preparation causing a gritty substance to form or may interact with the preservative in the idoxuridine preparation causing a toxic effect in the eye.
entities: Boric acid / idoxuridine
ddi: null
>>> match: interact_nsubj_obl
-------------
sentence: Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone.
entities: oxyphenbutazone / oxyphenbutazone
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone.
entities: androgens / oxyphenbutazone
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In diabetic patients, the metabolic effects of androgens may decrease blood glucose and therefore, insulin requirements.
entities: androgens / insulin
ddi: effect
>>> match: decrease_nsubj_conj
-------------
sentence: Because of the danger of a potentially fatal prolongation of the QTc interval, halofantrine must not be given simultaneously with or subsequent to Mefloquine.
entities: halofantrine / Mefloquine
ddi: advise
>>> match: give_nsubj:pass_obl
-------------
sentence: In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.
entities: anticonvulsant / Mefloquine
ddi: effect
>>> match: reduce_obl_nsubj
-------------
sentence: In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.
entities: anticonvulsant / anticonvulsant
ddi: null
>>> match: reduce_obl_advcl
-------------
sentence: In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.
entities: valproic acid / Mefloquine
ddi: effect
>>> match: reduce_obl_nsubj
-------------
sentence: In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.
entities: valproic acid / anticonvulsant
ddi: null
>>> match: reduce_obl_advcl
-------------
sentence: In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.
entities: carbamazepine / Mefloquine
ddi: effect
>>> match: reduce_obl_nsubj
-------------
sentence: In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.
entities: carbamazepine / anticonvulsant
ddi: null
>>> match: reduce_obl_advcl
-------------
sentence: In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.
entities: phenobarbital / Mefloquine
ddi: effect
>>> match: reduce_obl_nsubj
-------------
sentence: In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.
entities: phenobarbital / anticonvulsant
ddi: null
>>> match: reduce_obl_advcl
-------------
sentence: In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.
entities: phenytoin / Mefloquine
ddi: effect
>>> match: reduce_obl_nsubj
-------------
sentence: In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.
entities: phenytoin / anticonvulsant
ddi: null
>>> match: reduce_obl_advcl
-------------
sentence: In patients taking an anticonvulsant (eg, valproic acid, carbamazepine, phenobarbital or phenytoin), the concomitant use of Mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant.
entities: Mefloquine / anticonvulsant
ddi: null
>>> match: reduce_nsubj_advcl
-------------
sentence: When Mefloquine is taken concurrently with oral live typhoid vaccines, attenuation of immunization cannot be excluded.
entities: Mefloquine / live typhoid vaccines
ddi: effect
>>> match: take_nsubj:pass_obl
-------------
sentence: CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, simvastatin). 
entities: Macrolide antibiotics / HMG-CoA reductase inhibitors
ddi: null
>>> match: inhibit_nsubj_obj
-------------
sentence: CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, simvastatin). 
entities: Macrolide antibiotics / atorvastatin
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, simvastatin). 
entities: Macrolide antibiotics / cerivastatin
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, simvastatin). 
entities: Macrolide antibiotics / lovastatin
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: CONCLUSIONS: Macrolide antibiotics inhibit the metabolism of HMG-CoA reductase inhibitors that are metabolized by CYP3A4 (i.e., atorvastatin, cerivastatin, lovastatin, simvastatin). 
entities: Macrolide antibiotics / simvastatin
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: The possibility of hypotensive effects with Lotensin can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with Lotensin.
entities: Lotensin / diuretic
ddi: null
>>> match: minimize_nsubj:pass_obl
-------------
sentence: The possibility of hypotensive effects with Lotensin can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with Lotensin.
entities: Lotensin / Lotensin
ddi: null
>>> match: minimize_nsubj:pass_obl
-------------
sentence: The possibility of hypotensive effects with Lotensin can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with Lotensin.
entities: diuretic / Lotensin
ddi: advise
>>> match: discontinue_obj_conj
-------------
sentence: Potassium Supplements and Potassium-Sparing Diuretics Lotensin can attenuate potassium loss caused by thiazide diuretics.
entities: Potassium / thiazide diuretics
ddi: null
>>> match: attenuate_nsubj_dep
-------------
sentence: Oral Anticoagulants Interaction studies with warfarin and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants.
entities: Anticoagulants / anticoagulants
ddi: null
>>> match: fail_nsubj_xcomp
-------------
sentence: Oral Anticoagulants Interaction studies with warfarin and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants.
entities: warfarin / anticoagulants
ddi: null
>>> match: fail_nsubj_xcomp
-------------
sentence: Oral Anticoagulants Interaction studies with warfarin and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants.
entities: acenocoumarol / anticoagulants
ddi: null
>>> match: fail_nsubj_xcomp
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.
entities: lithium / ACE inhibitors
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.
entities: lithium / lithium
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.
entities: lithium / ACE inhibitors
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.
entities: lithium / lithium
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.
entities: ACE inhibitors / lithium
ddi: mechanism
>>> match: receive_obj_obl
-------------
sentence: If a diuretic is also used, the risk of lithium toxicity may be increased.
entities: diuretic / lithium
ddi: effect
>>> match: increase_advcl_nsubj:pass
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / hydrochlorothiazide
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / chlorthalidone
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / furosemide
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / digoxin
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / propranolol
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / atenolol
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / naproxen
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / cimetidine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Lotensin has been used concomitantly with beta-adrenergic-blocking agents, calcium-channel-blocking agents, diuretics, digoxin, and hydralazine, without evidence of clinically important adverse interactions.
entities: Lotensin / beta-adrenergic-blocking agents
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Lotensin has been used concomitantly with beta-adrenergic-blocking agents, calcium-channel-blocking agents, diuretics, digoxin, and hydralazine, without evidence of clinically important adverse interactions.
entities: Lotensin / calcium-channel-blocking agents
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Lotensin has been used concomitantly with beta-adrenergic-blocking agents, calcium-channel-blocking agents, diuretics, digoxin, and hydralazine, without evidence of clinically important adverse interactions.
entities: Lotensin / diuretics
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Lotensin has been used concomitantly with beta-adrenergic-blocking agents, calcium-channel-blocking agents, diuretics, digoxin, and hydralazine, without evidence of clinically important adverse interactions.
entities: Lotensin / digoxin
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Lotensin has been used concomitantly with beta-adrenergic-blocking agents, calcium-channel-blocking agents, diuretics, digoxin, and hydralazine, without evidence of clinically important adverse interactions.
entities: Lotensin / hydralazine
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Benazepril, like other ACE inhibitors, has had less than additive effects with beta-adrenergic blockers, presumably because both drugs lower blood pressure by inhibiting parts of the renin-angiotensin system
entities: Benazepril / beta-adrenergic blockers
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Benazepril, like other ACE inhibitors, has had less than additive effects with beta-adrenergic blockers, presumably because both drugs lower blood pressure by inhibiting parts of the renin-angiotensin system
entities: ACE inhibitors / beta-adrenergic blockers
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Cypermethrin-induced oxidative stress in rat brain and liver is prevented by vitamin E or allopurinol.

entities: Cypermethrin / vitamin E
ddi: effect
>>> match: prevent_nsubj:pass_obl
-------------
sentence: Cypermethrin-induced oxidative stress in rat brain and liver is prevented by vitamin E or allopurinol.

entities: Cypermethrin / allopurinol
ddi: effect
>>> match: prevent_nsubj:pass_obl
-------------
sentence: Pretreatment of rats with allopurinol (100 mg/kg, ip) or Vitamin E (100 mg/kg per day, ig, for 3 days and a dose of 40 mg/kg on the 4th day) provided significant protection against the elevation of TBARS levels in cerebral and hepatic tissues, induced by single high dose of oral cypermethrin administration within 4 h. 
entities: allopurinol / cypermethrin
ddi: effect
>>> match: provide_nsubj_dep
-------------
sentence: Pretreatment of rats with allopurinol (100 mg/kg, ip) or Vitamin E (100 mg/kg per day, ig, for 3 days and a dose of 40 mg/kg on the 4th day) provided significant protection against the elevation of TBARS levels in cerebral and hepatic tissues, induced by single high dose of oral cypermethrin administration within 4 h. 
entities: Vitamin E / cypermethrin
ddi: effect
>>> match: provide_nsubj_dep
-------------
sentence: Thus, the results suggest that cypermethrin exposure of rats results in free radical-mediated tissue damage, as indicated by elevated cerebral and hepatic lipid peroxidation, which was prevented by allopurinol and Vitamin E.
entities: cypermethrin / allopurinol
ddi: effect
>>> match: result_nsubj_advcl
-------------
sentence: Thus, the results suggest that cypermethrin exposure of rats results in free radical-mediated tissue damage, as indicated by elevated cerebral and hepatic lipid peroxidation, which was prevented by allopurinol and Vitamin E.
entities: cypermethrin / Vitamin E
ddi: effect
>>> match: result_nsubj_advcl
-------------
sentence: Failure of neomycin to modify ACTH induced hypertension in sheep.
entities: neomycin / ACTH
ddi: null
>>> match: modify_nsubj_obj
-------------
sentence: Studies in rats have shown that neomycin administration attenuates certain types of adrenocortical steroid dependent hypertension, including ACTH hypertension. 
entities: neomycin / ACTH
ddi: effect
>>> match: attenuate_nsubj_obj
-------------
sentence: Neomycin has no effect on the blood pressure or metabolic responses to ACTH in sheep.
entities: Neomycin / ACTH
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Preliminary data which suggest that dapsone may inhibit the anti-inflammatory activity of Lamprene have not been confirmed.
entities: dapsone / Lamprene
ddi: effect
>>> match: inhibit_nsubj_obj
-------------
sentence: Ibandronate should be taken at least 60 minutes before any oral medications containing multivalent cations (including antacids, supplements or vitamins).
entities: Ibandronate / antacids
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Ibandronate should be taken at least 60 minutes before any oral medications containing multivalent cations (including antacids, supplements or vitamins).
entities: Ibandronate / vitamins
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Of over 3500 patients enrolled in the Ibandronate osteoporosis Treatment and Prevention Studies, 15% used anti-peptic agents (primarily H2 blockers and PPIs).
entities: Ibandronate / H2 blockers
ddi: null
>>> match: use_obl_iobj
-------------
sentence: Of over 3500 patients enrolled in the Ibandronate osteoporosis Treatment and Prevention Studies, 15% used anti-peptic agents (primarily H2 blockers and PPIs).
entities: Ibandronate / PPIs
ddi: null
>>> match: use_obl_iobj
-------------
sentence: Among these patients, the incidence of upper gastrointestinal adverse experiences in the patients treated with Ibandronate 150 mg once monthly was similar to that in patients treated with Ibandronate 2.5 mg once daily.
entities: Ibandronate / Ibandronate
ddi: null
>>> match: treat_obl_advcl
-------------
sentence: Among aspirin or NSAID users, the incidence of upper gastrointestinal adverse events in patients treated with ibandronate 2.5 mg daily (28.9%) was similar to that in placebo-treated patients (30.7%).
entities: aspirin / ibandronate
ddi: null
>>> match: treat_obl_obl
-------------
sentence: Among aspirin or NSAID users, the incidence of upper gastrointestinal adverse events in patients treated with ibandronate 2.5 mg daily (28.9%) was similar to that in placebo-treated patients (30.7%).
entities: NSAID / ibandronate
ddi: null
>>> match: treat_obl_obl
-------------
sentence: However, since aspirin, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with Ibandronate.
entities: aspirin / aspirin
ddi: null
>>> match: associate_nsubj:pass_parataxis
-------------
sentence: However, since aspirin, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with Ibandronate.
entities: aspirin / NSAIDs
ddi: null
>>> match: associate_nsubj:pass_parataxis
-------------
sentence: However, since aspirin, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with Ibandronate.
entities: aspirin / Ibandronate
ddi: null
>>> match: associate_nsubj:pass_parataxis
-------------
sentence: However, since aspirin, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with Ibandronate.
entities: NSAIDs / aspirin
ddi: null
>>> match: associate_nsubj:pass_parataxis
-------------
sentence: However, since aspirin, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with Ibandronate.
entities: NSAIDs / NSAIDs
ddi: null
>>> match: associate_nsubj:pass_parataxis
-------------
sentence: However, since aspirin, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with Ibandronate.
entities: NSAIDs / Ibandronate
ddi: null
>>> match: associate_nsubj:pass_parataxis
-------------
sentence: However, since aspirin, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with Ibandronate.
entities: bisphosphonates / aspirin
ddi: null
>>> match: associate_nsubj:pass_parataxis
-------------
sentence: However, since aspirin, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with Ibandronate.
entities: bisphosphonates / NSAIDs
ddi: null
>>> match: associate_nsubj:pass_parataxis
-------------
sentence: However, since aspirin, NSAIDs, and bisphosphonates are all associated with gastrointestinal irritation, caution should be exercised in the concomitant use of aspirin or NSAIDs with Ibandronate.
entities: bisphosphonates / Ibandronate
ddi: null
>>> match: associate_nsubj:pass_parataxis
-------------
sentence: Treatment with antidepressant drugs can directly interfere with blood glucose levels or may interact with hypoglycemic agents. 
entities: antidepressant drugs / hypoglycemic agents
ddi: int
>>> match: interfere_nsubj_conj
-------------
sentence: Fluoxetine and moclobemide increased blood glucose at different times after the glucose overload. 
entities: Fluoxetine / glucose
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Fluoxetine and moclobemide increased blood glucose at different times after the glucose overload. 
entities: moclobemide / glucose
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Sertraline neutralized the increase of glycemia induced by oral glucose overload. 
entities: Sertraline / glucose
ddi: null
>>> match: neutralize_nsubj_dep
-------------
sentence: Again, sertraline neutralized the increase in glycemia after glucose overload both in diabetic and non-diabetic rats. 
entities: sertraline / glucose
ddi: null
>>> match: neutralize_nsubj_obl
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / phenylbutazone
ddi: mechanism
>>> match: delay_nsubj_obj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / warfarin
ddi: mechanism
>>> match: delay_nsubj_obj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / thiazide diuretics
ddi: mechanism
>>> match: delay_nsubj_obj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / propranolol
ddi: mechanism
>>> match: delay_nsubj_obj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / tetracycline
ddi: mechanism
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / penicillin G
ddi: mechanism
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / phenobarbital
ddi: mechanism
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / thyroxine
ddi: mechanism
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / estrogens
ddi: mechanism
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / progestins
ddi: mechanism
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: Cholestyramine / digitalis
ddi: mechanism
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / phenylbutazone
ddi: null
>>> match: delay_nsubj_obj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / warfarin
ddi: null
>>> match: delay_nsubj_obj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / thiazide diuretics
ddi: null
>>> match: delay_nsubj_obj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / propranolol
ddi: null
>>> match: delay_nsubj_obj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / tetracycline
ddi: null
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / penicillin G
ddi: null
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / phenobarbital
ddi: null
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / thyroxine
ddi: null
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / estrogens
ddi: null
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / progestins
ddi: null
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: resin / digitalis
ddi: null
>>> match: delay_nsubj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: phenylbutazone / tetracycline
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: phenylbutazone / penicillin G
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: phenylbutazone / phenobarbital
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: phenylbutazone / thyroxine
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: phenylbutazone / estrogens
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: phenylbutazone / progestins
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: phenylbutazone / digitalis
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: warfarin / tetracycline
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: warfarin / penicillin G
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: warfarin / phenobarbital
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: warfarin / thyroxine
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: warfarin / estrogens
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: warfarin / progestins
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: warfarin / digitalis
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: thiazide diuretics / tetracycline
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: thiazide diuretics / penicillin G
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: thiazide diuretics / phenobarbital
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: thiazide diuretics / thyroxine
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: thiazide diuretics / estrogens
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: thiazide diuretics / progestins
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: thiazide diuretics / digitalis
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: propranolol / tetracycline
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: propranolol / penicillin G
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: propranolol / phenobarbital
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: propranolol / thyroxine
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: propranolol / estrogens
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: propranolol / progestins
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic) or propranolol (basic), as well as tetracycline penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis.
entities: propranolol / digitalis
ddi: null
>>> match: delay_obj_conj
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: Cholestyramine / cholestyramine
ddi: null
>>> match: interfere_nsubj_parataxis
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: Cholestyramine / resin
ddi: null
>>> match: interfere_nsubj_parataxis
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: Cholestyramine / digitalis
ddi: null
>>> match: interfere_nsubj_parataxis
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: Cholestyramine / cholestyramine
ddi: null
>>> match: interfere_nsubj_parataxis
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: Cholestyramine / resin
ddi: null
>>> match: interfere_nsubj_parataxis
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: resin / cholestyramine
ddi: null
>>> match: interfere_nsubj_parataxis
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: resin / resin
ddi: null
>>> match: interfere_nsubj_parataxis
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: resin / digitalis
ddi: null
>>> match: interfere_nsubj_parataxis
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: resin / cholestyramine
ddi: null
>>> match: interfere_nsubj_parataxis
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: resin / resin
ddi: null
>>> match: interfere_nsubj_parataxis
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: cholestyramine / digitalis
ddi: mechanism
>>> match: pose_nsubj_advcl
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: cholestyramine / cholestyramine
ddi: null
>>> match: pose_nsubj_advcl
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: cholestyramine / resin
ddi: null
>>> match: pose_nsubj_advcl
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: resin / digitalis
ddi: null
>>> match: pose_nsubj_advcl
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: resin / cholestyramine
ddi: null
>>> match: pose_nsubj_advcl
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: resin / resin
ddi: null
>>> match: pose_nsubj_advcl
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: digitalis / cholestyramine
ddi: null
>>> match: filtrate_nsubj:pass_advcl
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: digitalis / resin
ddi: null
>>> match: filtrate_nsubj:pass_advcl
-------------
sentence: Because cholestyramine binds bile acids, cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat soluble vitamins such as A, D, E, and K.
entities: cholestyramine / cholestyramine
ddi: null
>>> match: interfere_advcl_nsubj
-------------
sentence: Because cholestyramine binds bile acids, cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat soluble vitamins such as A, D, E, and K.
entities: cholestyramine / resin
ddi: null
>>> match: interfere_advcl_nsubj
-------------
sentence: Because cholestyramine binds bile acids, cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat soluble vitamins such as A, D, E, and K.
entities: cholestyramine / fat soluble vitamins
ddi: null
>>> match: interfere_advcl_conj
-------------
sentence: Because cholestyramine binds bile acids, cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat soluble vitamins such as A, D, E, and K.
entities: cholestyramine / fat soluble vitamins
ddi: null
>>> match: interfere_nsubj_conj
-------------
sentence: Because cholestyramine binds bile acids, cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat soluble vitamins such as A, D, E, and K.
entities: resin / fat soluble vitamins
ddi: null
>>> match: interfere_nsubj_conj
-------------
sentence: When cholestyramine resin is given for long periods of time, concomitant supplementation with water-miscible (or parenteral) forms of fat-soluble vitamins should be considered.
entities: cholestyramine / fat-soluble vitamins
ddi: null
>>> match: consider_advcl_nsubj:pass
-------------
sentence: When cholestyramine resin is given for long periods of time, concomitant supplementation with water-miscible (or parenteral) forms of fat-soluble vitamins should be considered.
entities: resin / fat-soluble vitamins
ddi: null
>>> match: consider_advcl_nsubj:pass
-------------
sentence: SINCE CHOLESTYRAMINE RESIN MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST 1 HOUR BEFORE OR 4 TO 6 HOURS AFTER CHOLESTYRAMINE RESIN (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION.
entities: CHOLESTYRAMINE / CHOLESTYRAMINE
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: SINCE CHOLESTYRAMINE RESIN MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST 1 HOUR BEFORE OR 4 TO 6 HOURS AFTER CHOLESTYRAMINE RESIN (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION.
entities: CHOLESTYRAMINE / RESIN
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: SINCE CHOLESTYRAMINE RESIN MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST 1 HOUR BEFORE OR 4 TO 6 HOURS AFTER CHOLESTYRAMINE RESIN (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION.
entities: RESIN / CHOLESTYRAMINE
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: SINCE CHOLESTYRAMINE RESIN MAY BIND OTHER DRUGS GIVEN CONCURRENTLY, IT IS RECOMMENDED THAT PATIENTS TAKE OTHER DRUGS AT LEAST 1 HOUR BEFORE OR 4 TO 6 HOURS AFTER CHOLESTYRAMINE RESIN (OR AT AS GREAT AN INTERVAL AS POSSIBLE) TO AVOID IMPEDING THEIR ABSORPTION.
entities: RESIN / RESIN
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: Coumarin Anticoagulants Altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon.
entities: Coumarin Anticoagulants / capecitabine
ddi: null
>>> match: alter_nsubj_dep
-------------
sentence: Coumarin Anticoagulants Altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon.
entities: Coumarin Anticoagulants / coumarin-derivative anticoagulants
ddi: null
>>> match: alter_nsubj_dep
-------------
sentence: Coumarin Anticoagulants Altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon.
entities: Coumarin Anticoagulants / warfarin
ddi: null
>>> match: alter_nsubj_dep
-------------
sentence: Coumarin Anticoagulants Altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon.
entities: Coumarin Anticoagulants / phenprocoumon
ddi: null
>>> match: alter_nsubj_dep
-------------
sentence: Coumarin Anticoagulants Altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon.
entities: capecitabine / coumarin-derivative anticoagulants
ddi: effect
>>> match: take_obj_obl
-------------
sentence: Coumarin Anticoagulants Altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon.
entities: capecitabine / warfarin
ddi: null
>>> match: take_obj_obl
-------------
sentence: Coumarin Anticoagulants Altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin and phenprocoumon.
entities: capecitabine / phenprocoumon
ddi: effect
>>> match: take_obj_obl
-------------
sentence: Patients taking coumarin-derivative anticoagulants concomitantly with capecitabine should be monitored regularly for alterations in their coagulation parameters (PT or INR).
entities: coumarin-derivative anticoagulants / capecitabine
ddi: advise
>>> match: take_obj_obl
-------------
sentence: Leucovorin: The concentration of 5-fluorouracil is increased and its toxicity may be enhanced by leucovorin.
entities: 5-fluorouracil / leucovorin
ddi: mechanism
>>> match: increase_nsubj:pass_conj
-------------
sentence: This study investigates the ability of cyclooxygenase-2 inhibitors to sensitize cells from different origins to several chemotherapeutic agents. 
entities: cyclooxygenase-2 inhibitors / chemotherapeutic agents
ddi: null
>>> match: investigate_obj_xcomp
-------------
sentence: We found antagonism between celecoxib and the four drugs in the breast cancer cells MCF7 following all incubation schedules and between celecoxib and doxorubicin in all cell lines except for two combinations in HCT116 cells. 
entities: celecoxib / celecoxib
ddi: null
>>> match: find_obj_obl
-------------
sentence: We found antagonism between celecoxib and the four drugs in the breast cancer cells MCF7 following all incubation schedules and between celecoxib and doxorubicin in all cell lines except for two combinations in HCT116 cells. 
entities: celecoxib / doxorubicin
ddi: null
>>> match: find_obj_obl
-------------
sentence: Phospholine Iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides.
entities: Phospholine Iodide / cholinesterase inhibitors
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Phospholine Iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides.
entities: Phospholine Iodide / succinylcholine
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Phospholine Iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides.
entities: Phospholine Iodide / carbamate insecticides
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Plasma levels of anticonvulsant agents may become subtherapeutic during cisplatin therapy.
entities: anticonvulsant agents / cisplatin
ddi: mechanism
>>> match: become_nsubj_obl
-------------
sentence: No clinically significant changes to lamivudine or zidovudine pharmacokinetics were observed following concomitant administration of abacavir. 
entities: lamivudine / abacavir
ddi: null
>>> match: observe_nsubj:pass_obl
-------------
sentence: No clinically significant changes to lamivudine or zidovudine pharmacokinetics were observed following concomitant administration of abacavir. 
entities: zidovudine / abacavir
ddi: null
>>> match: observe_nsubj:pass_obl
-------------
sentence: Abacavir has no effect on the pharmacokinetic properties of ethanol. 
entities: Abacavir / ethanol
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Ethanol decreases the elimination of abacavir causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of abacavir. 
entities: Ethanol / abacavir
ddi: mechanism
>>> match: decrease_nsubj_dep
-------------
sentence: Ethanol decreases the elimination of abacavir causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of abacavir. 
entities: Ethanol / methadone
ddi: null
>>> match: decrease_nsubj_parataxis
-------------
sentence: Ethanol decreases the elimination of abacavir causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of abacavir. 
entities: Ethanol / abacavir
ddi: null
>>> match: decrease_nsubj_parataxis
-------------
sentence: Ethanol decreases the elimination of abacavir causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of abacavir. 
entities: abacavir / methadone
ddi: null
>>> match: decrease_dep_parataxis
-------------
sentence: Ethanol decreases the elimination of abacavir causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of abacavir. 
entities: abacavir / abacavir
ddi: null
>>> match: decrease_dep_parataxis
-------------
sentence: Ethanol decreases the elimination of abacavir causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of abacavir. 
entities: methadone / abacavir
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: In a study of 11 HIV-infected patients receiving methadone-maintenance therapy (40 mg and 90 mg daily) with 600 mg of ZIAGEN twice daily (twice the currently recommended dose), oral methadone clearance increased 22% (90% CI 6% to 42%). 
entities: methadone / ZIAGEN
ddi: mechanism
>>> match: receive_obj_obl
-------------
sentence: In a study of 11 HIV-infected patients receiving methadone-maintenance therapy (40 mg and 90 mg daily) with 600 mg of ZIAGEN twice daily (twice the currently recommended dose), oral methadone clearance increased 22% (90% CI 6% to 42%). 
entities: methadone / methadone
ddi: null
>>> match: increase_obl_nsubj
-------------
sentence: In a study of 11 HIV-infected patients receiving methadone-maintenance therapy (40 mg and 90 mg daily) with 600 mg of ZIAGEN twice daily (twice the currently recommended dose), oral methadone clearance increased 22% (90% CI 6% to 42%). 
entities: ZIAGEN / methadone
ddi: null
>>> match: increase_obl_nsubj
-------------
sentence: Corticotropin may accentuate the electrolyte loss associated with diuretic therapy.
entities: Corticotropin / diuretic
ddi: effect
>>> match: accentuate_nsubj_obj
-------------
sentence: Prior administration of succinylcholine had no effect on the duration of neuromuscular block following initial or maintenance bolus doses of NIMBEX.
entities: succinylcholine / NIMBEX
ddi: null
>>> match: have_nsubj_obl
-------------
sentence: Although not studied systematically in clinical trials, no drug interactions were observed when vecuronium, pancuronium, or atracurium were administered following varying degrees of recovery from single doses or infusions of NIMBEX.
entities: vecuronium / NIMBEX
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Although not studied systematically in clinical trials, no drug interactions were observed when vecuronium, pancuronium, or atracurium were administered following varying degrees of recovery from single doses or infusions of NIMBEX.
entities: pancuronium / NIMBEX
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Although not studied systematically in clinical trials, no drug interactions were observed when vecuronium, pancuronium, or atracurium were administered following varying degrees of recovery from single doses or infusions of NIMBEX.
entities: atracurium / NIMBEX
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 MAC [Minimum Alveolar Concentration] may prolong the clinically effective duration of action of initial and maintenance doses of NIMBEX and decrease the required infusion rate of NIMBEX.
entities: Isoflurane / oxygen
ddi: null
>>> match: administer_nsubj_obl
-------------
sentence: Isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 MAC [Minimum Alveolar Concentration] may prolong the clinically effective duration of action of initial and maintenance doses of NIMBEX and decrease the required infusion rate of NIMBEX.
entities: Isoflurane / NIMBEX
ddi: effect
>>> match: administer_nsubj_parataxis
-------------
sentence: Isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 MAC [Minimum Alveolar Concentration] may prolong the clinically effective duration of action of initial and maintenance doses of NIMBEX and decrease the required infusion rate of NIMBEX.
entities: Isoflurane / NIMBEX
ddi: effect
>>> match: administer_nsubj_parataxis
-------------
sentence: Isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 MAC [Minimum Alveolar Concentration] may prolong the clinically effective duration of action of initial and maintenance doses of NIMBEX and decrease the required infusion rate of NIMBEX.
entities: enflurane / oxygen
ddi: null
>>> match: administer_nsubj_obl
-------------
sentence: Isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 MAC [Minimum Alveolar Concentration] may prolong the clinically effective duration of action of initial and maintenance doses of NIMBEX and decrease the required infusion rate of NIMBEX.
entities: enflurane / NIMBEX
ddi: effect
>>> match: administer_nsubj_parataxis
-------------
sentence: Isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 MAC [Minimum Alveolar Concentration] may prolong the clinically effective duration of action of initial and maintenance doses of NIMBEX and decrease the required infusion rate of NIMBEX.
entities: enflurane / NIMBEX
ddi: effect
>>> match: administer_nsubj_parataxis
-------------
sentence: Isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 MAC [Minimum Alveolar Concentration] may prolong the clinically effective duration of action of initial and maintenance doses of NIMBEX and decrease the required infusion rate of NIMBEX.
entities: oxygen / NIMBEX
ddi: null
>>> match: administer_obl_parataxis
-------------
sentence: Isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 MAC [Minimum Alveolar Concentration] may prolong the clinically effective duration of action of initial and maintenance doses of NIMBEX and decrease the required infusion rate of NIMBEX.
entities: oxygen / NIMBEX
ddi: null
>>> match: administer_obl_parataxis
-------------
sentence: Isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 MAC [Minimum Alveolar Concentration] may prolong the clinically effective duration of action of initial and maintenance doses of NIMBEX and decrease the required infusion rate of NIMBEX.
entities: NIMBEX / NIMBEX
ddi: null
>>> match: prolong_obj_conj
-------------
sentence: Fifteen to 30 minutes of exposure to 1.25 MAC isoflurane or enflurane had minimal effects on the duration of action of initial doses of NIMBEX and therefore, no adjustment to the initial dose should be necessary when NIMBEX is administered shortly after initiation of volatile agents.
entities: isoflurane / NIMBEX
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Fifteen to 30 minutes of exposure to 1.25 MAC isoflurane or enflurane had minimal effects on the duration of action of initial doses of NIMBEX and therefore, no adjustment to the initial dose should be necessary when NIMBEX is administered shortly after initiation of volatile agents.
entities: isoflurane / NIMBEX
ddi: null
>>> match: have_nsubj_conj
-------------
sentence: Fifteen to 30 minutes of exposure to 1.25 MAC isoflurane or enflurane had minimal effects on the duration of action of initial doses of NIMBEX and therefore, no adjustment to the initial dose should be necessary when NIMBEX is administered shortly after initiation of volatile agents.
entities: enflurane / NIMBEX
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Fifteen to 30 minutes of exposure to 1.25 MAC isoflurane or enflurane had minimal effects on the duration of action of initial doses of NIMBEX and therefore, no adjustment to the initial dose should be necessary when NIMBEX is administered shortly after initiation of volatile agents.
entities: enflurane / NIMBEX
ddi: null
>>> match: have_nsubj_conj
-------------
sentence: Fifteen to 30 minutes of exposure to 1.25 MAC isoflurane or enflurane had minimal effects on the duration of action of initial doses of NIMBEX and therefore, no adjustment to the initial dose should be necessary when NIMBEX is administered shortly after initiation of volatile agents.
entities: NIMBEX / NIMBEX
ddi: null
>>> match: have_obj_conj
-------------
sentence: In clinical studies propofol had no effect on the duration of action or dosing requirements for NIMBEX.
entities: propofol / NIMBEX
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / antibiotics
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / aminoglycosides
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / tetracyclines
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / bacitracin
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / polymyxins
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / lincomycin
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / clindamycin
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / colistin
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / sodium colistemethate
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / magnesium
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / lithium
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / anesthetics
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / procainamide
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: nondepolarizing agents / quinidine
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / antibiotics
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / aminoglycosides
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / tetracyclines
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / bacitracin
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / polymyxins
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / lincomycin
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / clindamycin
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / colistin
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / sodium colistemethate
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / magnesium
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / lithium
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / anesthetics
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / procainamide
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NIMBEX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistemethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NIMBEX / quinidine
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine.
entities: nondepolarizing neuromuscular blocking agents / phenytoin
ddi: effect
>>> match: demonstrate_nsubj:pass_obl
-------------
sentence: Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine.
entities: nondepolarizing neuromuscular blocking agents / carbamazepine
ddi: effect
>>> match: demonstrate_nsubj:pass_obl
-------------
sentence: Since MEXITIL is a substrate for the metabolic pathways involving CYP2D6 and CYP1A2 enzymes, inhibition or induction of either of these enzymes would be expected to alter mexiletine plasma concentrations. 
entities: MEXITIL / mexiletine
ddi: null
>>> match: expect_advcl_xcomp
-------------
sentence: In a formal, single-dose interaction study (n = 6 males) the clearance of mexiletine was decreased by 38% following the coadministration of fluvoxamine, an inhibitor of CYP1A2. 
entities: mexiletine / fluvoxamine
ddi: mechanism
>>> match: decrease_nsubj:pass_nmod
-------------
sentence: When concomitant administration of either of these two drugs with mexiletine is initiated, the dose of mexiletine should be slowly titrated to desired effect. 
entities: mexiletine / mexiletine
ddi: null
>>> match: titrate_advcl_nsubj:pass
-------------
sentence: In a large compassionate use program Mexitil    has been used concurrently with commonly employed antianginal, antihypertensive, and anticoagulant drugs without observed interactions. 
entities: Mexitil / antihypertensive
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: In a large compassionate use program Mexitil    has been used concurrently with commonly employed antianginal, antihypertensive, and anticoagulant drugs without observed interactions. 
entities: Mexitil / anticoagulant drugs
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported. 
entities: phenytoin / Mexitil
ddi: mechanism
>>> match: take_nsubj:pass_obl
-------------
sentence: When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported. 
entities: phenytoin / Mexitil
ddi: null
>>> match: lower_advcl_obj
-------------
sentence: When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported. 
entities: rifampin / Mexitil
ddi: mechanism
>>> match: take_nsubj:pass_obl
-------------
sentence: When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported. 
entities: rifampin / Mexitil
ddi: null
>>> match: lower_advcl_obj
-------------
sentence: When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported. 
entities: phenobarbital / Mexitil
ddi: mechanism
>>> match: take_nsubj:pass_obl
-------------
sentence: When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported. 
entities: phenobarbital / Mexitil
ddi: null
>>> match: lower_advcl_obj
-------------
sentence: When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported. 
entities: Mexitil / Mexitil
ddi: null
>>> match: lower_advcl_obj
-------------
sentence: In a formal study, benzodiazepines were shown not to affect Mexitil    plasma concentrations. 
entities: benzodiazepines / Mexitil
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Concurrent administration of cimetidine and Mexitil    has been reported to increase, decrease, or leave unchanged Mexitil    plasma levels; 
entities: cimetidine / Mexitil
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Concurrent administration of cimetidine and Mexitil    has been reported to increase, decrease, or leave unchanged Mexitil    plasma levels; 
entities: Mexitil / Mexitil
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Mexitil    does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum digoxin levels. 
entities: Mexitil / digoxin
ddi: null
>>> match: treat_obl_dep
-------------
sentence: Concurrent use of Mexitil    and theophylline may lead to increased plasma theophylline levels. 
entities: Mexitil / theophylline
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: Concurrent use of Mexitil    and theophylline may lead to increased plasma theophylline levels. 
entities: theophylline / theophylline
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / Theophylline
ddi: null
>>> match: observe_obl_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / Mexitil
ddi: null
>>> match: observe_obl_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / Mexitil
ddi: null
>>> match: observe_obl_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / Mexitil
ddi: null
>>> match: observe_obl_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / theophylline
ddi: null
>>> match: observe_obl_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / theophylline
ddi: null
>>> match: observe_obl_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / Mexitil
ddi: null
>>> match: observe_obl_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Theophylline / Mexitil
ddi: null
>>> match: return_nsubj_obl
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Theophylline / Mexitil
ddi: mechanism
>>> match: return_nsubj_obl
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Theophylline / Mexitil
ddi: null
>>> match: observe_parataxis_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Theophylline / theophylline
ddi: null
>>> match: observe_parataxis_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Theophylline / theophylline
ddi: null
>>> match: observe_parataxis_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Theophylline / Mexitil
ddi: null
>>> match: observe_parataxis_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / Mexitil
ddi: null
>>> match: return_obl_obl
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / Mexitil
ddi: null
>>> match: observe_parataxis_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / theophylline
ddi: null
>>> match: observe_parataxis_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / theophylline
ddi: null
>>> match: observe_parataxis_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / Mexitil
ddi: null
>>> match: observe_parataxis_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / Mexitil
ddi: null
>>> match: observe_parataxis_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / theophylline
ddi: null
>>> match: observe_parataxis_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / theophylline
ddi: null
>>> match: observe_parataxis_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / Mexitil
ddi: null
>>> match: observe_parataxis_parataxis
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / theophylline
ddi: null
>>> match: monitor_advcl_nsubj:pass
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: Mexitil / Mexitil
ddi: null
>>> match: monitor_advcl_advcl
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: theophylline / theophylline
ddi: null
>>> match: monitor_advcl_nsubj:pass
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: theophylline / Mexitil
ddi: null
>>> match: monitor_advcl_advcl
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed. 
entities: theophylline / Mexitil
ddi: null
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of Mexitil   .
entities: caffeine / Mexitil
ddi: mechanism
>>> match: decrease_nsubj:pass_obl
-------------
sentence: Vasopressors, particularly metaraminol, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all. 
entities: Vasopressors / halothane
ddi: effect
>>> match: cause_nsubj_obl
-------------
sentence: Vasopressors, particularly metaraminol, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all. 
entities: metaraminol / halothane
ddi: effect
>>> match: cause_nsubj_obl
-------------
sentence: MAO Inhibitors - The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors (MAOI). 
entities: sympathomimetic pressor amines / monoamine oxidase inhibitors
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: MAO Inhibitors - The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors (MAOI). 
entities: sympathomimetic pressor amines / MAOI
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The pressor response of adrenergic agents may also be potentiated by tricyclic antidepressants.
entities: adrenergic agents / tricyclic antidepressants
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine, antipyrine, ketoconazole, erythromycin and azithromycin.
entities: cetirizine / pseudoephedrine
ddi: null
>>> match: conduct_nsubj:pass_obl
-------------
sentence: Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine, antipyrine, ketoconazole, erythromycin and azithromycin.
entities: cetirizine / antipyrine
ddi: null
>>> match: conduct_nsubj:pass_obl
-------------
sentence: Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine, antipyrine, ketoconazole, erythromycin and azithromycin.
entities: cetirizine / ketoconazole
ddi: null
>>> match: conduct_nsubj:pass_obl
-------------
sentence: Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine, antipyrine, ketoconazole, erythromycin and azithromycin.
entities: cetirizine / erythromycin
ddi: null
>>> match: conduct_nsubj:pass_obl
-------------
sentence: Pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine, antipyrine, ketoconazole, erythromycin and azithromycin.
entities: cetirizine / azithromycin
ddi: null
>>> match: conduct_nsubj:pass_obl
-------------
sentence: In a multiple dose study of theophylline (400 mg once daily for 3 days) and cetirizine (20 mg once daily for 3 days), a 16% decrease in the clearance of cetirizine was observed.
entities: theophylline / cetirizine
ddi: null
>>> match: observe_obl_nsubj:pass
-------------
sentence: In a multiple dose study of theophylline (400 mg once daily for 3 days) and cetirizine (20 mg once daily for 3 days), a 16% decrease in the clearance of cetirizine was observed.
entities: cetirizine / cetirizine
ddi: null
>>> match: observe_obl_nsubj:pass
-------------
sentence: Drug-Drug Interactions: No clinically significant drug interactions have been found with theophylline at a low dose, azithromycin, pseudoephedrine, ketoconazole, or erythromycin.
entities: theophylline / azithromycin
ddi: null
>>> match: find_obl_obl
-------------
sentence: Drug-Drug Interactions: No clinically significant drug interactions have been found with theophylline at a low dose, azithromycin, pseudoephedrine, ketoconazole, or erythromycin.
entities: theophylline / pseudoephedrine
ddi: null
>>> match: find_obl_obl
-------------
sentence: Drug-Drug Interactions: No clinically significant drug interactions have been found with theophylline at a low dose, azithromycin, pseudoephedrine, ketoconazole, or erythromycin.
entities: theophylline / ketoconazole
ddi: null
>>> match: find_obl_obl
-------------
sentence: Drug-Drug Interactions: No clinically significant drug interactions have been found with theophylline at a low dose, azithromycin, pseudoephedrine, ketoconazole, or erythromycin.
entities: theophylline / erythromycin
ddi: null
>>> match: find_obl_obl
-------------
sentence: There was a small decrease in the clearance of cetirizine caused by a 400-mg dose of theophylline;
entities: cetirizine / theophylline
ddi: mechanism
>>> match: cause_nsubj_obl
-------------
sentence: Pretreatment of megakaryocytes with extracellular RR (50 microM) also inhibited InsP(3)-induced responses. 
entities: RR / InsP(3)
ddi: effect
>>> match: inhibit_nsubj_obj
-------------
sentence: The possibility of hypotensive effects with PRINIVIL can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with PRINIVIL.
entities: PRINIVIL / diuretic
ddi: null
>>> match: minimize_nsubj:pass_obl
-------------
sentence: The possibility of hypotensive effects with PRINIVIL can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with PRINIVIL.
entities: PRINIVIL / PRINIVIL
ddi: null
>>> match: minimize_nsubj:pass_obl
-------------
sentence: The possibility of hypotensive effects with PRINIVIL can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with PRINIVIL.
entities: diuretic / PRINIVIL
ddi: effect
>>> match: discontinue_obj_conj
-------------
sentence: If it is necessary to continue the diuretic, initiate therapy with PRINIVIL at a dose of 5 mg daily, and provide close medical supervision after the initial dose until blood pressure has stabilized.
entities: diuretic / PRINIVIL
ddi: advise
>>> match: initiate_advcl_obl
-------------
sentence: When a diuretic is added to the therapy of a patient receiving PRINIVIL, an additional antihypertensive effect is usually observed.
entities: diuretic / PRINIVIL
ddi: effect
>>> match: add_nsubj:pass_obl
-------------
sentence: Studies with ACE inhibitors in combination with diuretics indicate that the dose of the ACE inhibitor can be reduced when it is given with a diuretic.
entities: ACE inhibitors / ACE inhibitor
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: Studies with ACE inhibitors in combination with diuretics indicate that the dose of the ACE inhibitor can be reduced when it is given with a diuretic.
entities: ACE inhibitors / diuretic
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: Studies with ACE inhibitors in combination with diuretics indicate that the dose of the ACE inhibitor can be reduced when it is given with a diuretic.
entities: diuretics / ACE inhibitor
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: Studies with ACE inhibitors in combination with diuretics indicate that the dose of the ACE inhibitor can be reduced when it is given with a diuretic.
entities: diuretics / diuretic
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: Studies with ACE inhibitors in combination with diuretics indicate that the dose of the ACE inhibitor can be reduced when it is given with a diuretic.
entities: ACE inhibitor / diuretic
ddi: advise
>>> match: reduce_nsubj:pass_advcl
-------------
sentence: Non-steroidal Anti-inflammatory Agents: In some patients with compromised renal function who are being treated with non-steroidal anti-inflammatory drugs, the co-administration of lisinopril may result in a further deterioration of renal function.
entities: non-steroidal anti-inflammatory drugs / lisinopril
ddi: effect
>>> match: result_obl_nsubj
-------------
sentence: Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors, including lisinopril.
entities: NSAIDs / ACE inhibitors
ddi: effect
>>> match: diminish_nsubj_obj
-------------
sentence: Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors, including lisinopril.
entities: NSAIDs / lisinopril
ddi: effect
>>> match: diminish_nsubj_obj
-------------
sentence: This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE inhibitors.
entities: NSAIDs / ACE inhibitors
ddi: advise
>>> match: take_obj_obl
-------------
sentence: In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to PRINIVIL given concomitantly with indomethacin, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.
entities: PRINIVIL / PRINIVIL
ddi: null
>>> match: compare_nsubj:pass_obl
-------------
sentence: In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to PRINIVIL given concomitantly with indomethacin, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.
entities: PRINIVIL / indomethacin
ddi: null
>>> match: compare_nsubj:pass_obl
-------------
sentence: In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to PRINIVIL given concomitantly with indomethacin, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.
entities: PRINIVIL / indomethacin
ddi: null
>>> match: associate_advcl_nsubj:pass
-------------
sentence: In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to PRINIVIL given concomitantly with indomethacin, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.
entities: PRINIVIL / indomethacin
ddi: null
>>> match: associate_advcl_nsubj:pass
-------------
sentence: In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to PRINIVIL given concomitantly with indomethacin, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.
entities: indomethacin / indomethacin
ddi: null
>>> match: associate_advcl_nsubj:pass
-------------
sentence: Other Agents: PRINIVIL has been used concomitantly with nitrates and/or digoxin without evidence of clinically significant adverse interactions.
entities: PRINIVIL / nitrates
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other Agents: PRINIVIL has been used concomitantly with nitrates and/or digoxin without evidence of clinically significant adverse interactions.
entities: PRINIVIL / digoxin
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: No clinically important pharmacokinetic interactions occurred when PRINIVIL was used concomitantly with propranolol or hydrochlorothiazide.
entities: PRINIVIL / propranolol
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: No clinically important pharmacokinetic interactions occurred when PRINIVIL was used concomitantly with propranolol or hydrochlorothiazide.
entities: PRINIVIL / hydrochlorothiazide
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Agents Increasing Serum Potassium: PRINIVIL attenuates potassium loss caused by thiazide-type diuretics.
entities: PRINIVIL / thiazide-type diuretics
ddi: effect
>>> match: attenuate_nsubj_dep
-------------
sentence: Lithium: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.
entities: Lithium / lithium
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.
entities: Lithium / ACE inhibitors
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors.
entities: lithium / ACE inhibitors
ddi: effect
>>> match: receive_obj_obl
-------------
sentence: It is recommended that serum lithium levels be monitored frequently if PRINIVIL is administered concomitantly with lithium.
entities: lithium / PRINIVIL
ddi: null
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: It is recommended that serum lithium levels be monitored frequently if PRINIVIL is administered concomitantly with lithium.
entities: lithium / lithium
ddi: null
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: It is recommended that serum lithium levels be monitored frequently if PRINIVIL is administered concomitantly with lithium.
entities: PRINIVIL / lithium
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Administration of diltiazem hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50%.
entities: diltiazem hydrochloride / propranolol
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Administration of diltiazem hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50%.
entities: diltiazem hydrochloride / propranolol
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Administration of diltiazem hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50%.
entities: propranolol / propranolol
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Administration of diltiazem hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50%.
entities: propranolol / propranolol
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In vitro, propranolol appears to be displaced from its binding sites by diltiazem.
entities: propranolol / diltiazem
ddi: mechanism
>>> match: appear_nsubj_xcomp
-------------
sentence: If combination therapy is initiated or withdrawn in conjunction with propranolol, an adjustment in the propranolol dose may be warranted.
entities: propranolol / propranolol
ddi: null
>>> match: warrant_advcl_nsubj:pass
-------------
sentence: A study in six healthy volunteers has shown a significant increase in peak diltiazem plasma levels (58%) and AUC (53%) after a 1-week course of cimetidine 1200 mg/day and a single dose of diltiazem 60mg.
entities: diltiazem / cimetidine
ddi: null
>>> match: show_obj_obl
-------------
sentence: A study in six healthy volunteers has shown a significant increase in peak diltiazem plasma levels (58%) and AUC (53%) after a 1-week course of cimetidine 1200 mg/day and a single dose of diltiazem 60mg.
entities: diltiazem / diltiazem
ddi: null
>>> match: show_obj_dep
-------------
sentence: A study in six healthy volunteers has shown a significant increase in peak diltiazem plasma levels (58%) and AUC (53%) after a 1-week course of cimetidine 1200 mg/day and a single dose of diltiazem 60mg.
entities: cimetidine / diltiazem
ddi: mechanism
>>> match: show_obl_dep
-------------
sentence: Patients currently receiving diltiazem therapy should be carefully monitored for a change in pharmacological effect when initiating and discontinuing therapy with cimetidine.
entities: diltiazem / cimetidine
ddi: advise
>>> match: monitor_nsubj:pass_dep
-------------
sentence: Administration of diltiazem hydrochloride with digoxin in 24 healthy male subjects increased plasma digoxin concentrations approximately 20%.
entities: diltiazem hydrochloride / digoxin
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Administration of diltiazem hydrochloride with digoxin in 24 healthy male subjects increased plasma digoxin concentrations approximately 20%.
entities: digoxin / digoxin
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Since there have been conflicting results regarding the effect of digoxin levels, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing diltiazem hydrochloride therapy to avoid possible over- or under-digitalization.
entities: digoxin / digoxin
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: Since there have been conflicting results regarding the effect of digoxin levels, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing diltiazem hydrochloride therapy to avoid possible over- or under-digitalization.
entities: digoxin / diltiazem hydrochloride
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: Since there have been conflicting results regarding the effect of digoxin levels, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing diltiazem hydrochloride therapy to avoid possible over- or under-digitalization.
entities: digoxin / diltiazem hydrochloride
ddi: advise
>>> match: monitor_nsubj:pass_dep
-------------
sentence: The depression of cardiac contractility, conductivity, and automaticity as well as the vascular dilation associated with anesthetics may be potentiated by calcium channel blockers.
entities: anesthetics / calcium channel blockers
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: If these agents are to be administered concurrently, cyclosporine concentrations should be monitored, especially when diltiazem therapy is initiated, adjusted, or discontinued.
entities: cyclosporine / diltiazem
ddi: advise
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: Concomitant administration of diltiazem with carbamazepine has been reported to result in elevated serum levels of carbamazepine (40% to 72% increase), resulting in toxicity in some cases.
entities: diltiazem / carbamazepine
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Concomitant administration of diltiazem with carbamazepine has been reported to result in elevated serum levels of carbamazepine (40% to 72% increase), resulting in toxicity in some cases.
entities: carbamazepine / carbamazepine
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Studies showed that diltiazem increased the AUC of midazolam and triazolam by 3-4 fold and the Cmax by 2-fold, compared to placebo.
entities: diltiazem / midazolam
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Studies showed that diltiazem increased the AUC of midazolam and triazolam by 3-4 fold and the Cmax by 2-fold, compared to placebo.
entities: diltiazem / triazolam
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: The elimination half life of midazolam and triazolam also increased (1.5-2.5 fold) during coadministration with diltiazem.
entities: midazolam / diltiazem
ddi: mechanism
>>> match: increase_nsubj_obl
-------------
sentence: The elimination half life of midazolam and triazolam also increased (1.5-2.5 fold) during coadministration with diltiazem.
entities: triazolam / diltiazem
ddi: mechanism
>>> match: increase_nsubj_obl
-------------
sentence: These pharmacokinetic effects seen during diltiazem coadministration can result in increased clinical effects (e.g., prolonged sodation)of both midazolam and triazolam.
entities: diltiazem / midazolam
ddi: effect
>>> match: result_csubj_obl
-------------
sentence: These pharmacokinetic effects seen during diltiazem coadministration can result in increased clinical effects (e.g., prolonged sodation)of both midazolam and triazolam.
entities: diltiazem / triazolam
ddi: effect
>>> match: result_csubj_obl
-------------
sentence: In a ten-subject study, coadministration of diltiazem (120 mg bid) with lovastatin resulted in a 3-4 times increase in mean lovastatin AUC and Cmax vs. lovastatin alone;
entities: diltiazem / lovastatin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In a ten-subject study, coadministration of diltiazem (120 mg bid) with lovastatin resulted in a 3-4 times increase in mean lovastatin AUC and Cmax vs. lovastatin alone;
entities: diltiazem / lovastatin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In a ten-subject study, coadministration of diltiazem (120 mg bid) with lovastatin resulted in a 3-4 times increase in mean lovastatin AUC and Cmax vs. lovastatin alone;
entities: lovastatin / lovastatin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In a ten-subject study, coadministration of diltiazem (120 mg bid) with lovastatin resulted in a 3-4 times increase in mean lovastatin AUC and Cmax vs. lovastatin alone;
entities: lovastatin / lovastatin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: no change in pravastatin AUC and Cmax was observed during diltiazem coadministration.
entities: pravastatin / diltiazem
ddi: null
>>> match: observe_nsubj:pass_obl
-------------
sentence: Diltiazem plasma levels were not significantly affected by lovastatin or pravastatin.
entities: Diltiazem / lovastatin
ddi: null
>>> match: affect_nsubj:pass_obl
-------------
sentence: Diltiazem plasma levels were not significantly affected by lovastatin or pravastatin.
entities: Diltiazem / pravastatin
ddi: null
>>> match: affect_nsubj:pass_obl
-------------
sentence: Coadministration of rifampin with diltiazem lowered the diltiazem plasma concentrations to undetectable levels.
entities: rifampin / diltiazem
ddi: null
>>> match: lower_nsubj_obj
-------------
sentence: Coadministration of rifampin with diltiazem lowered the diltiazem plasma concentrations to undetectable levels.
entities: diltiazem / diltiazem
ddi: null
>>> match: lower_nsubj_obj
-------------
sentence: DOXIL  may interact with drugs known to interact with the conventional formulation of doxorubicin HCl.
entities: DOXIL / doxorubicin HCl
ddi: null
>>> match: interact_nsubj_dep
-------------
sentence: Concurrent use with probenecid or other drugs significantly eliminated by active renal tubular secretion may result in increased plasma concentrations of penciclovir.
entities: probenecid / penciclovir
ddi: mechanism
>>> match: result_csubj_obl
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: bosentan / norethindrone
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: bosentan / ethinyl estradiol
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: hormonal contraceptive / norethindrone
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: hormonal contraceptive / ethinyl estradiol
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: Ortho-Novum / norethindrone
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: Ortho-Novum / ethinyl estradiol
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Co-administration of bosentan decreased the plasma concentrations of cyclosporine A (a CYP3A4 substrate) by approximately 50%.
entities: bosentan / cyclosporine A
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Co-administration of tacrolimus and bosentan resulted in markedly increased plasma concentrations of bosentan in animals.
entities: tacrolimus / bosentan
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Co-administration of tacrolimus and bosentan resulted in markedly increased plasma concentrations of bosentan in animals.
entities: bosentan / bosentan
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Therefore, the concomitant administration of TRACLEER and glyburide is contraindicated, and alternative hypoglycemic agents should be considered.
entities: TRACLEER / hypoglycemic agents
ddi: null
>>> match: contraindicate_nsubj:pass_conj
-------------
sentence: Therefore, the concomitant administration of TRACLEER and glyburide is contraindicated, and alternative hypoglycemic agents should be considered.
entities: glyburide / hypoglycemic agents
ddi: null
>>> match: contraindicate_nsubj:pass_conj
-------------
sentence: Co-administration of bosentan decreased the plasma concentrations of glyburide by approximately 40%.
entities: bosentan / glyburide
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Bosentan is also expected to reduce plasma concentrations of other oral hypoglycemic agents that are predominantly metabolized by CYP2C9 or CYP3A4.
entities: Bosentan / hypoglycemic agents
ddi: mechanism
>>> match: expect_nsubj:pass_xcomp
-------------
sentence: Ketoconazole: Co-administration of bosentan 125 mg b.i.d. and ketoconazole, a potent CYP3A4 inhibitor, increased the plasma concentrations of bosentan by approximately 2-fold.
entities: bosentan / ketoconazole
ddi: mechanism
>>> match: b._nsubj_obl
-------------
sentence: Ketoconazole: Co-administration of bosentan 125 mg b.i.d. and ketoconazole, a potent CYP3A4 inhibitor, increased the plasma concentrations of bosentan by approximately 2-fold.
entities: bosentan / bosentan
ddi: null
>>> match: b._nsubj_dep
-------------
sentence: Ketoconazole: Co-administration of bosentan 125 mg b.i.d. and ketoconazole, a potent CYP3A4 inhibitor, increased the plasma concentrations of bosentan by approximately 2-fold.
entities: ketoconazole / bosentan
ddi: null
>>> match: b._obl_dep
-------------
sentence: Simvastatin and Other Statins: Co-administration of bosentan decreased the plasma concentrations of simvastatin (a CYP3A4 substrate), and its active  -hydroxy acid metabolite, by approximately 50%.
entities: bosentan / simvastatin
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Bosentan is also expected to reduce plasma concentrations of other statins that have significant metabolism by CYP3A4, such as lovastatin and atorvastatin.
entities: Bosentan / statins
ddi: mechanism
>>> match: expect_nsubj:pass_xcomp
-------------
sentence: Bosentan is also expected to reduce plasma concentrations of other statins that have significant metabolism by CYP3A4, such as lovastatin and atorvastatin.
entities: Bosentan / lovastatin
ddi: mechanism
>>> match: expect_nsubj:pass_xcomp
-------------
sentence: Bosentan is also expected to reduce plasma concentrations of other statins that have significant metabolism by CYP3A4, such as lovastatin and atorvastatin.
entities: Bosentan / atorvastatin
ddi: mechanism
>>> match: expect_nsubj:pass_xcomp
-------------
sentence: Patients using CYP3A4 metabolized statins should have cholesterol levels monitored after TRACLEER is initiated to see whether the statin dose needs adjustment.
entities: statins / TRACLEER
ddi: advise
>>> match: have_csubj_ccomp
-------------
sentence: Patients using CYP3A4 metabolized statins should have cholesterol levels monitored after TRACLEER is initiated to see whether the statin dose needs adjustment.
entities: statins / statin
ddi: null
>>> match: have_csubj_ccomp
-------------
sentence: Patients using CYP3A4 metabolized statins should have cholesterol levels monitored after TRACLEER is initiated to see whether the statin dose needs adjustment.
entities: TRACLEER / statin
ddi: null
>>> match: initiate_nsubj:pass_xcomp
-------------
sentence: Warfarin: Co-administration of bosentan 500 mg b.i.d. for 6 days decreased the plasma concentrations of both S-warfarin (a CYP2C9 substrate) and R-warfarin (a CYP3A4 substrate) by 29 and 38%, respectively.
entities: bosentan / S-warfarin
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Warfarin: Co-administration of bosentan 500 mg b.i.d. for 6 days decreased the plasma concentrations of both S-warfarin (a CYP2C9 substrate) and R-warfarin (a CYP3A4 substrate) by 29 and 38%, respectively.
entities: bosentan / R-warfarin
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: Bosentan / digoxin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: Bosentan / nimodipine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: Bosentan / losartan
ddi: null
>>> match: have_nsubj_conj
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: Bosentan / bosentan
ddi: null
>>> match: have_nsubj_conj
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: digoxin / losartan
ddi: null
>>> match: have_obj_conj
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: digoxin / bosentan
ddi: null
>>> match: have_obj_conj
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: nimodipine / losartan
ddi: null
>>> match: have_obj_conj
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: nimodipine / bosentan
ddi: null
>>> match: have_obj_conj
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: losartan / bosentan
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Administration of paclitaxel in combination with HERCEPTIN resulted in a two-fold decrease in HERCEPTIN clearance in a non-human primate study and in a 1.5-fold increase in HERCEPTIN serum levels in clinical studies.
entities: paclitaxel / HERCEPTIN
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Administration of paclitaxel in combination with HERCEPTIN resulted in a two-fold decrease in HERCEPTIN clearance in a non-human primate study and in a 1.5-fold increase in HERCEPTIN serum levels in clinical studies.
entities: paclitaxel / HERCEPTIN
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Administration of paclitaxel in combination with HERCEPTIN resulted in a two-fold decrease in HERCEPTIN clearance in a non-human primate study and in a 1.5-fold increase in HERCEPTIN serum levels in clinical studies.
entities: HERCEPTIN / HERCEPTIN
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Administration of paclitaxel in combination with HERCEPTIN resulted in a two-fold decrease in HERCEPTIN clearance in a non-human primate study and in a 1.5-fold increase in HERCEPTIN serum levels in clinical studies.
entities: HERCEPTIN / HERCEPTIN
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The rate of metabolism and the leukopenic activity of cyclophosphamide reportedly are increased by chronic administration of high doses of phenobarbital.
entities: cyclophosphamide / phenobarbital
ddi: mechanism
>>> match: increase_nsubj:pass_obl
-------------
sentence: The physician should be alert for possible combined drug actions, desirable or undesirable, involving cyclophosphamide even though cyclophosphamide has been used successfully concurrently with other drugs, including other cytotoxic drugs.
entities: cyclophosphamide / cyclophosphamide
ddi: null
>>> match: involve_obj_advcl
-------------
sentence: Cyclophosphamide treatment, which causes a marked and persistent inhibition of cholinesterase activity, potentiates the effect of succinylcholine chloride.
entities: Cyclophosphamide / succinylcholine chloride
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Catecholamine-depleting drugs (e.g., reserpine) may have an additive effect when given with beta-blocking agents. 
entities: reserpine / beta-blocking agents
ddi: effect
>>> match: have_nsubj_advcl
-------------
sentence: Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions. 
entities: Pindolol / antihypertensive agents
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions. 
entities: Pindolol / hydrochlorothiazide
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions. 
entities: Pindolol / hydralazine
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions. 
entities: Pindolol / guanethidine
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Pindolol has been shown to increase serum thioridazine levels when both drugs are co-administered. 
entities: Pindolol / thioridazine
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Neuropathy has occurred more frequently in patients with a history of neuropathy or neurotoxic drug therapy, including stavudine, and these patients may be at increased risk of neuropathy during VIDEX therapy (see ADVERSE REACTIONS).
entities: stavudine / VIDEX
ddi: null
>>> match: occur_obl_conj
-------------
sentence: Allopurinol: The AUC of didanosine was increased about 4-fold when allopurinol at 300 mg/day was coadministered with a single 200-mg dose of VIDEX to two patients with renal impairment (CLcr=15 and 18 mL/min).
entities: didanosine / allopurinol
ddi: null
>>> match: increase_nsubj:pass_advcl
-------------
sentence: Allopurinol: The AUC of didanosine was increased about 4-fold when allopurinol at 300 mg/day was coadministered with a single 200-mg dose of VIDEX to two patients with renal impairment (CLcr=15 and 18 mL/min).
entities: didanosine / VIDEX
ddi: null
>>> match: increase_nsubj:pass_advcl
-------------
sentence: Allopurinol: The AUC of didanosine was increased about 4-fold when allopurinol at 300 mg/day was coadministered with a single 200-mg dose of VIDEX to two patients with renal impairment (CLcr=15 and 18 mL/min).
entities: allopurinol / VIDEX
ddi: mechanism
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Antacids: Concomitant administration of antacids containing magnesium or aluminum with VIDEX Chewable/Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the antacid components.
entities: antacids / antacid
ddi: null
>>> match: potentiate_nsubj_obj
-------------
sentence: Antacids: Concomitant administration of antacids containing magnesium or aluminum with VIDEX Chewable/Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the antacid components.
entities: magnesium / VIDEX
ddi: effect
>>> match: contain_obj_advcl
-------------
sentence: Antacids: Concomitant administration of antacids containing magnesium or aluminum with VIDEX Chewable/Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the antacid components.
entities: magnesium / antacid
ddi: null
>>> match: potentiate_nsubj_obj
-------------
sentence: Antacids: Concomitant administration of antacids containing magnesium or aluminum with VIDEX Chewable/Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the antacid components.
entities: aluminum / VIDEX
ddi: effect
>>> match: contain_obj_advcl
-------------
sentence: Antacids: Concomitant administration of antacids containing magnesium or aluminum with VIDEX Chewable/Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the antacid components.
entities: aluminum / antacid
ddi: null
>>> match: potentiate_nsubj_obj
-------------
sentence: Antacids: Concomitant administration of antacids containing magnesium or aluminum with VIDEX Chewable/Dispersible Buffered Tablets or Pediatric Powder for Oral Solution may potentiate adverse events associated with the antacid components.
entities: VIDEX / antacid
ddi: null
>>> match: potentiate_nsubj_obj
-------------
sentence: Drugs Whose Absorption Can Be Affected by the Level of Acidity in the Stomach: Drugs such as ketoconazole and itraconazole should be administered at least 2 hours prior to dosing with VIDEX.
entities: ketoconazole / VIDEX
ddi: advise
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Drugs Whose Absorption Can Be Affected by the Level of Acidity in the Stomach: Drugs such as ketoconazole and itraconazole should be administered at least 2 hours prior to dosing with VIDEX.
entities: itraconazole / VIDEX
ddi: advise
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Ganciclovir: Administration of VIDEX 2 hours prior to or concurrent with oral ganciclovir was associated with a 111 (114)% increase in the steady-state AUC of didanosine (n = 12).
entities: VIDEX / didanosine
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: Ganciclovir: Administration of VIDEX 2 hours prior to or concurrent with oral ganciclovir was associated with a 111 (114)% increase in the steady-state AUC of didanosine (n = 12).
entities: ganciclovir / didanosine
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: A 21 (17)% decrease in the steady-state AUC of ganciclovir was observed when VIDEX was administered 2 hours prior to ganciclovir, but not when the two drugs were administered simultaneously (n = 12).
entities: ganciclovir / VIDEX
ddi: null
>>> match: observe_nsubj:pass_advcl
-------------
sentence: A 21 (17)% decrease in the steady-state AUC of ganciclovir was observed when VIDEX was administered 2 hours prior to ganciclovir, but not when the two drugs were administered simultaneously (n = 12).
entities: ganciclovir / ganciclovir
ddi: null
>>> match: observe_nsubj:pass_advcl
-------------
sentence: A 21 (17)% decrease in the steady-state AUC of ganciclovir was observed when VIDEX was administered 2 hours prior to ganciclovir, but not when the two drugs were administered simultaneously (n = 12).
entities: VIDEX / ganciclovir
ddi: mechanism
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: VIDEX / ciprofloxacin
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: VIDEX / ciprofloxacin
ddi: null
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: VIDEX / antacids
ddi: null
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: VIDEX / magnesium
ddi: null
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: VIDEX / calcium
ddi: null
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: VIDEX / aluminum
ddi: null
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / ciprofloxacin
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / antacids
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / magnesium
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / calcium
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / aluminum
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / antacids
ddi: null
>>> match: decrease_nsubj:pass_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / magnesium
ddi: mechanism
>>> match: decrease_nsubj:pass_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / calcium
ddi: mechanism
>>> match: decrease_nsubj:pass_advcl
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / aluminum
ddi: mechanism
>>> match: decrease_nsubj:pass_advcl
-------------
sentence: In eight HIV-infected patients, the steady-state AUC of ciprofloxacin was decreased an average of 26% (95% CI = 14%, 37%) when ciprofloxacin was administered 2 hours prior to a marketed chewable/dispersible tablet formulation of VIDEX.
entities: ciprofloxacin / ciprofloxacin
ddi: null
>>> match: decrease_nsubj:pass_advcl
-------------
sentence: In eight HIV-infected patients, the steady-state AUC of ciprofloxacin was decreased an average of 26% (95% CI = 14%, 37%) when ciprofloxacin was administered 2 hours prior to a marketed chewable/dispersible tablet formulation of VIDEX.
entities: ciprofloxacin / VIDEX
ddi: null
>>> match: decrease_nsubj:pass_advcl
-------------
sentence: In eight HIV-infected patients, the steady-state AUC of ciprofloxacin was decreased an average of 26% (95% CI = 14%, 37%) when ciprofloxacin was administered 2 hours prior to a marketed chewable/dispersible tablet formulation of VIDEX.
entities: ciprofloxacin / VIDEX
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: The AUC of ciprofloxacin was decreased an average of 15-fold in 12 healthy subjects given ciprofloxacin and didanosine-placebo tablets concurrently.
entities: ciprofloxacin / ciprofloxacin
ddi: null
>>> match: decrease_nsubj:pass_obl
-------------
sentence: The AUC of ciprofloxacin was decreased an average of 15-fold in 12 healthy subjects given ciprofloxacin and didanosine-placebo tablets concurrently.
entities: ciprofloxacin / didanosine
ddi: null
>>> match: decrease_nsubj:pass_obl
-------------
sentence: In a single subject given one dose of ciprofloxacin 2 hours after a dose of didanosine-placebo tablets, a greater than 50% reduction in the AUC of ciprofloxacin was observed.
entities: ciprofloxacin / ciprofloxacin
ddi: null
>>> match: observe_obl_nsubj:pass
-------------
sentence: In a single subject given one dose of ciprofloxacin 2 hours after a dose of didanosine-placebo tablets, a greater than 50% reduction in the AUC of ciprofloxacin was observed.
entities: didanosine / ciprofloxacin
ddi: null
>>> match: observe_obl_nsubj:pass
-------------
sentence: Plasma concentrations of quinolone antibiotics are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: quinolone antibiotics / antacids
ddi: null
>>> match: decrease_nsubj:pass_advcl
-------------
sentence: Plasma concentrations of quinolone antibiotics are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: quinolone antibiotics / magnesium
ddi: mechanism
>>> match: decrease_nsubj:pass_advcl
-------------
sentence: Plasma concentrations of quinolone antibiotics are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: quinolone antibiotics / calcium
ddi: mechanism
>>> match: decrease_nsubj:pass_advcl
-------------
sentence: Plasma concentrations of quinolone antibiotics are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: quinolone antibiotics / aluminum
ddi: mechanism
>>> match: decrease_nsubj:pass_advcl
-------------
sentence: The optimal dosing interval for coadministration with VIDEX should be determined by consulting the appropriate quinolone package insert.
entities: VIDEX / quinolone
ddi: null
>>> match: determine_nsubj:pass_advcl
-------------
sentence: Interactions with Other Antiretroviral Drugs: Significant decreases in the AUC of delavirdine (20%) and indinavir (84%) occurred following simultaneous administration of these agents with VIDEX.
entities: delavirdine / VIDEX
ddi: mechanism
>>> match: occur_nsubj_obl
-------------
sentence: Interactions with Other Antiretroviral Drugs: Significant decreases in the AUC of delavirdine (20%) and indinavir (84%) occurred following simultaneous administration of these agents with VIDEX.
entities: indinavir / VIDEX
ddi: mechanism
>>> match: occur_nsubj_obl
-------------
sentence: To avoid this interaction, delavirdine or indinavir should be given 1 hour prior to dosing with VIDEX.
entities: delavirdine / VIDEX
ddi: advise
>>> match: avoid_obj_dep
-------------
sentence: To avoid this interaction, delavirdine or indinavir should be given 1 hour prior to dosing with VIDEX.
entities: indinavir / VIDEX
ddi: advise
>>> match: avoid_obj_dep
-------------
sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).
entities: Zarontin / antiepileptic drugs
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).
entities: ethosuximide / antiepileptic drugs
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).
entities: ethosuximide / phenytoin
ddi: mechanism
>>> match: elevate_nsubj_obj
-------------
sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).
entities: ethosuximide / valproic acid
ddi: null
>>> match: elevate_nsubj_obj
-------------
sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).
entities: ethosuximide / ethosuximide
ddi: null
>>> match: elevate_nsubj_dep
-------------
sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).
entities: phenytoin / ethosuximide
ddi: null
>>> match: elevate_obj_dep
-------------
sentence: Since Zarontin (ethosuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg, ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels).
entities: valproic acid / ethosuximide
ddi: mechanism
>>> match: elevate_obj_dep
-------------
sentence: Cyclopentolate may interfere with the anti-glaucoma action of carbachol or pilocarpine;
entities: Cyclopentolate / carbachol
ddi: effect
>>> match: interfere_nsubj_obl
-------------
sentence: Cyclopentolate may interfere with the anti-glaucoma action of carbachol or pilocarpine;
entities: Cyclopentolate / pilocarpine
ddi: effect
>>> match: interfere_nsubj_obl
-------------
sentence: The gonadotropin levels may be transiently elevated by spironolactone, minimally elevated by levodopa, and suppressed by oral contraceptives and digoxin.
entities: spironolactone / levodopa
ddi: null
>>> match: elevate_obl_conj
-------------
sentence: The gonadotropin levels may be transiently elevated by spironolactone, minimally elevated by levodopa, and suppressed by oral contraceptives and digoxin.
entities: spironolactone / contraceptives
ddi: null
>>> match: elevate_obl_conj
-------------
sentence: The gonadotropin levels may be transiently elevated by spironolactone, minimally elevated by levodopa, and suppressed by oral contraceptives and digoxin.
entities: spironolactone / digoxin
ddi: null
>>> match: elevate_obl_conj
-------------
sentence: The gonadotropin levels may be transiently elevated by spironolactone, minimally elevated by levodopa, and suppressed by oral contraceptives and digoxin.
entities: levodopa / contraceptives
ddi: null
>>> match: elevate_conj_conj
-------------
sentence: The gonadotropin levels may be transiently elevated by spironolactone, minimally elevated by levodopa, and suppressed by oral contraceptives and digoxin.
entities: levodopa / digoxin
ddi: null
>>> match: elevate_conj_conj
-------------
sentence: The response to Factrel may be blunted by phenothiazines and dopamine antagonists which cause a rise in prolactin.
entities: Factrel / phenothiazines
ddi: effect
>>> match: blunt_nsubj:pass_obl
-------------
sentence: The response to Factrel may be blunted by phenothiazines and dopamine antagonists which cause a rise in prolactin.
entities: Factrel / dopamine antagonists
ddi: effect
>>> match: blunt_nsubj:pass_obl
-------------
sentence: In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus.

entities: minocycline / fosfomycin
ddi: null
>>> match: combine_nsubj_obl
-------------
sentence: In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus.

entities: minocycline / methicillin
ddi: null
>>> match: combine_nsubj_obl
-------------
sentence: This study aimed to evaluate the in vitro activity of minocycline combined with fosfomycin against isolates of methicillin-resistant Staphylococcus aureus (MRSA). 
entities: minocycline / fosfomycin
ddi: null
>>> match: evaluate_obj_advcl
-------------
sentence: This study aimed to evaluate the in vitro activity of minocycline combined with fosfomycin against isolates of methicillin-resistant Staphylococcus aureus (MRSA). 
entities: minocycline / methicillin
ddi: null
>>> match: evaluate_obj_advcl
-------------
sentence: Cholestyramine: Cholestyramine binds both T4 and T3 in the intestine, thus impairing absorption of these thyroid hormones.
entities: Cholestyramine / T4
ddi: mechanism
>>> match: bind_nsubj_obj
-------------
sentence: Cholestyramine: Cholestyramine binds both T4 and T3 in the intestine, thus impairing absorption of these thyroid hormones.
entities: Cholestyramine / T3
ddi: mechanism
>>> match: bind_nsubj_obj
-------------
sentence: Cholestyramine: Cholestyramine binds both T4 and T3 in the intestine, thus impairing absorption of these thyroid hormones.
entities: Cholestyramine / thyroid hormones
ddi: null
>>> match: bind_nsubj_dep
-------------
sentence: Cholestyramine: Cholestyramine binds both T4 and T3 in the intestine, thus impairing absorption of these thyroid hormones.
entities: T4 / thyroid hormones
ddi: null
>>> match: bind_obj_dep
-------------
sentence: Cholestyramine: Cholestyramine binds both T4 and T3 in the intestine, thus impairing absorption of these thyroid hormones.
entities: T3 / thyroid hormones
ddi: null
>>> match: bind_obj_dep
-------------
sentence: In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy, free levothyroxine may be decreased when estrogens are started thus increasing thyroid requirements.
entities: levothyroxine / estrogens
ddi: mechanism
>>> match: decrease_obl_advcl
-------------
sentence: In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy, free levothyroxine may be decreased when estrogens are started thus increasing thyroid requirements.
entities: levothyroxine / thyroid
ddi: null
>>> match: decrease_obl_advcl
-------------
sentence: In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy, free levothyroxine may be decreased when estrogens are started thus increasing thyroid requirements.
entities: estrogens / thyroid
ddi: null
>>> match: start_nsubj:pass_dep
-------------
sentence: Digitalis: Thyroid preparations may potentiate the toxic effects of digitalis.
entities: Thyroid preparations / digitalis
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Ketamine: When administered to patients on a thyroid preparation, this parenteral anesthetic may cause hypertension and tachycardia.
entities: thyroid preparation / anesthetic
ddi: effect
>>> match: cause_advcl_nsubj
-------------
sentence: Vasopressors: Thyroxine increases the adrenergic effect of catecholamines such as epinephrine and norepinephrine.
entities: Thyroxine / epinephrine
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Vasopressors: Thyroxine increases the adrenergic effect of catecholamines such as epinephrine and norepinephrine.
entities: Thyroxine / norepinephrine
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: While co-administration of ZAVESCA    appeared to increase the clearance of Cerezyme by 70%, these results are not conclusive because of the small number of subjects studied and because patients took variable doses of Cerezyme. 
entities: ZAVESCA / Cerezyme
ddi: mechanism
>>> match: appear_nsubj_xcomp
-------------
sentence: The potential for clinically significant drug-drug interactions posed by dolasetron and hydrodolasetron appears to be low for drugs commonly used in chemotherapy or surgery, because hydrodolasetron is eliminated by multiple routes.
entities: dolasetron / hydrodolasetron
ddi: null
>>> match: appear_csubj_advcl
-------------
sentence: The potential for clinically significant drug-drug interactions posed by dolasetron and hydrodolasetron appears to be low for drugs commonly used in chemotherapy or surgery, because hydrodolasetron is eliminated by multiple routes.
entities: hydrodolasetron / hydrodolasetron
ddi: null
>>> match: appear_csubj_advcl
-------------
sentence: Blood levels of hydrodolasetron increased 24% when dolasetron was coadministered with cimetidine (nonselective inhibitor of cytochrome P-450) for 7 days, and decreased 28% with coadministration of rifampin (potent inducer of cytochrome P-450) for 7 days.
entities: hydrodolasetron / dolasetron
ddi: null
>>> match: increase_nsubj_advcl
-------------
sentence: Blood levels of hydrodolasetron increased 24% when dolasetron was coadministered with cimetidine (nonselective inhibitor of cytochrome P-450) for 7 days, and decreased 28% with coadministration of rifampin (potent inducer of cytochrome P-450) for 7 days.
entities: hydrodolasetron / cimetidine
ddi: null
>>> match: increase_nsubj_advcl
-------------
sentence: Blood levels of hydrodolasetron increased 24% when dolasetron was coadministered with cimetidine (nonselective inhibitor of cytochrome P-450) for 7 days, and decreased 28% with coadministration of rifampin (potent inducer of cytochrome P-450) for 7 days.
entities: hydrodolasetron / rifampin
ddi: null
>>> match: increase_nsubj_advcl
-------------
sentence: Blood levels of hydrodolasetron increased 24% when dolasetron was coadministered with cimetidine (nonselective inhibitor of cytochrome P-450) for 7 days, and decreased 28% with coadministration of rifampin (potent inducer of cytochrome P-450) for 7 days.
entities: dolasetron / cimetidine
ddi: mechanism
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Blood levels of hydrodolasetron increased 24% when dolasetron was coadministered with cimetidine (nonselective inhibitor of cytochrome P-450) for 7 days, and decreased 28% with coadministration of rifampin (potent inducer of cytochrome P-450) for 7 days.
entities: dolasetron / rifampin
ddi: mechanism
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Clearance of hydrodolasetron decreased by about 27% when dolasetron mesylate was administered intravenously concomitantly with atenolol.
entities: hydrodolasetron / dolasetron mesylate
ddi: null
>>> match: decrease_nsubj_advcl
-------------
sentence: Clearance of hydrodolasetron decreased by about 27% when dolasetron mesylate was administered intravenously concomitantly with atenolol.
entities: hydrodolasetron / atenolol
ddi: null
>>> match: decrease_nsubj_advcl
-------------
sentence: Clearance of hydrodolasetron decreased by about 27% when dolasetron mesylate was administered intravenously concomitantly with atenolol.
entities: dolasetron mesylate / atenolol
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: Coadministration of fluoxetine significantly decreased cisapride plasma concentrations. 
entities: fluoxetine / cisapride
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Cisapride was well tolerated when administered alone or with fluoxetine. 
entities: Cisapride / fluoxetine
ddi: null
>>> match: tolerate_nsubj:pass_advcl
-------------
sentence: CONCLUSION: Cisapride can be administered safely to patients receiving low therapeutic dosages of fluoxetine.
entities: Cisapride / fluoxetine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or aspirin potentiated the risk of bleeding.
entities: psychotropic drugs / NSAID
ddi: effect
>>> match: show_nsubj_ccomp
-------------
sentence: Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or aspirin potentiated the risk of bleeding.
entities: psychotropic drugs / aspirin
ddi: effect
>>> match: show_nsubj_ccomp
-------------
sentence: Cimetidine - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in citalopram AUC and Cmax of 43% and 39%, respectively.
entities: citalopram / cimetidine
ddi: mechanism
>>> match: receive_obl:tmod_ccomp
-------------
sentence: Cimetidine - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in citalopram AUC and Cmax of 43% and 39%, respectively.
entities: citalopram / citalopram
ddi: null
>>> match: receive_obl:tmod_ccomp
-------------
sentence: Cimetidine - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in citalopram AUC and Cmax of 43% and 39%, respectively.
entities: cimetidine / citalopram
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: Digoxin / citalopram
ddi: null
>>> match: affect_nsubj_nsubj
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: Digoxin / digoxin
ddi: null
>>> match: affect_nsubj_nsubj
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: Digoxin / citalopram
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: Digoxin / digoxin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: citalopram / citalopram
ddi: null
>>> match: affect_nsubj_nsubj
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: citalopram / digoxin
ddi: null
>>> match: affect_nsubj_nsubj
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: citalopram / citalopram
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: citalopram / digoxin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: citalopram / citalopram
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: citalopram / digoxin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: digoxin / citalopram
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Digoxin - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin.
entities: digoxin / digoxin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Lithium - Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.
entities: Lithium / citalopram
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Lithium - Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.
entities: Lithium / lithium
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Lithium - Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.
entities: citalopram / citalopram
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Lithium - Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.
entities: citalopram / lithium
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Lithium - Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.
entities: lithium / citalopram
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Lithium - Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.
entities: lithium / lithium
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice.
entities: lithium / lithium
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Because lithium may enhance the serotonergic effects of escitalopram, caution should be exercised when LEXAPRO and lithium are coadministered.
entities: lithium / escitalopram
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Because lithium may enhance the serotonergic effects of escitalopram, caution should be exercised when LEXAPRO and lithium are coadministered.
entities: lithium / LEXAPRO
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: Because lithium may enhance the serotonergic effects of escitalopram, caution should be exercised when LEXAPRO and lithium are coadministered.
entities: lithium / lithium
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: Because lithium may enhance the serotonergic effects of escitalopram, caution should be exercised when LEXAPRO and lithium are coadministered.
entities: escitalopram / LEXAPRO
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: Because lithium may enhance the serotonergic effects of escitalopram, caution should be exercised when LEXAPRO and lithium are coadministered.
entities: escitalopram / lithium
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: Pimozide and Celexa - In a controlled study, a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone.
entities: pimozide / citalopram
ddi: effect
>>> match: associate_dep_nsubj:pass
-------------
sentence: Pimozide and Celexa - In a controlled study, a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone.
entities: pimozide / pimozide
ddi: null
>>> match: associate_dep_advcl
-------------
sentence: Pimozide and Celexa - In a controlled study, a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone.
entities: citalopram / pimozide
ddi: null
>>> match: associate_nsubj:pass_advcl
-------------
sentence: Carbamazepine - Combined administration of racemic citalopram (40 mg/day for 14 days) and carbamazepine (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of carbamazepine, a CYP3A4 substrate.
entities: Carbamazepine / carbamazepine
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Carbamazepine - Combined administration of racemic citalopram (40 mg/day for 14 days) and carbamazepine (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of carbamazepine, a CYP3A4 substrate.
entities: citalopram / carbamazepine
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Carbamazepine - Combined administration of racemic citalopram (40 mg/day for 14 days) and carbamazepine (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of carbamazepine, a CYP3A4 substrate.
entities: carbamazepine / carbamazepine
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Although trough citalopram plasma levels were unaffected, given the enzyme-inducing properties of carbamazepine, the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered.
entities: citalopram / carbamazepine
ddi: null
>>> match: consider_advcl_obl
-------------
sentence: Although trough citalopram plasma levels were unaffected, given the enzyme-inducing properties of carbamazepine, the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered.
entities: citalopram / carbamazepine
ddi: null
>>> match: consider_advcl_nsubj:pass
-------------
sentence: Although trough citalopram plasma levels were unaffected, given the enzyme-inducing properties of carbamazepine, the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered.
entities: citalopram / escitalopram
ddi: null
>>> match: consider_advcl_nsubj:pass
-------------
sentence: Although trough citalopram plasma levels were unaffected, given the enzyme-inducing properties of carbamazepine, the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered.
entities: carbamazepine / carbamazepine
ddi: null
>>> match: consider_obl_nsubj:pass
-------------
sentence: Although trough citalopram plasma levels were unaffected, given the enzyme-inducing properties of carbamazepine, the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered.
entities: carbamazepine / escitalopram
ddi: null
>>> match: consider_obl_nsubj:pass
-------------
sentence: Although trough citalopram plasma levels were unaffected, given the enzyme-inducing properties of carbamazepine, the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered.
entities: carbamazepine / escitalopram
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Triazolam - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.
entities: Triazolam / citalopram
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Triazolam - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.
entities: Triazolam / triazolam
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Triazolam - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.
entities: citalopram / citalopram
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Triazolam - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.
entities: citalopram / triazolam
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Triazolam - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.
entities: triazolam / citalopram
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Triazolam - Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.
entities: triazolam / triazolam
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Ketoconazole - Combined administration of racemic citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram.
entities: Ketoconazole / ketoconazole
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Ketoconazole - Combined administration of racemic citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram.
entities: Ketoconazole / citalopram
ddi: null
>>> match: decrease_nsubj_conj
-------------
sentence: Ketoconazole - Combined administration of racemic citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram.
entities: citalopram / ketoconazole
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Ketoconazole - Combined administration of racemic citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram.
entities: citalopram / citalopram
ddi: null
>>> match: decrease_nsubj_conj
-------------
sentence: Ketoconazole - Combined administration of racemic citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram.
entities: ketoconazole / ketoconazole
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Ketoconazole - Combined administration of racemic citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram.
entities: ketoconazole / citalopram
ddi: null
>>> match: decrease_nsubj_conj
-------------
sentence: Ketoconazole - Combined administration of racemic citalopram (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram.
entities: ketoconazole / citalopram
ddi: null
>>> match: decrease_obj_conj
-------------
sentence: However, coadministration of escitalopram (20 mg) and ritonavir (600 mg), a potent inhibitor of CYP3A4, did not significantly affect the pharmacokinetics of escitalopram.
entities: escitalopram / escitalopram
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: However, coadministration of escitalopram (20 mg) and ritonavir (600 mg), a potent inhibitor of CYP3A4, did not significantly affect the pharmacokinetics of escitalopram.
entities: ritonavir / escitalopram
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Because escitalopram is metabolized by multiple enzyme systems, inhibition of a single enzyme may not appreciably decrease escitalopram clearance.
entities: escitalopram / escitalopram
ddi: null
>>> match: decrease_advcl_obj
-------------
sentence: However, there are limited in vivo data suggesting a modest CYP2D6 inhibitory effect for escitalopram, i.e., coadministration of escitalopram (20 mg/day for 21 days) with the tricyclic antidepressant desipramine (single dose of 50 mg), a substrate for CYP2D6, resulted in a 40% increase in Cmax and a 100% increase in AUC of desipramine.
entities: escitalopram / desipramine
ddi: null
>>> match: be_nsubj_dep
-------------
sentence: However, there are limited in vivo data suggesting a modest CYP2D6 inhibitory effect for escitalopram, i.e., coadministration of escitalopram (20 mg/day for 21 days) with the tricyclic antidepressant desipramine (single dose of 50 mg), a substrate for CYP2D6, resulted in a 40% increase in Cmax and a 100% increase in AUC of desipramine.
entities: escitalopram / desipramine
ddi: null
>>> match: be_nsubj_dep
-------------
sentence: However, there are limited in vivo data suggesting a modest CYP2D6 inhibitory effect for escitalopram, i.e., coadministration of escitalopram (20 mg/day for 21 days) with the tricyclic antidepressant desipramine (single dose of 50 mg), a substrate for CYP2D6, resulted in a 40% increase in Cmax and a 100% increase in AUC of desipramine.
entities: desipramine / desipramine
ddi: null
>>> match: be_nsubj_dep
-------------
sentence: Metoprolol - Administration of 20 mg/day LEXAPRO for 21 days in healthy volunteers resulted in a 50% increase in Cmax and 82% increase in AUC of the beta-adrenergic blocker metoprolol (given in a single dose of 100 mg).
entities: Metoprolol / metoprolol
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Metoprolol - Administration of 20 mg/day LEXAPRO for 21 days in healthy volunteers resulted in a 50% increase in Cmax and 82% increase in AUC of the beta-adrenergic blocker metoprolol (given in a single dose of 100 mg).
entities: LEXAPRO / metoprolol
ddi: mechanism
>>> match: result_nsubj_obl
-------------
sentence: Insulin: A clinical study in 6 insulin-dependent diabetic patients demonstrated no effect of EXTRANEAL on insulin absorption from the peritoneal cavity or on insulin's ability to control blood glucose when insulin was administered intraperitoneally with EXTRANEAL.
entities: insulin / EXTRANEAL
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: vancomycin / antibiotics
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: vancomycin / EXTRANEAL
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: cefazolin / antibiotics
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: cefazolin / EXTRANEAL
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: ampicillin / antibiotics
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: ampicillin / EXTRANEAL
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: ampicillin / antibiotics
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: ampicillin / EXTRANEAL
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: ceftazidime / antibiotics
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: ceftazidime / EXTRANEAL
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: gentamicin / antibiotics
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: gentamicin / EXTRANEAL
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: amphotericin / antibiotics
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In vitro studies evaluating the minimum inhibitory concentration (MIC) of vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin demonstrated no evidence of incompatibility of these antibiotics with EXTRANEAL.
entities: amphotericin / EXTRANEAL
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin.
entities: MONUROL / fosfomycin
ddi: null
>>> match: coadminister_obl_dep
-------------
sentence: Metoclopramide: When coadministered with MONUROL, metoclopramide, a drug which increases gastrointestinal motility, lowers the serum concentration and urinary excretion of fosfomycin.
entities: metoclopramide / fosfomycin
ddi: null
>>> match: coadminister_obl_dep
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / contraceptives
ddi: int
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / antibiotics
ddi: int
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / quinidine
ddi: int
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / theophylline
ddi: int
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / corticosteroids
ddi: int
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / anticoagulants
ddi: int
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: Barbiturates / beta blockers
ddi: int
>>> match: decrease_nsubj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: contraceptives / antibiotics
ddi: null
>>> match: decrease_obj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: contraceptives / quinidine
ddi: null
>>> match: decrease_obj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: contraceptives / theophylline
ddi: null
>>> match: decrease_obj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: contraceptives / corticosteroids
ddi: null
>>> match: decrease_obj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: contraceptives / anticoagulants
ddi: null
>>> match: decrease_obj_obj
-------------
sentence: Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.
entities: contraceptives / beta blockers
ddi: null
>>> match: decrease_obj_obj
-------------
sentence: The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy. 
entities: anticoagulant / coumarin
ddi: null
>>> match: investigate_nsubj:pass_obl
-------------
sentence: The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy. 
entities: phenobarbital / coumarin
ddi: null
>>> match: investigate_nsubj:pass_obl
-------------
sentence: The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy. 
entities: secobarbital / coumarin
ddi: null
>>> match: investigate_nsubj:pass_obl
-------------
sentence: The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy. 
entities: glutethimide / coumarin
ddi: null
>>> match: investigate_nsubj:pass_obl
-------------
sentence: The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy. 
entities: chloral hydrate / coumarin
ddi: null
>>> match: investigate_nsubj:pass_obl
-------------
sentence: The intensity, uniformity and time course of anticoagulant interference by phenobarbital, secobarbital, glutethimide, chloral hydrate and methaqualone were systematically investigated in 16 patients receiving coumarin therapy. 
entities: methaqualone / coumarin
ddi: null
>>> match: investigate_nsubj:pass_obl
-------------
sentence: Barbiturates and glutethimide should not be administered to patients receiving coumarin drugs. 
entities: Barbiturates / coumarin drugs
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Barbiturates and glutethimide should not be administered to patients receiving coumarin drugs. 
entities: glutethimide / coumarin drugs
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Chloral hydrate and methaqualone interact pharmacologically with orally administered anticoagulant agents, but the effect is not clinically significant. 
entities: Chloral hydrate / anticoagulant agents
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Chloral hydrate and methaqualone interact pharmacologically with orally administered anticoagulant agents, but the effect is not clinically significant. 
entities: methaqualone / anticoagulant agents
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: It is concluded that chloral hydrate and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy.
entities: chloral hydrate / anticoagulant
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: It is concluded that chloral hydrate and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy.
entities: methaqualone / anticoagulant
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Cimetidine (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg Vardenafil in healthy volunteers.
entities: Cimetidine / vardenafil
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Cimetidine (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg Vardenafil in healthy volunteers.
entities: Cimetidine / vardenafil
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Cimetidine (400 mg b.i.d.) had no effect on vardenafil bioavailability (AUC) and maximum concentration (Cmax) of vardenafil when co-administered with 20 mg Vardenafil in healthy volunteers.
entities: Cimetidine / Vardenafil
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Erythromycin (500 mg t.i.d) produced a 4-fold increase in vardenafil AUC and a 3-fold increase in Cmax when co-administered with Vardenafil 5 mg in healthy volunteers.
entities: Erythromycin / vardenafil
ddi: mechanism
>>> match: produce_nsubj_obj
-------------
sentence: Erythromycin (500 mg t.i.d) produced a 4-fold increase in vardenafil AUC and a 3-fold increase in Cmax when co-administered with Vardenafil 5 mg in healthy volunteers.
entities: Erythromycin / Vardenafil
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: It is recommended not to exceed a single 5 mg dose of Vardenafil in a 24-hour period when used in combination with erythromycin.
entities: Vardenafil / erythromycin
ddi: advise
>>> match: exceed_obj_obl
-------------
sentence: Ketoconazole (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in Cmax when co-administered with Vardenafil (5 mg) in healthy volunteers.
entities: Ketoconazole / vardenafil
ddi: mechanism
>>> match: produce_nsubj_obj
-------------
sentence: Ketoconazole (200 mg once daily) produced a 10-fold increase in vardenafil AUC and a 4-fold increase in Cmax when co-administered with Vardenafil (5 mg) in healthy volunteers.
entities: Ketoconazole / Vardenafil
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: A 5-mg Vardenafil dose should not be exceeded when used in combination with 200 mg once daily ketoconazole.
entities: Vardenafil / ketoconazole
ddi: advise
>>> match: exceed_nsubj:pass_advcl
-------------
sentence: Since higher doses of ketoconazole (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of Vardenafil should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily.
entities: ketoconazole / Vardenafil
ddi: null
>>> match: result_obl_parataxis
-------------
sentence: Since higher doses of ketoconazole (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of Vardenafil should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily.
entities: ketoconazole / ketoconazole
ddi: null
>>> match: result_obl_parataxis
-------------
sentence: Since higher doses of ketoconazole (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of Vardenafil should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily.
entities: Vardenafil / ketoconazole
ddi: advise
>>> match: exceed_nsubj:pass_advcl
-------------
sentence: HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.
entities: Indinavir / vardenafil
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.
entities: Indinavir / vardenafil
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.
entities: Indinavir / vardenafil
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.
entities: Vardenafil / vardenafil
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.
entities: Vardenafil / vardenafil
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: HIV Protease Inhibitors: Indinavir (800 mg t.i.d.) co-administered with Vardenafil 10 mg resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax and a 2-fold increase in vardenafil half-life.
entities: Vardenafil / vardenafil
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: It is recommended not to exceed a single 2.5 mg Vardenafil dose in a 24-hour period when used in combination with indinavir.
entities: Vardenafil / indinavir
ddi: advise
>>> match: exceed_obj_obl
-------------
sentence: Ritonavir (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in vardenafil Cmax.
entities: Ritonavir / vardenafil
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Ritonavir (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in vardenafil Cmax.
entities: Ritonavir / vardenafil
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Ritonavir (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in vardenafil Cmax.
entities: Vardenafil / vardenafil
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Ritonavir (600 mg b.i.d.) co-administered with Vardenafil 5 mg resulted in a 49-fold increase in vardenafil AUC and a 13-fold increase in vardenafil Cmax.
entities: Vardenafil / vardenafil
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Ritonavir significantly prolonged the half-life of vardenafil to 26 hours.
entities: Ritonavir / vardenafil
ddi: mechanism
>>> match: prolong_nsubj_obj
-------------
sentence: Consequently, it is recommended not to exceed a single 2.5 mg Vardenafil dose in a 72-hour period when used in combination with ritonavir.
entities: Vardenafil / ritonavir
ddi: advise
>>> match: exceed_obj_obl
-------------
sentence: Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, Maalox, and ranitidine.
entities: vardenafil / glyburide
ddi: null
>>> match: observe_obl_parataxis
-------------
sentence: Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, Maalox, and ranitidine.
entities: vardenafil / warfarin
ddi: null
>>> match: observe_obl_parataxis
-------------
sentence: Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, Maalox, and ranitidine.
entities: vardenafil / digoxin
ddi: null
>>> match: observe_obl_parataxis
-------------
sentence: Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, Maalox, and ranitidine.
entities: vardenafil / Maalox
ddi: null
>>> match: observe_obl_parataxis
-------------
sentence: Other Drug Interactions: No pharmacokinetic interactions were observed between vardenafil and the following drugs: glyburide, warfarin, digoxin, Maalox, and ranitidine.
entities: vardenafil / ranitidine
ddi: null
>>> match: observe_obl_parataxis
-------------
sentence: In the warfarin study, vardenafil had no effect on the prothrombin time or other pharmacodynamic parameters.
entities: warfarin / vardenafil
ddi: null
>>> match: have_obl_nsubj
-------------
sentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.
entities: nitrates / vardenafil
ddi: mechanism
>>> match: take_nsubj_obl
-------------
sentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.
entities: nitrates / Vardenafil
ddi: null
>>> match: take_nsubj_conj
-------------
sentence: In vivo studies: Nitrates: The blood pressure lowering effects of sublingual nitrates (0.4 mg) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1, 4 and 8 hours were potentiated by a 20 mg dose of Vardenafil in healthy middle-aged subjects.
entities: vardenafil / Vardenafil
ddi: null
>>> match: take_obl_conj
-------------
sentence: These effects were not observed when Vardenafil 20 mg was taken 24 hours before the NTG.
entities: Vardenafil / NTG
ddi: null
>>> match: take_nsubj:pass_obl
-------------
sentence: Potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated, and concomitant use of Vardenafil and nitrates is contraindicated.
entities: nitrates / Vardenafil
ddi: null
>>> match: evaluate_nsubj:pass_conj
-------------
sentence: Potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated, and concomitant use of Vardenafil and nitrates is contraindicated.
entities: nitrates / nitrates
ddi: null
>>> match: evaluate_nsubj:pass_conj
-------------
sentence: Alpha-blockers: When Vardenafil 10 or 20 mg was given to healthy volunteers either simultaneously or 6 hours after a 10 mg dose of terazosin, significant hypotension developed in a substantial number of subjects.
entities: Vardenafil / terazosin
ddi: effect
>>> match: give_nsubj:pass_dep
-------------
sentence: With simultaneous dosing of Vardenafil 20 mg and terazosin 10 mg, 2 of 9 subjects experienced a standing systolic blood pressure of less than 85 mm Hg.
entities: Vardenafil / terazosin
ddi: effect
>>> match: experience_obl_nsubj
-------------
sentence: When Vardenafil dosing was separated from terazosin 10 mg by 6 hours, 7 of 28 subjects who received 20 mg of Vardenafil experienced a decrease in standing systolic blood pressure below 85 mm Hg.
entities: Vardenafil / terazosin
ddi: effect
>>> match: separate_nsubj:pass_obl
-------------
sentence: When Vardenafil dosing was separated from terazosin 10 mg by 6 hours, 7 of 28 subjects who received 20 mg of Vardenafil experienced a decrease in standing systolic blood pressure below 85 mm Hg.
entities: Vardenafil / Vardenafil
ddi: null
>>> match: experience_advcl_nsubj
-------------
sentence: When Vardenafil dosing was separated from terazosin 10 mg by 6 hours, 7 of 28 subjects who received 20 mg of Vardenafil experienced a decrease in standing systolic blood pressure below 85 mm Hg.
entities: terazosin / Vardenafil
ddi: null
>>> match: experience_advcl_nsubj
-------------
sentence: In a similar study with tamsulosin in healthy volunteers, 1 of 24 subjects dosed with Vardenafil 20 mg and tamsulosin 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg.
entities: tamsulosin / Vardenafil
ddi: null
>>> match: dose_obl_obl
-------------
sentence: In a similar study with tamsulosin in healthy volunteers, 1 of 24 subjects dosed with Vardenafil 20 mg and tamsulosin 0.4 mg separated by 6 hours experienced a standing systolic blood pressure below 85 mm Hg.
entities: tamsulosin / tamsulosin
ddi: null
>>> match: dose_obl_obl
-------------
sentence: Based on these data, Vardenafil should not be used in patients on alpha-blocker therapy.
entities: Vardenafil / alpha-blocker
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Upon administration of 10 mg of Vardenafil with 800 mg TID indinavir, the Cmax and AUC of indinavir were reduced by 40% and 30%, respectively.
entities: Vardenafil / indinavir
ddi: null
>>> match: reduce_obl_nsubj:pass
-------------
sentence: Upon administration of 10 mg of Vardenafil with 800 mg TID indinavir, the Cmax and AUC of indinavir were reduced by 40% and 30%, respectively.
entities: indinavir / indinavir
ddi: null
>>> match: reduce_obl_nsubj:pass
-------------
sentence: Other interactions: Vardenafil had no effect on the pharmacodynamics of glyburide (glucose and insulin concentrations) and warfarin (prothrombin time or other pharmacodynamic parameters).
entities: Vardenafil / glyburide
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Other interactions: Vardenafil had no effect on the pharmacodynamics of glyburide (glucose and insulin concentrations) and warfarin (prothrombin time or other pharmacodynamic parameters).
entities: Vardenafil / warfarin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Drug Interactions: Women on oral contraceptives have shown a significant increase in plasma vitamin A levels.
entities: contraceptives / vitamin A
ddi: mechanism
>>> match: show_nsubj_obj
-------------
sentence: Tablets: The benzodiazepines, including lorazepam, produce CNS-depressant effects when administered with such medications as barbiturates or alcohol.
entities: benzodiazepines / barbiturates
ddi: effect
>>> match: produce_nsubj_advcl
-------------
sentence: Tablets: The benzodiazepines, including lorazepam, produce CNS-depressant effects when administered with such medications as barbiturates or alcohol.
entities: benzodiazepines / alcohol
ddi: effect
>>> match: produce_nsubj_advcl
-------------
sentence: Tablets: The benzodiazepines, including lorazepam, produce CNS-depressant effects when administered with such medications as barbiturates or alcohol.
entities: lorazepam / barbiturates
ddi: effect
>>> match: produce_nsubj_advcl
-------------
sentence: Tablets: The benzodiazepines, including lorazepam, produce CNS-depressant effects when administered with such medications as barbiturates or alcohol.
entities: lorazepam / alcohol
ddi: effect
>>> match: produce_nsubj_advcl
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: ethyl alcohol / scopolamine
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: ethyl alcohol / lorazepam
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: phenothiazines / scopolamine
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: phenothiazines / lorazepam
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: barbiturates / scopolamine
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: barbiturates / lorazepam
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: MAO inhibitors / scopolamine
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: MAO inhibitors / lorazepam
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: antidepressants / scopolamine
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: antidepressants / lorazepam
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: scopolamine / lorazepam
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: Drug/Laboratory Test Interactions As with cephalothin, high concentrations of cefoxitin ( 100 micrograms/mL) may interfere with measurement of serum and urine creatinine levels by the Jaff  reaction, and produce false increases of modest degree in the levels of creatinine reported.
entities: cephalothin / cefoxitin
ddi: null
>>> match: interfere_obl_nsubj
-------------
sentence: In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.
entities: warfarin / warfarin
ddi: null
>>> match: have_obl_obj
-------------
sentence: In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.
entities: warfarin / digoxin
ddi: null
>>> match: have_obl_conj
-------------
sentence: In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.
entities: hydrochlorothiazide / warfarin
ddi: null
>>> match: have_obl_obj
-------------
sentence: In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.
entities: hydrochlorothiazide / digoxin
ddi: null
>>> match: have_obl_conj
-------------
sentence: In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.
entities: digoxin / warfarin
ddi: null
>>> match: have_obl_obj
-------------
sentence: In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.
entities: digoxin / digoxin
ddi: null
>>> match: have_obl_conj
-------------
sentence: In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.
entities: irbesartan / warfarin
ddi: null
>>> match: have_obl_obj
-------------
sentence: In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.
entities: irbesartan / digoxin
ddi: null
>>> match: have_obl_conj
-------------
sentence: In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin.
entities: warfarin / digoxin
ddi: null
>>> match: have_obj_conj
-------------
sentence: Patients studied in clinical trials of TNKase were routinely treated with heparin and aspirin. 
entities: TNKase / heparin
ddi: null
>>> match: treat_csubj:pass_obl
-------------
sentence: Patients studied in clinical trials of TNKase were routinely treated with heparin and aspirin. 
entities: TNKase / aspirin
ddi: null
>>> match: treat_csubj:pass_obl
-------------
sentence: Anticoagulants (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. 
entities: Anticoagulants / TNKase
ddi: effect
>>> match: increase_nsubj_advcl
-------------
sentence: Anticoagulants (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. 
entities: heparin / TNKase
ddi: effect
>>> match: increase_nsubj_advcl
-------------
sentence: Anticoagulants (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. 
entities: acetylsalicylic acid / TNKase
ddi: effect
>>> match: increase_nsubj_advcl
-------------
sentence: Anticoagulants (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy. 
entities: dipyridamole / TNKase
ddi: effect
>>> match: increase_nsubj_advcl
-------------
sentence: Pilocarpine should be administered with caution to patients taking beta adrenergic antagonists because of the possibility of conduction disturbances. 
entities: Pilocarpine / beta adrenergic antagonists
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: No drug interaction studies have been conducted for COLAZAL, however the use of orally administered antibiotics could, theoretically, interfere with the release of mesalamine in the colon.
entities: COLAZAL / antibiotics
ddi: null
>>> match: conduct_obl_parataxis
-------------
sentence: No drug interaction studies have been conducted for COLAZAL, however the use of orally administered antibiotics could, theoretically, interfere with the release of mesalamine in the colon.
entities: COLAZAL / mesalamine
ddi: null
>>> match: conduct_obl_parataxis
-------------
sentence: No drug interaction studies have been conducted for COLAZAL, however the use of orally administered antibiotics could, theoretically, interfere with the release of mesalamine in the colon.
entities: antibiotics / mesalamine
ddi: null
>>> match: interfere_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / antidepressants
ddi: null
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / tricyclic
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / MAO inhibitors
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / phenelzine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / linezolid
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / tranylcypromine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / isocarboxazid
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / selegiline
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / furazolidone
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / quinidine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / amantadine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / antihistamines
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / diphenhydramine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / anticholinergics
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / potassium chloride
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / antacids
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / absorbent-type anti-diarrhea medicines
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / kaolin
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / pectin
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / phenothiazines
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / chlorpromazine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).
entities: Methscopolamine / promethazine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: Steroids / edetate calcium disodium
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: Steroids / Edetate calcium disodium
ddi: null
>>> match: enhance_nsubj_parataxis
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: Steroids / zinc insulin
ddi: null
>>> match: enhance_nsubj_parataxis
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: Steroids / zinc
ddi: null
>>> match: enhance_nsubj_parataxis
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: edetate calcium disodium / Edetate calcium disodium
ddi: null
>>> match: enhance_obj_parataxis
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: edetate calcium disodium / zinc insulin
ddi: null
>>> match: enhance_obj_parataxis
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: edetate calcium disodium / zinc
ddi: null
>>> match: enhance_obj_parataxis
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: Edetate calcium disodium / zinc insulin
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: Edetate calcium disodium / zinc
ddi: null
>>> match: interfere_nsubj_advcl
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: zinc insulin / zinc
ddi: null
>>> match: interfere_obl_advcl
-------------
sentence: Concomitant use of barbiturates usually depresses griseofulvin activity and may necessitate raising the dosage.
entities: barbiturates / griseofulvin
ddi: effect
>>> match: depress_nsubj_obj
-------------
sentence: The concomitant administration of griseofulvin has been reported to reduce the efficacy of oral contraceptives and to increase the incidence of breakthrough bleeding.
entities: griseofulvin / contraceptives
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: photosensitizing agents / LEVULAN KERASTICK
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: griseofulvin / LEVULAN KERASTICK
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: thiazide diuretics / LEVULAN KERASTICK
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: sulfonylureas / LEVULAN KERASTICK
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: phenothiazines / LEVULAN KERASTICK
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: sulfonamides / LEVULAN KERASTICK
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: It is, however, possible that concomitant use of other known photosensitizing agents such as griseofulvin, thiazide diuretics, sulfonylureas, phenothiazines, sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the LEVULAN KERASTICK for Topical Solution.
entities: tetracyclines / LEVULAN KERASTICK
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Mean oxybutynin chloride plasma concentrations were approximately 2 fold higher when DITROPAN XL was administered with ketoconazole, a potent CYP3A4 inhibitor. 
entities: DITROPAN XL / ketoconazole
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). 
entities: antimycotic agents / oxybutynin
ddi: mechanism
>>> match: alter_nsubj_ccomp
-------------
sentence: Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). 
entities: itraconazole / oxybutynin
ddi: mechanism
>>> match: alter_nsubj_ccomp
-------------
sentence: Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). 
entities: miconazole / oxybutynin
ddi: mechanism
>>> match: alter_nsubj_ccomp
-------------
sentence: Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). 
entities: macrolide antibiotics / oxybutynin
ddi: mechanism
>>> match: alter_nsubj_ccomp
-------------
sentence: Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). 
entities: erythromycin / oxybutynin
ddi: mechanism
>>> match: alter_nsubj_ccomp
-------------
sentence: Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC). 
entities: clarithromycin / oxybutynin
ddi: mechanism
>>> match: alter_nsubj_ccomp
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: antacid / oxybutynin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: antacid / desethyloxybutynin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: antacid / oxybutynin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: antacid / desethyloxybutynin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: aluminum hydroxide / oxybutynin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: aluminum hydroxide / desethyloxybutynin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: magnesium hydroxide / oxybutynin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: magnesium hydroxide / desethyloxybutynin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: simethicone / oxybutynin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.    
entities: simethicone / desethyloxybutynin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Patients on oral antidiabetic agents receiving VELCADE treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their antidiabetic medication.
entities: antidiabetic agents / antidiabetic medication
ddi: null
>>> match: require_nsubj_obj
-------------
sentence: Patients on oral antidiabetic agents receiving VELCADE treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their antidiabetic medication.
entities: VELCADE / antidiabetic medication
ddi: null
>>> match: require_nsubj_obj
-------------
sentence: Although the occurrence has not been reported with Cefizox, nephrotoxicity has been reported following concomitant administration of other cephalosporins and aminoglycosides.
entities: Cefizox / cephalosporins
ddi: null
>>> match: report_advcl_obl
-------------
sentence: Although the occurrence has not been reported with Cefizox, nephrotoxicity has been reported following concomitant administration of other cephalosporins and aminoglycosides.
entities: Cefizox / aminoglycosides
ddi: null
>>> match: report_advcl_obl
-------------
sentence: Concomitant use with iron supplements may result in the reduced absorption of iron.
entities: iron supplements / iron
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In a drug interaction study, co-administration of orally inhaled ciclesonide and oral erythromycin, an inhibitor of cytochrome P450 3A4, had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin.
entities: ciclesonide / des-ciclesonide
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: In a drug interaction study, co-administration of orally inhaled ciclesonide and oral erythromycin, an inhibitor of cytochrome P450 3A4, had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin.
entities: ciclesonide / erythromycin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: In a drug interaction study, co-administration of orally inhaled ciclesonide and oral erythromycin, an inhibitor of cytochrome P450 3A4, had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin.
entities: erythromycin / des-ciclesonide
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: In a drug interaction study, co-administration of orally inhaled ciclesonide and oral erythromycin, an inhibitor of cytochrome P450 3A4, had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin.
entities: erythromycin / erythromycin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: In another drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.
entities: ciclesonide / des-ciclesonide
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: In another drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.
entities: ciclesonide / ciclesonide
ddi: null
>>> match: increase_nsubj_advcl
-------------
sentence: In another drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.
entities: ketoconazole / des-ciclesonide
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: In another drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.
entities: ketoconazole / ciclesonide
ddi: null
>>> match: increase_nsubj_advcl
-------------
sentence: In another drug interaction study, co-administration of orally inhaled ciclesonide and oral ketoconazole, a potent inhibitor of cytochrome P450 3A4, increased the exposure (AUC) of des-ciclesonide by approximately 3.6-fold at steady state, while levels of ciclesonide remained unchanged.
entities: des-ciclesonide / ciclesonide
ddi: null
>>> match: increase_obj_advcl
-------------
sentence: Therefore, ketoconazole should be administered with caution with intranasal ciclesonide.
entities: ketoconazole / ciclesonide
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Probenecid: As with other b-lactam antibiotics, renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80% increase in the AUC for loracarbef.
entities: b-lactam antibiotics / loracarbef
ddi: null
>>> match: inhibit_obl_nsubj:pass
-------------
sentence: Probenecid: As with other b-lactam antibiotics, renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80% increase in the AUC for loracarbef.
entities: b-lactam antibiotics / probenecid
ddi: mechanism
>>> match: inhibit_obl_obl
-------------
sentence: Probenecid: As with other b-lactam antibiotics, renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80% increase in the AUC for loracarbef.
entities: b-lactam antibiotics / loracarbef
ddi: null
>>> match: inhibit_obl_conj
-------------
sentence: Probenecid: As with other b-lactam antibiotics, renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80% increase in the AUC for loracarbef.
entities: loracarbef / probenecid
ddi: mechanism
>>> match: inhibit_nsubj:pass_obl
-------------
sentence: Probenecid: As with other b-lactam antibiotics, renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80% increase in the AUC for loracarbef.
entities: loracarbef / loracarbef
ddi: null
>>> match: inhibit_nsubj:pass_conj
-------------
sentence: Probenecid: As with other b-lactam antibiotics, renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80% increase in the AUC for loracarbef.
entities: probenecid / loracarbef
ddi: null
>>> match: inhibit_obl_conj
-------------
sentence: We report the case of an adolescent with altered consciousness caused by carbamazepine overdose with a positive tricyclic antidepressant level to alert clinicians to the cross-reactivity of carbamazepine with a toxicology screen for tricyclic antidepressants.
entities: carbamazepine / carbamazepine
ddi: null
>>> match: cause_obl_advcl
-------------
sentence: We report the case of an adolescent with altered consciousness caused by carbamazepine overdose with a positive tricyclic antidepressant level to alert clinicians to the cross-reactivity of carbamazepine with a toxicology screen for tricyclic antidepressants.
entities: carbamazepine / tricyclic antidepressants
ddi: null
>>> match: cause_obl_advcl
-------------
sentence: We report the case of an adolescent with altered consciousness caused by carbamazepine overdose with a positive tricyclic antidepressant level to alert clinicians to the cross-reactivity of carbamazepine with a toxicology screen for tricyclic antidepressants.
entities: carbamazepine / tricyclic antidepressants
ddi: advise
>>> match: alert_obl_obl
-------------
sentence: In two controlled crossover clinical pharmacology studies in healthy male (n=12 in each study) a nd female (n=12 in each study) volunteers, desloratadine 7.5 mg (1.5 times the daily dose) once daily was coadministered with erythromycin 500 mg every 8 hours or ketoconazole 200 mg every 12 hours for 10 days.
entities: erythromycin / ketoconazole
ddi: null
>>> match: coadminister_obl_dep
-------------
sentence: In three separate controlled, parallel group clinical pharmacology studies, desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days (n=18) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine (n=18) or with cimetidine 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers.
entities: desloratadine / azithromycin
ddi: null
>>> match: coadminister_nsubj:pass_dep
-------------
sentence: In three separate controlled, parallel group clinical pharmacology studies, desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days (n=18) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine (n=18) or with cimetidine 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers.
entities: desloratadine / fluoxetine
ddi: null
>>> match: coadminister_nsubj:pass_dep
-------------
sentence: In three separate controlled, parallel group clinical pharmacology studies, desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days (n=18) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine (n=18) or with cimetidine 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers.
entities: desloratadine / fluoxetine
ddi: null
>>> match: coadminister_nsubj:pass_dep
-------------
sentence: In three separate controlled, parallel group clinical pharmacology studies, desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days (n=18) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine (n=18) or with cimetidine 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers.
entities: desloratadine / cimetidine
ddi: null
>>> match: coadminister_nsubj:pass_dep
-------------
sentence: In three separate controlled, parallel group clinical pharmacology studies, desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days (n=18) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine (n=18) or with cimetidine 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers.
entities: azithromycin / fluoxetine
ddi: null
>>> match: follow_obl_dep
-------------
sentence: In three separate controlled, parallel group clinical pharmacology studies, desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days (n=18) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine (n=18) or with cimetidine 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers.
entities: azithromycin / fluoxetine
ddi: null
>>> match: follow_obl_dep
-------------
sentence: In three separate controlled, parallel group clinical pharmacology studies, desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days (n=18) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine (n=18) or with cimetidine 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers.
entities: azithromycin / cimetidine
ddi: null
>>> match: follow_obl_dep
-------------
sentence: Although increased plasma concentrations (C max and AUC 0-24 hrs) of desloratadine and 3-hydroxydesloratadine were observed , there were no clinically relevant changes in the safety profile of desloratadine, as assessed by electrocardiographic parameters (including the corrected QT interval), clinical laboratory tests, vital signs, and adverse events.
entities: desloratadine / desloratadine
ddi: null
>>> match: be_advcl_nsubj
-------------
sentence: Although increased plasma concentrations (C max and AUC 0-24 hrs) of desloratadine and 3-hydroxydesloratadine were observed , there were no clinically relevant changes in the safety profile of desloratadine, as assessed by electrocardiographic parameters (including the corrected QT interval), clinical laboratory tests, vital signs, and adverse events.
entities: 3-hydroxydesloratadine / desloratadine
ddi: null
>>> match: be_advcl_nsubj
-------------
sentence: Cholestyramine: Cholestyramine causes a 60% reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with EVISTA. 
entities: Cholestyramine / raloxifene
ddi: mechanism
>>> match: cause_nsubj_obj
-------------
sentence: Cholestyramine: Cholestyramine causes a 60% reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with EVISTA. 
entities: Cholestyramine / EVISTA
ddi: advise
>>> match: cause_nsubj_conj
-------------
sentence: Cholestyramine: Cholestyramine causes a 60% reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with EVISTA. 
entities: raloxifene / EVISTA
ddi: null
>>> match: cause_obj_conj
-------------
sentence: If EVISTA is given concurrently with warfarin, prothrombin time should be monitored. 
entities: EVISTA / warfarin
ddi: advise
>>> match: give_nsubj:pass_obl
-------------
sentence: Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide. 
entities: EVISTA / clofibrate
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide. 
entities: EVISTA / indomethacin
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide. 
entities: EVISTA / naproxen
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide. 
entities: EVISTA / ibuprofen
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide. 
entities: EVISTA / diazepam
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide. 
entities: EVISTA / diazoxide
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / nonsteroidal anti-inflammatory agents
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / azoles
ddi: effect
>>> match: potentiate_nsubj:pass_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / salicylates
ddi: effect
>>> match: potentiate_nsubj:pass_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / sulfonamides
ddi: effect
>>> match: potentiate_nsubj:pass_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / chloramphenicol
ddi: effect
>>> match: potentiate_nsubj:pass_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / probenecid
ddi: effect
>>> match: potentiate_nsubj:pass_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / coumarins
ddi: effect
>>> match: potentiate_nsubj:pass_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / monoamine oxidase inhibitors
ddi: effect
>>> match: potentiate_nsubj:pass_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / beta adrenergic blocking agents
ddi: effect
>>> match: potentiate_nsubj:pass_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / azoles
ddi: null
>>> match: potentiate_obl_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / salicylates
ddi: null
>>> match: potentiate_obl_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / sulfonamides
ddi: null
>>> match: potentiate_obl_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / chloramphenicol
ddi: null
>>> match: potentiate_obl_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / probenecid
ddi: null
>>> match: potentiate_obl_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / coumarins
ddi: null
>>> match: potentiate_obl_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / monoamine oxidase inhibitors
ddi: null
>>> match: potentiate_obl_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / beta adrenergic blocking agents
ddi: null
>>> match: potentiate_obl_obj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / sulfonamides
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / chloramphenicol
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / probenecid
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / coumarins
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / monoamine oxidase inhibitors
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / beta adrenergic blocking agents
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / chloramphenicol
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / probenecid
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / coumarins
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / monoamine oxidase inhibitors
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / beta adrenergic blocking agents
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: chloramphenicol / probenecid
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: chloramphenicol / coumarins
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: chloramphenicol / monoamine oxidase inhibitors
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: chloramphenicol / beta adrenergic blocking agents
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: probenecid / coumarins
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: probenecid / monoamine oxidase inhibitors
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: probenecid / beta adrenergic blocking agents
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: coumarins / monoamine oxidase inhibitors
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: coumarins / beta adrenergic blocking agents
ddi: null
>>> match: bind_conj_conj
-------------
sentence: Immediate and Extended Release Tablets The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: monoamine oxidase inhibitors / beta adrenergic blocking agents
ddi: null
>>> match: bind_conj_conj
-------------
sentence: In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol.
entities: glipizide / tolbutamide
ddi: null
>>> match: bind_nsubj_advmod
-------------
sentence: In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol.
entities: glipizide / salicylate
ddi: null
>>> match: bind_nsubj_conj
-------------
sentence: In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol.
entities: glipizide / dicumarol
ddi: null
>>> match: bind_nsubj_conj
-------------
sentence: In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol.
entities: tolbutamide / salicylate
ddi: null
>>> match: bind_advmod_conj
-------------
sentence: In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol.
entities: tolbutamide / dicumarol
ddi: null
>>> match: bind_advmod_conj
-------------
sentence: All subjects received glipizide alone and following treatment with 100 mg of fluconazole as a single daily oral dose for seven days.
entities: glipizide / fluconazole
ddi: null
>>> match: receive_obj_conj
-------------
sentence: however, in patients with Paget's Disease prior diphosphonate use appears to reduce the anti-resorptive response to Calcitonin (salmon) nasal spray.
entities: diphosphonate / Calcitonin (salmon)
ddi: effect
>>> match: appear_nsubj_xcomp
-------------
sentence: In a study in which patients with active RA were treated for up to 24 weeks with concurrent Kineret and etanercept therapy, a 7% rate of serious infections was observed, which was higher than that observed with etanercept alone (0%).
entities: Kineret / etanercept
ddi: null
>>> match: observe_obl_ccomp
-------------
sentence: In a study in which patients with active RA were treated for up to 24 weeks with concurrent Kineret and etanercept therapy, a 7% rate of serious infections was observed, which was higher than that observed with etanercept alone (0%).
entities: etanercept / etanercept
ddi: null
>>> match: observe_obl_ccomp
-------------
sentence: Then, the effects of metabotropic glutamate receptor (mGluR) agonists, DCG-IV and L-CCG-1, on the above behavioral changes induced by PCP were found. 
entities: DCG-IV / PCP
ddi: null
>>> match: find_nsubj:pass_obl
-------------
sentence: In order to examine some molecular mechanisms of PCP-induced behavioral changes, Northern blot analysis of total RNA from prefrontal cortical tissues of mice treated with PCP, DCG-IV, and L-CCG-1 was carried out.
entities: PCP / PCP
ddi: null
>>> match: treat_advcl_obl
-------------
sentence: In order to examine some molecular mechanisms of PCP-induced behavioral changes, Northern blot analysis of total RNA from prefrontal cortical tissues of mice treated with PCP, DCG-IV, and L-CCG-1 was carried out.
entities: PCP / DCG-IV
ddi: null
>>> match: treat_advcl_obl
-------------
sentence: Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); 
entities: Dopamine antagonists / Permax
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); 
entities: Dopamine antagonists / dopamine agonist
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); 
entities: neuroleptics / Permax
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); 
entities: neuroleptics / dopamine agonist
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); 
entities: phenothiazines / Permax
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); 
entities: phenothiazines / dopamine agonist
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); 
entities: butyrophenones / Permax
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); 
entities: butyrophenones / dopamine agonist
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); 
entities: thioxanthines / Permax
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); 
entities: thioxanthines / dopamine agonist
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); 
entities: metoclopramide / Permax
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist); 
entities: metoclopramide / dopamine agonist
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Because pergolide mesylate is approximately 90% bound to plasma proteins, caution should be exercised if pergolide mesylate is coadministered with other drugs known to affect protein binding.
entities: pergolide mesylate / pergolide mesylate
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: Because tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. 
entities: tetracyclines / anticoagulant
ddi: null
>>> match: require_csubj_obj
-------------
sentence: Because tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. 
entities: anticoagulant / anticoagulant
ddi: null
>>> match: require_csubj_obj
-------------
sentence: Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline class drugs in conjunction with penicillin. 
entities: tetracycline class drugs / penicillin
ddi: advise
>>> match: give_obj_obl
-------------
sentence: Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium, and iron-containing preparations. 
entities: tetracyclines / antacids
ddi: null
>>> match: impair_nsubj:pass_obl
-------------
sentence: Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium, and iron-containing preparations. 
entities: tetracyclines / aluminum
ddi: mechanism
>>> match: impair_nsubj:pass_obl
-------------
sentence: Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium, and iron-containing preparations. 
entities: tetracyclines / calcium
ddi: mechanism
>>> match: impair_nsubj:pass_obl
-------------
sentence: Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium, and iron-containing preparations. 
entities: tetracyclines / magnesium
ddi: mechanism
>>> match: impair_nsubj:pass_obl
-------------
sentence: Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium, and iron-containing preparations. 
entities: tetracyclines / iron
ddi: mechanism
>>> match: impair_nsubj:pass_obl
-------------
sentence: Concurrent use of tetracyclines with oral contraceptives may render oral contraceptives less effective.
entities: tetracyclines / contraceptives
ddi: null
>>> match: render_nsubj_xcomp
-------------
sentence: Concurrent use of tetracyclines with oral contraceptives may render oral contraceptives less effective.
entities: contraceptives / contraceptives
ddi: null
>>> match: render_nsubj_xcomp
-------------
sentence: In vivo CYP3A activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipients.

entities: cyclosporine / tacrolimus
ddi: null
>>> match: treat_dep_obl
-------------
sentence: The latter displayed midazolam clearances similar to those in two larger cohorts of nonmatched tacrolimus-treated patients (n = 58 and n = 80) and to those receiving a calcineurin inhibitor-free regimen (n = 6). 
entities: midazolam / calcineurin inhibitor
ddi: null
>>> match: display_obj_dep
-------------
sentence: The latter displayed midazolam clearances similar to those in two larger cohorts of nonmatched tacrolimus-treated patients (n = 58 and n = 80) and to those receiving a calcineurin inhibitor-free regimen (n = 6). 
entities: tacrolimus / calcineurin inhibitor
ddi: null
>>> match: display_obj_dep
-------------
sentence: Such occurrences have been reported when propoxyphene was administered to patients on antidepressants, anticonvulsants, or warfarin-like drugs. 
entities: propoxyphene / antidepressants
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Such occurrences have been reported when propoxyphene was administered to patients on antidepressants, anticonvulsants, or warfarin-like drugs. 
entities: propoxyphene / anticonvulsants
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Such occurrences have been reported when propoxyphene was administered to patients on antidepressants, anticonvulsants, or warfarin-like drugs. 
entities: propoxyphene / warfarin
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Careful observation is required when amantadine is administered concurrently with central nervous system stimulants.
entities: amantadine / central nervous system stimulants
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. 
entities: Matulane / sympathomimetic drugs
ddi: advise
>>> match: avoid_advcl_nsubj:pass
-------------
sentence: Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. 
entities: Matulane / amitriptyline HCl
ddi: advise
>>> match: avoid_advcl_nsubj:pass
-------------
sentence: Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. 
entities: Matulane / imipramine HCl
ddi: advise
>>> match: avoid_advcl_nsubj:pass
-------------
sentence: Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided. 
entities: Matulane / tyramine
ddi: advise
>>> match: avoid_advcl_nsubj:pass
-------------
sentence: Warfarin: Meclofenamate sodium enhances the effect of warfarin.
entities: Meclofenamate sodium / warfarin
ddi: null
>>> match: enhance_nsubj_obj
-------------
sentence: Therefore, when meclofenamate sodium is given to a patient receiving warfarin, the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time.
entities: meclofenamate sodium / warfarin
ddi: advise
>>> match: give_nsubj:pass_obl
-------------
sentence: Therefore, when meclofenamate sodium is given to a patient receiving warfarin, the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time.
entities: meclofenamate sodium / warfarin
ddi: null
>>> match: reduce_advcl_nsubj:pass
-------------
sentence: Therefore, when meclofenamate sodium is given to a patient receiving warfarin, the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time.
entities: warfarin / warfarin
ddi: null
>>> match: reduce_advcl_nsubj:pass
-------------
sentence: Aspirin: Concurrent administration of aspirin may lower meclofenamate sodium plasma levels, possibly by competing for protein-binding sites.
entities: aspirin / meclofenamate sodium
ddi: mechanism
>>> match: lower_nsubj_obj
-------------
sentence: CNS-Active Drugs Ethanol: Sonata 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration.
entities: Sonata / ethanol
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: CNS-Active Drugs Ethanol: Sonata 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration.
entities: Sonata / ethanol
ddi: null
>>> match: potentiate_nsubj_obj
-------------
sentence: CNS-Active Drugs Ethanol: Sonata 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration.
entities: Sonata / ethanol
ddi: null
>>> match: potentiate_nsubj_obj
-------------
sentence: Promethazine: Coadministration of a single dose of zaleplon and promethazine (10 and 25 mg, respectively) resulted in a 15% decrease in maximal plasma concentrations of zaleplon, but no change in the area under the plasma concentration-time curve.
entities: Promethazine / zaleplon
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Promethazine: Coadministration of a single dose of zaleplon and promethazine (10 and 25 mg, respectively) resulted in a 15% decrease in maximal plasma concentrations of zaleplon, but no change in the area under the plasma concentration-time curve.
entities: zaleplon / zaleplon
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Promethazine: Coadministration of a single dose of zaleplon and promethazine (10 and 25 mg, respectively) resulted in a 15% decrease in maximal plasma concentrations of zaleplon, but no change in the area under the plasma concentration-time curve.
entities: promethazine / zaleplon
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Drugs That Induce CYP3A4 Rifampin: CYP3A4 is ordinarily a minor metabolizing enzyme of zaleplon.
entities: Rifampin / zaleplon
ddi: null
>>> match: induce_obj_parataxis
-------------
sentence: An alternative non-CYP3A4 substrate hypnotic agent may be considered in patients taking CYP3A4 inducers such as rifampin, phenytoin, carbamazepine, and phenobarbital.
entities: hypnotic agent / rifampin
ddi: null
>>> match: consider_nsubj:pass_obl
-------------
sentence: An alternative non-CYP3A4 substrate hypnotic agent may be considered in patients taking CYP3A4 inducers such as rifampin, phenytoin, carbamazepine, and phenobarbital.
entities: hypnotic agent / phenytoin
ddi: null
>>> match: consider_nsubj:pass_obl
-------------
sentence: An alternative non-CYP3A4 substrate hypnotic agent may be considered in patients taking CYP3A4 inducers such as rifampin, phenytoin, carbamazepine, and phenobarbital.
entities: hypnotic agent / carbamazepine
ddi: null
>>> match: consider_nsubj:pass_obl
-------------
sentence: An alternative non-CYP3A4 substrate hypnotic agent may be considered in patients taking CYP3A4 inducers such as rifampin, phenytoin, carbamazepine, and phenobarbital.
entities: hypnotic agent / phenobarbital
ddi: null
>>> match: consider_nsubj:pass_obl
-------------
sentence: Other strong selective CYP3A4 inhibitors such as ketoconazole can also be expected to increase the exposure of zaleplon.
entities: ketoconazole / zaleplon
ddi: mechanism
>>> match: expect_nsubj:pass_xcomp
-------------
sentence: Drugs That Inhibit Both Aldehyde Oxidase and CYP3A4 Cimetidine: Cimetidine inhibits both aldehyde oxidase (in vitro) and CYP3A4 (in vitro and in vivo), the primary and secondary enzymes, respectively, responsible for zaleplon metabolism.
entities: Cimetidine / Cimetidine
ddi: null
>>> match: inhibit_obj_parataxis
-------------
sentence: Drugs That Inhibit Both Aldehyde Oxidase and CYP3A4 Cimetidine: Cimetidine inhibits both aldehyde oxidase (in vitro) and CYP3A4 (in vitro and in vivo), the primary and secondary enzymes, respectively, responsible for zaleplon metabolism.
entities: Cimetidine / zaleplon
ddi: null
>>> match: inhibit_obj_parataxis
-------------
sentence: Drugs That Inhibit Both Aldehyde Oxidase and CYP3A4 Cimetidine: Cimetidine inhibits both aldehyde oxidase (in vitro) and CYP3A4 (in vitro and in vivo), the primary and secondary enzymes, respectively, responsible for zaleplon metabolism.
entities: Cimetidine / zaleplon
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Concomitant administration of Sonata (10 mg) and cimetidine (800 mg) produced an 85% increase in the mean Cmax and AUC of zaleplon.
entities: Sonata / zaleplon
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Concomitant administration of Sonata (10 mg) and cimetidine (800 mg) produced an 85% increase in the mean Cmax and AUC of zaleplon.
entities: cimetidine / zaleplon
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Drugs That Alter Renal Excretion Ibuprofen: Ibuprofen is known to affect renal function and, consequently, alter the renal excretion of other drugs.
entities: Ibuprofen / Ibuprofen
ddi: null
>>> match: alter_obj_parataxis
-------------
sentence: This was expected because zaleplon is primarily metabolized and renal excretion of unchanged zaleplon accounts for less than 1% of the administered dose.
entities: zaleplon / zaleplon
ddi: null
>>> match: metabolize_nsubj:pass_dep
-------------
sentence: Effects of Other Drugs on Aliskiren Based on in-vitro studies, aliskiren is metabolized by CYP 3A4.
entities: Aliskiren / aliskiren
ddi: null
>>> match: metabolize_advcl_nsubj:pass
-------------
sentence: Co-administration of irbesartan reduced aliskiren Cmax up to 50% after multiple dosing.
entities: irbesartan / aliskiren
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Co-administration of atorvastatin resulted in about a 50% increase in aliskiren Cmax and AUC after multiple dosing.
entities: atorvastatin / aliskiren
ddi: mechanism
>>> match: result_nsubj_obl
-------------
sentence: Ketoconazole: Co-administration of 200 mg twice-daily ketoconazole with aliskiren resulted in an approximate 80% increase in plasma levels of aliskiren.
entities: ketoconazole / aliskiren
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Ketoconazole: Co-administration of 200 mg twice-daily ketoconazole with aliskiren resulted in an approximate 80% increase in plasma levels of aliskiren.
entities: aliskiren / aliskiren
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / lovastatin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / digoxin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / valsartan
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / amlodipine
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / metformin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / celecoxib
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / atenolol
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / atorvastatin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / ramipril
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin, digoxin, valsartan, amlodipine, metformin, celecoxib, atenolol, atorvastatin, ramipril or hydrochlorothiazide.
entities: aliskiren / hydrochlorothiazide
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Furosemide: When aliskiren was co-administered with furosemide, the AUC and Cmax of furosemide were reduced by about 30% and 50%, respectively.
entities: aliskiren / furosemide
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: Furosemide: When aliskiren was co-administered with furosemide, the AUC and Cmax of furosemide were reduced by about 30% and 50%, respectively.
entities: aliskiren / furosemide
ddi: null
>>> match: reduce_advcl_nsubj:pass
-------------
sentence: Furosemide: When aliskiren was co-administered with furosemide, the AUC and Cmax of furosemide were reduced by about 30% and 50%, respectively.
entities: furosemide / furosemide
ddi: null
>>> match: reduce_advcl_nsubj:pass
-------------
sentence: Other TNFa-blocking agents (including REMICADE) used in combination with anakinra may also result in similar toxicities.
entities: TNFa-blocking agents / anakinra
ddi: effect
>>> match: use_nsubj_obl
-------------
sentence: Other TNFa-blocking agents (including REMICADE) used in combination with anakinra may also result in similar toxicities.
entities: REMICADE / anakinra
ddi: effect
>>> match: use_nsubj_obl
-------------
sentence: In psoriatic arthritis clinical trials, concomitant medications included MTX in approximately half of the patients as well as nonsteroidal anti-inflammatory agents, folic acid and corticosteroids.
entities: MTX / nonsteroidal anti-inflammatory agents
ddi: null
>>> match: include_obj_obl
-------------
sentence: In psoriatic arthritis clinical trials, concomitant medications included MTX in approximately half of the patients as well as nonsteroidal anti-inflammatory agents, folic acid and corticosteroids.
entities: MTX / folic acid
ddi: null
>>> match: include_obj_obl
-------------
sentence: In psoriatic arthritis clinical trials, concomitant medications included MTX in approximately half of the patients as well as nonsteroidal anti-inflammatory agents, folic acid and corticosteroids.
entities: MTX / corticosteroids
ddi: null
>>> match: include_obj_obl
-------------
sentence: Patients with Crohn s disease who received immunosuppressants tended to experience fewer infusion reactions compared to patients on no immunosuppressants.
entities: immunosuppressants / immunosuppressants
ddi: null
>>> match: receive_obj_advcl
-------------
sentence: Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including corticosteroids, antibiotics (metronidazole or ciprofloxacin) and aminosalicylates.
entities: infliximab / corticosteroids
ddi: null
>>> match: appear_nsubj_xcomp
-------------
sentence: Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including corticosteroids, antibiotics (metronidazole or ciprofloxacin) and aminosalicylates.
entities: infliximab / antibiotics
ddi: null
>>> match: appear_nsubj_xcomp
-------------
sentence: Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including corticosteroids, antibiotics (metronidazole or ciprofloxacin) and aminosalicylates.
entities: infliximab / metronidazole
ddi: null
>>> match: appear_nsubj_xcomp
-------------
sentence: Serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of Crohn s disease including corticosteroids, antibiotics (metronidazole or ciprofloxacin) and aminosalicylates.
entities: infliximab / ciprofloxacin
ddi: null
>>> match: appear_nsubj_xcomp
-------------
sentence: Prothrombin time or other suitable anticoagulation test should be monitored if tigecycline is administered with warfarin.   
entities: tigecycline / warfarin
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Concurrent use of antibacterial drugs with oral contraceptives may render oral contraceptives less effective.  
entities: antibacterial drugs / contraceptives
ddi: null
>>> match: render_nsubj_xcomp
-------------
sentence: Concurrent use of antibacterial drugs with oral contraceptives may render oral contraceptives less effective.  
entities: contraceptives / contraceptives
ddi: null
>>> match: render_nsubj_xcomp
-------------
sentence: Mequitazine can interact with CNS depressant, antichlolinergic, TCA, MAOIs, and alcohol.
entities: Mequitazine / CNS depressant
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Mequitazine can interact with CNS depressant, antichlolinergic, TCA, MAOIs, and alcohol.
entities: Mequitazine / antichlolinergic
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Mequitazine can interact with CNS depressant, antichlolinergic, TCA, MAOIs, and alcohol.
entities: Mequitazine / TCA
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Mequitazine can interact with CNS depressant, antichlolinergic, TCA, MAOIs, and alcohol.
entities: Mequitazine / MAOIs
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Mequitazine can interact with CNS depressant, antichlolinergic, TCA, MAOIs, and alcohol.
entities: Mequitazine / alcohol
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Usage with Alcohol: Due to the potential for increased CNS depressants effects, alcohol should be used with caution in patients who are currently receiving pentazocine.
entities: alcohol / pentazocine
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Renal function should be carefully monitored, especially if higher dosages of the aminoglycosides are to be administered or if therapy is prolonged, because of the potential nephrotoxicity and ototoxicity of aminoglycosidic antibiotics.
entities: aminoglycosides / aminoglycosidic antibiotics
ddi: null
>>> match: monitor_advcl_obl
-------------
sentence: Chloramphenicol has been shown to be antagonistic to beta-lactam antibiotics, including ceftazidime, based on in vitro studies and time kill curves with enteric gram-negative bacilli.
entities: Chloramphenicol / beta-lactam antibiotics
ddi: effect
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Chloramphenicol has been shown to be antagonistic to beta-lactam antibiotics, including ceftazidime, based on in vitro studies and time kill curves with enteric gram-negative bacilli.
entities: Chloramphenicol / ceftazidime
ddi: effect
>>> match: show_nsubj:pass_xcomp
-------------
sentence: In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.
entities: clonazepam / propantheline
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.
entities: clonazepam / anticholinergic agent
ddi: null
>>> match: administer_nsubj:pass_dep
-------------
sentence: In a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline (an anticholinergic agent with multiple effects on the GI tract) to healthy volunteers, the AUC of clonazepam was 10% lower and the Cmax of clonazepam was 20% lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone.
entities: propantheline / anticholinergic agent
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Cytochrome P-450 inducers, such as phenytoin, carbamazepine and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.
entities: phenytoin / clonazepam
ddi: mechanism
>>> match: induce_nsubj_obj
-------------
sentence: Cytochrome P-450 inducers, such as phenytoin, carbamazepine and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.
entities: phenytoin / clonazepam
ddi: null
>>> match: induce_nsubj_dep
-------------
sentence: Cytochrome P-450 inducers, such as phenytoin, carbamazepine and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.
entities: carbamazepine / clonazepam
ddi: mechanism
>>> match: induce_nsubj_obj
-------------
sentence: Cytochrome P-450 inducers, such as phenytoin, carbamazepine and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.
entities: carbamazepine / clonazepam
ddi: null
>>> match: induce_nsubj_dep
-------------
sentence: Cytochrome P-450 inducers, such as phenytoin, carbamazepine and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.
entities: phenobarbital / clonazepam
ddi: mechanism
>>> match: induce_nsubj_obj
-------------
sentence: Cytochrome P-450 inducers, such as phenytoin, carbamazepine and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.
entities: phenobarbital / clonazepam
ddi: null
>>> match: induce_nsubj_dep
-------------
sentence: Cytochrome P-450 inducers, such as phenytoin, carbamazepine and phenobarbital, induce clonazepam metabolism, causing an approximately 30% decrease in plasma clonazepam levels.
entities: clonazepam / clonazepam
ddi: null
>>> match: induce_obj_dep
-------------
sentence: Although clinical studies have not been performed, based on the involvement of the cytochrome P-450 3A family in clonazepam metabolism, inhibitors of this enzyme system, notably oral antifungal agents, should be used cautiously in patients receiving clonazepam.
entities: clonazepam / antifungal agents
ddi: null
>>> match: use_advcl_nsubj:pass
-------------
sentence: Although clinical studies have not been performed, based on the involvement of the cytochrome P-450 3A family in clonazepam metabolism, inhibitors of this enzyme system, notably oral antifungal agents, should be used cautiously in patients receiving clonazepam.
entities: clonazepam / clonazepam
ddi: null
>>> match: use_advcl_obl
-------------
sentence: Although clinical studies have not been performed, based on the involvement of the cytochrome P-450 3A family in clonazepam metabolism, inhibitors of this enzyme system, notably oral antifungal agents, should be used cautiously in patients receiving clonazepam.
entities: antifungal agents / clonazepam
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: benzodiazepine class / alcohol
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: benzodiazepine class / narcotics
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: benzodiazepine class / barbiturates
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: benzodiazepine class / nonbarbiturate hypnotics
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: benzodiazepine class / antianxiety agents
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: benzodiazepine class / monoamine oxidase inhibitors
ddi: effect
>>> match: potentiate_nsubj:pass_conj
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: benzodiazepine class / tricyclic antidepressants
ddi: effect
>>> match: potentiate_nsubj:pass_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: benzodiazepine class / anticonvulsant drugs
ddi: effect
>>> match: potentiate_nsubj:pass_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: alcohol / monoamine oxidase inhibitors
ddi: null
>>> match: potentiate_obl_conj
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: alcohol / tricyclic antidepressants
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: alcohol / anticonvulsant drugs
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: narcotics / monoamine oxidase inhibitors
ddi: null
>>> match: potentiate_obl_conj
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: narcotics / tricyclic antidepressants
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: narcotics / anticonvulsant drugs
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: barbiturates / monoamine oxidase inhibitors
ddi: null
>>> match: potentiate_obl_conj
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: barbiturates / tricyclic antidepressants
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: barbiturates / anticonvulsant drugs
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: nonbarbiturate hypnotics / monoamine oxidase inhibitors
ddi: null
>>> match: potentiate_obl_conj
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: nonbarbiturate hypnotics / tricyclic antidepressants
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: nonbarbiturate hypnotics / anticonvulsant drugs
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: antianxiety agents / monoamine oxidase inhibitors
ddi: null
>>> match: potentiate_obl_conj
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: antianxiety agents / tricyclic antidepressants
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: antianxiety agents / anticonvulsant drugs
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: monoamine oxidase inhibitors / tricyclic antidepressants
ddi: null
>>> match: potentiate_conj_dep
-------------
sentence: Pharmacodynamic Interactions: The CNS-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antianxiety agents, the phenothiazines, thioxanthene and butyrophenone classes of antipsychotic agents, monoamine oxidase inhibitors and the tricyclic antidepressants, and by other anticonvulsant drugs.
entities: monoamine oxidase inhibitors / anticonvulsant drugs
ddi: null
>>> match: potentiate_conj_dep
-------------
sentence: Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, sedatives, antihistaminics, or psychotropic drugs. 
entities: morphine / CNS depressants
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, sedatives, antihistaminics, or psychotropic drugs. 
entities: morphine / alcohol
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, sedatives, antihistaminics, or psychotropic drugs. 
entities: morphine / sedatives
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, sedatives, antihistaminics, or psychotropic drugs. 
entities: morphine / antihistaminics
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, sedatives, antihistaminics, or psychotropic drugs. 
entities: morphine / psychotropic drugs
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).
entities: candesartan cilexetil / glyburide
ddi: null
>>> match: report_obl_obl
-------------
sentence: No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).
entities: candesartan cilexetil / nifedipine
ddi: null
>>> match: report_obl_obl
-------------
sentence: No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).
entities: candesartan cilexetil / digoxin
ddi: null
>>> match: report_obl_obl
-------------
sentence: No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).
entities: candesartan cilexetil / warfarin
ddi: null
>>> match: report_obl_obl
-------------
sentence: No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).
entities: candesartan cilexetil / hydrochlorothiazide
ddi: null
>>> match: report_obl_obl
-------------
sentence: No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).
entities: candesartan cilexetil / contraceptives
ddi: null
>>> match: report_obl_obl
-------------
sentence: No significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide, nifedipine, digoxin, warfarin, hydrochlorothiazide, and oral contraceptives in healthy volunteers, or given with enalapril to patients with heart failure (NYHA class II and III).
entities: candesartan cilexetil / enalapril
ddi: null
>>> match: report_obl_obl
-------------
sentence: Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some angiotensin II receptor antagonists.
entities: Lithium / lithium
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some angiotensin II receptor antagonists.
entities: Lithium / ACE inhibitors
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some angiotensin II receptor antagonists.
entities: Lithium / angiotensin II receptor antagonists
ddi: null
>>> match: report_nsubj:pass_conj
-------------
sentence: Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some angiotensin II receptor antagonists.
entities: lithium / lithium
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some angiotensin II receptor antagonists.
entities: lithium / ACE inhibitors
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some angiotensin II receptor antagonists.
entities: lithium / angiotensin II receptor antagonists
ddi: null
>>> match: report_nsubj:pass_conj
-------------
sentence: Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some angiotensin II receptor antagonists.
entities: lithium / ACE inhibitors
ddi: mechanism
>>> match: report_obl_obl
-------------
sentence: Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some angiotensin II receptor antagonists.
entities: lithium / angiotensin II receptor antagonists
ddi: mechanism
>>> match: report_obl_conj
-------------
sentence: Lithium Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ACE inhibitors, and with some angiotensin II receptor antagonists.
entities: ACE inhibitors / angiotensin II receptor antagonists
ddi: null
>>> match: report_obl_conj
-------------
sentence: An increase in serum lithium concentration has been reported during concomitant administration of lithium with ATACAND, so careful monitoring of serum lithium levels is recommended during concomitant use.
entities: lithium / lithium
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: An increase in serum lithium concentration has been reported during concomitant administration of lithium with ATACAND, so careful monitoring of serum lithium levels is recommended during concomitant use.
entities: lithium / ATACAND
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: An increase in serum lithium concentration has been reported during concomitant administration of lithium with ATACAND, so careful monitoring of serum lithium levels is recommended during concomitant use.
entities: lithium / lithium
ddi: null
>>> match: report_nsubj:pass_parataxis
-------------
sentence: An increase in serum lithium concentration has been reported during concomitant administration of lithium with ATACAND, so careful monitoring of serum lithium levels is recommended during concomitant use.
entities: lithium / ATACAND
ddi: mechanism
>>> match: report_obl_obl
-------------
sentence: An increase in serum lithium concentration has been reported during concomitant administration of lithium with ATACAND, so careful monitoring of serum lithium levels is recommended during concomitant use.
entities: lithium / lithium
ddi: null
>>> match: report_obl_parataxis
-------------
sentence: An increase in serum lithium concentration has been reported during concomitant administration of lithium with ATACAND, so careful monitoring of serum lithium levels is recommended during concomitant use.
entities: ATACAND / lithium
ddi: null
>>> match: report_obl_parataxis
-------------
sentence: The most significant drug interactions following administration of Cerebyx are expected to occur with drugs that interact with phenytoin.
entities: Cerebyx / phenytoin
ddi: null
>>> match: expect_nsubj:pass_xcomp
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / alcohol
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / amiodarone
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / chlordiazepoxide
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / cimetidine
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / diazepam
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / dicumarol
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / disulfiram
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / estrogens
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / ethosuximide
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / fluoxetine
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / H2-antagonists
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / halothane
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / isoniazid
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / methylphenidate
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / phenothiazines
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / phenylbutazone
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / salicylates
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / succinimides
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / sulfonamides
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / tolbutamide
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: The most commonly occurring drug interactions are listed below: - Drugs that may increase plasma phenytoin concentrations include: acute alcohol intake, amiodarone, chboramphenicol, chlordiazepoxide, cimetidine, diazepam, dicumarol, disulfiram, estrogens, ethosuximide, fluoxetine, H2-antagonists, halothane, isoniazid, methylphenidate, phenothiazines, phenylbutazone, salicylates, succinimides, sulfonamides, tolbutamide, trazodone
entities: phenytoin / trazodone
ddi: mechanism
>>> match: list_obl_obl
-------------
sentence: - Drugs that may decrease plasma phenytoin concentrations include: carbamazepine, chronic alcohol abuse, reserpine
entities: phenytoin / carbamazepine
ddi: mechanism
>>> match: include_nsubj_obj
-------------
sentence: - Drugs that may decrease plasma phenytoin concentrations include: carbamazepine, chronic alcohol abuse, reserpine
entities: phenytoin / alcohol
ddi: mechanism
>>> match: include_nsubj_obj
-------------
sentence: - Drugs that may decrease plasma phenytoin concentrations include: carbamazepine, chronic alcohol abuse, reserpine
entities: phenytoin / reserpine
ddi: mechanism
>>> match: include_nsubj_obj
-------------
sentence: - Drugs that may either increase or decrease plasma phenytoin concentrations include: phenobarbital, vaiproic acid, and sodium valproate.
entities: phenytoin / phenobarbital
ddi: mechanism
>>> match: include_nsubj_obj
-------------
sentence: - Drugs that may either increase or decrease plasma phenytoin concentrations include: phenobarbital, vaiproic acid, and sodium valproate.
entities: phenytoin / sodium valproate
ddi: mechanism
>>> match: include_nsubj_obj
-------------
sentence: - Although not a true drug interaction, tricyclic antidepressants may precipitate seizures in susceptible patients and Cerebyx dosage may need to be adjusted
entities: tricyclic antidepressants / Cerebyx
ddi: effect
>>> match: need_nsubj_nsubj
-------------
sentence: Care should be taken when using immunoanalytical methods to measure plasma phenytoin concentrations following Cerebyx administration.
entities: phenytoin / Cerebyx
ddi: null
>>> match: measure_obj_obl
-------------
sentence: Cimetidine increased the AUC of epirubicin by 50%.
entities: Cimetidine / epirubicin
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Cimetidine treatment should be stopped during treatment with ELLENCE.
entities: Cimetidine / ELLENCE
ddi: advise
>>> match: stop_nsubj:pass_obl
-------------
sentence: If you are also using a steroid inhaler, take bitolterol first and then wait about 15 minutes before using the steroid inhaler.
entities: steroid / bitolterol
ddi: advise
>>> match: take_advcl_obj
-------------
sentence: If you are also using a steroid inhaler, take bitolterol first and then wait about 15 minutes before using the steroid inhaler.
entities: steroid / steroid
ddi: null
>>> match: take_advcl_conj
-------------
sentence: If you are also using a steroid inhaler, take bitolterol first and then wait about 15 minutes before using the steroid inhaler.
entities: bitolterol / steroid
ddi: advise
>>> match: take_obj_conj
-------------
sentence: This allows bitolterol to open air passages, increasing the effectiveness of the steroid.
entities: bitolterol / steroid
ddi: effect
>>> match: allow_obj_xcomp
-------------
sentence: As there is in vitro evidence that aminosalicylate derivatives (e.g., olsalazine, mesalazine, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.    
entities: aminosalicylate derivatives / thioguanine
ddi: mechanism
>>> match: administer_advcl_obl
-------------
sentence: As there is in vitro evidence that aminosalicylate derivatives (e.g., olsalazine, mesalazine, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.    
entities: olsalazine / thioguanine
ddi: mechanism
>>> match: administer_advcl_obl
-------------
sentence: As there is in vitro evidence that aminosalicylate derivatives (e.g., olsalazine, mesalazine, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.    
entities: mesalazine / thioguanine
ddi: mechanism
>>> match: administer_advcl_obl
-------------
sentence: As there is in vitro evidence that aminosalicylate derivatives (e.g., olsalazine, mesalazine, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.    
entities: sulphasalazine / thioguanine
ddi: mechanism
>>> match: administer_advcl_obl
-------------
sentence: Nimodipine had no effect on ginsenosides response. 
entities: Nimodipine / ginsenosides
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and nimodipine/omega-conotoxin GVIA/omega-agatoxin VIA-resistant (presumptive Q-type) channel. 
entities: ginsenosides / nimodipine
ddi: null
>>> match: couple_nsubj:pass_obl
-------------
sentence: Broad-Spectrum Antibiotics-Broad-spectrum antibiotics may sterilize the bowel and decrease the vitamin K contribution to the body by the intestinal microflora.
entities: Broad-spectrum antibiotics / vitamin K
ddi: null
>>> match: sterilize_nsubj_conj
-------------
sentence: Cholestyramine-Concomitant intake of cholestyramine and vitamin K may reduce the absorption of vitamin K.
entities: Cholestyramine / vitamin K
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: Cholestyramine-Concomitant intake of cholestyramine and vitamin K may reduce the absorption of vitamin K.
entities: cholestyramine / vitamin K
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: Cholestyramine-Concomitant intake of cholestyramine and vitamin K may reduce the absorption of vitamin K.
entities: vitamin K / vitamin K
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: Colestipol-Concomitant intake of colestipol and vitamin K may reduce the absorption of vitamin K.
entities: Colestipol / vitamin K
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: Colestipol-Concomitant intake of colestipol and vitamin K may reduce the absorption of vitamin K.
entities: colestipol / vitamin K
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: Colestipol-Concomitant intake of colestipol and vitamin K may reduce the absorption of vitamin K.
entities: vitamin K / vitamin K
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: Mineral Oil-Concomitant intake of mineral oil and vitamin K may reduce the absorption of vitamin K.
entities: mineral oil / vitamin K
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: Mineral Oil-Concomitant intake of mineral oil and vitamin K may reduce the absorption of vitamin K.
entities: vitamin K / vitamin K
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: Orlistat-Orlistat may decrease the absorption of vitamin K.
entities: Orlistat / vitamin K
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Orlistat-Orlistat may decrease the absorption of vitamin K.
entities: Orlistat / vitamin K
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Warfarin-Vitamin K can antagonize the effect of warfarin
entities: Warfarin / warfarin
ddi: null
>>> match: antagonize_nsubj_obj
-------------
sentence: Warfarin-Vitamin K can antagonize the effect of warfarin
entities: Vitamin K / warfarin
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: Amitriptyline: Concurrent administration of 25 mg or 100 mg cinacalcet with 50 mg amitriptyline increased amitriptyline exposure and nortriptyline (active metabolite) exposure by approximately 20% in CYP2D6 extensive metabolizers.
entities: cinacalcet / amitriptyline
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Amitriptyline: Concurrent administration of 25 mg or 100 mg cinacalcet with 50 mg amitriptyline increased amitriptyline exposure and nortriptyline (active metabolite) exposure by approximately 20% in CYP2D6 extensive metabolizers.
entities: cinacalcet / nortriptyline
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Amitriptyline: Concurrent administration of 25 mg or 100 mg cinacalcet with 50 mg amitriptyline increased amitriptyline exposure and nortriptyline (active metabolite) exposure by approximately 20% in CYP2D6 extensive metabolizers.
entities: amitriptyline / amitriptyline
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Amitriptyline: Concurrent administration of 25 mg or 100 mg cinacalcet with 50 mg amitriptyline increased amitriptyline exposure and nortriptyline (active metabolite) exposure by approximately 20% in CYP2D6 extensive metabolizers.
entities: amitriptyline / nortriptyline
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Co-administration of ketoconazole, a strong inhibitor of CYP3A4, increased cinacalcet exposure following a single 90 mg dose of Sensipar by 2.3 fold.
entities: ketoconazole / cinacalcet
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Co-administration of ketoconazole, a strong inhibitor of CYP3A4, increased cinacalcet exposure following a single 90 mg dose of Sensipar by 2.3 fold.
entities: ketoconazole / Sensipar
ddi: null
>>> match: increase_nsubj_obl
-------------
sentence: Co-administration of ketoconazole, a strong inhibitor of CYP3A4, increased cinacalcet exposure following a single 90 mg dose of Sensipar by 2.3 fold.
entities: cinacalcet / Sensipar
ddi: null
>>> match: increase_obj_obl
-------------
sentence: Dose adjustment of Sensipar may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYP3A4 inhibitor (e.g., ketoconazole, erythromycin, itraconazole;
entities: Sensipar / ketoconazole
ddi: advise
>>> match: require_nsubj:pass_advcl
-------------
sentence: Dose adjustment of Sensipar may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYP3A4 inhibitor (e.g., ketoconazole, erythromycin, itraconazole;
entities: Sensipar / erythromycin
ddi: advise
>>> match: require_nsubj:pass_advcl
-------------
sentence: Dose adjustment of Sensipar may be required and PTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYP3A4 inhibitor (e.g., ketoconazole, erythromycin, itraconazole;
entities: Sensipar / itraconazole
ddi: advise
>>> match: require_nsubj:pass_advcl
-------------
sentence: Among 494 subjects who received Angiomax in clinical trials and were tested for antibodies, 2 subjects had treatment-emergent positive bivalirudin antibody tests.
entities: Angiomax / bivalirudin
ddi: null
>>> match: receive_obj_conj
-------------
sentence: Ephedrine enhances the antinociceptive effect of dexmedetomidine in mice.

entities: Ephedrine / dexmedetomidine
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: The purpose of this study was to evaluate whether the psychostimulant drug ephedrine has any effect on dexmedetomidine-induced antinociception and locomotor inhibitor activity in mice in acute application.
entities: ephedrine / dexmedetomidine
ddi: null
>>> match: have_nsubj_ccomp
-------------
sentence: At the same time, the locomotor inhibitory effect of dexmedetomidine was counteracted by ephedrine. 
entities: dexmedetomidine / ephedrine
ddi: effect
>>> match: counteract_nsubj:pass_obl
-------------
sentence: We concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.
entities: dexmedetomidine / dexmedetomidine
ddi: null
>>> match: have_nsubj_ccomp
-------------
sentence: We concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.
entities: dexmedetomidine / analgesic
ddi: null
>>> match: have_nsubj_ccomp
-------------
sentence: We concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.
entities: ephedrine / dexmedetomidine
ddi: null
>>> match: have_nsubj_ccomp
-------------
sentence: We concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.
entities: ephedrine / analgesic
ddi: null
>>> match: have_nsubj_ccomp
-------------
sentence: We concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.
entities: dexmedetomidine / analgesic
ddi: null
>>> match: limit_obj_obl
-------------
sentence: Auranofin should be avoided by patients with a history of serious reaction to any gold medication, including Solganal and Myochrysine.
entities: Auranofin / gold medication
ddi: advise
>>> match: avoid_nsubj:pass_obl
-------------
sentence: Auranofin should be avoided by patients with a history of serious reaction to any gold medication, including Solganal and Myochrysine.
entities: Auranofin / Solganal
ddi: advise
>>> match: avoid_nsubj:pass_obl
-------------
sentence: Auranofin should be avoided by patients with a history of serious reaction to any gold medication, including Solganal and Myochrysine.
entities: Auranofin / Myochrysine
ddi: advise
>>> match: avoid_nsubj:pass_obl
-------------
sentence: Auranofin should not be used together with penicillamine (Depen, Cuprimine), another arthritis medication.
entities: Auranofin / penicillamine
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Auranofin should not be used together with penicillamine (Depen, Cuprimine), another arthritis medication.
entities: Auranofin / Depen
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Auranofin should not be used together with penicillamine (Depen, Cuprimine), another arthritis medication.
entities: Auranofin / Cuprimine
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: These six volunteers received terfenadine alone (60 mg twice daily) for 8 days, followed by terfenadine in combination with dirithromycin (500 mg once daily) for 10 days.
entities: terfenadine / terfenadine
ddi: null
>>> match: receive_obj_advcl
-------------
sentence: These six volunteers received terfenadine alone (60 mg twice daily) for 8 days, followed by terfenadine in combination with dirithromycin (500 mg once daily) for 10 days.
entities: terfenadine / dirithromycin
ddi: null
>>> match: receive_obj_advcl
-------------
sentence: The pharmacokinetics of terfenadine and its acid metabolite and the electrocardiographic QT c interval were measured during both periods: with terfenadine alone, and with terfenadine plus dirithromycin.
entities: terfenadine / terfenadine
ddi: null
>>> match: measure_nsubj:pass_obl
-------------
sentence: The pharmacokinetics of terfenadine and its acid metabolite and the electrocardiographic QT c interval were measured during both periods: with terfenadine alone, and with terfenadine plus dirithromycin.
entities: terfenadine / terfenadine
ddi: null
>>> match: measure_nsubj:pass_obl
-------------
sentence: The pharmacokinetics of terfenadine and its acid metabolite and the electrocardiographic QT c interval were measured during both periods: with terfenadine alone, and with terfenadine plus dirithromycin.
entities: terfenadine / dirithromycin
ddi: null
>>> match: measure_nsubj:pass_obl
-------------
sentence: Thus, the interaction observed between erythromycin and terfenadine is not expected for dirithromycin.
entities: erythromycin / dirithromycin
ddi: null
>>> match: observe_obl_dep
-------------
sentence: Thus, the interaction observed between erythromycin and terfenadine is not expected for dirithromycin.
entities: terfenadine / dirithromycin
ddi: null
>>> match: observe_obl_dep
-------------
sentence: Serious cardiac dysrhythmias, some resulting in death, have occurred in patients receiving terfenadine concomitantly with other macrolide antibiotics.
entities: terfenadine / macrolide antibiotics
ddi: effect
>>> match: receive_obj_obl
-------------
sentence: In addition, most macrolides are contraindicated in patients receiving terfenadine therapy who have pre-existing cardiac abnormalities (arrhythmia, bradycardia, QT c interval prolongation, ischemic heart disease, congestive heart failure, etc.) or electrolyte disturbances.
entities: macrolides / terfenadine
ddi: advise
>>> match: contraindicate_nsubj:pass_obl
-------------
sentence: Theophylline: Following co-administration of two 250-mg dirithromycin tablets administered once daily with 200-mg theophylline tablets administered twice daily for 10 days to 14 healthy subjects, the steady-state plasma concentration of theophylline was not significantly altered.
entities: dirithromycin / theophylline
ddi: null
>>> match: alter_obl_nsubj:pass
-------------
sentence: Theophylline: Following co-administration of two 250-mg dirithromycin tablets administered once daily with 200-mg theophylline tablets administered twice daily for 10 days to 14 healthy subjects, the steady-state plasma concentration of theophylline was not significantly altered.
entities: theophylline / theophylline
ddi: null
>>> match: alter_obl_nsubj:pass
-------------
sentence: In general, most patients treated with dirithromycin who are receiving concomitant theophylline therapy may not require empiric adjustment of theophylline dosage or monitoring of theophylline plasma concentrations.
entities: dirithromycin / theophylline
ddi: null
>>> match: treat_obl_dep
-------------
sentence: In general, most patients treated with dirithromycin who are receiving concomitant theophylline therapy may not require empiric adjustment of theophylline dosage or monitoring of theophylline plasma concentrations.
entities: dirithromycin / theophylline
ddi: null
>>> match: treat_obl_dep
-------------
sentence: In general, most patients treated with dirithromycin who are receiving concomitant theophylline therapy may not require empiric adjustment of theophylline dosage or monitoring of theophylline plasma concentrations.
entities: theophylline / theophylline
ddi: null
>>> match: treat_obl_dep
-------------
sentence: In general, most patients treated with dirithromycin who are receiving concomitant theophylline therapy may not require empiric adjustment of theophylline dosage or monitoring of theophylline plasma concentrations.
entities: theophylline / theophylline
ddi: null
>>> match: treat_obl_dep
-------------
sentence: However, theophylline plasma concentrations should be monitored, with dosage adjustment as appropriate, in patients whose pulmonary disease requires maintaining a given theophylline plasma concentration for optimal pulmonary function or in patients with theophylline concentrations at the higher end of the therapeutic range.
entities: theophylline / theophylline
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: However, theophylline plasma concentrations should be monitored, with dosage adjustment as appropriate, in patients whose pulmonary disease requires maintaining a given theophylline plasma concentration for optimal pulmonary function or in patients with theophylline concentrations at the higher end of the therapeutic range.
entities: theophylline / theophylline
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Antacids or H 2 receptor antagonists: When dirithromycin is administered immediately following antacids or H 2 -receptor antagonists, the absorption of dirithromycin is slightly enhanced.
entities: dirithromycin / antacids
ddi: mechanism
>>> match: enhance_advcl_obl
-------------
sentence: Antacids or H 2 receptor antagonists: When dirithromycin is administered immediately following antacids or H 2 -receptor antagonists, the absorption of dirithromycin is slightly enhanced.
entities: dirithromycin / dirithromycin
ddi: null
>>> match: enhance_advcl_nsubj:pass
-------------
sentence: Antacids or H 2 receptor antagonists: When dirithromycin is administered immediately following antacids or H 2 -receptor antagonists, the absorption of dirithromycin is slightly enhanced.
entities: antacids / dirithromycin
ddi: null
>>> match: enhance_obl_nsubj:pass
-------------
sentence: Triazolam: Erythromycin has been reported to decrease the clearance of triazolam and, thus, may increase the pharmacologic effect of triazolam.
entities: Erythromycin / triazolam
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Triazolam: Erythromycin has been reported to decrease the clearance of triazolam and, thus, may increase the pharmacologic effect of triazolam.
entities: Erythromycin / triazolam
ddi: effect
>>> match: report_nsubj:pass_conj
-------------
sentence: Triazolam: Erythromycin has been reported to decrease the clearance of triazolam and, thus, may increase the pharmacologic effect of triazolam.
entities: triazolam / triazolam
ddi: null
>>> match: report_xcomp_conj
-------------
sentence: Digoxin: Concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels.
entities: erythromycin / digoxin
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Digoxin: Concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels.
entities: digoxin / digoxin
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Given the primary CNS effects of paliperidone, INVEGA    should be used with caution in combination with other centrally acting drugs and alcohol. 
entities: paliperidone / INVEGA
ddi: null
>>> match: use_obl_nsubj:pass
-------------
sentence: Given the primary CNS effects of paliperidone, INVEGA    should be used with caution in combination with other centrally acting drugs and alcohol. 
entities: paliperidone / centrally acting drugs
ddi: advise
>>> match: use_obl_obl
-------------
sentence: Given the primary CNS effects of paliperidone, INVEGA    should be used with caution in combination with other centrally acting drugs and alcohol. 
entities: paliperidone / alcohol
ddi: advise
>>> match: use_obl_obl
-------------
sentence: Given the primary CNS effects of paliperidone, INVEGA    should be used with caution in combination with other centrally acting drugs and alcohol. 
entities: INVEGA / centrally acting drugs
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Given the primary CNS effects of paliperidone, INVEGA    should be used with caution in combination with other centrally acting drugs and alcohol. 
entities: INVEGA / alcohol
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Paliperidone may antagonize the effect of levodopa and other dopamine agonists. 
entities: Paliperidone / levodopa
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: Paliperidone may antagonize the effect of levodopa and other dopamine agonists. 
entities: Paliperidone / dopamine agonists
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: CANCIDAS has no effect on the pharmacokinetics of itraconazole, amphotericin B, or the active metabolite of mycophenolate.
entities: CANCIDAS / itraconazole
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: CANCIDAS has no effect on the pharmacokinetics of itraconazole, amphotericin B, or the active metabolite of mycophenolate.
entities: CANCIDAS / amphotericin B
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.
entities: CANCIDAS / tacrolimus
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.
entities: CANCIDAS / tacrolimus
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.
entities: CANCIDAS / CANCIDAS
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.
entities: CANCIDAS / tacrolimus
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.
entities: tacrolimus / tacrolimus
ddi: null
>>> match: reduce_obj_obj
-------------
sentence: CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.
entities: tacrolimus / CANCIDAS
ddi: null
>>> match: reduce_obj_obj
-------------
sentence: CANCIDAS reduced the blood AUC0-12 of tacrolimus by approximately 20%, peak blood concentration (Cmax) by 16%, and 12-hour blood concentration (C12hr) by 26% in healthy subjects when tacrolimus (2 doses of 0.1 mg/kg 12 hours apart) was administered on the 10th day of CANCIDAS 70 mg daily, as compared to results from a control period in which tacrolimus was administered alone.
entities: tacrolimus / tacrolimus
ddi: null
>>> match: reduce_obj_obj
-------------
sentence: In two clinical studies, cyclosporine (one 4 mg/kg dose or two 3 mg/kg doses) increased the AUC of caspofungin by approximately 35%.
entities: cyclosporine / caspofungin
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: A drug-drug interaction study with rifampin in healthy volunteers has shown a 30% decrease in caspofungin trough concentrations.
entities: rifampin / caspofungin
ddi: mechanism
>>> match: show_nsubj_obj
-------------
sentence: Patients on rifampin should receive 70 mg of CANCIDAS daily.
entities: rifampin / CANCIDAS
ddi: advise
>>> match: receive_nsubj_obj
-------------
sentence: In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.
entities: efavirenz / caspofungin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.
entities: nevirapine / caspofungin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.
entities: phenytoin / caspofungin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.
entities: dexamethasone / caspofungin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.
entities: carbamazepine / caspofungin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.
entities: CANCIDAS / caspofungin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered
entities: CANCIDAS / efavirenz
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered
entities: CANCIDAS / nevirapine
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered
entities: CANCIDAS / phenytoin
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered
entities: CANCIDAS / dexamethasone
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered
entities: CANCIDAS / carbamazepine
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered
entities: CANCIDAS / CANCIDAS
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: But the use of fixed combination amlodipine/valsartan compared with traditional therapy was associated with lower clinical and self measured BP, quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days, respectively, 0.05), lesser number of antihypertensive drugs (2.5+/-0.6 and 3.0+/-0.9 days, respectively), lower rate of concealed inefficacy of treatment (12 and 31%, respectively, 0.05). 
entities: amlodipine / antihypertensive drugs
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: But the use of fixed combination amlodipine/valsartan compared with traditional therapy was associated with lower clinical and self measured BP, quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days, respectively, 0.05), lesser number of antihypertensive drugs (2.5+/-0.6 and 3.0+/-0.9 days, respectively), lower rate of concealed inefficacy of treatment (12 and 31%, respectively, 0.05). 
entities: valsartan / antihypertensive drugs
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: We have demonstrated appropriateness of inhospital administration of fixed amlodipine/valsartan combination as an approach allowing to achieve target BP in shorter time, with the use of fewer antihypertensive drugs, and diminishing concealed inefficacy of treatment.
entities: amlodipine / antihypertensive drugs
ddi: null
>>> match: demonstrate_obj_advcl
-------------
sentence: We have demonstrated appropriateness of inhospital administration of fixed amlodipine/valsartan combination as an approach allowing to achieve target BP in shorter time, with the use of fewer antihypertensive drugs, and diminishing concealed inefficacy of treatment.
entities: valsartan / antihypertensive drugs
ddi: null
>>> match: demonstrate_obj_advcl
-------------
sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. 
entities: phenobarbital / corticosteroids
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. 
entities: phenobarbital / corticosteroid
ddi: mechanism
>>> match: increase_nsubj_conj
-------------
sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. 
entities: phenytoin / corticosteroids
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. 
entities: phenytoin / corticosteroid
ddi: mechanism
>>> match: increase_nsubj_conj
-------------
sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. 
entities: rifampin / corticosteroids
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. 
entities: rifampin / corticosteroid
ddi: mechanism
>>> match: increase_nsubj_conj
-------------
sentence: Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response. 
entities: corticosteroids / corticosteroid
ddi: null
>>> match: increase_obj_conj
-------------
sentence: Drugs such as troleandomycin and ketoconazole may inhibit the metabolism of corticosteroids and thus decrease their clearance. 
entities: troleandomycin / corticosteroids
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Drugs such as troleandomycin and ketoconazole may inhibit the metabolism of corticosteroids and thus decrease their clearance. 
entities: ketoconazole / corticosteroids
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Corticosteroids may increase the clearance of chronic high dose aspirin. 
entities: Corticosteroids / aspirin
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: This could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn. 
entities: salicylate / salicylate
ddi: null
>>> match: lead_obl_conj
-------------
sentence: This could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn. 
entities: salicylate / corticosteroid
ddi: null
>>> match: lead_obl_conj
-------------
sentence: This could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn. 
entities: salicylate / corticosteroid
ddi: effect
>>> match: increase_obj_advcl
-------------
sentence: Aspirin should be used cautiously in conjunction with corticosteroids in patients suffering from hypoprothrombinemia. 
entities: Aspirin / corticosteroids
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: There are reports of enhanced as well as diminished effects of anticoagulants when given concurrently with corticosteroids. 
entities: anticoagulants / corticosteroids
ddi: effect
>>> match: be_nsubj_advcl
-------------
sentence: Dimenhydrinate may decrease emetic response to apomorphine.
entities: Dimenhydrinate / emetic
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Dimenhydrinate may decrease emetic response to apomorphine.
entities: Dimenhydrinate / apomorphine
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: MAO inhibitors prolong and intensify the effects of antihistamines.
entities: MAO inhibitors / antihistamines
ddi: effect
>>> match: prolong_nsubj_obj
-------------
sentence: When sympathomimetic drugs are given to patients receiving monoamine oxidase inhibitors, hypertensive reactions, including hypertensive crises, may occur.
entities: sympathomimetic drugs / monoamine oxidase inhibitors
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: The antihypertensive effects of methyldopa, mecamylamine, reserpine, and veratrum alkaloids may be reduced by sympathomimetics.
entities: methyldopa / sympathomimetics
ddi: effect
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The antihypertensive effects of methyldopa, mecamylamine, reserpine, and veratrum alkaloids may be reduced by sympathomimetics.
entities: mecamylamine / sympathomimetics
ddi: effect
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The antihypertensive effects of methyldopa, mecamylamine, reserpine, and veratrum alkaloids may be reduced by sympathomimetics.
entities: reserpine / sympathomimetics
ddi: effect
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The antihypertensive effects of methyldopa, mecamylamine, reserpine, and veratrum alkaloids may be reduced by sympathomimetics.
entities: veratrum alkaloids / sympathomimetics
ddi: effect
>>> match: reduce_nsubj:pass_obl
-------------
sentence: Beta-adrenergic blocking agents may also interact with sympathomimetics.
entities: Beta-adrenergic blocking agents / sympathomimetics
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Increased ectopic pacemaker activity can occur when pseudoephedrine is used concomitantly with digitalis.
entities: pseudoephedrine / digitalis
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: Antacids increase the rate of absorption of pseudoephedrine, while kaolin decreases it.
entities: Antacids / pseudoephedrine
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Antacids increase the rate of absorption of pseudoephedrine, while kaolin decreases it.
entities: Antacids / kaolin
ddi: null
>>> match: increase_nsubj_advcl
-------------
sentence: Antacids increase the rate of absorption of pseudoephedrine, while kaolin decreases it.
entities: pseudoephedrine / kaolin
ddi: mechanism
>>> match: increase_obj_advcl
-------------
sentence: Although MIVACRON (a mixture of three stereoisomers) has been administered safely following succinylcholine-facilitated tracheal intubation, the interaction between MIVACRON and succinylcholine has not been systematically studied. 
entities: MIVACRON / MIVACRON
ddi: null
>>> match: study_advcl_nsubj:pass
-------------
sentence: Although MIVACRON (a mixture of three stereoisomers) has been administered safely following succinylcholine-facilitated tracheal intubation, the interaction between MIVACRON and succinylcholine has not been systematically studied. 
entities: MIVACRON / succinylcholine
ddi: null
>>> match: study_advcl_nsubj:pass
-------------
sentence: Prior administration of succinylcholine can potentiate the neuromuscular blocking effects of nondepolarizing agents. 
entities: succinylcholine / nondepolarizing agents
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Evidence of spontaneous recovery from succinylcholine should be observed before the administration of MIVACRON. 
entities: succinylcholine / MIVACRON
ddi: advise
>>> match: observe_nsubj:pass_obl
-------------
sentence: A greater potentiation of the neuromuscular blocking effects of MIVACRON may be expected with higher concentrations of enflurane or isoflurane. 
entities: MIVACRON / enflurane
ddi: null
>>> match: expect_nsubj:pass_obl
-------------
sentence: A greater potentiation of the neuromuscular blocking effects of MIVACRON may be expected with higher concentrations of enflurane or isoflurane. 
entities: MIVACRON / isoflurane
ddi: null
>>> match: expect_nsubj:pass_obl
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / antibiotics
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / aminoglycosides
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / tetracyclines
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / bacitracin
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / polymyxins
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / lincomycin
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / clindamycin
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / colistin
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / sodium colistimethate
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / magnesium
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / lithium
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / anesthetics
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / procainamide
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: nondepolarizing agents / quinidine
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / antibiotics
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / aminoglycosides
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / tetracyclines
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / bacitracin
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / polymyxins
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / lincomycin
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / clindamycin
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / colistin
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / sodium colistimethate
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / magnesium
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / lithium
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / anesthetics
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / procainamide
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine. 
entities: MIVACRON / quinidine
ddi: int
>>> match: include_nsubj_obj
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: MIVACRON / contraceptives
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: MIVACRON / glucocorticoids
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: MIVACRON / monoamine oxidase inhibitors
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: MIVACRON / neuromuscular blocking agents
ddi: null
>>> match: enhance_nsubj:pass_obl
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: MIVACRON / phenytoin
ddi: null
>>> match: enhance_nsubj:pass_obl
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: MIVACRON / carbamazepine
ddi: null
>>> match: enhance_nsubj:pass_obl
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: contraceptives / neuromuscular blocking agents
ddi: null
>>> match: reduce_obj_parataxis
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: contraceptives / phenytoin
ddi: null
>>> match: reduce_obj_parataxis
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: contraceptives / carbamazepine
ddi: null
>>> match: reduce_obj_parataxis
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: glucocorticoids / neuromuscular blocking agents
ddi: null
>>> match: reduce_obj_parataxis
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: glucocorticoids / phenytoin
ddi: null
>>> match: reduce_obj_parataxis
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: glucocorticoids / carbamazepine
ddi: null
>>> match: reduce_obj_parataxis
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: monoamine oxidase inhibitors / neuromuscular blocking agents
ddi: null
>>> match: reduce_obj_parataxis
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: monoamine oxidase inhibitors / phenytoin
ddi: null
>>> match: reduce_obj_parataxis
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: monoamine oxidase inhibitors / carbamazepine
ddi: null
>>> match: reduce_obj_parataxis
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: neuromuscular blocking agents / phenytoin
ddi: effect
>>> match: demonstrate_nsubj:pass_obl
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine. 
entities: neuromuscular blocking agents / carbamazepine
ddi: effect
>>> match: demonstrate_nsubj:pass_obl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: phenytoin / cisplatin
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: phenytoin / edrophonium
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: phenytoin / neostigmine
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: phenytoin / polymyxin B
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: phenytoin / bacitracin
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: phenytoin / anesthetics
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: phenytoin / procaine
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: phenytoin / anesthetics
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: phenytoin / succinylcholine
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: phenytoin / muscle relaxants
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: carbamazepine / cisplatin
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: carbamazepine / edrophonium
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: carbamazepine / neostigmine
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: carbamazepine / polymyxin B
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: carbamazepine / bacitracin
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: carbamazepine / anesthetics
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: carbamazepine / procaine
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: carbamazepine / anesthetics
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: carbamazepine / succinylcholine
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: carbamazepine / muscle relaxants
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: antibiotics / cisplatin
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: antibiotics / edrophonium
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: antibiotics / neostigmine
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: antibiotics / polymyxin B
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: antibiotics / bacitracin
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: antibiotics / anesthetics
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: antibiotics / procaine
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: antibiotics / anesthetics
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: antibiotics / succinylcholine
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants
entities: antibiotics / muscle relaxants
ddi: null
>>> match: control_obj_advcl
-------------
sentence: Rifampin: Coadministration of rifampin and MEPRON Suspension results in a significant decrease in average steady- state plasma atovaquone concentrations.
entities: rifampin / atovaquone
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Rifampin: Coadministration of rifampin and MEPRON Suspension results in a significant decrease in average steady- state plasma atovaquone concentrations.
entities: MEPRON / atovaquone
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Alternatives to rifampin should be considered during the course of PCP treatment with MEPRON.
entities: rifampin / MEPRON
ddi: advise
>>> match: consider_csubj:pass_obl
-------------
sentence: The blockade of the spinal endorphinergic system by intrathecal naloxone on the production of tail-flick inhibition induced by intraventricular beta-endorphin and morphine was then studied. 
entities: naloxone / beta-endorphin
ddi: null
>>> match: induce_nsubj_advmod
-------------
sentence: The blockade of the spinal endorphinergic system by intrathecal naloxone on the production of tail-flick inhibition induced by intraventricular beta-endorphin and morphine was then studied. 
entities: naloxone / morphine
ddi: null
>>> match: induce_nsubj_advmod
-------------
sentence: Intrathecal injection of naloxone at doses of 0.4 to 40 micrograms caused a dose-related blockade of the inhibition of the tail-flick response induced by intraventricular injection of beta-endorphin, and a high dose of naloxone (40 micrograms) completely blocked the tail-flick inhibition induced by intraventricular beta-endorphin (16 micrograms). 
entities: beta-endorphin / beta-endorphin
ddi: null
>>> match: block_nsubj_dep
-------------
sentence: Intrathecal injection of naloxone at doses of 0.4 to 40 micrograms caused a dose-related blockade of the inhibition of the tail-flick response induced by intraventricular injection of beta-endorphin, and a high dose of naloxone (40 micrograms) completely blocked the tail-flick inhibition induced by intraventricular beta-endorphin (16 micrograms). 
entities: naloxone / beta-endorphin
ddi: effect
>>> match: block_nsubj_dep
-------------
sentence: On the other hand, intrathecal naloxone (12-120 micrograms) had only a very weak effect on the tail-flick inhibition induced by intraventricular morphine (40 micrograms). 
entities: naloxone / morphine
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems; 
entities: naloxone / beta-endorphin
ddi: null
>>> match: involve_nsubj:pass_obl
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems; 
entities: naloxone / morphine
ddi: null
>>> match: involve_nsubj:pass_obl
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems; 
entities: naloxone / beta-endorphin
ddi: null
>>> match: involve_nsubj:pass_conj
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems; 
entities: naloxone / morphine
ddi: null
>>> match: involve_nsubj:pass_conj
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems; 
entities: beta-endorphin / beta-endorphin
ddi: null
>>> match: involve_obl_conj
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems; 
entities: beta-endorphin / morphine
ddi: null
>>> match: involve_obl_conj
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems; 
entities: morphine / beta-endorphin
ddi: null
>>> match: involve_obl_conj
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems; 
entities: morphine / morphine
ddi: null
>>> match: involve_obl_conj
-------------
sentence: In patients with mild to moderate hypertension, administration of 25 mg daily of VIOXX with the ACE inhibitor benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone.
entities: VIOXX / ACE inhibitor
ddi: null
>>> match: associate_obl_advcl
-------------
sentence: In patients with mild to moderate hypertension, administration of 25 mg daily of VIOXX with the ACE inhibitor benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone.
entities: ACE inhibitor / ACE inhibitor
ddi: null
>>> match: associate_obl_advcl
-------------
sentence: In patients with mild to moderate hypertension, administration of 25 mg daily of VIOXX with the ACE inhibitor benazepril, 10 to 40 mg for 4 weeks, was associated with an average increase in mean arterial pressure of about 3 mm Hg compared to ACE inhibitor alone.
entities: benazepril / ACE inhibitor
ddi: null
>>> match: associate_obl_advcl
-------------
sentence: This interaction should be given consideration in patients taking VIOXX concomitantly with ACE inhibitors.
entities: VIOXX / ACE inhibitors
ddi: advise
>>> match: take_obj_obl
-------------
sentence: Aspirin: Concomitant administration of low-dose aspirin with VIOXX may result in an increased rate of GI ulceration or other complications, compared to use of VIOXX alone.
entities: aspirin / VIOXX
ddi: null
>>> match: result_nsubj_advcl
-------------
sentence: Aspirin: Concomitant administration of low-dose aspirin with VIOXX may result in an increased rate of GI ulceration or other complications, compared to use of VIOXX alone.
entities: VIOXX / VIOXX
ddi: null
>>> match: result_nsubj_advcl
-------------
sentence: In a 12-week endoscopy study conducted in OA patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose (81 mg) enteric coated aspirin plus VIOXX 25 mg daily, as compared to those taking ibuprofen 2400 mg daily alone.
entities: aspirin / ibuprofen
ddi: null
>>> match: take_obj_obj
-------------
sentence: In a 12-week endoscopy study conducted in OA patients there was no difference in the cumulative incidence of endoscopic gastroduodenal ulcers in patients taking low-dose (81 mg) enteric coated aspirin plus VIOXX 25 mg daily, as compared to those taking ibuprofen 2400 mg daily alone.
entities: VIOXX / ibuprofen
ddi: null
>>> match: take_obj_obj
-------------
sentence: Patients taking low-dose aspirin plus ibuprofen were not studied.
entities: aspirin / ibuprofen
ddi: null
>>> match: take_obj_conj
-------------
sentence: At steady state, VIOXX 50 mg once daily had no effect on the anti-platelet activity of low-dose (81 mg once daily) aspirin, as assessed by ex vivo platelet aggregation and serum TXB2 generation in clotting blood.
entities: VIOXX / aspirin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Cimetidine: Co-administration with high doses of cimetidine [800 mg twice daily] increased the Cmax of rofecoxib by 21%, the AUC0-120hr by 23% and the t1/2 by 15%.
entities: Cimetidine / rofecoxib
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Cimetidine: Co-administration with high doses of cimetidine [800 mg twice daily] increased the Cmax of rofecoxib by 21%, the AUC0-120hr by 23% and the t1/2 by 15%.
entities: cimetidine / rofecoxib
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
entities: NSAIDs / furosemide
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
entities: NSAIDs / thiazides
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Lithium: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.
entities: NSAIDs / lithium
ddi: mechanism
>>> match: produce_nsubj_obj
-------------
sentence: Lithium: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.
entities: NSAIDs / lithium
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Thus, when VIOXX and lithium are administered concurrently, subjects should be observed carefully for signs of lithium toxicity.
entities: VIOXX / lithium
ddi: null
>>> match: observe_advcl_obl
-------------
sentence: Thus, when VIOXX and lithium are administered concurrently, subjects should be observed carefully for signs of lithium toxicity.
entities: lithium / lithium
ddi: null
>>> match: observe_advcl_obl
-------------
sentence: Methotrexate VIOXX 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of methotrexate as measured by AUC0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis.
entities: Methotrexate / methotrexate
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Methotrexate VIOXX 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of methotrexate as measured by AUC0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis.
entities: Methotrexate / methotrexate
ddi: null
>>> match: have_nsubj_dep
-------------
sentence: Methotrexate VIOXX 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of methotrexate as measured by AUC0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis.
entities: VIOXX / methotrexate
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Methotrexate VIOXX 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of methotrexate as measured by AUC0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis.
entities: VIOXX / methotrexate
ddi: null
>>> match: have_nsubj_dep
-------------
sentence: Methotrexate VIOXX 12.5, 25, and 50 mg, each dose administered once daily for 7 days, had no effect on the plasma concentration of methotrexate as measured by AUC0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis.
entities: methotrexate / methotrexate
ddi: null
>>> match: have_obj_dep
-------------
sentence: At higher than recommended doses, VIOXX 75 mg administered once daily for 10 days increased plasma concentrations by 23% as measured by AUC0-24hr in patients receiving methotrexate 7.5 to 15 mg/week for rheumatoid arthritis.
entities: VIOXX / methotrexate
ddi: mechanism
>>> match: administer_nsubj_advcl
-------------
sentence: At 24 hours postdose, a similar proportion of patients treated with methotrexate alone (94%) and subsequently treated with methotrexate co-administered with 75 mg of rofecoxib (88%) had methotrexate plasma concentrations below the measurable limit (5 ng/mL).
entities: methotrexate / rofecoxib
ddi: mechanism
>>> match: administer_dep_obl
-------------
sentence: At 24 hours postdose, a similar proportion of patients treated with methotrexate alone (94%) and subsequently treated with methotrexate co-administered with 75 mg of rofecoxib (88%) had methotrexate plasma concentrations below the measurable limit (5 ng/mL).
entities: methotrexate / methotrexate
ddi: null
>>> match: administer_dep_dep
-------------
sentence: At 24 hours postdose, a similar proportion of patients treated with methotrexate alone (94%) and subsequently treated with methotrexate co-administered with 75 mg of rofecoxib (88%) had methotrexate plasma concentrations below the measurable limit (5 ng/mL).
entities: rofecoxib / methotrexate
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Standard monitoring of methotrexate-related toxicity should be continued if VIOXX and methotrexate are administered concomitantly.
entities: methotrexate / VIOXX
ddi: null
>>> match: continue_nsubj:pass_advcl
-------------
sentence: Standard monitoring of methotrexate-related toxicity should be continued if VIOXX and methotrexate are administered concomitantly.
entities: methotrexate / methotrexate
ddi: null
>>> match: continue_nsubj:pass_advcl
-------------
sentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.
entities: VIOXX / rifampin
ddi: mechanism
>>> match: produce_nsubj_obl
-------------
sentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.
entities: VIOXX / rofecoxib
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Rifampin: Co-administration of VIOXX with rifampin 600 mg daily, a potent inducer of hepatic metabolism, produced an approximate 50% decrease in rofecoxib plasma concentrations.
entities: rifampin / rofecoxib
ddi: null
>>> match: produce_obl_obj
-------------
sentence: Therefore, a starting daily dose of 25 mg of VIOXX should be considered for the treatment of osteoarthritis when VIOXX is co-administered with potent inducers of hepatic metabolism.
entities: VIOXX / VIOXX
ddi: null
>>> match: consider_nsubj:pass_advcl
-------------
sentence: Theophylline VIOXX 12.5, 25, and 50 mg administered once daily for 7 days increased plasma theophylline concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of theophylline.
entities: Theophylline / theophylline
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Theophylline VIOXX 12.5, 25, and 50 mg administered once daily for 7 days increased plasma theophylline concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of theophylline.
entities: Theophylline / theophylline
ddi: null
>>> match: increase_nsubj_obl
-------------
sentence: Theophylline VIOXX 12.5, 25, and 50 mg administered once daily for 7 days increased plasma theophylline concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of theophylline.
entities: VIOXX / theophylline
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Theophylline VIOXX 12.5, 25, and 50 mg administered once daily for 7 days increased plasma theophylline concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of theophylline.
entities: VIOXX / theophylline
ddi: null
>>> match: increase_nsubj_obl
-------------
sentence: Theophylline VIOXX 12.5, 25, and 50 mg administered once daily for 7 days increased plasma theophylline concentrations (AUC(0- )) by 38 to 60% in healthy subjects administered a single 300-mg dose of theophylline.
entities: theophylline / theophylline
ddi: null
>>> match: increase_obj_obl
-------------
sentence: Adequate monitoring of theophylline plasma concentrations should be considered when therapy with VIOXX is initiated or changed in patients receiving theophylline.
entities: theophylline / VIOXX
ddi: null
>>> match: consider_nsubj:pass_advcl
-------------
sentence: Adequate monitoring of theophylline plasma concentrations should be considered when therapy with VIOXX is initiated or changed in patients receiving theophylline.
entities: theophylline / theophylline
ddi: null
>>> match: consider_nsubj:pass_advcl
-------------
sentence: Adequate monitoring of theophylline plasma concentrations should be considered when therapy with VIOXX is initiated or changed in patients receiving theophylline.
entities: VIOXX / theophylline
ddi: advise
>>> match: initiate_nsubj:pass_obl
-------------
sentence: In post-marketing experience, bleeding events have been reported, predominantly in the elderly, in association with increases in prothrombin time in patients receiving VIOXX concurrently with warfarin.
entities: VIOXX / warfarin
ddi: effect
>>> match: receive_obj_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / digitalis preparations
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / furosemide
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / spironolactone
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / lidocaine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / glyceryl trinitrate
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / isosorbide dinitrate
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / morphine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / atropine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / heparin
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / protamine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / potassium chloride
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / folic acid
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs, including digitalis preparations, furosemide, spironolactone, lidocaine, glyceryl trinitrate, isosorbide dinitrate, morphine, atropine, heparin, protamine, potassium chloride, folic acid, and acetaminophen.
entities: dobutamine / acetaminophen
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Elevated plasma levels of theophylline have been reported with concomitant use of some quinolones.
entities: theophylline / quinolones
ddi: mechanism
>>> match: report_nsubj:pass_obl
-------------
sentence: Therefore, monitoring of theophylline plasma levels should be considered and dosage of theophylline adjusted as required.
entities: theophylline / theophylline
ddi: null
>>> match: consider_nsubj:pass_conj
-------------
sentence: Quinolones have also been shown to interfere with the metabolism of caffeine.
entities: Quinolones / caffeine
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Although this interaction has not been reported with cinoxacin, caution should be exercised when cinoxacin is given concomitantly with caffeine-containing products.
entities: cinoxacin / cinoxacin
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: Although this interaction has not been reported with cinoxacin, caution should be exercised when cinoxacin is given concomitantly with caffeine-containing products.
entities: cinoxacin / caffeine
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: Although this interaction has not been reported with cinoxacin, caution should be exercised when cinoxacin is given concomitantly with caffeine-containing products.
entities: cinoxacin / caffeine
ddi: advise
>>> match: give_nsubj:pass_obl
-------------
sentence: Antacids or sucralfate substantially interfere with the absorption of some quinolones, resulting in low urine levels.
entities: Antacids / quinolones
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Antacids or sucralfate substantially interfere with the absorption of some quinolones, resulting in low urine levels.
entities: sucralfate / quinolones
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Quinolones, including cinoxacin, may enhance the effects of oral anticoagulants, such as warfarin or its derivatives.
entities: Quinolones / anticoagulants
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Quinolones, including cinoxacin, may enhance the effects of oral anticoagulants, such as warfarin or its derivatives.
entities: Quinolones / warfarin
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Quinolones, including cinoxacin, may enhance the effects of oral anticoagulants, such as warfarin or its derivatives.
entities: cinoxacin / anticoagulants
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Quinolones, including cinoxacin, may enhance the effects of oral anticoagulants, such as warfarin or its derivatives.
entities: cinoxacin / warfarin
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Elevated cyclosporine serum levels have been reported with the concomitant use of quinolones and cyclosporine.
entities: cyclosporine / quinolones
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Elevated cyclosporine serum levels have been reported with the concomitant use of quinolones and cyclosporine.
entities: cyclosporine / cyclosporine
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Since Celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).
entities: Celontin / antiepileptic drugs
ddi: advise
>>> match: interact_nsubj_obl
-------------
sentence: Since Celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).
entities: methsuximide / antiepileptic drugs
ddi: advise
>>> match: interact_nsubj_obl
-------------
sentence: Since Celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).
entities: methsuximide / phenytoin
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Since Celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).
entities: methsuximide / phenobarbital
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: When methyldopa is used with other antihypertensive drugs, potentiation of antihypertensive effect may occur. 
entities: methyldopa / antihypertensive drugs
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: Patients may require reduced doses of anesthetics when on methyldopa. 
entities: anesthetics / methyldopa
ddi: advise
>>> match: require_obj_advmod
-------------
sentence: When methyldopa and lithium are given concomitantly the patient should be carefully monitored for symptoms of lithium toxicity. 
entities: methyldopa / lithium
ddi: null
>>> match: monitor_advcl_obl
-------------
sentence: When methyldopa and lithium are given concomitantly the patient should be carefully monitored for symptoms of lithium toxicity. 
entities: lithium / lithium
ddi: null
>>> match: monitor_advcl_obl
-------------
sentence: Several studies demonstrate a decrease in the bioavailability of methyldopa when it is ingested with ferrous sulfate or ferrous gluconate. 
entities: methyldopa / ferrous sulfate
ddi: mechanism
>>> match: demonstrate_obj_advcl
-------------
sentence: Several studies demonstrate a decrease in the bioavailability of methyldopa when it is ingested with ferrous sulfate or ferrous gluconate. 
entities: methyldopa / ferrous gluconate
ddi: mechanism
>>> match: demonstrate_obj_advcl
-------------
sentence: Methyldopa does not interfere with measurement of VMA (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert VMA to vanillin. 
entities: VMA / vanillin
ddi: null
>>> match: convert_obj_obl
-------------
sentence: Aprepitant has been shown to induce the metabolism of S(-) warfarin and tolbutamide, which are metabolized through CYP2C9.
entities: Aprepitant / S(-) warfarin
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Aprepitant has been shown to induce the metabolism of S(-) warfarin and tolbutamide, which are metabolized through CYP2C9.
entities: Aprepitant / tolbutamide
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Corticosteroids: Dexamethasone: Aprepitant, when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on Day 1, and Aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on Days 2 through 5, increased the AUC of dexamethasone, a CYP3A4 substrate by 2.2-fold, on Days 1 and 5.
entities: dexamethasone / Aprepitant
ddi: null
>>> match: give_obl_conj
-------------
sentence: Corticosteroids: Dexamethasone: Aprepitant, when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on Day 1, and Aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on Days 2 through 5, increased the AUC of dexamethasone, a CYP3A4 substrate by 2.2-fold, on Days 1 and 5.
entities: dexamethasone / dexamethasone
ddi: null
>>> match: give_obl_conj
-------------
sentence: Corticosteroids: Dexamethasone: Aprepitant, when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on Day 1, and Aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on Days 2 through 5, increased the AUC of dexamethasone, a CYP3A4 substrate by 2.2-fold, on Days 1 and 5.
entities: dexamethasone / dexamethasone
ddi: null
>>> match: give_obl_conj
-------------
sentence: Corticosteroids: Dexamethasone: Aprepitant, when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on Day 1, and Aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on Days 2 through 5, increased the AUC of dexamethasone, a CYP3A4 substrate by 2.2-fold, on Days 1 and 5.
entities: dexamethasone / dexamethasone
ddi: null
>>> match: increase_dep_obj
-------------
sentence: The oral dexamethasone doses should be reduced by approximately 50% when coadministered with Aprepitant, to achieve exposures of dexamethasone similar to those obtained when it is given without Aprepitant.
entities: dexamethasone / Aprepitant
ddi: advise
>>> match: reduce_nsubj:pass_advcl
-------------
sentence: The oral dexamethasone doses should be reduced by approximately 50% when coadministered with Aprepitant, to achieve exposures of dexamethasone similar to those obtained when it is given without Aprepitant.
entities: dexamethasone / dexamethasone
ddi: null
>>> match: reduce_nsubj:pass_advcl
-------------
sentence: The oral dexamethasone doses should be reduced by approximately 50% when coadministered with Aprepitant, to achieve exposures of dexamethasone similar to those obtained when it is given without Aprepitant.
entities: dexamethasone / Aprepitant
ddi: null
>>> match: reduce_nsubj:pass_advcl
-------------
sentence: The oral dexamethasone doses should be reduced by approximately 50% when coadministered with Aprepitant, to achieve exposures of dexamethasone similar to those obtained when it is given without Aprepitant.
entities: Aprepitant / dexamethasone
ddi: null
>>> match: reduce_advcl_advcl
-------------
sentence: The oral dexamethasone doses should be reduced by approximately 50% when coadministered with Aprepitant, to achieve exposures of dexamethasone similar to those obtained when it is given without Aprepitant.
entities: Aprepitant / Aprepitant
ddi: null
>>> match: reduce_advcl_advcl
-------------
sentence: The daily dose of dexamethasone administered in clinical studies with Aprepitant reflects an approximate 50% reduction of the dose of dexamethasone.
entities: dexamethasone / Aprepitant
ddi: mechanism
>>> match: administer_nsubj_obl
-------------
sentence: The daily dose of dexamethasone administered in clinical studies with Aprepitant reflects an approximate 50% reduction of the dose of dexamethasone.
entities: dexamethasone / dexamethasone
ddi: null
>>> match: reflect_csubj_obj
-------------
sentence: The daily dose of dexamethasone administered in clinical studies with Aprepitant reflects an approximate 50% reduction of the dose of dexamethasone.
entities: Aprepitant / dexamethasone
ddi: null
>>> match: reflect_csubj_obj
-------------
sentence: Aprepitant, when given as a regimen of 125 mg on Day 1 and 80 mg/day on Days 2 and 3, increased the AUC of methylprednisolone, a CYP3A4 substrate, by 1.34-fold on Day 1 and by 2.5-fold on Day 3, when methylprednisolone was coadministered intravenously as 125 mg on Day 1 and orally as 40 mg on Days 2 and 3.
entities: methylprednisolone / methylprednisolone
ddi: null
>>> match: increase_obj_obl
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: methylprednisolone / methylprednisolone
ddi: null
>>> match: reduce_nsubj:pass_conj
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: methylprednisolone / Aprepitant
ddi: advise
>>> match: reduce_nsubj:pass_conj
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: methylprednisolone / methylprednisolone
ddi: null
>>> match: reduce_nsubj:pass_conj
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: methylprednisolone / Aprepitant
ddi: null
>>> match: reduce_nsubj:pass_conj
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: methylprednisolone / Aprepitant
ddi: advise
>>> match: reduce_nsubj:pass_advmod
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: methylprednisolone / methylprednisolone
ddi: null
>>> match: reduce_nsubj:pass_advmod
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: methylprednisolone / Aprepitant
ddi: null
>>> match: reduce_nsubj:pass_advmod
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: Aprepitant / methylprednisolone
ddi: null
>>> match: achieve_nsubj_obj
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: Aprepitant / Aprepitant
ddi: null
>>> match: achieve_nsubj_obj
-------------
sentence: Warfarin: A single 125-mg dose of Aprepitant was administered on Day 1 and 80 mg/day on Days 2 and 3 to healthy subjects who were stabilized on chronic warfarin therapy.
entities: Aprepitant / warfarin
ddi: null
>>> match: administer_nsubj:pass_dep
-------------
sentence: Although there was no effect of Aprepitant on the plasma AUC of R(+) or S(-) warfarin determined on Day 3, there was a 34% decrease in S(-)warfarin (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with Aprepitant.
entities: Aprepitant / S(-)warfarin
ddi: null
>>> match: determine_advcl_parataxis
-------------
sentence: Although there was no effect of Aprepitant on the plasma AUC of R(+) or S(-) warfarin determined on Day 3, there was a 34% decrease in S(-)warfarin (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with Aprepitant.
entities: Aprepitant / Aprepitant
ddi: null
>>> match: determine_advcl_parataxis
-------------
sentence: Although there was no effect of Aprepitant on the plasma AUC of R(+) or S(-) warfarin determined on Day 3, there was a 34% decrease in S(-)warfarin (a CYP2C9 substrate) trough concentration accompanied by a 14% decrease in the prothrombin time (reported as International Normalized Ratio or INR) 5 days after completion of dosing with Aprepitant.
entities: S(-)warfarin / Aprepitant
ddi: mechanism
>>> match: accompany_nsubj_dep
-------------
sentence: In patients on chronic warfarin therapy, the prothrombin time (INR) should be closely monitored in the 2-week period, particularly at 7 to 10 days, following initiation of the 3-day regimen of Aprepitant with each chemotherapy cycle.
entities: warfarin / Aprepitant
ddi: advise
>>> match: monitor_obl_obl
-------------
sentence: Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.
entities: tolbutamide / tolbutamide
ddi: null
>>> match: decrease_obj_obl
-------------
sentence: Tolbutamide: Aprepitant, when given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, decreased the AUC of tolbutamide (a CYP2C9 substrate) by 23% on Day 4, 28% on Day 8, and 15% on Day 15, when a single dose of tolbutamide 500 mg was admini,stered orally prior to the administration of the 3-day regimen of Aprepitant and on Days 4,8, and 15.
entities: tolbutamide / Aprepitant
ddi: null
>>> match: decrease_obj_obl
-------------
sentence: Oral contraceptives: Aprepitant, when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone, decreased the AUC of ethinyl estradiol by 43%, and decreased the AUC of norethindrone by 8%;
entities: contraceptive / ethinyl estradiol
ddi: null
>>> match: decrease_advcl_obj
-------------
sentence: Oral contraceptives: Aprepitant, when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone, decreased the AUC of ethinyl estradiol by 43%, and decreased the AUC of norethindrone by 8%;
entities: contraceptive / norethindrone
ddi: null
>>> match: decrease_advcl_conj
-------------
sentence: Oral contraceptives: Aprepitant, when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone, decreased the AUC of ethinyl estradiol by 43%, and decreased the AUC of norethindrone by 8%;
entities: ethinyl estradiol / ethinyl estradiol
ddi: null
>>> match: decrease_advcl_obj
-------------
sentence: Oral contraceptives: Aprepitant, when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone, decreased the AUC of ethinyl estradiol by 43%, and decreased the AUC of norethindrone by 8%;
entities: ethinyl estradiol / norethindrone
ddi: null
>>> match: decrease_advcl_conj
-------------
sentence: Oral contraceptives: Aprepitant, when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone, decreased the AUC of ethinyl estradiol by 43%, and decreased the AUC of norethindrone by 8%;
entities: norethindrone / ethinyl estradiol
ddi: null
>>> match: decrease_advcl_obj
-------------
sentence: Oral contraceptives: Aprepitant, when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone, decreased the AUC of ethinyl estradiol by 43%, and decreased the AUC of norethindrone by 8%;
entities: norethindrone / norethindrone
ddi: null
>>> match: decrease_advcl_conj
-------------
sentence: Oral contraceptives: Aprepitant, when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone, decreased the AUC of ethinyl estradiol by 43%, and decreased the AUC of norethindrone by 8%;
entities: ethinyl estradiol / norethindrone
ddi: null
>>> match: decrease_obj_conj
-------------
sentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.
entities: Aprepitant / midazolam
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.
entities: Aprepitant / midazolam
ddi: null
>>> match: increase_nsubj_dep
-------------
sentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.
entities: Aprepitant / Aprepitant
ddi: null
>>> match: increase_nsubj_dep
-------------
sentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.
entities: midazolam / midazolam
ddi: null
>>> match: increase_obj_dep
-------------
sentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.
entities: midazolam / Aprepitant
ddi: null
>>> match: increase_obj_dep
-------------
sentence: Midazolam: Aprepitant increased the AUC of midazolam, a sensitive CYP3A4 substrate, by 2.3-fold on Day 1 and 3.3-fold on Day 5, when a single oral dose of midazolam 2 mg was coadministered on Day 1 and Day 5 of a regimen of Aprepitant 125 mg on Day 1 and 80 mg/day on Days 2 through 5.
entities: midazolam / Aprepitant
ddi: null
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: The potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) should be considered when coadministering these agents with Aprepitant.
entities: midazolam / alprazolam
ddi: null
>>> match: metabolize_nsubj_obl
-------------
sentence: The potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) should be considered when coadministering these agents with Aprepitant.
entities: midazolam / triazolam
ddi: null
>>> match: metabolize_nsubj_obl
-------------
sentence: The potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) should be considered when coadministering these agents with Aprepitant.
entities: midazolam / Aprepitant
ddi: advise
>>> match: metabolize_nsubj_dep
-------------
sentence: The potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) should be considered when coadministering these agents with Aprepitant.
entities: benzodiazepines / alprazolam
ddi: null
>>> match: metabolize_nsubj_obl
-------------
sentence: The potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) should be considered when coadministering these agents with Aprepitant.
entities: benzodiazepines / triazolam
ddi: null
>>> match: metabolize_nsubj_obl
-------------
sentence: The potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) should be considered when coadministering these agents with Aprepitant.
entities: benzodiazepines / Aprepitant
ddi: advise
>>> match: metabolize_nsubj_dep
-------------
sentence: The potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) should be considered when coadministering these agents with Aprepitant.
entities: alprazolam / Aprepitant
ddi: advise
>>> match: metabolize_obl_dep
-------------
sentence: The potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) should be considered when coadministering these agents with Aprepitant.
entities: triazolam / Aprepitant
ddi: advise
>>> match: metabolize_obl_dep
-------------
sentence: In another study with intravenous administration of midazolam, Aprepitant was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and midazolam 2 mg IV was given prior to the administration of the 3-day regimen of Aprepitant and on Days 4, 8, and 15.
entities: midazolam / Aprepitant
ddi: null
>>> match: give_obl_nsubj:pass
-------------
sentence: In another study with intravenous administration of midazolam, Aprepitant was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and midazolam 2 mg IV was given prior to the administration of the 3-day regimen of Aprepitant and on Days 4, 8, and 15.
entities: midazolam / midazolam
ddi: null
>>> match: give_obl_conj
-------------
sentence: In another study with intravenous administration of midazolam, Aprepitant was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and midazolam 2 mg IV was given prior to the administration of the 3-day regimen of Aprepitant and on Days 4, 8, and 15.
entities: midazolam / Aprepitant
ddi: null
>>> match: give_obl_dep
-------------
sentence: In another study with intravenous administration of midazolam, Aprepitant was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and midazolam 2 mg IV was given prior to the administration of the 3-day regimen of Aprepitant and on Days 4, 8, and 15.
entities: Aprepitant / midazolam
ddi: null
>>> match: give_nsubj:pass_conj
-------------
sentence: In another study with intravenous administration of midazolam, Aprepitant was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and midazolam 2 mg IV was given prior to the administration of the 3-day regimen of Aprepitant and on Days 4, 8, and 15.
entities: Aprepitant / Aprepitant
ddi: null
>>> match: give_nsubj:pass_dep
-------------
sentence: In another study with intravenous administration of midazolam, Aprepitant was given as 125 mg on Day 1 and 80 mg/day on Days 2 and 3, and midazolam 2 mg IV was given prior to the administration of the 3-day regimen of Aprepitant and on Days 4, 8, and 15.
entities: midazolam / Aprepitant
ddi: null
>>> match: give_conj_dep
-------------
sentence: Aprepitant increased the AUC of midazolam by 25% on Day 4 and decreased the AUC of midazolam by 19% on Day 8 relative to the dosing of Aprepitant on Days 1 through 3.
entities: Aprepitant / midazolam
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Aprepitant increased the AUC of midazolam by 25% on Day 4 and decreased the AUC of midazolam by 19% on Day 8 relative to the dosing of Aprepitant on Days 1 through 3.
entities: Aprepitant / midazolam
ddi: mechanism
>>> match: increase_nsubj_conj
-------------
sentence: Aprepitant increased the AUC of midazolam by 25% on Day 4 and decreased the AUC of midazolam by 19% on Day 8 relative to the dosing of Aprepitant on Days 1 through 3.
entities: Aprepitant / Aprepitant
ddi: null
>>> match: increase_nsubj_conj
-------------
sentence: Aprepitant increased the AUC of midazolam by 25% on Day 4 and decreased the AUC of midazolam by 19% on Day 8 relative to the dosing of Aprepitant on Days 1 through 3.
entities: midazolam / midazolam
ddi: null
>>> match: increase_obj_conj
-------------
sentence: Aprepitant increased the AUC of midazolam by 25% on Day 4 and decreased the AUC of midazolam by 19% on Day 8 relative to the dosing of Aprepitant on Days 1 through 3.
entities: midazolam / Aprepitant
ddi: null
>>> match: increase_obj_conj
-------------
sentence: Aprepitant increased the AUC of midazolam by 25% on Day 4 and decreased the AUC of midazolam by 19% on Day 8 relative to the dosing of Aprepitant on Days 1 through 3.
entities: midazolam / Aprepitant
ddi: null
>>> match: decrease_obj_advmod
-------------
sentence: therefore, coadministration of Aprepitant with drugs that inhibit CYP3A4 activity may result in increased plasma concentrations of aprepitant.
entities: Aprepitant / aprepitant
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Because moderate CYP3A4 inhibitors (e.g., diltiazem) result in 2-fold increase in plasma concentrations of aprepitant, concomitant administration should also be approached with caution.
entities: diltiazem / aprepitant
ddi: advise
>>> match: result_nsubj_obl
-------------
sentence: therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.
entities: Aprepitant / aprepitant
ddi: mechanism
>>> match: result_nsubj_obl
-------------
sentence: therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.
entities: Aprepitant / Aprepitant
ddi: null
>>> match: result_nsubj_ccomp
-------------
sentence: therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.
entities: rifampin / aprepitant
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.
entities: rifampin / Aprepitant
ddi: null
>>> match: result_nsubj_ccomp
-------------
sentence: therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.
entities: carbamazepine / aprepitant
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.
entities: carbamazepine / Aprepitant
ddi: null
>>> match: result_nsubj_ccomp
-------------
sentence: therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.
entities: phenytoin / aprepitant
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.
entities: phenytoin / Aprepitant
ddi: null
>>> match: result_nsubj_ccomp
-------------
sentence: therefore, coadministration of Aprepitant with drugs that strongly induce CYP3A4 activity (e.g., rifampin, carbamazepine, phenytoin) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of Aprepitant.
entities: aprepitant / Aprepitant
ddi: null
>>> match: result_obl_ccomp
-------------
sentence: Ketoconazole: When a single 125-mg dose of Aprepitant was administered on Day5 of a 10-day regimen of 400 mg/day of ketoconazole, a strong CYP3A4 inhibitor, the AUC of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold.
entities: Aprepitant / ketoconazole
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: Ketoconazole: When a single 125-mg dose of Aprepitant was administered on Day5 of a 10-day regimen of 400 mg/day of ketoconazole, a strong CYP3A4 inhibitor, the AUC of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold.
entities: Aprepitant / aprepitant
ddi: null
>>> match: administer_nsubj:pass_conj
-------------
sentence: Ketoconazole: When a single 125-mg dose of Aprepitant was administered on Day5 of a 10-day regimen of 400 mg/day of ketoconazole, a strong CYP3A4 inhibitor, the AUC of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold.
entities: Aprepitant / aprepitant
ddi: null
>>> match: administer_nsubj:pass_conj
-------------
sentence: Ketoconazole: When a single 125-mg dose of Aprepitant was administered on Day5 of a 10-day regimen of 400 mg/day of ketoconazole, a strong CYP3A4 inhibitor, the AUC of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold.
entities: ketoconazole / aprepitant
ddi: null
>>> match: administer_obl_conj
-------------
sentence: Ketoconazole: When a single 125-mg dose of Aprepitant was administered on Day5 of a 10-day regimen of 400 mg/day of ketoconazole, a strong CYP3A4 inhibitor, the AUC of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold.
entities: ketoconazole / aprepitant
ddi: null
>>> match: administer_obl_conj
-------------
sentence: Ketoconazole: When a single 125-mg dose of Aprepitant was administered on Day5 of a 10-day regimen of 400 mg/day of ketoconazole, a strong CYP3A4 inhibitor, the AUC of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold.
entities: aprepitant / aprepitant
ddi: null
>>> match: administer_conj_conj
-------------
sentence: Rifampin: When a single 375-mg dose of Aprepitant was administered on Day9 of a 14-day regimen of 600 mg/day of rifampin, a strong CYP3A4 inducer, the AUC of aprepitant decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold.
entities: Aprepitant / rifampin
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: Rifampin: When a single 375-mg dose of Aprepitant was administered on Day9 of a 14-day regimen of 600 mg/day of rifampin, a strong CYP3A4 inducer, the AUC of aprepitant decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold.
entities: Aprepitant / aprepitant
ddi: null
>>> match: administer_nsubj:pass_parataxis
-------------
sentence: Rifampin: When a single 375-mg dose of Aprepitant was administered on Day9 of a 14-day regimen of 600 mg/day of rifampin, a strong CYP3A4 inducer, the AUC of aprepitant decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold.
entities: rifampin / aprepitant
ddi: null
>>> match: administer_obl_parataxis
-------------
sentence: Coadministration of Aprepitant with drugs that induce CYP3A4 activity may result in reduced plasma concentrations and decreased efficacy of Aprepitant.
entities: Aprepitant / Aprepitant
ddi: null
>>> match: result_nsubj_conj
-------------
sentence: Paroxetine: Coadministration of once daily doses of aprepitant, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with paroxetine 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both aprepitant and paroxetine.
entities: aprepitant / aprepitant
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Paroxetine: Coadministration of once daily doses of aprepitant, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with paroxetine 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both aprepitant and paroxetine.
entities: aprepitant / paroxetine
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Paroxetine: Coadministration of once daily doses of aprepitant, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with paroxetine 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both aprepitant and paroxetine.
entities: paroxetine / aprepitant
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Paroxetine: Coadministration of once daily doses of aprepitant, as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation, with paroxetine 20 mg once daily, resulted in a decrease in AUC by approximately 25% and Cmax, by approximately 20% of both aprepitant and paroxetine.
entities: paroxetine / paroxetine
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Vasopressors, particularly metaraminol, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all. 
entities: Vasopressors / halothane
ddi: effect
>>> match: cause_nsubj_obl
-------------
sentence: Vasopressors, particularly metaraminol, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all. 
entities: metaraminol / halothane
ddi: effect
>>> match: cause_nsubj_obl
-------------
sentence: MAO Inhibitors: The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors (MAOI). 
entities: sympathomimetic pressor amines / monoamine oxidase inhibitors
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: MAO Inhibitors: The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors (MAOI). 
entities: sympathomimetic pressor amines / MAOI
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The pressor response of adrenergic agents may also be potentiated by tricyclic antidepressants.
entities: adrenergic agents / tricyclic antidepressants
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Tissue culture and animal studies indicate that ELSPAR can diminish or abolish the effect of methotrexate on malignant cells.14 This effect on methotrexate activity persists as long as plasma asparagine levels are suppressed.
entities: ELSPAR / methotrexate
ddi: effect
>>> match: diminish_nsubj_obj
-------------
sentence: Tissue culture and animal studies indicate that ELSPAR can diminish or abolish the effect of methotrexate on malignant cells.14 This effect on methotrexate activity persists as long as plasma asparagine levels are suppressed.
entities: ELSPAR / methotrexate
ddi: null
>>> match: indicate_ccomp_parataxis
-------------
sentence: Tissue culture and animal studies indicate that ELSPAR can diminish or abolish the effect of methotrexate on malignant cells.14 This effect on methotrexate activity persists as long as plasma asparagine levels are suppressed.
entities: methotrexate / methotrexate
ddi: null
>>> match: indicate_ccomp_parataxis
-------------
sentence: In order to provide information for the appropriate package insert labeling of progestin-only oral contraceptives (POC) in the US, a comprehensive review was made of norgestrel (0.075 mg) and norethindrone (0.35 mg), with the clinical differences indicated where applicable.  
entities: progestin-only oral contraceptives / norgestrel
ddi: null
>>> match: make_advcl_obl
-------------
sentence: In order to provide information for the appropriate package insert labeling of progestin-only oral contraceptives (POC) in the US, a comprehensive review was made of norgestrel (0.075 mg) and norethindrone (0.35 mg), with the clinical differences indicated where applicable.  
entities: progestin-only oral contraceptives / norethindrone
ddi: null
>>> match: make_advcl_obl
-------------
sentence: In order to provide information for the appropriate package insert labeling of progestin-only oral contraceptives (POC) in the US, a comprehensive review was made of norgestrel (0.075 mg) and norethindrone (0.35 mg), with the clinical differences indicated where applicable.  
entities: POC / norgestrel
ddi: null
>>> match: make_advcl_obl
-------------
sentence: In order to provide information for the appropriate package insert labeling of progestin-only oral contraceptives (POC) in the US, a comprehensive review was made of norgestrel (0.075 mg) and norethindrone (0.35 mg), with the clinical differences indicated where applicable.  
entities: POC / norethindrone
ddi: null
>>> match: make_advcl_obl
-------------
sentence: When lansoprazole was administered concomitantly with theophylline (CYP1A2, CYP3A), a minor increase (10%) in the clearance of theophylline was seen.
entities: lansoprazole / theophylline
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: When lansoprazole was administered concomitantly with theophylline (CYP1A2, CYP3A), a minor increase (10%) in the clearance of theophylline was seen.
entities: lansoprazole / theophylline
ddi: null
>>> match: see_advcl_nsubj:pass
-------------
sentence: When lansoprazole was administered concomitantly with theophylline (CYP1A2, CYP3A), a minor increase (10%) in the clearance of theophylline was seen.
entities: theophylline / theophylline
ddi: null
>>> match: see_advcl_nsubj:pass
-------------
sentence: Nonetheless, individual patients may require additional titration of their theophylline dosage when lansoprazole is started or stopped to ensure clinically effective blood levels.
entities: theophylline / lansoprazole
ddi: advise
>>> match: require_obj_advcl
-------------
sentence: Lansoprazole has also been shown to have no clinically significant interaction with amoxicillin.
entities: Lansoprazole / amoxicillin
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: In a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram, absorption of the proton pump inhibitors was delayed and their bioavailability was reduced by 17% and 16%, respectively, when administered concomitantly with sucralfate.
entities: sucralfate / proton pump inhibitors
ddi: null
>>> match: delay_obl_nsubj:pass
-------------
sentence: Therefore, proton pump inhibitors should be taken at least 30 minutes prior to sucralfate.
entities: proton pump inhibitors / sucralfate
ddi: advise
>>> match: take_nsubj:pass_advcl
-------------
sentence: In clinical trials, antacids were administered concomitantly with lansoprazole delayed-release capsules;
entities: antacids / lansoprazole
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: therefore, it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g. ketoconazole, ampicillin esters, iron salts, digoxin).
entities: lansoprazole / ketoconazole
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: therefore, it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g. ketoconazole, ampicillin esters, iron salts, digoxin).
entities: lansoprazole / ampicillin
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: therefore, it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g. ketoconazole, ampicillin esters, iron salts, digoxin).
entities: lansoprazole / iron
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: therefore, it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g. ketoconazole, ampicillin esters, iron salts, digoxin).
entities: lansoprazole / digoxin
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: The effects of ERGOMAR may be potentiated by triacetyloleandomycin which inhibits the metabolism of ergotamine.
entities: ERGOMAR / triacetyloleandomycin
ddi: mechanism
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The effects of ERGOMAR may be potentiated by triacetyloleandomycin which inhibits the metabolism of ergotamine.
entities: ERGOMAR / ergotamine
ddi: null
>>> match: potentiate_nsubj:pass_ccomp
-------------
sentence: The effects of ERGOMAR may be potentiated by triacetyloleandomycin which inhibits the metabolism of ergotamine.
entities: triacetyloleandomycin / ergotamine
ddi: mechanism
>>> match: potentiate_obl_ccomp
-------------
sentence: Preliminary evidence suggests that cimetidine inhibits mebendazole metabolism and may result in an increase in plasma concentrations of mebendazole.
entities: cimetidine / mebendazole
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Preliminary evidence suggests that cimetidine inhibits mebendazole metabolism and may result in an increase in plasma concentrations of mebendazole.
entities: cimetidine / mebendazole
ddi: null
>>> match: inhibit_nsubj_conj
-------------
sentence: Preliminary evidence suggests that cimetidine inhibits mebendazole metabolism and may result in an increase in plasma concentrations of mebendazole.
entities: mebendazole / mebendazole
ddi: null
>>> match: inhibit_obj_conj
-------------
sentence: The potential for increased sedation when guanfacine is given with other CNS-depressant drug should be appreciated.
entities: guanfacine / CNS-depressant drug
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: TCAs decrease the hypotensive effect of guanfacine.
entities: TCAs / guanfacine
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Noncardioselective beta-blockers (nadolol,porpranolol,timolol) may exacerbate rebound hypertension when guanfacine is withdrawn.
entities: Noncardioselective beta-blockers / guanfacine
ddi: effect
>>> match: exacerbate_nsubj_advcl
-------------
sentence: Noncardioselective beta-blockers (nadolol,porpranolol,timolol) may exacerbate rebound hypertension when guanfacine is withdrawn.
entities: nadolol / guanfacine
ddi: effect
>>> match: exacerbate_nsubj_advcl
-------------
sentence: Noncardioselective beta-blockers (nadolol,porpranolol,timolol) may exacerbate rebound hypertension when guanfacine is withdrawn.
entities: timolol / guanfacine
ddi: effect
>>> match: exacerbate_nsubj_advcl
-------------
sentence: Anticoagulants: Ten patients who were stabilized on oral anticoagulants were given guanfacine, 1-2 mg/day, for 4 weeks.
entities: anticoagulants / guanfacine
ddi: null
>>> match: give_nsubj:pass_obj
-------------
sentence: In several well-controlled studies, guanfacine was administered together with diuretics with no drug interactions reported.
entities: guanfacine / diuretics
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: This study demonstrated that the potent cytochrome P450 enzyme-inducer phenytoin did indeed have a marked effect on the metabolism of quetiapine, resulting in a 5-fold increase in clearance when administered concomitantly to patients with DSM-IV-diagnosed schizophrenia, schizoaffective disorder, or bipolar disorder. 
entities: phenytoin / quetiapine
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, hyaluronan lyase, heparinase III, or chondroitin ABC lyase. 
entities: AAV2 / collagenase
ddi: null
>>> match: deliver_nsubj:pass_obl
-------------
sentence: AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, hyaluronan lyase, heparinase III, or chondroitin ABC lyase. 
entities: AAV2 / hyaluronan lyase
ddi: null
>>> match: deliver_nsubj:pass_obl
-------------
sentence: AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, hyaluronan lyase, heparinase III, or chondroitin ABC lyase. 
entities: AAV2 / heparinase III
ddi: null
>>> match: deliver_nsubj:pass_obl
-------------
sentence: AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, hyaluronan lyase, heparinase III, or chondroitin ABC lyase. 
entities: AAV2 / chondroitin ABC lyase
ddi: null
>>> match: deliver_nsubj:pass_obl
-------------
sentence: Hyaluronan lyase had a limited effect and collagenase was ineffective. 
entities: Hyaluronan lyase / collagenase
ddi: null
>>> match: have_nsubj_conj
-------------
sentence: AAV2-mediated retinal transduction is improved by co-injection of heparinase III or chondroitin ABC lyase. 
entities: AAV2 / heparinase III
ddi: effect
>>> match: improve_nsubj:pass_obl
-------------
sentence: AAV2-mediated retinal transduction is improved by co-injection of heparinase III or chondroitin ABC lyase. 
entities: AAV2 / chondroitin ABC lyase
ddi: effect
>>> match: improve_nsubj:pass_obl
-------------
sentence: Streptozocin has been reported to prolong the elimination half-life of doxorubicin and may lead to severe bone marrow suppression; 
entities: Streptozocin / doxorubicin
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: a reduction of the doxorubicin dosage should be considered in patients receiving ZANOSAR concurrently. 
entities: doxorubicin / ZANOSAR
ddi: advise
>>> match: consider_nsubj:pass_obl
-------------
sentence: The concurrent use of streptozocin and phenytoin has been reported in one case to result in reduced streptozocin cytotoxicity.    
entities: streptozocin / streptozocin
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: The concurrent use of streptozocin and phenytoin has been reported in one case to result in reduced streptozocin cytotoxicity.    
entities: phenytoin / streptozocin
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: In the present study, we tested whether the highly specific metabotropic glutamate receptor 5 antagonist, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, reduces dopaminergic and noradrenergic neuronal loss in monkeys rendered parkinsonian by chronic treatment with low doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. 
entities: 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine / 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
ddi: null
>>> match: reduce_nsubj_obl
-------------
sentence: After 21 weeks of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment, all 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated monkeys were significantly affected. 
entities: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine / 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
ddi: null
>>> match: display_obl_advcl
-------------
sentence: After 21 weeks of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment, all 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated monkeys were significantly affected. 
entities: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine / 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine
ddi: null
>>> match: display_obl_advcl
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: atropine / atropine
ddi: null
>>> match: occur_advcl_advmod
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: atropine / pralidoxime
ddi: null
>>> match: occur_advcl_advmod
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: atropine / atropine
ddi: null
>>> match: occur_advcl_advmod
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: pralidoxime / atropine
ddi: null
>>> match: occur_advcl_advmod
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: pralidoxime / pralidoxime
ddi: null
>>> match: occur_advcl_advmod
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: pralidoxime / atropine
ddi: null
>>> match: occur_advcl_advmod
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: atropine / pralidoxime
ddi: null
>>> match: use_nsubj:pass_advcl
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: atropine / atropine
ddi: null
>>> match: use_nsubj:pass_advcl
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: pralidoxime / atropine
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Since barbiturates are potentiated by the anticholinesterases, they should be used cautiously in the treatment of convulsions.
entities: barbiturates / anticholinesterases
ddi: advise
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.
entities: Warfarin / ketorolac tromethamine
ddi: null
>>> match: reduce_nsubj:pass_obl
-------------
sentence: Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.
entities: Warfarin / ketorolac
ddi: null
>>> match: reduce_nsubj:pass_advcl
-------------
sentence: Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.
entities: Digoxin / ketorolac tromethamine
ddi: null
>>> match: reduce_nsubj:pass_obl
-------------
sentence: Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.
entities: Digoxin / ketorolac
ddi: null
>>> match: reduce_nsubj:pass_advcl
-------------
sentence: Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.
entities: Salicylate / ketorolac tromethamine
ddi: null
>>> match: reduce_nsubj:pass_obl
-------------
sentence: Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.
entities: Salicylate / ketorolac
ddi: null
>>> match: reduce_nsubj:pass_advcl
-------------
sentence: Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.
entities: Heparin / ketorolac tromethamine
ddi: null
>>> match: reduce_nsubj:pass_obl
-------------
sentence: Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.
entities: Heparin / ketorolac
ddi: null
>>> match: reduce_nsubj:pass_advcl
-------------
sentence: Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.
entities: warfarin / ketorolac tromethamine
ddi: mechanism
>>> match: reduce_nsubj:pass_obl
-------------
sentence: Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.
entities: warfarin / ketorolac
ddi: null
>>> match: reduce_nsubj:pass_advcl
-------------
sentence: Warfarin, Digoxin, Salicylate, and Heparin The in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine (99.5% control vs 99.3%) when ketorolac plasma concentrations reach 5 to10 m g/mL.
entities: ketorolac tromethamine / ketorolac
ddi: null
>>> match: reduce_obl_advcl
-------------
sentence: In vitro studies indicate that, at therapeutic concentrations of salicylate (300 m g/mL), the binding of ketorolac was reduced from approximately 99.2% to 97.5%, representing a potential twofold increase in unbound ketorolac plasma levels.
entities: salicylate / ketorolac
ddi: mechanism
>>> match: reduce_obl_nsubj:pass
-------------
sentence: In vitro studies indicate that, at therapeutic concentrations of salicylate (300 m g/mL), the binding of ketorolac was reduced from approximately 99.2% to 97.5%, representing a potential twofold increase in unbound ketorolac plasma levels.
entities: salicylate / ketorolac
ddi: null
>>> match: reduce_obl_obj
-------------
sentence: In vitro studies indicate that, at therapeutic concentrations of salicylate (300 m g/mL), the binding of ketorolac was reduced from approximately 99.2% to 97.5%, representing a potential twofold increase in unbound ketorolac plasma levels.
entities: ketorolac / ketorolac
ddi: null
>>> match: reduce_nsubj:pass_obj
-------------
sentence: In a study involving 12 adult volunteers, TORADOLORAL was coadministered with a single dose of 25 mg warfarin, causing no significant changes in pharmacokinetics or pharmacodynamics of warfarin.
entities: warfarin / warfarin
ddi: null
>>> match: coadminister_obl_dep
-------------
sentence: In another study, TORADOLIV/IM was given with two doses of 5000 U of heparin to 11 healthy volunteers, resulting in a mean template bleeding time of 6.4 minutes (3.2 to 11.4 min) compared to a mean of 6.0 minutes (3.4 to 7.5 min) for heparin alone and 5.1 minutes (3.5 to 8.5 min) for placebo.
entities: heparin / heparin
ddi: null
>>> match: give_obl_parataxis
-------------
sentence: Although these results do not indicate a significant interaction between TORADOL and warfarin or heparin, the administration of TORADOL to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.
entities: TORADOL / TORADOL
ddi: null
>>> match: do_advcl_nsubj:pass
-------------
sentence: Although these results do not indicate a significant interaction between TORADOL and warfarin or heparin, the administration of TORADOL to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.
entities: TORADOL / anticoagulants
ddi: null
>>> match: do_advcl_nsubj:pass
-------------
sentence: Although these results do not indicate a significant interaction between TORADOL and warfarin or heparin, the administration of TORADOL to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.
entities: warfarin / TORADOL
ddi: null
>>> match: do_advcl_nsubj:pass
-------------
sentence: Although these results do not indicate a significant interaction between TORADOL and warfarin or heparin, the administration of TORADOL to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.
entities: warfarin / anticoagulants
ddi: null
>>> match: do_advcl_nsubj:pass
-------------
sentence: Although these results do not indicate a significant interaction between TORADOL and warfarin or heparin, the administration of TORADOL to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.
entities: heparin / TORADOL
ddi: null
>>> match: do_advcl_nsubj:pass
-------------
sentence: Although these results do not indicate a significant interaction between TORADOL and warfarin or heparin, the administration of TORADOL to patients taking anticoagulants should be done extremely cautiously, and patients should be closely monitored.
entities: heparin / anticoagulants
ddi: null
>>> match: do_advcl_nsubj:pass
-------------
sentence: Furosemide: TORADOL IV/IM reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20% (mean sodium and urinary output decreased 17%).
entities: TORADOL / diuretic
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: Furosemide: TORADOL IV/IM reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20% (mean sodium and urinary output decreased 17%).
entities: TORADOL / furosemide
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Probenecid: Concomitant administration of TORADOL ORAL and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.
entities: TORADOL / ketorolac
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Probenecid: Concomitant administration of TORADOL ORAL and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.
entities: TORADOL / ketorolac
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Probenecid: Concomitant administration of TORADOL ORAL and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.
entities: probenecid / ketorolac
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Probenecid: Concomitant administration of TORADOL ORAL and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels (total AUC increased approximately threefold from 5.4 to 17.8 m g/h/mL) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours.
entities: probenecid / ketorolac
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The effect of TORADOL on plasma lithium has not been studied, but cases of increased lithium plasma levels during TORADOL therapy have been reported.
entities: TORADOL / lithium
ddi: null
>>> match: study_nsubj:pass_conj
-------------
sentence: The effect of TORADOL on plasma lithium has not been studied, but cases of increased lithium plasma levels during TORADOL therapy have been reported.
entities: TORADOL / TORADOL
ddi: null
>>> match: study_nsubj:pass_conj
-------------
sentence: The effect of TORADOL on plasma lithium has not been studied, but cases of increased lithium plasma levels during TORADOL therapy have been reported.
entities: lithium / lithium
ddi: null
>>> match: study_nsubj:pass_conj
-------------
sentence: The effect of TORADOL on plasma lithium has not been studied, but cases of increased lithium plasma levels during TORADOL therapy have been reported.
entities: lithium / TORADOL
ddi: null
>>> match: study_nsubj:pass_conj
-------------
sentence: Methotrexate: Concomitant administration of methotrexate and some NSAIDs has been reported to reduce the clearance of methotrexate, enhancing the toxicity of methotrexate.
entities: methotrexate / methotrexate
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Methotrexate: Concomitant administration of methotrexate and some NSAIDs has been reported to reduce the clearance of methotrexate, enhancing the toxicity of methotrexate.
entities: methotrexate / methotrexate
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Methotrexate: Concomitant administration of methotrexate and some NSAIDs has been reported to reduce the clearance of methotrexate, enhancing the toxicity of methotrexate.
entities: NSAIDs / methotrexate
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Methotrexate: Concomitant administration of methotrexate and some NSAIDs has been reported to reduce the clearance of methotrexate, enhancing the toxicity of methotrexate.
entities: NSAIDs / methotrexate
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Methotrexate: Concomitant administration of methotrexate and some NSAIDs has been reported to reduce the clearance of methotrexate, enhancing the toxicity of methotrexate.
entities: methotrexate / methotrexate
ddi: null
>>> match: reduce_obj_dep
-------------
sentence: Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (fluoxetine, thiothixene, alprazolam).
entities: TORADOL / psychoactive drugs
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (fluoxetine, thiothixene, alprazolam).
entities: TORADOL / fluoxetine
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (fluoxetine, thiothixene, alprazolam).
entities: TORADOL / thiothixene
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (fluoxetine, thiothixene, alprazolam).
entities: TORADOL / alprazolam
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: Theophylline: In three pharmacokinetic studies including 46 normal, healthy subjects, theophylline clearance and concentration were not significantly altered by the addition of lomefloxacin.
entities: theophylline / lomefloxacin
ddi: null
>>> match: alter_obl_obl
-------------
sentence: In clinical studies where patients were on chronic theophylline therapy, lomefloxacin had no measurable effect on the mean distribution of theophylline concentrations or the mean estimates of theophylline clearance.
entities: lomefloxacin / theophylline
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: In clinical studies where patients were on chronic theophylline therapy, lomefloxacin had no measurable effect on the mean distribution of theophylline concentrations or the mean estimates of theophylline clearance.
entities: lomefloxacin / theophylline
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Antacids and sucralfate: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.
entities: Sucralfate / lomefloxacin
ddi: mechanism
>>> match: form_nsubj_obl
-------------
sentence: Antacids and sucralfate: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.
entities: antacids / lomefloxacin
ddi: null
>>> match: form_nsubj_obl
-------------
sentence: Antacids and sucralfate: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.
entities: magnesium / lomefloxacin
ddi: mechanism
>>> match: form_nsubj_obl
-------------
sentence: Antacids and sucralfate: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.
entities: aluminum / lomefloxacin
ddi: mechanism
>>> match: form_nsubj_obl
-------------
sentence: Antacids and sucralfate: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.
entities: Videx / lomefloxacin
ddi: mechanism
>>> match: form_nsubj_obl
-------------
sentence: Antacids and sucralfate: Sucralfate and antacids containing magnesium or aluminum, as well as formulations containing divalent and trivalent cations such as Videx  (didanosine), chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability.
entities: didanosine / lomefloxacin
ddi: mechanism
>>> match: form_nsubj_obl
-------------
sentence: Sucralfate administered 2 hours before lomefloxacin resulted in a slower absorption (mean C max decreased by 30% and mean T max increased by 1 hour) and a lesser extent of absorption (mean AUC decreased by approximately 25%).
entities: Sucralfate / lomefloxacin
ddi: mechanism
>>> match: administer_nsubj_advcl
-------------
sentence: Magnesium- and aluminum-containing antacids, administered concomitantly with lomefloxacin, significantly decreased the bioavailability (48%) of lomefloxacin.
entities: Magnesium / lomefloxacin
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Magnesium- and aluminum-containing antacids, administered concomitantly with lomefloxacin, significantly decreased the bioavailability (48%) of lomefloxacin.
entities: aluminum / lomefloxacin
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Magnesium- and aluminum-containing antacids, administered concomitantly with lomefloxacin, significantly decreased the bioavailability (48%) of lomefloxacin.
entities: antacids / lomefloxacin
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Magnesium- and aluminum-containing antacids, administered concomitantly with lomefloxacin, significantly decreased the bioavailability (48%) of lomefloxacin.
entities: lomefloxacin / lomefloxacin
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: therefore, administration of these agents should precede lomefloxacin dosing by 4 hours or follow lomefloxacin dosing by at least 2 hours.
entities: lomefloxacin / lomefloxacin
ddi: null
>>> match: precede_obj_conj
-------------
sentence: Caffeine: Two hundred mg of caffeine (equivalent to 1 to 3 cups of American coffee) was administered to 16 normal, healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd.
entities: caffeine / lomefloxacin
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Other quinolones have demonstrated moderate to marked interference with the metabolism of caffeine, resulting in a reduced clearance, a prolongation of plasma half-life, and an increase in symptoms that accompany high levels of caffeine.
entities: quinolones / caffeine
ddi: mechanism
>>> match: demonstrate_nsubj_xcomp
-------------
sentence: Other quinolones have demonstrated moderate to marked interference with the metabolism of caffeine, resulting in a reduced clearance, a prolongation of plasma half-life, and an increase in symptoms that accompany high levels of caffeine.
entities: quinolones / caffeine
ddi: null
>>> match: demonstrate_nsubj_dep
-------------
sentence: Other quinolones have demonstrated moderate to marked interference with the metabolism of caffeine, resulting in a reduced clearance, a prolongation of plasma half-life, and an increase in symptoms that accompany high levels of caffeine.
entities: caffeine / caffeine
ddi: null
>>> match: demonstrate_xcomp_dep
-------------
sentence: Cimetidine: Cimetidine has been demonstrated to interfere with the elimination of other quinolones.
entities: Cimetidine / quinolones
ddi: mechanism
>>> match: demonstrate_nsubj:pass_xcomp
-------------
sentence: Cyclosporine: Elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the quinolone class.
entities: cyclosporine / cyclosporine
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Cyclosporine: Elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the quinolone class.
entities: cyclosporine / quinolone class
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Omeprazole: No clinically significant changes in lomefloxacin pharmacokinetics (AUC, C max , or T max ) were observed when a single dose of lomefloxacin 400 mg was given after multiple doses of omeprazole (20 mg qd) in 13 healthy volunteers.
entities: Omeprazole / lomefloxacin
ddi: null
>>> match: observe_nsubj:pass_advcl
-------------
sentence: Omeprazole: No clinically significant changes in lomefloxacin pharmacokinetics (AUC, C max , or T max ) were observed when a single dose of lomefloxacin 400 mg was given after multiple doses of omeprazole (20 mg qd) in 13 healthy volunteers.
entities: Omeprazole / omeprazole
ddi: null
>>> match: observe_nsubj:pass_advcl
-------------
sentence: Omeprazole: No clinically significant changes in lomefloxacin pharmacokinetics (AUC, C max , or T max ) were observed when a single dose of lomefloxacin 400 mg was given after multiple doses of omeprazole (20 mg qd) in 13 healthy volunteers.
entities: lomefloxacin / lomefloxacin
ddi: null
>>> match: observe_nsubj:pass_advcl
-------------
sentence: Omeprazole: No clinically significant changes in lomefloxacin pharmacokinetics (AUC, C max , or T max ) were observed when a single dose of lomefloxacin 400 mg was given after multiple doses of omeprazole (20 mg qd) in 13 healthy volunteers.
entities: lomefloxacin / omeprazole
ddi: null
>>> match: observe_nsubj:pass_advcl
-------------
sentence: Omeprazole: No clinically significant changes in lomefloxacin pharmacokinetics (AUC, C max , or T max ) were observed when a single dose of lomefloxacin 400 mg was given after multiple doses of omeprazole (20 mg qd) in 13 healthy volunteers.
entities: lomefloxacin / omeprazole
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: Phenytoin: No significant differences were observed in mean phenytoin AUC, C max , C min or T max (although C max increased by 11%) when extended phenytoin sodium capsules (100 mg tid) were coadministered with lomefloxacin (400 mg qd) for five days in 15 healthy males.
entities: phenytoin / lomefloxacin
ddi: null
>>> match: observe_obl_punct
-------------
sentence: Warfarin: Quinolones may enhance the effects of the oral anticoagulant, warfarin, or its derivatives.
entities: Quinolones / anticoagulant
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Warfarin: Quinolones may enhance the effects of the oral anticoagulant, warfarin, or its derivatives.
entities: Quinolones / warfarin
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: However, no clinically or statistically significant differences in prothrombin time ratio or warfarin enantiomer pharmacokinetics were observed in a small study of 7 healthy males who received both warfarin and lomefloxacin under steady-state conditions.
entities: warfarin / warfarin
ddi: null
>>> match: observe_nsubj:pass_obl
-------------
sentence: However, no clinically or statistically significant differences in prothrombin time ratio or warfarin enantiomer pharmacokinetics were observed in a small study of 7 healthy males who received both warfarin and lomefloxacin under steady-state conditions.
entities: warfarin / lomefloxacin
ddi: null
>>> match: observe_nsubj:pass_obl
-------------
sentence: In the present study, the atypical antipsychotic clozapine was tested in combination with an active dose of PCP in two-lever drug discrimination and mixed signalled-unsignalled differential-reinforcement-of-low-rates (DRL) procedures. 
entities: clozapine / PCP
ddi: null
>>> match: test_nsubj:pass_obl
-------------
sentence: PCP produced distinctive effects in each task: it substituted for the training dose in PCP discrimination and it increased the number of responses with short (<3 s) interresponse times as well as increasing overall response rates in the DRL schedule. 
entities: PCP / PCP
ddi: null
>>> match: produce_nsubj_parataxis
-------------
sentence: Acute dosing with clozapine failed to alter the behavioral effects of PCP in either procedure even when tested up to doses that produced pharmacological effects alone. 
entities: clozapine / PCP
ddi: null
>>> match: fail_nsubj_xcomp
-------------
sentence: Since chronic dosing is required for therapeutic efficacy of antipsychotics, future studies should focus on investigation of chronic dosing effects of these drugs in combination with PCP.
entities: antipsychotics / PCP
ddi: null
>>> match: focus_advcl_obl
-------------
sentence: Isocarboxazid should be administered with caution to patients receiving Antabuse (disulfiram, Wyeth-Ayerst Laboratories).
entities: Isocarboxazid / Antabuse
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Isocarboxazid should be administered with caution to patients receiving Antabuse (disulfiram, Wyeth-Ayerst Laboratories).
entities: Isocarboxazid / disulfiram
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: In a single study, rats given high intraperitoneal doses of an MAO inhibitor plus disulfiram experienced severe toxicity, including convulsions and death.
entities: MAO inhibitor / disulfiram
ddi: effect
>>> match: give_obj_conj
-------------
sentence: The monoamine oxidase inhibitory effects of Isocarboxazid may persist for a substantial period after discontinuation of the drug, and this should be borne in mind when another drug is prescribed following Isocarboxazid.
entities: Isocarboxazid / Isocarboxazid
ddi: null
>>> match: persist_nsubj_conj
-------------
sentence: The successive application of glycine (5 or 10 mg/kg egg weight (e.w.) and glutamate (15 mg/kg e.w.) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of glutamate alone. 
entities: glycine / glutamate
ddi: effect
>>> match: increase_obl_nsubj
-------------
sentence: The successive application of glycine (5 or 10 mg/kg egg weight (e.w.) and glutamate (15 mg/kg e.w.) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of glutamate alone. 
entities: glycine / glutamate
ddi: null
>>> match: increase_obl_obl
-------------
sentence: The successive application of glycine (5 or 10 mg/kg egg weight (e.w.) and glutamate (15 mg/kg e.w.) in a 10 min interval significantly increased the activation of spontaneous motility of 17-day-old chick embryos in comparison with the effect of glutamate alone. 
entities: glutamate / glutamate
ddi: null
>>> match: increase_nsubj_obl
-------------
sentence: Probenecid competes with meropenem for active tubular secretion and thus inhibits the renal excretion of meropenem. 
entities: Probenecid / meropenem
ddi: mechanism
>>> match: compete_nsubj_obl
-------------
sentence: Probenecid competes with meropenem for active tubular secretion and thus inhibits the renal excretion of meropenem. 
entities: Probenecid / meropenem
ddi: null
>>> match: compete_nsubj_conj
-------------
sentence: Probenecid competes with meropenem for active tubular secretion and thus inhibits the renal excretion of meropenem. 
entities: meropenem / meropenem
ddi: null
>>> match: compete_obl_conj
-------------
sentence: There is evidence that meropenem may reduce serum levels of valproic acid to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total valproate).
entities: meropenem / valproic acid
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: There is evidence that meropenem may reduce serum levels of valproic acid to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total valproate).
entities: meropenem / valproate
ddi: null
>>> match: reduce_nsubj_obl
-------------
sentence: There is evidence that meropenem may reduce serum levels of valproic acid to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total valproate).
entities: valproic acid / valproate
ddi: null
>>> match: reduce_obj_obl
-------------
sentence: Concomitant administration of an aluminum-containing antacid had no significant effect in the bioavailability of 6MNA.
entities: aluminum / 6MNA
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Concomitant administration of an aluminum-containing antacid had no significant effect in the bioavailability of 6MNA.
entities: antacid / 6MNA
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: In patients receiving another serotonin reuptake inhibitor drug in combination with monoamine oxidase inhibitors (MAOI), there have been reports of serious, sometimes fatal, reactions including hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, and mental status changes that include extreme agitation progressing to delirium and coma.
entities: serotonin reuptake inhibitor drug / monoamine oxidase inhibitors
ddi: effect
>>> match: receive_obj_obl
-------------
sentence: In patients receiving another serotonin reuptake inhibitor drug in combination with monoamine oxidase inhibitors (MAOI), there have been reports of serious, sometimes fatal, reactions including hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, and mental status changes that include extreme agitation progressing to delirium and coma.
entities: serotonin reuptake inhibitor drug / MAOI
ddi: effect
>>> match: receive_obj_obl
-------------
sentence: Therefore, it is recommended that Fluvoxamine Tablets not be used in combination with MAOIs, or within 14 days of discontinuing treatment with a MAOI.
entities: Fluvoxamine / MAOIs
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Therefore, it is recommended that Fluvoxamine Tablets not be used in combination with MAOIs, or within 14 days of discontinuing treatment with a MAOI.
entities: Fluvoxamine / MAOI
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: After stopping Fluvoxamine Tablets, at least 2 weeks should be allowed before starting a MAOI.
entities: Fluvoxamine / MAOI
ddi: advise
>>> match: allow_obl_advcl
-------------
sentence: Terfenadine, astemizole and cisapride are all metabolized by the cytochrome P450IIIA4 isozyme, and it has been demonstrated that ketoconazole, a potent inhibitor of IIIA4, blocks the metabolism of these drugs, resulting in increased plasma concentrations of parent drug.
entities: Terfenadine / ketoconazole
ddi: mechanism
>>> match: metabolize_nsubj:pass_conj
-------------
sentence: Terfenadine, astemizole and cisapride are all metabolized by the cytochrome P450IIIA4 isozyme, and it has been demonstrated that ketoconazole, a potent inhibitor of IIIA4, blocks the metabolism of these drugs, resulting in increased plasma concentrations of parent drug.
entities: astemizole / ketoconazole
ddi: mechanism
>>> match: metabolize_nsubj:pass_conj
-------------
sentence: Terfenadine, astemizole and cisapride are all metabolized by the cytochrome P450IIIA4 isozyme, and it has been demonstrated that ketoconazole, a potent inhibitor of IIIA4, blocks the metabolism of these drugs, resulting in increased plasma concentrations of parent drug.
entities: cisapride / ketoconazole
ddi: mechanism
>>> match: metabolize_nsubj:pass_conj
-------------
sentence: Consequently, it is recommended that fluvoxamine not be used in combination with either terbinafine, astemizole, or cisapride.
entities: fluvoxamine / terbinafine
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Consequently, it is recommended that fluvoxamine not be used in combination with either terbinafine, astemizole, or cisapride.
entities: fluvoxamine / astemizole
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Consequently, it is recommended that fluvoxamine not be used in combination with either terbinafine, astemizole, or cisapride.
entities: fluvoxamine / cisapride
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Other Potentially Important Drug Interactions: Benzodiazepines: Benzodiazepines metabolized by hepatic oxidation (e.g., alprazolam, midazolam, triazolam elc.) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine.
entities: Benzodiazepines / fluvoxamine
ddi: null
>>> match: use_nsubj:pass_advcl
-------------
sentence: Other Potentially Important Drug Interactions: Benzodiazepines: Benzodiazepines metabolized by hepatic oxidation (e.g., alprazolam, midazolam, triazolam elc.) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine.
entities: Benzodiazepines / fluvoxamine
ddi: mechanism
>>> match: use_nsubj:pass_advcl
-------------
sentence: Other Potentially Important Drug Interactions: Benzodiazepines: Benzodiazepines metabolized by hepatic oxidation (e.g., alprazolam, midazolam, triazolam elc.) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine.
entities: alprazolam / fluvoxamine
ddi: mechanism
>>> match: use_nsubj:pass_advcl
-------------
sentence: Other Potentially Important Drug Interactions: Benzodiazepines: Benzodiazepines metabolized by hepatic oxidation (e.g., alprazolam, midazolam, triazolam elc.) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine.
entities: midazolam / fluvoxamine
ddi: mechanism
>>> match: use_nsubj:pass_advcl
-------------
sentence: Other Potentially Important Drug Interactions: Benzodiazepines: Benzodiazepines metabolized by hepatic oxidation (e.g., alprazolam, midazolam, triazolam elc.) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine.
entities: triazolam / fluvoxamine
ddi: mechanism
>>> match: use_nsubj:pass_advcl
-------------
sentence: The clearance of benzodiazepines metabolized by glucuronidation (e. g., lorazepam, oxazepam, temazepam) is unlikely to be affected by fluvoxamine.
entities: benzodiazepines / lorazepam
ddi: null
>>> match: metabolize_nsubj_obl
-------------
sentence: The clearance of benzodiazepines metabolized by glucuronidation (e. g., lorazepam, oxazepam, temazepam) is unlikely to be affected by fluvoxamine.
entities: benzodiazepines / oxazepam
ddi: null
>>> match: metabolize_nsubj_obl
-------------
sentence: The clearance of benzodiazepines metabolized by glucuronidation (e. g., lorazepam, oxazepam, temazepam) is unlikely to be affected by fluvoxamine.
entities: benzodiazepines / temazepam
ddi: null
>>> match: metabolize_nsubj_obl
-------------
sentence: This interaction, which has not been investigated using higher doses of fluvoxamine, may be more pronounced if a 300 mg daily dose is co-administered, particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg. If alprazolam is co-administered with Fluvoxamine Tablets, the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended.
entities: alprazolam / Fluvoxamine
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: This interaction, which has not been investigated using higher doses of fluvoxamine, may be more pronounced if a 300 mg daily dose is co-administered, particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg. If alprazolam is co-administered with Fluvoxamine Tablets, the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended.
entities: alprazolam / alprazolam
ddi: null
>>> match: halve_advcl_nsubj:pass
-------------
sentence: This interaction, which has not been investigated using higher doses of fluvoxamine, may be more pronounced if a 300 mg daily dose is co-administered, particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg. If alprazolam is co-administered with Fluvoxamine Tablets, the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended.
entities: Fluvoxamine / alprazolam
ddi: null
>>> match: halve_advcl_nsubj:pass
-------------
sentence: Because fluvoxamine reduces the clearance of both diazepam and its active metabolite, N-desmethyldiazepam, there is a strong likelihood of substantial accumulation of both species during chronic co-administration.
entities: fluvoxamine / diazepam
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Because fluvoxamine reduces the clearance of both diazepam and its active metabolite, N-desmethyldiazepam, there is a strong likelihood of substantial accumulation of both species during chronic co-administration.
entities: fluvoxamine / N-desmethyldiazepam
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam.
entities: fluvoxamine / fluvoxamine
ddi: null
>>> match: derive_nsubj:pass_obl
-------------
sentence: Evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam.
entities: fluvoxamine / diazepam
ddi: null
>>> match: derive_nsubj:pass_dep
-------------
sentence: Evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam.
entities: diazepam / fluvoxamine
ddi: null
>>> match: derive_nsubj:pass_obl
-------------
sentence: Evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam.
entities: diazepam / diazepam
ddi: null
>>> match: derive_nsubj:pass_dep
-------------
sentence: Evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam.
entities: fluvoxamine / diazepam
ddi: null
>>> match: derive_obl_dep
-------------
sentence: In these subjects (R= B), the clearance of diazepam was reduced by 65% and that of N-desmethyldiazepam to a level that was too low to measure over the course of the 2 week long study.
entities: diazepam / N-desmethyldiazepam
ddi: null
>>> match: reduce_nsubj:pass_dep
-------------
sentence: Therefore, if theophylline is co-administered with fluvoxamine maleate, its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of theophylline should to monitored.
entities: theophylline / fluvoxamine maleate
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, if theophylline is co-administered with fluvoxamine maleate, its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of theophylline should to monitored.
entities: theophylline / theophylline
ddi: null
>>> match: reduce_advcl_obl
-------------
sentence: Therefore, if theophylline is co-administered with fluvoxamine maleate, its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of theophylline should to monitored.
entities: fluvoxamine maleate / theophylline
ddi: null
>>> match: reduce_advcl_obl
-------------
sentence: Warfarin: When fluvoxamine maleate (50 mg tid) was administered concomitantly with warfarin for two weeks, warfarin plasma concentrations increased by 98% and prothrombin times were prolonged.
entities: fluvoxamine maleate / warfarin
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: Warfarin: When fluvoxamine maleate (50 mg tid) was administered concomitantly with warfarin for two weeks, warfarin plasma concentrations increased by 98% and prothrombin times were prolonged.
entities: fluvoxamine maleate / warfarin
ddi: null
>>> match: increase_advcl_nsubj
-------------
sentence: Warfarin: When fluvoxamine maleate (50 mg tid) was administered concomitantly with warfarin for two weeks, warfarin plasma concentrations increased by 98% and prothrombin times were prolonged.
entities: warfarin / warfarin
ddi: null
>>> match: increase_advcl_nsubj
-------------
sentence: Thus patients receiving oral anticoagulants and Fluvoxamine Tablets should have their prothrombin time monitored and their anticoagulant dose adjusted accordingly.
entities: anticoagulants / anticoagulant
ddi: null
>>> match: have_nsubj_ccomp
-------------
sentence: Thus patients receiving oral anticoagulants and Fluvoxamine Tablets should have their prothrombin time monitored and their anticoagulant dose adjusted accordingly.
entities: Fluvoxamine / anticoagulant
ddi: null
>>> match: have_nsubj_ccomp
-------------
sentence: The objective of this study was to determine if there is a pharmacokinetic interaction when amprenavir is given with rifabutin or rifampin and to determine the effects of these drugs on the erythromycin breath test (ERMBT). 
entities: amprenavir / rifabutin
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: The objective of this study was to determine if there is a pharmacokinetic interaction when amprenavir is given with rifabutin or rifampin and to determine the effects of these drugs on the erythromycin breath test (ERMBT). 
entities: amprenavir / rifampin
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: All subjects received amprenavir (1,200 mg twice a day) for 4 days, followed by a 7-day washout period, followed by either rifabutin (300 mg once a day [QD]) (cohort 1) or rifampin (600 mg QD) (cohort 2) for 14 days. 
entities: amprenavir / rifabutin
ddi: null
>>> match: receive_obj_advcl
-------------
sentence: All subjects received amprenavir (1,200 mg twice a day) for 4 days, followed by a 7-day washout period, followed by either rifabutin (300 mg once a day [QD]) (cohort 1) or rifampin (600 mg QD) (cohort 2) for 14 days. 
entities: amprenavir / rifampin
ddi: null
>>> match: receive_obj_advcl
-------------
sentence: Cohort 1 then received amprenavir plus rifabutin for 10 days, and cohort 2 received amprenavir plus rifampin for 4 days. 
entities: amprenavir / amprenavir
ddi: null
>>> match: receive_obj_conj
-------------
sentence: Cohort 1 then received amprenavir plus rifabutin for 10 days, and cohort 2 received amprenavir plus rifampin for 4 days. 
entities: amprenavir / rifampin
ddi: null
>>> match: receive_obj_conj
-------------
sentence: Cohort 1 then received amprenavir plus rifabutin for 10 days, and cohort 2 received amprenavir plus rifampin for 4 days. 
entities: rifabutin / amprenavir
ddi: null
>>> match: receive_obj_conj
-------------
sentence: Cohort 1 then received amprenavir plus rifabutin for 10 days, and cohort 2 received amprenavir plus rifampin for 4 days. 
entities: rifabutin / rifampin
ddi: null
>>> match: receive_obj_conj
-------------
sentence: Rifabutin did not significantly affect amprenavir's pharmacokinetics. 
entities: Rifabutin / amprenavir
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Amprenavir significantly increased the area under the curve at steady state (AUC(ss)) of rifabutin by 2.93-fold and the AUC(ss) of 25-O-desacetylrifabutin by 13.3-fold. 
entities: Amprenavir / rifabutin
ddi: mechanism
>>> match: increase_nsubj_obl
-------------
sentence: Amprenavir significantly increased the area under the curve at steady state (AUC(ss)) of rifabutin by 2.93-fold and the AUC(ss) of 25-O-desacetylrifabutin by 13.3-fold. 
entities: Amprenavir / 25-O-desacetylrifabutin
ddi: mechanism
>>> match: increase_nsubj_dep
-------------
sentence: Amprenavir significantly increased the area under the curve at steady state (AUC(ss)) of rifabutin by 2.93-fold and the AUC(ss) of 25-O-desacetylrifabutin by 13.3-fold. 
entities: rifabutin / 25-O-desacetylrifabutin
ddi: null
>>> match: increase_obl_dep
-------------
sentence: Rifampin significantly decreased the AUC(ss) of amprenavir by 82%, but amprenavir had no effect on rifampin pharmacokinetics. 
entities: Rifampin / amprenavir
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Rifampin significantly decreased the AUC(ss) of amprenavir by 82%, but amprenavir had no effect on rifampin pharmacokinetics. 
entities: Rifampin / amprenavir
ddi: null
>>> match: decrease_nsubj_conj
-------------
sentence: Rifampin significantly decreased the AUC(ss) of amprenavir by 82%, but amprenavir had no effect on rifampin pharmacokinetics. 
entities: Rifampin / rifampin
ddi: null
>>> match: decrease_nsubj_conj
-------------
sentence: Rifampin significantly decreased the AUC(ss) of amprenavir by 82%, but amprenavir had no effect on rifampin pharmacokinetics. 
entities: amprenavir / amprenavir
ddi: null
>>> match: decrease_obj_conj
-------------
sentence: Rifampin significantly decreased the AUC(ss) of amprenavir by 82%, but amprenavir had no effect on rifampin pharmacokinetics. 
entities: amprenavir / rifampin
ddi: null
>>> match: decrease_obj_conj
-------------
sentence: Rifampin significantly decreased the AUC(ss) of amprenavir by 82%, but amprenavir had no effect on rifampin pharmacokinetics. 
entities: amprenavir / rifampin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Rifampin markedly increases the metabolic clearance of amprenavir, and coadministration is contraindicated. 
entities: Rifampin / amprenavir
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Amprenavir significantly decreases clearance of rifabutin and 25-O-desacetylrifabutin, and the combination is poorly tolerated. 
entities: Amprenavir / rifabutin
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Amprenavir significantly decreases clearance of rifabutin and 25-O-desacetylrifabutin, and the combination is poorly tolerated. 
entities: Amprenavir / 25-O-desacetylrifabutin
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Amprenavir inhibits the ERMBT, and rifampin and rifabutin are equipotent inducers of the ERMBT.
entities: Amprenavir / rifampin
ddi: null
>>> match: inhibit_nsubj_conj
-------------
sentence: Amprenavir inhibits the ERMBT, and rifampin and rifabutin are equipotent inducers of the ERMBT.
entities: Amprenavir / rifabutin
ddi: null
>>> match: inhibit_nsubj_conj
-------------
sentence: Hypertensive crises have resulted when sympathomimetic amines have been used concomitantly within14 days following use of monoamine oxidase inhibitors.
entities: sympathomimetic amines / monoamine oxidase inhibitors
ddi: effect
>>> match: use_nsubj:pass_obl:tmod
-------------
sentence: DIDREX should not be used concomitantly with other CNS stimulants.
entities: DIDREX / CNS stimulants
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Amphetamines may decrease the hypotensive effect of antihypertensives.
entities: Amphetamines / antihypertensives
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Amphetamines may enhance the effects of tricyclic antidepressants.
entities: Amphetamines / tricyclic antidepressants
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: DRUG INTERACTIONS  There are no known drug/drug interactions with oral ALKERAN  Vaccinations with live organism vaccines are not recommended in immunocompromised individuals  Nalidixic acid together with high-dose intravenous melphalan has caused deaths in children due to haemorrhagic enterocolitis.  
entities: ALKERAN / Nalidixic acid
ddi: null
>>> match: be_nsubj_dep
-------------
sentence: DRUG INTERACTIONS  There are no known drug/drug interactions with oral ALKERAN  Vaccinations with live organism vaccines are not recommended in immunocompromised individuals  Nalidixic acid together with high-dose intravenous melphalan has caused deaths in children due to haemorrhagic enterocolitis.  
entities: ALKERAN / melphalan
ddi: null
>>> match: be_nsubj_dep
-------------
sentence: DRUG INTERACTIONS  There are no known drug/drug interactions with oral ALKERAN  Vaccinations with live organism vaccines are not recommended in immunocompromised individuals  Nalidixic acid together with high-dose intravenous melphalan has caused deaths in children due to haemorrhagic enterocolitis.  
entities: live organism vaccines / Nalidixic acid
ddi: null
>>> match: be_nsubj_dep
-------------
sentence: DRUG INTERACTIONS  There are no known drug/drug interactions with oral ALKERAN  Vaccinations with live organism vaccines are not recommended in immunocompromised individuals  Nalidixic acid together with high-dose intravenous melphalan has caused deaths in children due to haemorrhagic enterocolitis.  
entities: live organism vaccines / melphalan
ddi: null
>>> match: be_nsubj_dep
-------------
sentence: Impaired renal function has been described in bone marrow transplant patients who were conditioned with high-dose intravenous melphalan and who subsequently received cyclosporin to prevent graft-versus-host disease
entities: melphalan / cyclosporin
ddi: effect
>>> match: condition_obl_conj
-------------
sentence: Gabapentin is not appreciably metabolized nor does it interfere with the metabolism of commonly coadministered antiepileptic drugs.
entities: Gabapentin / antiepileptic drugs
ddi: null
>>> match: metabolize_nsubj:pass_conj
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: Neurontin / phenytoin
ddi: null
>>> match: maintain_nsubj_obl
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: Neurontin / gabapentin
ddi: null
>>> match: maintain_nsubj_parataxis
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: Neurontin / phenytoin
ddi: null
>>> match: maintain_nsubj_parataxis
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: Neurontin / phenytoin
ddi: null
>>> match: maintain_nsubj_parataxis
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: Neurontin / gabapentin
ddi: null
>>> match: maintain_nsubj_parataxis
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: phenytoin / gabapentin
ddi: null
>>> match: maintain_obl_parataxis
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: phenytoin / phenytoin
ddi: null
>>> match: maintain_obl_parataxis
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: phenytoin / phenytoin
ddi: null
>>> match: maintain_obl_parataxis
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: phenytoin / gabapentin
ddi: null
>>> match: maintain_obl_parataxis
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: gabapentin / phenytoin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: gabapentin / phenytoin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: gabapentin / gabapentin
ddi: null
>>> match: have_nsubj_dep
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: phenytoin / gabapentin
ddi: null
>>> match: have_obj_dep
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: phenytoin / gabapentin
ddi: null
>>> match: have_obj_dep
-------------
sentence: N=17) were not different and neither were gabapentin pharmacokinetic parameters affected by valproic acid.
entities: gabapentin / valproic acid
ddi: null
>>> match: affect_nsubj:pass_obl
-------------
sentence: Naproxen: Coadministration (N=18) of naproxen sodium capsules (250 mg) with Neurontin (125 mg) appears to increase the amount of gabapentin absorbed by 12% to 15%.
entities: Neurontin / gabapentin
ddi: null
>>> match: appear_nsubj_xcomp
-------------
sentence: Gabapentin had no effect on naproxen pharmacokinetic parameters.
entities: Gabapentin / naproxen
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Hydrocodone increases gabapentin AUC values by 14%.
entities: Hydrocodone / gabapentin
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Morphine: A literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg Neurontin  capsule (N=12), mean gabapentin AUC increased by 44% compared to gabapentin administered without morphine.
entities: morphine / Neurontin
ddi: mechanism
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Cimetidine: In the presence of cimetidine at 300 mg QID (N=12) the mean apparent oral clearance of gabapentin fell by 14% and creatinine clearance fell by 10%.
entities: cimetidine / gabapentin
ddi: mechanism
>>> match: fall_obl_nsubj
-------------
sentence: Thus cimetidine appeared to alter the renal excretion of both gabapentin and creatinine, an endogenous marker of renal function.
entities: cimetidine / gabapentin
ddi: mechanism
>>> match: appear_nsubj_xcomp
-------------
sentence: Antacid (Maalox ): Maalox reduced the bioavailability of gabapentin (N=16) by about 20%.
entities: Maalox / gabapentin
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: This decrease in bioavailability was about 5% when gabapentin was administered 2 hours after Maalox.
entities: gabapentin / Maalox
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: It is recommended that gabapentin be taken at least 2 hours following Maalox administration.
entities: gabapentin / Maalox
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Drug/Laboratory Tests Interactions Because false positive readings were reported with the Ames N-Multistix SG dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein
entities: gabapentin / antiepileptic drugs
ddi: null
>>> match: add_nsubj:pass_obl
-------------
sentence: Loperamide and morphine (0.1 and 1.0 mg/kg, s.c.) inhibited the dmPGE2 (0.3 mg/kg, p.o.)-induced diarrhea in cecectomized rats. 
entities: Loperamide / dmPGE2
ddi: effect
>>> match: inhibit_nsubj_iobj
-------------
sentence: Loperamide and morphine (0.1 and 1.0 mg/kg, s.c.) inhibited the dmPGE2 (0.3 mg/kg, p.o.)-induced diarrhea in cecectomized rats. 
entities: morphine / dmPGE2
ddi: effect
>>> match: inhibit_nsubj_iobj
-------------
sentence: N-methyllevallorphan (5 mg/kg, s.c.) completely antagonized the inhibitory effect of loperamide and partly antagonized the effect of morphine. 
entities: N-methyllevallorphan / loperamide
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: N-methyllevallorphan (5 mg/kg, s.c.) completely antagonized the inhibitory effect of loperamide and partly antagonized the effect of morphine. 
entities: N-methyllevallorphan / morphine
ddi: effect
>>> match: antagonize_nsubj_conj
-------------
sentence: N-methyllevallorphan (5 mg/kg, s.c.) completely antagonized the inhibitory effect of loperamide and partly antagonized the effect of morphine. 
entities: loperamide / morphine
ddi: null
>>> match: antagonize_obj_conj
-------------
sentence: Taking a rauwolfia alkaloid while you are taking or within 2 weeks of taking MAO inhibitors may increase the risk of central nervous system depression or may cause a severe high blood pressure reaction.
entities: rauwolfia alkaloid / MAO inhibitors
ddi: effect
>>> match: take_obj_advcl
-------------
sentence: Some anticonvulsants may interact with Mephenytoin. 
entities: anticonvulsants / Mephenytoin
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Those anticonvulsants include divalproex sodium, valproic acid, and phenobarbital. 
entities: anticonvulsants / divalproex sodium
ddi: null
>>> match: include_nsubj_obj
-------------
sentence: Those anticonvulsants include divalproex sodium, valproic acid, and phenobarbital. 
entities: anticonvulsants / valproic acid
ddi: null
>>> match: include_nsubj_obj
-------------
sentence: Those anticonvulsants include divalproex sodium, valproic acid, and phenobarbital. 
entities: anticonvulsants / phenobarbital
ddi: null
>>> match: include_nsubj_obj
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: Mephenytoin / steroid medications
ddi: effect
>>> match: affect_nsubj_obj
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: Mephenytoin / warfarin
ddi: effect
>>> match: affect_nsubj_obj
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: Mephenytoin / anti-infective medicines
ddi: effect
>>> match: affect_nsubj_obj
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: Mephenytoin / furosemide
ddi: effect
>>> match: affect_nsubj_obj
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: Mephenytoin / theophylline
ddi: effect
>>> match: affect_nsubj_obj
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: Mephenytoin / Mephenytoin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: steroid medications / Mephenytoin
ddi: null
>>> match: include_obj_dep
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: warfarin / Mephenytoin
ddi: null
>>> match: include_obj_dep
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: anti-infective medicines / Mephenytoin
ddi: null
>>> match: include_obj_dep
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: furosemide / Mephenytoin
ddi: null
>>> match: include_obj_dep
-------------
sentence: Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.
entities: theophylline / Mephenytoin
ddi: null
>>> match: include_obj_dep
-------------
sentence: Inhibitors of CYP1A2: Concomitant use of duloxetine with fluvoxamine, an inhibitor of CYP1A2, results in approximately a 6-fold increase in AUC and about a 2.5-fold increase in Cmax of duloxetine.
entities: duloxetine / duloxetine
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Inhibitors of CYP1A2: Concomitant use of duloxetine with fluvoxamine, an inhibitor of CYP1A2, results in approximately a 6-fold increase in AUC and about a 2.5-fold increase in Cmax of duloxetine.
entities: fluvoxamine / duloxetine
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Inhibitors of CYP2D6: Because CYP2D6 is involved in duloxetine metabolism, concomitant use of duloxetine with potent inhibitors of CYP2D6 may result in higher concentrations of duloxetine.
entities: duloxetine / duloxetine
ddi: null
>>> match: involve_obl_obj
-------------
sentence: Inhibitors of CYP2D6: Because CYP2D6 is involved in duloxetine metabolism, concomitant use of duloxetine with potent inhibitors of CYP2D6 may result in higher concentrations of duloxetine.
entities: duloxetine / duloxetine
ddi: null
>>> match: result_csubj_obl
-------------
sentence: Inhibitors of CYP2D6: Because CYP2D6 is involved in duloxetine metabolism, concomitant use of duloxetine with potent inhibitors of CYP2D6 may result in higher concentrations of duloxetine.
entities: duloxetine / duloxetine
ddi: null
>>> match: result_csubj_obl
-------------
sentence: Paroxetine (20 mg QD) increased the concentration of duloxetine (40 mg QD) by about 60%, and greater degrees of inhibition are expected with higher doses of paroxetine.
entities: Paroxetine / duloxetine
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Paroxetine (20 mg QD) increased the concentration of duloxetine (40 mg QD) by about 60%, and greater degrees of inhibition are expected with higher doses of paroxetine.
entities: Paroxetine / paroxetine
ddi: null
>>> match: increase_nsubj_conj
-------------
sentence: Paroxetine (20 mg QD) increased the concentration of duloxetine (40 mg QD) by about 60%, and greater degrees of inhibition are expected with higher doses of paroxetine.
entities: duloxetine / paroxetine
ddi: null
>>> match: increase_obj_conj
-------------
sentence: Potential for Duloxetine to Affect Other Drugs: Drugs Metabolized by CYP1A2: In vitro drug interaction studies demonstrate that duloxetine does not induce CYP1A2 activity, and it is unlikely to have a clinically significant effect on the metabolism of CYP1A2 substrates.
entities: Duloxetine / duloxetine
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: When duloxetine was administered (at a dose of 60 mg BID) in conjunction with a single 50-mg dose of desipramine, a CYP2D6 substrate, the AUC of desipramine increased 3-fold.
entities: duloxetine / desipramine
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: When duloxetine was administered (at a dose of 60 mg BID) in conjunction with a single 50-mg dose of desipramine, a CYP2D6 substrate, the AUC of desipramine increased 3-fold.
entities: duloxetine / desipramine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Plasma TCA concentrations may need to be monitored and the dose of the TCA may need to be reduced if a TCA is co-administered with Duloxetine.
entities: TCA / TCA
ddi: null
>>> match: need_nsubj_xcomp
-------------
sentence: Plasma TCA concentrations may need to be monitored and the dose of the TCA may need to be reduced if a TCA is co-administered with Duloxetine.
entities: TCA / TCA
ddi: null
>>> match: need_nsubj_xcomp
-------------
sentence: Plasma TCA concentrations may need to be monitored and the dose of the TCA may need to be reduced if a TCA is co-administered with Duloxetine.
entities: TCA / Duloxetine
ddi: null
>>> match: need_nsubj_xcomp
-------------
sentence: Plasma TCA concentrations may need to be monitored and the dose of the TCA may need to be reduced if a TCA is co-administered with Duloxetine.
entities: TCA / TCA
ddi: null
>>> match: need_nsubj_xcomp
-------------
sentence: Plasma TCA concentrations may need to be monitored and the dose of the TCA may need to be reduced if a TCA is co-administered with Duloxetine.
entities: TCA / Duloxetine
ddi: null
>>> match: need_nsubj_xcomp
-------------
sentence: Plasma TCA concentrations may need to be monitored and the dose of the TCA may need to be reduced if a TCA is co-administered with Duloxetine.
entities: TCA / Duloxetine
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Duloxetine May Have a Clinically Important Interaction with the Following Other Drugs: Alcohol: When Duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide, Duloxetine did not increase the impairment of mental and motor skills caused by alcohol.
entities: Duloxetine / Alcohol
ddi: null
>>> match: have_nsubj_obl
-------------
sentence: Duloxetine May Have a Clinically Important Interaction with the Following Other Drugs: Alcohol: When Duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide, Duloxetine did not increase the impairment of mental and motor skills caused by alcohol.
entities: Duloxetine / Duloxetine
ddi: null
>>> match: have_nsubj_obl
-------------
sentence: Duloxetine May Have a Clinically Important Interaction with the Following Other Drugs: Alcohol: When Duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide, Duloxetine did not increase the impairment of mental and motor skills caused by alcohol.
entities: Duloxetine / ethanol
ddi: null
>>> match: have_nsubj_obl
-------------
sentence: Duloxetine May Have a Clinically Important Interaction with the Following Other Drugs: Alcohol: When Duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide, Duloxetine did not increase the impairment of mental and motor skills caused by alcohol.
entities: Duloxetine / Duloxetine
ddi: null
>>> match: have_nsubj_obl
-------------
sentence: Duloxetine May Have a Clinically Important Interaction with the Following Other Drugs: Alcohol: When Duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide, Duloxetine did not increase the impairment of mental and motor skills caused by alcohol.
entities: Duloxetine / alcohol
ddi: null
>>> match: have_nsubj_obl
-------------
sentence: Duloxetine May Have a Clinically Important Interaction with the Following Other Drugs: Alcohol: When Duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide, Duloxetine did not increase the impairment of mental and motor skills caused by alcohol.
entities: Duloxetine / Duloxetine
ddi: null
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Duloxetine May Have a Clinically Important Interaction with the Following Other Drugs: Alcohol: When Duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide, Duloxetine did not increase the impairment of mental and motor skills caused by alcohol.
entities: Duloxetine / alcohol
ddi: null
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Duloxetine May Have a Clinically Important Interaction with the Following Other Drugs: Alcohol: When Duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide, Duloxetine did not increase the impairment of mental and motor skills caused by alcohol.
entities: ethanol / Duloxetine
ddi: null
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Duloxetine May Have a Clinically Important Interaction with the Following Other Drugs: Alcohol: When Duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide, Duloxetine did not increase the impairment of mental and motor skills caused by alcohol.
entities: ethanol / alcohol
ddi: null
>>> match: administer_nsubj:pass_advcl
-------------
sentence: In the Duloxetine clinical trials database, three Duloxetine-treated patients had liver injury as manifested by ALT and total bilirubin elevations, with evidence of obstruction.
entities: Duloxetine / Duloxetine
ddi: null
>>> match: have_obl_nsubj
-------------
sentence: However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose.
entities: Duloxetine / duloxetine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose.
entities: aluminum / duloxetine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose.
entities: magnesium / duloxetine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose.
entities: antacids / duloxetine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose.
entities: Duloxetine / duloxetine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: However, co-administration of Duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or Duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose.
entities: famotidine / duloxetine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: It is unknown whether the concomitant administration of proton pump inhibitors affects duloxetine absorption.
entities: proton pump inhibitors / duloxetine
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Geocillin (carbenicillin indanyl sodium) blood levels may be increased and prolonged by concurrent administration of probenecid.
entities: Geocillin / probenecid
ddi: mechanism
>>> match: increase_nsubj:pass_obl
-------------
sentence: Geocillin (carbenicillin indanyl sodium) blood levels may be increased and prolonged by concurrent administration of probenecid.
entities: carbenicillin indanyl sodium / probenecid
ddi: mechanism
>>> match: increase_nsubj:pass_obl
-------------
sentence: In normal volunteers receiving indomethacin, the administration of diflunisal decreased the renal clearance and significantly increased the plasma levels of indomethacin.
entities: indomethacin / diflunisal
ddi: null
>>> match: decrease_obl_nsubj
-------------
sentence: In normal volunteers receiving indomethacin, the administration of diflunisal decreased the renal clearance and significantly increased the plasma levels of indomethacin.
entities: indomethacin / indomethacin
ddi: null
>>> match: decrease_obl_conj
-------------
sentence: In normal volunteers receiving indomethacin, the administration of diflunisal decreased the renal clearance and significantly increased the plasma levels of indomethacin.
entities: diflunisal / indomethacin
ddi: mechanism
>>> match: decrease_nsubj_conj
-------------
sentence: In a study in normal volunteers, it was found that chronic concurrent administration of 3.6 g of aspirin per day decreases indomethacin blood levels approximately 20%.
entities: aspirin / indomethacin
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: However, when any additional drug, including INDOCIN, is added to the treatment of patients on anticoagulant therapy, the patients should be observed for alterations of the prothrombin time.
entities: INDOCIN / anticoagulant
ddi: advise
>>> match: add_nsubj:pass_obl
-------------
sentence: When INDOCIN is given to patients receiving probenecid, the plasma levels of indomethacin are likely to be increased.
entities: INDOCIN / probenecid
ddi: mechanism
>>> match: give_nsubj:pass_obl
-------------
sentence: Caution should be used if INDOCIN is administered simultaneously with methotrexate.
entities: INDOCIN / methotrexate
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: INDOCIN has been reported to decrease the tubular secretion of methotrexate and to potentiate its toxicity.
entities: INDOCIN / methotrexate
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Administration of non-steroidal anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.
entities: non-steroidal anti-inflammatory drugs / cyclosporine
ddi: effect
>>> match: associate_nsubj:pass_advmod
-------------
sentence: Administration of non-steroidal anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.
entities: non-steroidal anti-inflammatory drugs / cyclosporine
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: Administration of non-steroidal anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.
entities: cyclosporine / cyclosporine
ddi: null
>>> match: associate_advmod_obl
-------------
sentence: NSAIDs should be used with caution in patients taking cyclosporine, and renal function should be carefully monitored.
entities: NSAIDs / cyclosporine
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Capsules INDOCIN 50 mg t.i.d. produced a clinically relevant elevation of plasma lithium and reduction in renal lithium clearance in psychiatric patients and normal subjects with steady state plasma lithium concentrations.
entities: INDOCIN / lithium
ddi: mechanism
>>> match: produce_nsubj_obj
-------------
sentence: Capsules INDOCIN 50 mg t.i.d. produced a clinically relevant elevation of plasma lithium and reduction in renal lithium clearance in psychiatric patients and normal subjects with steady state plasma lithium concentrations.
entities: INDOCIN / lithium
ddi: null
>>> match: produce_nsubj_obl
-------------
sentence: Capsules INDOCIN 50 mg t.i.d. produced a clinically relevant elevation of plasma lithium and reduction in renal lithium clearance in psychiatric patients and normal subjects with steady state plasma lithium concentrations.
entities: INDOCIN / lithium
ddi: null
>>> match: produce_nsubj_obl
-------------
sentence: Capsules INDOCIN 50 mg t.i.d. produced a clinically relevant elevation of plasma lithium and reduction in renal lithium clearance in psychiatric patients and normal subjects with steady state plasma lithium concentrations.
entities: lithium / lithium
ddi: null
>>> match: produce_obj_obl
-------------
sentence: Capsules INDOCIN 50 mg t.i.d. produced a clinically relevant elevation of plasma lithium and reduction in renal lithium clearance in psychiatric patients and normal subjects with steady state plasma lithium concentrations.
entities: lithium / lithium
ddi: null
>>> match: produce_obj_obl
-------------
sentence: As a consequence, when INDOCIN and lithium are given concomitantly, the patient should be carefully observed for signs of lithium toxicity.
entities: INDOCIN / lithium
ddi: null
>>> match: observe_advcl_obl
-------------
sentence: As a consequence, when INDOCIN and lithium are given concomitantly, the patient should be carefully observed for signs of lithium toxicity.
entities: lithium / lithium
ddi: null
>>> match: observe_advcl_obl
-------------
sentence: INDOCIN given concomitantly with digoxin has been reported to increase the serum concentration and prolong the half-life of digoxin.
entities: INDOCIN / digoxin
ddi: mechanism
>>> match: give_nsubj_obl
-------------
sentence: INDOCIN given concomitantly with digoxin has been reported to increase the serum concentration and prolong the half-life of digoxin.
entities: INDOCIN / digoxin
ddi: null
>>> match: report_csubj:pass_xcomp
-------------
sentence: INDOCIN given concomitantly with digoxin has been reported to increase the serum concentration and prolong the half-life of digoxin.
entities: digoxin / digoxin
ddi: null
>>> match: report_csubj:pass_xcomp
-------------
sentence: Therefore, when INDOCIN and digoxin are used concomitantly, serum digoxin levels should be closely monitored.
entities: INDOCIN / digoxin
ddi: null
>>> match: monitor_advcl_nsubj:pass
-------------
sentence: Therefore, when INDOCIN and digoxin are used concomitantly, serum digoxin levels should be closely monitored.
entities: digoxin / digoxin
ddi: null
>>> match: monitor_advcl_nsubj:pass
-------------
sentence: In some patients, the administration of INDOCIN can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing, and thiazide diuretics.
entities: INDOCIN / thiazide diuretics
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: (Indomethacin) diuretics are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.
entities: Indomethacin / diuretic
ddi: null
>>> match: use_nsubj:pass_parataxis
-------------
sentence: (Indomethacin) diuretics are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained.
entities: diuretics / diuretic
ddi: null
>>> match: use_nsubj:pass_parataxis
-------------
sentence: INDOCIN reduces basal plasma renin activity (PRA), as well as those elevations of PRA induced by furosemide administration, or salt or volume depletion.
entities: INDOCIN / furosemide
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: Most of the above effects concerning diuretics have been attributed, at least in part, to mechanisms involving inhibition of prostaglandin synthesis by INDOCIN.
entities: diuretics / INDOCIN
ddi: effect
>>> match: attribute_nsubj:pass_obl
-------------
sentence: INDOCIN can reduce the antihypertensive effects of captopril and losartan.
entities: INDOCIN / captopril
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: INDOCIN can reduce the antihypertensive effects of captopril and losartan.
entities: INDOCIN / losartan
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: May interact with the following: cholestyramine, colestipol (use with thiazide diuretics may prevent the diuretic from working properly;
entities: cholestyramine / diuretic
ddi: null
>>> match: prevent_nsubj_obj
-------------
sentence: May interact with the following: cholestyramine, colestipol (use with thiazide diuretics may prevent the diuretic from working properly;
entities: colestipol / diuretic
ddi: null
>>> match: prevent_nsubj_obj
-------------
sentence: May interact with the following: cholestyramine, colestipol (use with thiazide diuretics may prevent the diuretic from working properly;
entities: thiazide diuretics / diuretic
ddi: null
>>> match: prevent_nsubj_obj
-------------
sentence: After prolonged administration of neuroleptics the displacing effect of cerulein, an analog of cholecystokinin octapeptide, was replaced by the stimulant action on 3H-spiroperidol binding. 
entities: neuroleptics / cerulein
ddi: null
>>> match: replace_obl_nsubj:pass
-------------
sentence: After prolonged administration of neuroleptics the displacing effect of cerulein, an analog of cholecystokinin octapeptide, was replaced by the stimulant action on 3H-spiroperidol binding. 
entities: neuroleptics / 3H-spiroperidol
ddi: null
>>> match: replace_obl_obl
-------------
sentence: After prolonged administration of neuroleptics the displacing effect of cerulein, an analog of cholecystokinin octapeptide, was replaced by the stimulant action on 3H-spiroperidol binding. 
entities: cerulein / 3H-spiroperidol
ddi: null
>>> match: replace_nsubj:pass_obl
-------------
sentence: It is assumed that increased interaction between 3H-spiroperidol and high affinity binding sites for apomorphine on dopamine2- and serotonin2-receptors underlies the antipsychotic action of neuroleptics after their prolonged administration. 
entities: 3H-spiroperidol / neuroleptics
ddi: null
>>> match: underlie_csubj_obj
-------------
sentence: It is assumed that increased interaction between 3H-spiroperidol and high affinity binding sites for apomorphine on dopamine2- and serotonin2-receptors underlies the antipsychotic action of neuroleptics after their prolonged administration. 
entities: apomorphine / neuroleptics
ddi: null
>>> match: underlie_csubj_obj
-------------
sentence: Results of preliminary studies in humans and rats suggest that nonabsorbable antacids given concurrently with lactulose may inhibit the desired lactulose-induced drop in colonic pH.
entities: antacids / lactulose
ddi: mechanism
>>> match: give_nsubj_obl
-------------
sentence: Results of preliminary studies in humans and rats suggest that nonabsorbable antacids given concurrently with lactulose may inhibit the desired lactulose-induced drop in colonic pH.
entities: antacids / lactulose
ddi: null
>>> match: inhibit_csubj_obj
-------------
sentence: Results of preliminary studies in humans and rats suggest that nonabsorbable antacids given concurrently with lactulose may inhibit the desired lactulose-induced drop in colonic pH.
entities: lactulose / lactulose
ddi: null
>>> match: inhibit_csubj_obj
-------------
sentence: Buprenorphine is metabolized to norbuprenorphine by cytochrome CYP 3A4.
entities: Buprenorphine / norbuprenorphine
ddi: null
>>> match: metabolize_nsubj:pass_obl
-------------
sentence: Because CYP 3A4 inhibitors may increase plasma concentrations of buprenorphine, patients already on CYP 3A4 inhibitors such as azole antifungals (e.g.
entities: buprenorphine / azole antifungals
ddi: null
>>> match: increase_obj_punct
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: ketoconazole / SUBUTEX
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: ketoconazole / SUBOXONE
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: macrolide antibiotics / SUBUTEX
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: macrolide antibiotics / SUBOXONE
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: erythromycin / SUBUTEX
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: erythromycin / SUBOXONE
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: HIV protease inhibitors / SUBUTEX
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: HIV protease inhibitors / SUBOXONE
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: ritonavir / SUBUTEX
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: ritonavir / SUBOXONE
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: indinavir / SUBUTEX
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: indinavir / SUBOXONE
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: saquinavir / SUBUTEX
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: saquinavir / SUBOXONE
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: In many of these cases, buprenorphine was misused by self-injection of crushed SUBUTEX tablets.
entities: buprenorphine / SUBUTEX
ddi: null
>>> match: misuse_nsubj:pass_obl
-------------
sentence: SUBUTEX and SUBOXONE should be prescribed with caution to patients on benzodiazepines or other drugs that act on the central nervous system, regardless of whether these drugs are taken on the advice of a physician or are taken as drugs of abuse.
entities: SUBUTEX / benzodiazepines
ddi: advise
>>> match: prescribe_nsubj:pass_obl
-------------
sentence: SUBUTEX and SUBOXONE should be prescribed with caution to patients on benzodiazepines or other drugs that act on the central nervous system, regardless of whether these drugs are taken on the advice of a physician or are taken as drugs of abuse.
entities: SUBOXONE / benzodiazepines
ddi: advise
>>> match: prescribe_nsubj:pass_obl
-------------
sentence: Patients should be warned of the potential danger of the intravenous self-administration of benzodiazepines while under treatment with SUBOXONE or SUBUTEX.
entities: benzodiazepines / SUBOXONE
ddi: advise
>>> match: warn_obl_advmod
-------------
sentence: Patients should be warned of the potential danger of the intravenous self-administration of benzodiazepines while under treatment with SUBOXONE or SUBUTEX.
entities: benzodiazepines / SUBUTEX
ddi: advise
>>> match: warn_obl_advmod
-------------
sentence: When such drugs are withdrawn from patients receiving Acarbose in combination with sulfonylureas or insulin, patients should be observed closely for any evidence of hypoglycemia.
entities: Acarbose / sulfonylureas
ddi: null
>>> match: receive_obj_obl
-------------
sentence: When such drugs are withdrawn from patients receiving Acarbose in combination with sulfonylureas or insulin, patients should be observed closely for any evidence of hypoglycemia.
entities: Acarbose / insulin
ddi: null
>>> match: receive_obj_obl
-------------
sentence: Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.
entities: Intestinal adsorbents / Acarbose
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.
entities: charcoal / Acarbose
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.
entities: digestive enzyme preparations / Acarbose
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.
entities: amylase / Acarbose
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Intestinal adsorbents (e. g., charcoal) and digestive enzyme preparations containing carbohydrate-splitting enzymes (e. g., amylase, pancreatin) may reduce the effect of Acarbose and should not be taken concomitantly.
entities: pancreatin / Acarbose
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Acarbose has been shown to change the bioavailabillty digoxin when they are co-administered, which may require digoxin dose adjustment.
entities: Acarbose / digoxin
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Acarbose has been shown to change the bioavailabillty digoxin when they are co-administered, which may require digoxin dose adjustment.
entities: Acarbose / digoxin
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Acarbose has been shown to change the bioavailabillty digoxin when they are co-administered, which may require digoxin dose adjustment.
entities: digoxin / digoxin
ddi: null
>>> match: change_obj_advcl
-------------
sentence: Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.
entities: Acarbose / digoxin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.
entities: Acarbose / nifedipine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.
entities: Acarbose / propranolol
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.
entities: Acarbose / ranitidine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: Acarbose / digoxin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: Acarbose / digoxin
ddi: null
>>> match: affect_nsubj_conj
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: Acarbose / digoxin
ddi: null
>>> match: affect_nsubj_conj
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: Acarbose / digoxin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: digoxin / digoxin
ddi: null
>>> match: affect_obj_conj
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: digoxin / digoxin
ddi: null
>>> match: affect_obj_conj
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: digoxin / digoxin
ddi: null
>>> match: affect_obj_obj
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: digoxin / digoxin
ddi: null
>>> match: require_obj_obl
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: digoxin / digoxin
ddi: null
>>> match: affect_conj_obj
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: digoxin / digoxin
ddi: null
>>> match: affect_conj_obj
-------------
sentence: The amount of metformin absorbed while taking Acarbose was bioequivalent to the amount absorbed when taking placebo, as indicated by the plasma AUC values.
entities: metformin / Acarbose
ddi: null
>>> match: absorb_nsubj_advcl
-------------
sentence: However, the peak plasma level of metformin was reduced by approximately 20% when taking Acarbose due to a slight delay in the absorption of metformin.
entities: metformin / Acarbose
ddi: mechanism
>>> match: reduce_nsubj:pass_dep
-------------
sentence: However, the peak plasma level of metformin was reduced by approximately 20% when taking Acarbose due to a slight delay in the absorption of metformin.
entities: metformin / metformin
ddi: null
>>> match: reduce_nsubj:pass_dep
-------------
sentence: However, the peak plasma level of metformin was reduced by approximately 20% when taking Acarbose due to a slight delay in the absorption of metformin.
entities: Acarbose / metformin
ddi: mechanism
>>> match: take_obj_obl
-------------
sentence: We examined the effect of exogenous estradiol on the changes in serum steroid hormone levels induced by a nonlethal dose of Escherichia coli endotoxin in male rats and the deaths due to nonlethal and lethal doses of endotoxin. 
entities: estradiol / endotoxin
ddi: null
>>> match: examine_obj_obl
-------------
sentence: We examined the effect of exogenous estradiol on the changes in serum steroid hormone levels induced by a nonlethal dose of Escherichia coli endotoxin in male rats and the deaths due to nonlethal and lethal doses of endotoxin. 
entities: estradiol / endotoxin
ddi: null
>>> match: examine_obj_obl
-------------
sentence: Injection of estradiol 5 min before a nonlethal dose of endotoxin changed the serum sex steroid hormone response of male rats to endotoxin. 
entities: estradiol / endotoxin
ddi: null
>>> match: change_nsubj_obl
-------------
sentence: Injection of estradiol 5 min before a nonlethal dose of endotoxin changed the serum sex steroid hormone response of male rats to endotoxin. 
entities: endotoxin / endotoxin
ddi: null
>>> match: change_nsubj_obl
-------------
sentence: The serum estrogen concentrations of estradiol + endotoxin-treated rats decreased by 50%, while those of the endotoxin-treated rats increased (2- to 5-fold). 
entities: estradiol / endotoxin
ddi: null
>>> match: decrease_nsubj_advcl
-------------
sentence: The serum estrogen concentrations of estradiol + endotoxin-treated rats decreased by 50%, while those of the endotoxin-treated rats increased (2- to 5-fold). 
entities: endotoxin / endotoxin
ddi: null
>>> match: decrease_nsubj_advcl
-------------
sentence: Exogenous estradiol also appeared to influence the percentage of endotoxin-induced deaths in a dose-dependent manner. 
entities: estradiol / endotoxin
ddi: effect
>>> match: appear_nsubj_xcomp
-------------
sentence: These results, together with the known relationships between estrogen and the immune response, suggest that estrogens affect the course of septic shock in a complex fashion and may have either protective or deleterious effect.
entities: estrogen / estrogens
ddi: null
>>> match: suggest_obl_ccomp
-------------
sentence: Concomitant oral administration of ketoconazole (a known inhibitor of CYP3A4 activity in the liver and in the intestinal mucosa) caused an eight-fold increase of the systemic exposure to oral budesonide.
entities: ketoconazole / budesonide
ddi: mechanism
>>> match: cause_nsubj_obj
-------------
sentence: If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.
entities: ketoconazole / budesonide
ddi: advise
>>> match: consider_advcl_nsubj:pass
-------------
sentence: If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.
entities: intraconazole / budesonide
ddi: advise
>>> match: consider_advcl_nsubj:pass
-------------
sentence: If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.
entities: ritonavir / budesonide
ddi: advise
>>> match: consider_advcl_nsubj:pass
-------------
sentence: If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.
entities: indinavir / budesonide
ddi: advise
>>> match: consider_advcl_nsubj:pass
-------------
sentence: If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.
entities: saquinavir / budesonide
ddi: advise
>>> match: consider_advcl_nsubj:pass
-------------
sentence: If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered.
entities: erythromycin / budesonide
ddi: advise
>>> match: consider_advcl_nsubj:pass
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / antihistamines
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / anticholinergics
ddi: null
>>> match: interact_obl_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_obl_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: alcohol / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / antihistamines
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / anticholinergics
ddi: null
>>> match: interact_obl_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_obl_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: CNS depressants / antihistamines
ddi: null
>>> match: interact_obl_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / anticholinergics
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_parataxis_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: anticholinergics / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_conj_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: anticholinergics / antihistamines
ddi: null
>>> match: interact_conj_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: anticholinergics / antihistamines
ddi: null
>>> match: interact_conj_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / monoamine oxidase (MAO) inhibitors
ddi: null
>>> match: interact_conj_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_conj_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: interact_conj_conj
-------------
sentence: This drug may interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
entities: antihistamines / antihistamines
ddi: null
>>> match: prolong_nsubj_obj
-------------
sentence: Monoamine Oxidase Inhibitors: Coadministration of moclobemide resulted in a 27% decrease in almotriptan clearance and an increase in Cmax of approximately 6%.
entities: moclobemide / almotriptan
ddi: mechanism
>>> match: result_nsubj_obl
-------------
sentence: Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.
entities: SSRIs / 5-HT1 agonists
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.
entities: fluoxetine / 5-HT1 agonists
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.
entities: fluvoxamine / 5-HT1 agonists
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.
entities: paroxetine / 5-HT1 agonists
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Selective Serotonin Reuptake Inhibitors (SSRIs): SSRIs (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been rarely reported to cause weakness, hyperreflexia, and incoordination when coadministered with 5-HT1 agonists.
entities: sertraline / 5-HT1 agonists
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Verapamil: Coadministration of almotriptan and verapamil resulted in a 24% increase in plasma concentrations of almotriptan.
entities: almotriptan / almotriptan
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Verapamil: Coadministration of almotriptan and verapamil resulted in a 24% increase in plasma concentrations of almotriptan.
entities: verapamil / almotriptan
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Coadministration of almotriptan and the potent CYP3A4 inhibitor ketoconazole (400 mg q.d. for 3 days) resulted in an approximately 60% increase in the area under the plasma concentration-time curve and maximal plasma concentrations of almotriptan.
entities: almotriptan / almotriptan
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Coadministration of almotriptan and the potent CYP3A4 inhibitor ketoconazole (400 mg q.d. for 3 days) resulted in an approximately 60% increase in the area under the plasma concentration-time curve and maximal plasma concentrations of almotriptan.
entities: ketoconazole / almotriptan
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.
entities: almotriptan / almotriptan
ddi: null
>>> match: expect_advcl_nsubj:pass
-------------
sentence: Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.
entities: almotriptan / almotriptan
ddi: null
>>> match: expect_advcl_advcl
-------------
sentence: Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.
entities: itraconazole / almotriptan
ddi: null
>>> match: expect_advcl_nsubj:pass
-------------
sentence: Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.
entities: itraconazole / almotriptan
ddi: advise
>>> match: expect_advcl_advcl
-------------
sentence: Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.
entities: ritonavir / almotriptan
ddi: null
>>> match: expect_advcl_nsubj:pass
-------------
sentence: Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.
entities: ritonavir / almotriptan
ddi: advise
>>> match: expect_advcl_advcl
-------------
sentence: Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.
entities: erythromycin / almotriptan
ddi: null
>>> match: expect_advcl_nsubj:pass
-------------
sentence: Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.
entities: erythromycin / almotriptan
ddi: advise
>>> match: expect_advcl_advcl
-------------
sentence: Although the interaction between almotriptan and other potent CYP3A4 inhibitors (e.g., itraconazole, ritonavir, and erythromycin) has not been studied, increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications.
entities: almotriptan / almotriptan
ddi: null
>>> match: expect_nsubj:pass_advcl
-------------
sentence: In a study in which patients with active RA were treated for up to 24 weeks with concurrent ENBREL  and anakinra therapy, a 7% rate of serious infections was observed, which was higher than that observed with ENBREL  alone (0%).
entities: ENBREL / ENBREL
ddi: null
>>> match: observe_obl_ccomp
-------------
sentence: In a study in which patients with active RA were treated for up to 24 weeks with concurrent ENBREL  and anakinra therapy, a 7% rate of serious infections was observed, which was higher than that observed with ENBREL  alone (0%).
entities: anakinra / ENBREL
ddi: null
>>> match: observe_obl_ccomp
-------------
sentence: Patients in a clinical study who were on established therapy with sulfasalazine, to which ENBREL was added, were noted to develop a mild decrease in mean neutrophil counts in comparison to groups treated with either ENBREL CI or sulfasalazine alone.
entities: ENBREL / ENBREL
ddi: null
>>> match: add_nsubj:pass_dep
-------------
sentence: Patients in a clinical study who were on established therapy with sulfasalazine, to which ENBREL was added, were noted to develop a mild decrease in mean neutrophil counts in comparison to groups treated with either ENBREL CI or sulfasalazine alone.
entities: ENBREL / sulfasalazine
ddi: null
>>> match: add_nsubj:pass_dep
-------------
sentence: Use with Allopurinol: The principal pathway for detoxification of azathioprine is inhibited by allopurinol.
entities: azathioprine / allopurinol
ddi: mechanism
>>> match: inhibit_nsubj:pass_obl
-------------
sentence: Patients receiving azathioprine and allopurinol concomitantly should have a dose reduction of azathioprine, to approximately 1/3 to 1/4 the usual dose.
entities: azathioprine / azathioprine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Patients receiving azathioprine and allopurinol concomitantly should have a dose reduction of azathioprine, to approximately 1/3 to 1/4 the usual dose.
entities: allopurinol / azathioprine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / acetaminophen
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / acyclovir
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / angiotensin-converting enzyme inhibitors
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / aminosalicylic acid
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / barbiturates
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / benzodiazepines
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / bumetanide
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / clofibrate
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / methotrexate
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / famotidine
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / furosemide
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / theophylline
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Probenecid : Probenecid is known to interact with the metabolism or renal tubular excretion of many drugs (e.g., acetaminophen, acyclovir, angiotensin-converting enzyme inhibitors, aminosalicylic acid, barbiturates, benzodiazepines, bumetanide, clofibrate, methotrexate, famotidine, furosemide, nonsteroidal anti-inflammatory agents, theophylline, and zidovudine).
entities: Probenecid / zidovudine
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Zidovudine should either be temporarily discontinued or decreased by 50% when coadministered with probenecid on the day of VISTIDE infusion.
entities: Zidovudine / probenecid
ddi: advise
>>> match: discontinue_nsubj:pass_advcl
-------------
sentence: Zidovudine should either be temporarily discontinued or decreased by 50% when coadministered with probenecid on the day of VISTIDE infusion.
entities: Zidovudine / VISTIDE
ddi: null
>>> match: discontinue_nsubj:pass_advcl
-------------
sentence: Zidovudine should either be temporarily discontinued or decreased by 50% when coadministered with probenecid on the day of VISTIDE infusion.
entities: probenecid / VISTIDE
ddi: null
>>> match: coadminister_obl_obl
-------------
sentence: In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. 
entities: TOBI / TOBI
ddi: null
>>> match: demonstrate_obl_nsubj
-------------
sentence: In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. 
entities: TOBI / dornase alfa
ddi: null
>>> match: demonstrate_obl_nsubj
-------------
sentence: In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. 
entities: TOBI / PULMOZYME
ddi: null
>>> match: demonstrate_obl_nsubj
-------------
sentence: In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. 
entities: TOBI / (beta)-agonists
ddi: null
>>> match: demonstrate_obl_nsubj
-------------
sentence: In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. 
entities: TOBI / corticosteroids
ddi: null
>>> match: demonstrate_obl_nsubj
-------------
sentence: In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. 
entities: TOBI / anti-pseudomonal antibiotics
ddi: null
>>> match: demonstrate_obl_nsubj
-------------
sentence: In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. 
entities: TOBI / aminoglycosides
ddi: null
>>> match: demonstrate_obl_nsubj
-------------
sentence: In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. 
entities: TOBI / dornase alfa
ddi: effect
>>> match: take_obj_obl
-------------
sentence: In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole. 
entities: TOBI / PULMOZYME
ddi: effect
>>> match: take_obj_obl
-------------
sentence: Some diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue. 
entities: diuretics / aminoglycoside
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Some diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue. 
entities: diuretics / antibiotic
ddi: null
>>> match: enhance_nsubj_obl
-------------
sentence: Some diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue. 
entities: aminoglycoside / antibiotic
ddi: null
>>> match: enhance_obj_obl
-------------
sentence: TOBI should not be administered concomitantly with ethacrynic acid, furosemide, urea, or mannitol.
entities: TOBI / ethacrynic acid
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: TOBI should not be administered concomitantly with ethacrynic acid, furosemide, urea, or mannitol.
entities: TOBI / furosemide
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: TOBI should not be administered concomitantly with ethacrynic acid, furosemide, urea, or mannitol.
entities: TOBI / urea
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: TOBI should not be administered concomitantly with ethacrynic acid, furosemide, urea, or mannitol.
entities: TOBI / mannitol
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Catecholamine-depleting drugs, such as reserpine, may have an additive effect when given with beta-blocking agents.
entities: Catecholamine-depleting drugs / beta-blocking agents
ddi: effect
>>> match: have_nsubj_advcl
-------------
sentence: Catecholamine-depleting drugs, such as reserpine, may have an additive effect when given with beta-blocking agents.
entities: reserpine / beta-blocking agents
ddi: effect
>>> match: have_nsubj_advcl
-------------
sentence: Administration of 1,3-difluoroacetone (100 mg kg(-1) body weight) to rats in vivo resulted in (-)-erythro-fluorocitrate synthesis in the kidney, which was preceded by an elevation in fluoride levels and followed by citrate accumulation. 
entities: 1,3-difluoroacetone / (-)-erythro-fluorocitrate
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Animals dosed with 1,3-difluoroacetone did not display the 2-3 hour lag phase in either (-)-erythro-fluorocitrate synthesis or in citrate and fluoride accumulation characteristic of animals dosed with 1,3-difluoro-2-propanol. 
entities: 1,3-difluoroacetone / (-)-erythro-fluorocitrate
ddi: null
>>> match: dose_obl_dep
-------------
sentence: Prior administration of 4-methylpyrazole (90 mg kg(-1) body weight) was shown to prevent the conversion of 1,3-difluoro-2-propanol (100 mg kg(-1) body weight) to (-)-erythro-fluorocitrate in vivo and to eliminate the fluoride and citrate elevations seen in 1,3-difluoro-2-propanol-intoxicated animals. 
entities: 4-methylpyrazole / (-)-erythro-fluorocitrate
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: We conclude that the prophylactic and antidotal properties of 4-methylpyrazole seen in animals treated with 1,3-difluoro-2-propanol derive from its capacity to inhibit the NAD+-dependent oxidation responsible for converting 1,3-difluoro-2-propanol to 1,3-difluoroacetone in the committed step of the toxic pathway.
entities: 4-methylpyrazole / 1,3-difluoro-2-propanol
ddi: null
>>> match: see_nsubj_obl
-------------
sentence: We conclude that the prophylactic and antidotal properties of 4-methylpyrazole seen in animals treated with 1,3-difluoro-2-propanol derive from its capacity to inhibit the NAD+-dependent oxidation responsible for converting 1,3-difluoro-2-propanol to 1,3-difluoroacetone in the committed step of the toxic pathway.
entities: 4-methylpyrazole / 1,3-difluoroacetone
ddi: null
>>> match: see_nsubj_obl
-------------
sentence: We conclude that the prophylactic and antidotal properties of 4-methylpyrazole seen in animals treated with 1,3-difluoro-2-propanol derive from its capacity to inhibit the NAD+-dependent oxidation responsible for converting 1,3-difluoro-2-propanol to 1,3-difluoroacetone in the committed step of the toxic pathway.
entities: 1,3-difluoro-2-propanol / 1,3-difluoroacetone
ddi: null
>>> match: inhibit_obj_obl
-------------
sentence: Probenecid may decrease renal tubular secretion of cephalosporins when used concurrently, resulting in increased and more prolonged cephalosporin blood levels.
entities: Probenecid / cephalosporins
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Probenecid may decrease renal tubular secretion of cephalosporins when used concurrently, resulting in increased and more prolonged cephalosporin blood levels.
entities: Probenecid / cephalosporin
ddi: null
>>> match: decrease_nsubj_advcl
-------------
sentence: Probenecid may decrease renal tubular secretion of cephalosporins when used concurrently, resulting in increased and more prolonged cephalosporin blood levels.
entities: cephalosporins / cephalosporin
ddi: null
>>> match: decrease_obj_advcl
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Vindesine / Phenytoin
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Vindesine / Live virus vaccines
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Vindesine / vaccine
ddi: null
>>> match: interact_nsubj_obl
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Vindesine / Mitomycin-C
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Vindesine / Killed virus vaccines
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Vindesine / vaccine
ddi: null
>>> match: interact_nsubj_obl
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Phenytoin / Live virus vaccines
ddi: null
>>> match: cause_obj_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Phenytoin / vaccine
ddi: null
>>> match: cause_obj_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Phenytoin / Mitomycin-C
ddi: null
>>> match: cause_obj_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Phenytoin / Killed virus vaccines
ddi: null
>>> match: cause_obj_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Phenytoin / vaccine
ddi: null
>>> match: cause_obj_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Live virus vaccines / vaccine
ddi: null
>>> match: increase_obj_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Live virus vaccines / Mitomycin-C
ddi: null
>>> match: increase_obj_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Live virus vaccines / Killed virus vaccines
ddi: null
>>> match: increase_obj_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Live virus vaccines / vaccine
ddi: null
>>> match: increase_obj_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: vaccine / Mitomycin-C
ddi: null
>>> match: potentiate_obj_conj
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: vaccine / Killed virus vaccines
ddi: null
>>> match: increase_dep_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: vaccine / vaccine
ddi: null
>>> match: increase_dep_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Mitomycin-C / Killed virus vaccines
ddi: null
>>> match: increase_dep_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Mitomycin-C / vaccine
ddi: null
>>> match: increase_dep_dep
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Killed virus vaccines / vaccine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Few systemic data have been collected on the metabolism of WELLBUTRIN following concomitant administration with other drugs or, alternatively, the effect of concomitant administration of WELLBUTRIN on the metabolism of other drugs.
entities: WELLBUTRIN / WELLBUTRIN
ddi: null
>>> match: collect_obl_obl
-------------
sentence: In vitro studies indicate that bupropion is primarily metabolized to hydroxybupropion by the CYP2B6 isoenzyme.
entities: bupropion / hydroxybupropion
ddi: null
>>> match: metabolize_nsubj:pass_obl
-------------
sentence: In a study of 15 male subjects (ages 19 to 35 years) who were extensive metabolizers of the CYP2D6 isoenzyme, daily doses of bupropion given as 150 mg twice daily followed by a single dose of 50 mg desipramine increased the Cmax, AUC, and t1/2 of desipramine by an average of approximately 2-, 5- and 2-fold, respectively.
entities: bupropion / desipramine
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: In a study of 15 male subjects (ages 19 to 35 years) who were extensive metabolizers of the CYP2D6 isoenzyme, daily doses of bupropion given as 150 mg twice daily followed by a single dose of 50 mg desipramine increased the Cmax, AUC, and t1/2 of desipramine by an average of approximately 2-, 5- and 2-fold, respectively.
entities: desipramine / desipramine
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .
entities: bupropion / MAO inhibitor
ddi: null
>>> match: enhance_nsubj:pass_obl
-------------
sentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .
entities: bupropion / phenelzine
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: Levodopa and Amantadine: Limited clinical data suggest a higher incidence of adverse experiences in patients receiving bupropion concurrently with either levodopa or amantadine.
entities: bupropion / levodopa
ddi: effect
>>> match: receive_obj_obl
-------------
sentence: Levodopa and Amantadine: Limited clinical data suggest a higher incidence of adverse experiences in patients receiving bupropion concurrently with either levodopa or amantadine.
entities: bupropion / amantadine
ddi: effect
>>> match: receive_obj_obl
-------------
sentence: Alcohol: In post-marketing experience, there have been rare reports of adverse neuropsychiatric events or reduced alcohol tolerance in patients who were drinking alcohol during treatment with WELLBUTRIN.
entities: alcohol / WELLBUTRIN
ddi: effect
>>> match: drink_obj_obl
-------------
sentence: In patients who have received muscle relaxants, doxapram may temporarily mask the residual effects of muscle relaxant drugs.
entities: muscle relaxants / doxapram
ddi: null
>>> match: receive_obj_parataxis
-------------
sentence: In patients who have received muscle relaxants, doxapram may temporarily mask the residual effects of muscle relaxant drugs.
entities: muscle relaxants / muscle relaxant drugs
ddi: null
>>> match: receive_obj_parataxis
-------------
sentence: In patients who have received muscle relaxants, doxapram may temporarily mask the residual effects of muscle relaxant drugs.
entities: doxapram / muscle relaxant drugs
ddi: effect
>>> match: mask_nsubj_obj
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Monoamine oxidase inhibitors
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / MAOI
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / MAOI
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / flupenthixol
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Arecoline
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Ethanol
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Flupenthixol
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Ethanol
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Tricyclic antidepressants
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Flupenthixol
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Tricyclic antidepressants
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Monoamine oxidase inhibitors / MAOI
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Monoamine oxidase inhibitors / flupenthixol
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Monoamine oxidase inhibitors / Arecoline
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Monoamine oxidase inhibitors / Ethanol
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Monoamine oxidase inhibitors / Flupenthixol
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Monoamine oxidase inhibitors / Ethanol
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Monoamine oxidase inhibitors / Tricyclic antidepressants
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Monoamine oxidase inhibitors / Flupenthixol
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Monoamine oxidase inhibitors / Tricyclic antidepressants
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / MAOI
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / flupenthixol
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Arecoline
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Ethanol
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Flupenthixol
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Ethanol
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Tricyclic antidepressants
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Flupenthixol
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Tricyclic antidepressants
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / flupenthixol
ddi: effect
>>> match: affect_nsubj_obj
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Arecoline
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Ethanol
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Flupenthixol
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Ethanol
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Tricyclic antidepressants
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Flupenthixol
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Tricyclic antidepressants
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Tricyclic antidepressants
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Flupenthixol
ddi: null
>>> match: cause_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Tricyclic antidepressants
ddi: null
>>> match: cause_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Ethanol / Tricyclic antidepressants
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Ethanol / Flupenthixol
ddi: null
>>> match: cause_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Ethanol / Tricyclic antidepressants
ddi: null
>>> match: cause_nsubj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Tricyclic antidepressants / Flupenthixol
ddi: null
>>> match: cause_obj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Tricyclic antidepressants / Tricyclic antidepressants
ddi: null
>>> match: cause_obj_parataxis
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Tricyclic antidepressants
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Chlorprothixene may increase the plasma-level of concomitantly given lithium.
entities: Chlorprothixene / lithium
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: chlorprothixene / opioids
ddi: advise
>>> match: give_nsubj:pass_obl
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: chlorprothixene / opioid
ddi: null
>>> match: reduce_advcl_nsubj:pass
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: chlorprothixene / chlorprothixene
ddi: null
>>> match: reduce_advcl_advcl
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: chlorprothixene / opioids
ddi: null
>>> match: reduce_advcl_advcl
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: opioids / opioid
ddi: null
>>> match: reduce_advcl_nsubj:pass
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: opioids / chlorprothixene
ddi: null
>>> match: reduce_advcl_advcl
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: opioids / opioids
ddi: null
>>> match: reduce_advcl_advcl
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: opioid / chlorprothixene
ddi: null
>>> match: reduce_nsubj:pass_advcl
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: opioid / opioids
ddi: null
>>> match: reduce_nsubj:pass_advcl
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: chlorprothixene / opioids
ddi: effect
>>> match: amplify_nsubj_obj
-------------
sentence: Consider additive sedative effects and confusional states to emerge, if chlorprothixene is given with benzodiazepines or barbituates.
entities: chlorprothixene / benzodiazepines
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: Consider additive sedative effects and confusional states to emerge, if chlorprothixene is given with benzodiazepines or barbituates.
entities: chlorprothixene / barbituates
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: Results from human in vitro metabolism studies and nonclinical studies show that REVLIMID  (lenalidomide) is neither metabolized by nor inhibits or induces the cytochrome P450 pathway suggesting that lenalidomide is not likely to cause or be subject to P450-based metabolic drug interactions in man.
entities: REVLIMID / lenalidomide
ddi: null
>>> match: metabolize_nsubj:pass_conj
-------------
sentence: Results from human in vitro metabolism studies and nonclinical studies show that REVLIMID  (lenalidomide) is neither metabolized by nor inhibits or induces the cytochrome P450 pathway suggesting that lenalidomide is not likely to cause or be subject to P450-based metabolic drug interactions in man.
entities: lenalidomide / lenalidomide
ddi: null
>>> match: metabolize_nsubj:pass_conj
-------------
sentence: Co-administration of multiple doses of 10 mg of lenalidomide had no effect on the single dose pharmacokinetics of R- and S- warfarin.
entities: lenalidomide / R- warfarin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Co-administration of multiple doses of 10 mg of lenalidomide had no effect on the single dose pharmacokinetics of R- and S- warfarin.
entities: lenalidomide / S- warfarin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Co-administration of single 25-mg dose warfarin had no effect on the pharmacokinetics of total lenalidomide.
entities: warfarin / lenalidomide
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Expected changes in laboratory assessments of PT and INR were observed after warfarin administration, but these changes were not affected by concomitant lenalidomide administration.
entities: warfarin / lenalidomide
ddi: null
>>> match: observe_obl_conj
-------------
sentence: Cholestyramine, an anionic-binding resin, has a considerable effect in lowering the rate and extent of fluvastatin bioavailability. 
entities: Cholestyramine / fluvastatin
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: Although this effect was noted even when cholestyramine was given 4 hours prior to fluvastatin, this regimen did not result in diminished efficacy. 
entities: cholestyramine / fluvastatin
ddi: effect
>>> match: give_nsubj:pass_advcl
-------------
sentence: Further, no effects on either warfarin levels or prothrombin times were observed in a study involving concomitant administration of warfarin and fluvastatin. 
entities: warfarin / warfarin
ddi: null
>>> match: observe_nsubj:pass_obl
-------------
sentence: Further, no effects on either warfarin levels or prothrombin times were observed in a study involving concomitant administration of warfarin and fluvastatin. 
entities: warfarin / fluvastatin
ddi: null
>>> match: observe_nsubj:pass_obl
-------------
sentence: Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data. 
entities: digoxin / digoxin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Caution should be exercised when the following drugs are administered concomitantly with LODOSYN (Carbidopa) given with levodopa or carbidopa-levodopa combination products.
entities: LODOSYN / levodopa
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Caution should be exercised when the following drugs are administered concomitantly with LODOSYN (Carbidopa) given with levodopa or carbidopa-levodopa combination products.
entities: LODOSYN / carbidopa
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Caution should be exercised when the following drugs are administered concomitantly with LODOSYN (Carbidopa) given with levodopa or carbidopa-levodopa combination products.
entities: LODOSYN / levodopa
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Caution should be exercised when the following drugs are administered concomitantly with LODOSYN (Carbidopa) given with levodopa or carbidopa-levodopa combination products.
entities: Carbidopa / levodopa
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Caution should be exercised when the following drugs are administered concomitantly with LODOSYN (Carbidopa) given with levodopa or carbidopa-levodopa combination products.
entities: Carbidopa / carbidopa
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Caution should be exercised when the following drugs are administered concomitantly with LODOSYN (Carbidopa) given with levodopa or carbidopa-levodopa combination products.
entities: Carbidopa / levodopa
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone) and isoniazid may reduce the therapeutic effects of levodopa.
entities: Dopamine D2 receptor antagonists / levodopa
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone) and isoniazid may reduce the therapeutic effects of levodopa.
entities: phenothiazines / levodopa
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone) and isoniazid may reduce the therapeutic effects of levodopa.
entities: butyrophenones / levodopa
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone) and isoniazid may reduce the therapeutic effects of levodopa.
entities: risperidone / levodopa
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone) and isoniazid may reduce the therapeutic effects of levodopa.
entities: isoniazid / levodopa
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: In addition, the beneficial effects of levodopa in Parkinsons disease have been reported to be reversed by phenytoin and papaverine.
entities: levodopa / phenytoin
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: In addition, the beneficial effects of levodopa in Parkinsons disease have been reported to be reversed by phenytoin and papaverine.
entities: levodopa / papaverine
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Iron salts may reduce the bioavailability of carbidopa and levodopa.
entities: Iron / carbidopa
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Iron salts may reduce the bioavailability of carbidopa and levodopa.
entities: Iron / levodopa
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Although metoclopramide may increase the bioavailability of levodopa by increasing gastric emptying, metoclopramide may also adversely affect disease control by its dopamine receptor antagonistic properties.
entities: metoclopramide / levodopa
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Although metoclopramide may increase the bioavailability of levodopa by increasing gastric emptying, metoclopramide may also adversely affect disease control by its dopamine receptor antagonistic properties.
entities: metoclopramide / metoclopramide
ddi: null
>>> match: increase_nsubj_advmod
-------------
sentence: Although metoclopramide may increase the bioavailability of levodopa by increasing gastric emptying, metoclopramide may also adversely affect disease control by its dopamine receptor antagonistic properties.
entities: levodopa / metoclopramide
ddi: null
>>> match: increase_obj_advmod
-------------
sentence: Azlocillin should not be administered concomitantly with amikacin, ciprofloxacin, gentamicin, netilmicin, or tobramycin.
entities: Azlocillin / amikacin
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Azlocillin should not be administered concomitantly with amikacin, ciprofloxacin, gentamicin, netilmicin, or tobramycin.
entities: Azlocillin / ciprofloxacin
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Azlocillin should not be administered concomitantly with amikacin, ciprofloxacin, gentamicin, netilmicin, or tobramycin.
entities: Azlocillin / gentamicin
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Azlocillin should not be administered concomitantly with amikacin, ciprofloxacin, gentamicin, netilmicin, or tobramycin.
entities: Azlocillin / netilmicin
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Azlocillin should not be administered concomitantly with amikacin, ciprofloxacin, gentamicin, netilmicin, or tobramycin.
entities: Azlocillin / tobramycin
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Co-administration of BOTOX and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated.
entities: BOTOX / toxin
ddi: null
>>> match: perform_nsubj:pass_obl
-------------
sentence: Co-administration of BOTOX and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated.
entities: aminoglycosides / toxin
ddi: null
>>> match: perform_nsubj:pass_obl
-------------
sentence: Co-administration of BOTOX and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated.
entities: curare-like compounds / toxin
ddi: null
>>> match: perform_nsubj:pass_obl
-------------
sentence: Excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.
entities: botulinum toxin / botulinum toxin
ddi: effect
>>> match: exacerbate_obl_advcl
-------------
sentence: OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of everolimus and cyclosporine (INN, ciclosporin) when coadministered in de novo kidney allograft recipients during the first year after transplantation. 
entities: everolimus / ciclosporin
ddi: null
>>> match: characterize_obj_dep
-------------
sentence: OBJECTIVE: Our objective was to characterize the steady-state pharmacokinetics of everolimus and cyclosporine (INN, ciclosporin) when coadministered in de novo kidney allograft recipients during the first year after transplantation. 
entities: cyclosporine / ciclosporin
ddi: null
>>> match: characterize_obj_dep
-------------
sentence: METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive everolimus tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with cyclosporine and prednisone. 
entities: everolimus / cyclosporine
ddi: null
>>> match: receive_obj_obl
-------------
sentence: METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive everolimus tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with cyclosporine and prednisone. 
entities: everolimus / prednisone
ddi: null
>>> match: receive_obj_obl
-------------
sentence: Cyclosporine doses, trough concentrations, and AUC exhibited similar temporal patterns during the course of the study regardless of the co-administered everolimus dose level (P = .13, .82, and .76, respectively). 
entities: Cyclosporine / everolimus
ddi: null
>>> match: exhibit_nsubj_advmod
-------------
sentence: For a 4-fold range of everolimus doses there were no differential effects on cyclosporine dosing or pharmacokinetics.
entities: everolimus / cyclosporine
ddi: null
>>> match: be_obl_nsubj
-------------
sentence: Because ondansetron is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes (CYP3A4, CYP2D6, CYP1A2), inducers or inhibitors of these enzymes may change the clearance and, hence, the half-life of ondansetron. 
entities: ondansetron / ondansetron
ddi: null
>>> match: change_advcl_obj
-------------
sentence: Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. 
entities: phenytoin / ondansetron
ddi: mechanism
>>> match: increase_obl_nsubj:pass
-------------
sentence: Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. 
entities: phenytoin / ondansetron
ddi: mechanism
>>> match: increase_obl_conj
-------------
sentence: Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. 
entities: carbamazepine / ondansetron
ddi: mechanism
>>> match: increase_obl_nsubj:pass
-------------
sentence: Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. 
entities: carbamazepine / ondansetron
ddi: mechanism
>>> match: increase_obl_conj
-------------
sentence: Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. 
entities: rifampicin / ondansetron
ddi: mechanism
>>> match: increase_obl_nsubj:pass
-------------
sentence: Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. 
entities: rifampicin / ondansetron
ddi: mechanism
>>> match: increase_obl_conj
-------------
sentence: Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. 
entities: ondansetron / ondansetron
ddi: null
>>> match: increase_nsubj:pass_conj
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: ondansetron / Tramadol
ddi: null
>>> match: recommend_nsubj:pass_obj
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: ondansetron / ondansetron
ddi: null
>>> match: recommend_nsubj:pass_obj
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: ondansetron / tramadol
ddi: null
>>> match: recommend_nsubj:pass_obj
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: ondansetron / ondansetron
ddi: null
>>> match: recommend_nsubj:pass_obj
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: ondansetron / tramadol
ddi: null
>>> match: recommend_nsubj:pass_obj
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: ondansetron / ondansetron
ddi: null
>>> match: recommend_nsubj:pass_obj
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: ondansetron / ondansetron
ddi: null
>>> match: indicate_advcl_ccomp
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: ondansetron / tramadol
ddi: null
>>> match: indicate_advcl_ccomp
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: ondansetron / ondansetron
ddi: null
>>> match: indicate_advcl_obj
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: tramadol / ondansetron
ddi: null
>>> match: indicate_advcl_ccomp
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: tramadol / tramadol
ddi: null
>>> match: indicate_advcl_ccomp
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: tramadol / ondansetron
ddi: null
>>> match: indicate_advcl_obj
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: ondansetron / tramadol
ddi: effect
>>> match: associate_nsubj:pass_obl
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: ondansetron / ondansetron
ddi: null
>>> match: indicate_ccomp_obj
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron. 
entities: tramadol / ondansetron
ddi: null
>>> match: indicate_ccomp_obj
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: ketoconazole / dasatinib
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: itraconazole / dasatinib
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: erythromycin / dasatinib
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: clarithromycin / dasatinib
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: ritonavir / dasatinib
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: atazanavir / dasatinib
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: indinavir / dasatinib
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: nefazodone / dasatinib
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: nelfinavir / dasatinib
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: saquinavir / dasatinib
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Concomitant use of SPRYCEL and drugs that inhibit CYP3A4 (eg, ketoconazole, itraconazole, erythromycin, clarithromycin, ritonavir, atazanavir, indinavir, nefazodone, nelfinavir, saquinavir, telithromycin) may increase exposure to dasatinib and should be avoided.
entities: telithromycin / dasatinib
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: In patients receiving treatment with SPRYCEL, close monitoring for toxicity and a SPRYCEL dose reduction should be considered if systemic administration of a potent CYP3A4 inhibitor cannot be avoided.
entities: SPRYCEL / SPRYCEL
ddi: null
>>> match: consider_obl_nsubj:pass
-------------
sentence: If SPRYCEL must be administered with a CYP3A4 inducer, a dose increase in SPRYCEL should be considered.
entities: SPRYCEL / SPRYCEL
ddi: null
>>> match: consider_advcl_nsubj:pass
-------------
sentence: If antacid therapy is needed, the antacid dose should be administered at least 2 hours prior to or 2 hours after the dose of SPRYCEL.
entities: antacid / SPRYCEL
ddi: advise
>>> match: administer_advcl_obl
-------------
sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.
entities: antacids / H2 blockers
ddi: null
>>> match: consider_nsubj:pass_obl
-------------
sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.
entities: antacids / proton pump inhibitors
ddi: null
>>> match: consider_nsubj:pass_obl
-------------
sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.
entities: antacids / SPRYCEL
ddi: null
>>> match: consider_nsubj:pass_obl
-------------
sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.
entities: H2 blockers / SPRYCEL
ddi: advise
>>> match: consider_obl_obl
-------------
sentence: The use of antacids should be considered in place of H2 blockers or proton pump inhibitors in patients receiving SPRYCEL therapy.
entities: proton pump inhibitors / SPRYCEL
ddi: advise
>>> match: consider_obl_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: alfentanil / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: astemizole / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: terfenadine / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: cisapride / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: cyclosporine / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: fentanyl / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: pimozide / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: quinidine / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: sirolimus / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: tacrolimus / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: ergot alkaloids / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: ergotamine / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Therefore, CYP3A4 substrates known to have a narrow therapeutic index such as alfentanil, astemizole, terfenadine, cisapride, cyclosporine, fentanyl, pimozide, quinidine, sirolimus, tacrolimus, or ergot alkaloids (ergotamine, dihydroergotamine) should be administered with caution in patients receiving SPRYCEL.
entities: dihydroergotamine / SPRYCEL
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: anagrelide / digoxin
ddi: null
>>> match: affect_advmod_obj
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: anagrelide / warfarin
ddi: null
>>> match: affect_advmod_obj
-------------
sentence: Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with anagrelide in clinical trials were aspirin, acetaminophen, furosemide, iron, ranitidine, hydroxyurea, and allopurinol.
entities: anagrelide / aspirin
ddi: null
>>> match: use_obl_dep
-------------
sentence: Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with anagrelide in clinical trials were aspirin, acetaminophen, furosemide, iron, ranitidine, hydroxyurea, and allopurinol.
entities: anagrelide / acetaminophen
ddi: null
>>> match: use_obl_dep
-------------
sentence: Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with anagrelide in clinical trials were aspirin, acetaminophen, furosemide, iron, ranitidine, hydroxyurea, and allopurinol.
entities: anagrelide / furosemide
ddi: null
>>> match: use_obl_dep
-------------
sentence: Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with anagrelide in clinical trials were aspirin, acetaminophen, furosemide, iron, ranitidine, hydroxyurea, and allopurinol.
entities: anagrelide / iron
ddi: null
>>> match: use_obl_dep
-------------
sentence: Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with anagrelide in clinical trials were aspirin, acetaminophen, furosemide, iron, ranitidine, hydroxyurea, and allopurinol.
entities: anagrelide / ranitidine
ddi: null
>>> match: use_obl_dep
-------------
sentence: Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with anagrelide in clinical trials were aspirin, acetaminophen, furosemide, iron, ranitidine, hydroxyurea, and allopurinol.
entities: anagrelide / hydroxyurea
ddi: null
>>> match: use_obl_dep
-------------
sentence: Although additional drug interaction studies have not been conducted, the most common medications used concomitantly with anagrelide in clinical trials were aspirin, acetaminophen, furosemide, iron, ranitidine, hydroxyurea, and allopurinol.
entities: anagrelide / allopurinol
ddi: null
>>> match: use_obl_dep
-------------
sentence: An in vivo interaction study in humans demonstrated that a single 1mg dose of anagrelide administered concomitantly with a single 900 mg dose of aspirin was generally well tolerated.
entities: anagrelide / aspirin
ddi: null
>>> match: administer_nsubj_obl
-------------
sentence: Anagrelide alone had no effect on platelet aggregation, but did slightly enhance the inhibition of platelet aggregation by aspirin.
entities: Anagrelide / aspirin
ddi: effect
>>> match: have_nsubj_conj
-------------
sentence: It is known that CYP1A2 is inhibited by several medicinal products, including fluvoxamine, and such medicinal products could theoretically adversely influence the clearance of anagrelide.
entities: fluvoxamine / anagrelide
ddi: mechanism
>>> match: influence_csubj_obj
-------------
sentence: Anagrelide demonstrates some limited inhibitory activity towards CYP1A2 which may present a theoretical potential for interaction with other coadministered medicinal products sharing that clearance mechanism e.g. theophylline.
entities: Anagrelide / theophylline
ddi: mechanism
>>> match: demonstrate_nsubj_obj
-------------
sentence: The effects of medicinal products with similar properties such as inotropes milrinone, enoximone, amrinone, olprinone and cilostazol may be exacerbated by anagrelide.
entities: milrinone / anagrelide
ddi: effect
>>> match: exacerbate_nsubj:pass_obl
-------------
sentence: The effects of medicinal products with similar properties such as inotropes milrinone, enoximone, amrinone, olprinone and cilostazol may be exacerbated by anagrelide.
entities: enoximone / anagrelide
ddi: effect
>>> match: exacerbate_nsubj:pass_obl
-------------
sentence: The effects of medicinal products with similar properties such as inotropes milrinone, enoximone, amrinone, olprinone and cilostazol may be exacerbated by anagrelide.
entities: amrinone / anagrelide
ddi: effect
>>> match: exacerbate_nsubj:pass_obl
-------------
sentence: The effects of medicinal products with similar properties such as inotropes milrinone, enoximone, amrinone, olprinone and cilostazol may be exacerbated by anagrelide.
entities: olprinone / anagrelide
ddi: effect
>>> match: exacerbate_nsubj:pass_obl
-------------
sentence: The effects of medicinal products with similar properties such as inotropes milrinone, enoximone, amrinone, olprinone and cilostazol may be exacerbated by anagrelide.
entities: cilostazol / anagrelide
ddi: effect
>>> match: exacerbate_nsubj:pass_obl
-------------
sentence: There is a single case report, which suggests that sucralfate may interfere with anagrelide absorption.
entities: sucralfate / anagrelide
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Oral Anticoagulants CAUTION SHOULD BE EXERCISED WHEN COUMARIN ANTICOAGULANTS ARE GIVEN IN CONJUNCTION WITH TRICOR.
entities: Anticoagulants / COUMARIN ANTICOAGULANTS
ddi: null
>>> match: exercise_nsubj:pass_advcl
-------------
sentence: Oral Anticoagulants CAUTION SHOULD BE EXERCISED WHEN COUMARIN ANTICOAGULANTS ARE GIVEN IN CONJUNCTION WITH TRICOR.
entities: Anticoagulants / TRICOR
ddi: null
>>> match: exercise_nsubj:pass_advcl
-------------
sentence: Resins: Since bile acid sequestrants may bind other drugs given concurrently, patients should take TRICOR at least 1 hour before or 4-6 hours after a bile acid binding resin to avoid impeding its absorption.
entities: bile acid sequestrants / TRICOR
ddi: null
>>> match: take_advcl_obj
-------------
sentence: Resins: Since bile acid sequestrants may bind other drugs given concurrently, patients should take TRICOR at least 1 hour before or 4-6 hours after a bile acid binding resin to avoid impeding its absorption.
entities: bile acid sequestrants / bile acid binding resin
ddi: null
>>> match: take_advcl_obl:tmod
-------------
sentence: Resins: Since bile acid sequestrants may bind other drugs given concurrently, patients should take TRICOR at least 1 hour before or 4-6 hours after a bile acid binding resin to avoid impeding its absorption.
entities: TRICOR / bile acid binding resin
ddi: mechanism
>>> match: take_obj_obl:tmod
-------------
sentence: Cyclosporine: Because cyclosporine can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine, and because renal excretion is the primary elimination route of fibrate drugs including TRICOR, there is a risk that an interaction will lead to deterioration.
entities: cyclosporine / fibrate drugs
ddi: effect
>>> match: produce_nsubj_conj
-------------
sentence: Cyclosporine: Because cyclosporine can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine, and because renal excretion is the primary elimination route of fibrate drugs including TRICOR, there is a risk that an interaction will lead to deterioration.
entities: cyclosporine / TRICOR
ddi: effect
>>> match: produce_nsubj_conj
-------------
sentence: Therefore, fenofibrate should be taken at least 1 hour before or 4-6 hours after a bile acid binding resin to avoid impeding its absorption .
entities: fenofibrate / bile acid binding resin
ddi: advise
>>> match: take_nsubj:pass_advcl
-------------
sentence: Concomitant administration of fenofibrate (equivalent to 145mg TRICOR) with pravastatin (40 mg) once daily for 10 days has been shown to increase the mean Cmax and AUC values for pravastatin by 36% (range from 69% decrease to 321% increase) and 28% (range from 54% decrease to 128% increase), respectively, and for 3 -hydroxy-iso-pravastatin by 55% (range from 32% decrease to 314% increase) and 39% (range from 24% decrease to 261% increase), respectively in 23 healthy adults.
entities: fenofibrate / pravastatin
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Concomitant administration of fenofibrate (equivalent to 145mg TRICOR) with pravastatin (40 mg) once daily for 10 days has been shown to increase the mean Cmax and AUC values for pravastatin by 36% (range from 69% decrease to 321% increase) and 28% (range from 54% decrease to 128% increase), respectively, and for 3 -hydroxy-iso-pravastatin by 55% (range from 32% decrease to 314% increase) and 39% (range from 24% decrease to 261% increase), respectively in 23 healthy adults.
entities: TRICOR / pravastatin
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Concomitant administration of fenofibrate (equivalent to 145mg TRICOR) with pravastatin (40 mg) once daily for 10 days has been shown to increase the mean Cmax and AUC values for pravastatin by 36% (range from 69% decrease to 321% increase) and 28% (range from 54% decrease to 128% increase), respectively, and for 3 -hydroxy-iso-pravastatin by 55% (range from 32% decrease to 314% increase) and 39% (range from 24% decrease to 261% increase), respectively in 23 healthy adults.
entities: pravastatin / pravastatin
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: A single dose of pravastatin had no clinically important effect on the pharmacokinetics of fenofibric acid.
entities: pravastatin / fenofibric acid
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Concomitant administration of fenofibrate (equivalent to 145 mg TRICOR) with atorvastatin (20 mg) once daily for 10 days resulted in approximately 17% decrease (range from 67% decrease to 44% increase) in atorvastatin AUC values in 22 healthy males.
entities: fenofibrate / atorvastatin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Concomitant administration of fenofibrate (equivalent to 145 mg TRICOR) with atorvastatin (20 mg) once daily for 10 days resulted in approximately 17% decrease (range from 67% decrease to 44% increase) in atorvastatin AUC values in 22 healthy males.
entities: TRICOR / atorvastatin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Concomitant administration of fenofibrate (equivalent to 145 mg TRICOR) with atorvastatin (20 mg) once daily for 10 days resulted in approximately 17% decrease (range from 67% decrease to 44% increase) in atorvastatin AUC values in 22 healthy males.
entities: atorvastatin / atorvastatin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The atorvastatin Cmax values were not significantly affected by fenofibrate.
entities: atorvastatin / fenofibrate
ddi: null
>>> match: affect_nsubj:pass_obl
-------------
sentence: The pharmacokinetics of fenofibric acid were not significantly affected by atorvastatin
entities: fenofibric acid / atorvastatin
ddi: null
>>> match: affect_nsubj:pass_obl
-------------
sentence: Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); 
entities: dasatinib / dasatinib
ddi: null
>>> match: inhibit_nsubj_obj
-------------
sentence: Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); 
entities: dasatinib / paclitaxel
ddi: null
>>> match: inhibit_nsubj_obj
-------------
sentence: Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); 
entities: dasatinib / paclitaxel
ddi: null
>>> match: inhibit_nsubj_obj
-------------
sentence: Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); 
entities: paclitaxel / dasatinib
ddi: null
>>> match: inhibit_nsubj_obj
-------------
sentence: Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); 
entities: paclitaxel / paclitaxel
ddi: null
>>> match: inhibit_nsubj_obj
-------------
sentence: Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014); 
entities: paclitaxel / paclitaxel
ddi: null
>>> match: inhibit_nsubj_obj
-------------
sentence: The siRNA knockdown of p27(Kip1) decreased dasatinib- and paclitaxel-induced apoptosis compared with a negative control siRNA (sub-G1 fraction, control siRNA vs. p27(Kip1) siRNA: 42.5% vs. 20.1%, difference = 22.4%, 95% CI = 20.1% to 24.7%, P = .017). 
entities: dasatinib / paclitaxel
ddi: null
>>> match: decrease_punct_conj
-------------
sentence: Inhibition of Src family and Abl kinases with either siRNAs or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.
entities: dasatinib / paclitaxel
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: In healthy volunteers, the pharmacokinetics of a 1-mg dose of butorphanol administered as STADOL NS were not affected by the coadministration of a single 6-mg subcutaneous dose of sumatriptan.
entities: butorphanol / STADOL NS
ddi: null
>>> match: administer_nsubj_advcl
-------------
sentence: In healthy volunteers, the pharmacokinetics of a 1-mg dose of butorphanol administered as STADOL NS were not affected by the coadministration of a single 6-mg subcutaneous dose of sumatriptan.
entities: butorphanol / sumatriptan
ddi: null
>>> match: administer_nsubj_advcl
-------------
sentence: However, in another study in healthy volunteers, the pharmacokinetics of butorphanol were significantly altered (29% decrease in AUC and 38% decrease in Cmax) when a 1-mg dose of STADOL NS was administered 1 minute after a 20-mg dose of sumatriptan nasal spray.
entities: butorphanol / STADOL NS
ddi: null
>>> match: alter_nsubj:pass_advcl
-------------
sentence: However, in another study in healthy volunteers, the pharmacokinetics of butorphanol were significantly altered (29% decrease in AUC and 38% decrease in Cmax) when a 1-mg dose of STADOL NS was administered 1 minute after a 20-mg dose of sumatriptan nasal spray.
entities: butorphanol / sumatriptan
ddi: null
>>> match: alter_nsubj:pass_advcl
-------------
sentence: However, in another study in healthy volunteers, the pharmacokinetics of butorphanol were significantly altered (29% decrease in AUC and 38% decrease in Cmax) when a 1-mg dose of STADOL NS was administered 1 minute after a 20-mg dose of sumatriptan nasal spray.
entities: STADOL NS / sumatriptan
ddi: mechanism
>>> match: administer_nsubj:pass_obj
-------------
sentence: When the STADOL NS was administered 30 minutes after the sumatriptan nasal spray, the AUC of butorphanol increased 11% and Cmax decreased 18%.
entities: STADOL NS / sumatriptan
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: When the STADOL NS was administered 30 minutes after the sumatriptan nasal spray, the AUC of butorphanol increased 11% and Cmax decreased 18%.
entities: STADOL NS / butorphanol
ddi: null
>>> match: increase_advcl_nsubj
-------------
sentence: When the STADOL NS was administered 30 minutes after the sumatriptan nasal spray, the AUC of butorphanol increased 11% and Cmax decreased 18%.
entities: sumatriptan / butorphanol
ddi: null
>>> match: increase_advcl_nsubj
-------------
sentence: These results suggest that the analgesic effect of STADOL NS may be diminished when it is administered shortly after sumatriptan nasal spray, but by 30 minutes any such reduction in effect should be minimal.
entities: STADOL NS / sumatriptan
ddi: effect
>>> match: diminish_nsubj:pass_advcl
-------------
sentence: The pharmacokinetics of a 1-mg dose of butorphanol administered as STADOL NS were not affected by the coadministration of cimetidine (300 mg QID).
entities: butorphanol / STADOL NS
ddi: null
>>> match: administer_nsubj_advcl
-------------
sentence: The pharmacokinetics of a 1-mg dose of butorphanol administered as STADOL NS were not affected by the coadministration of cimetidine (300 mg QID).
entities: butorphanol / cimetidine
ddi: null
>>> match: administer_nsubj_advcl
-------------
sentence: It is not known if the effects of butorphanol are altered by concomitant medications that affect hepatic metabolism of drugs (erythromycin, etc.), but physicians should be alert to the possibility that a smaller initial dose and longer intervals between doses may be needed.
entities: butorphanol / erythromycin
ddi: advise
>>> match: alter_nsubj:pass_obl
-------------
sentence: We sought to evaluate whether initiation of an antidepressant increases the risk of hospitalization for gastrointestinal bleeding in warfarin users.
entities: antidepressant / warfarin
ddi: null
>>> match: increase_nsubj_obl
-------------
sentence: In total, 430,455 warfarin users contributed 407,370 person-years of warfarin use. 
entities: warfarin / warfarin
ddi: null
>>> match: contribute_nsubj_iobj
-------------
sentence: Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). 
entities: Warfarin / citalopram
ddi: effect
>>> match: have_nsubj_obl
-------------
sentence: Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). 
entities: Warfarin / fluoxetine
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). 
entities: Warfarin / paroxetine
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). 
entities: Warfarin / amitriptyline
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). 
entities: citalopram / fluoxetine
ddi: null
>>> match: have_obl_obj
-------------
sentence: Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). 
entities: citalopram / paroxetine
ddi: null
>>> match: have_obl_obj
-------------
sentence: Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]). 
entities: citalopram / amitriptyline
ddi: null
>>> match: have_obl_obj
-------------
sentence: Long Acting Nitrates: Nifedipine may be safely co-administered with nitrates, but there have been no controlled studies to evaluate the antianginal effectiveness of this combination.
entities: Nifedipine / nitrates
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Digitalis: Immediate Release Capsules: Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / digoxin
ddi: null
>>> match: isolate_obj_conj
-------------
sentence: Digitalis: Immediate Release Capsules: Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / nifedipine
ddi: null
>>> match: isolate_obj_conj
-------------
sentence: Digitalis: Immediate Release Capsules: Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / digoxin
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: Digitalis: Immediate Release Capsules: Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / nifedipine
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: Digitalis: Immediate Release Capsules: Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / digoxin
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: Digitalis: Immediate Release Capsules: Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / nifedipine
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: Digitalis: Immediate Release Capsules: Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: nifedipine / digoxin
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: Digitalis: Immediate Release Capsules: Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: nifedipine / nifedipine
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: Digitalis: Immediate Release Capsules: Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / nifedipine
ddi: advise
>>> match: monitor_nsubj:pass_dep
-------------
sentence: Extended Release Tablets: Administration of nifedipine with digoxin increased digoxin levels in 9 of 12 normal volunteers.
entities: nifedipine / digoxin
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Extended Release Tablets: Administration of nifedipine with digoxin increased digoxin levels in 9 of 12 normal volunteers.
entities: digoxin / digoxin
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Since there have been isolated reports of patients with elevated digoxin levels, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / digoxin
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: Since there have been isolated reports of patients with elevated digoxin levels, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / nifedipine
ddi: null
>>> match: recommend_advcl_ccomp
-------------
sentence: Since there have been isolated reports of patients with elevated digoxin levels, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / nifedipine
ddi: advise
>>> match: monitor_nsubj:pass_dep
-------------
sentence: Coumarin Anticoagulants: There have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom nifedipine was administered.
entities: coumarin anticoagulants / nifedipine
ddi: effect
>>> match: take_obj_advcl
-------------
sentence: If nifedipine therapy is initiated in a patient currently receiving cimetidine, cautious titration is advised.
entities: nifedipine / cimetidine
ddi: advise
>>> match: initiate_nsubj:pass_advcl
-------------
sentence: Improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal disease.

entities: cinacalcet / darbepoetin
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: The primary objective of the study was to ascertain the difference in darbepoetin responsiveness before and after 12 months of cinacalcet therapy. 
entities: darbepoetin / cinacalcet
ddi: null
>>> match: ascertain_obj_advmod
-------------
sentence: Reduction of PTH by cinacalcet is associated with a decrease in darbepoetin requirement. 
entities: cinacalcet / darbepoetin
ddi: effect
>>> match: associate_nsubj:pass_obl
-------------
sentence: In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after cisplatin than with the alternate sequence (ie, TAXOL before cisplatin).
entities: TAXOL / cisplatin
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after cisplatin than with the alternate sequence (ie, TAXOL before cisplatin).
entities: TAXOL / TAXOL
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after cisplatin than with the alternate sequence (ie, TAXOL before cisplatin).
entities: TAXOL / cisplatin
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after cisplatin than with the alternate sequence (ie, TAXOL before cisplatin).
entities: cisplatin / TAXOL
ddi: null
>>> match: give_obl_obl
-------------
sentence: In a Phase I trial using escalating doses of TAXOL (110-200 mg/m2) and cisplatin (50 or 75 mg/m2) given as sequential infusions, myelosuppression was more profound when TAXOL was given after cisplatin than with the alternate sequence (ie, TAXOL before cisplatin).
entities: cisplatin / cisplatin
ddi: null
>>> match: give_obl_obl
-------------
sentence: Pharmacokinetic data from these patients demonstrated a decrease in paclitaxel clearance of approximately 33% when TAXOL was administered following cisplatin.
entities: TAXOL / cisplatin
ddi: mechanism
>>> match: administer_nsubj:pass_obl
-------------
sentence: Reports in the literature suggest that plasma levels of doxorubicin (and its active metabolite doxorubicinol) may be increased when paclitaxel and doxorubicin are used in combination.
entities: doxorubicin / paclitaxel
ddi: null
>>> match: increase_nsubj:pass_advcl
-------------
sentence: Reports in the literature suggest that plasma levels of doxorubicin (and its active metabolite doxorubicinol) may be increased when paclitaxel and doxorubicin are used in combination.
entities: doxorubicin / doxorubicin
ddi: null
>>> match: increase_nsubj:pass_advcl
-------------
sentence: Reports in the literature suggest that plasma levels of doxorubicin (and its active metabolite doxorubicinol) may be increased when paclitaxel and doxorubicin are used in combination.
entities: doxorubicinol / paclitaxel
ddi: null
>>> match: increase_nsubj:pass_advcl
-------------
sentence: Reports in the literature suggest that plasma levels of doxorubicin (and its active metabolite doxorubicinol) may be increased when paclitaxel and doxorubicin are used in combination.
entities: doxorubicinol / doxorubicin
ddi: null
>>> match: increase_nsubj:pass_advcl
-------------
sentence: Hypersensitivity Reactions: Patients with a history of severe hypersensitivity reactions to products containing Cremophor  EL (eg, cyclosporin for injection concentrate and teniposide for injection concentrate) should not be treated with TAXOL.
entities: cyclosporin / TAXOL
ddi: advise
>>> match: treat_nsubj:pass_obl
-------------
sentence: Hypersensitivity Reactions: Patients with a history of severe hypersensitivity reactions to products containing Cremophor  EL (eg, cyclosporin for injection concentrate and teniposide for injection concentrate) should not be treated with TAXOL.
entities: teniposide / TAXOL
ddi: advise
>>> match: treat_nsubj:pass_obl
-------------
sentence: In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with corticosteroids (such as dexamethasone), diphen-hydramine and H2 antagonists (such as cimetidine or ranitidine).
entities: TAXOL / corticosteroids
ddi: null
>>> match: treat_obl_dep
-------------
sentence: In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with corticosteroids (such as dexamethasone), diphen-hydramine and H2 antagonists (such as cimetidine or ranitidine).
entities: TAXOL / dexamethasone
ddi: null
>>> match: treat_obl_dep
-------------
sentence: In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with corticosteroids (such as dexamethasone), diphen-hydramine and H2 antagonists (such as cimetidine or ranitidine).
entities: TAXOL / H2 antagonists
ddi: null
>>> match: treat_obl_dep
-------------
sentence: In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with corticosteroids (such as dexamethasone), diphen-hydramine and H2 antagonists (such as cimetidine or ranitidine).
entities: TAXOL / cimetidine
ddi: null
>>> match: treat_obl_dep
-------------
sentence: In order to avoid the occurrence of severe hypersensitivity reactions, all patients treated with TAXOL should be premedicated with corticosteroids (such as dexamethasone), diphen-hydramine and H2 antagonists (such as cimetidine or ranitidine).
entities: TAXOL / ranitidine
ddi: null
>>> match: treat_obl_dep
-------------
sentence: However, severe reactions, such as hypotension requiring treatment, dyspnea requiring bronchodilators, angioedema, or generalized urticaria require immediate discontinuation of TAXOL and aggressive symptomatic therapy.
entities: bronchodilators / TAXOL
ddi: null
>>> match: require_nsubj_obj
-------------
sentence: Caution should be exercised when Methergine    (methylergonovine maleate) is used concurrently with other vasoconstrictors or ergot alkaloids.
entities: Methergine / vasoconstrictors
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Caution should be exercised when Methergine    (methylergonovine maleate) is used concurrently with other vasoconstrictors or ergot alkaloids.
entities: Methergine / ergot alkaloids
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Caution should be exercised when Methergine    (methylergonovine maleate) is used concurrently with other vasoconstrictors or ergot alkaloids.
entities: methylergonovine maleate / vasoconstrictors
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Caution should be exercised when Methergine    (methylergonovine maleate) is used concurrently with other vasoconstrictors or ergot alkaloids.
entities: methylergonovine maleate / ergot alkaloids
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: ethambutol / ethambutol
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: ethambutol / ethambutol
ddi: null
>>> match: show_nsubj_dep
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: ethambutol / antacid products
ddi: null
>>> match: show_nsubj_dep
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: aluminum hydroxide / ethambutol
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: aluminum hydroxide / ethambutol
ddi: null
>>> match: show_nsubj_dep
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: aluminum hydroxide / antacid products
ddi: null
>>> match: show_nsubj_dep
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: antacid / ethambutol
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: antacid / ethambutol
ddi: null
>>> match: show_nsubj_dep
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: antacid / antacid products
ddi: null
>>> match: show_nsubj_dep
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: ethambutol / ethambutol
ddi: null
>>> match: show_obj_dep
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: ethambutol / antacid products
ddi: null
>>> match: show_obj_dep
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: ethambutol / antacid products
ddi: null
>>> match: reduce_nsubj:pass_obl
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: ethambutol / aluminum hydroxide
ddi: advise
>>> match: avoid_obj_advcl
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: ethambutol / antacids
ddi: null
>>> match: avoid_obj_advcl
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: ethambutol / ethambutol
ddi: null
>>> match: avoid_obj_advcl
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: aluminum hydroxide / antacids
ddi: null
>>> match: contain_nsubj_obj
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: aluminum hydroxide / ethambutol
ddi: null
>>> match: contain_nsubj_obl
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: antacids / ethambutol
ddi: null
>>> match: contain_obj_obl
-------------
sentence: Antacid: When atorvastatin and Maalox TC suspension were coadministered, plasma concentrations of atorvastatin decreased approximately 35%.
entities: atorvastatin / atorvastatin
ddi: null
>>> match: coadminister_nsubj:pass_parataxis
-------------
sentence: Antacid: When atorvastatin and Maalox TC suspension were coadministered, plasma concentrations of atorvastatin decreased approximately 35%.
entities: Maalox TC / atorvastatin
ddi: null
>>> match: coadminister_nsubj:pass_parataxis
-------------
sentence: Antipyrine: Because atorvastatin does not affect the pharmacokinetics of antipyrine, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.
entities: atorvastatin / drugs
ddi: null
>>> match: metabolize_advcl_nsubj
-------------
sentence: Antipyrine: Because atorvastatin does not affect the pharmacokinetics of antipyrine, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.
entities: antipyrine / drugs
ddi: null
>>> match: metabolize_advcl_nsubj
-------------
sentence: Colestipol: Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and atorvastatin were coadministered.
entities: atorvastatin / colestipol
ddi: null
>>> match: decrease_nsubj_advcl
-------------
sentence: Colestipol: Plasma concentrations of atorvastatin decreased approximately 25% when colestipol and atorvastatin were coadministered.
entities: atorvastatin / atorvastatin
ddi: null
>>> match: decrease_nsubj_advcl
-------------
sentence: Digoxin: When multiple doses of atorvastatin and digoxin were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.
entities: atorvastatin / digoxin
ddi: null
>>> match: increase_advcl_nsubj
-------------
sentence: Digoxin: When multiple doses of atorvastatin and digoxin were coadministered, steady-state plasma digoxin concentrations increased by approximately 20%.
entities: digoxin / digoxin
ddi: null
>>> match: increase_advcl_nsubj
-------------
sentence: Erythromycin: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of atorvastatin and erythromycin, a known inhibitor of cytochrome P450 3A4.
entities: atorvastatin / atorvastatin
ddi: null
>>> match: increase_nsubj_obl
-------------
sentence: Erythromycin: In healthy individuals, plasma concentrations of atorvastatin increased approximately 40% with coadministration of atorvastatin and erythromycin, a known inhibitor of cytochrome P450 3A4.
entities: atorvastatin / erythromycin
ddi: null
>>> match: increase_nsubj_obl
-------------
sentence: Oral Contraceptives: Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.
entities: atorvastatin / norethindrone
ddi: mechanism
>>> match: increase_nsubj_ccomp
-------------
sentence: Oral Contraceptives: Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.
entities: atorvastatin / ethinyl estradiol
ddi: mechanism
>>> match: increase_nsubj_ccomp
-------------
sentence: Oral Contraceptives: Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.
entities: contraceptive / norethindrone
ddi: null
>>> match: increase_nsubj_ccomp
-------------
sentence: Oral Contraceptives: Coadministration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol by approximately 30% and 20%.
entities: contraceptive / ethinyl estradiol
ddi: null
>>> match: increase_nsubj_ccomp
-------------
sentence: Warfarin: Atorvastatin had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.
entities: Atorvastatin / warfarin
ddi: null
>>> match: have_nsubj_advcl
-------------
sentence: Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, spironolactone, and cimetidine.
entities: HMG-CoA reductase inhibitor / ketoconazole
ddi: advise
>>> match: administer_nsubj:pass_ccomp
-------------
sentence: Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, spironolactone, and cimetidine.
entities: HMG-CoA reductase inhibitor / spironolactone
ddi: advise
>>> match: administer_nsubj:pass_ccomp
-------------
sentence: Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, spironolactone, and cimetidine.
entities: HMG-CoA reductase inhibitor / cimetidine
ddi: advise
>>> match: administer_nsubj:pass_ccomp
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: buspirone hydrochloride / MAO inhibitors
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: buspirone hydrochloride / buspirone HCl
ddi: null
>>> match: use_nsubj:pass_advcl
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: buspirone hydrochloride / psychotropic drugs
ddi: null
>>> match: use_nsubj:pass_advcl
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: buspirone hydrochloride / buspirone HCl
ddi: null
>>> match: use_nsubj:pass_advcl
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: MAO inhibitors / buspirone HCl
ddi: null
>>> match: use_obl_advcl
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: MAO inhibitors / psychotropic drugs
ddi: null
>>> match: use_obl_advcl
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: MAO inhibitors / buspirone HCl
ddi: null
>>> match: use_obl_advcl
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: buspirone HCl / buspirone HCl
ddi: null
>>> match: study_nsubj:pass_parataxis
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: psychotropic drugs / buspirone HCl
ddi: null
>>> match: study_nsubj:pass_parataxis
-------------
sentence: In a study in normal volunteers, concomitant administration of buspirone HCl and haloperidol resulted in increased serum haloperidol concentrations.
entities: buspirone HCl / haloperidol
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In a study in normal volunteers, concomitant administration of buspirone HCl and haloperidol resulted in increased serum haloperidol concentrations.
entities: haloperidol / haloperidol
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: However, there has been one report of prolonged prothrombin time when buspirone was added to the regimen of a patient treated with warfarin.
entities: buspirone / warfarin
ddi: effect
>>> match: add_nsubj:pass_obl
-------------
sentence: In vitro, buspirone may displace less firmly bound drugs like digoxin.
entities: buspirone / digoxin
ddi: mechanism
>>> match: displace_nsubj_obj
-------------
sentence: Benzodiazepines were administered to mice 30 min before applying the analgesic drugs. 
entities: Benzodiazepines / analgesic drugs
ddi: null
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Diazepam at doses of 0.25 mg/kg and 2.5 mg/kg injected with morphine was found to decrease the antinociceptive effect of morphine. 
entities: morphine / morphine
ddi: null
>>> match: find_nsubj:pass_xcomp
-------------
sentence: Similarly, diazepam decreased the antinociceptive effect of metamizol (only in the tail-flick test) and indomethacin. 
entities: diazepam / metamizol
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Similarly, diazepam decreased the antinociceptive effect of metamizol (only in the tail-flick test) and indomethacin. 
entities: diazepam / indomethacin
ddi: effect
>>> match: decrease_nsubj_conj
-------------
sentence: Similarly, diazepam decreased the antinociceptive effect of metamizol (only in the tail-flick test) and indomethacin. 
entities: metamizol / indomethacin
ddi: null
>>> match: decrease_obj_conj
-------------
sentence: Midazolam used at doses of 1.25 mg/kg and 2.5 mg/kg decreased the antinociceptive effect of morphine, metamizol (only in the tail-flick test) and indomethacin.
entities: Midazolam / morphine
ddi: effect
>>> match: use_nsubj_obl
-------------
sentence: Midazolam used at doses of 1.25 mg/kg and 2.5 mg/kg decreased the antinociceptive effect of morphine, metamizol (only in the tail-flick test) and indomethacin.
entities: Midazolam / metamizol
ddi: effect
>>> match: use_nsubj_obl
-------------
sentence: Midazolam used at doses of 1.25 mg/kg and 2.5 mg/kg decreased the antinociceptive effect of morphine, metamizol (only in the tail-flick test) and indomethacin.
entities: Midazolam / indomethacin
ddi: effect
>>> match: use_nsubj_obl
-------------
sentence: Midazolam used at doses of 1.25 mg/kg and 2.5 mg/kg decreased the antinociceptive effect of morphine, metamizol (only in the tail-flick test) and indomethacin.
entities: morphine / indomethacin
ddi: null
>>> match: decrease_obj_conj
-------------
sentence: Midazolam used at doses of 1.25 mg/kg and 2.5 mg/kg decreased the antinociceptive effect of morphine, metamizol (only in the tail-flick test) and indomethacin.
entities: metamizol / indomethacin
ddi: null
>>> match: decrease_obj_conj
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / central nervous system depressants
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / alcohol
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / barbiturates
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / hypnotics
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / narcotic analgesics
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / sedatives
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers. 
entities: Triprolidine / tranquillisers
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: The effects of anticholinergic drugs, such as atropine and tricyclic antidepressants may be enhanced by the concomitant administration of triprolidine. 
entities: anticholinergic drugs / triprolidine
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: The effects of anticholinergic drugs, such as atropine and tricyclic antidepressants may be enhanced by the concomitant administration of triprolidine. 
entities: atropine / triprolidine
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: The effects of anticholinergic drugs, such as atropine and tricyclic antidepressants may be enhanced by the concomitant administration of triprolidine. 
entities: tricyclic antidepressants / triprolidine
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: Agents Affecting Cytochrome P450 3A4 Isoenzyme System Fentanyl is metabolized mainly via the human cytochrome P450 3A4 isoenzyme system (CYP3A4), therefore potential interactions may occur when DURAGESIC  is given concurrently with agents that affect CYP3A4 activity.
entities: Fentanyl / DURAGESIC
ddi: null
>>> match: metabolize_nsubj:pass_parataxis
-------------
sentence: The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.
entities: fentanyl / fentanyl
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.
entities: ritonavir / fentanyl
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.
entities: ketoconazole / fentanyl
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.
entities: itraconazole / fentanyl
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.
entities: troleandomycin / fentanyl
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.
entities: clarithromycin / fentanyl
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The concomitant use of transdermal fentanyl with ritonavir or other potent 3A4 inhibitors such as ketoconazole, itraconazole, troleandomycin, clarithromycin, nelfinavir, and nefazadone may result in an increase in fentanyl plasma concentrations.
entities: nelfinavir / fentanyl
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The concomitant use of other CYP3A4 inhibitors such as diltiazem and erythromycin with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.
entities: diltiazem / fentanyl
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The concomitant use of other CYP3A4 inhibitors such as diltiazem and erythromycin with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.
entities: erythromycin / fentanyl
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The concomitant use of other CYP3A4 inhibitors such as diltiazem and erythromycin with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause serious respiratory depression.
entities: fentanyl / fentanyl
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics
entities: MAOI / MAO inhibitors
ddi: null
>>> match: receive_obj_advcl
-------------
sentence: MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics
entities: MAOI / opioid analgesics
ddi: null
>>> match: receive_obj_advcl
-------------
sentence: MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics
entities: MAO inhibitors / opioid analgesics
ddi: advise
>>> match: report_nsubj:pass_obl
-------------
sentence: Behavioral responses to repeated cocaine exposure in mice selectively bred for differential sensitivity to pentobarbital.

entities: cocaine / pentobarbital
ddi: null
>>> match: breed_nsubj_obl
-------------
sentence: Mice from the 20th generation of three lines divergently selected for response to pentobarbital-induced sedation times [long-sedation time (LST), short sedation time (SST), and randomly bred control (RBC)] were used to study cocaine-induced behavioral sensitization. 
entities: pentobarbital / cocaine
ddi: null
>>> match: use_nsubj:pass_xcomp
-------------
sentence: These results suggest that the hepatoxicity of ethanol in alcoholic beverages is enhanced by interaction with its congeners and acetaldehyde; 
entities: ethanol / acetaldehyde
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: anticoagulants / divalproex sodium
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: anticoagulants / valproic acid
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: anticoagulants / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: anticoagulants / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: anticoagulants / estrogens
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: anticoagulants / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: anticoagulants / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: blood thinners / divalproex sodium
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: blood thinners / valproic acid
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: blood thinners / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: blood thinners / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: blood thinners / estrogens
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: blood thinners / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: blood thinners / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: carbamazepine / divalproex sodium
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: carbamazepine / valproic acid
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: carbamazepine / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: carbamazepine / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: carbamazepine / estrogens
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: carbamazepine / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: carbamazepine / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: corticotropin / divalproex sodium
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: corticotropin / valproic acid
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: corticotropin / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: corticotropin / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: corticotropin / estrogens
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: corticotropin / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: corticotropin / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / divalproex sodium
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / valproic acid
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / estrogens
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: central nervous system (CNS) depressants / divalproex sodium
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: central nervous system (CNS) depressants / valproic acid
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: central nervous system (CNS) depressants / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: central nervous system (CNS) depressants / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: central nervous system (CNS) depressants / estrogens
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: central nervous system (CNS) depressants / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: central nervous system (CNS) depressants / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / divalproex sodium
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / valproic acid
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / estrogens
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / barbiturates
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / contraceptives
ddi: null
>>> match: occur_advcl_parataxis
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / barbiturates
ddi: null
>>> match: change_nsubj_csubj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / contraceptives
ddi: null
>>> match: change_nsubj_obj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / estrogens
ddi: null
>>> match: change_nsubj_obj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / barbiturates
ddi: null
>>> match: change_nsubj_obj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / contraceptives
ddi: null
>>> match: change_nsubj_obj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / barbiturates
ddi: null
>>> match: change_nsubj_csubj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / contraceptives
ddi: null
>>> match: change_nsubj_obj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / estrogens
ddi: null
>>> match: change_nsubj_obj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / barbiturates
ddi: null
>>> match: change_nsubj_obj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / contraceptives
ddi: null
>>> match: change_nsubj_obj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / contraceptives
ddi: null
>>> match: change_csubj_obj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / estrogens
ddi: null
>>> match: change_csubj_obj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / barbiturates
ddi: null
>>> match: change_csubj_obj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / contraceptives
ddi: null
>>> match: change_csubj_obj
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / contraceptives
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone.
entities: oxyphenbutazone / oxyphenbutazone
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Concurrent administration of oxyphenbutazone and androgens may result in elevated serum levels of oxyphenbutazone.
entities: androgens / oxyphenbutazone
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: In diabetic patients, the metabolic effects of androgens may decrease blood glucose and therefore, insulin requirements.
entities: androgens / insulin
ddi: effect
>>> match: decrease_nsubj_conj
-------------
sentence: Since caffeine is frequently co-administered with acetaminophen, it is of clinical interest to study the effect of caffeine on the hepatotoxicity of acetaminophen. 
entities: caffeine / acetaminophen
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Careful observations on hepatotoxicity are suggested when acetaminophen is prescribed with caffeine.
entities: acetaminophen / caffeine
ddi: effect
>>> match: prescribe_nsubj:pass_obl
-------------
sentence: In adult diabetic patients under treatment with either sulfonylureas or insulin there is no change in the clinical effects of either TOLECTIN or the hypoglycemic agents. 
entities: sulfonylureas / TOLECTIN
ddi: null
>>> match: be_obl_nsubj
-------------
sentence: In adult diabetic patients under treatment with either sulfonylureas or insulin there is no change in the clinical effects of either TOLECTIN or the hypoglycemic agents. 
entities: sulfonylureas / hypoglycemic agents
ddi: null
>>> match: be_obl_nsubj
-------------
sentence: In adult diabetic patients under treatment with either sulfonylureas or insulin there is no change in the clinical effects of either TOLECTIN or the hypoglycemic agents. 
entities: insulin / TOLECTIN
ddi: null
>>> match: be_obl_nsubj
-------------
sentence: In adult diabetic patients under treatment with either sulfonylureas or insulin there is no change in the clinical effects of either TOLECTIN or the hypoglycemic agents. 
entities: insulin / hypoglycemic agents
ddi: null
>>> match: be_obl_nsubj
-------------
sentence: Caution should be used if TOLECTIN is administered concomitantly with methotrexate. 
entities: TOLECTIN / methotrexate
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: TOLECTIN and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of methotrexate. 
entities: TOLECTIN / methotrexate
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: TOLECTIN and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of methotrexate. 
entities: TOLECTIN / methotrexate
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: TOLECTIN and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of methotrexate. 
entities: nonsteroidal anti-inflammatory drugs / methotrexate
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: TOLECTIN and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of methotrexate. 
entities: nonsteroidal anti-inflammatory drugs / methotrexate
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: TOLECTIN and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of methotrexate. 
entities: methotrexate / methotrexate
ddi: null
>>> match: reduce_obj_dep
-------------
sentence: Acetaminophen: A report of severe acetaminophen toxicity was reported in a patient receiving Isoniazid.
entities: acetaminophen / Isoniazid
ddi: effect
>>> match: report_nsubj:pass_obl
-------------
sentence: Furthermore it has been proposed that isoniazid resulted In induction of P-450IIE1 in the patients liver which, in turn, resulted in a greater proportion of the ingested acetaminophen being converted to the toxic metabolites.
entities: isoniazid / acetaminophen
ddi: mechanism
>>> match: result_nsubj_obl
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Isoniazid / carbamazepine
ddi: mechanism
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Isoniazid / Carbamazepine
ddi: null
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Isoniazid / isoniazid
ddi: null
>>> match: know_nsubj:pass_conj
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Isoniazid / carbamazepine
ddi: null
>>> match: know_nsubj:pass_conj
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Isoniazid / anticonvulsant
ddi: null
>>> match: know_nsubj:pass_conj
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: carbamazepine / Carbamazepine
ddi: null
>>> match: slow_obj_conj
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: carbamazepine / isoniazid
ddi: null
>>> match: know_xcomp_conj
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: carbamazepine / carbamazepine
ddi: null
>>> match: know_xcomp_conj
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: carbamazepine / anticonvulsant
ddi: null
>>> match: know_xcomp_conj
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Carbamazepine / isoniazid
ddi: advise
>>> match: know_xcomp_conj
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Carbamazepine / carbamazepine
ddi: null
>>> match: know_xcomp_conj
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Carbamazepine / anticonvulsant
ddi: null
>>> match: know_xcomp_conj
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: isoniazid / anticonvulsant
ddi: null
>>> match: know_conj_conj
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: carbamazepine / anticonvulsant
ddi: null
>>> match: know_conj_conj
-------------
sentence: Phenytoin: Isoniazid may increase serum levels of phenytoin.
entities: Isoniazid / phenytoin
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Therophylline: A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of isoniazid.
entities: isoniazid / theophylline
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: Therophylline: A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of isoniazid.
entities: isoniazid / isoniazid
ddi: null
>>> match: show_ccomp_dep
-------------
sentence: Therophylline: A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of isoniazid.
entities: theophylline / theophylline
ddi: null
>>> match: cause_nsubj_obj
-------------
sentence: Therophylline: A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of isoniazid.
entities: theophylline / isoniazid
ddi: null
>>> match: show_ccomp_dep
-------------
sentence: Therophylline: A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of isoniazid.
entities: theophylline / isoniazid
ddi: null
>>> match: show_ccomp_dep
-------------
sentence: Since the therapeutic range of theophylline is narrow theophylline serum levels should be monitored closely, and appropriate dosage adjustments of theophylline should be made.
entities: theophylline / theophylline
ddi: null
>>> match: monitor_advcl_conj
-------------
sentence: Since the therapeutic range of theophylline is narrow theophylline serum levels should be monitored closely, and appropriate dosage adjustments of theophylline should be made.
entities: theophylline / theophylline
ddi: null
>>> match: monitor_advcl_conj
-------------
sentence: Plasma valproate concentration should be monitored when isoniazid and valproate are co administered, and appropriate dosage adjustments of valproate should be made.
entities: valproate / isoniazid
ddi: null
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: Plasma valproate concentration should be monitored when isoniazid and valproate are co administered, and appropriate dosage adjustments of valproate should be made.
entities: valproate / valproate
ddi: null
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: Plasma valproate concentration should be monitored when isoniazid and valproate are co administered, and appropriate dosage adjustments of valproate should be made.
entities: valproate / valproate
ddi: null
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: Plasma valproate concentration should be monitored when isoniazid and valproate are co administered, and appropriate dosage adjustments of valproate should be made.
entities: isoniazid / valproate
ddi: null
>>> match: administer_nsubj:pass_conj
-------------
sentence: Plasma valproate concentration should be monitored when isoniazid and valproate are co administered, and appropriate dosage adjustments of valproate should be made.
entities: valproate / valproate
ddi: null
>>> match: administer_nsubj:pass_conj
-------------
sentence: Trimethoprim may inhibit the hepatic metabolism of phenytoin. 
entities: Trimethoprim / phenytoin
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Trimethoprim, given at a common clinical dosage, increased the phenytoin half-life by 51% and decreased the phenytoin metabolic clearance rate by 30%. 
entities: Trimethoprim / phenytoin
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Trimethoprim, given at a common clinical dosage, increased the phenytoin half-life by 51% and decreased the phenytoin metabolic clearance rate by 30%. 
entities: Trimethoprim / phenytoin
ddi: mechanism
>>> match: increase_nsubj_conj
-------------
sentence: Trimethoprim, given at a common clinical dosage, increased the phenytoin half-life by 51% and decreased the phenytoin metabolic clearance rate by 30%. 
entities: phenytoin / phenytoin
ddi: null
>>> match: increase_obj_conj
-------------
sentence: Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide.

entities: Fluvoxamine / tolbutamide
ddi: mechanism
>>> match: inhibit_nsubj_ccomp
-------------
sentence: OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. 
entities: fluvoxamine / fluvoxamine
ddi: null
>>> match: examine_obj_xcomp
-------------
sentence: OBJECTIVE: Our objective was to examine the interaction between fluvoxamine and tolbutamide to confirm that fluvoxamine inhibits CYP2C9. 
entities: tolbutamide / fluvoxamine
ddi: null
>>> match: examine_obj_xcomp
-------------
sentence: Plasma was analyzed for tolbutamide, and urine was analyzed for tolbutamide and its two metabolites, 4-hydroxytolbutamide and carboxytolbutamide by means of HPLC. 
entities: tolbutamide / tolbutamide
ddi: null
>>> match: analyze_obl_conj
-------------
sentence: Plasma was analyzed for tolbutamide, and urine was analyzed for tolbutamide and its two metabolites, 4-hydroxytolbutamide and carboxytolbutamide by means of HPLC. 
entities: tolbutamide / 4-hydroxytolbutamide
ddi: null
>>> match: analyze_obl_conj
-------------
sentence: Plasma was analyzed for tolbutamide, and urine was analyzed for tolbutamide and its two metabolites, 4-hydroxytolbutamide and carboxytolbutamide by means of HPLC. 
entities: tolbutamide / carboxytolbutamide
ddi: null
>>> match: analyze_obl_conj
-------------
sentence: RESULTS: During treatment with fluvoxamine, there was a statistically significant decrease in the median of the total clearance of tolbutamide, from 845 mL/h to 688 mL/h, among the volunteers who received 75 mg/d. 
entities: fluvoxamine / tolbutamide
ddi: mechanism
>>> match: be_obl_nsubj
-------------
sentence: The clearance by means of 4-hydroxytolbutamide and carboxytolbutamide was significantly reduced in both groups (ie, from 901 mL/h to 318 mL/h in the group that received 150 mg of tolbutamide per day and from 723 mL/h to 457 mL/h in the group that received 75 mg of tolbutamide per day). 
entities: 4-hydroxytolbutamide / tolbutamide
ddi: null
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The clearance by means of 4-hydroxytolbutamide and carboxytolbutamide was significantly reduced in both groups (ie, from 901 mL/h to 318 mL/h in the group that received 150 mg of tolbutamide per day and from 723 mL/h to 457 mL/h in the group that received 75 mg of tolbutamide per day). 
entities: 4-hydroxytolbutamide / tolbutamide
ddi: null
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The clearance by means of 4-hydroxytolbutamide and carboxytolbutamide was significantly reduced in both groups (ie, from 901 mL/h to 318 mL/h in the group that received 150 mg of tolbutamide per day and from 723 mL/h to 457 mL/h in the group that received 75 mg of tolbutamide per day). 
entities: carboxytolbutamide / tolbutamide
ddi: null
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The clearance by means of 4-hydroxytolbutamide and carboxytolbutamide was significantly reduced in both groups (ie, from 901 mL/h to 318 mL/h in the group that received 150 mg of tolbutamide per day and from 723 mL/h to 457 mL/h in the group that received 75 mg of tolbutamide per day). 
entities: carboxytolbutamide / tolbutamide
ddi: null
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The clearance by means of 4-hydroxytolbutamide and carboxytolbutamide was significantly reduced in both groups (ie, from 901 mL/h to 318 mL/h in the group that received 150 mg of tolbutamide per day and from 723 mL/h to 457 mL/h in the group that received 75 mg of tolbutamide per day). 
entities: tolbutamide / tolbutamide
ddi: null
>>> match: receive_obj_conj
-------------
sentence: To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin. 
entities: thiosulfate / cisplatin
ddi: null
>>> match: permit_nsubj_obj
-------------
sentence: To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin. 
entities: thiosulfate / thiosulfate
ddi: null
>>> match: give_advcl_nsubj:pass
-------------
sentence: To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin. 
entities: thiosulfate / cisplatin
ddi: null
>>> match: give_advcl_obl
-------------
sentence: To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin. 
entities: cisplatin / thiosulfate
ddi: null
>>> match: give_advcl_nsubj:pass
-------------
sentence: To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin. 
entities: cisplatin / cisplatin
ddi: null
>>> match: give_advcl_obl
-------------
sentence: To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin. 
entities: thiosulfate / cisplatin
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: Cisplatin was administered over the last two hours of the thiosulfate infusion. 
entities: Cisplatin / thiosulfate
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Comparison of cisplatin pharmacokinetics in patients treated with 202.5 mg/m2 plus thiosulfate to those in patients treated with 100 mg/m2 without thiosulfate indicated that there were no changes in the elimination rate constant, volume of distribution, or total body clearance of cisplatin. 
entities: cisplatin / cisplatin
ddi: null
>>> match: indicate_nsubj_conj
-------------
sentence: Comparison of cisplatin pharmacokinetics in patients treated with 202.5 mg/m2 plus thiosulfate to those in patients treated with 100 mg/m2 without thiosulfate indicated that there were no changes in the elimination rate constant, volume of distribution, or total body clearance of cisplatin. 
entities: thiosulfate / cisplatin
ddi: null
>>> match: indicate_nsubj_conj
-------------
sentence: Comparison of cisplatin pharmacokinetics in patients treated with 202.5 mg/m2 plus thiosulfate to those in patients treated with 100 mg/m2 without thiosulfate indicated that there were no changes in the elimination rate constant, volume of distribution, or total body clearance of cisplatin. 
entities: thiosulfate / cisplatin
ddi: null
>>> match: indicate_nsubj_conj
-------------
sentence: This may occur because diflunisal competitively displaces coumarins from protein binding sites.
entities: diflunisal / coumarins
ddi: mechanism
>>> match: displace_nsubj_obj
-------------
sentence: Accordingly, when diflunisal is administered with oral anticoagulants, the prothrombin time should be closely monitored during and for several days after concomitant drug administration.
entities: diflunisal / anticoagulants
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Tolbutamide: In diabetic patients receiving diflunisal and tolbutamide, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.
entities: diflunisal / tolbutamide
ddi: null
>>> match: see_obl_obl
-------------
sentence: Tolbutamide: In diabetic patients receiving diflunisal and tolbutamide, no significant effects were seen on tolbutamide plasma levels or fasting blood glucose.
entities: tolbutamide / tolbutamide
ddi: null
>>> match: see_obl_obl
-------------
sentence: Hydrochlorothiazide: In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide.
entities: diflunisal / hydrochlorothiazide
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Hydrochlorothiazide: In normal volunteers, concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide.
entities: hydrochlorothiazide / hydrochlorothiazide
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Diflunisal decreased the hyperuricemic effect of hydrochlorothiazide.
entities: Diflunisal / hydrochlorothiazide
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Furosemide: In normal volunteers, the concomitant administration of diflunisal and furosemide had no effect on the diuretic activity of furosemide.
entities: furosemide / furosemide
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Diflunisal decreased the hyperuricemic effect of furosemide.
entities: Diflunisal / furosemide
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Antacids: Concomitant administration of antacids may reduce plasma levels of diflunisal.
entities: antacids / diflunisal
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Acetaminophen: In normal volunteers, concomitant administration of diflunisal and acetaminophen resulted in an approximate 50% increase in plasma levels of acetaminophen.
entities: diflunisal / acetaminophen
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Acetaminophen: In normal volunteers, concomitant administration of diflunisal and acetaminophen resulted in an approximate 50% increase in plasma levels of acetaminophen.
entities: acetaminophen / acetaminophen
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Acetaminophen had no effect on plasma levels of diflunisal.
entities: Acetaminophen / diflunisal
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Since acetaminophen in high doses has been associated with hepatotoxicity, concomitant administration of diflunisal and acetaminophen should be used cautiously, with careful monitoring of patients.
entities: acetaminophen / diflunisal
ddi: null
>>> match: associate_obl_obl
-------------
sentence: Since acetaminophen in high doses has been associated with hepatotoxicity, concomitant administration of diflunisal and acetaminophen should be used cautiously, with careful monitoring of patients.
entities: acetaminophen / acetaminophen
ddi: null
>>> match: associate_obl_obl
-------------
sentence: Methotrexate: Caution should be used if diflunisal is administered concomitantly with methotrexate.
entities: diflunisal / methotrexate
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Nonsteroidal anti-inflammatory drugs have been reported to decrease the tubular secretion of methotrexate and to potentiate its toxicity.
entities: Nonsteroidal anti-inflammatory drugs / methotrexate
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Cyclosporine: Administration of nonsteroial anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.
entities: nonsteroial anti-inflammatory drugs / cyclosporine
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: Cyclosporine: Administration of nonsteroial anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity, possibly due to decreased synthesis of renal prostacyclin.
entities: cyclosporine / cyclosporine
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: NSAIDs should be used with caution in patients taking cyclosporine, and renal function should be carefully monitored.
entities: NSAIDs / cyclosporine
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Nonsteroidal Anti-Inflammatory Drugs: The administration of diflunisal to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin.
entities: diflunisal / indomethacin
ddi: null
>>> match: decrease_nsubj_conj
-------------
sentence: Nonsteroidal Anti-Inflammatory Drugs: The administration of diflunisal to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin.
entities: indomethacin / indomethacin
ddi: null
>>> match: decrease_nsubj_conj
-------------
sentence: Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.
entities: diflunisal / diflunisal
ddi: null
>>> match: observe_obl_dep
-------------
sentence: Aspirin: In normal volunteers, a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly.
entities: diflunisal / aspirin
ddi: null
>>> match: observe_obl_dep
-------------
sentence: Naproxen: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.
entities: diflunisal / naproxen
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Naproxen: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.
entities: diflunisal / naproxen
ddi: null
>>> match: have_nsubj_conj
-------------
sentence: Naproxen: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.
entities: naproxen / naproxen
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Naproxen: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.
entities: naproxen / naproxen
ddi: null
>>> match: have_nsubj_conj
-------------
sentence: Naproxen: The concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen, but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite.
entities: naproxen / naproxen
ddi: null
>>> match: have_obj_conj
-------------
sentence: Naproxen had no effect on plasma levels of diflunisal.
entities: Naproxen / diflunisal
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate.
entities: Acetaminophen / acetaminophen
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate.
entities: Acetaminophen / methotrexate
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate.
entities: methotrexate / acetaminophen
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate.
entities: methotrexate / methotrexate
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate.
entities: L-methionine / acetaminophen
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Acetaminophen and methotrexate - L-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate.
entities: L-methionine / methotrexate
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Gentamicin - Methionine may protect against the ototoxic effects of gentamicin.
entities: Gentamicin / gentamicin
ddi: null
>>> match: protect_nsubj_obl
-------------
sentence: Gentamicin - Methionine may protect against the ototoxic effects of gentamicin.
entities: Methionine / gentamicin
ddi: effect
>>> match: protect_nsubj_obl
-------------
sentence: Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and tricyclic antidepressants. 
entities: Posicor / terfenadine
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and tricyclic antidepressants. 
entities: Posicor / astemizole
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and tricyclic antidepressants. 
entities: Posicor / cisapride
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and tricyclic antidepressants. 
entities: Posicor / cyclosporine
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and tricyclic antidepressants. 
entities: Posicor / tricyclic antidepressants
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: DOSTINEX should not be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthines, or metoclopramide.
entities: DOSTINEX / phenothiazines
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: DOSTINEX should not be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthines, or metoclopramide.
entities: DOSTINEX / butyrophenones
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: DOSTINEX should not be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthines, or metoclopramide.
entities: DOSTINEX / thioxanthines
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: DOSTINEX should not be administered concurrently with D2-antagonists, such as phenothiazines, butyrophenones, thioxanthines, or metoclopramide.
entities: DOSTINEX / metoclopramide
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: However, since there is an increased risk of bleeding with Xigris, caution should be employed when Xigris is used with other drugs that affect hemostasis.
entities: Xigris / Xigris
ddi: null
>>> match: employ_advcl_advcl
-------------
sentence: Drug/Laboratory Test Interaction Because Xigris may affect the APTT assay, Xigris present in plasma samples may interfere with one-stage coagulation assays based on the APTT (such as factor VIII, IX, and XI assays).
entities: Xigris / Xigris
ddi: null
>>> match: affect_nsubj_parataxis
-------------
sentence: n-dodecyl gallate showed the most potent inhibition (66% inhibition at 10 microM), which was far more potent than that of crude tannic acid. 
entities: n-dodecyl gallate / tannic acid
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: Thalidomide has been reported to enhance the sedative activity of barbiturates, alcohol, chlorpromazine, and reserpine. 
entities: Thalidomide / barbiturates
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Thalidomide has been reported to enhance the sedative activity of barbiturates, alcohol, chlorpromazine, and reserpine. 
entities: Thalidomide / alcohol
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Thalidomide has been reported to enhance the sedative activity of barbiturates, alcohol, chlorpromazine, and reserpine. 
entities: Thalidomide / chlorpromazine
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Thalidomide has been reported to enhance the sedative activity of barbiturates, alcohol, chlorpromazine, and reserpine. 
entities: Thalidomide / reserpine
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of ethinyl estradiol were studied. 
entities: norethindrone / norethindrone acetate
ddi: null
>>> match: study_obl_nsubj:pass
-------------
sentence: Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of ethinyl estradiol were studied. 
entities: norethindrone / ethinyl estradiol
ddi: null
>>> match: study_obl_nsubj:pass
-------------
sentence: Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of ethinyl estradiol were studied. 
entities: ethinyl estradiol / norethindrone acetate
ddi: null
>>> match: study_obl_nsubj:pass
-------------
sentence: Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of ethinyl estradiol were studied. 
entities: ethinyl estradiol / ethinyl estradiol
ddi: null
>>> match: study_obl_nsubj:pass
-------------
sentence: The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and barbiturates, and the antituberculosis drug rifampin.
entities: progestin / anticonvulsants
ddi: null
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and barbiturates, and the antituberculosis drug rifampin.
entities: progestin / phenytoin
ddi: effect
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and barbiturates, and the antituberculosis drug rifampin.
entities: progestin / carbamazepine
ddi: effect
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and barbiturates, and the antituberculosis drug rifampin.
entities: progestin / barbiturates
ddi: effect
>>> match: reduce_nsubj:pass_obl
-------------
sentence: The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and barbiturates, and the antituberculosis drug rifampin.
entities: progestin / rifampin
ddi: effect
>>> match: reduce_nsubj:pass_obl
-------------
sentence: Due to its nephrotoxicity, gentamicin may cause abnormal renal uptake to be seen on 99mTc-MDP bone scintigraphy. 
entities: gentamicin / 99mTc-MDP
ddi: mechanism
>>> match: cause_nsubj_xcomp
-------------
sentence: Therapeutic drug monitoring (TDM) of gentamicin therapy, and bone scintigraphy employing 99mTc-MDP as the radiopharmaceutical was carried out in 22 patients. 
entities: 99mTc-MDP / radiopharmaceutical
ddi: null
>>> match: employ_obj_advcl
-------------
sentence: The data presented here demonstrate that with serial pharmacokinetic dosing of gentamicin, the iatrogenic alteration caused by gentamicin therapy can be avoided.
entities: gentamicin / gentamicin
ddi: null
>>> match: cause_obl_obl
-------------
sentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.
entities: epinephrine / monoamine oxidase inhibitors
ddi: effect
>>> match: contain_obj_obl
-------------
sentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.
entities: epinephrine / tricyclic antidepressants
ddi: effect
>>> match: contain_obj_obl
-------------
sentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.
entities: norepinephrine / monoamine oxidase inhibitors
ddi: effect
>>> match: contain_obj_obl
-------------
sentence: The administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors or tricyclic antidepressants may produce severe, prolonged hypertension.
entities: norepinephrine / tricyclic antidepressants
ddi: effect
>>> match: contain_obj_obl
-------------
sentence: Phenothiazines and butyrophenones may reduce or reverse the pressor effect of epinephrine.
entities: Phenothiazines / epinephrine
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Phenothiazines and butyrophenones may reduce or reverse the pressor effect of epinephrine.
entities: butyrophenones / epinephrine
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: MAO-A inhibitors reduce sumatriptan clearance, significantly increasing systemic exposure. 
entities: MAO-A inhibitors / sumatriptan
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: MAO-A inhibitors / Selective serotonin reuptake inhibitors
ddi: null
>>> match: contraindicate_nsubj:pass_parataxis
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: MAO-A inhibitors / SSRIs
ddi: null
>>> match: contraindicate_nsubj:pass_parataxis
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: MAO-A inhibitors / fluoxetine
ddi: null
>>> match: contraindicate_nsubj:pass_parataxis
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: MAO-A inhibitors / fluvoxamine
ddi: null
>>> match: contraindicate_nsubj:pass_parataxis
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: MAO-A inhibitors / paroxetine
ddi: null
>>> match: contraindicate_nsubj:pass_parataxis
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: MAO-A inhibitors / sertraline
ddi: null
>>> match: contraindicate_nsubj:pass_parataxis
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: MAO-A inhibitors / sumatriptan
ddi: null
>>> match: contraindicate_nsubj:pass_parataxis
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: Selective serotonin reuptake inhibitors / sumatriptan
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: SSRIs / sumatriptan
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: fluoxetine / sumatriptan
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: fluvoxamine / sumatriptan
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: paroxetine / sumatriptan
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan. 
entities: sertraline / sumatriptan
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: We retrospectively reviewed the records of 7 pediatric oncology patients who received low-dose ketamine in conjunction with propofol for total intravenous anesthesia (TIVA) repeatedly for radiation therapy. 
entities: ketamine / propofol
ddi: null
>>> match: receive_obj_obl
-------------
sentence: EA signs were observed in all 7 patients in association with propofol TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low-dose ketamine was added to propofol. 
entities: propofol / ketamine
ddi: null
>>> match: observe_obl_conj
-------------
sentence: EA signs were observed in all 7 patients in association with propofol TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low-dose ketamine was added to propofol. 
entities: propofol / propofol
ddi: null
>>> match: observe_obl_conj
-------------
sentence: EA signs were observed in all 7 patients in association with propofol TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low-dose ketamine was added to propofol. 
entities: ketamine / propofol
ddi: null
>>> match: add_nsubj:pass_obl
-------------
sentence: Based on this experience, we suggest that low-dose ketamine added to propofol may be associated with prevention of EA in children with a history of EA with propofol TIVA.
entities: ketamine / propofol
ddi: effect
>>> match: add_nsubj_obl
-------------
sentence: Based on this experience, we suggest that low-dose ketamine added to propofol may be associated with prevention of EA in children with a history of EA with propofol TIVA.
entities: ketamine / propofol
ddi: null
>>> match: add_nsubj_dep
-------------
sentence: Based on this experience, we suggest that low-dose ketamine added to propofol may be associated with prevention of EA in children with a history of EA with propofol TIVA.
entities: propofol / propofol
ddi: null
>>> match: add_obl_dep
-------------
sentence: Mitotane has been reported to accelerate the metabolism of warfarin by the mechanism of hepatic microsomal enzyme induction, leading to an increase in dosage requirements for warfarin. 
entities: Mitotane / warfarin
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Mitotane has been reported to accelerate the metabolism of warfarin by the mechanism of hepatic microsomal enzyme induction, leading to an increase in dosage requirements for warfarin. 
entities: Mitotane / warfarin
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Mitotane has been reported to accelerate the metabolism of warfarin by the mechanism of hepatic microsomal enzyme induction, leading to an increase in dosage requirements for warfarin. 
entities: warfarin / warfarin
ddi: null
>>> match: accelerate_obj_dep
-------------
sentence: Therefore, physicians should closely monitor patients for a change in anticoagulant dosage requirements when administering Mitotane to patients on coumarin-type anticoagulants. 
entities: anticoagulant / Mitotane
ddi: null
>>> match: monitor_obj_dep
-------------
sentence: Therefore, physicians should closely monitor patients for a change in anticoagulant dosage requirements when administering Mitotane to patients on coumarin-type anticoagulants. 
entities: anticoagulant / coumarin-type anticoagulants
ddi: null
>>> match: monitor_obj_dep
-------------
sentence: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. 
entities: metoclopramide / anticholinergic drugs
ddi: effect
>>> match: antagonize_nsubj:pass_obl
-------------
sentence: The effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics. 
entities: metoclopramide / narcotic analgesics
ddi: effect
>>> match: antagonize_nsubj:pass_obl
-------------
sentence: Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers. 
entities: metoclopramide / alcohol
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers. 
entities: metoclopramide / sedatives
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers. 
entities: metoclopramide / hypnotics
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers. 
entities: metoclopramide / narcotics
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers. 
entities: metoclopramide / tranquilizers
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: The finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxi-dase inhibitors. 
entities: metoclopramide / monoamine oxi-dase inhibitors
ddi: advise
>>> match: suggest_nsubj_ccomp
-------------
sentence: Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). 
entities: digoxin / metoclopramide
ddi: mechanism
>>> match: diminish_dep_obl
-------------
sentence: Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). 
entities: digoxin / acetaminophen
ddi: null
>>> match: diminish_dep_advcl
-------------
sentence: Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). 
entities: digoxin / tetracycline
ddi: null
>>> match: diminish_dep_advcl
-------------
sentence: Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). 
entities: digoxin / levodopa
ddi: null
>>> match: diminish_dep_advcl
-------------
sentence: Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). 
entities: digoxin / ethanol
ddi: null
>>> match: diminish_dep_advcl
-------------
sentence: Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). 
entities: digoxin / cyclosporine
ddi: null
>>> match: diminish_dep_advcl
-------------
sentence: Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). 
entities: metoclopramide / acetaminophen
ddi: mechanism
>>> match: diminish_obl_advcl
-------------
sentence: Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). 
entities: metoclopramide / tetracycline
ddi: null
>>> match: diminish_obl_advcl
-------------
sentence: Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). 
entities: metoclopramide / levodopa
ddi: null
>>> match: diminish_obl_advcl
-------------
sentence: Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). 
entities: metoclopramide / ethanol
ddi: null
>>> match: diminish_obl_advcl
-------------
sentence: Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine). 
entities: metoclopramide / cyclosporine
ddi: null
>>> match: diminish_obl_advcl
-------------
sentence: Because the action of metoclopramide will influence the delivery of food to the intestines and thus the rate of absorption, insulin dosage or timing of dosage may require adjustment.
entities: metoclopramide / insulin
ddi: advise
>>> match: require_advcl_nsubj
-------------
sentence: Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.
entities: clorazepate dipotassium / hexobarbital
ddi: effect
>>> match: prolong_nsubj_advcl
-------------
sentence: Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.
entities: clorazepate dipotassium / ethyl alcohol
ddi: effect
>>> match: prolong_nsubj_advcl
-------------
sentence: Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.
entities: clorazepate dipotassium / chlorpromazine
ddi: effect
>>> match: prolong_nsubj_advcl
-------------
sentence: Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.
entities: hexobarbital / chlorpromazine
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.
entities: ethyl alcohol / chlorpromazine
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.
entities: benzodiazepines / barbiturates
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.
entities: benzodiazepines / narcotics
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.
entities: benzodiazepines / phenothiazines
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.
entities: benzodiazepines / monoamine oxidase inhibitors
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The actions of the benzodiazepines may be potentiated by barbiturates, narcotics, phenothiazines, monoamine oxidase inhibitors or other antidepressants.
entities: benzodiazepines / antidepressants
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: In bioavailability studies with normal subjects, the concurrent administration of antacids at therapeutic levels did not significantly influence the bioavailability of TRANXENE tablets.
entities: antacids / TRANXENE
ddi: null
>>> match: influence_nsubj_obj
-------------
sentence: Interactions for Vitamin B3 (Niacin): Antihypertensive Therapy: Nicotinic acid may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension.
entities: Nicotinic acid / ganglionic blocking agents
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Aspirin: Concomitant aspirin may decrease the metabolic clearance of nicotinic acid.
entities: aspirin / nicotinic acid
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: The treatment of ewes with an intravenous (IV) injection of trichlorfon, insufficient to produce significant inhibition of erythrocyte acetylcholinesterase (AChE) activity, appeared to produce additive effects with those produced by subsequent treatment with 4 mg of coumaphos/kg/day. 
entities: trichlorfon / coumaphos
ddi: effect
>>> match: appear_nsubj_xcomp
-------------
sentence: Because dopamine is metabolized by monoamine oxidase (MAO), inhibition of this enzyme prolongs and potentiates the effect of dopamine.
entities: dopamine / dopamine
ddi: null
>>> match: prolong_advcl_obj
-------------
sentence: Patients who have been treated with MAO inhibitors within two to three weeks prior to the administration of dopamine HCl should receive initial doses of dopamine HCl no greater than one-tenth (1/10) of the usual dose.
entities: MAO inhibitors / dopamine HCl
ddi: advise
>>> match: treat_obl_obl
-------------
sentence: Patients who have been treated with MAO inhibitors within two to three weeks prior to the administration of dopamine HCl should receive initial doses of dopamine HCl no greater than one-tenth (1/10) of the usual dose.
entities: MAO inhibitors / dopamine HCl
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: Patients who have been treated with MAO inhibitors within two to three weeks prior to the administration of dopamine HCl should receive initial doses of dopamine HCl no greater than one-tenth (1/10) of the usual dose.
entities: dopamine HCl / dopamine HCl
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: Cardiac effects of dopamine are antagonized by beta-adrenergic blocking agents, such as propranolol and metoprolol.
entities: dopamine / beta-adrenergic blocking agents
ddi: effect
>>> match: antagonize_nsubj:pass_obl
-------------
sentence: Cardiac effects of dopamine are antagonized by beta-adrenergic blocking agents, such as propranolol and metoprolol.
entities: dopamine / propranolol
ddi: effect
>>> match: antagonize_nsubj:pass_obl
-------------
sentence: Cardiac effects of dopamine are antagonized by beta-adrenergic blocking agents, such as propranolol and metoprolol.
entities: dopamine / metoprolol
ddi: effect
>>> match: antagonize_nsubj:pass_obl
-------------
sentence: The peripheral vasoconstriction caused by high doses of dopamine HCl is antagonized by alpha-adrenergic blocking agents.
entities: dopamine HCl / alpha-adrenergic blocking agents
ddi: effect
>>> match: antagonize_csubj:pass_obl
-------------
sentence: Butyrophenones (such as haloperidol) and phenothiazines can suppress the dopaminergic renal and mesenteric vasodilation induced with low dose dopamine infusion.
entities: Butyrophenones / dopamine
ddi: effect
>>> match: suppress_nsubj_dep
-------------
sentence: Butyrophenones (such as haloperidol) and phenothiazines can suppress the dopaminergic renal and mesenteric vasodilation induced with low dose dopamine infusion.
entities: haloperidol / dopamine
ddi: effect
>>> match: suppress_nsubj_dep
-------------
sentence: Butyrophenones (such as haloperidol) and phenothiazines can suppress the dopaminergic renal and mesenteric vasodilation induced with low dose dopamine infusion.
entities: phenothiazines / dopamine
ddi: effect
>>> match: suppress_nsubj_dep
-------------
sentence: Cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines, such as dopamine.
entities: Cyclopropane / catecholamines
ddi: effect
>>> match: increase_nsubj_conj
-------------
sentence: Cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines, such as dopamine.
entities: Cyclopropane / dopamine
ddi: effect
>>> match: increase_nsubj_conj
-------------
sentence: Cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines, such as dopamine.
entities: halogenated hydrocarbon anesthetics / catecholamines
ddi: effect
>>> match: increase_nsubj_conj
-------------
sentence: Cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines, such as dopamine.
entities: halogenated hydrocarbon anesthetics / dopamine
ddi: effect
>>> match: increase_nsubj_conj
-------------
sentence: It has been reported that results of studies in animals indicate that dopamine-induced ventricular arrhythmias during anesthesia can be reversed by propranolol.
entities: dopamine / propranolol
ddi: effect
>>> match: reverse_nsubj:pass_obl
-------------
sentence: It is suggested that in patients receiving dopamine HCl, alternatives to phenytoin should be used if anticonvulsant therapy is needed.
entities: dopamine HCl / phenytoin
ddi: advise
>>> match: use_obl_nsubj:pass
-------------
sentence: It is suggested that in patients receiving dopamine HCl, alternatives to phenytoin should be used if anticonvulsant therapy is needed.
entities: dopamine HCl / anticonvulsant
ddi: null
>>> match: use_obl_advcl
-------------
sentence: It is suggested that in patients receiving dopamine HCl, alternatives to phenytoin should be used if anticonvulsant therapy is needed.
entities: phenytoin / anticonvulsant
ddi: null
>>> match: use_nsubj:pass_advcl
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: alcohol / sedatives
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: alcohol / hypnotics
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: alcohol / opioids
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: alcohol / anesthetics
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: alcohol / barbiturates
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: alcohol / tricyclic antidepressants
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: alcohol / phenothiazines
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: alcohol / tranquilizers
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: alcohol / skeletal muscle relaxants
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: alcohol / antihistamines
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: sedatives / hypnotics
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: sedatives / opioids
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: sedatives / anesthetics
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: sedatives / barbiturates
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: sedatives / tricyclic antidepressants
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: sedatives / phenothiazines
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: sedatives / tranquilizers
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: sedatives / skeletal muscle relaxants
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Interactions with Other CNS Agents: Concurrent use of Levo-Dromoran with all central nervous system depressants (eg, alcohol, sedatives, hypnotics, other opioids, general anesthetics, barbiturates, tricyclic antidepressants, phenothiazines, tranquilizers, skeletal muscle relaxants and antihistamines) may result in additive central nervous system depressant effects.
entities: sedatives / antihistamines
ddi: null
>>> match: result_nsubj_nsubj
-------------
sentence: Most cases of serious or fatal adverse events involving Levo-Dromoran reported to the manufacturer or the FDA have involved either the administration of large initial doses or too frequent doses of the drug to nonopioid tolerant patients, or the simultaneous administration of levorphanol with other drugs affecting respiration.
entities: Levo-Dromoran / levorphanol
ddi: null
>>> match: report_nsubj_dep
-------------
sentence: Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.
entities: Agonist/antagonist analgesics / Levo-Dromoran
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.
entities: pentazocine / Levo-Dromoran
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.
entities: nalbuphine / Levo-Dromoran
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.
entities: butorphanol / Levo-Dromoran
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.
entities: dezocine / Levo-Dromoran
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Interactions with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (eg, pentazocine, nalbuphine, butorphanol, dezocine and buprenorphine) should NOT be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as Levo-Dromoran.
entities: buprenorphine / Levo-Dromoran
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Co-administration of naltrexone with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.
entities: naltrexone / acamprosate
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Co-administration of naltrexone with Acamprosate produced a 25% increase in AUC and a 33% increase in the Cmax of acamprosate.
entities: Acamprosate / acamprosate
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.
entities: Acamprosate / anxiolytics
ddi: null
>>> match: treat_obl_obl
-------------
sentence: Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.
entities: Acamprosate / hypnotics
ddi: null
>>> match: treat_obl_obl
-------------
sentence: Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.
entities: Acamprosate / sedatives
ddi: null
>>> match: treat_obl_obl
-------------
sentence: Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.
entities: Acamprosate / benzodiazepines
ddi: null
>>> match: treat_obl_obl
-------------
sentence: Other concomitant therapies: In clinical trials, the safety profile in subjects treated with Acamprosate concomitantly with anxiolytics, hypnotics and sedatives (including benzodiazepines), or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications.
entities: Acamprosate / non-opioid analgesics
ddi: null
>>> match: treat_obl_obl
-------------
sentence: Patients taking Acamprosate concomitantly with antidepressants more commonly reported both weight gain and weight loss, compared with patients taking either medication alone.
entities: Acamprosate / antidepressants
ddi: effect
>>> match: take_obj_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / acetaminophen
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / acetylsalicylic acid
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / analgesics
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / angiotensin-converting enzyme (ACE) inhibitors
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / anticonvulsants
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / benzodiazepines
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / beta blockers
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / calcium-channel blockers
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / nitrates
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / diuretics
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / H2 antagonists
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / HMG-CoA reductase inhibitors
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / prostaglandin synthetase inhibitors
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / NSAIDs
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Other concomitant therapy Although specific interaction studies were not performed, finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen, acetylsalicylic acid, a-blockers, analgesics, angiotensin-converting enzyme (ACE) inhibitors, anticonvulsants, benzodiazepines, beta blockers, calcium-channel blockers, cardiac nitrates, diuretics, H2 antagonists, HMG-CoA reductase inhibitors, prostaglandin synthetase inhibitors (also referred to as NSAIDs), and quinolone anti-infectives without evidence of clinically significant adverse interactions.
entities: finasteride / quinolone anti-infectives
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Treatment with PEGASYS once weekly for 4 weeks in healthy subjects was associated with an inhibition of P450 1A2 and a 25% increase in theophylline AUC.
entities: PEGASYS / theophylline
ddi: mechanism
>>> match: associate_nsubj:pass_obl
-------------
sentence: Theophylline serum levels should be monitored and appropriate dose adjustments considered for patients given both theophylline and PEGASYS.
entities: Theophylline / theophylline
ddi: null
>>> match: monitor_nsubj:pass_conj
-------------
sentence: Theophylline serum levels should be monitored and appropriate dose adjustments considered for patients given both theophylline and PEGASYS.
entities: Theophylline / PEGASYS
ddi: null
>>> match: monitor_nsubj:pass_conj
-------------
sentence: In patients with chronic hepatitis C treated with PEGASYS in combination with COPEGUS, PEGASYS treatment did not affect ribavirin distribution or clearance.
entities: PEGASYS / COPEGUS
ddi: null
>>> match: treat_obl_obl
-------------
sentence: In patients with chronic hepatitis C treated with PEGASYS in combination with COPEGUS, PEGASYS treatment did not affect ribavirin distribution or clearance.
entities: PEGASYS / PEGASYS
ddi: null
>>> match: treat_obl_obl
-------------
sentence: Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.
entities: Stavudine / stavudine
ddi: null
>>> match: antagonize_nsubj_obj
-------------
sentence: Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.
entities: Stavudine / zidovudine
ddi: null
>>> match: antagonize_nsubj_obj
-------------
sentence: Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.
entities: Zidovudine / stavudine
ddi: null
>>> match: antagonize_nsubj_obj
-------------
sentence: Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.
entities: Zidovudine / zidovudine
ddi: null
>>> match: antagonize_nsubj_obj
-------------
sentence: Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.
entities: Ribavirin / stavudine
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: Stavudine and Zidovudine Ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against HIV.
entities: Ribavirin / zidovudine
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: Pregnancy: Category X: Use With Ribavirin (see CONTRAINDICATIONS) Significant teratogenic and/or embryocidal effects have been demonstrated in all animal species exposed to ribavirin.
entities: Ribavirin / ribavirin
ddi: null
>>> match: demonstrate_dep_obl
-------------
sentence: PEGASYS contains benzyl alcohol.
entities: PEGASYS / benzyl alcohol
ddi: null
>>> match: contain_nsubj_obj
-------------
sentence: Adverse reactions related to alpha interferons, such as CNS, cardiac, and systemic (eg, flu-like) effects may be more severe in the elderly and caution should be exercised in the use of PEGASYS in this population.
entities: alpha interferons / PEGASYS
ddi: null
>>> match: exercise_nsubj:pass_obl
-------------
sentence: PEGASYS should be used with caution in patients with creatinine clearance  50 mL/min and COPEGUS should not be administered to patients with creatinine clearance  50 mL/min
entities: PEGASYS / COPEGUS
ddi: null
>>> match: use_nsubj:pass_conj
-------------
sentence: The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.
entities: SSRI / SSRI
ddi: null
>>> match: depend_nsubj_obl
-------------
sentence: The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.
entities: TCA / SSRI
ddi: null
>>> match: depend_nsubj_obl
-------------
sentence: Nevertheless, caution is indicated in the co-administration of T.A. with any of the SSRIs and also in switching from one class to the other.
entities: T.A. / SSRIs
ddi: advise
>>> match: indicate_obl_obl
-------------
sentence: Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.
entities: tricyclic antidepressants / tricyclic antidepressant
ddi: null
>>> match: require_nsubj_obj
-------------
sentence: It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6.
entities: TCA / TCA
ddi: null
>>> match: monitor_obj_advcl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine hydrochloride / psychotropic agents
ddi: effect
>>> match: combine_nsubj:pass_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine hydrochloride / tranquilizers
ddi: effect
>>> match: combine_nsubj:pass_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine hydrochloride / sedative
ddi: effect
>>> match: combine_nsubj:pass_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine hydrochloride / hypnotics
ddi: effect
>>> match: combine_nsubj:pass_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine hydrochloride / desipramine
ddi: null
>>> match: give_advcl_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine hydrochloride / benzodiazepines
ddi: null
>>> match: give_advcl_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine hydrochloride / chlordiazepoxide
ddi: null
>>> match: give_advcl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine hydrochloride / diazepam
ddi: null
>>> match: give_advcl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: psychotropic agents / desipramine
ddi: null
>>> match: give_advcl_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: psychotropic agents / benzodiazepines
ddi: null
>>> match: give_advcl_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: psychotropic agents / chlordiazepoxide
ddi: null
>>> match: give_advcl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: psychotropic agents / diazepam
ddi: null
>>> match: give_advcl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: tranquilizers / desipramine
ddi: null
>>> match: give_advcl_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: tranquilizers / benzodiazepines
ddi: null
>>> match: give_advcl_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: tranquilizers / chlordiazepoxide
ddi: null
>>> match: give_advcl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: tranquilizers / diazepam
ddi: null
>>> match: give_advcl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: sedative / desipramine
ddi: null
>>> match: give_advcl_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: sedative / benzodiazepines
ddi: null
>>> match: give_advcl_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: sedative / chlordiazepoxide
ddi: null
>>> match: give_advcl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: sedative / diazepam
ddi: null
>>> match: give_advcl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: hypnotics / desipramine
ddi: null
>>> match: give_advcl_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: hypnotics / benzodiazepines
ddi: null
>>> match: give_advcl_obl
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: hypnotics / chlordiazepoxide
ddi: null
>>> match: give_advcl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: hypnotics / diazepam
ddi: null
>>> match: give_advcl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine / chlordiazepoxide
ddi: effect
>>> match: give_obl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine / diazepam
ddi: effect
>>> match: give_obl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: benzodiazepines / chlordiazepoxide
ddi: null
>>> match: give_obl_dep
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: benzodiazepines / diazepam
ddi: null
>>> match: give_obl_dep
-------------
sentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.
entities: cimetidine / tricyclic antidepressants
ddi: null
>>> match: produce_nsubj_obl
-------------
sentence: Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants.
entities: tricyclic antidepressants / tricyclic antidepressants
ddi: null
>>> match: produce_nsubj_obl
-------------
sentence: Conversely, decreases in plasma levels of the tricyclic antidepressants have been reported upon discontinuation of cimetidine which may result in the loss of the therapeutic efficacy of the tricyclic antidepressant 6.
entities: tricyclic antidepressants / cimetidine
ddi: mechanism
>>> match: decrease_obl_dep
-------------
sentence: Conversely, decreases in plasma levels of the tricyclic antidepressants have been reported upon discontinuation of cimetidine which may result in the loss of the therapeutic efficacy of the tricyclic antidepressant 6.
entities: tricyclic antidepressants / tricyclic antidepressant
ddi: null
>>> match: decrease_obl_dep
-------------
sentence: Oral Contraceptives Multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl estradiol, the estrogenic component in most oral contraceptives.
entities: Contraceptives / cefditoren pivoxil
ddi: null
>>> match: have_nsubj_nsubj
-------------
sentence: Oral Contraceptives Multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl estradiol, the estrogenic component in most oral contraceptives.
entities: Contraceptives / ethinyl estradiol
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Oral Contraceptives Multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl estradiol, the estrogenic component in most oral contraceptives.
entities: Contraceptives / contraceptives
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Oral Contraceptives Multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl estradiol, the estrogenic component in most oral contraceptives.
entities: cefditoren pivoxil / ethinyl estradiol
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Oral Contraceptives Multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl estradiol, the estrogenic component in most oral contraceptives.
entities: cefditoren pivoxil / contraceptives
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Oral Contraceptives Multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl estradiol, the estrogenic component in most oral contraceptives.
entities: ethinyl estradiol / contraceptives
ddi: null
>>> match: have_obj_obj
-------------
sentence: Although the clinical significance is not known, it is not recommended that cefditoren pivoxil be taken concomitantly with antacids.
entities: cefditoren pivoxil / antacids
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: H2-Receptor Antagonists: Co-administration of a single dose of intravenously administered famotidine (20 mg) reduced the oral absorption of a single 400 mg dose of cefditoren pivoxil administered following a meal, as evidenced by a 27% decrease in mean Cmax and a 22% decrease in mean AUC.
entities: H2-Receptor Antagonists / cefditoren pivoxil
ddi: null
>>> match: reduce_nsubj_obj
-------------
sentence: H2-Receptor Antagonists: Co-administration of a single dose of intravenously administered famotidine (20 mg) reduced the oral absorption of a single 400 mg dose of cefditoren pivoxil administered following a meal, as evidenced by a 27% decrease in mean Cmax and a 22% decrease in mean AUC.
entities: famotidine / cefditoren pivoxil
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Although the clinical significance is not known, it is not recommended that cefditoren pivoxil be taken concomitantly with H2 receptor antagonists.
entities: cefditoren pivoxil / H2 receptor antagonists
ddi: null
>>> match: take_nsubj:pass_obl
-------------
sentence: Probenecid: As with other b-lactam antibiotics, co-administration of probenecid with cefditoren pivoxil resulted in an increase in the plasma exposure of cefditoren, with a 49% increase in mean Cmax, a 122% increase in mean AUC, and a 53% increase in half-life.
entities: b-lactam antibiotics / probenecid
ddi: null
>>> match: result_obl_nsubj
-------------
sentence: Probenecid: As with other b-lactam antibiotics, co-administration of probenecid with cefditoren pivoxil resulted in an increase in the plasma exposure of cefditoren, with a 49% increase in mean Cmax, a 122% increase in mean AUC, and a 53% increase in half-life.
entities: b-lactam antibiotics / cefditoren pivoxil
ddi: mechanism
>>> match: result_obl_nsubj
-------------
sentence: Probenecid: As with other b-lactam antibiotics, co-administration of probenecid with cefditoren pivoxil resulted in an increase in the plasma exposure of cefditoren, with a 49% increase in mean Cmax, a 122% increase in mean AUC, and a 53% increase in half-life.
entities: b-lactam antibiotics / cefditoren
ddi: null
>>> match: result_obl_obl
-------------
sentence: Probenecid: As with other b-lactam antibiotics, co-administration of probenecid with cefditoren pivoxil resulted in an increase in the plasma exposure of cefditoren, with a 49% increase in mean Cmax, a 122% increase in mean AUC, and a 53% increase in half-life.
entities: probenecid / cefditoren
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Probenecid: As with other b-lactam antibiotics, co-administration of probenecid with cefditoren pivoxil resulted in an increase in the plasma exposure of cefditoren, with a 49% increase in mean Cmax, a 122% increase in mean AUC, and a 53% increase in half-life.
entities: cefditoren pivoxil / cefditoren
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: A study of interaction between BREVIBLOC and warfarin showed that concomitant administration of BREVIBLOC and warfarin does not alter warfarin plasma levels.
entities: BREVIBLOC / BREVIBLOC
ddi: null
>>> match: show_nsubj_ccomp
-------------
sentence: A study of interaction between BREVIBLOC and warfarin showed that concomitant administration of BREVIBLOC and warfarin does not alter warfarin plasma levels.
entities: BREVIBLOC / warfarin
ddi: null
>>> match: show_nsubj_ccomp
-------------
sentence: A study of interaction between BREVIBLOC and warfarin showed that concomitant administration of BREVIBLOC and warfarin does not alter warfarin plasma levels.
entities: BREVIBLOC / warfarin
ddi: null
>>> match: show_nsubj_ccomp
-------------
sentence: A study of interaction between BREVIBLOC and warfarin showed that concomitant administration of BREVIBLOC and warfarin does not alter warfarin plasma levels.
entities: warfarin / BREVIBLOC
ddi: null
>>> match: show_nsubj_ccomp
-------------
sentence: A study of interaction between BREVIBLOC and warfarin showed that concomitant administration of BREVIBLOC and warfarin does not alter warfarin plasma levels.
entities: warfarin / warfarin
ddi: null
>>> match: show_nsubj_ccomp
-------------
sentence: A study of interaction between BREVIBLOC and warfarin showed that concomitant administration of BREVIBLOC and warfarin does not alter warfarin plasma levels.
entities: warfarin / warfarin
ddi: null
>>> match: show_nsubj_ccomp
-------------
sentence: When digoxin and BREVIBLOC were concomitantly administered intravenously to normal volunteers, there was a 10-20% increase in digoxin blood levels at some time points.
entities: digoxin / digoxin
ddi: null
>>> match: be_advcl_nsubj
-------------
sentence: When digoxin and BREVIBLOC were concomitantly administered intravenously to normal volunteers, there was a 10-20% increase in digoxin blood levels at some time points.
entities: BREVIBLOC / digoxin
ddi: null
>>> match: be_advcl_nsubj
-------------
sentence: When intravenous morphine and BREVIBLOC were concomitantly administered in normal subjects, no effect on morphine blood levels was seen, but BREVIBLOC steady-state blood levels were increased by 46% in the presence of morphine.
entities: morphine / morphine
ddi: null
>>> match: see_advcl_nsubj:pass
-------------
sentence: When intravenous morphine and BREVIBLOC were concomitantly administered in normal subjects, no effect on morphine blood levels was seen, but BREVIBLOC steady-state blood levels were increased by 46% in the presence of morphine.
entities: morphine / BREVIBLOC
ddi: null
>>> match: see_advcl_conj
-------------
sentence: When intravenous morphine and BREVIBLOC were concomitantly administered in normal subjects, no effect on morphine blood levels was seen, but BREVIBLOC steady-state blood levels were increased by 46% in the presence of morphine.
entities: morphine / morphine
ddi: null
>>> match: see_advcl_conj
-------------
sentence: When intravenous morphine and BREVIBLOC were concomitantly administered in normal subjects, no effect on morphine blood levels was seen, but BREVIBLOC steady-state blood levels were increased by 46% in the presence of morphine.
entities: BREVIBLOC / morphine
ddi: null
>>> match: see_advcl_nsubj:pass
-------------
sentence: When intravenous morphine and BREVIBLOC were concomitantly administered in normal subjects, no effect on morphine blood levels was seen, but BREVIBLOC steady-state blood levels were increased by 46% in the presence of morphine.
entities: BREVIBLOC / BREVIBLOC
ddi: null
>>> match: see_advcl_conj
-------------
sentence: When intravenous morphine and BREVIBLOC were concomitantly administered in normal subjects, no effect on morphine blood levels was seen, but BREVIBLOC steady-state blood levels were increased by 46% in the presence of morphine.
entities: BREVIBLOC / morphine
ddi: null
>>> match: see_advcl_conj
-------------
sentence: When intravenous morphine and BREVIBLOC were concomitantly administered in normal subjects, no effect on morphine blood levels was seen, but BREVIBLOC steady-state blood levels were increased by 46% in the presence of morphine.
entities: morphine / BREVIBLOC
ddi: null
>>> match: see_nsubj:pass_conj
-------------
sentence: When intravenous morphine and BREVIBLOC were concomitantly administered in normal subjects, no effect on morphine blood levels was seen, but BREVIBLOC steady-state blood levels were increased by 46% in the presence of morphine.
entities: morphine / morphine
ddi: null
>>> match: see_nsubj:pass_conj
-------------
sentence: When intravenous morphine and BREVIBLOC were concomitantly administered in normal subjects, no effect on morphine blood levels was seen, but BREVIBLOC steady-state blood levels were increased by 46% in the presence of morphine.
entities: BREVIBLOC / morphine
ddi: mechanism
>>> match: increase_advmod_obl
-------------
sentence: Although the interactions observed in these studies do not appear to be of major clinical importance, BREVIBLOC should be titrated with caution in patients being treated concurrently with digoxin, morphine, succinylcholine or warfarin.
entities: BREVIBLOC / digoxin
ddi: advise
>>> match: titrate_nsubj:pass_obl
-------------
sentence: Although the interactions observed in these studies do not appear to be of major clinical importance, BREVIBLOC should be titrated with caution in patients being treated concurrently with digoxin, morphine, succinylcholine or warfarin.
entities: BREVIBLOC / morphine
ddi: advise
>>> match: titrate_nsubj:pass_obl
-------------
sentence: Although the interactions observed in these studies do not appear to be of major clinical importance, BREVIBLOC should be titrated with caution in patients being treated concurrently with digoxin, morphine, succinylcholine or warfarin.
entities: BREVIBLOC / succinylcholine
ddi: advise
>>> match: titrate_nsubj:pass_obl
-------------
sentence: Although the interactions observed in these studies do not appear to be of major clinical importance, BREVIBLOC should be titrated with caution in patients being treated concurrently with digoxin, morphine, succinylcholine or warfarin.
entities: BREVIBLOC / warfarin
ddi: advise
>>> match: titrate_nsubj:pass_obl
-------------
sentence: Additionally, BREVIBLOC should not be used to control supraventricular tachycardia in the presence of agents which are vasoconstrictive and inotropic such as dopamine, epinephrine, and norepinephrine because of the danger of blocking cardiac contractility when systemic vascular resistance is high.
entities: BREVIBLOC / dopamine
ddi: advise
>>> match: use_nsubj:pass_xcomp
-------------
sentence: Additionally, BREVIBLOC should not be used to control supraventricular tachycardia in the presence of agents which are vasoconstrictive and inotropic such as dopamine, epinephrine, and norepinephrine because of the danger of blocking cardiac contractility when systemic vascular resistance is high.
entities: BREVIBLOC / epinephrine
ddi: advise
>>> match: use_nsubj:pass_xcomp
-------------
sentence: Additionally, BREVIBLOC should not be used to control supraventricular tachycardia in the presence of agents which are vasoconstrictive and inotropic such as dopamine, epinephrine, and norepinephrine because of the danger of blocking cardiac contractility when systemic vascular resistance is high.
entities: BREVIBLOC / norepinephrine
ddi: advise
>>> match: use_nsubj:pass_xcomp
-------------
sentence: The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.
entities: SSRI / SSRI
ddi: null
>>> match: depend_nsubj_obl
-------------
sentence: The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.
entities: TCA / SSRI
ddi: null
>>> match: depend_nsubj_obl
-------------
sentence: Nevertheless, caution is indicated in the coadministration of TCAs with any of the SSRIs and also in switching from one class to the other.
entities: TCAs / SSRIs
ddi: advise
>>> match: indicate_obl_obl
-------------
sentence: Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.
entities: tricyclic antidepressants / tricyclic antidepressant
ddi: null
>>> match: require_nsubj_obj
-------------
sentence: It is desirable to monitor TCA plasma levels whenever a TCA is going to be coadministered with another drug known to be an inhibitor of P450 2D6.
entities: TCA / TCA
ddi: null
>>> match: monitor_obj_advcl
-------------
sentence: and disulfiram When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.
entities: amitriptyline HCl / anticholinergic
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: and disulfiram When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.
entities: amitriptyline HCl / sympathomimetic
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: and disulfiram When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.
entities: amitriptyline HCl / epinephrine
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: and disulfiram When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.
entities: amitriptyline HCl / anesthetics
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: Hyperpyrexia has been reported when amitriptyline HCl is administered with anticholinergic agents or with neuroleptic drugs, particularly during hot weather.
entities: amitriptyline HCl / anticholinergic
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Hyperpyrexia has been reported when amitriptyline HCl is administered with anticholinergic agents or with neuroleptic drugs, particularly during hot weather.
entities: amitriptyline HCl / neuroleptic
ddi: null
>>> match: administer_nsubj:pass_conj
-------------
sentence: Hyperpyrexia has been reported when amitriptyline HCl is administered with anticholinergic agents or with neuroleptic drugs, particularly during hot weather.
entities: anticholinergic / neuroleptic
ddi: null
>>> match: administer_obl_conj
-------------
sentence: Paralytic ileus may occur in patients taking tricyclic antidepressants in combination with anticholinergic-type drugs.
entities: tricyclic antidepressants / anticholinergic
ddi: effect
>>> match: take_obj_obl
-------------
sentence: Cimetidine is reported to reduce hepatic metabolism of certain tricyclic antidepressants, thereby delaying elimination and increasing steady-state concentrations of these drugs.
entities: Cimetidine / tricyclic antidepressants
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Cimetidine is reported to reduce hepatic metabolism of certain tricyclic antidepressants, thereby delaying elimination and increasing steady-state concentrations of these drugs.
entities: Cimetidine / drugs
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Cimetidine is reported to reduce hepatic metabolism of certain tricyclic antidepressants, thereby delaying elimination and increasing steady-state concentrations of these drugs.
entities: tricyclic antidepressants / drugs
ddi: null
>>> match: reduce_obj_conj
-------------
sentence: Clinically significant effects have been reported with the tricyclic antidepressants when used concomitantly with cimetidine.
entities: tricyclic antidepressants / cimetidine
ddi: effect
>>> match: report_obl_dep
-------------
sentence: Increases in plasma levels of tricyclic antidepressants, and in the frequency and severity of side effects, particularly anticholinergic, have been reported when cimetidine was added to the drug regimen.
entities: tricyclic antidepressants / anticholinergic
ddi: null
>>> match: increase_obl_conj
-------------
sentence: Increases in plasma levels of tricyclic antidepressants, and in the frequency and severity of side effects, particularly anticholinergic, have been reported when cimetidine was added to the drug regimen.
entities: tricyclic antidepressants / cimetidine
ddi: mechanism
>>> match: increase_obl_conj
-------------
sentence: Increases in plasma levels of tricyclic antidepressants, and in the frequency and severity of side effects, particularly anticholinergic, have been reported when cimetidine was added to the drug regimen.
entities: tricyclic antidepressants / drug
ddi: null
>>> match: increase_obl_conj
-------------
sentence: Increases in plasma levels of tricyclic antidepressants, and in the frequency and severity of side effects, particularly anticholinergic, have been reported when cimetidine was added to the drug regimen.
entities: anticholinergic / cimetidine
ddi: null
>>> match: report_dep_advcl
-------------
sentence: Increases in plasma levels of tricyclic antidepressants, and in the frequency and severity of side effects, particularly anticholinergic, have been reported when cimetidine was added to the drug regimen.
entities: anticholinergic / drug
ddi: null
>>> match: report_dep_advcl
-------------
sentence: Increases in plasma levels of tricyclic antidepressants, and in the frequency and severity of side effects, particularly anticholinergic, have been reported when cimetidine was added to the drug regimen.
entities: cimetidine / drug
ddi: null
>>> match: add_nsubj:pass_obl
-------------
sentence: Discontinuation of cimetidine in well-controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants.
entities: cimetidine / antidepressants
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Discontinuation of cimetidine in well-controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants.
entities: tricyclic antidepressants / antidepressants
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Discontinuation of cimetidine in well-controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants.
entities: cimetidine / antidepressants
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Ethanol:Clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol.
entities: etretinate / acitretin
ddi: null
>>> match: form_nsubj:pass_obl
-------------
sentence: Ethanol:Clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol.
entities: etretinate / ethanol
ddi: null
>>> match: form_nsubj:pass_obl
-------------
sentence: Glibenclamide: In a study of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose lowering effect of glibenclamide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects.
entities: acitretin / glibenclamide
ddi: effect
>>> match: potentiate_nsubj_dep
-------------
sentence: Glibenclamide: In a study of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose lowering effect of glibenclamide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects.
entities: acitretin / sulfonylurea
ddi: null
>>> match: potentiate_nsubj_dep
-------------
sentence: Glibenclamide: In a study of 7 healthy male volunteers, acitretin treatment potentiated the blood glucose lowering effect of glibenclamide (a sulfonylurea similar to chlorpropamide) in 3 of the 7 subjects.
entities: acitretin / chlorpropamide
ddi: null
>>> match: potentiate_nsubj_dep
-------------
sentence: However, it has been established that acitretin interferes with the contraceptive effect of microdosed progestin minipill preparations.
entities: acitretin / progestin
ddi: effect
>>> match: interfere_nsubj_obl
-------------
sentence: Phenytoin: If acitretin is given concurrently with phenytoin, the protein binding of phenytoin may be reduced.
entities: acitretin / phenytoin
ddi: mechanism
>>> match: give_nsubj:pass_obl
-------------
sentence: Phenytoin: If acitretin is given concurrently with phenytoin, the protein binding of phenytoin may be reduced.
entities: acitretin / phenytoin
ddi: null
>>> match: reduce_advcl_nsubj:pass
-------------
sentence: Phenytoin: If acitretin is given concurrently with phenytoin, the protein binding of phenytoin may be reduced.
entities: phenytoin / phenytoin
ddi: null
>>> match: reduce_advcl_nsubj:pass
-------------
sentence: Increases in prothrombin time have been noted in patients receiving long- term warfarin therapy after flutamide was initiated.
entities: warfarin / flutamide
ddi: effect
>>> match: receive_obj_advcl
-------------
sentence: Therefore, close monitoring of prothrombin time is recommended and adjustment of the anticoagulant dose may be necessary when EULEXIN Capsules are administered concomitantly with warfarin.
entities: EULEXIN / warfarin
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: In clinical studies, Tilade has been co-administered with other anti-asthma medications, including inhaled and oral bronchodilators, and inhaled corticosteroids, with no evidence of increased frequency of adverse events or laboratory abnormalities.
entities: Tilade / bronchodilators
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: In clinical studies, Tilade has been co-administered with other anti-asthma medications, including inhaled and oral bronchodilators, and inhaled corticosteroids, with no evidence of increased frequency of adverse events or laboratory abnormalities.
entities: Tilade / corticosteroids
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Wait 5 weeks after stopping escitalopram before starting a non-selective MAO inhibitor.
entities: escitalopram / non-selective MAO inhibitor
ddi: advise
>>> match: stop_obj_advcl
-------------
sentence: Wait 2 weeks after stopping an MAO inhibitor before starting escitalopram.
entities: MAO inhibitor / escitalopram
ddi: advise
>>> match: stop_obj_obl
-------------
sentence: In vitro studies have shown that precipitation occurs when eye drops containing thimerosal are mixed with latanoprost.
entities: thimerosal / latanoprost
ddi: null
>>> match: mix_nsubj:pass_obl
-------------
sentence: Mineral oil interferes with the absorption of fat-soluble vitamins, including vitamin D preparations.
entities: Mineral oil / fat-soluble vitamins
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Mineral oil interferes with the absorption of fat-soluble vitamins, including vitamin D preparations.
entities: Mineral oil / vitamin D preparations
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: With the morning dose of ceftibuten on day 6, each volunteer received a single intravenous infusion of theophylline (4 mg/kg).
entities: ceftibuten / theophylline
ddi: null
>>> match: receive_obl_obj
-------------
sentence: however, 150 mg of ranitidine q12h for 3 days increased the ceftibuten C max by 23% and ceftibuten AUC by 16%.
entities: ranitidine / ceftibuten
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: however, 150 mg of ranitidine q12h for 3 days increased the ceftibuten C max by 23% and ceftibuten AUC by 16%.
entities: ranitidine / ceftibuten
ddi: mechanism
>>> match: increase_nsubj_obl
-------------
sentence: however, 150 mg of ranitidine q12h for 3 days increased the ceftibuten C max by 23% and ceftibuten AUC by 16%.
entities: ceftibuten / ceftibuten
ddi: null
>>> match: increase_obj_obl
-------------
sentence: The results of assays using red cells from healthy subjects to determine whether ceftibuten would cause direct Coombs reactions in vitro showed no positive reaction at ceftibuten concentrations as high as 40  g/mL.
entities: ceftibuten / ceftibuten
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: Exemestane is extensively metabolized by CYP 3A4, but coadministration of ketoconazole, a potent inhibitor of CYP 3A4, has no significant effect on exemestane pharmacokinetics.
entities: Exemestane / ketoconazole
ddi: null
>>> match: metabolize_nsubj:pass_conj
-------------
sentence: Exemestane is extensively metabolized by CYP 3A4, but coadministration of ketoconazole, a potent inhibitor of CYP 3A4, has no significant effect on exemestane pharmacokinetics.
entities: Exemestane / exemestane
ddi: null
>>> match: metabolize_nsubj:pass_conj
-------------
sentence: Exemestane is extensively metabolized by CYP 3A4, but coadministration of ketoconazole, a potent inhibitor of CYP 3A4, has no significant effect on exemestane pharmacokinetics.
entities: ketoconazole / exemestane
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Co-medications that induce CYP 3A4 (e.g., rifampicin, phenytoin, carbamazepine, phenobarbital, or St. John s wort) may significantly decrease exposure to exemestane.
entities: rifampicin / exemestane
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Co-medications that induce CYP 3A4 (e.g., rifampicin, phenytoin, carbamazepine, phenobarbital, or St. John s wort) may significantly decrease exposure to exemestane.
entities: phenytoin / exemestane
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Co-medications that induce CYP 3A4 (e.g., rifampicin, phenytoin, carbamazepine, phenobarbital, or St. John s wort) may significantly decrease exposure to exemestane.
entities: carbamazepine / exemestane
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Co-medications that induce CYP 3A4 (e.g., rifampicin, phenytoin, carbamazepine, phenobarbital, or St. John s wort) may significantly decrease exposure to exemestane.
entities: phenobarbital / exemestane
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: glucocorticoids / PROLEUKIN
ddi: effect
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: glucocorticoids / PROLEUKIN
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: glucocorticoids / PROLEUKIN
ddi: null
>>> match: reduce_csubj_obj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: glucocorticoids / Beta-blockers
ddi: null
>>> match: reduce_csubj_conj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: glucocorticoids / antihypertensives
ddi: null
>>> match: reduce_csubj_conj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: glucocorticoids / PROLEUKIN
ddi: null
>>> match: reduce_csubj_conj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: PROLEUKIN / PROLEUKIN
ddi: null
>>> match: reduce_csubj_obj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: PROLEUKIN / Beta-blockers
ddi: null
>>> match: reduce_csubj_conj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: PROLEUKIN / antihypertensives
ddi: null
>>> match: reduce_csubj_conj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: PROLEUKIN / PROLEUKIN
ddi: null
>>> match: reduce_csubj_conj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: PROLEUKIN / PROLEUKIN
ddi: null
>>> match: reduce_csubj_obj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: PROLEUKIN / Beta-blockers
ddi: null
>>> match: reduce_csubj_conj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: PROLEUKIN / antihypertensives
ddi: null
>>> match: reduce_csubj_conj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: PROLEUKIN / PROLEUKIN
ddi: null
>>> match: reduce_csubj_conj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: PROLEUKIN / Beta-blockers
ddi: null
>>> match: reduce_obj_conj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: PROLEUKIN / antihypertensives
ddi: null
>>> match: reduce_obj_conj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: PROLEUKIN / PROLEUKIN
ddi: null
>>> match: reduce_obj_conj
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: Beta-blockers / PROLEUKIN
ddi: effect
>>> match: potentiate_nsubj_dep
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: antihypertensives / PROLEUKIN
ddi: effect
>>> match: potentiate_nsubj_dep
-------------
sentence: These antibiotics should be used in the myasthenic patient only where definitely indicated, and then careful adjustment should be made of adjunctive anticholinesterase dosage.
entities: antibiotics / anticholinesterase
ddi: advise
>>> match: use_nsubj:pass_advcl
-------------
sentence: Since entecavir is primarily eliminated by the kidneys, coadministration of BARACLUDE with drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either entecavir or the coadministered drug.
entities: entecavir / BARACLUDE
ddi: null
>>> match: increase_advcl_nsubj
-------------
sentence: Since entecavir is primarily eliminated by the kidneys, coadministration of BARACLUDE with drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either entecavir or the coadministered drug.
entities: entecavir / entecavir
ddi: null
>>> match: increase_advcl_obj
-------------
sentence: Since entecavir is primarily eliminated by the kidneys, coadministration of BARACLUDE with drugs that reduce renal function or compete for active tubular secretion may increase serum concentrations of either entecavir or the coadministered drug.
entities: BARACLUDE / entecavir
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: The effects of coadministration of BARACLUDE with other drugs that are renally eliminated or are known to affect renal function have not been evaluated, and patients should be monitored closely for adverse events when BARACLUDE is coadministered with such drugs.
entities: BARACLUDE / BARACLUDE
ddi: null
>>> match: evaluate_nsubj:pass_conj
-------------
sentence: However, halothane anesthetic requirement (i.e., MAC) was depressed in a dose-dependent fashion as much as 56% 1-2 hours and as much as 14% 5-6 hours after injection of ketamine, 50 mg/kg, im. 
entities: halothane / ketamine
ddi: mechanism
>>> match: depress_nsubj:pass_obj
-------------
sentence: The reduction in MAC was correlated with brain levels of ketamine or metabolite I, suggesting a ketamine:metabolite I potency ration of 3:1. 
entities: ketamine / ketamine
ddi: null
>>> match: correlate_obl_obj
-------------
sentence: The co-administration of Natrecor with IV vasodilators such as nitroglycerin, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).
entities: Natrecor / Natrecor
ddi: null
>>> match: evaluate_nsubj:pass_parataxis
-------------
sentence: The co-administration of Natrecor with IV vasodilators such as nitroglycerin, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).
entities: vasodilators / Natrecor
ddi: null
>>> match: evaluate_nsubj:pass_parataxis
-------------
sentence: The co-administration of Natrecor with IV vasodilators such as nitroglycerin, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).
entities: nitroglycerin / Natrecor
ddi: null
>>> match: evaluate_nsubj:pass_parataxis
-------------
sentence: The co-administration of Natrecor with IV vasodilators such as nitroglycerin, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).
entities: nitroprusside / Natrecor
ddi: null
>>> match: evaluate_nsubj:pass_parataxis
-------------
sentence: The co-administration of Natrecor with IV vasodilators such as nitroglycerin, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).
entities: milrinone / Natrecor
ddi: null
>>> match: evaluate_nsubj:pass_parataxis
-------------
sentence: The co-administration of Natrecor with IV vasodilators such as nitroglycerin, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated (these drugs were not co-administered with Natrecor in clinical trials).
entities: ACE inhibitors / Natrecor
ddi: null
>>> match: evaluate_nsubj:pass_parataxis
-------------
sentence: The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.
entities: benzodiazepines / psychotropic medications
ddi: effect
>>> match: produce_nsubj_advcl
-------------
sentence: The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.
entities: benzodiazepines / anticonvulsants
ddi: effect
>>> match: produce_nsubj_advcl
-------------
sentence: The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.
entities: benzodiazepines / antihistaminics
ddi: effect
>>> match: produce_nsubj_advcl
-------------
sentence: The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.
entities: benzodiazepines / ethanol
ddi: effect
>>> match: produce_nsubj_advcl
-------------
sentence: The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.
entities: alprazolam / psychotropic medications
ddi: effect
>>> match: produce_nsubj_advcl
-------------
sentence: The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.
entities: alprazolam / anticonvulsants
ddi: effect
>>> match: produce_nsubj_advcl
-------------
sentence: The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.
entities: alprazolam / antihistaminics
ddi: effect
>>> match: produce_nsubj_advcl
-------------
sentence: The benzodiazepines, including alprazolam, produce additive CNS depressant effects when co-administered with other psychotropic medications, anticonvulsants, antihistaminics, ethanol, and other drugs which themselves produce CNS depression.
entities: alprazolam / ethanol
ddi: effect
>>> match: produce_nsubj_advcl
-------------
sentence: The steady state plasma concentrations of imipramine and desipramine have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of alprazolam tablets in doses up to 4 mg/day.
entities: imipramine / alprazolam
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: The steady state plasma concentrations of imipramine and desipramine have been reported to be increased an average of 31% and 20%, respectively, by the concomitant administration of alprazolam tablets in doses up to 4 mg/day.
entities: desipramine / alprazolam
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.
entities: fluoxetine / alprazolam
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Drugs Demonstrated to be CYP 3A Inhibitors of Possible Clinical Significance on the Basis of Clinical Studies Involving Alprazolam (caution is recommended during coadministration with alprazolam): Coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46%, decreased clearance by 21%, increased half-life by 17%, and decreased measured psychomotor performance.
entities: alprazolam / alprazolam
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Coadministration of propoxyphene decreased the maximum plasma concentration of alprazolam by 6%, decreased clearance by 38%, and increased half-life by 58%.
entities: propoxyphene / alprazolam
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Coadministration of oral contraceptives increased the maximum plasma concentration of alprazolam by 18%, decreased clearance by 22%, and increased half-life by 29%.
entities: contraceptives / alprazolam
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: benzodiazepines / alprazolam
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: benzodiazepines / diltiazem
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: benzodiazepines / isoniazid
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: benzodiazepines / macrolide antibiotics
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: benzodiazepines / erythromycin
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: benzodiazepines / clarithromycin
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: alprazolam / alprazolam
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: alprazolam / diltiazem
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: alprazolam / isoniazid
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: alprazolam / macrolide antibiotics
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: alprazolam / erythromycin
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Drugs and other substances demonstrated to be CYP 3A inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines (caution is recommended during coadministration with alprazolam): Available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following: diltiazem, isoniazid, macrolide antibiotics such as erythromycin and clarithromycin, and grapefruit juice.
entities: alprazolam / clarithromycin
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following: sertraline and paroxetine.
entities: alprazolam / alprazolam
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following: sertraline and paroxetine.
entities: alprazolam / sertraline
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following: sertraline and paroxetine.
entities: alprazolam / paroxetine
ddi: null
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: benzodiazepines / ergotamine
ddi: int
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: benzodiazepines / cyclosporine
ddi: int
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: benzodiazepines / amiodarone
ddi: int
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: benzodiazepines / nicardipine
ddi: int
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: benzodiazepines / nifedipine
ddi: int
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: alprazolam / ergotamine
ddi: int
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: alprazolam / cyclosporine
ddi: int
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: alprazolam / amiodarone
ddi: int
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: alprazolam / nicardipine
ddi: int
>>> match: suggest_nsubj_obj
-------------
sentence: Data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine.
entities: alprazolam / nifedipine
ddi: int
>>> match: suggest_nsubj_obj
-------------
sentence: Concomitant use of calcium supplements and L-lysine may increase calcium absorption
entities: calcium / calcium
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Concomitant use of calcium supplements and L-lysine may increase calcium absorption
entities: L-lysine / calcium
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: However, interactions may be expected, and UROXATRAL should NOT be used in combination with other alpha-blockers.
entities: UROXATRAL / alpha-blockers
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: However, co  administration of fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine.
entities: fexofenadine hydrochloride / fexofenadine
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: However, co  administration of fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine.
entities: ketoconazole / fexofenadine
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: However, co  administration of fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine.
entities: erythromycin / fexofenadine
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole.
entities: Fexofenadine / erythromycin
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole.
entities: Fexofenadine / ketoconazole
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: In 2 separate studies, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was co-administered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy volunteers (n=24, each study).
entities: fexofenadine hydrochloride / erythromycin
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: In 2 separate studies, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was co-administered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy volunteers (n=24, each study).
entities: fexofenadine hydrochloride / ketoconazole
ddi: null
>>> match: administer_nsubj:pass_obl:tmod
-------------
sentence: In 2 separate studies, fexofenadine hydrochloride 120 mg twice daily (240 mg total daily dose) was co-administered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy volunteers (n=24, each study).
entities: erythromycin / ketoconazole
ddi: null
>>> match: administer_obl_obl:tmod
-------------
sentence: These studies indicate that ketoconazole or erythromycin co-administration enhances fexofenadine gastrointestinal absorption.
entities: ketoconazole / fexofenadine
ddi: mechanism
>>> match: enhance_nsubj_obj
-------------
sentence: These studies indicate that ketoconazole or erythromycin co-administration enhances fexofenadine gastrointestinal absorption.
entities: erythromycin / fexofenadine
ddi: mechanism
>>> match: enhance_nsubj_obj
-------------
sentence: This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. in vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary excretion.
entities: ketoconazole / fexofenadine
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. in vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary excretion.
entities: ketoconazole / erythromycin
ddi: null
>>> match: decrease_nsubj_advcl
-------------
sentence: This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. in vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary excretion.
entities: fexofenadine / erythromycin
ddi: null
>>> match: decrease_obj_advcl
-------------
sentence: Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.
entities: Antacids / fexofenadine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.
entities: fexofenadine hydrochloride / fexofenadine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.
entities: aluminum / fexofenadine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.
entities: magnesium / fexofenadine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.
entities: antacid / fexofenadine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Drug Interactions with Antacids Administration of 120 mg of fexofenadine hydrochloride (2 x 60 mg capsule) within 15 minutes of an aluminum and magnesium containing antacid (Maalox ) decreased fexofenadine AUC by 41% and cmax by 43%.
entities: Maalox / fexofenadine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: ALLEGRA should not be taken closely in time with aluminum and magnesium containing antacids.
entities: ALLEGRA / aluminum
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: ALLEGRA should not be taken closely in time with aluminum and magnesium containing antacids.
entities: ALLEGRA / magnesium
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: ALLEGRA should not be taken closely in time with aluminum and magnesium containing antacids.
entities: ALLEGRA / antacids
ddi: null
>>> match: take_nsubj:pass_obl
-------------
sentence: Therefore, to maximize the effects of fexofenadine, it is recommended that ALLEGRA should be taken with water
entities: fexofenadine / ALLEGRA
ddi: null
>>> match: maximize_obj_parataxis
-------------
sentence: Indinavir steady-state Cmax, A.C. and Cmin were decreased by 22%, 38%, and 27%, respectively, by concomitant amprenavir.
entities: Indinavir / amprenavir
ddi: mechanism
>>> match: decrease_nsubj:pass_obl
-------------
sentence: Saquinavir steady-state Cmax, A.C. and Cmin were increased 21%, decreased 19%, and decreased 48%, respectively, by concomitant amprenavir.
entities: Saquinavir / amprenavir
ddi: mechanism
>>> match: increase_nsubj:pass_conj
-------------
sentence: Nelfinavir steady-state Cmax, A.C. and Cmin were increased by 12%, 15%, and 14%, respectively, by concomitant amprenavir.
entities: Nelfinavir / amprenavir
ddi: mechanism
>>> match: increase_nsubj:pass_obl
-------------
sentence: Methadone: Coadministration of amprenavir and methadone can decrease plasma levels of methadone.
entities: amprenavir / methadone
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Methadone: Coadministration of amprenavir and methadone can decrease plasma levels of methadone.
entities: methadone / methadone
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Coadministration of amprenavir and methadone as compared to a non-matched historicalcontrol group resulted in a 30%, 27%, and 25% decrease in serum amprenavir AUC, Cmax, andCmin, respectively.
entities: amprenavir / amprenavir
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Coadministration of amprenavir and methadone as compared to a non-matched historicalcontrol group resulted in a 30%, 27%, and 25% decrease in serum amprenavir AUC, Cmax, andCmin, respectively.
entities: methadone / amprenavir
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: For comprehensive information concerning laboratory test alterations associated with ritonavir, physicians should refer to the complete prescribing information for NORVIR (ritonavir).
entities: ritonavir / NORVIR
ddi: null
>>> match: refer_obl_obl
-------------
sentence: For comprehensive information concerning laboratory test alterations associated with ritonavir, physicians should refer to the complete prescribing information for NORVIR (ritonavir).
entities: ritonavir / ritonavir
ddi: null
>>> match: refer_obl_obl
-------------
sentence: Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.
entities: Tetracycline / penicillin
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.
entities: bacteriostatic antibiotic / penicillin
ddi: null
>>> match: antagonize_nsubj_obj
-------------
sentence: Since photic evoked potential components are representations of neural pathways which are activated during photic stimulation, study of the effects of alcohol on these components may help to trace pathways which are affected by alcohol. 
entities: alcohol / alcohol
ddi: null
>>> match: help_csubj_xcomp
-------------
sentence: Physostigmine pretreatment augmented the depressant effect of alcohol on the early components P1 and N1, while attenuating alcohol's influence on components P2 and P3. 
entities: Physostigmine / alcohol
ddi: effect
>>> match: augment_nsubj_obj
-------------
sentence: Physostigmine pretreatment augmented the depressant effect of alcohol on the early components P1 and N1, while attenuating alcohol's influence on components P2 and P3. 
entities: Physostigmine / alcohol
ddi: effect
>>> match: augment_nsubj_dep
-------------
sentence: Physostigmine pretreatment augmented the depressant effect of alcohol on the early components P1 and N1, while attenuating alcohol's influence on components P2 and P3. 
entities: alcohol / alcohol
ddi: null
>>> match: augment_obj_dep
-------------
sentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.
entities: benzodiazepines / anticonvulsants
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.
entities: benzodiazepines / antihistamines
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.
entities: benzodiazepines / alcohol
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.
entities: benzodiazepines / barbiturates
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.
entities: benzodiazepines / monoamine oxidase inhibitors
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.
entities: benzodiazepines / narcotics
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.
entities: benzodiazepines / phenothiazines
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression.
entities: benzodiazepines / psychotropic medications
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: Consequently, estazolam should be avoided in patients receiving ketoconazole and itraconazole, which are very potent inhibitors of CYP3A.
entities: estazolam / ketoconazole
ddi: advise
>>> match: avoid_nsubj:pass_obl
-------------
sentence: Consequently, estazolam should be avoided in patients receiving ketoconazole and itraconazole, which are very potent inhibitors of CYP3A.
entities: estazolam / itraconazole
ddi: advise
>>> match: avoid_nsubj:pass_obl
-------------
sentence: Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, warfarin, diazepam, or fluoxetine. 
entities: rivastigmine / digoxin
ddi: null
>>> match: affect_nsubj:pass_obl
-------------
sentence: Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, warfarin, diazepam, or fluoxetine. 
entities: rivastigmine / warfarin
ddi: null
>>> match: affect_nsubj:pass_obl
-------------
sentence: Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, warfarin, diazepam, or fluoxetine. 
entities: rivastigmine / diazepam
ddi: null
>>> match: affect_nsubj:pass_obl
-------------
sentence: Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, warfarin, diazepam, or fluoxetine. 
entities: rivastigmine / fluoxetine
ddi: null
>>> match: affect_nsubj:pass_obl
-------------
sentence: Use with Anticholinergics: Because of their mechanism of action, cholinesterase inhibitors have the potential to interfere with the activity of anticholinergic medications. 
entities: Anticholinergics / cholinesterase inhibitors
ddi: null
>>> match: use_obl_dep
-------------
sentence: Use with Anticholinergics: Because of their mechanism of action, cholinesterase inhibitors have the potential to interfere with the activity of anticholinergic medications. 
entities: Anticholinergics / anticholinergic medications
ddi: null
>>> match: use_obl_dep
-------------
sentence: Use with Anticholinergics: Because of their mechanism of action, cholinesterase inhibitors have the potential to interfere with the activity of anticholinergic medications. 
entities: cholinesterase inhibitors / anticholinergic medications
ddi: int
>>> match: have_nsubj_ccomp
-------------
sentence: Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.
entities: cholinesterase inhibitors / succinylcholine
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.
entities: cholinesterase inhibitors / neuromuscular blocking agents
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.
entities: cholinesterase inhibitors / cholinergic agonists
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.
entities: cholinesterase inhibitors / bethanechol
ddi: effect
>>> match: give_nsubj:pass_obl
-------------
sentence: However, neither phenobarbital nor diazepam appears to affect Dantrium metabolism.
entities: phenobarbital / Dantrium
ddi: null
>>> match: appear_nsubj_xcomp
-------------
sentence: However, neither phenobarbital nor diazepam appears to affect Dantrium metabolism.
entities: diazepam / Dantrium
ddi: null
>>> match: appear_nsubj_xcomp
-------------
sentence: Binding to plasma proteins is reduced by warfarin and clotibrate and increased by tolbutamide.
entities: warfarin / tolbutamide
ddi: null
>>> match: reduce_obl_conj
-------------
sentence: Administration of dantrolene may potentiate vecuronium-induced neuromuscular block.
entities: dantrolene / vecuronium
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: On the basis of the metabolism of bexarotene by cytochrome P450 3A4, ketoconazole, itraconazole, erythromycin, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.
entities: bexarotene / bexarotene
ddi: null
>>> match: expect_obl_xcomp
-------------
sentence: On the basis of the metabolism of bexarotene by cytochrome P450 3A4, ketoconazole, itraconazole, erythromycin, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.
entities: ketoconazole / bexarotene
ddi: mechanism
>>> match: expect_obl_xcomp
-------------
sentence: On the basis of the metabolism of bexarotene by cytochrome P450 3A4, ketoconazole, itraconazole, erythromycin, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.
entities: itraconazole / bexarotene
ddi: mechanism
>>> match: expect_obl_xcomp
-------------
sentence: On the basis of the metabolism of bexarotene by cytochrome P450 3A4, ketoconazole, itraconazole, erythromycin, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.
entities: erythromycin / bexarotene
ddi: mechanism
>>> match: expect_obl_xcomp
-------------
sentence: On the basis of the metabolism of bexarotene by cytochrome P450 3A4, ketoconazole, itraconazole, erythromycin, gemfibrozil, grapefruit juice, and other inhibitors of cytochrome P450 3A4 would be expected to lead to an increase in plasma bexarotene concentrations.
entities: gemfibrozil / bexarotene
ddi: mechanism
>>> match: expect_obl_xcomp
-------------
sentence: Furthermore, rifampin, phenytoin, phenobarbital, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma bexarotene concentrations.
entities: rifampin / bexarotene
ddi: mechanism
>>> match: cause_nsubj_obj
-------------
sentence: Furthermore, rifampin, phenytoin, phenobarbital, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma bexarotene concentrations.
entities: phenytoin / bexarotene
ddi: mechanism
>>> match: cause_nsubj_obj
-------------
sentence: Furthermore, rifampin, phenytoin, phenobarbital, and other inducers of cytochrome P450 3A4 may cause a reduction in plasma bexarotene concentrations.
entities: phenobarbital / bexarotene
ddi: mechanism
>>> match: cause_nsubj_obj
-------------
sentence: Concomitant administration of Targretin capsules and gemfibrozil resulted in substantial increases in plasma concentrations of bexarotene, probably at least partially related to cytochrome P450 3A4 inhibition by gemfibrozil.
entities: Targretin / bexarotene
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Concomitant administration of Targretin capsules and gemfibrozil resulted in substantial increases in plasma concentrations of bexarotene, probably at least partially related to cytochrome P450 3A4 inhibition by gemfibrozil.
entities: Targretin / gemfibrozil
ddi: null
>>> match: result_nsubj_dep
-------------
sentence: Concomitant administration of Targretin capsules and gemfibrozil resulted in substantial increases in plasma concentrations of bexarotene, probably at least partially related to cytochrome P450 3A4 inhibition by gemfibrozil.
entities: gemfibrozil / bexarotene
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Concomitant administration of Targretin capsules and gemfibrozil resulted in substantial increases in plasma concentrations of bexarotene, probably at least partially related to cytochrome P450 3A4 inhibition by gemfibrozil.
entities: gemfibrozil / gemfibrozil
ddi: null
>>> match: result_nsubj_dep
-------------
sentence: Concomitant administration of Targretin capsules and gemfibrozil resulted in substantial increases in plasma concentrations of bexarotene, probably at least partially related to cytochrome P450 3A4 inhibition by gemfibrozil.
entities: bexarotene / gemfibrozil
ddi: null
>>> match: result_obl_dep
-------------
sentence: Drugs that Inhibit or Induce Cytochrome P450 3A4 Enzymes Lapatinib undergoes extensive metabolism by CYP3A4, and concomitant administration of strong inhibitors or inducers of CYP3A4 alter lapatinib concentrations significantly.
entities: Lapatinib / lapatinib
ddi: null
>>> match: undergo_nsubj_conj
-------------
sentence: Ketoconazole: In healthy subjects receiving ketoconazole, a CYP3A4 inhibitor, at 200 mg twice daily for 7 days, systemic exposure (AUC) to lapatinib was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control.
entities: ketoconazole / lapatinib
ddi: mechanism
>>> match: increase_obl_nsubj:pass
-------------
sentence: If TYKERB is administered with drugs that inhibit Pgp, increased concentrations of lapatinib are likely, and caution should be exercised.
entities: TYKERB / lapatinib
ddi: null
>>> match: administer_nsubj:pass_ccomp
-------------
sentence: Other Chemotherapy Agents In a separate study, concomitant administration of lapatinib with capecitabine did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of capecitabine).
entities: lapatinib / capecitabine
ddi: null
>>> match: alter_nsubj_obj
-------------
sentence: Other Chemotherapy Agents In a separate study, concomitant administration of lapatinib with capecitabine did not meaningfully alter the pharmacokinetics of either agent (or the metabolites of capecitabine).
entities: capecitabine / capecitabine
ddi: null
>>> match: alter_nsubj_obj
-------------
sentence: For example, when vitamin K antagonists are administered concomitantly with nilutamide, prothrombin time should be carefully monitored and if necessary, the dosage of vitamin K antagonists should be reduced.
entities: vitamin K antagonists / nilutamide
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: For example, when vitamin K antagonists are administered concomitantly with nilutamide, prothrombin time should be carefully monitored and if necessary, the dosage of vitamin K antagonists should be reduced.
entities: vitamin K antagonists / vitamin K antagonists
ddi: null
>>> match: monitor_advcl_parataxis
-------------
sentence: For example, when vitamin K antagonists are administered concomitantly with nilutamide, prothrombin time should be carefully monitored and if necessary, the dosage of vitamin K antagonists should be reduced.
entities: nilutamide / vitamin K antagonists
ddi: null
>>> match: monitor_advcl_parataxis
-------------
sentence: ZEBETA should not be combined with other beta-blocking agents.
entities: ZEBETA / beta-blocking agents
ddi: advise
>>> match: combine_nsubj:pass_obl
-------------
sentence: Patients receiving catecholamine-depleting drugs, such as reserpine or guanethidine, should be closely monitored, because the added beta-adrenergic blocking action of ZEBETA may produce excessive reduction of sympathetic activity.
entities: reserpine / ZEBETA
ddi: effect
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: Patients receiving catecholamine-depleting drugs, such as reserpine or guanethidine, should be closely monitored, because the added beta-adrenergic blocking action of ZEBETA may produce excessive reduction of sympathetic activity.
entities: guanethidine / ZEBETA
ddi: effect
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that ZEBETA be discontinued for several days before the withdrawal of clonidine.
entities: clonidine / ZEBETA
ddi: null
>>> match: suggest_obl_ccomp
-------------
sentence: In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that ZEBETA be discontinued for several days before the withdrawal of clonidine.
entities: clonidine / clonidine
ddi: null
>>> match: suggest_obl_ccomp
-------------
sentence: In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that ZEBETA be discontinued for several days before the withdrawal of clonidine.
entities: ZEBETA / clonidine
ddi: advise
>>> match: discontinue_nsubj:pass_obl
-------------
sentence: ZEBETA should be used with care when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists (particularly of the phenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic agents, such as disopyramide, are used concurrently.
entities: ZEBETA / myocardial depressants
ddi: advise
>>> match: use_nsubj:pass_advcl
-------------
sentence: ZEBETA should be used with care when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists (particularly of the phenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic agents, such as disopyramide, are used concurrently.
entities: ZEBETA / calcium antagonists
ddi: advise
>>> match: use_nsubj:pass_advcl
-------------
sentence: ZEBETA should be used with care when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists (particularly of the phenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic agents, such as disopyramide, are used concurrently.
entities: ZEBETA / phenylalkylamine
ddi: advise
>>> match: use_nsubj:pass_advcl
-------------
sentence: ZEBETA should be used with care when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists (particularly of the phenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic agents, such as disopyramide, are used concurrently.
entities: ZEBETA / verapamil
ddi: advise
>>> match: use_nsubj:pass_advcl
-------------
sentence: ZEBETA should be used with care when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists (particularly of the phenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic agents, such as disopyramide, are used concurrently.
entities: ZEBETA / benzothiazepine
ddi: advise
>>> match: use_nsubj:pass_advcl
-------------
sentence: ZEBETA should be used with care when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists (particularly of the phenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic agents, such as disopyramide, are used concurrently.
entities: ZEBETA / diltiazem
ddi: advise
>>> match: use_nsubj:pass_advcl
-------------
sentence: ZEBETA should be used with care when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists (particularly of the phenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic agents, such as disopyramide, are used concurrently.
entities: ZEBETA / antiarrhythmic agents
ddi: advise
>>> match: use_nsubj:pass_advcl
-------------
sentence: ZEBETA should be used with care when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists (particularly of the phenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic agents, such as disopyramide, are used concurrently.
entities: ZEBETA / disopyramide
ddi: advise
>>> match: use_nsubj:pass_advcl
-------------
sentence: Concurrent use of rifampin increases the metabolic clearance of ZEBETA, resulting in a shortened elimination half-life of ZEBETA.
entities: rifampin / ZEBETA
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Concurrent use of rifampin increases the metabolic clearance of ZEBETA, resulting in a shortened elimination half-life of ZEBETA.
entities: rifampin / ZEBETA
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: There was no effect of ZEBETA on prothrombin time in patients on stable doses of warfarin.
entities: ZEBETA / warfarin
ddi: null
>>> match: be_nsubj_obl
-------------
sentence: Before taking glimepiride, tell your doctor if you are taking any of the following medicines: - aspirin or another salicylate such as magnesium/choline salicylate (Trilisate), salsalate (Disalcid, others), choline salicylate (Arthropan), magnesium salicylate (Magan), or bismuth subsalicylate (Pepto-Bismol);
entities: glimepiride / aspirin
ddi: advise
>>> match: tell_obl_advcl
-------------
sentence: Before taking glimepiride, tell your doctor if you are taking any of the following medicines: - aspirin or another salicylate such as magnesium/choline salicylate (Trilisate), salsalate (Disalcid, others), choline salicylate (Arthropan), magnesium salicylate (Magan), or bismuth subsalicylate (Pepto-Bismol);
entities: glimepiride / salicylate
ddi: advise
>>> match: tell_obl_advcl
-------------
sentence: Before taking glimepiride, tell your doctor if you are taking any of the following medicines: - aspirin or another salicylate such as magnesium/choline salicylate (Trilisate), salsalate (Disalcid, others), choline salicylate (Arthropan), magnesium salicylate (Magan), or bismuth subsalicylate (Pepto-Bismol);
entities: glimepiride / magnesium/choline salicylate
ddi: advise
>>> match: tell_obl_advcl
-------------
sentence: Before taking glimepiride, tell your doctor if you are taking any of the following medicines: - aspirin or another salicylate such as magnesium/choline salicylate (Trilisate), salsalate (Disalcid, others), choline salicylate (Arthropan), magnesium salicylate (Magan), or bismuth subsalicylate (Pepto-Bismol);
entities: glimepiride / Trilisate
ddi: advise
>>> match: tell_obl_advcl
-------------
sentence: Before taking glimepiride, tell your doctor if you are taking any of the following medicines: - aspirin or another salicylate such as magnesium/choline salicylate (Trilisate), salsalate (Disalcid, others), choline salicylate (Arthropan), magnesium salicylate (Magan), or bismuth subsalicylate (Pepto-Bismol);
entities: glimepiride / salsalate
ddi: advise
>>> match: tell_obl_advcl
-------------
sentence: Before taking glimepiride, tell your doctor if you are taking any of the following medicines: - aspirin or another salicylate such as magnesium/choline salicylate (Trilisate), salsalate (Disalcid, others), choline salicylate (Arthropan), magnesium salicylate (Magan), or bismuth subsalicylate (Pepto-Bismol);
entities: glimepiride / Disalcid
ddi: advise
>>> match: tell_obl_advcl
-------------
sentence: Before taking glimepiride, tell your doctor if you are taking any of the following medicines: - aspirin or another salicylate such as magnesium/choline salicylate (Trilisate), salsalate (Disalcid, others), choline salicylate (Arthropan), magnesium salicylate (Magan), or bismuth subsalicylate (Pepto-Bismol);
entities: glimepiride / choline salicylate
ddi: advise
>>> match: tell_obl_advcl
-------------
sentence: Before taking glimepiride, tell your doctor if you are taking any of the following medicines: - aspirin or another salicylate such as magnesium/choline salicylate (Trilisate), salsalate (Disalcid, others), choline salicylate (Arthropan), magnesium salicylate (Magan), or bismuth subsalicylate (Pepto-Bismol);
entities: glimepiride / Arthropan
ddi: advise
>>> match: tell_obl_advcl
-------------
sentence: Before taking glimepiride, tell your doctor if you are taking any of the following medicines: - aspirin or another salicylate such as magnesium/choline salicylate (Trilisate), salsalate (Disalcid, others), choline salicylate (Arthropan), magnesium salicylate (Magan), or bismuth subsalicylate (Pepto-Bismol);
entities: glimepiride / magnesium salicylate
ddi: advise
>>> match: tell_obl_advcl
-------------
sentence: Before taking glimepiride, tell your doctor if you are taking any of the following medicines: - aspirin or another salicylate such as magnesium/choline salicylate (Trilisate), salsalate (Disalcid, others), choline salicylate (Arthropan), magnesium salicylate (Magan), or bismuth subsalicylate (Pepto-Bismol);
entities: glimepiride / Magan
ddi: advise
>>> match: tell_obl_advcl
-------------
sentence: Before taking glimepiride, tell your doctor if you are taking any of the following medicines: - aspirin or another salicylate such as magnesium/choline salicylate (Trilisate), salsalate (Disalcid, others), choline salicylate (Arthropan), magnesium salicylate (Magan), or bismuth subsalicylate (Pepto-Bismol);
entities: glimepiride / bismuth subsalicylate
ddi: advise
>>> match: tell_obl_advcl
-------------
sentence: Before taking glimepiride, tell your doctor if you are taking any of the following medicines: - aspirin or another salicylate such as magnesium/choline salicylate (Trilisate), salsalate (Disalcid, others), choline salicylate (Arthropan), magnesium salicylate (Magan), or bismuth subsalicylate (Pepto-Bismol);
entities: glimepiride / Pepto-Bismol
ddi: advise
>>> match: tell_obl_advcl
-------------
sentence: Ethopropazine may interact with alcohol or other CNS depressants, causing increased sedative effects.
entities: Ethopropazine / alcohol
ddi: effect
>>> match: interact_nsubj_obl
-------------
sentence: Ethopropazine may interact with alcohol or other CNS depressants, causing increased sedative effects.
entities: Ethopropazine / CNS depressants
ddi: effect
>>> match: interact_nsubj_obl
-------------
sentence: Ethopropazine can interact with chlorpromazine, increasing the metabolism of chlorpromazine.
entities: Ethopropazine / chlorpromazine
ddi: mechanism
>>> match: interact_nsubj_obl
-------------
sentence: Ethopropazine can interact with chlorpromazine, increasing the metabolism of chlorpromazine.
entities: Ethopropazine / chlorpromazine
ddi: null
>>> match: interact_nsubj_dep
-------------
sentence: Ethopropazine can interact with chlorpromazine, increasing the metabolism of chlorpromazine.
entities: chlorpromazine / chlorpromazine
ddi: null
>>> match: interact_obl_dep
-------------
sentence: When Bezalip or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and Bezalip retard may enhance the action of anticoagulants of the coumarin type.
entities: Bezalip / Bezalip
ddi: null
>>> match: take_dep_parataxis
-------------
sentence: When Bezalip or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and Bezalip retard may enhance the action of anticoagulants of the coumarin type.
entities: Bezalip / anticoagulants of the coumarin type
ddi: null
>>> match: take_dep_parataxis
-------------
sentence: When Bezalip or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and Bezalip retard may enhance the action of anticoagulants of the coumarin type.
entities: Bezalip retard / Bezalip
ddi: null
>>> match: take_dep_parataxis
-------------
sentence: When Bezalip or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and Bezalip retard may enhance the action of anticoagulants of the coumarin type.
entities: Bezalip retard / anticoagulants of the coumarin type
ddi: null
>>> match: take_dep_parataxis
-------------
sentence: When Bezalip or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and Bezalip retard may enhance the action of anticoagulants of the coumarin type.
entities: Bezalip / anticoagulants of the coumarin type
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: For this reason, the dose of the anticoagulant should be reduced by 30 - 50% at the start of treatment with Bezalip or Bezalip retard and then titrated according to the blood clotting parameters
entities: anticoagulant / Bezalip
ddi: advise
>>> match: reduce_nsubj:pass_obl
-------------
sentence: For this reason, the dose of the anticoagulant should be reduced by 30 - 50% at the start of treatment with Bezalip or Bezalip retard and then titrated according to the blood clotting parameters
entities: anticoagulant / Bezalip
ddi: advise
>>> match: reduce_nsubj:pass_obl
-------------
sentence: - The action of sulphonylureas and insulin may be enhanced by Bezalip or Bezalip retard.
entities: sulphonylureas / Bezalip
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: - The action of sulphonylureas and insulin may be enhanced by Bezalip or Bezalip retard.
entities: insulin / Bezalip
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: - When Bezalip or Bezalip retard is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired
entities: Bezalip / anion-exchange resins
ddi: advise
>>> match: use_csubj:pass_obl
-------------
sentence: - When Bezalip or Bezalip retard is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired
entities: Bezalip / cholestryramine
ddi: advise
>>> match: use_csubj:pass_obl
-------------
sentence: - When Bezalip or Bezalip retard is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired
entities: Bezalip / Bezalip
ddi: null
>>> match: use_csubj:pass_obl
-------------
sentence: - When Bezalip or Bezalip retard is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired
entities: Bezalip retard / anion-exchange resins
ddi: advise
>>> match: use_csubj:pass_obl
-------------
sentence: - When Bezalip or Bezalip retard is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired
entities: Bezalip retard / cholestryramine
ddi: advise
>>> match: use_csubj:pass_obl
-------------
sentence: - When Bezalip or Bezalip retard is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired
entities: Bezalip retard / Bezalip
ddi: null
>>> match: use_csubj:pass_obl
-------------
sentence: - Perhexiline hydrogen maleate or MAO-inhibitors (with hepatotoxic potential) must not be administered together with Bezalip or Bezalip retard.
entities: MAO-inhibitors / Bezalip
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Other beta adrenergic aerosol bronchodilators should not be used concomitantly with Alupent    (metaproterenol sulfate USP) because they may have additive effects. 
entities: beta adrenergic aerosol bronchodilators / Alupent
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Other beta adrenergic aerosol bronchodilators should not be used concomitantly with Alupent    (metaproterenol sulfate USP) because they may have additive effects. 
entities: beta adrenergic aerosol bronchodilators / metaproterenol sulfate
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Beta adrenergic agonists should be administered with caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, since the action of beta adrenergic agonists on the vascular system may be potentiated.
entities: Beta adrenergic agonists / monoamine oxidase inhibitors
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Beta adrenergic agonists should be administered with caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, since the action of beta adrenergic agonists on the vascular system may be potentiated.
entities: Beta adrenergic agonists / tricyclic antidepressants
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Beta adrenergic agonists should be administered with caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, since the action of beta adrenergic agonists on the vascular system may be potentiated.
entities: Beta adrenergic agonists / beta adrenergic agonists
ddi: null
>>> match: administer_nsubj:pass_advcl
-------------
sentence: Beta adrenergic agonists should be administered with caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, since the action of beta adrenergic agonists on the vascular system may be potentiated.
entities: monoamine oxidase inhibitors / beta adrenergic agonists
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Beta adrenergic agonists should be administered with caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, since the action of beta adrenergic agonists on the vascular system may be potentiated.
entities: tricyclic antidepressants / beta adrenergic agonists
ddi: null
>>> match: administer_obl_advcl
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / narcotic analgesics
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / alcohol
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / anesthetics
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / tranquilizers
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / chlordiazepoxide
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / sedative-hypnotics
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: Butalbital / CNS depressants
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / narcotic analgesics
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / alcohol
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / anesthetics
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / tranquilizers
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / chlordiazepoxide
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / sedative-hypnotics
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: acetaminophen / CNS depressants
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / narcotic analgesics
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / alcohol
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / anesthetics
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / tranquilizers
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / chlordiazepoxide
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / sedative-hypnotics
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Butalbital, acetaminophen and caffeine may enhance the effects of: other narcotic analgesics, alcohol, general anesthetics, tranquilizers such as chlordiazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.
entities: caffeine / CNS depressants
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.
entities: anticholinergic drugs / amantadine
ddi: null
>>> match: increase_obj_obj
-------------
sentence: The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.
entities: anticholinergic drugs / antiarrhythmic agents
ddi: null
>>> match: increase_obj_obj
-------------
sentence: The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.
entities: anticholinergic drugs / quinidine
ddi: null
>>> match: increase_obj_obj
-------------
sentence: The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.
entities: anticholinergic drugs / antihistamines
ddi: null
>>> match: increase_obj_obj
-------------
sentence: The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.
entities: anticholinergic drugs / antipsychotic agents
ddi: null
>>> match: increase_obj_obj
-------------
sentence: The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.
entities: anticholinergic drugs / phenothiazines
ddi: null
>>> match: increase_obj_obj
-------------
sentence: The following agents may increase certain actions or side effects of anticholinergic drugs. amantadine antiarrhythmic agents of class (e.g. quinidine), antihistamines antipsychotic agents (e.g. phenothiazines), benzodiazepines.
entities: anticholinergic drugs / benzodiazepines
ddi: null
>>> match: increase_obj_obj
-------------
sentence: Anticholinergics antagonize the effects of antiglaucoma agents.
entities: Anticholinergics / antiglaucoma agents
ddi: null
>>> match: antagonize_nsubj_obj
-------------
sentence: Anticholinergic agents may affect gastrointestinal absorption of various drugs, such as slowly dissolving dosage forms of digoxin;
entities: Anticholinergic agents / digoxin
ddi: mechanism
>>> match: affect_nsubj_obj
-------------
sentence: Anticholinergic drugs may antagonize the effects of the drugs that alter gastrointestinal motility, such as metoclopramide.
entities: Anticholinergic drugs / metoclopramide
ddi: mechanism
>>> match: antagonize_nsubj_obj
-------------
sentence: Because antacids may interfere with the absorption of anticholinergic agents, simultaneous use of these drugs should be avoided.
entities: antacids / anticholinergic agents
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Clinical trials have indicated that Pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral, inhaled and/or parenteral antibiotics, bronchodilators, enzyme supplements, vitamins, oral or inhaled corticosteroids, and analgesics.
entities: Pulmozyme / antibiotics
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Clinical trials have indicated that Pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral, inhaled and/or parenteral antibiotics, bronchodilators, enzyme supplements, vitamins, oral or inhaled corticosteroids, and analgesics.
entities: Pulmozyme / bronchodilators
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Clinical trials have indicated that Pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral, inhaled and/or parenteral antibiotics, bronchodilators, enzyme supplements, vitamins, oral or inhaled corticosteroids, and analgesics.
entities: Pulmozyme / vitamins
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Clinical trials have indicated that Pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral, inhaled and/or parenteral antibiotics, bronchodilators, enzyme supplements, vitamins, oral or inhaled corticosteroids, and analgesics.
entities: Pulmozyme / corticosteroids
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Clinical trials have indicated that Pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral, inhaled and/or parenteral antibiotics, bronchodilators, enzyme supplements, vitamins, oral or inhaled corticosteroids, and analgesics.
entities: Pulmozyme / analgesics
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Potential drug interactions for doxylamine include, increased sedation if doxylamine is combined with other CNS depressant drugs.
entities: doxylamine / doxylamine
ddi: null
>>> match: include_nsubj_obj
-------------
sentence: Potential drug interactions for doxylamine include, increased sedation if doxylamine is combined with other CNS depressant drugs.
entities: doxylamine / CNS depressant drugs
ddi: null
>>> match: include_nsubj_obj
-------------
sentence: Potential drug interactions for doxylamine include, increased sedation if doxylamine is combined with other CNS depressant drugs.
entities: doxylamine / CNS depressant drugs
ddi: effect
>>> match: combine_nsubj:pass_obl
-------------
sentence: Antihistamines may partially counteract the anticoagulation effects of heparin or warfarin.
entities: Antihistamines / heparin
ddi: effect
>>> match: counteract_nsubj_obj
-------------
sentence: Antihistamines may partially counteract the anticoagulation effects of heparin or warfarin.
entities: Antihistamines / warfarin
ddi: effect
>>> match: counteract_nsubj_obj
-------------
sentence: Doxylamine may enhance the effects of epinephrine.
entities: Doxylamine / epinephrine
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Methotrexate: HUMIRA has been studied in rheumatoid arthritis patients taking concomitant MTX.
entities: HUMIRA / MTX
ddi: null
>>> match: study_nsubj:pass_obl
-------------
sentence: The safety and efficacy of anakinra used in combination with HUMIRA has not been studied.
entities: anakinra / HUMIRA
ddi: null
>>> match: use_nsubj_obl
-------------
sentence: In the treatment of acute MI, aspirin, when not otherwise contraindicated, should be administered with Streptokinase ( see below ). 
entities: aspirin / Streptokinase
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: In addition, oxcarbazepine and MHD induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of dihydropyridine calcium antagonists and oral contraceptives, resulting in a lower plasma concentration of these drugs.
entities: oxcarbazepine / dihydropyridine calcium antagonists
ddi: null
>>> match: induce_nsubj_obj
-------------
sentence: In addition, oxcarbazepine and MHD induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of dihydropyridine calcium antagonists and oral contraceptives, resulting in a lower plasma concentration of these drugs.
entities: oxcarbazepine / contraceptives
ddi: null
>>> match: induce_nsubj_obj
-------------
sentence: In addition, oxcarbazepine and MHD induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of dihydropyridine calcium antagonists and oral contraceptives, resulting in a lower plasma concentration of these drugs.
entities: MHD / dihydropyridine calcium antagonists
ddi: null
>>> match: induce_nsubj_obj
-------------
sentence: In addition, oxcarbazepine and MHD induce a subgroup of the cytochrome P450 3A family (CYP3A4 and CYP3A5) responsible for the metabolism of dihydropyridine calcium antagonists and oral contraceptives, resulting in a lower plasma concentration of these drugs.
entities: MHD / contraceptives
ddi: null
>>> match: induce_nsubj_obj
-------------
sentence: 1- nc denotes a mean change of less than 10% 2- Pediatrics 3- Mean increase in adults at high Trileptal doses In vivo, the plasma levels of phenytoin increased by up to 40%, when Trileptal was given at doses above 1200 mg/day.
entities: Trileptal / phenytoin
ddi: null
>>> match: denote_obl_dep
-------------
sentence: 1- nc denotes a mean change of less than 10% 2- Pediatrics 3- Mean increase in adults at high Trileptal doses In vivo, the plasma levels of phenytoin increased by up to 40%, when Trileptal was given at doses above 1200 mg/day.
entities: Trileptal / Trileptal
ddi: null
>>> match: denote_obl_dep
-------------
sentence: 1- nc denotes a mean change of less than 10% 2- Pediatrics 3- Mean increase in adults at high Trileptal doses In vivo, the plasma levels of phenytoin increased by up to 40%, when Trileptal was given at doses above 1200 mg/day.
entities: phenytoin / Trileptal
ddi: mechanism
>>> match: increase_nsubj_advcl
-------------
sentence: Strong inducers of cytochrome P450 enzymes (i.e. carbamazepine, phenytoin and phenobarbital) have been shown to decrease the plasma levels of MHD (29-40%).
entities: carbamazepine / MHD
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Strong inducers of cytochrome P450 enzymes (i.e. carbamazepine, phenytoin and phenobarbital) have been shown to decrease the plasma levels of MHD (29-40%).
entities: phenytoin / MHD
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Strong inducers of cytochrome P450 enzymes (i.e. carbamazepine, phenytoin and phenobarbital) have been shown to decrease the plasma levels of MHD (29-40%).
entities: phenobarbital / MHD
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Hormonal contraceptives Co-administration of Trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components, ethinylestradiol (EE) and levonorgestrel (LNG).
entities: contraceptives / ethinylestradiol
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Hormonal contraceptives Co-administration of Trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components, ethinylestradiol (EE) and levonorgestrel (LNG).
entities: contraceptives / levonorgestrel
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Hormonal contraceptives Co-administration of Trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components, ethinylestradiol (EE) and levonorgestrel (LNG).
entities: Trileptal / ethinylestradiol
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Hormonal contraceptives Co-administration of Trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components, ethinylestradiol (EE) and levonorgestrel (LNG).
entities: Trileptal / levonorgestrel
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Hormonal contraceptives Co-administration of Trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components, ethinylestradiol (EE) and levonorgestrel (LNG).
entities: contraceptive / ethinylestradiol
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Hormonal contraceptives Co-administration of Trileptal with an oral contraceptive has been shown to influence the plasma concentrations of the two hormonal components, ethinylestradiol (EE) and levonorgestrel (LNG).
entities: contraceptive / levonorgestrel
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Therefore, concurrent use of Trileptal with hormonal contraceptives may render these contraceptives less effective.
entities: Trileptal / contraceptives
ddi: null
>>> match: render_nsubj_xcomp
-------------
sentence: Therefore, concurrent use of Trileptal with hormonal contraceptives may render these contraceptives less effective.
entities: hormonal contraceptives / contraceptives
ddi: null
>>> match: render_nsubj_xcomp
-------------
sentence: Calcium Antagonists: After repeated co-administration of Trileptal, the AUC of felodipine was lowered by 28% [90% CI: 20-33].
entities: Trileptal / felodipine
ddi: mechanism
>>> match: lower_obl_nsubj:pass
-------------
sentence: Verapamil produced a decrease of 20% [90% CI: 18-27] of the plasma levels of MHD.
entities: Verapamil / MHD
ddi: null
>>> match: produce_nsubj_obj
-------------
sentence: Other drug interactions Cimetidine, erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of MHD.
entities: Cimetidine / MHD
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Other drug interactions Cimetidine, erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of MHD.
entities: erythromycin / MHD
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Other drug interactions Cimetidine, erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of MHD.
entities: dextropropoxyphene / MHD
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays.
entities: antibiotics / folic acid
ddi: null
>>> match: invalidate_nsubj_obj
-------------
sentence: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays.
entities: antibiotics / vitamin B12
ddi: null
>>> match: invalidate_nsubj_obj
-------------
sentence: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays.
entities: methotrexate / folic acid
ddi: null
>>> match: invalidate_nsubj_obj
-------------
sentence: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays.
entities: methotrexate / vitamin B12
ddi: null
>>> match: invalidate_nsubj_obj
-------------
sentence: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays.
entities: pyrimethamine / folic acid
ddi: null
>>> match: invalidate_nsubj_obj
-------------
sentence: Persons taking most antibiotics, methotrexate and pyrimethamine invalidate folic acid and vitamin B12 diagnostic blood assays.
entities: pyrimethamine / vitamin B12
ddi: null
>>> match: invalidate_nsubj_obj
-------------
sentence: Colchicine para-aminosalicylic acid and heavy alcohol intake for longer than 2 weeks may produce malabsorption of vitamin B12.
entities: Colchicine / vitamin B12
ddi: mechanism
>>> match: produce_nsubj_obj
-------------
sentence: Colchicine para-aminosalicylic acid and heavy alcohol intake for longer than 2 weeks may produce malabsorption of vitamin B12.
entities: para-aminosalicylic acid / vitamin B12
ddi: mechanism
>>> match: produce_nsubj_obj
-------------
sentence: Colchicine para-aminosalicylic acid and heavy alcohol intake for longer than 2 weeks may produce malabsorption of vitamin B12.
entities: alcohol / vitamin B12
ddi: mechanism
>>> match: produce_nsubj_obj
-------------
sentence: May interact with addictive medications, especially central nervous system (CNS) depressants with habituating potential (prolonged concurrent use may increase the risk of habituation), alcohol or CNS depression producing medications (concurrent use may increase the CNS depressant effects of either these medications or ethinamate).
entities: alcohol / ethinamate
ddi: null
>>> match: increase_conj_obj
-------------
sentence: Treatment with entacapone coadministered with levodopa/dopa decarboxylase inhibitor does not change these effects.
entities: entacapone / levodopa
ddi: null
>>> match: coadminister_nsubj_obl
-------------
sentence: Treatment with entacapone coadministered with levodopa/dopa decarboxylase inhibitor does not change these effects.
entities: entacapone / dopa decarboxylase inhibitor
ddi: null
>>> match: coadminister_nsubj_obl
-------------
sentence: No interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor (n=29).
entities: MAO-B inhibitor / entacapone
ddi: null
>>> match: note_obl_advcl
-------------
sentence: No interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor (n=29).
entities: MAO-B inhibitor / levodopa
ddi: null
>>> match: note_obl_advcl
-------------
sentence: No interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor (n=29).
entities: MAO-B inhibitor / dopa decarboxylase inhibitor
ddi: null
>>> match: note_obl_advcl
-------------
sentence: No interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor (n=29).
entities: selegiline / entacapone
ddi: null
>>> match: note_obl_advcl
-------------
sentence: No interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor (n=29).
entities: selegiline / levodopa
ddi: null
>>> match: note_obl_advcl
-------------
sentence: No interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor (n=29).
entities: selegiline / dopa decarboxylase inhibitor
ddi: null
>>> match: note_obl_advcl
-------------
sentence: No interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor (n=29).
entities: entacapone / levodopa
ddi: null
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: No interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor (n=29).
entities: entacapone / dopa decarboxylase inhibitor
ddi: null
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: More than 600 Parkinsons disease patients in clinical trials have used selegiline in combination with entacapone and levodopa/dopa decarboxylase inhibitor.
entities: selegiline / entacapone
ddi: null
>>> match: use_obj_obl
-------------
sentence: More than 600 Parkinsons disease patients in clinical trials have used selegiline in combination with entacapone and levodopa/dopa decarboxylase inhibitor.
entities: selegiline / levodopa
ddi: null
>>> match: use_obj_obl
-------------
sentence: More than 600 Parkinsons disease patients in clinical trials have used selegiline in combination with entacapone and levodopa/dopa decarboxylase inhibitor.
entities: selegiline / dopa decarboxylase inhibitor
ddi: null
>>> match: use_obj_obl
-------------
sentence: As most entacapone excretion is via the bile, caution should be exercised when drugs known to interfere with biliary excretion, glucuronidation, and intestinal beta-glucuronidase are given concurrently with entacapone.
entities: entacapone / entacapone
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/dopa-decarboxylase inhibitor.
entities: imipramine / entacapone
ddi: null
>>> match: show_nsubj:pass_obl
-------------
sentence: No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/dopa-decarboxylase inhibitor.
entities: imipramine / levodopa
ddi: null
>>> match: show_nsubj:pass_obl
-------------
sentence: No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/dopa-decarboxylase inhibitor.
entities: imipramine / dopa-decarboxylase inhibitor
ddi: null
>>> match: show_nsubj:pass_obl
-------------
sentence: No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/dopa-decarboxylase inhibitor.
entities: entacapone / levodopa
ddi: null
>>> match: show_obl_obl
-------------
sentence: No interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/dopa-decarboxylase inhibitor.
entities: entacapone / dopa-decarboxylase inhibitor
ddi: null
>>> match: show_obl_obl
-------------
sentence: A pharmacokinetic study evaluating the administration of a single dose of INSPRA 100 mg with ketoconazole 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of eplerenone and a 5.4-fold increase in AUC of eplerenone.
entities: INSPRA / ketoconazole
ddi: mechanism
>>> match: evaluate_obj_obl:npmod
-------------
sentence: A pharmacokinetic study evaluating the administration of a single dose of INSPRA 100 mg with ketoconazole 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of eplerenone and a 5.4-fold increase in AUC of eplerenone.
entities: INSPRA / eplerenone
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: A pharmacokinetic study evaluating the administration of a single dose of INSPRA 100 mg with ketoconazole 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of eplerenone and a 5.4-fold increase in AUC of eplerenone.
entities: INSPRA / eplerenone
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: A pharmacokinetic study evaluating the administration of a single dose of INSPRA 100 mg with ketoconazole 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of eplerenone and a 5.4-fold increase in AUC of eplerenone.
entities: ketoconazole / eplerenone
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: A pharmacokinetic study evaluating the administration of a single dose of INSPRA 100 mg with ketoconazole 200 mg BID, a potent inhibitor of the CYP3A4 pathway, showed a 1.7-fold increase in Cmax of eplerenone and a 5.4-fold increase in AUC of eplerenone.
entities: ketoconazole / eplerenone
ddi: null
>>> match: show_nsubj_obj
-------------
sentence: Administration of eplerenone with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, verapamil 240 mg QD, saquinavir 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.
entities: eplerenone / eplerenone
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Administration of eplerenone with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, verapamil 240 mg QD, saquinavir 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.
entities: erythromycin / eplerenone
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Administration of eplerenone with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, verapamil 240 mg QD, saquinavir 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.
entities: verapamil / eplerenone
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Administration of eplerenone with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, verapamil 240 mg QD, saquinavir 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.
entities: saquinavir / eplerenone
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Administration of eplerenone with other CYP3A4 inhibitors (e.g., erythromycin 500 mg BID, verapamil 240 mg QD, saquinavir 1200 mg TID, fluconazole 200 mg QD) resulted in increases in Cmax of eplerenone ranging from 1.4- to 1.6- fold and AUC from 2.0- to 2.9- fold.
entities: fluconazole / eplerenone
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: ACE Inhibitors / ACE inhibitors
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: ACE Inhibitors / angiotensin II receptor antagonists
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: ACE Inhibitors / ACEI
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: ACE Inhibitors / ARB
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: Angiotensin II Receptor Antagonists / ACE inhibitors
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: Angiotensin II Receptor Antagonists / angiotensin II receptor antagonists
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: Angiotensin II Receptor Antagonists / ACEI
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: Angiotensin II Receptor Antagonists / ARB
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: INSPRA / ACE inhibitors
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: INSPRA / angiotensin II receptor antagonists
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: INSPRA / ACEI
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: ACE Inhibitors and Angiotensin II Receptor Antagonists (Congestive Heart Failure Post-Myocardial Infarction)- In EPHESUS, 3020 (91%) patients receiving INSPRA 25 to 50 mg also received ACE inhibitors or angiotensin II receptor antagonists (ACEI/ARB).
entities: INSPRA / ARB
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: In a study in diabetics with microalbuminuria INSPRA 200 mg combined with the ACE inhibitor enalapril 10 mg increased the frequency of hyperkalemia (serum potassium  5.5 mEq/L) from 17% on enalapril alone to 38%.
entities: INSPRA / enalapril
ddi: null
>>> match: increase_obl_obl
-------------
sentence: In a study in diabetics with microalbuminuria INSPRA 200 mg combined with the ACE inhibitor enalapril 10 mg increased the frequency of hyperkalemia (serum potassium  5.5 mEq/L) from 17% on enalapril alone to 38%.
entities: ACE inhibitor / enalapril
ddi: null
>>> match: increase_obl_obl
-------------
sentence: In a study in diabetics with microalbuminuria INSPRA 200 mg combined with the ACE inhibitor enalapril 10 mg increased the frequency of hyperkalemia (serum potassium  5.5 mEq/L) from 17% on enalapril alone to 38%.
entities: enalapril / enalapril
ddi: null
>>> match: increase_obl_obl
-------------
sentence: Serum lithium levels should be monitored frequently if INSPRA is administered concomitantly with lithium.
entities: lithium / INSPRA
ddi: null
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: Serum lithium levels should be monitored frequently if INSPRA is administered concomitantly with lithium.
entities: lithium / lithium
ddi: null
>>> match: monitor_nsubj:pass_advcl
-------------
sentence: Serum lithium levels should be monitored frequently if INSPRA is administered concomitantly with lithium.
entities: INSPRA / lithium
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: If additional adrenergic drugs are to be administered by any route, they should be used with caution because the pharmacologically predictable sympathetic effects of BROVANA may be potentiated.
entities: adrenergic drugs / BROVANA
ddi: advise
>>> match: use_advcl_advcl
-------------
sentence: When paroxetine, a potent inhibitor of CYP2D6, was co-administered with BROVANA at steady-state, exposure to either drug was not altered.
entities: paroxetine / BROVANA
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Concomitant treatment with methylxanthines (aminophylline, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.
entities: methylxanthines / adrenergic agonists
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Concomitant treatment with methylxanthines (aminophylline, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.
entities: aminophylline / adrenergic agonists
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Concomitant treatment with methylxanthines (aminophylline, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.
entities: theophylline / adrenergic agonists
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Concomitant treatment with methylxanthines (aminophylline, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.
entities: steroids / adrenergic agonists
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Concomitant treatment with methylxanthines (aminophylline, theophylline), steroids, or diuretics may potentiate any hypokalemic effect of adrenergic agonists.
entities: diuretics / adrenergic agonists
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded.
entities: non-potassium sparing diuretics / beta-agonists
ddi: effect
>>> match: worsen_nsubj:pass_obl
-------------
sentence: The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded.
entities: non-potassium sparing diuretics / beta-agonist
ddi: null
>>> match: worsen_nsubj:pass_advcl
-------------
sentence: The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded.
entities: loop diuretics / beta-agonists
ddi: effect
>>> match: worsen_nsubj:pass_obl
-------------
sentence: The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded.
entities: loop diuretics / beta-agonist
ddi: null
>>> match: worsen_nsubj:pass_advcl
-------------
sentence: The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded.
entities: thiazide diuretics / beta-agonists
ddi: effect
>>> match: worsen_nsubj:pass_obl
-------------
sentence: The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded.
entities: thiazide diuretics / beta-agonist
ddi: null
>>> match: worsen_nsubj:pass_advcl
-------------
sentence: The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics (such as loop or thiazide diuretics) can be acutely worsened by beta-agonists, especially when the recommended dose of the beta-agonist is exceeded.
entities: beta-agonists / beta-agonist
ddi: null
>>> match: worsen_obl_advcl
-------------
sentence: Although the clinical significance of these effects is not known, caution is advised in the co-administration of beta-agonists with non-potassium sparing diuretics.
entities: beta-agonists / non-potassium sparing diuretics
ddi: advise
>>> match: advise_obl_obl
-------------
sentence: BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.
entities: BROVANA / beta2-agonists
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.
entities: BROVANA / monoamine oxidase inhibitors
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.
entities: BROVANA / tricyclic antidepressants
ddi: advise
>>> match: administer_nsubj:pass_obj
-------------
sentence: BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.
entities: BROVANA / adrenergic agonists
ddi: null
>>> match: administer_nsubj:pass_obj
-------------
sentence: BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.
entities: beta2-agonists / monoamine oxidase inhibitors
ddi: advise
>>> match: administer_obl_obl
-------------
sentence: BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.
entities: beta2-agonists / tricyclic antidepressants
ddi: advise
>>> match: administer_obl_obj
-------------
sentence: BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.
entities: beta2-agonists / adrenergic agonists
ddi: null
>>> match: administer_obl_obj
-------------
sentence: BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.
entities: monoamine oxidase inhibitors / tricyclic antidepressants
ddi: null
>>> match: administer_obl_obj
-------------
sentence: BROVANA, as with other beta2-agonists, should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors, tricyclic antidepressants, or drugs known to prolong the QTc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents.
entities: monoamine oxidase inhibitors / adrenergic agonists
ddi: effect
>>> match: administer_obl_obj
-------------
sentence: In two combined 12-week placebo controlled trials that included BROVANA doses of 15 mcg twice daily, 25 mcg twice daily, and 50 mcg once daily, 54 of 873 BROVANA -treated subjects received concomitant theophylline at study entry.
entities: BROVANA / theophylline
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: In a 12-month controlled trial that included a 50 mcg once daily BROVANA dose, 30 of the 528 BROVANA -treated subjects received concomitant theophylline at study entry.
entities: BROVANA / theophylline
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: In a 12-month controlled trial that included a 50 mcg once daily BROVANA dose, 30 of the 528 BROVANA -treated subjects received concomitant theophylline at study entry.
entities: BROVANA / theophylline
ddi: null
>>> match: receive_nsubj_obj
-------------
sentence: Beta-blockers not only block the therapeutic effects of beta-agonists, but may produce severe bronchospasm in COPD patients.
entities: Beta-blockers / beta-agonists
ddi: effect
>>> match: block_nsubj_obj
-------------
sentence: Clinical interaction studies with cimetidine and warfarin indicated that the coadministration of Femara with these drugs does not result in clinically- significant drug interactions.
entities: cimetidine / Femara
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: Clinical interaction studies with cimetidine and warfarin indicated that the coadministration of Femara with these drugs does not result in clinically- significant drug interactions.
entities: warfarin / Femara
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.
entities: Femara / letrozole
ddi: null
>>> match: see_iobj_dep
-------------
sentence: (See CLINICAL PHARMACOLOGY) Coadministration of Femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38% on average.
entities: tamoxifen / letrozole
ddi: null
>>> match: see_iobj_dep
-------------
sentence: Medroxyprogesterone Acetate - L-histidine was observed to enhance (in tissue culture) the effect of medroxyprogesterone acetate in reducing the number of human breast cancer cells that were in the S phase.
entities: L-histidine / medroxyprogesterone acetate
ddi: effect
>>> match: observe_nsubj:pass_xcomp
-------------
sentence: H1 and H2 Blockers - Although not reported, L-histidine, via its metabolism to histamine, might decrease the efficacy of H1 and H2 blockers.
entities: L-histidine / H1 blockers
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: H1 and H2 Blockers - Although not reported, L-histidine, via its metabolism to histamine, might decrease the efficacy of H1 and H2 blockers.
entities: L-histidine / H2 blockers
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Diphenoxylate HCl and atropine sulfate may interact with MAO inhibitors In studies with male rats, diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day.
entities: Diphenoxylate HCl / MAO inhibitors
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Diphenoxylate HCl and atropine sulfate may interact with MAO inhibitors In studies with male rats, diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day.
entities: Diphenoxylate HCl / diphenoxylate hydrochloride
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Diphenoxylate HCl and atropine sulfate may interact with MAO inhibitors In studies with male rats, diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day.
entities: atropine sulfate / MAO inhibitors
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Diphenoxylate HCl and atropine sulfate may interact with MAO inhibitors In studies with male rats, diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day.
entities: atropine sulfate / diphenoxylate hydrochloride
ddi: null
>>> match: interact_nsubj_parataxis
-------------
sentence: Diphenoxylate HCl and atropine sulfate may interact with MAO inhibitors In studies with male rats, diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day.
entities: MAO inhibitors / diphenoxylate hydrochloride
ddi: null
>>> match: interact_obl_parataxis
-------------
sentence: In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.
entities: heparin / Retavase
ddi: effect
>>> match: increase_obl_advcl
-------------
sentence: In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.
entities: vitamin K antagonists / Retavase
ddi: effect
>>> match: increase_obl_advcl
-------------
sentence: In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.
entities: aspirin / Retavase
ddi: effect
>>> match: increase_obl_advcl
-------------
sentence: In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.
entities: dipyridamole / Retavase
ddi: effect
>>> match: increase_obl_advcl
-------------
sentence: In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.
entities: abciximab / Retavase
ddi: effect
>>> match: increase_obl_advcl
-------------
sentence: While in vitro studies have shown that mirtazapine is not a potent inhibitor of any of these enzymes, an indication that mirtazapine is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome P450 enzymes, the concomitant use of REMERON SolTab with most other drugs metabolized by these enzymes has not been formally studied. 
entities: mirtazapine / mirtazapine
ddi: null
>>> match: show_ccomp_punct
-------------
sentence: While in vitro studies have shown that mirtazapine is not a potent inhibitor of any of these enzymes, an indication that mirtazapine is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome P450 enzymes, the concomitant use of REMERON SolTab with most other drugs metabolized by these enzymes has not been formally studied. 
entities: mirtazapine / REMERON SolTab
ddi: null
>>> match: show_ccomp_punct
-------------
sentence: Alcohol: Concomitant administration of alcohol (equivalent to 60 g) had a minimal effect on plasma levels of mirtazapine (15 mg) in 6 healthy male subjects. 
entities: alcohol / mirtazapine
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: However, the impairment of cognitive and motor skills produced by REMERON    were shown to be additive with those produced by alcohol. 
entities: REMERON / alcohol
ddi: effect
>>> match: produce_obl_dep
-------------
sentence: Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. 
entities: alcohol / REMERON SolTab
ddi: advise
>>> match: avoid_obj_advcl
-------------
sentence: Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. 
entities: alcohol / Diazepam
ddi: null
>>> match: advise_xcomp_dep
-------------
sentence: Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. 
entities: alcohol / diazepam
ddi: null
>>> match: advise_xcomp_dep
-------------
sentence: Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. 
entities: alcohol / mirtazapine
ddi: null
>>> match: advise_xcomp_dep
-------------
sentence: Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. 
entities: REMERON SolTab / Diazepam
ddi: null
>>> match: advise_xcomp_dep
-------------
sentence: Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. 
entities: REMERON SolTab / diazepam
ddi: null
>>> match: advise_xcomp_dep
-------------
sentence: Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. 
entities: REMERON SolTab / mirtazapine
ddi: null
>>> match: advise_xcomp_dep
-------------
sentence: Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects. 
entities: diazepam / mirtazapine
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: However, the impairment of motor skills produced by REMERON has been shown to be additive with those caused by diazepam. 
entities: REMERON / diazepam
ddi: effect
>>> match: produce_obl_dep
-------------
sentence: Accordingly, patients should be advised to avoid diazepam and other similar drugs while taking REMERON SolTab.
entities: diazepam / REMERON SolTab
ddi: advise
>>> match: avoid_obj_advcl
-------------
sentence: In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.
entities: Fondaparinux / fondaparinux sodium
ddi: null
>>> match: affect_obl_obj
-------------
sentence: In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.
entities: anticoagulants / fondaparinux sodium
ddi: null
>>> match: affect_obl_obj
-------------
sentence: In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.
entities: warfarin / fondaparinux sodium
ddi: null
>>> match: affect_obl_obj
-------------
sentence: In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.
entities: platelet inhibitors / fondaparinux sodium
ddi: null
>>> match: affect_obl_obj
-------------
sentence: In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.
entities: acetylsalicylic acid / fondaparinux sodium
ddi: null
>>> match: affect_obl_obj
-------------
sentence: In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.
entities: NSAIDs / fondaparinux sodium
ddi: null
>>> match: affect_obl_obj
-------------
sentence: In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.
entities: piroxicam / fondaparinux sodium
ddi: null
>>> match: affect_obl_obj
-------------
sentence: In clinical studies performed with Fondaparinux, the concomitant use of oral anticoagulants (warfarin), platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam), and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium.
entities: digoxin / fondaparinux sodium
ddi: null
>>> match: affect_obl_obj
-------------
sentence: In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.
entities: Fondaparinux / warfarin
ddi: null
>>> match: influence_nsubj_obj
-------------
sentence: In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.
entities: Fondaparinux / acetylsalicylic acid
ddi: null
>>> match: influence_nsubj_obj
-------------
sentence: In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.
entities: Fondaparinux / piroxicam
ddi: null
>>> match: influence_nsubj_obj
-------------
sentence: In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.
entities: Fondaparinux / digoxin
ddi: null
>>> match: influence_nsubj_obj
-------------
sentence: In addition, Fondaparinux neither influenced the pharmacodynamics of warfarin, acetylsalicylic acid, piroxicam, and digoxin, nor the pharmacokinetics of digoxin at steady state.
entities: Fondaparinux / digoxin
ddi: null
>>> match: influence_nsubj_obj
-------------
sentence: Therefore, linezolid has the potential for interaction with adrenergic and serotonergic agents.
entities: linezolid / adrenergic
ddi: int
>>> match: have_nsubj_obj
-------------
sentence: Therefore, linezolid has the potential for interaction with adrenergic and serotonergic agents.
entities: linezolid / serotonergic agents
ddi: int
>>> match: have_nsubj_obj
-------------
sentence: Adrenergic Agents:Some individuals receiving ZYVOX may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents, vasopressor or dopaminergic agents.
entities: ZYVOX / sympathomimetic agents
ddi: effect
>>> match: experience_nsubj_obj
-------------
sentence: Adrenergic Agents:Some individuals receiving ZYVOX may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents, vasopressor or dopaminergic agents.
entities: ZYVOX / vasopressor
ddi: effect
>>> match: experience_nsubj_obj
-------------
sentence: Adrenergic Agents:Some individuals receiving ZYVOX may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents, vasopressor or dopaminergic agents.
entities: ZYVOX / dopaminergic agents
ddi: effect
>>> match: experience_nsubj_obj
-------------
sentence: Methysergide may reverse the analgesic activity of narcotic analgesics. 
entities: Methysergide / narcotic analgesics
ddi: effect
>>> match: reverse_nsubj_obj
-------------
sentence: A 30 to 45% increase in AUC and Cmax of nisoldipine was observed with concomitant administration of cimetidine 400 mg twice daily.
entities: nisoldipine / cimetidine 400 mg
ddi: mechanism
>>> match: observe_nsubj:pass_obl
-------------
sentence: Coadministration of phenytoin with 40 mg SULAR tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels.
entities: phenytoin / nisoldipine
ddi: null
>>> match: lower_nsubj_obj
-------------
sentence: Coadministration of phenytoin with 40 mg SULAR tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels.
entities: SULAR / nisoldipine
ddi: null
>>> match: lower_nsubj_obj
-------------
sentence: Coadministration of SULAR with phenytoin or any known CYP3A4 inducer should be avoided and alternative antihypertensive therapy should be considered.
entities: SULAR / antihypertensive
ddi: null
>>> match: avoid_nsubj:pass_conj
-------------
sentence: Coadministration of SULAR with phenytoin or any known CYP3A4 inducer should be avoided and alternative antihypertensive therapy should be considered.
entities: phenytoin / antihypertensive
ddi: null
>>> match: avoid_nsubj:pass_conj
-------------
sentence: Propranolol attenuated the heart rate increase following administration of immediate release nisoldipine.
entities: Propranolol / nisoldipine
ddi: effect
>>> match: attenuate_nsubj_obj
-------------
sentence: The blood pressure effect of SULAR tended to be greater in patients on atenolol than in patients on no other antihypertensive therapy.
entities: SULAR / atenolol
ddi: effect
>>> match: tend_nsubj_xcomp
-------------
sentence: The blood pressure effect of SULAR tended to be greater in patients on atenolol than in patients on no other antihypertensive therapy.
entities: SULAR / antihypertensive
ddi: null
>>> match: tend_nsubj_xcomp
-------------
sentence: Quinidine at 648 mg bid decreased the bioavailability (AUC) of nisoldipine by 26%, but not the peak concentration.
entities: Quinidine / nisoldipine
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: The immediate release, but not the coat-core formulation of nisoldipine increased plasma quinidine concentrations by about 20%.
entities: nisoldipine / quinidine
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: When combined with ofloxacin, KRM-1648 exhibited strong synergistic activity while only additive effects were observed with the combination of rifampicin (or rifabutin) and ofloxacin. 
entities: ofloxacin / rifampicin
ddi: null
>>> match: exhibit_nsubj_advcl
-------------
sentence: When combined with ofloxacin, KRM-1648 exhibited strong synergistic activity while only additive effects were observed with the combination of rifampicin (or rifabutin) and ofloxacin. 
entities: ofloxacin / rifabutin
ddi: null
>>> match: exhibit_nsubj_advcl
-------------
sentence: When combined with ofloxacin, KRM-1648 exhibited strong synergistic activity while only additive effects were observed with the combination of rifampicin (or rifabutin) and ofloxacin. 
entities: ofloxacin / ofloxacin
ddi: null
>>> match: exhibit_nsubj_advcl
-------------
sentence: When combined with ofloxacin, KRM-1648 exhibited strong synergistic activity while only additive effects were observed with the combination of rifampicin (or rifabutin) and ofloxacin. 
entities: KRM-1648 / rifampicin
ddi: null
>>> match: exhibit_nsubj_advcl
-------------
sentence: When combined with ofloxacin, KRM-1648 exhibited strong synergistic activity while only additive effects were observed with the combination of rifampicin (or rifabutin) and ofloxacin. 
entities: KRM-1648 / rifabutin
ddi: null
>>> match: exhibit_nsubj_advcl
-------------
sentence: When combined with ofloxacin, KRM-1648 exhibited strong synergistic activity while only additive effects were observed with the combination of rifampicin (or rifabutin) and ofloxacin. 
entities: KRM-1648 / ofloxacin
ddi: null
>>> match: exhibit_nsubj_advcl
-------------
sentence: The risk of using bromocriptine mesylate in combination with other drugs has not been systematically evaluated, but alcohol may potentiate the side effects of bromocriptine mesylate.
entities: bromocriptine mesylate / alcohol
ddi: null
>>> match: evaluate_nsubj:pass_conj
-------------
sentence: The risk of using bromocriptine mesylate in combination with other drugs has not been systematically evaluated, but alcohol may potentiate the side effects of bromocriptine mesylate.
entities: bromocriptine mesylate / bromocriptine mesylate
ddi: null
>>> match: evaluate_nsubj:pass_conj
-------------
sentence: The risk of using bromocriptine mesylate in combination with other drugs has not been systematically evaluated, but alcohol may potentiate the side effects of bromocriptine mesylate.
entities: alcohol / bromocriptine mesylate
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: Bromocriptine mesylate may interact with dopamine antagonists, butyrophenones, and certain other agents.
entities: Bromocriptine mesylate / dopamine antagonists
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bromocriptine mesylate may interact with dopamine antagonists, butyrophenones, and certain other agents.
entities: Bromocriptine mesylate / butyrophenones
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Physiological changes resulting from smoking cessation, with or without nicotine replacement, may alter the pharmacokinetics of certain concomitant medications, such as tricyclic antidepressants and theophylline.
entities: nicotine / tricyclic antidepressants
ddi: null
>>> match: alter_nsubj_obj
-------------
sentence: Physiological changes resulting from smoking cessation, with or without nicotine replacement, may alter the pharmacokinetics of certain concomitant medications, such as tricyclic antidepressants and theophylline.
entities: nicotine / theophylline
ddi: null
>>> match: alter_nsubj_obj
-------------
sentence: The concurrent administration of allopurinol and ampicillin increases substantially the incidence of rashes in patients receiving both drugs as compared to patients receiving ampicillin alone.
entities: allopurinol / ampicillin
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: The concurrent administration of allopurinol and ampicillin increases substantially the incidence of rashes in patients receiving both drugs as compared to patients receiving ampicillin alone.
entities: ampicillin / ampicillin
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: In controlled clinical trials of AUGMENTIN XR, 22 patients received concomitant allopurinol and AUGMENTIN XR.
entities: AUGMENTIN XR / allopurinol
ddi: null
>>> match: receive_obl_obj
-------------
sentence: In controlled clinical trials of AUGMENTIN XR, 22 patients received concomitant allopurinol and AUGMENTIN XR.
entities: AUGMENTIN XR / AUGMENTIN XR
ddi: null
>>> match: receive_obl_obj
-------------
sentence: In common with other broad-spectrum antibiotics, AUGMENTIN XR may reduce the efficacy of oral contraceptives
entities: broad-spectrum antibiotics / AUGMENTIN XR
ddi: null
>>> match: reduce_advcl_nsubj
-------------
sentence: In common with other broad-spectrum antibiotics, AUGMENTIN XR may reduce the efficacy of oral contraceptives
entities: broad-spectrum antibiotics / contraceptives
ddi: effect
>>> match: reduce_advcl_obj
-------------
sentence: In common with other broad-spectrum antibiotics, AUGMENTIN XR may reduce the efficacy of oral contraceptives
entities: AUGMENTIN XR / contraceptives
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Co-administration of nelfinavir at steady-state with a single dose of azithromycin (2 x 600 mg tablets) results in increased azithromycin serum concentrations.
entities: nelfinavir / azithromycin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Co-administration of nelfinavir at steady-state with a single dose of azithromycin (2 x 600 mg tablets) results in increased azithromycin serum concentrations.
entities: azithromycin / azithromycin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is warranted.
entities: azithromycin / azithromycin
ddi: null
>>> match: warrant_advcl_nsubj:pass
-------------
sentence: Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is warranted.
entities: nelfinavir / azithromycin
ddi: null
>>> match: warrant_advcl_nsubj:pass
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / atorvastatin
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / carbamazepine
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / cetirizine
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / didanosine
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / efavirenz
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / fluconazole
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / indinavir
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / midazolam
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / rifabutin
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / sildenafil
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / theophylline
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / triazolam
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / trimethoprim
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / sulfamethoxazole
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: When used in therapeutic doses, azithromycin had a modest effect on the pharmacokinetics of atorvastatin, carbamazepine, cetirizine, didanosine, efavirenz, fluconazole, indinavir, midazolam, rifabutin, sildenafil, theophylline (intravenous and oral), triazolam, trimethoprim/sulfamethoxazole or zidovudine.
entities: azithromycin / zidovudine
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: Co-administration with efavirenz or fluconazole had a modest effect on the pharmacokinetics of azithromycin.
entities: efavirenz / azithromycin
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: Co-administration with efavirenz or fluconazole had a modest effect on the pharmacokinetics of azithromycin.
entities: fluconazole / azithromycin
ddi: mechanism
>>> match: have_nsubj_obj
-------------
sentence: Until further data are developed regarding drug interactions when azithromycin and these drugs are used concomitantly, careful monitoring of patients is advised: Digoxin elevated digoxin concentrations.
entities: azithromycin / Digoxin
ddi: null
>>> match: advise_nsubj:pass_obj
-------------
sentence: Until further data are developed regarding drug interactions when azithromycin and these drugs are used concomitantly, careful monitoring of patients is advised: Digoxin elevated digoxin concentrations.
entities: azithromycin / digoxin
ddi: null
>>> match: advise_nsubj:pass_obj
-------------
sentence: Among the polyene antibiotics, many, like filipin, cannot be used clinically because they are toxic; 
entities: polyene antibiotics / filipin
ddi: null
>>> match: use_obl_obl
-------------
sentence: Both the toxicity of filipin and the therapeutic value of amphotericin B can be rationalized at the cellular and molecular level by the following observations: (i) these polyene antibiotics showed differential effects on cells; 
entities: filipin / polyene antibiotics
ddi: null
>>> match: rationalize_nsubj:pass_obl
-------------
sentence: Both the toxicity of filipin and the therapeutic value of amphotericin B can be rationalized at the cellular and molecular level by the following observations: (i) these polyene antibiotics showed differential effects on cells; 
entities: amphotericin B / polyene antibiotics
ddi: null
>>> match: rationalize_nsubj:pass_obl
-------------
sentence: and (ii) the effects of filipin were more efficiently inhibited by added cholesterol, the major membrane sterol in human cells, whereas the effects of amphotericin B were more efficiently inhibited by ergosterol, the major membrane sterol in yeast. 
entities: filipin / amphotericin B
ddi: null
>>> match: inhibit_nsubj:pass_advcl
-------------
sentence: Itraconazole decreases busulfan clearance by up to 25%, and may produce AUCs   1500  M min in some patients.
entities: Itraconazole / busulfan
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Fluconazole, and the 5-HT3 antiemetics ondansetron (Zofran) and granisetron (Kytril) have all been used with BUSULFEX.
entities: Fluconazole / BUSULFEX
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Fluconazole, and the 5-HT3 antiemetics ondansetron (Zofran) and granisetron (Kytril) have all been used with BUSULFEX.
entities: ondansetron / BUSULFEX
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Fluconazole, and the 5-HT3 antiemetics ondansetron (Zofran) and granisetron (Kytril) have all been used with BUSULFEX.
entities: Zofran / BUSULFEX
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Fluconazole, and the 5-HT3 antiemetics ondansetron (Zofran) and granisetron (Kytril) have all been used with BUSULFEX.
entities: granisetron / BUSULFEX
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Fluconazole, and the 5-HT3 antiemetics ondansetron (Zofran) and granisetron (Kytril) have all been used with BUSULFEX.
entities: Kytril / BUSULFEX
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Phenytoin increases the clearance of busulfan by 15% or more, possibly due to the induction of glutathione-S-transferase.
entities: Phenytoin / busulfan
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Since the pharmacokinetics of BUSULFEX were studied in patients treated with phenytoin, the clearance of BUSULFEX at the recommended dose may be lower and exposure (AUC) higher in patients not treated with phenytoin.
entities: BUSULFEX / phenytoin
ddi: mechanism
>>> match: study_nsubj:pass_obl
-------------
sentence: Because busulfan is eliminated from the body via conjugation with glutathione, use of acetaminophen prior to ( 72 hours) or concurrent with BUSULFEX may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues.
entities: busulfan / acetaminophen
ddi: null
>>> match: result_advcl_nsubj
-------------
sentence: Because busulfan is eliminated from the body via conjugation with glutathione, use of acetaminophen prior to ( 72 hours) or concurrent with BUSULFEX may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues.
entities: busulfan / BUSULFEX
ddi: null
>>> match: result_advcl_nsubj
-------------
sentence: Because busulfan is eliminated from the body via conjugation with glutathione, use of acetaminophen prior to ( 72 hours) or concurrent with BUSULFEX may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues.
entities: busulfan / busulfan
ddi: null
>>> match: result_advcl_obl
-------------
sentence: Because busulfan is eliminated from the body via conjugation with glutathione, use of acetaminophen prior to ( 72 hours) or concurrent with BUSULFEX may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues.
entities: busulfan / acetaminophen
ddi: null
>>> match: result_advcl_obl
-------------
sentence: Because busulfan is eliminated from the body via conjugation with glutathione, use of acetaminophen prior to ( 72 hours) or concurrent with BUSULFEX may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues.
entities: acetaminophen / busulfan
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Because busulfan is eliminated from the body via conjugation with glutathione, use of acetaminophen prior to ( 72 hours) or concurrent with BUSULFEX may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues.
entities: acetaminophen / acetaminophen
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Because busulfan is eliminated from the body via conjugation with glutathione, use of acetaminophen prior to ( 72 hours) or concurrent with BUSULFEX may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues.
entities: BUSULFEX / busulfan
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Because busulfan is eliminated from the body via conjugation with glutathione, use of acetaminophen prior to ( 72 hours) or concurrent with BUSULFEX may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues.
entities: BUSULFEX / acetaminophen
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: There are no significant effects on cefdinir pharmacokinetics if the antacid is administered 2 hours before or 2 hours after cefdinir.
entities: cefdinir / antacid
ddi: null
>>> match: be_nsubj_advcl
-------------
sentence: There are no significant effects on cefdinir pharmacokinetics if the antacid is administered 2 hours before or 2 hours after cefdinir.
entities: cefdinir / cefdinir
ddi: null
>>> match: be_nsubj_advcl
-------------
sentence: There are no significant effects on cefdinir pharmacokinetics if the antacid is administered 2 hours before or 2 hours after cefdinir.
entities: antacid / cefdinir
ddi: null
>>> match: administer_nsubj:pass_advmod
-------------
sentence: If antacids are required during OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the antacid.
entities: antacids / OMNICEF
ddi: null
>>> match: require_nsubj:pass_obl
-------------
sentence: If antacids are required during OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the antacid.
entities: antacids / OMNICEF
ddi: null
>>> match: take_advcl_nsubj:pass
-------------
sentence: If antacids are required during OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the antacid.
entities: antacids / antacid
ddi: null
>>> match: take_advcl_advmod
-------------
sentence: If antacids are required during OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the antacid.
entities: OMNICEF / OMNICEF
ddi: null
>>> match: take_advcl_nsubj:pass
-------------
sentence: If antacids are required during OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the antacid.
entities: OMNICEF / antacid
ddi: null
>>> match: take_advcl_advmod
-------------
sentence: If antacids are required during OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the antacid.
entities: OMNICEF / antacid
ddi: advise
>>> match: take_nsubj:pass_advmod
-------------
sentence: Probenecid: As with other b-lactam antibiotics, probenecid inhibits the renal excretion of cefdinir, resulting in an approximate doubling in A.C. a 54% increase in peak cefdinir plasma levels, and a 50% prolongation in the apparent elimination half-life.
entities: b-lactam antibiotics / probenecid
ddi: null
>>> match: inhibit_obl_nsubj
-------------
sentence: Probenecid: As with other b-lactam antibiotics, probenecid inhibits the renal excretion of cefdinir, resulting in an approximate doubling in A.C. a 54% increase in peak cefdinir plasma levels, and a 50% prolongation in the apparent elimination half-life.
entities: b-lactam antibiotics / cefdinir
ddi: mechanism
>>> match: inhibit_obl_obj
-------------
sentence: Probenecid: As with other b-lactam antibiotics, probenecid inhibits the renal excretion of cefdinir, resulting in an approximate doubling in A.C. a 54% increase in peak cefdinir plasma levels, and a 50% prolongation in the apparent elimination half-life.
entities: b-lactam antibiotics / cefdinir
ddi: null
>>> match: inhibit_obl_dep
-------------
sentence: Probenecid: As with other b-lactam antibiotics, probenecid inhibits the renal excretion of cefdinir, resulting in an approximate doubling in A.C. a 54% increase in peak cefdinir plasma levels, and a 50% prolongation in the apparent elimination half-life.
entities: probenecid / cefdinir
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Probenecid: As with other b-lactam antibiotics, probenecid inhibits the renal excretion of cefdinir, resulting in an approximate doubling in A.C. a 54% increase in peak cefdinir plasma levels, and a 50% prolongation in the apparent elimination half-life.
entities: probenecid / cefdinir
ddi: null
>>> match: inhibit_nsubj_dep
-------------
sentence: Probenecid: As with other b-lactam antibiotics, probenecid inhibits the renal excretion of cefdinir, resulting in an approximate doubling in A.C. a 54% increase in peak cefdinir plasma levels, and a 50% prolongation in the apparent elimination half-life.
entities: cefdinir / cefdinir
ddi: null
>>> match: inhibit_obj_dep
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: Iron Supplements / Iron
ddi: null
>>> match: fortify_nsubj_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: Iron Supplements / cefdinir
ddi: null
>>> match: fortify_nsubj_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: Iron Supplements / iron supplement
ddi: null
>>> match: fortify_nsubj_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: Iron Supplements / iron
ddi: null
>>> match: fortify_nsubj_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: Iron Supplements / vitamins
ddi: null
>>> match: fortify_nsubj_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: Iron Supplements / iron
ddi: null
>>> match: fortify_nsubj_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: Iron / iron supplement
ddi: null
>>> match: fortify_obl_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: Iron / iron
ddi: null
>>> match: fortify_obl_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: Iron / vitamins
ddi: null
>>> match: fortify_obl_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: Iron / iron
ddi: null
>>> match: fortify_obl_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: cefdinir / iron supplement
ddi: null
>>> match: fortify_obl_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: cefdinir / iron
ddi: mechanism
>>> match: fortify_obl_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: cefdinir / vitamins
ddi: null
>>> match: fortify_obl_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: cefdinir / iron
ddi: mechanism
>>> match: fortify_obl_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: iron supplement / vitamins
ddi: null
>>> match: fortify_obl_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: iron supplement / iron
ddi: null
>>> match: fortify_obl_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: iron / vitamins
ddi: null
>>> match: fortify_obl_obl
-------------
sentence: Iron Supplements and Foods Fortified With Iron Concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron (as FeSO4) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80% and 31%, respectively.
entities: iron / iron
ddi: null
>>> match: fortify_obl_obl
-------------
sentence: If iron supplements are required during OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the supplement.
entities: iron supplements / OMNICEF
ddi: null
>>> match: require_nsubj:pass_obl
-------------
sentence: If iron supplements are required during OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the supplement.
entities: iron supplements / OMNICEF
ddi: advise
>>> match: take_advcl_nsubj:pass
-------------
sentence: If iron supplements are required during OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the supplement.
entities: OMNICEF / OMNICEF
ddi: null
>>> match: take_advcl_nsubj:pass
-------------
sentence: Concomitantly administered iron-fortified infant formula (2.2 mg elemental iron/6 oz) has no significant effect on cefdinir pharmacokinetics.
entities: iron / cefdinir
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Concomitantly administered iron-fortified infant formula (2.2 mg elemental iron/6 oz) has no significant effect on cefdinir pharmacokinetics.
entities: iron / cefdinir
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Therefore, OMNICEF for Oral Suspension can be administered with iron-fortified infant formula.
entities: OMNICEF / iron
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Drug/Laboratory Test Interactions A false-positive reaction for ketones in the urine may occur with tests using nitroprusside, but not with those using nitroferricyanide.
entities: nitroprusside / nitroferricyanide
ddi: null
>>> match: occur_advcl_dep
-------------
sentence: Trecator has been found to temporarily raise serum concentrations of isoniazid.
entities: Trecator / isoniazid
ddi: mechanism
>>> match: find_nsubj:pass_xcomp
-------------
sentence: Trecator may potentiate the adverse effects of other antituberculous drugs administered concomitantly.
entities: Trecator / antituberculous drugs
ddi: effect
>>> match: potentiate_nsubj_dep
-------------
sentence: In particular, convulsions have been reported when ethionamide is administered with cycloserine and special care should be taken when the treatment regimen includes both of these drugs.
entities: ethionamide / cycloserine
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Agents that Inhibit Cytochrome P450 Isoenzymes and/or Epoxide Hydrolase Carbamazepine is metabolized mainly by cytochrome P450 (CYP) 3A4 to the active carbamazepine 10,11-epoxide, which is further metabolized to the trans-diol by epoxide hydrolase.
entities: Carbamazepine / carbamazepine 10,11-epoxide
ddi: null
>>> match: metabolize_nsubj:pass_obl
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: EQUETROTM / EQUETROTM
ddi: null
>>> match: find_parataxis_advcl
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: EQUETROTM / EQUETROTM
ddi: null
>>> match: find_parataxis_parataxis
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: Cisplatin / EQUETROTM
ddi: null
>>> match: find_parataxis_advcl
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: Cisplatin / EQUETROTM
ddi: null
>>> match: find_parataxis_parataxis
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: doxorubicin HCL / EQUETROTM
ddi: null
>>> match: find_parataxis_advcl
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: doxorubicin HCL / EQUETROTM
ddi: null
>>> match: find_parataxis_parataxis
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: felbamate / EQUETROTM
ddi: null
>>> match: find_parataxis_advcl
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: felbamate / EQUETROTM
ddi: null
>>> match: find_parataxis_parataxis
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: rifampin / EQUETROTM
ddi: null
>>> match: find_parataxis_advcl
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: rifampin / EQUETROTM
ddi: null
>>> match: find_parataxis_parataxis
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: phenobarbital / EQUETROTM
ddi: null
>>> match: find_parataxis_advcl
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: phenobarbital / EQUETROTM
ddi: null
>>> match: find_parataxis_parataxis
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: Phenytoin / EQUETROTM
ddi: null
>>> match: find_parataxis_advcl
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: Phenytoin / EQUETROTM
ddi: null
>>> match: find_parataxis_parataxis
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: primidone / EQUETROTM
ddi: null
>>> match: find_parataxis_advcl
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: primidone / EQUETROTM
ddi: null
>>> match: find_parataxis_parataxis
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: methsuximide / EQUETROTM
ddi: null
>>> match: find_parataxis_advcl
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: methsuximide / EQUETROTM
ddi: null
>>> match: find_parataxis_parataxis
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: theophylline / EQUETROTM
ddi: null
>>> match: find_parataxis_advcl
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: theophylline / EQUETROTM
ddi: null
>>> match: find_parataxis_parataxis
-------------
sentence: Agents that are CYP inducers that have been found, or are expected, to decrease plasma levels of EQUETROTM are the following: Cisplatin, doxorubicin HCL, felbamate, rifampin, phenobarbital, Phenytoin(2), primidone, methsuximide, and theophylline Thus, if a patient has been titrated to a stable dosage on EQUETROTM, and then begins a course of treatment with one of these CYP3A4 inducers, it is reasonable to expect that a dose increase for EQUETROTM may be necessary.
entities: EQUETROTM / EQUETROTM
ddi: null
>>> match: find_advcl_parataxis
-------------
sentence: Agents with Increased Levels in the Presence of Carbamazepine: EQUETROTM increases the plasma levels of the following agents: Clomipramine HCl, Phenytoin(6), and primidone Thus, if a patient has been titrated to a stable dosage on one of the agents in this category, and then begins a course of the treatment with EQUETROTM, it is reasonable to expect that a dose decrease for the concomitant agent may be necessary.
entities: EQUETROTM / Clomipramine HCl
ddi: mechanism
>>> match: increase_nsubj_dep
-------------
sentence: Agents with Increased Levels in the Presence of Carbamazepine: EQUETROTM increases the plasma levels of the following agents: Clomipramine HCl, Phenytoin(6), and primidone Thus, if a patient has been titrated to a stable dosage on one of the agents in this category, and then begins a course of the treatment with EQUETROTM, it is reasonable to expect that a dose decrease for the concomitant agent may be necessary.
entities: EQUETROTM / Phenytoin
ddi: mechanism
>>> match: increase_nsubj_dep
-------------
sentence: Agents with Increased Levels in the Presence of Carbamazepine: EQUETROTM increases the plasma levels of the following agents: Clomipramine HCl, Phenytoin(6), and primidone Thus, if a patient has been titrated to a stable dosage on one of the agents in this category, and then begins a course of the treatment with EQUETROTM, it is reasonable to expect that a dose decrease for the concomitant agent may be necessary.
entities: EQUETROTM / primidone
ddi: mechanism
>>> match: increase_nsubj_dep
-------------
sentence: Agents with Increased Levels in the Presence of Carbamazepine: EQUETROTM increases the plasma levels of the following agents: Clomipramine HCl, Phenytoin(6), and primidone Thus, if a patient has been titrated to a stable dosage on one of the agents in this category, and then begins a course of the treatment with EQUETROTM, it is reasonable to expect that a dose decrease for the concomitant agent may be necessary.
entities: EQUETROTM / EQUETROTM
ddi: null
>>> match: increase_nsubj_dep
-------------
sentence: Given the anticonvulsant properties of carbamazepine, EQUETROTM may reduce the thyroid function as has been reported with other anticonvulsants.
entities: carbamazepine / EQUETROTM
ddi: null
>>> match: reduce_obl_nsubj
-------------
sentence: Given the anticonvulsant properties of carbamazepine, EQUETROTM may reduce the thyroid function as has been reported with other anticonvulsants.
entities: carbamazepine / anticonvulsants
ddi: null
>>> match: reduce_obl_advcl
-------------
sentence: Given the anticonvulsant properties of carbamazepine, EQUETROTM may reduce the thyroid function as has been reported with other anticonvulsants.
entities: EQUETROTM / anticonvulsants
ddi: null
>>> match: reduce_nsubj_advcl
-------------
sentence: Additionally, anti-malarial drugs, such as chloroquine and mefloquine, may antagonize the activity of carbamazepine.
entities: anti-malarial drugs / carbamazepine
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: Additionally, anti-malarial drugs, such as chloroquine and mefloquine, may antagonize the activity of carbamazepine.
entities: chloroquine / carbamazepine
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: Additionally, anti-malarial drugs, such as chloroquine and mefloquine, may antagonize the activity of carbamazepine.
entities: mefloquine / carbamazepine
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: Because of its primary CNS effect, caution should be used when EQUETROTM is taken with other centrally acting drugs and alcohol.
entities: EQUETROTM / centrally acting drugs
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Because of its primary CNS effect, caution should be used when EQUETROTM is taken with other centrally acting drugs and alcohol.
entities: EQUETROTM / alcohol
ddi: advise
>>> match: take_nsubj:pass_obl
-------------
sentence: Mercaptopurine/Azathioprine: Allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid.
entities: Allopurinol / mercaptopurine
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Mercaptopurine/Azathioprine: Allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid.
entities: Allopurinol / azathioprine
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Mercaptopurine/Azathioprine: Allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid.
entities: Allopurinol / 6-thiouric acid
ddi: null
>>> match: inhibit_nsubj_obl
-------------
sentence: Mercaptopurine/Azathioprine: Allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid.
entities: mercaptopurine / 6-thiouric acid
ddi: null
>>> match: inhibit_obj_obl
-------------
sentence: Mercaptopurine/Azathioprine: Allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid.
entities: azathioprine / 6-thiouric acid
ddi: null
>>> match: inhibit_obj_obl
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: mercaptopurine / allopurinol
ddi: null
>>> match: require_obl_nsubj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: mercaptopurine / mercaptopurine
ddi: null
>>> match: require_obl_obj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: mercaptopurine / azathioprine
ddi: null
>>> match: require_obl_obj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: Purinethol / allopurinol
ddi: null
>>> match: require_obl_nsubj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: Purinethol / mercaptopurine
ddi: null
>>> match: require_obl_obj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: Purinethol / azathioprine
ddi: null
>>> match: require_obl_obj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: azathioprine / allopurinol
ddi: null
>>> match: require_obl_nsubj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: azathioprine / mercaptopurine
ddi: null
>>> match: require_obl_obj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: azathioprine / azathioprine
ddi: null
>>> match: require_obl_obj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: Imuran / allopurinol
ddi: null
>>> match: require_obl_nsubj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: Imuran / mercaptopurine
ddi: null
>>> match: require_obl_obj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: Imuran / azathioprine
ddi: null
>>> match: require_obl_obj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: allopurinol / mercaptopurine
ddi: advise
>>> match: require_nsubj_obj
-------------
sentence: In patients receiving mercaptopurine (Purinethol) or azathioprine (Imuran), the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine.
entities: allopurinol / azathioprine
ddi: advise
>>> match: require_nsubj_obj
-------------
sentence: Dicumarol: It has been reported that allopurinol prolongs the half-life of the anticoagulant, dicumarol.
entities: allopurinol / anticoagulant
ddi: null
>>> match: prolong_nsubj_obj
-------------
sentence: Dicumarol: It has been reported that allopurinol prolongs the half-life of the anticoagulant, dicumarol.
entities: allopurinol / dicumarol
ddi: mechanism
>>> match: prolong_nsubj_obj
-------------
sentence: The clinical basis of this drug interaction has not been established but should be noted when allopurinol is given to patients already on dicumarol therapy.
entities: allopurinol / dicumarol
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: The concomitant administration of uricosuric agents and allopurinol has been associated with a decrease in the excretion of oxypurines (hypoxanthine and xanthine) and an increase in urinary uric acid excretion compared with that observed with allopurinol alone.
entities: uricosuric agents / allopurinol
ddi: null
>>> match: associate_nsubj:pass_conj
-------------
sentence: The concomitant administration of uricosuric agents and allopurinol has been associated with a decrease in the excretion of oxypurines (hypoxanthine and xanthine) and an increase in urinary uric acid excretion compared with that observed with allopurinol alone.
entities: allopurinol / allopurinol
ddi: null
>>> match: associate_nsubj:pass_conj
-------------
sentence: Thiazide Diuretics: The reports that the concomitant use of allopurinol and thiazide diuretics may contribute to the enhancement of allopurinol toxicity in some patients have been reviewed in an attempt to establish a cause-and-effect relationship and a mechanism of causation.
entities: allopurinol / allopurinol
ddi: null
>>> match: contribute_nsubj_obl
-------------
sentence: Thiazide Diuretics: The reports that the concomitant use of allopurinol and thiazide diuretics may contribute to the enhancement of allopurinol toxicity in some patients have been reviewed in an attempt to establish a cause-and-effect relationship and a mechanism of causation.
entities: thiazide diuretics / allopurinol
ddi: null
>>> match: contribute_nsubj_obl
-------------
sentence: Ampicillin/Amoxicillin: An increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs.
entities: ampicillin / allopurinol
ddi: effect
>>> match: receive_obj_obl
-------------
sentence: Ampicillin/Amoxicillin: An increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs.
entities: amoxicillin / allopurinol
ddi: effect
>>> match: receive_obj_obl
-------------
sentence: Cytotoxic Agents: Enhanced bone marrow suppression by cyclophosphamide and other cytotoxic agents has been reported among patients with neoplastic disease, except leukemia, in the presence of allopurinol.
entities: cyclophosphamide / allopurinol
ddi: effect
>>> match: report_nsubj:pass_obl
-------------
sentence: Cytotoxic Agents: Enhanced bone marrow suppression by cyclophosphamide and other cytotoxic agents has been reported among patients with neoplastic disease, except leukemia, in the presence of allopurinol.
entities: cytotoxic agents / allopurinol
ddi: effect
>>> match: report_nsubj:pass_obl
-------------
sentence: Chlorpropamide: Chlorpropamide's plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.
entities: Chlorpropamide / allopurinol
ddi: mechanism
>>> match: prolong_nsubj:pass_obl
-------------
sentence: Chlorpropamide: Chlorpropamide's plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.
entities: Chlorpropamide / allopurinol
ddi: null
>>> match: prolong_nsubj:pass_obl
-------------
sentence: Chlorpropamide: Chlorpropamide's plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.
entities: Chlorpropamide / chlorpropamide
ddi: null
>>> match: prolong_nsubj:pass_obl
-------------
sentence: Chlorpropamide: Chlorpropamide's plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.
entities: allopurinol / allopurinol
ddi: null
>>> match: prolong_obl_obl
-------------
sentence: Chlorpropamide: Chlorpropamide's plasma half-life may be prolonged by allopurinol, since allopurinol and chlorpropamide may compete for excretion in the renal tubule.
entities: allopurinol / chlorpropamide
ddi: null
>>> match: prolong_obl_obl
-------------
sentence: Cyclosporin: Reports indicate that cyclosporine levels may be increased during concomitant treatment with allopurinol sodium for injection.
entities: cyclosporine / allopurinol sodium
ddi: mechanism
>>> match: increase_nsubj:pass_obl
-------------
sentence: Steady-state serum concentrations of tricyclic antidepressants are reported to fluctuate significantly when cimetidine is either added or deleted from the drug regimen.
entities: tricyclic antidepressants / cimetidine
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Serious anticholinergic symptoms (severe dry mouth, urinary retention, blurred vision) have been associated with elevations in the serum levels of tricyclic antidepressants when cimetidine is added to the drug regimen.
entities: tricyclic antidepressants / cimetidine
ddi: effect
>>> match: associate_obl_advcl
-------------
sentence: In addition, higher-than expected steady-state serum concentrations of tricyclic antidepressants have been observed when therapy is initiated in patients already taking cimetidine.
entities: tricyclic antidepressants / cimetidine
ddi: mechanism
>>> match: observe_nsubj:pass_advcl
-------------
sentence: In well-controlled patients undergoing concurrent therapy with cimetidine, a decrease in the steady-state serum concentrations of tricyclic antidepressants may occur when cime-tidine therapy is discontinued.
entities: cimetidine / tricyclic antidepressants
ddi: mechanism
>>> match: occur_obl_nsubj
-------------
sentence: The therapeutic efficacy of tricyclic antidepressants may be compromised in these patients when cimetidine is discontinued.
entities: tricyclic antidepressants / cimetidine
ddi: effect
>>> match: compromise_nsubj:pass_advcl
-------------
sentence: Fluoxetine and its active metabolite, norfluoxe-tine, have long half-lives (4 to 16 days for norfluoxetine), that may affect strategies during conversion from one drug to the other.
entities: Fluoxetine / norfluoxetine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Close supervision and careful adjustment of the dosage are required when nortriptyline hydrochloride is used with other anticholinergic drugs or sympathomimetic drugs.
entities: nortriptyline hydrochloride / anticholinergic drugs
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Close supervision and careful adjustment of the dosage are required when nortriptyline hydrochloride is used with other anticholinergic drugs or sympathomimetic drugs.
entities: nortriptyline hydrochloride / sympathomimetic drugs
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Concomitant use of tricyclic antidepressants with other drugs metabolized by cytochrome P450IID6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.
entities: tricyclic antidepressants / tricyclic antidepressant
ddi: null
>>> match: require_csubj_obj
-------------
sentence: In the presence of ouabain (10(-5) M), PTX (10(-8) M) failed to cause the first contraction; 
entities: ouabain / PTX
ddi: effect
>>> match: fail_obl_nsubj
-------------
sentence: When ouabain was applied to the muscle in the presence of phentolamine, both first and second contractile responses to PTX were abolished. 
entities: ouabain / phentolamine
ddi: effect
>>> match: apply_nsubj:pass_obl
-------------
sentence: When ouabain was applied to the muscle in the presence of phentolamine, both first and second contractile responses to PTX were abolished. 
entities: ouabain / PTX
ddi: null
>>> match: abolish_advcl_nsubj:pass
-------------
sentence: When ouabain was applied to the muscle in the presence of phentolamine, both first and second contractile responses to PTX were abolished. 
entities: phentolamine / PTX
ddi: null
>>> match: abolish_advcl_nsubj:pass
-------------
sentence: Exposure of the muscle to ouabain (10(-5) M) markedly increased the PTX-induced release. 
entities: ouabain / PTX
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: The second response is due to a release of norepinephrine from nerves and was potentiated by ouabain through the increase in the norepinephrine release, whereas the first response was not due to the norepinephrine release but presumably to a direct action on smooth muscle cell and was inhibited by ouabain. 
entities: ouabain / ouabain
ddi: null
>>> match: potentiate_obl_advcl
-------------
sentence: Clindamycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents.
entities: Clindamycin / neuromuscular blocking agents
ddi: effect
>>> match: show_nsubj:pass_xcomp
-------------
sentence: In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole and Abciximab) may increase the risk of bleeding if administered prior to, during, or after Activase therapy.
entities: heparin / Activase
ddi: effect
>>> match: increase_obl_advcl
-------------
sentence: In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole and Abciximab) may increase the risk of bleeding if administered prior to, during, or after Activase therapy.
entities: vitamin K antagonists / Activase
ddi: effect
>>> match: increase_obl_advcl
-------------
sentence: In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole and Abciximab) may increase the risk of bleeding if administered prior to, during, or after Activase therapy.
entities: acetylsalicylic acid / Activase
ddi: int
>>> match: increase_obl_advcl
-------------
sentence: In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole and Abciximab) may increase the risk of bleeding if administered prior to, during, or after Activase therapy.
entities: dipyridamole / Activase
ddi: effect
>>> match: increase_obl_advcl
-------------
sentence: In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole and Abciximab) may increase the risk of bleeding if administered prior to, during, or after Activase therapy.
entities: Abciximab / Activase
ddi: effect
>>> match: increase_obl_advcl
-------------
sentence: Use of Antithrombotics Aspirin and heparin have been administered concomitantly with and following infusions of Activase in the management of acute myocardial infarction or pulmonary embolism.
entities: Antithrombotics / Activase
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Use of Antithrombotics Aspirin and heparin have been administered concomitantly with and following infusions of Activase in the management of acute myocardial infarction or pulmonary embolism.
entities: Aspirin / Activase
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Use of Antithrombotics Aspirin and heparin have been administered concomitantly with and following infusions of Activase in the management of acute myocardial infarction or pulmonary embolism.
entities: heparin / Activase
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Interactions for vitamin D analogues (Vitamin D2, Vitamin D3, Calcitriol, and Calcidiol): Cholestyramine: Cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins;
entities: Cholestyramine / fat soluble vitamins
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Since blood level of calcitriol/ergocalcitriol will be reduced, higher doses of Rocaltrol may be necessary if these drugs are administered simultaneously.
entities: calcitriol / Rocaltrol
ddi: null
>>> match: reduce_obl_parataxis
-------------
sentence: Thiazides: Thiazides are known to induce hypercalcemia by the reduction of calcium excretion in urine.
entities: Thiazides / calcium
ddi: null
>>> match: know_nsubj:pass_xcomp
-------------
sentence: Digitalis: Vitamin D dosage must be determined with care in patients undergoing treatment with digitalis, as hypercalcemia in such patients may precipitate cardiac arrhythmias.
entities: Vitamin D / digitalis
ddi: advise
>>> match: determine_nsubj:pass_obl
-------------
sentence: Ketoconazole: Ketoconazole may inhibit both synthetic and catabolic enzymes of vitamin D.
entities: Ketoconazole / vitamin D
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Magnesium: Magnesium-containing preparations (eg, antacids) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin D by patients on chronic renal dialysis.
entities: Magnesium / vitamin D
ddi: advise
>>> match: cause_nsubj_conj
-------------
sentence: Magnesium: Magnesium-containing preparations (eg, antacids) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin D by patients on chronic renal dialysis.
entities: antacids / vitamin D
ddi: advise
>>> match: cause_nsubj_conj
-------------
sentence: Additive CNS depression may occur when antihistamines are administered concomitantly with other CNS depressants including barbiturates, tranquilizers, and alcohol.
entities: antihistamines / CNS depressants
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Additive CNS depression may occur when antihistamines are administered concomitantly with other CNS depressants including barbiturates, tranquilizers, and alcohol.
entities: antihistamines / barbiturates
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Additive CNS depression may occur when antihistamines are administered concomitantly with other CNS depressants including barbiturates, tranquilizers, and alcohol.
entities: antihistamines / tranquilizers
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Additive CNS depression may occur when antihistamines are administered concomitantly with other CNS depressants including barbiturates, tranquilizers, and alcohol.
entities: antihistamines / alcohol
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Patients receiving antihistamines should be advised against the concurrent use of other CNS depressant drugs.
entities: antihistamines / CNS depressant drugs
ddi: advise
>>> match: advise_nsubj:pass_obl
-------------
sentence: Monoamine oxidase (MAO) inhibitors prolong and intensify the anticholinergic effects of antihistamines.
entities: Monoamine oxidase (MAO) inhibitors / antihistamines
ddi: effect
>>> match: prolong_nsubj_obj
-------------
sentence: Antihistamines may enhance the effects of tricyclic antidepressants, barbiturates, alcohol, and other CNS depressants.
entities: Antihistamines / tricyclic antidepressants
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Antihistamines may enhance the effects of tricyclic antidepressants, barbiturates, alcohol, and other CNS depressants.
entities: Antihistamines / barbiturates
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Antihistamines may enhance the effects of tricyclic antidepressants, barbiturates, alcohol, and other CNS depressants.
entities: Antihistamines / alcohol
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Antihistamines may enhance the effects of tricyclic antidepressants, barbiturates, alcohol, and other CNS depressants.
entities: Antihistamines / CNS depressants
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: MAO inhibitors prolong and intensify the anticholinergic effects of antihistamines.
entities: MAO inhibitors / antihistamines
ddi: effect
>>> match: prolong_nsubj_obj
-------------
sentence: Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine.
entities: Sympathomimetic amines / reserpine
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine.
entities: Sympathomimetic amines / veratrum alkaloids
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine.
entities: Sympathomimetic amines / methyldopa
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine.
entities: Sympathomimetic amines / mecamylamine
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine.
entities: reserpine / veratrum alkaloids
ddi: null
>>> match: reduce_obj_obj
-------------
sentence: Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine.
entities: reserpine / methyldopa
ddi: null
>>> match: reduce_obj_obj
-------------
sentence: Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine.
entities: reserpine / mecamylamine
ddi: null
>>> match: reduce_obj_obj
-------------
sentence: Effects of sympathomimetics are increased with MAO inhibitors and beta adrenergic blockers.
entities: sympathomimetics / MAO inhibitors
ddi: effect
>>> match: increase_nsubj:pass_obl
-------------
sentence: Effects of sympathomimetics are increased with MAO inhibitors and beta adrenergic blockers.
entities: sympathomimetics / beta adrenergic blockers
ddi: effect
>>> match: increase_nsubj:pass_obl
-------------
sentence: Atracurium was again given by infusion to maintain 40% twitch for a second hour, then 2 mg gentamycin/kg bwt were given i.v. 
entities: Atracurium / gentamycin
ddi: null
>>> match: give_nsubj:pass_dep
-------------
sentence: It was concluded that, although gentamycin did augment the neuromuscular blockade of atracurium, the effect was minimal.
entities: gentamycin / atracurium
ddi: effect
>>> match: augment_nsubj_obj
-------------
sentence: The pressor effects of catecholamines such as dopamine or norepinephrine are enhanced by Bretylium Tosylate.
entities: catecholamines / Bretylium Tosylate
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: The pressor effects of catecholamines such as dopamine or norepinephrine are enhanced by Bretylium Tosylate.
entities: dopamine / Bretylium Tosylate
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: The pressor effects of catecholamines such as dopamine or norepinephrine are enhanced by Bretylium Tosylate.
entities: norepinephrine / Bretylium Tosylate
ddi: effect
>>> match: enhance_nsubj:pass_obl
-------------
sentence: Interactions for vitamin D analogues (Vitamin D2, Vitamin D3, Calcitriol, and Calcidiol): Cholestyramine: Cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins;
entities: Cholestyramine / fat soluble vitamins
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Since blood level of calcitriol/ergocalcitriol will be reduced, higher doses of Rocaltrol may be necessary if these drugs are administered simultaneously.
entities: calcitriol / Rocaltrol
ddi: null
>>> match: reduce_obl_parataxis
-------------
sentence: Digitalis: Vitamin D dosage must be determined with care in patients undergoing treatment with digitalis, as hypercalcemia in such patients may precipitate cardiac arrhythmias.
entities: Vitamin D / digitalis
ddi: advise
>>> match: determine_nsubj:pass_obl
-------------
sentence: Ketoconazole: Ketoconazole may inhibit both synthetic and catabolic enzymes of vitamin D.
entities: Ketoconazole / vitamin D
ddi: mechanism
>>> match: inhibit_nsubj_obj
-------------
sentence: Magnesium: Magnesium-containing preparations (eg, antacids) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin D by patients on chronic renal dialysis.
entities: Magnesium / vitamin D
ddi: advise
>>> match: cause_nsubj_conj
-------------
sentence: Magnesium: Magnesium-containing preparations (eg, antacids) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin D by patients on chronic renal dialysis.
entities: antacids / vitamin D
ddi: advise
>>> match: cause_nsubj_conj
-------------
sentence: There is a significant increase in exposure to imatinib when Gleevec is coadministered with ketoconazole (CYP3A4 inhibitor).
entities: imatinib / Gleevec
ddi: null
>>> match: be_nsubj_advcl
-------------
sentence: There is a significant increase in exposure to imatinib when Gleevec is coadministered with ketoconazole (CYP3A4 inhibitor).
entities: imatinib / ketoconazole
ddi: null
>>> match: be_nsubj_advcl
-------------
sentence: There is a significant increase in exposure to imatinib when Gleevec is coadministered with ketoconazole (CYP3A4 inhibitor).
entities: Gleevec / ketoconazole
ddi: mechanism
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Pretreatment of healthy volunteers with multiple doses of rifampin followed by a single dose of Gleevec, increased Gleevec oral-dose clearance by 3.8-fold, which significantly (p 0.05) decreased mean cmax and AUC(0-8).
entities: rifampin / Gleevec
ddi: mechanism
>>> match: follow_nsubj_obl
-------------
sentence: Drugs that may have their plasma concentration altered by Gleevec Gleevec increases the mean cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by Gleevec.
entities: Gleevec / simvastatin
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Drugs that may have their plasma concentration altered by Gleevec Gleevec increases the mean cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by Gleevec.
entities: Gleevec / Gleevec
ddi: null
>>> match: increase_nsubj_dep
-------------
sentence: Drugs that may have their plasma concentration altered by Gleevec Gleevec increases the mean cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by Gleevec.
entities: Gleevec / simvastatin
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Drugs that may have their plasma concentration altered by Gleevec Gleevec increases the mean cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by Gleevec.
entities: Gleevec / Gleevec
ddi: null
>>> match: increase_nsubj_dep
-------------
sentence: Drugs that may have their plasma concentration altered by Gleevec Gleevec increases the mean cmax and AUC of simvastatin (CYP3A4 substrate) 2- and 3.5-fold, respectively, suggesting an inhibition of the CYP3A4 by Gleevec.
entities: simvastatin / Gleevec
ddi: null
>>> match: increase_obj_dep
-------------
sentence: Particular caution is recommended when administering Gleevec with CYP3A4 substrates that have a narrow therapeutic window (e.g., cyclosporine or pimozide).
entities: Gleevec / cyclosporine
ddi: advise
>>> match: have_nsubj_iobj
-------------
sentence: Particular caution is recommended when administering Gleevec with CYP3A4 substrates that have a narrow therapeutic window (e.g., cyclosporine or pimozide).
entities: Gleevec / pimozide
ddi: advise
>>> match: have_nsubj_iobj
-------------
sentence: Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, dihydropyridine calcium channel blockers, certain HMG-CoA reductase inhibitors, etc.).
entities: Gleevec / benzodiazepines
ddi: mechanism
>>> match: increase_nsubj_ccomp
-------------
sentence: Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, dihydropyridine calcium channel blockers, certain HMG-CoA reductase inhibitors, etc.).
entities: Gleevec / dihydropyridine calcium channel blockers
ddi: mechanism
>>> match: increase_nsubj_ccomp
-------------
sentence: Gleevec will increase plasmaconcentration of other CYP3A4 metabolized drugs (e.g., triazolo-benzodiazepines, dihydropyridine calcium channel blockers, certain HMG-CoA reductase inhibitors, etc.).
entities: Gleevec / HMG-CoA reductase inhibitors
ddi: mechanism
>>> match: increase_nsubj_ccomp
-------------
sentence: Because warfarin is metabolized by CYP2C9 and CYP3A4, patients who require anticoagulation should receive low-molecular weight or standard heparin.
entities: warfarin / heparin
ddi: null
>>> match: metabolize_nsubj:pass_punct
-------------
sentence: Systemic exposure to acetaminophen is expected to be increased when coadministered with Gleevec.
entities: acetaminophen / Gleevec
ddi: mechanism
>>> match: expect_nsubj:pass_xcomp
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: ibogaine / 18-MC
ddi: null
>>> match: decrease_obl_nsubj
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: ibogaine / morphine
ddi: null
>>> match: decrease_obl_obj
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: ibogaine / cocaine
ddi: null
>>> match: decrease_obl_obj
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: ibogaine / ethanol
ddi: null
>>> match: decrease_obl_obj
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: ibogaine / nicotine
ddi: null
>>> match: decrease_obl_obj
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: 18-MC / morphine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: 18-MC / cocaine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: 18-MC / ethanol
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Like ibogaine (40 mg/kg), 18-MC (40 mg/kg) decreases the intravenous self-administration of morphine and cocaine and the oral self-administration of ethanol and nicotine in rats; 
entities: 18-MC / nicotine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Both ibogaine and 18-MC ameliorate opioid withdrawal signs. 
entities: ibogaine / opioid
ddi: null
>>> match: ameliorate_nsubj_obj
-------------
sentence: Both ibogaine and 18-MC ameliorate opioid withdrawal signs. 
entities: 18-MC / opioid
ddi: null
>>> match: ameliorate_nsubj_obj
-------------
sentence: Both ibogaine and 18-MC block morphine-induced and nicotine-induced dopamine release in the nucleus accumbens; 
entities: morphine / nicotine
ddi: null
>>> match: induce_dep_conj
-------------
sentence: only ibogaine enhances cocaine-induced increases in accumbal dopamine. 
entities: ibogaine / cocaine
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Ibogaine attenuates, but 18-MC potentiates, the acute locomotor effects of morphine; 
entities: Ibogaine / 18-MC
ddi: null
>>> match: attenuate_nsubj_dep
-------------
sentence: Ibogaine attenuates, but 18-MC potentiates, the acute locomotor effects of morphine; 
entities: Ibogaine / morphine
ddi: effect
>>> match: attenuate_nsubj_dep
-------------
sentence: both compounds attenuate morphine-induced locomotion in morphine-experienced rats. 
entities: morphine / morphine
ddi: null
>>> match: attenuate_obj_obl
-------------
sentence: While 18-MC and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter. 
entities: 18-MC / 18-MC
ddi: null
>>> match: have_advcl_nsubj
-------------
sentence: While 18-MC and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter. 
entities: 18-MC / ibogaine
ddi: null
>>> match: have_advcl_obj
-------------
sentence: While 18-MC and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter. 
entities: ibogaine / 18-MC
ddi: null
>>> match: have_advcl_nsubj
-------------
sentence: While 18-MC and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter. 
entities: ibogaine / ibogaine
ddi: null
>>> match: have_advcl_obj
-------------
sentence: While 18-MC and ibogaine have similar affinities for kappa opioid and possibly nicotinic receptors, 18-MC has much lower affinities than ibogaine for NMDA and sigma-2 receptors, sodium channels, and the 5-HT transporter. 
entities: 18-MC / ibogaine
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Both 18-MC and ibogaine are sequestered in fat and, like ibogaine, 18-MC probably has an active metabolite. 
entities: 18-MC / ibogaine
ddi: null
>>> match: sequester_nsubj:pass_conj
-------------
sentence: Both 18-MC and ibogaine are sequestered in fat and, like ibogaine, 18-MC probably has an active metabolite. 
entities: 18-MC / 18-MC
ddi: null
>>> match: sequester_nsubj:pass_conj
-------------
sentence: Both 18-MC and ibogaine are sequestered in fat and, like ibogaine, 18-MC probably has an active metabolite. 
entities: ibogaine / ibogaine
ddi: null
>>> match: sequester_nsubj:pass_conj
-------------
sentence: Both 18-MC and ibogaine are sequestered in fat and, like ibogaine, 18-MC probably has an active metabolite. 
entities: ibogaine / 18-MC
ddi: null
>>> match: sequester_nsubj:pass_conj
-------------
sentence: Both 18-MC and ibogaine are sequestered in fat and, like ibogaine, 18-MC probably has an active metabolite. 
entities: ibogaine / 18-MC
ddi: null
>>> match: have_obl_nsubj
-------------
sentence: The data suggest that 18-MC has a narrower spectrum of actions and will have a substantially greater therapeutic index than ibogaine.
entities: 18-MC / ibogaine
ddi: null
>>> match: have_nsubj_conj
-------------
sentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.
entities: diclofenac / aspirin
ddi: mechanism
>>> match: displace_nsubj:pass_obl
-------------
sentence: Anticoagulants: While studies have not shown diclofenac to interact with anticoagulants of the warfarin type, caution should be exercised, nonetheless, since interactions have been seen with other NSAIDs.
entities: diclofenac / NSAIDs
ddi: advise
>>> match: exercise_advcl_advcl
-------------
sentence: Anticoagulants: While studies have not shown diclofenac to interact with anticoagulants of the warfarin type, caution should be exercised, nonetheless, since interactions have been seen with other NSAIDs.
entities: anticoagulants of the warfarin type / NSAIDs
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including diclofenac, and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.
entities: NSAIDs / NSAIDs
ddi: null
>>> match: require_advcl_nsubj
-------------
sentence: Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including diclofenac, and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.
entities: NSAIDs / diclofenac
ddi: null
>>> match: require_advcl_nsubj
-------------
sentence: Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including diclofenac, and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.
entities: NSAIDs / warfarin
ddi: null
>>> match: require_advcl_nsubj
-------------
sentence: Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including diclofenac, and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.
entities: NSAIDs / anticoagulant
ddi: null
>>> match: require_advcl_xcomp
-------------
sentence: Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including diclofenac, and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.
entities: NSAIDs / anticoagulant
ddi: null
>>> match: require_nsubj_xcomp
-------------
sentence: Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including diclofenac, and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.
entities: diclofenac / anticoagulant
ddi: null
>>> match: require_nsubj_xcomp
-------------
sentence: Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including diclofenac, and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.
entities: warfarin / anticoagulant
ddi: null
>>> match: require_nsubj_xcomp
-------------
sentence: Ingestion of diclofenac may increase serum concentrations of digoxin and methotrexate and increase cyclosporine s nephrotoxicity.
entities: diclofenac / digoxin
ddi: mechanism
>>> match: increase_nsubj_iobj
-------------
sentence: Ingestion of diclofenac may increase serum concentrations of digoxin and methotrexate and increase cyclosporine s nephrotoxicity.
entities: diclofenac / methotrexate
ddi: mechanism
>>> match: increase_nsubj_iobj
-------------
sentence: Ingestion of diclofenac may increase serum concentrations of digoxin and methotrexate and increase cyclosporine s nephrotoxicity.
entities: diclofenac / cyclosporine
ddi: effect
>>> match: increase_nsubj_iobj
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / diclofenac
ddi: null
>>> match: take_obj_conj
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / NSAID
ddi: null
>>> match: take_obj_conj
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / digoxin
ddi: effect
>>> match: take_obj_conj
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / methotrexate
ddi: effect
>>> match: take_obj_conj
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / cyclosporine
ddi: effect
>>> match: take_obj_conj
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / digoxin
ddi: null
>>> match: increase_obj_advcl
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / methotrexate
ddi: null
>>> match: increase_obj_advcl
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / cyclosporine
ddi: null
>>> match: increase_obj_advcl
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: NSAID / digoxin
ddi: effect
>>> match: increase_obj_advcl
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: NSAID / methotrexate
ddi: effect
>>> match: increase_obj_advcl
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: NSAID / cyclosporine
ddi: effect
>>> match: increase_obj_advcl
-------------
sentence: Lithium: Diclofenac decreases lithium renal clearance and increases lithium plasma levels.
entities: Diclofenac / lithium
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Lithium: Diclofenac decreases lithium renal clearance and increases lithium plasma levels.
entities: Diclofenac / lithium
ddi: mechanism
>>> match: decrease_nsubj_conj
-------------
sentence: Lithium: Diclofenac decreases lithium renal clearance and increases lithium plasma levels.
entities: lithium / lithium
ddi: null
>>> match: decrease_obj_conj
-------------
sentence: In patients taking diclofenac and lithium concomitantly, lithium toxicity may develop.
entities: diclofenac / lithium
ddi: null
>>> match: develop_obl_nsubj
-------------
sentence: In patients taking diclofenac and lithium concomitantly, lithium toxicity may develop.
entities: lithium / lithium
ddi: null
>>> match: develop_obl_nsubj
-------------
sentence: A direct causal relationship has not been established, but physicians should consider the possibility that diclofenac may alter a diabetic patient s response to insulin or oral hypoglycemic agents.
entities: diclofenac / insulin
ddi: effect
>>> match: alter_nsubj_obj
-------------
sentence: A direct causal relationship has not been established, but physicians should consider the possibility that diclofenac may alter a diabetic patient s response to insulin or oral hypoglycemic agents.
entities: diclofenac / hypoglycemic agents
ddi: effect
>>> match: alter_nsubj_obj
-------------
sentence: Diuretics: Diclofenac and other NSAIDs can inhibit the activity of diuretics.
entities: Diclofenac / diuretics
ddi: effect
>>> match: inhibit_nsubj_obj
-------------
sentence: Diuretics: Diclofenac and other NSAIDs can inhibit the activity of diuretics.
entities: NSAIDs / diuretics
ddi: effect
>>> match: inhibit_nsubj_obj
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: azathioprine / diclofenac
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: gold / diclofenac
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: chloroquine / diclofenac
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: D-penicillamine / diclofenac
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: prednisolone / diclofenac
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: doxycycline / diclofenac
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of diclofenac.
entities: digitoxin / diclofenac
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Phenobarbital toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of diclofenac therapy.
entities: Phenobarbital / phenobarbital
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Phenobarbital toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of diclofenac therapy.
entities: Phenobarbital / diclofenac
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Phenobarbital toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of diclofenac therapy.
entities: phenobarbital / diclofenac
ddi: effect
>>> match: occur_obl_obl
-------------
sentence: Protein Binding In vitro, diclofenac interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding), tolbutamide, prednisolone (10% decrease in binding), or warfarin.
entities: diclofenac / salicylic acid
ddi: mechanism
>>> match: interfere_nsubj_conj
-------------
sentence: Protein Binding In vitro, diclofenac interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding), tolbutamide, prednisolone (10% decrease in binding), or warfarin.
entities: diclofenac / tolbutamide
ddi: mechanism
>>> match: interfere_nsubj_conj
-------------
sentence: Protein Binding In vitro, diclofenac interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding), tolbutamide, prednisolone (10% decrease in binding), or warfarin.
entities: diclofenac / prednisolone
ddi: mechanism
>>> match: interfere_nsubj_conj
-------------
sentence: Protein Binding In vitro, diclofenac interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding), tolbutamide, prednisolone (10% decrease in binding), or warfarin.
entities: diclofenac / warfarin
ddi: mechanism
>>> match: interfere_nsubj_conj
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: Benzylpenicillin / diclofenac
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: ampicillin / diclofenac
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: oxacillin / diclofenac
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: chlortetracycline / diclofenac
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: doxycycline / diclofenac
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: cephalothin / diclofenac
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: erythromycin / diclofenac
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum.
entities: sulfamethoxazole / diclofenac
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, and fluconazole pharmacokinetics. 
entities: MYCAMINE / mycophenolate mofetil
ddi: null
>>> match: be_nsubj_obl
-------------
sentence: There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, and fluconazole pharmacokinetics. 
entities: MYCAMINE / cyclosporine
ddi: null
>>> match: be_nsubj_obl
-------------
sentence: There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, and fluconazole pharmacokinetics. 
entities: MYCAMINE / tacrolimus
ddi: null
>>> match: be_nsubj_obl
-------------
sentence: There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, and fluconazole pharmacokinetics. 
entities: MYCAMINE / prednisolone
ddi: null
>>> match: be_nsubj_obl
-------------
sentence: There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, and fluconazole pharmacokinetics. 
entities: MYCAMINE / fluconazole
ddi: null
>>> match: be_nsubj_obl
-------------
sentence: Sirolimus AUC was increased by 21% with no effect on Cmax in the presence of steady-state MYCAMINE compared with sirolimus alone. 
entities: Sirolimus / MYCAMINE
ddi: mechanism
>>> match: increase_nsubj:pass_obl
-------------
sentence: Sirolimus AUC was increased by 21% with no effect on Cmax in the presence of steady-state MYCAMINE compared with sirolimus alone. 
entities: Sirolimus / sirolimus
ddi: null
>>> match: increase_nsubj:pass_advcl
-------------
sentence: Sirolimus AUC was increased by 21% with no effect on Cmax in the presence of steady-state MYCAMINE compared with sirolimus alone. 
entities: MYCAMINE / sirolimus
ddi: null
>>> match: increase_obl_advcl
-------------
sentence: Nifedipine AUC and Cmax were increased by 18% and 42%, respectively, in the presence of steady-state MYCAMINE compared with nifedipine alone. 
entities: Nifedipine / MYCAMINE
ddi: mechanism
>>> match: increase_nsubj:pass_obl
-------------
sentence: Nifedipine AUC and Cmax were increased by 18% and 42%, respectively, in the presence of steady-state MYCAMINE compared with nifedipine alone. 
entities: Nifedipine / nifedipine
ddi: null
>>> match: increase_nsubj:pass_advcl
-------------
sentence: Nifedipine AUC and Cmax were increased by 18% and 42%, respectively, in the presence of steady-state MYCAMINE compared with nifedipine alone. 
entities: MYCAMINE / nifedipine
ddi: null
>>> match: increase_obl_advcl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: sirolimus / MYCAMINE
ddi: advise
>>> match: receive_obj_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: sirolimus / sirolimus
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: sirolimus / nifedipine
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: sirolimus / sirolimus
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: sirolimus / nifedipine
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: nifedipine / MYCAMINE
ddi: advise
>>> match: receive_obj_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: nifedipine / sirolimus
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: nifedipine / nifedipine
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: nifedipine / sirolimus
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: nifedipine / nifedipine
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: MYCAMINE / sirolimus
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: MYCAMINE / nifedipine
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: MYCAMINE / sirolimus
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary. 
entities: MYCAMINE / nifedipine
ddi: null
>>> match: monitor_nsubj:pass_obl
-------------
sentence: Because alosetron is metabolized by a variety of hepatic CYP drug-metabolizing enzymes, inducers or inhibitors of these enzymes may change the clearance of alosetron.
entities: alosetron / alosetron
ddi: null
>>> match: change_csubj_obj
-------------
sentence: In a pharmacokinetic study, 40 healthy female subjects received fluvoxamine in escalating doses from 50 to 200 mg per day for 16 days, with coadministration of alosetron 1 mg on the last day.
entities: fluvoxamine / alosetron
ddi: null
>>> match: receive_obj_obl
-------------
sentence: Fluvoxamine increased mean alosetron plasma concentrations (AUC) approximately 6-fold and prolonged the half-life by approximately 3-fold.
entities: Fluvoxamine / alosetron
ddi: mechanism
>>> match: increase_nsubj_iobj
-------------
sentence: In a pharmacokinetic study, 38 healthy female subjects received ketoconazole 200 mg twice daily for 7 days, with coadministration of alosetron 1 mg on the last day.
entities: ketoconazole / alosetron
ddi: null
>>> match: receive_obj_obl
-------------
sentence: Ketoconazole increased mean alosetron plasma concentrations (AUC) by 29%.
entities: Ketoconazole / alosetron
ddi: mechanism
>>> match: increase_nsubj_iobj
-------------
sentence: Although not studied with alosetron, inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid, procainamide, and hydralazine.
entities: alosetron / isoniazid
ddi: effect
>>> match: have_advcl_obj
-------------
sentence: Although not studied with alosetron, inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid, procainamide, and hydralazine.
entities: alosetron / procainamide
ddi: effect
>>> match: have_advcl_obj
-------------
sentence: Although not studied with alosetron, inhibition of N-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid, procainamide, and hydralazine.
entities: alosetron / hydralazine
ddi: effect
>>> match: have_advcl_obj
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: alosetron / contraceptive agents
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: alosetron / ethinyl estradiol
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: alosetron / levonorgestrel
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: contraceptive agents / ethinyl estradiol
ddi: null
>>> match: have_obj_obj
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: contraceptive agents / levonorgestrel
ddi: null
>>> match: have_obj_obj
-------------
sentence: There have been isolated reports of patients experiencing increases in their prothrombin times when etidronate was added to warfarin therapy.
entities: etidronate / warfarin
ddi: effect
>>> match: add_nsubj:pass_obl
-------------
sentence: The homodimeric disintegrin contortrostatin was compared directly to the monomeric disintegrins echistatin and flavoridin for the ability to affect protein tyrosine phosphorylation in tumor cells. 
entities: contortrostatin / echistatin
ddi: null
>>> match: compare_nsubj:pass_obl
-------------
sentence: The homodimeric disintegrin contortrostatin was compared directly to the monomeric disintegrins echistatin and flavoridin for the ability to affect protein tyrosine phosphorylation in tumor cells. 
entities: contortrostatin / flavoridin
ddi: null
>>> match: compare_nsubj:pass_obl
-------------
sentence: Echistatin alone had no effect on tyrosine phosphorylation in T24 cells, but dose-dependently inhibits the effects of contortrostatin when both are added simultaneously. 
entities: Echistatin / contortrostatin
ddi: effect
>>> match: have_nsubj_conj
-------------
sentence: Flavoridin alone was found to have no effect on CAS, but can completely block contortrostatin-induced phosphorylation of this protein in MDA-MB-435 cells. 
entities: Flavoridin / contortrostatin
ddi: effect
>>> match: find_nsubj:pass_conj
-------------
sentence: Cholestyramine: Concomitant cholestyramine administration decreased the mean AUC of total ezetimibe approximately 55%. 
entities: cholestyramine / ezetimibe
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: The incremental LDL-C reduction due to adding ezetimibe to cholestyramine may be reduced by this interaction. 
entities: ezetimibe / cholestyramine
ddi: effect
>>> match: add_obj_obl
-------------
sentence: Fibrates: The safety and effectiveness of ezetimibe administered with fibrates have not been established. 
entities: ezetimibe / fibrates
ddi: null
>>> match: administer_nsubj_obl
-------------
sentence: Fenofibrate: In a pharmacokinetic study, concomitant fenofibrate administration increased total ezetimibe concentrations approximately 1.5-fold. 
entities: fenofibrate / ezetimibe
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Gemfibrozil: In a pharmacokinetic study, concomitant gemfibrozil administration increased total ezetimibe concentrations approximately 1.7-fold. 
entities: gemfibrozil / ezetimibe
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin. 
entities: ezetimibe / atorvastatin
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin. 
entities: ezetimibe / simvastatin
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin. 
entities: ezetimibe / pravastatin
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin. 
entities: ezetimibe / lovastatin
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin. 
entities: ezetimibe / fluvastatin
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Cyclosporine: The total ezetimibe level increased 12-fold in one renal transplant patient receiving multiple medications, including cyclosporine. 
entities: ezetimibe / cyclosporine
ddi: mechanism
>>> match: increase_nsubj_obl
-------------
sentence: Carcinogenesis, Mutagenesis, Impairment of Fertility A 104-week dietary carcinogenicity study with ezetimibe was conducted in rats at doses up to 1500 mg/kg/day (males) and 500 mg/kg/day (females) (~20 times the human exposure at 10 mg daily based on AUC0-24hr for total ezetimibe). 
entities: ezetimibe / ezetimibe
ddi: null
>>> match: conduct_nsubj:pass_obl
-------------
sentence: A 104-week dietary carcinogenicity study with ezetimibe was also conducted in mice at doses up to 500 mg/kg/day (>150 times the human exposure at 10 mg daily based on AUC0-24hr for total ezetimibe). 
entities: ezetimibe / ezetimibe
ddi: null
>>> match: conduct_nsubj:pass_obl
-------------
sentence: In oral (gavage) fertility studies of ezetimibe conducted in rats, there was no evidence of reproductive toxicity at doses up to 1000 mg/kg/day in male or female rats (~7 times the human exposure at 10 mg daily based on AUC0-24hr for total ezetimibe). 
entities: ezetimibe / ezetimibe
ddi: null
>>> match: be_obl_obl
-------------
sentence: In rabbits treated with ezetimibe, an increased incidence of extra thoracic ribs was observed at 1000 mg/kg/day (150 times the human exposure at 10 mg daily based on AUC0-24hr for total ezetimibe). 
entities: ezetimibe / ezetimibe
ddi: null
>>> match: observe_obl_advmod
-------------
sentence: When ZETIA is administered with an HMG-CoA reductase inhibitor in a woman of childbearing potential, refer to the pregnancy category and package labeling for the HMG-CoA reductase inhibitor. 
entities: ZETIA / HMG-CoA reductase inhibitor
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: When ZETIA is administered with an HMG-CoA reductase inhibitor in a woman of childbearing potential, refer to the pregnancy category and package labeling for the HMG-CoA reductase inhibitor. 
entities: ZETIA / HMG-CoA reductase inhibitor
ddi: null
>>> match: administer_nsubj:pass_dep
-------------
sentence: When ZETIA is administered with an HMG-CoA reductase inhibitor in a woman of childbearing potential, refer to the pregnancy category and package labeling for the HMG-CoA reductase inhibitor. 
entities: HMG-CoA reductase inhibitor / HMG-CoA reductase inhibitor
ddi: null
>>> match: administer_obl_dep
-------------
sentence: Advantages offered by this class of antibiotics include optimal pharmacokinetics, effectiveness against multidrug-resistant organisms, and oral administration even when parenteral antibiotics are generally used. 
entities: antibiotics / antibiotics
ddi: null
>>> match: offer_obl_dep
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals. 
entities: moxifloxacin / sucralfate
ddi: null
>>> match: fluoroquinolone_nsubj_obj
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals. 
entities: moxifloxacin / gelusil
ddi: null
>>> match: fluoroquinolone_nsubj_obj
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals. 
entities: moxifloxacin / erythromycin
ddi: null
>>> match: fluoroquinolone_nsubj_obj
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals. 
entities: moxifloxacin / multi minerals
ddi: null
>>> match: fluoroquinolone_nsubj_obj
-------------
sentence: Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. 
entities: Moxifloxacin / sucralfate
ddi: mechanism
>>> match: react_nsubj_obl
-------------
sentence: Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. 
entities: Moxifloxacin / gelusil
ddi: mechanism
>>> match: react_nsubj_obl
-------------
sentence: Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. 
entities: Moxifloxacin / erythromycin
ddi: mechanism
>>> match: react_nsubj_advmod
-------------
sentence: Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. 
entities: Moxifloxacin / multi-minerals
ddi: mechanism
>>> match: react_nsubj_advmod
-------------
sentence: Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. 
entities: Lomefloxacin / sucralfate
ddi: mechanism
>>> match: react_nsubj_obl
-------------
sentence: Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. 
entities: Lomefloxacin / gelusil
ddi: mechanism
>>> match: react_nsubj_obl
-------------
sentence: Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. 
entities: Lomefloxacin / erythromycin
ddi: mechanism
>>> match: react_nsubj_advmod
-------------
sentence: Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. 
entities: Lomefloxacin / multi-minerals
ddi: mechanism
>>> match: react_nsubj_advmod
-------------
sentence: Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. 
entities: sucralfate / erythromycin
ddi: null
>>> match: react_obl_advmod
-------------
sentence: Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. 
entities: sucralfate / multi-minerals
ddi: null
>>> match: react_obl_advmod
-------------
sentence: Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. 
entities: gelusil / erythromycin
ddi: null
>>> match: react_obl_advmod
-------------
sentence: Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media. 
entities: gelusil / multi-minerals
ddi: null
>>> match: react_obl_advmod
-------------
sentence: Prolonged recovery time may occur if barbiturates and/or narcotics are used concurrently with ketamine.
entities: barbiturates / ketamine
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: Prolonged recovery time may occur if barbiturates and/or narcotics are used concurrently with ketamine.
entities: narcotics / ketamine
ddi: effect
>>> match: use_nsubj:pass_obl
-------------
sentence: PGF2alpha produced significantly increased vasoconstriction after a single administration of oxytocin. 
entities: PGF2alpha / oxytocin
ddi: effect
>>> match: produce_nsubj_obl
-------------
sentence: The effects of diethyl pyrocarbonate could be reversed by hydroxylamine treatment. 
entities: diethyl pyrocarbonate / hydroxylamine
ddi: null
>>> match: reverse_nsubj:pass_obl
-------------
sentence: Zidovudine competitively inhibits the intracellular phosphorylation of stavudine. 
entities: Zidovudine / stavudine
ddi: effect
>>> match: inhibit_nsubj_obj
-------------
sentence: In vitro data indicate that the phosphorylation of stavudine is also inhibited at relevant concentrations by doxorubicin and ribavirin. 
entities: stavudine / doxorubicin
ddi: effect
>>> match: inhibit_nsubj:pass_obl
-------------
sentence: In vitro data indicate that the phosphorylation of stavudine is also inhibited at relevant concentrations by doxorubicin and ribavirin. 
entities: stavudine / ribavirin
ddi: effect
>>> match: inhibit_nsubj:pass_obl
-------------
sentence: Elevated plasma levels of theophylline have been reported with concomitant quinolone use.
entities: theophylline / quinolone
ddi: mechanism
>>> match: report_nsubj:pass_obl
-------------
sentence: Therefore, monitoring of theophylline plasma levels should be considered and dosage of theophylline adjusted, as required.
entities: theophylline / theophylline
ddi: null
>>> match: consider_nsubj:pass_conj
-------------
sentence: Quinolones have been shown to interfere with the metabolism of caffeine.
entities: Quinolones / caffeine
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Quinolones, including nalidixic acid, may enhance the effects of the oral anticoagulant warfarin or its derivatives.
entities: Quinolones / anticoagulant
ddi: null
>>> match: enhance_nsubj_obj
-------------
sentence: Quinolones, including nalidixic acid, may enhance the effects of the oral anticoagulant warfarin or its derivatives.
entities: Quinolones / warfarin
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Quinolones, including nalidixic acid, may enhance the effects of the oral anticoagulant warfarin or its derivatives.
entities: nalidixic acid / anticoagulant
ddi: null
>>> match: enhance_nsubj_obj
-------------
sentence: Quinolones, including nalidixic acid, may enhance the effects of the oral anticoagulant warfarin or its derivatives.
entities: nalidixic acid / warfarin
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Nitrofurantoin interferes with the therapeutic action of nalidixic acid.
entities: Nitrofurantoin / nalidixic acid
ddi: effect
>>> match: interfere_nsubj_obl
-------------
sentence: and Videx , (Didanosine), chewable/buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of quinolones, resulting in systemic levels considerably lower than desired.
entities: Videx / quinolones
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: and Videx , (Didanosine), chewable/buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of quinolones, resulting in systemic levels considerably lower than desired.
entities: Didanosine / quinolones
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Elevated serum levels of cyclosporine have been reported with the concomitant use of some quinolones and cyclosporine.
entities: cyclosporine / quinolones
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Elevated serum levels of cyclosporine have been reported with the concomitant use of some quinolones and cyclosporine.
entities: cyclosporine / cyclosporine
ddi: null
>>> match: report_nsubj:pass_obl
-------------
sentence: Therefore, cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly.
entities: cyclosporine / cyclosporine
ddi: null
>>> match: monitor_nsubj:pass_dep
-------------
sentence: anticholinergics or other medications with anticholinergic activity - anticholinergic effects may be potentiated when these medications are used concurrently with diphenidol;
entities: anticholinergics / diphenidol
ddi: null
>>> match: potentiate_nsubj:pass_advcl
-------------
sentence: apomorphine - prior ingestion of diphenidol may decrease the emetic response to apomorphine in the treatment of poisoning.
entities: diphenidol / emetic
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: apomorphine - prior ingestion of diphenidol may decrease the emetic response to apomorphine in the treatment of poisoning.
entities: diphenidol / apomorphine
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Among the risk factors studied, two appear to increase the risk of ARE: the prescription of thiabendazole to treat strongyloidiasis during the melarsoprol cure and the bad general clinical conditions of patients. 
entities: thiabendazole / melarsoprol
ddi: effect
>>> match: treat_nsubj_obl
-------------
sentence: Recommendations were to avoid administration of diffusible anti-helminthic treatment during the cure, and to improve the general conditions of patients before the cure of melarsoprol.
entities: anti-helminthic / melarsoprol
ddi: null
>>> match: avoid_obj_conj
-------------
sentence: HEMABATE may augment the activity of other oxytocic agents.
entities: HEMABATE / oxytocic agents
ddi: effect
>>> match: augment_nsubj_obj
-------------
sentence: Sublingual nitroglycerin may be taken if necessary for the control of acute angina attacks during Bepridil therapy.
entities: nitroglycerin / Bepridil
ddi: null
>>> match: take_nsubj:pass_obl
-------------
sentence: Digoxin: In controlled studies in healthy volunteers, bepridil hydrochloride either had no effect (one study) or was associated with modest increases, about 30% (two studies) in steady-state serum digoxin concentrations.
entities: bepridil hydrochloride / digoxin
ddi: mechanism
>>> match: have_nsubj_conj
-------------
sentence: Oral Hypoglycemics: Bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic agents.
entities: Bepridil / insulin
ddi: null
>>> match: use_nsubj:pass_advcl
-------------
sentence: Oral Hypoglycemics: Bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic agents.
entities: Bepridil / hypoglycemic agents
ddi: null
>>> match: use_nsubj:pass_advcl
-------------
sentence: Anti-arrhythmics and tricyclic anti-depressants could exaggerate the prolongation of the QT interval observed with bepridil hydrochloride.
entities: Anti-arrhythmics / bepridil hydrochloride
ddi: effect
>>> match: exaggerate_nsubj_dep
-------------
sentence: Anti-arrhythmics and tricyclic anti-depressants could exaggerate the prolongation of the QT interval observed with bepridil hydrochloride.
entities: tricyclic anti-depressants / bepridil hydrochloride
ddi: effect
>>> match: exaggerate_nsubj_dep
-------------
sentence: Cardiac glycosides could exaggerate the depression of AV nodal conduction observed with bepridil hydrochloride.
entities: Cardiac glycosides / bepridil hydrochloride
ddi: effect
>>> match: exaggerate_nsubj_dep
-------------
sentence: Concomitant administrations not recommended:  - Terfenadine and astemizole: Certain macrolides interact with terfenadine and astemizole leading to increased serum concentrations of the latter. 
entities: macrolides / terfenadine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Concomitant administrations not recommended:  - Terfenadine and astemizole: Certain macrolides interact with terfenadine and astemizole leading to increased serum concentrations of the latter. 
entities: macrolides / astemizole
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: - Cisapride, pimozide: Other drugs such as cisapride or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials. 
entities: cisapride / macrolide antibacterials
ddi: mechanism
>>> match: associate_nsubj:pass_obl
-------------
sentence: - Cisapride, pimozide: Other drugs such as cisapride or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials. 
entities: pimozide / macrolide antibacterials
ddi: null
>>> match: associate_nsubj:pass_obl
-------------
sentence: Cytadren accelerates the metabolism of dexamethasone;
entities: Cytadren / dexamethasone
ddi: mechanism
>>> match: accelerate_nsubj_obj
-------------
sentence: therefore, if glucocorticoid replacement is needed, hydrocortisone should be prescribed.
entities: glucocorticoid / hydrocortisone
ddi: null
>>> match: prescribe_advcl_nsubj:pass
-------------
sentence: Aminoglutethimide diminishes the effect of coumarin and warfarin.
entities: Aminoglutethimide / coumarin
ddi: effect
>>> match: diminish_nsubj_obj
-------------
sentence: Aminoglutethimide diminishes the effect of coumarin and warfarin.
entities: Aminoglutethimide / warfarin
ddi: effect
>>> match: diminish_nsubj_obj
-------------
sentence: Synergism was also noted when methylglyoxal was combined with carbenicillin and amikacin.
entities: methylglyoxal / carbenicillin
ddi: effect
>>> match: combine_nsubj:pass_obl
-------------
sentence: Synergism was also noted when methylglyoxal was combined with carbenicillin and amikacin.
entities: methylglyoxal / amikacin
ddi: effect
>>> match: combine_nsubj:pass_obl
-------------
sentence: This report describes two cases in which theophylline clearance accelerated markedly with concomitant phenytoin administration. 
entities: theophylline / phenytoin
ddi: mechanism
>>> match: accelerate_nsubj_obl
-------------
sentence: With combined use, clinicians should be aware, when phenytoin is added, of the potential for reexacerbation of pulmonary symptomatology due to lowered serum theophylline concentrations.
entities: phenytoin / theophylline
ddi: effect
>>> match: add_nsubj:pass_obl
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / nonsteroidal anti-inflammatory agents
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / salicylates
ddi: effect
>>> match: potentiate_nsubj:pass_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / sulfonamides
ddi: effect
>>> match: potentiate_nsubj:pass_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / chloramphenicol
ddi: effect
>>> match: potentiate_nsubj:pass_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / probenecid
ddi: effect
>>> match: potentiate_nsubj:pass_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / coumarins
ddi: effect
>>> match: potentiate_nsubj:pass_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / monoamine oxidase inhibitors
ddi: effect
>>> match: potentiate_nsubj:pass_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonylureas / beta adrenergic blocking agents
ddi: effect
>>> match: potentiate_nsubj:pass_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / salicylates
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / sulfonamides
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / chloramphenicol
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / probenecid
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / coumarins
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / monoamine oxidase inhibitors
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: nonsteroidal anti-inflammatory agents / beta adrenergic blocking agents
ddi: null
>>> match: potentiate_obl_dep
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / sulfonamides
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / chloramphenicol
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / probenecid
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / coumarins
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / monoamine oxidase inhibitors
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / beta adrenergic blocking agents
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / chloramphenicol
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / probenecid
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / coumarins
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / monoamine oxidase inhibitors
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / beta adrenergic blocking agents
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: chloramphenicol / probenecid
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: chloramphenicol / coumarins
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: chloramphenicol / monoamine oxidase inhibitors
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: chloramphenicol / beta adrenergic blocking agents
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: probenecid / coumarins
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: probenecid / monoamine oxidase inhibitors
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: probenecid / beta adrenergic blocking agents
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: coumarins / monoamine oxidase inhibitors
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: coumarins / beta adrenergic blocking agents
ddi: null
>>> match: bind_conj_conj
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: monoamine oxidase inhibitors / beta adrenergic blocking agents
ddi: null
>>> match: bind_conj_conj
-------------
sentence: A possible interaction between glyburide and ciprofloxacin, a fluoroquinolone antibiotic, has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.
entities: glyburide / glyburide
ddi: null
>>> match: report_nsubj:pass_dep
-------------
sentence: A possible interaction between glyburide and ciprofloxacin, a fluoroquinolone antibiotic, has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.
entities: ciprofloxacin / glyburide
ddi: null
>>> match: report_nsubj:pass_dep
-------------
sentence: A possible interaction between glyburide and ciprofloxacin, a fluoroquinolone antibiotic, has been reported, resulting in a potentiation of the hypoglycemic action of glyburide.
entities: fluoroquinolone antibiotic / glyburide
ddi: null
>>> match: report_nsubj:pass_dep
-------------
sentence: Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.
entities: Adenocard / quinidine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.
entities: Adenocard / beta-adrenergic blocking agents
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.
entities: Adenocard / calcium channel blocking agents
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.
entities: Adenocard / angiotensin converting enzyme inhibitors
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.
entities: adenosine / quinidine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.
entities: adenosine / beta-adrenergic blocking agents
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.
entities: adenosine / calcium channel blocking agents
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Intravenous Adenocard (adenosine) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile.
entities: adenosine / angiotensin converting enzyme inhibitors
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Digoxin and verapamil use may be rarely associated with ventricular fibrillation when combined with Adenocard.
entities: Digoxin / Adenocard
ddi: effect
>>> match: associate_csubj:pass_advcl
-------------
sentence: Digoxin and verapamil use may be rarely associated with ventricular fibrillation when combined with Adenocard.
entities: verapamil / Adenocard
ddi: effect
>>> match: associate_csubj:pass_advcl
-------------
sentence: The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.
entities: adenosine / methylxanthines
ddi: effect
>>> match: antagonize_nsubj:pass_obl
-------------
sentence: The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.
entities: adenosine / caffeine
ddi: effect
>>> match: antagonize_nsubj:pass_obl
-------------
sentence: The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline.
entities: adenosine / theophylline
ddi: effect
>>> match: antagonize_nsubj:pass_obl
-------------
sentence: In the presence of these methylxanthines, larger doses of adenosine may be required or adenosine may not be effective.
entities: methylxanthines / adenosine
ddi: advise
>>> match: require_obl_nsubj:pass
-------------
sentence: In the presence of these methylxanthines, larger doses of adenosine may be required or adenosine may not be effective.
entities: methylxanthines / adenosine
ddi: advise
>>> match: require_obl_conj
-------------
sentence: In the presence of these methylxanthines, larger doses of adenosine may be required or adenosine may not be effective.
entities: adenosine / adenosine
ddi: null
>>> match: require_nsubj:pass_conj
-------------
sentence: Adenosine effects are potentiated by dipyridamole.
entities: Adenosine / dipyridamole
ddi: effect
>>> match: potentiate_nsubj:pass_obl
-------------
sentence: As the primary effect of adenosine is to decrease conduction through the A-V node, higher degrees of heart block may be produced in the presence of carbamazepine.
entities: adenosine / carbamazepine
ddi: effect
>>> match: produce_advcl_obl
-------------
sentence: There was no change in the plasma kinetics of teniposide when coadministered with methotrexate. 
entities: teniposide / methotrexate
ddi: null
>>> match: be_nsubj_advcl
-------------
sentence: An increase in intracellular levels of methotrexate was observed in vitro in the presence of teniposide.
entities: methotrexate / teniposide
ddi: mechanism
>>> match: observe_nsubj:pass_obl
-------------
sentence: Patients receiving antibiotics and sulfonamides generally should not be treated with ganglion blockers.  
entities: antibiotics / ganglion blockers
ddi: advise
>>> match: treat_nsubj:pass_obl
-------------
sentence: Patients receiving antibiotics and sulfonamides generally should not be treated with ganglion blockers.  
entities: sulfonamides / ganglion blockers
ddi: advise
>>> match: treat_nsubj:pass_obl
-------------
sentence: The action of Mecamylamine may be potentiated by anesthesia, other antihypertensive drugs and alcohol.
entities: Mecamylamine / antihypertensive drugs
ddi: effect
>>> match: potentiate_nsubj:pass_obj
-------------
sentence: The action of Mecamylamine may be potentiated by anesthesia, other antihypertensive drugs and alcohol.
entities: Mecamylamine / alcohol
ddi: effect
>>> match: potentiate_nsubj:pass_obj
-------------
sentence: ADL 8-2698, a trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia.

entities: ADL 8-2698 / morphine
ddi: effect
>>> match: prevent_nsubj_obj
-------------
sentence: We conclude that ADL 8-2698 prevents morphine-induced increases in gastrointestinal transit time by means of selective peripheral opioid anitagonism without affecting central opioid analgesia.
entities: ADL 8-2698 / morphine
ddi: effect
>>> match: prevent_nsubj_obj
-------------
sentence: Milk, milk products, and calcium-rich foods or drugs may impair the absorption of EMCYT.
entities: calcium / EMCYT
ddi: mechanism
>>> match: impair_nsubj_obj
-------------
sentence: DIAMOX modifies phenytoin metabolism with increased serum levels of phenytoin.
entities: DIAMOX / phenytoin
ddi: mechanism
>>> match: modify_nsubj_obj
-------------
sentence: DIAMOX modifies phenytoin metabolism with increased serum levels of phenytoin.
entities: DIAMOX / phenytoin
ddi: mechanism
>>> match: modify_nsubj_obl
-------------
sentence: DIAMOX modifies phenytoin metabolism with increased serum levels of phenytoin.
entities: phenytoin / phenytoin
ddi: null
>>> match: modify_obj_obl
-------------
sentence: By decreasing the gastrointestinal absorption of primidone, DIAMOX may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect.
entities: primidone / DIAMOX
ddi: null
>>> match: decrease_obl_nsubj
-------------
sentence: By decreasing the gastrointestinal absorption of primidone, DIAMOX may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect.
entities: primidone / primidone
ddi: null
>>> match: decrease_obl_obj
-------------
sentence: By decreasing the gastrointestinal absorption of primidone, DIAMOX may decrease serum concentrations of primidone and its metabolites, with a consequent possible decrease in anticonvulsant effect.
entities: DIAMOX / primidone
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Caution is advised when beginning, discontinuing, or changing the dose of DIAMOX in patients receiving primidone.
entities: DIAMOX / primidone
ddi: advise
>>> match: change_obj_obl
-------------
sentence: Acetazolamide may increase the effects of other folic acid antagonists.
entities: Acetazolamide / folic acid antagonists
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect.
entities: Acetazolamide / amphetamine
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Acetazolamide reduces urinary excretion of quinidine and may enhance its effect.
entities: Acetazolamide / quinidine
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Acetazolamide may prevent the urinary antiseptic effect of methenamine.
entities: Acetazolamide / methenamine
ddi: effect
>>> match: prevent_nsubj_obj
-------------
sentence: Acetazolamide increases lithium excretion and the lithium may be decreased.
entities: Acetazolamide / lithium
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Acetazolamide increases lithium excretion and the lithium may be decreased.
entities: Acetazolamide / lithium
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Acetazolamide may elevate cyclosporine levels.
entities: Acetazolamide / cyclosporine
ddi: mechanism
>>> match: elevate_nsubj_obj
-------------
sentence: Adenosine: Dipyridamole has been reported to increase the plasma levels and cardiovascular effects of adenosine.
entities: Dipyridamole / adenosine
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Cholinesterase Inhibitors: Dipyridamole may counteract the anticholinesterase effect of cholinesterase inhibitors, thereby potentially aggravating myasthenia gravis.
entities: Dipyridamole / cholinesterase inhibitors
ddi: effect
>>> match: counteract_nsubj_obj
-------------
sentence: Beta-Blockers: In controlled clinical studies, adrenergic beta-receptor blockers have been frequently administered concomitantly with nicardipine HCl.
entities: adrenergic beta-receptor blockers / nicardipine HCl
ddi: null
>>> match: administer_obl_obl
-------------
sentence: Digoxin: Some calcium blockers may increase the concentration of digitalis preparations in the blood.
entities: calcium blockers / digitalis preparations
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Nicardipine HCl usually does not alter the plasma levels of digoxin, however, serum digoxin levels should be evaluated after concomitant therapy with nicardipine HCl is initiated.
entities: digoxin / nicardipine HCl
ddi: advise
>>> match: evaluate_nsubj:pass_obl
-------------
sentence: Maalox * Coadministration of Maalox TC had no effect on nicardipine HCl absorption.
entities: Maalox / nicardipine HCl
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Maalox * Coadministration of Maalox TC had no effect on nicardipine HCl absorption.
entities: Maalox TC / nicardipine HCl
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Plasma concentrations of cyclosporine should therefore be closely monitored, and its dosage reduced accordingly, in patients treated with nicardipine.
entities: cyclosporine / nicardipine
ddi: advise
>>> match: monitor_nsubj:pass_conj
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: Diphenhydramine hydrochloride / alcohol
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: Diphenhydramine hydrochloride / CNS depressants
ddi: effect
>>> match: have_nsubj_obj
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: Diphenhydramine hydrochloride / hypnotics
ddi: effect
>>> match: have_nsubj_dep
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: Diphenhydramine hydrochloride / sedatives
ddi: effect
>>> match: have_nsubj_dep
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: Diphenhydramine hydrochloride / tranquilizers
ddi: effect
>>> match: have_nsubj_dep
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: alcohol / hypnotics
ddi: null
>>> match: have_obj_dep
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: alcohol / sedatives
ddi: null
>>> match: have_obj_dep
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: alcohol / tranquilizers
ddi: null
>>> match: have_obj_dep
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: CNS depressants / hypnotics
ddi: null
>>> match: have_obj_dep
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: CNS depressants / sedatives
ddi: null
>>> match: have_obj_dep
-------------
sentence: Diphenhydramine hydrochloride has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc).
entities: CNS depressants / tranquilizers
ddi: null
>>> match: have_obj_dep
-------------
sentence: MAO inhibitors prolong and intensify the anticholinergic (drying) effects of antihistamines.
entities: MAO inhibitors / antihistamines
ddi: effect
>>> match: prolong_nsubj_obj
-------------
sentence: Anticholinergics or other medications with anticholinergic activity when used concurrently with opioid analgesics may result in increased risk of urinary retention and/or severe constipation, which may lead to paralytic ileus. 
entities: Anticholinergics / opioid analgesics
ddi: effect
>>> match: result_nsubj_dep
-------------
sentence: It has been reported that the incidence of bradycardia was increased when oxymorphone was combined with propofol for induction of anesthesia. 
entities: oxymorphone / propofol
ddi: effect
>>> match: combine_nsubj:pass_obl
-------------
sentence: Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.
entities: Benzthiazide / alcohol
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.
entities: Benzthiazide / blood thinners
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.
entities: Benzthiazide / decongestant drugs
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.
entities: Benzthiazide / lithium
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.
entities: Benzthiazide / norepinephrine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.
entities: Benzthiazide / NSAIDs
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.
entities: Benzthiazide / Aleve
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Benzthiazide may interact with alcohol, blood thinners, decongestant drugs (allergy, cold, and sinus medicines), diabetic drugs, lithium, norepinephrine, NSAIDs like Aleve or Ibuprofen, and high blood pressure medications.
entities: Benzthiazide / Ibuprofen
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Tetracycline, a bacteriostatic antibiotic, may antagonize the bactercidal effect of penicillin and concurrent use of these drugs should be avoided.
entities: Tetracycline / penicillin
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: Tetracycline, a bacteriostatic antibiotic, may antagonize the bactercidal effect of penicillin and concurrent use of these drugs should be avoided.
entities: bacteriostatic antibiotic / penicillin
ddi: null
>>> match: antagonize_nsubj_obj
-------------
sentence: The behavioral effects of the stereoisomers of N-allylnormetazocine (NANM) were compared with those of phencyclidine (PCP) in pigeons and squirrel monkeys responding under a multiple fixed-interval fixed-ratio (FI FR) schedule of food presentation. 
entities: N-allylnormetazocine / phencyclidine
ddi: null
>>> match: compare_nsubj:pass_obl
-------------
sentence: The behavioral effects of the stereoisomers of N-allylnormetazocine (NANM) were compared with those of phencyclidine (PCP) in pigeons and squirrel monkeys responding under a multiple fixed-interval fixed-ratio (FI FR) schedule of food presentation. 
entities: N-allylnormetazocine / PCP
ddi: null
>>> match: compare_nsubj:pass_obl
-------------
sentence: The behavioral effects of the stereoisomers of N-allylnormetazocine (NANM) were compared with those of phencyclidine (PCP) in pigeons and squirrel monkeys responding under a multiple fixed-interval fixed-ratio (FI FR) schedule of food presentation. 
entities: NANM / phencyclidine
ddi: null
>>> match: compare_nsubj:pass_obl
-------------
sentence: The behavioral effects of the stereoisomers of N-allylnormetazocine (NANM) were compared with those of phencyclidine (PCP) in pigeons and squirrel monkeys responding under a multiple fixed-interval fixed-ratio (FI FR) schedule of food presentation. 
entities: NANM / PCP
ddi: null
>>> match: compare_nsubj:pass_obl
-------------
sentence: In both species, (-)-NANM, but not (+)-NANM, antagonized the rate-decreasing effects of morphine on FI and FR responding. 
entities: (-)-NANM / morphine
ddi: effect
>>> match: antagonize_dep_dep
-------------
sentence: In monkeys, the effects of (-)-NANM, but not (+)-NANM or PCP, were antagonized by naloxone; 
entities: (-)-NANM / naloxone
ddi: effect
>>> match: antagonize_nsubj:pass_obl
-------------
sentence: In monkeys, the effects of (-)-NANM, but not (+)-NANM or PCP, were antagonized by naloxone; 
entities: PCP / naloxone
ddi: null
>>> match: antagonize_nsubj:pass_obl
-------------
sentence: In pigeons, naloxone did not systematically alter the effects of (-)-NANM, (+)-NANM or PCP. 
entities: naloxone / (-)-NANM
ddi: null
>>> match: alter_nsubj_obj
-------------
sentence: In pigeons, naloxone did not systematically alter the effects of (-)-NANM, (+)-NANM or PCP. 
entities: naloxone / PCP
ddi: null
>>> match: alter_nsubj_obj
-------------
sentence: Haloperidol reduced or eliminated the increases in FI responding produced by intermediate doses of either (+)-NANM or PCP in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of NANM. 
entities: Haloperidol / (+)-NANM
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Haloperidol reduced or eliminated the increases in FI responding produced by intermediate doses of either (+)-NANM or PCP in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of NANM. 
entities: Haloperidol / PCP
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Haloperidol reduced or eliminated the increases in FI responding produced by intermediate doses of either (+)-NANM or PCP in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of NANM. 
entities: Haloperidol / NANM
ddi: null
>>> match: reduce_nsubj_conj
-------------
sentence: Haloperidol reduced or eliminated the increases in FI responding produced by intermediate doses of either (+)-NANM or PCP in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of NANM. 
entities: (+)-NANM / NANM
ddi: null
>>> match: reduce_obj_conj
-------------
sentence: Haloperidol reduced or eliminated the increases in FI responding produced by intermediate doses of either (+)-NANM or PCP in pigeons, but did not antagonize the decreases in FI or FR responding produced by high doses of PCP or either stereoisomer of NANM. 
entities: PCP / NANM
ddi: null
>>> match: reduce_obj_conj
-------------
sentence: Avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine (e.g., epinephrine, norepinephrine), since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines.
entities: sympathomimetic amine / tricyclic antidepressants
ddi: advise
>>> match: contain_obj_advcl
-------------
sentence: Avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine (e.g., epinephrine, norepinephrine), since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines.
entities: epinephrine / tricyclic antidepressants
ddi: advise
>>> match: contain_obj_advcl
-------------
sentence: Avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine (e.g., epinephrine, norepinephrine), since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines.
entities: norepinephrine / tricyclic antidepressants
ddi: advise
>>> match: contain_obj_advcl
-------------
sentence: Imipramine hydrochloride may potentiate the effects of CNS depressant drugs.
entities: Imipramine hydrochloride / CNS depressant drugs
ddi: effect
>>> match: potentiate_nsubj_obj
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: imipramine / cimetidine
ddi: mechanism
>>> match: increase_nsubj_advcl
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: imipramine / fluoxetine
ddi: mechanism
>>> match: increase_nsubj_advcl
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: imipramine / barbiturates
ddi: mechanism
>>> match: increase_nsubj_advcl
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: imipramine / phenytoin
ddi: mechanism
>>> match: increase_nsubj_advcl
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: imipramine / imipramine
ddi: null
>>> match: increase_nsubj_advcl
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: cimetidine / imipramine
ddi: null
>>> match: give_obl_conj
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: fluoxetine / imipramine
ddi: null
>>> match: give_obl_conj
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: barbiturates / imipramine
ddi: null
>>> match: give_obl_conj
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: phenytoin / imipramine
ddi: null
>>> match: give_obl_conj
-------------
sentence: The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition, and the pharmacokinetics of the SSRI involved.
entities: SSRI / SSRI
ddi: null
>>> match: depend_nsubj_conj
-------------
sentence: The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition, and the pharmacokinetics of the SSRI involved.
entities: TCA / SSRI
ddi: null
>>> match: depend_nsubj_conj
-------------
sentence: Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.
entities: tricyclic antidepressants / tricyclic antidepressant
ddi: null
>>> match: require_nsubj_obj
-------------
sentence: It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6.
entities: TCA / TCA
ddi: null
>>> match: monitor_obj_advcl
-------------
sentence: Caution should be observed when anileridine is coadministered with other opioids, sedatives, phenothiazines, or anesthetics, as these agents may increase respiratory and circulatory depression.
entities: anileridine / opioids
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Caution should be observed when anileridine is coadministered with other opioids, sedatives, phenothiazines, or anesthetics, as these agents may increase respiratory and circulatory depression.
entities: anileridine / sedatives
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Caution should be observed when anileridine is coadministered with other opioids, sedatives, phenothiazines, or anesthetics, as these agents may increase respiratory and circulatory depression.
entities: anileridine / phenothiazines
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Caution should be observed when anileridine is coadministered with other opioids, sedatives, phenothiazines, or anesthetics, as these agents may increase respiratory and circulatory depression.
entities: anileridine / anesthetics
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: A possible interaction has been suggested with hormonal contraceptives and the herbal supplement St. Johns Wort based on some reports of oral contraceptive users experiencing breakthrough bleeding shortly after starting St. Johns Wort.
entities: hormonal contraceptives / contraceptive
ddi: null
>>> match: suggest_obl_advcl
-------------
sentence: Pyrimethamine may be used with sulfonamides, quinine and other antimalarials, and with other antibiotics. 
entities: Pyrimethamine / sulfonamides
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Pyrimethamine may be used with sulfonamides, quinine and other antimalarials, and with other antibiotics. 
entities: Pyrimethamine / quinine
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Pyrimethamine may be used with sulfonamides, quinine and other antimalarials, and with other antibiotics. 
entities: Pyrimethamine / antimalarials
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Pyrimethamine may be used with sulfonamides, quinine and other antimalarials, and with other antibiotics. 
entities: Pyrimethamine / antibiotics
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: Prior administration of succinylcholine has no clinically important effect on the neuromuscular blocking action of NUROMAX.
entities: succinylcholine / NUROMAX
ddi: null
>>> match: have_nsubj_obj
-------------
sentence: Isoflurane, enflurane, and halothane decrease the ED50 of NUROMAX by 30% to 45%.
entities: Isoflurane / NUROMAX
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Isoflurane, enflurane, and halothane decrease the ED50 of NUROMAX by 30% to 45%.
entities: enflurane / NUROMAX
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Isoflurane, enflurane, and halothane decrease the ED50 of NUROMAX by 30% to 45%.
entities: halothane / NUROMAX
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / antibiotics
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / aminoglycosides
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / tetracyclines
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / bacitracin
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / polymyxins
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / lincomycin
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / clindamycin
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / colistin
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / sodium colistimethate
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / magnesium
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / lithium
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / anesthetics
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / procainamide
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as NUROMAX include certain antibiotics (e. g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.
entities: NUROMAX / quinidine
ddi: effect
>>> match: include_nsubj_obj
-------------
sentence: As with some other nondepolarizing neuromuscular blocking agents, the time of onset of neuromuscular block induced by NUROMAX is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine.
entities: nondepolarizing neuromuscular blocking agents / NUROMAX
ddi: null
>>> match: induce_obl_obl
-------------
sentence: As with some other nondepolarizing neuromuscular blocking agents, the time of onset of neuromuscular block induced by NUROMAX is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine.
entities: nondepolarizing neuromuscular blocking agents / phenytoin
ddi: effect
>>> match: induce_obl_dep
-------------
sentence: As with some other nondepolarizing neuromuscular blocking agents, the time of onset of neuromuscular block induced by NUROMAX is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine.
entities: nondepolarizing neuromuscular blocking agents / carbamazepine
ddi: effect
>>> match: induce_obl_dep
-------------
sentence: As with some other nondepolarizing neuromuscular blocking agents, the time of onset of neuromuscular block induced by NUROMAX is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine.
entities: NUROMAX / phenytoin
ddi: effect
>>> match: induce_obl_dep
-------------
sentence: As with some other nondepolarizing neuromuscular blocking agents, the time of onset of neuromuscular block induced by NUROMAX is lengthened and the duration of block is shortened in patients receiving phenytoin or carbamazepine.
entities: NUROMAX / carbamazepine
ddi: effect
>>> match: induce_obl_dep
-------------
sentence: Anafranil should not be used with MAO inhibitors.
entities: Anafranil / MAO inhibitors
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Close supervision and careful adjustment of dosage are required when Anafranil is administered with anticholinergic or sympathomimetic drugs.
entities: Anafranil / anticholinergic
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Close supervision and careful adjustment of dosage are required when Anafranil is administered with anticholinergic or sympathomimetic drugs.
entities: Anafranil / sympathomimetic drugs
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.
entities: tricyclic antidepressants / guanethidine
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.
entities: tricyclic antidepressants / clonidine
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.
entities: tricyclic antidepressants / CMI
ddi: effect
>>> match: report_nsubj:pass_dep
-------------
sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.
entities: tricyclic antidepressants / tricyclic antidepressants
ddi: effect
>>> match: report_nsubj:pass_dep
-------------
sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.
entities: guanethidine / CMI
ddi: null
>>> match: report_xcomp_dep
-------------
sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.
entities: guanethidine / tricyclic antidepressants
ddi: null
>>> match: report_xcomp_dep
-------------
sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.
entities: clonidine / CMI
ddi: null
>>> match: report_xcomp_dep
-------------
sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.
entities: clonidine / tricyclic antidepressants
ddi: null
>>> match: report_xcomp_dep
-------------
sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.
entities: CMI / tricyclic antidepressants
ddi: null
>>> match: anticipate_obl_obl
-------------
sentence: The plasma concentration of CMI has been reported to be increased by the concomitant administration of haloperidol;
entities: CMI / haloperidol
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: tricyclic antidepressants / methylphenidate
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: tricyclic antidepressants / cimetidine
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: tricyclic antidepressants / fluoxetine
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: tricyclic antidepressants / barbiturates
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: tricyclic antidepressants / phenytoin
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: tricyclic antidepressants / CMI
ddi: null
>>> match: report_nsubj:pass_xcomp
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: methylphenidate / cimetidine
ddi: null
>>> match: increase_obl_dep
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: methylphenidate / fluoxetine
ddi: null
>>> match: increase_obl_dep
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: methylphenidate / barbiturates
ddi: null
>>> match: increase_obl_conj
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: methylphenidate / phenytoin
ddi: null
>>> match: increase_obl_conj
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: methylphenidate / CMI
ddi: mechanism
>>> match: increase_obl_conj
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: cimetidine / barbiturates
ddi: null
>>> match: increase_dep_conj
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: cimetidine / phenytoin
ddi: null
>>> match: increase_dep_conj
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: cimetidine / CMI
ddi: mechanism
>>> match: increase_dep_conj
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: fluoxetine / barbiturates
ddi: null
>>> match: increase_dep_conj
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: fluoxetine / phenytoin
ddi: null
>>> match: increase_dep_conj
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: fluoxetine / CMI
ddi: mechanism
>>> match: increase_dep_conj
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: barbiturates / CMI
ddi: mechanism
>>> match: increase_conj_conj
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: phenytoin / CMI
ddi: mechanism
>>> match: increase_conj_conj
-------------
sentence: Administration of CMI has been reported to increase the plasma levels of phenobarbital, if given concomitantly.
entities: CMI / phenobarbital
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Fluvoxamine has also been shown to inhibit P450 1A2, an isoform also involved in TCAmetabolism.
entities: Fluvoxamine / TCA
ddi: mechanism
>>> match: show_nsubj:pass_xcomp
-------------
sentence: The extent to which SSRI-TCAinteractions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.
entities: SSRI / SSRI
ddi: null
>>> match: depend_nsubj_obl
-------------
sentence: The extent to which SSRI-TCAinteractions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.
entities: TCA / SSRI
ddi: null
>>> match: depend_nsubj_obl
-------------
sentence: Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other.
entities: TCAs / SSRIs
ddi: advise
>>> match: indicate_obl_obl
-------------
sentence: Of particular importance, sufficient time must elapse before initiating TCAtreatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary).
entities: TCA / fluoxetine
ddi: advise
>>> match: elapse_obl_obl
-------------
sentence: Concomitant use of agents in the tricyclic antidepressant class (which includes Anafranil) with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant agent or the other drug.
entities: tricyclic antidepressant class / tricyclic antidepressant agent
ddi: null
>>> match: require_csubj_obj
-------------
sentence: Concomitant use of agents in the tricyclic antidepressant class (which includes Anafranil) with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant agent or the other drug.
entities: Anafranil / tricyclic antidepressant agent
ddi: null
>>> match: require_csubj_obj
-------------
sentence: It is desirable to monitor TCAplasma levels whenever an agent of the tricyclic antidepressant class including Anafranil is going to be co-administered with another drug known to be an inhibitor of P450 2D6 (and/or P450 1A2).
entities: TCA / tricyclic antidepressant class
ddi: null
>>> match: monitor_obj_advcl
-------------
sentence: It is desirable to monitor TCAplasma levels whenever an agent of the tricyclic antidepressant class including Anafranil is going to be co-administered with another drug known to be an inhibitor of P450 2D6 (and/or P450 1A2).
entities: TCA / Anafranil
ddi: null
>>> match: monitor_obj_advcl
-------------
sentence: Because Anafranil is highly bound to serum protein, the administration of Anafranil to patients taking other drugs that are highly bound to protein (e.g., warfarin, digoxin) may cause an increase in plasma concentrations of these drugs, potentially resulting in adverse effects.
entities: Anafranil / Anafranil
ddi: null
>>> match: cause_advcl_nsubj
-------------
sentence: Because Anafranil is highly bound to serum protein, the administration of Anafranil to patients taking other drugs that are highly bound to protein (e.g., warfarin, digoxin) may cause an increase in plasma concentrations of these drugs, potentially resulting in adverse effects.
entities: Anafranil / warfarin
ddi: null
>>> match: cause_advcl_nsubj
-------------
sentence: Because Anafranil is highly bound to serum protein, the administration of Anafranil to patients taking other drugs that are highly bound to protein (e.g., warfarin, digoxin) may cause an increase in plasma concentrations of these drugs, potentially resulting in adverse effects.
entities: Anafranil / digoxin
ddi: null
>>> match: cause_advcl_nsubj
-------------
sentence: Thiabendazole may compete with other drugs, such as theophylline, for sites of metabolism in the liver, thus elevating the serum levels of such compounds to potentially toxic levels. 
entities: Thiabendazole / theophylline
ddi: mechanism
>>> match: compete_nsubj_obl
-------------
sentence: Oral doses of Antizol (10-20 mg/kg), via alcohol dehydrogenase inhibition, significantly reduced the rate of elimination of ethanol (by approximately 40%) given to healthy volunteers in moderate doses.
entities: Antizol / ethanol
ddi: mechanism
>>> match: reduce_nsubj_obj
-------------
sentence: Similarly, ethanol decreased the rate of elimination of Antizol (by approximately 50%) by the same mechanism.
entities: ethanol / Antizol
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: Caution is advised when TRISENOX is coadministered with other medications that can prolong the QT interval (e.g. certain antiarrhythmics or thioridazine) or lead to electrolyte abnormalities (such as diuretics or amphotericin B).
entities: TRISENOX / antiarrhythmics
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Caution is advised when TRISENOX is coadministered with other medications that can prolong the QT interval (e.g. certain antiarrhythmics or thioridazine) or lead to electrolyte abnormalities (such as diuretics or amphotericin B).
entities: TRISENOX / thioridazine
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Caution is advised when TRISENOX is coadministered with other medications that can prolong the QT interval (e.g. certain antiarrhythmics or thioridazine) or lead to electrolyte abnormalities (such as diuretics or amphotericin B).
entities: TRISENOX / diuretics
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Caution is advised when TRISENOX is coadministered with other medications that can prolong the QT interval (e.g. certain antiarrhythmics or thioridazine) or lead to electrolyte abnormalities (such as diuretics or amphotericin B).
entities: TRISENOX / amphotericin B
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Caution is advised when TRISENOX is coadministered with other medications that can prolong the QT interval (e.g. certain antiarrhythmics or thioridazine) or lead to electrolyte abnormalities (such as diuretics or amphotericin B).
entities: antiarrhythmics / diuretics
ddi: null
>>> match: prolong_obj_conj
-------------
sentence: Caution is advised when TRISENOX is coadministered with other medications that can prolong the QT interval (e.g. certain antiarrhythmics or thioridazine) or lead to electrolyte abnormalities (such as diuretics or amphotericin B).
entities: antiarrhythmics / amphotericin B
ddi: null
>>> match: prolong_obj_conj
-------------
sentence: Caution is advised when TRISENOX is coadministered with other medications that can prolong the QT interval (e.g. certain antiarrhythmics or thioridazine) or lead to electrolyte abnormalities (such as diuretics or amphotericin B).
entities: thioridazine / diuretics
ddi: null
>>> match: prolong_obj_conj
-------------
sentence: Caution is advised when TRISENOX is coadministered with other medications that can prolong the QT interval (e.g. certain antiarrhythmics or thioridazine) or lead to electrolyte abnormalities (such as diuretics or amphotericin B).
entities: thioridazine / amphotericin B
ddi: null
>>> match: prolong_obj_conj
-------------
sentence: Pyrantel (e.g., Antiminth) - Taking piperazine and pyrantel together may decrease the effects of piperazine.
entities: Pyrantel / piperazine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Pyrantel (e.g., Antiminth) - Taking piperazine and pyrantel together may decrease the effects of piperazine.
entities: Antiminth / piperazine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Pyrantel (e.g., Antiminth) - Taking piperazine and pyrantel together may decrease the effects of piperazine.
entities: piperazine / piperazine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Pyrantel (e.g., Antiminth) - Taking piperazine and pyrantel together may decrease the effects of piperazine.
entities: pyrantel / piperazine
ddi: null
>>> match: decrease_nsubj_obj
-------------
sentence: Patients with Congenital or Acquired QT Prolongation In a study of the effect of solifenacin on the QT interval in 76 healthy women, the QT prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose. 
entities: solifenacin / solifenacin
ddi: null
>>> match: appear_nsubj_obl
-------------
sentence: Patients with Congenital or Acquired QT Prolongation In a study of the effect of solifenacin on the QT interval in 76 healthy women, the QT prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose. 
entities: solifenacin / solifenacin
ddi: null
>>> match: appear_nsubj_conj
-------------
sentence: Patients with Congenital or Acquired QT Prolongation In a study of the effect of solifenacin on the QT interval in 76 healthy women, the QT prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose. 
entities: solifenacin / moxifloxacin
ddi: null
>>> match: appear_nsubj_conj
-------------
sentence: Patients with Congenital or Acquired QT Prolongation In a study of the effect of solifenacin on the QT interval in 76 healthy women, the QT prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose. 
entities: solifenacin / solifenacin
ddi: null
>>> match: appear_obl_conj
-------------
sentence: Patients with Congenital or Acquired QT Prolongation In a study of the effect of solifenacin on the QT interval in 76 healthy women, the QT prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose. 
entities: solifenacin / moxifloxacin
ddi: null
>>> match: appear_obl_conj
-------------
sentence: Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage.
entities: tetracyclines / anticoagulant
ddi: null
>>> match: require_csubj_obj
-------------
sentence: Because the tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage.
entities: anticoagulant / anticoagulant
ddi: null
>>> match: require_csubj_obj
-------------
sentence: Since bacteriostatic drugs, such as the tetracycline class of antibiotics, may interfere with the bactericidal action of penicillins, it is not advisable to administer these drugs concomitantly.
entities: tetracycline class / penicillins
ddi: effect
>>> match: interfere_nsubj_obl
-------------
sentence: Since bacteriostatic drugs, such as the tetracycline class of antibiotics, may interfere with the bactericidal action of penicillins, it is not advisable to administer these drugs concomitantly.
entities: antibiotics / penicillins
ddi: null
>>> match: interfere_nsubj_obl
-------------
sentence: Concurrent use of tetracyclines with oral contraceptives may render oral contraceptives less effective.
entities: tetracyclines / contraceptives
ddi: null
>>> match: render_nsubj_xcomp
-------------
sentence: Concurrent use of tetracyclines with oral contraceptives may render oral contraceptives less effective.
entities: contraceptives / contraceptives
ddi: null
>>> match: render_nsubj_xcomp
-------------
sentence: Although studies designed to examine drug interactions have not been done, it was noted that corticosteroid or ACTH treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving Betaseron.
entities: corticosteroid / Betaseron
ddi: null
>>> match: administer_nsubj:pass_dep
-------------
sentence: Although studies designed to examine drug interactions have not been done, it was noted that corticosteroid or ACTH treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving Betaseron.
entities: ACTH / Betaseron
ddi: null
>>> match: administer_nsubj:pass_dep
-------------
sentence: Betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 The effect of alternate-day administration of 0.25 mg of Betaseron on drug metabolism in MS patients is unknown.
entities: Betaseron / antipyrine
ddi: mechanism
>>> match: lead_nsubj_obl
-------------
sentence: Betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 The effect of alternate-day administration of 0.25 mg of Betaseron on drug metabolism in MS patients is unknown.
entities: Betaseron / Betaseron
ddi: null
>>> match: lead_nsubj_obj
-------------
sentence: Betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 The effect of alternate-day administration of 0.25 mg of Betaseron on drug metabolism in MS patients is unknown.
entities: antipyrine / Betaseron
ddi: null
>>> match: lead_obl_obj
-------------
sentence: however, no deleterious interactions were seen when ROMAZICON was administered after narcotics, inhalational anesthetics, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.
entities: ROMAZICON / narcotics
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: however, no deleterious interactions were seen when ROMAZICON was administered after narcotics, inhalational anesthetics, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.
entities: ROMAZICON / anesthetics
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: however, no deleterious interactions were seen when ROMAZICON was administered after narcotics, inhalational anesthetics, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.
entities: ROMAZICON / muscle relaxants
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.
entities: ROMAZICON / cyclic antidepressants
ddi: effect
>>> match: use_obj_obl
-------------
sentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.
entities: ROMAZICON / benzodiazepine
ddi: null
>>> match: emerge_nsubj_obl
-------------
sentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.
entities: ROMAZICON / flumazenil
ddi: null
>>> match: emerge_nsubj_obl
-------------
sentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.
entities: cyclic antidepressants / benzodiazepine
ddi: null
>>> match: emerge_nsubj_obl
-------------
sentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.
entities: cyclic antidepressants / flumazenil
ddi: null
>>> match: emerge_nsubj_obl
-------------
sentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.
entities: benzodiazepine / flumazenil
ddi: null
>>> match: emerge_obl_obl
-------------
sentence: Although ROMAZICON exerts a slight intrinsic anticonvulsant effect, its abrupt suppression of the protective effect of a benzodiazepine agonist can give rise to convulsions in epileptic patients.
entities: ROMAZICON / benzodiazepine
ddi: effect
>>> match: give_advcl_nsubj
-------------
sentence: ROMAZICON blocks the central effects of benzodiazepines by competitive interaction at the receptor level.
entities: ROMAZICON / benzodiazepines
ddi: effect
>>> match: block_nsubj_obj
-------------
sentence: The effects of nonbenzodiazepine agonists at benzodiazepine receptors, such as zopiclone, triazolopyridazines and others, are also blocked by ROMAZICON.
entities: zopiclone / ROMAZICON
ddi: effect
>>> match: block_nsubj:pass_obl
-------------
sentence: Use in Ambulatory Patients The effects of ROMAZICON may wear off before a long-acting benzodiazepine is completely cleared from the body.
entities: ROMAZICON / long-acting benzodiazepine
ddi: null
>>> match: wear_nsubj_advcl
-------------
sentence: Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, alcohol and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned.
entities: benzodiazepine / ROMAZICON
ddi: null
>>> match: query_obl_obl
-------------
sentence: Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, alcohol and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned.
entities: alcohol / ROMAZICON
ddi: null
>>> match: query_obl_obl
-------------
sentence: Because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis, it is particularly important that physicians query patients or their guardians carefully about benzodiazepine, alcohol and sedative use as part of the history prior to any procedure in which the use of ROMAZICON is planned.
entities: sedative / ROMAZICON
ddi: null
>>> match: query_obl_obl
-------------
sentence: The coadministration of aspirin decreases the biologic half-life of fenoprofen because of an increase in metabolic clearance that results in a greater amount of hydroxylated fenoprofen in the urine.
entities: aspirin / fenoprofen
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: The coadministration of aspirin decreases the biologic half-life of fenoprofen because of an increase in metabolic clearance that results in a greater amount of hydroxylated fenoprofen in the urine.
entities: aspirin / hydroxylated fenoprofen
ddi: null
>>> match: decrease_nsubj_obl
-------------
sentence: The coadministration of aspirin decreases the biologic half-life of fenoprofen because of an increase in metabolic clearance that results in a greater amount of hydroxylated fenoprofen in the urine.
entities: fenoprofen / hydroxylated fenoprofen
ddi: null
>>> match: decrease_obj_obl
-------------
sentence: Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.
entities: Nalfon / aspirin
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.
entities: Nalfon / aspirin
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.
entities: Nalfon / Nalfon
ddi: null
>>> match: show_nsubj:pass_xcomp
-------------
sentence: Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.
entities: aspirin / Nalfon
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Chronic administration of phenobarbital, a known enzyme inducer, may be associated with a decrease in the plasma half-life of fenoprofen.
entities: phenobarbital / fenoprofen
ddi: mechanism
>>> match: associate_nsubj:pass_obl
-------------
sentence: When phenobarbital is added to or withdrawn from treatment, dosage adjustment of Nalfon may be required.
entities: phenobarbital / Nalfon
ddi: advise
>>> match: require_advcl_nsubj:pass
-------------
sentence: In patients receiving coumarin-type anticoagulants, the addition of Nalfon to therapy could prolong the prothrombin time.
entities: coumarin-type anticoagulants / Nalfon
ddi: effect
>>> match: prolong_obl_nsubj
-------------
sentence: Concurrent administration of HEXALEN and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased altretamine's half-life and toxicity in a rat model.
entities: HEXALEN / Cimetidine
ddi: null
>>> match: cause_nsubj_parataxis
-------------
sentence: Concurrent administration of HEXALEN and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased altretamine's half-life and toxicity in a rat model.
entities: HEXALEN / altretamine
ddi: null
>>> match: cause_nsubj_parataxis
-------------
sentence: Concurrent administration of HEXALEN and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased altretamine's half-life and toxicity in a rat model.
entities: Cimetidine / altretamine
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Data from a randomized trial of HEXALEN and cisplatin plus or minus pyridoxine in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity;
entities: HEXALEN / pyridoxine
ddi: null
>>> match: indicate_obl_nsubj
-------------
sentence: Data from a randomized trial of HEXALEN and cisplatin plus or minus pyridoxine in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity;
entities: HEXALEN / pyridoxine
ddi: null
>>> match: indicate_obl_ccomp
-------------
sentence: Data from a randomized trial of HEXALEN and cisplatin plus or minus pyridoxine in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity;
entities: cisplatin / pyridoxine
ddi: null
>>> match: indicate_obl_nsubj
-------------
sentence: Data from a randomized trial of HEXALEN and cisplatin plus or minus pyridoxine in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity;
entities: cisplatin / pyridoxine
ddi: null
>>> match: indicate_obl_ccomp
-------------
sentence: Data from a randomized trial of HEXALEN and cisplatin plus or minus pyridoxine in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity;
entities: pyridoxine / pyridoxine
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: however, it adversely affected response duration suggesting that pyridoxine should not be administered with HEXALEN and/or cisplatin.1
entities: pyridoxine / HEXALEN
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: however, it adversely affected response duration suggesting that pyridoxine should not be administered with HEXALEN and/or cisplatin.1
entities: pyridoxine / cisplatin
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: Sulfoxone may increase the effects of barbiturates, tolbutamide, and uricosurics. 
entities: Sulfoxone / barbiturates
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Sulfoxone may increase the effects of barbiturates, tolbutamide, and uricosurics. 
entities: Sulfoxone / tolbutamide
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Sulfoxone may increase the effects of barbiturates, tolbutamide, and uricosurics. 
entities: Sulfoxone / uricosurics
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / antimuscarinics
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / amantadine
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / haloperidol
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / phenothiazines
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / monoamine oxidase (MAO) inhibitors
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / tricyclic antidepressants
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / antihistamines
ddi: effect
>>> match: administer_nsubj:pass_obl
-------------
sentence: Antacids may interfere with the absorption of LEVSIN.
entities: Antacids / LEVSIN
ddi: mechanism
>>> match: interfere_nsubj_obl
-------------
sentence: Aerosol particles of budesonide were generated from an ethanol solution, dried, and collected by a cascade impactor for characterization or by a liquid impinger for dissolution experiments. 
entities: budesonide / ethanol
ddi: null
>>> match: generate_nsubj:pass_obl
-------------
sentence: Survanta increased the extent of dissolution of budesonide in proportion to the added concentration, which was also verified by equilibrium solubilization studies. 
entities: Survanta / budesonide
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Survanta also increased rate of dissolution, in a manner similar to sodium dodecyl sulfate. 
entities: Survanta / sodium dodecyl sulfate
ddi: null
>>> match: increase_nsubj_obl
-------------
sentence: Analysis of the concentration of budesonide following ultracentrifugation indicated that there is rapid equilibration of budesonide between the Survanta and aqueous phase. 
entities: budesonide / budesonide
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: Analysis of the concentration of budesonide following ultracentrifugation indicated that there is rapid equilibration of budesonide between the Survanta and aqueous phase. 
entities: budesonide / Survanta
ddi: null
>>> match: indicate_nsubj_ccomp
-------------
sentence: A study published in 2002 found that vigabatrin causes a statistically significant increase in plasma clearance of carbamazepine. 
entities: vigabatrin / carbamazepine
ddi: mechanism
>>> match: cause_nsubj_obj
-------------
sentence: In 1984, Drs Rimmer and Richens at the University of Wales reported that administering vigabatrin with phenytoin lowered the serum phenytoin concentration in patients with treatment-resistant epilepsy. 
entities: vigabatrin / phenytoin
ddi: null
>>> match: lower_nsubj_obj
-------------
sentence: In 1984, Drs Rimmer and Richens at the University of Wales reported that administering vigabatrin with phenytoin lowered the serum phenytoin concentration in patients with treatment-resistant epilepsy. 
entities: phenytoin / phenytoin
ddi: null
>>> match: lower_nsubj_obj
-------------
sentence: Caution should be taken when ENABLEX is used concomitantly with medications that are predominantly metabolized by CYP2D6 and which have a narrow therapeutic window, such as flecainide, thioridazine and tricyclic antidepressants (see CLINICAL PHARMACOLOGY).
entities: ENABLEX / flecainide
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Caution should be taken when ENABLEX is used concomitantly with medications that are predominantly metabolized by CYP2D6 and which have a narrow therapeutic window, such as flecainide, thioridazine and tricyclic antidepressants (see CLINICAL PHARMACOLOGY).
entities: ENABLEX / thioridazine
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Caution should be taken when ENABLEX is used concomitantly with medications that are predominantly metabolized by CYP2D6 and which have a narrow therapeutic window, such as flecainide, thioridazine and tricyclic antidepressants (see CLINICAL PHARMACOLOGY).
entities: ENABLEX / tricyclic antidepressants
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: CYP3A4 Inhibitors Felodipine is metabolized by CYP3A4.
entities: CYP3A4 / CYP3A4
ddi: null
>>> match: metabolize_nsubj:pass_obl
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: ketoconazole / itraconazole
ddi: null
>>> match: lead_dep_dep
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: ketoconazole / erythromycin
ddi: null
>>> match: lead_dep_dep
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: ketoconazole / cimetidine
ddi: null
>>> match: lead_dep_nsubj
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: ketoconazole / felodipine
ddi: null
>>> match: lead_dep_nsubj
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: ketoconazole / felodipine
ddi: null
>>> match: lead_dep_obl
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: itraconazole / erythromycin
ddi: null
>>> match: lead_dep_dep
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: itraconazole / cimetidine
ddi: null
>>> match: lead_dep_nsubj
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: itraconazole / felodipine
ddi: null
>>> match: lead_dep_nsubj
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: itraconazole / felodipine
ddi: null
>>> match: lead_dep_obl
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: erythromycin / cimetidine
ddi: null
>>> match: lead_dep_nsubj
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: erythromycin / felodipine
ddi: null
>>> match: lead_dep_nsubj
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: erythromycin / felodipine
ddi: null
>>> match: lead_dep_obl
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: cimetidine / felodipine
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: Co-administration of CYP3A4 inhibitors (eg, ketoconazole, itraconazole, erythromycin, grapefruit juice, cimetidine) with felodipine may lead to several- fold increases in the plasma levels of felodipine, either due to an increase in bioavailability or due to a decrease in metabolism.
entities: felodipine / felodipine
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: Caution should be used when CYP3A4 inhibitors are co-administered with felodipine.
entities: CYP3A4 / felodipine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: The following specific interactions have been reported: Itraconazole Co-administration of another extended release formulation of felodipine with itraconazole resulted in approximately 8-fold increase in the AUC, more than 6- fold increase in the Cmax, and 2-fold prolongation in the half- life of felodipine.
entities: felodipine / felodipine
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The following specific interactions have been reported: Itraconazole Co-administration of another extended release formulation of felodipine with itraconazole resulted in approximately 8-fold increase in the AUC, more than 6- fold increase in the Cmax, and 2-fold prolongation in the half- life of felodipine.
entities: itraconazole / felodipine
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Erythromycin Co-administration of felodipine (PLENDIL) with erythromycin resulted in approximately 2.5- fold increase in the AUC and Cmax, and about 2- fold prolongation in the half- life of felodipine.
entities: felodipine / felodipine
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Erythromycin Co-administration of felodipine (PLENDIL) with erythromycin resulted in approximately 2.5- fold increase in the AUC and Cmax, and about 2- fold prolongation in the half- life of felodipine.
entities: PLENDIL / felodipine
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Erythromycin Co-administration of felodipine (PLENDIL) with erythromycin resulted in approximately 2.5- fold increase in the AUC and Cmax, and about 2- fold prolongation in the half- life of felodipine.
entities: erythromycin / felodipine
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Grapefruit juice Co-administration of felodipine with grapefruit juice resulted in more than 2-fold increase in the AUC and Cmax, but no prolongation in the half- life of felodipine.
entities: felodipine / felodipine
ddi: null
>>> match: result_nsubj_dep
-------------
sentence: Cimetidine Co-administration of felodipine with cimetidine (a non-specific CYP-450 inhibitor) resulted in an increase of approximately 50% in the AUC and the Cmax, of felodipine.
entities: felodipine / felodipine
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Cimetidine Co-administration of felodipine with cimetidine (a non-specific CYP-450 inhibitor) resulted in an increase of approximately 50% in the AUC and the Cmax, of felodipine.
entities: cimetidine / felodipine
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Beta-Blocking Agents  A pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of felodipine.
entities: felodipine / felodipine
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: Beta-Blocking Agents  A pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of felodipine.
entities: metoprolol / felodipine
ddi: null
>>> match: demonstrate_nsubj_obj
-------------
sentence: In controlled clinical trials, however, beta blockers including metoprolol were concurrently administered with felodipine and were well tolerated.
entities: beta blockers / felodipine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: In controlled clinical trials, however, beta blockers including metoprolol were concurrently administered with felodipine and were well tolerated.
entities: metoprolol / felodipine
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: Digoxin  When given concomitantly with PLENDIL the pharmacokinetics of digoxin in patients with heart failure were not significantly altered.
entities: PLENDIL / digoxin
ddi: null
>>> match: alter_obl_nsubj:pass
-------------
sentence: Tacrolimus  Felodipine may increase the blood concentration of tacrolimus.
entities: Felodipine / tacrolimus
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: When given concomitantly with felodipine, the tacrolimus blood concentration should be followed and the tacrolimus dose may need to be adjusted.
entities: felodipine / tacrolimus
ddi: null
>>> match: follow_advcl_nsubj:pass
-------------
sentence: Other Concomitant Therapy  In healthy subjects there were no clinically significant interactions when felodipine was given concomitantly with indomethacin or spironolactone.
entities: felodipine / indomethacin
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: Other Concomitant Therapy  In healthy subjects there were no clinically significant interactions when felodipine was given concomitantly with indomethacin or spironolactone.
entities: felodipine / spironolactone
ddi: null
>>> match: give_nsubj:pass_obl
-------------
sentence: May interact with the following: beta-adrenergic blocking agents (these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly) and disopyramide, quinidine, phenothiazines, and procainamide (these medicines may increase the risk of heart problems).
entities: adrenergic bronchodilators / disopyramide
ddi: null
>>> match: prevent_obj_obl
-------------
sentence: May interact with the following: beta-adrenergic blocking agents (these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly) and disopyramide, quinidine, phenothiazines, and procainamide (these medicines may increase the risk of heart problems).
entities: adrenergic bronchodilators / quinidine
ddi: null
>>> match: prevent_obj_obl
-------------
sentence: May interact with the following: beta-adrenergic blocking agents (these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly) and disopyramide, quinidine, phenothiazines, and procainamide (these medicines may increase the risk of heart problems).
entities: adrenergic bronchodilators / phenothiazines
ddi: null
>>> match: prevent_obj_obl
-------------
sentence: May interact with the following: beta-adrenergic blocking agents (these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly) and disopyramide, quinidine, phenothiazines, and procainamide (these medicines may increase the risk of heart problems).
entities: adrenergic bronchodilators / procainamide
ddi: null
>>> match: prevent_obj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / acetaminophen
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / Tylenol
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / chloramphenicol
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / Chloromycetin
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / anesthetics
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / benzocaine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / lidocaine
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / para-aminobenzoic acid
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / PABA
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / multivitamins
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / procainamide
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / Pronestyl
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / sulfonamides
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / thiazide diuretics
ddi: int
>>> match: interact_nsubj_obl
-------------
sentence: FLEXERIL may have life-threatening interactions with MAO inhibitors.
entities: FLEXERIL / MAO inhibitors
ddi: int
>>> match: have_nsubj_obj
-------------
sentence: FLEXERIL may enhance the effects of alcohol, barbiturates, and other CNS depressants.
entities: FLEXERIL / alcohol
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: FLEXERIL may enhance the effects of alcohol, barbiturates, and other CNS depressants.
entities: FLEXERIL / barbiturates
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: FLEXERIL may enhance the effects of alcohol, barbiturates, and other CNS depressants.
entities: FLEXERIL / CNS depressants
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Tricyclic antidepressants may block the antihypertensive action of guanethidine and similarly acting compounds.
entities: Tricyclic antidepressants / guanethidine
ddi: effect
>>> match: block_nsubj_obj
-------------
sentence: Tricyclic antidepressants may enhance the seizure risk in patients taking tramadol
entities: Tricyclic antidepressants / tramadol
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as omeprazole.
entities: PLETAL / PLETAL
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as omeprazole.
entities: PLETAL / ketoconazole
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as omeprazole.
entities: PLETAL / erythromycin
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as omeprazole.
entities: PLETAL / omeprazole
ddi: null
>>> match: exercise_advcl_advcl
-------------
sentence: Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as omeprazole.
entities: PLETAL / ketoconazole
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as omeprazole.
entities: PLETAL / erythromycin
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as omeprazole.
entities: PLETAL / omeprazole
ddi: advise
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Pharmacokinetic studies have demonstrated that omeprazole and erythromycin significantly increased the systemic exposure of cilostazol and/or its major metabolites.
entities: omeprazole / cilostazol
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Pharmacokinetic studies have demonstrated that omeprazole and erythromycin significantly increased the systemic exposure of cilostazol and/or its major metabolites.
entities: erythromycin / cilostazol
ddi: mechanism
>>> match: increase_nsubj_obj
-------------
sentence: Pletal does not, however, appear to cause increased blood levels of drugs metabolized by CYP3A4, as it had no effect on lovastatin, a drug with metabolism very sensitive to C.P.A. inhibition.
entities: Pletal / lovastatin
ddi: null
>>> match: appear_nsubj_xcomp
-------------
sentence: It was shown that neurotensin antagonized evidently the antinociceptive effect of enkephalins and their analogue. 
entities: neurotensin / enkephalins
ddi: effect
>>> match: antagonize_nsubj_obj
-------------
sentence: It is concluded that neurotensin modulates in an opposite way the function of the enkephalinergic neurons and the central action of tuftsin.
entities: neurotensin / tuftsin
ddi: effect
>>> match: modulate_nsubj_obj
-------------
sentence: Concomitant administration of TRENTAL and theophylline-containing drugs leads to increased theophylline levels and theophylline toxicity in some individuals. 
entities: TRENTAL / theophylline
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: Concomitant administration of TRENTAL and theophylline-containing drugs leads to increased theophylline levels and theophylline toxicity in some individuals. 
entities: TRENTAL / theophylline
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: Concomitant administration of TRENTAL and theophylline-containing drugs leads to increased theophylline levels and theophylline toxicity in some individuals. 
entities: theophylline / theophylline
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: Concomitant administration of TRENTAL and theophylline-containing drugs leads to increased theophylline levels and theophylline toxicity in some individuals. 
entities: theophylline / theophylline
ddi: null
>>> match: lead_nsubj_obl
-------------
sentence: TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems. 
entities: TRENTAL / antihypertensive drugs
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems. 
entities: TRENTAL / beta blockers
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems. 
entities: TRENTAL / digitalis
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems. 
entities: TRENTAL / diuretics
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems. 
entities: TRENTAL / antidiabetic agents
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems. 
entities: TRENTAL / antiarrhythmics
ddi: null
>>> match: use_nsubj:pass_obl
-------------
sentence: In experiment 2, the same regimen of GSLS was administered to chickens inoculated with inactivated AI vaccines, and an enhanced serum antibody response to AI vaccination was also observed. 
entities: GSLS / inactivated AI vaccines
ddi: effect
>>> match: administer_nsubj:pass_dep
-------------
sentence: Five days of dofetilide treatment did not significantly affect steady-state pharmacokinetic variables of digoxin compared with placebo; 
entities: dofetilide / digoxin
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Diuretics: Furosemide and probably other loop diuretics given concomitantly with metolazone can cause unusually large or prolonged losses of fluid and electrolytes. 
entities: Furosemide / metolazone
ddi: effect
>>> match: give_nsubj_obl
-------------
sentence: Diuretics: Furosemide and probably other loop diuretics given concomitantly with metolazone can cause unusually large or prolonged losses of fluid and electrolytes. 
entities: loop diuretics / metolazone
ddi: effect
>>> match: give_nsubj_obl
-------------
sentence: Other Antihypertensives: When MYKROX Tablets are used with other antihypertensive drugs, care must be taken, especially during initial therapy. 
entities: MYKROX / antihypertensive drugs
ddi: advise
>>> match: use_nsubj:pass_obl
-------------
sentence: Digitalis Glycosides: Diuretic-induced hypokalemia can increase the sensitivity of the myocardium to digitalis. 
entities: Diuretic / digitalis
ddi: effect
>>> match: increase_nsubj_obj
-------------
sentence: Curariform Drugs: Diuretic-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea. 
entities: Diuretic / curariform drugs
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Curariform Drugs: Diuretic-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea. 
entities: Diuretic / tubocurarine
ddi: effect
>>> match: enhance_nsubj_obj
-------------
sentence: Salicylates and Other Non-Steroidal Anti-Inflammatory Drugs: May decrease the antihypertensive effects of MYKROX Tablets. 
entities: Salicylates / MYKROX
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Salicylates and Other Non-Steroidal Anti-Inflammatory Drugs: May decrease the antihypertensive effects of MYKROX Tablets. 
entities: Non-Steroidal Anti-Inflammatory Drugs / MYKROX
ddi: effect
>>> match: decrease_nsubj_obj
-------------
sentence: Sympathomimetics: Metolazone may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use. 
entities: Metolazone / norepinephrine
ddi: effect
>>> match: decrease_nsubj_obl
-------------
sentence: Anticoagulants: Metolazone, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to anticoagulants; 
entities: Metolazone / anticoagulants
ddi: effect
>>> match: affect_nsubj_obj
-------------
sentence: Anticoagulants: Metolazone, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to anticoagulants; 
entities: thiazide-like diuretics / anticoagulants
ddi: null
>>> match: affect_nsubj_obj
-------------
sentence: Methotrexate: NSAIDs have been reported to competitively inhibit methotrexate accumulation in rabbit kidney slices.
entities: NSAIDs / methotrexate
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Caution should be used when NSAIDs are administered concomitantly with methotrexate.
entities: NSAIDs / methotrexate
ddi: advise
>>> match: administer_nsubj:pass_obl
-------------
sentence: ACE inhibitors: Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors.
entities: NSAIDs / ACE inhibitors
ddi: effect
>>> match: diminish_nsubj_obj
-------------
sentence: This interaction should be given consideration in patients taking NSAIDs concomitantly with ACE inhibitors.
entities: NSAIDs / ACE inhibitors
ddi: advise
>>> match: take_obj_obl
-------------
sentence: Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
entities: NSAIDs / furosemide
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
entities: NSAIDs / thiazides
ddi: effect
>>> match: reduce_nsubj_obj
-------------
sentence: Lithium: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.
entities: NSAIDs / lithium
ddi: mechanism
>>> match: produce_nsubj_obj
-------------
sentence: Lithium: NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.
entities: NSAIDs / lithium
ddi: mechanism
>>> match: produce_nsubj_obj
-------------
sentence: Thus, when NSAIDs and lithium are administered concurrently, subjects should be observed carefully for signs of lithium toxicity.
entities: NSAIDs / lithium
ddi: null
>>> match: observe_advcl_obl
-------------
sentence: Thus, when NSAIDs and lithium are administered concurrently, subjects should be observed carefully for signs of lithium toxicity.
entities: lithium / lithium
ddi: null
>>> match: observe_advcl_obl
-------------
sentence: Antacids: In a single dose study (n=6), ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the Cmax and AUC of mefenamic acid by 125% and 36%, respectively.  A number of compounds are inhibitors of CYP2C9 including fluconazole, lovastatin and trimethoprim.
entities: antacid / mefenamic acid
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Antacids: In a single dose study (n=6), ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the Cmax and AUC of mefenamic acid by 125% and 36%, respectively.  A number of compounds are inhibitors of CYP2C9 including fluconazole, lovastatin and trimethoprim.
entities: magnesium hydroxide / mefenamic acid
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Antacids: In a single dose study (n=6), ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the Cmax and AUC of mefenamic acid by 125% and 36%, respectively.  A number of compounds are inhibitors of CYP2C9 including fluconazole, lovastatin and trimethoprim.
entities: mefenamic acid / mefenamic acid
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: A drug interaction study was performed in which ERBITUX was administered in combination with irinotecan.
entities: ERBITUX / irinotecan
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: ERGAMISOL  (levamisole hydrochloride) has been reported to produce ANTABUSE-like side effects when given concomitantly with alcohol.
entities: ERGAMISOL / alcohol
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: ERGAMISOL  (levamisole hydrochloride) has been reported to produce ANTABUSE-like side effects when given concomitantly with alcohol.
entities: levamisole hydrochloride / alcohol
ddi: effect
>>> match: report_nsubj:pass_xcomp
-------------
sentence: Because of reports of prolongation of the prothrombin time beyond the therapeutic range in patients taking concurrent levamisole and warfarin sodium, it is suggested that the prothrombin time be monitored carefully, and the dose of warfarin sodium or other coumarin-like drugs should be adjusted accordingly, in patients taking both drugs.
entities: levamisole / warfarin sodium
ddi: null
>>> match: suggest_obl_conj
-------------
sentence: Because of reports of prolongation of the prothrombin time beyond the therapeutic range in patients taking concurrent levamisole and warfarin sodium, it is suggested that the prothrombin time be monitored carefully, and the dose of warfarin sodium or other coumarin-like drugs should be adjusted accordingly, in patients taking both drugs.
entities: levamisole / coumarin
ddi: null
>>> match: suggest_obl_conj
-------------
sentence: Because of reports of prolongation of the prothrombin time beyond the therapeutic range in patients taking concurrent levamisole and warfarin sodium, it is suggested that the prothrombin time be monitored carefully, and the dose of warfarin sodium or other coumarin-like drugs should be adjusted accordingly, in patients taking both drugs.
entities: warfarin sodium / warfarin sodium
ddi: null
>>> match: suggest_obl_conj
-------------
sentence: Because of reports of prolongation of the prothrombin time beyond the therapeutic range in patients taking concurrent levamisole and warfarin sodium, it is suggested that the prothrombin time be monitored carefully, and the dose of warfarin sodium or other coumarin-like drugs should be adjusted accordingly, in patients taking both drugs.
entities: warfarin sodium / coumarin
ddi: null
>>> match: suggest_obl_conj
-------------
sentence: When ertapenem is co-administered with probenecid (500 mg p.o. every 6 hours), probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem.
entities: ertapenem / probenecid
ddi: null
>>> match: administer_nsubj:pass_obl
-------------
sentence: When ertapenem is co-administered with probenecid (500 mg p.o. every 6 hours), probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem.
entities: ertapenem / probenecid
ddi: null
>>> match: compete_advcl_nsubj
-------------
sentence: When ertapenem is co-administered with probenecid (500 mg p.o. every 6 hours), probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem.
entities: ertapenem / ertapenem
ddi: null
>>> match: compete_advcl_conj
-------------
sentence: When ertapenem is co-administered with probenecid (500 mg p.o. every 6 hours), probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem.
entities: probenecid / probenecid
ddi: null
>>> match: compete_advcl_nsubj
-------------
sentence: When ertapenem is co-administered with probenecid (500 mg p.o. every 6 hours), probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem.
entities: probenecid / ertapenem
ddi: null
>>> match: compete_advcl_conj
-------------
sentence: When ertapenem is co-administered with probenecid (500 mg p.o. every 6 hours), probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem.
entities: probenecid / ertapenem
ddi: mechanism
>>> match: compete_nsubj_conj
-------------
sentence: Based on total ertapenem concentrations, probenecid increased the AUC by 25% and reduced the plasma and renal clearances by 20% and 35%, respectively.
entities: ertapenem / probenecid
ddi: mechanism
>>> match: increase_advcl_nsubj
-------------
sentence: Because of the small effect on half-life, the coadministration with probenecid to extend the half-life of ertapenem is not recommended.
entities: probenecid / ertapenem
ddi: advise
>>> match: extend_nsubj_obj
-------------
sentence: Concomitant treatment with thrombolytics (eg, rt-PA or streptokinase) may: - increase the risk of bleeding complications - considerably enhance the effect of REFLUDAN on aPTT prolongation
entities: thrombolytics / REFLUDAN
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: Concomitant treatment with thrombolytics (eg, rt-PA or streptokinase) may: - increase the risk of bleeding complications - considerably enhance the effect of REFLUDAN on aPTT prolongation
entities: streptokinase / REFLUDAN
ddi: null
>>> match: increase_nsubj_obj
-------------
sentence: The use of codeine may result in additive CNS depressant effects when coadministered with alcohol, antihistamines, psychotropics or other drugs that produce CNS depression.
entities: codeine / alcohol
ddi: effect
>>> match: result_nsubj_obl
-------------
sentence: The use of codeine may result in additive CNS depressant effects when coadministered with alcohol, antihistamines, psychotropics or other drugs that produce CNS depression.
entities: codeine / antihistamines
ddi: effect
>>> match: result_nsubj_obl
-------------
sentence: The use of codeine may result in additive CNS depressant effects when coadministered with alcohol, antihistamines, psychotropics or other drugs that produce CNS depression.
entities: codeine / psychotropics
ddi: effect
>>> match: result_nsubj_obl
-------------
sentence: Serious toxicity may result if dextromethorphan is coadministered with monoamine oxidase inhibitors (MAOIs).
entities: dextromethorphan / monoamine oxidase inhibitors
ddi: effect
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: Serious toxicity may result if dextromethorphan is coadministered with monoamine oxidase inhibitors (MAOIs).
entities: dextromethorphan / MAOIs
ddi: effect
>>> match: coadminister_nsubj:pass_obl
-------------
sentence: The use of dextromethorphan hydrobromide may result in additive CNS depressant effects when coadministered with alcohol, antihistamines, psychotropics or other drugs that produce CNS depression.
entities: dextromethorphan hydrobromide / alcohol
ddi: effect
>>> match: result_nsubj_obl
-------------
sentence: The use of dextromethorphan hydrobromide may result in additive CNS depressant effects when coadministered with alcohol, antihistamines, psychotropics or other drugs that produce CNS depression.
entities: dextromethorphan hydrobromide / antihistamines
ddi: effect
>>> match: result_nsubj_obl
-------------
sentence: The use of dextromethorphan hydrobromide may result in additive CNS depressant effects when coadministered with alcohol, antihistamines, psychotropics or other drugs that produce CNS depression.
entities: dextromethorphan hydrobromide / psychotropics
ddi: effect
>>> match: result_nsubj_obl
-------------
sentence: COPAXONE  has not been formally evaluated in combination with Interferon beta.
entities: COPAXONE / Interferon beta
ddi: null
>>> match: evaluate_nsubj:pass_obl
-------------
sentence: However, 10 patients who switched from therapy with Interferon beta to COPAXONE  did not report any serious and unexpected adverse reactions thought to be related to treatment.
entities: Interferon beta / COPAXONE
ddi: null
>>> match: switch_obl_obl
-------------
sentence: Rifampin has been reported to increase the warfarin requirements in human subjects ingesting these agents simultaneously. 
entities: Rifampin / warfarin
ddi: mechanism
>>> match: report_nsubj:pass_xcomp
-------------
sentence: The concomitant administration of rifampin and warfarin resulted in the need for an unusually high maintenance dose of warfarin (20 mg per day) in order to produce a therapeutic effect. 
entities: rifampin / warfarin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: The concomitant administration of rifampin and warfarin resulted in the need for an unusually high maintenance dose of warfarin (20 mg per day) in order to produce a therapeutic effect. 
entities: warfarin / warfarin
ddi: null
>>> match: result_nsubj_obl
-------------
sentence: Withdrawal of rifampin decreased the warfarin requirement by 50%. 
entities: rifampin / warfarin
ddi: mechanism
>>> match: decrease_nsubj_obj
-------------
sentence: The effect of rifampin on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after rifampin withdrawal. 
entities: rifampin / rifampin
ddi: null
>>> match: appear_nsubj_xcomp
-------------
sentence: The effect of rifampin on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after rifampin withdrawal. 
entities: rifampin / rifampin
ddi: null
>>> match: appear_nsubj_xcomp
-------------
sentence: The effect of rifampin on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after rifampin withdrawal. 
entities: warfarin / rifampin
ddi: null
>>> match: appear_nsubj_xcomp
-------------
sentence: The effect of rifampin on the warfarin requirement of our patient appeared to be maximal 5 to 7 days after the initiation of rifampin and extended a similar length of time after rifampin withdrawal. 
entities: warfarin / rifampin
ddi: null
>>> match: appear_nsubj_xcomp
----------------------
5594 matches found
----------------------
P(mechanism|ANY) = 644/5594 = 0.11512334644261708
P(effect|ANY) = 942/5594 = 0.16839470861637468
P(int|ANY) = 174/5594 = 0.03110475509474437
P(advise|ANY) = 383/5594 = 0.06846621380050054
P(null|ANY) = 3451/5594 = 0.6169109760457633
----------------------
P(mechanism|cause_nsubj_obj) = 8/23 = 0.34782608695652173
P(effect|cause_nsubj_obj) = 1/23 = 0.043478260869565216
P(null|cause_nsubj_obj) = 14/23 = 0.6086956521739131
P(null|cause_nsubj_dep) = 2/2 = 1.0
P(effect|use_nsubj:pass_obl) = 13/108 = 0.12037037037037036
P(advise|use_nsubj:pass_obl) = 42/108 = 0.3888888888888889
P(null|use_nsubj:pass_obl) = 53/108 = 0.49074074074074076
P(mechanism|administer_nsubj:pass_obl) = 15/207 = 0.07246376811594203
P(effect|administer_nsubj:pass_obl) = 14/207 = 0.06763285024154589
P(advise|administer_nsubj:pass_obl) = 90/207 = 0.43478260869565216
P(null|administer_nsubj:pass_obl) = 88/207 = 0.4251207729468599
P(advise|monitor_nsubj:pass_obl) = 3/19 = 0.15789473684210525
P(null|monitor_nsubj:pass_obl) = 16/19 = 0.8421052631578947
P(effect|take_obj_advcl) = 4/4 = 1.0
P(mechanism|reduce_nsubj_obj) = 28/87 = 0.3218390804597701
P(effect|reduce_nsubj_obj) = 44/87 = 0.5057471264367817
P(null|reduce_nsubj_obj) = 15/87 = 0.1724137931034483
P(null|indicate_nsubj_ccomp) = 16/16 = 1.0
P(effect|exacerbate_nsubj_obj) = 1/1 = 1.0
P(null|see_obl_dep) = 3/3 = 1.0
P(effect|potentiate_nsubj_dep) = 5/7 = 0.7142857142857143
P(null|potentiate_nsubj_dep) = 2/7 = 0.2857142857142857
P(mechanism|report_nsubj:pass_xcomp) = 32/88 = 0.36363636363636365
P(effect|report_nsubj:pass_xcomp) = 30/88 = 0.3409090909090909
P(null|report_nsubj:pass_xcomp) = 26/88 = 0.29545454545454547
P(effect|augment_nsubj_obj) = 6/6 = 1.0
P(effect|augment_nsubj_dep) = 2/2 = 1.0
P(advise|exercise_obl_obl) = 1/1 = 1.0
P(null|restrict_nsubj:pass_conj) = 1/1 = 1.0
P(null|apply_obl_conj) = 3/3 = 1.0
P(null|prove_obl_dep) = 2/2 = 1.0
P(null|prove_obl_xcomp) = 2/2 = 1.0
P(null|prove_dep_xcomp) = 1/1 = 1.0
P(null|suggest_obj_dep) = 1/1 = 1.0
P(mechanism|have_nsubj_advcl) = 2/9 = 0.2222222222222222
P(effect|have_nsubj_advcl) = 3/9 = 0.3333333333333333
P(null|have_nsubj_advcl) = 4/9 = 0.4444444444444444
P(mechanism|associate_nsubj:pass_obl) = 3/19 = 0.15789473684210525
P(effect|associate_nsubj:pass_obl) = 2/19 = 0.10526315789473684
P(null|associate_nsubj:pass_obl) = 14/19 = 0.7368421052631579
P(mechanism|report_obl_obl) = 2/13 = 0.15384615384615385
P(null|report_obl_obl) = 11/13 = 0.8461538461538461
P(mechanism|increase_nsubj_advcl) = 5/18 = 0.2777777777777778
P(effect|increase_nsubj_advcl) = 4/18 = 0.2222222222222222
P(null|increase_nsubj_advcl) = 9/18 = 0.5
P(null|report_advcl_nsubj:pass) = 2/2 = 1.0
P(null|improve_nsubj_obl) = 5/5 = 1.0
P(null|demonstrate_nsubj_advcl) = 1/1 = 1.0
P(null|compare_obl_dep) = 2/2 = 1.0
P(mechanism|decrease_nsubj_obj) = 39/105 = 0.37142857142857144
P(effect|decrease_nsubj_obj) = 25/105 = 0.23809523809523808
P(int|decrease_nsubj_obj) = 7/105 = 0.06666666666666667
P(null|decrease_nsubj_obj) = 34/105 = 0.3238095238095238
P(mechanism|increase_nsubj_obj) = 50/141 = 0.3546099290780142
P(effect|increase_nsubj_obj) = 36/141 = 0.2553191489361702
P(null|increase_nsubj_obj) = 55/141 = 0.3900709219858156
P(mechanism|increase_nsubj:pass_obl) = 10/16 = 0.625
P(effect|increase_nsubj:pass_obl) = 3/16 = 0.1875
P(null|increase_nsubj:pass_obl) = 3/16 = 0.1875
P(mechanism|increase_nsubj:pass_conj) = 3/5 = 0.6
P(null|increase_nsubj:pass_conj) = 2/5 = 0.4
P(mechanism|increase_obl_conj) = 5/12 = 0.4166666666666667
P(null|increase_obl_conj) = 7/12 = 0.5833333333333334
P(mechanism|show_nsubj:pass_xcomp) = 19/56 = 0.3392857142857143
P(effect|show_nsubj:pass_xcomp) = 6/56 = 0.10714285714285714
P(null|show_nsubj:pass_xcomp) = 31/56 = 0.5535714285714286
P(mechanism|cause_nsubj_obl) = 3/7 = 0.42857142857142855
P(effect|cause_nsubj_obl) = 4/7 = 0.5714285714285714
P(effect|accentuate_nsubj:pass_obl) = 9/9 = 1.0
P(null|need_advcl_obl) = 24/24 = 1.0
P(mechanism|interfere_nsubj_obl) = 20/33 = 0.6060606060606061
P(effect|interfere_nsubj_obl) = 9/33 = 0.2727272727272727
P(null|interfere_nsubj_obl) = 4/33 = 0.12121212121212122
P(null|induce_nsubj_dep) = 9/9 = 1.0
P(null|preconstrict_obl_conj) = 1/1 = 1.0
P(effect|enhance_nsubj:pass_obl) = 14/18 = 0.7777777777777778
P(null|enhance_nsubj:pass_obl) = 4/18 = 0.2222222222222222
P(mechanism|observe_nsubj:pass_obl) = 2/13 = 0.15384615384615385
P(effect|observe_nsubj:pass_obl) = 1/13 = 0.07692307692307693
P(advise|observe_nsubj:pass_obl) = 1/13 = 0.07692307692307693
P(null|observe_nsubj:pass_obl) = 9/13 = 0.6923076923076923
P(null|show_obj_obl) = 3/3 = 1.0
P(null|use_dep_xcomp) = 26/26 = 1.0
P(mechanism|decrease_csubj_obj) = 1/3 = 0.3333333333333333
P(null|decrease_csubj_obj) = 2/3 = 0.6666666666666666
P(advise|consider_nsubj:pass_xcomp) = 1/2 = 0.5
P(null|consider_nsubj:pass_xcomp) = 1/2 = 0.5
P(mechanism|have_nsubj_obj) = 28/184 = 0.15217391304347827
P(effect|have_nsubj_obj) = 19/184 = 0.10326086956521739
P(int|have_nsubj_obj) = 3/184 = 0.016304347826086956
P(null|have_nsubj_obj) = 134/184 = 0.7282608695652174
P(mechanism|take_obj_obl) = 1/17 = 0.058823529411764705
P(effect|take_obj_obl) = 7/17 = 0.4117647058823529
P(advise|take_obj_obl) = 4/17 = 0.23529411764705882
P(null|take_obj_obl) = 5/17 = 0.29411764705882354
P(mechanism|have_nsubj_conj) = 1/15 = 0.06666666666666667
P(effect|have_nsubj_conj) = 2/15 = 0.13333333333333333
P(null|have_nsubj_conj) = 12/15 = 0.8
P(null|have_obj_conj) = 9/9 = 1.0
P(mechanism|decrease_nsubj_dep) = 2/2 = 1.0
P(effect|have_nsubj_obl) = 1/10 = 0.1
P(null|have_nsubj_obl) = 9/10 = 0.9
P(null|have_obl_obj) = 8/8 = 1.0
P(null|observe_obl_dep) = 5/5 = 1.0
P(mechanism|show_nsubj_obj) = 2/23 = 0.08695652173913043
P(null|show_nsubj_obj) = 21/23 = 0.9130434782608695
P(advise|use_obl_obl) = 4/5 = 0.8
P(null|use_obl_obl) = 1/5 = 0.2
P(null|consider_nsubj_xcomp) = 1/1 = 1.0
P(null|encourage_advcl_xcomp) = 2/2 = 1.0
P(null|see_nsubj:pass_obl) = 3/3 = 1.0
P(mechanism|increase_nsubj:pass_parataxis) = 1/1 = 1.0
P(mechanism|decrease_nsubj:pass_obl) = 4/7 = 0.5714285714285714
P(null|decrease_nsubj:pass_obl) = 3/7 = 0.42857142857142855
P(mechanism|find_nsubj:pass_xcomp) = 1/9 = 0.1111111111111111
P(effect|find_nsubj:pass_xcomp) = 1/9 = 0.1111111111111111
P(null|find_nsubj:pass_xcomp) = 7/9 = 0.7777777777777778
P(mechanism|decrease_nsubj_iobj) = 2/2 = 1.0
P(null|identify_nsubj:pass_obl) = 2/2 = 1.0
P(mechanism|demonstrate_nsubj_obj) = 1/19 = 0.05263157894736842
P(null|demonstrate_nsubj_obj) = 18/19 = 0.9473684210526315
P(mechanism|inhibit_obj_dep) = 1/6 = 0.16666666666666666
P(null|inhibit_obj_dep) = 5/6 = 0.8333333333333334
P(advise|need_advcl_xcomp) = 1/1 = 1.0
P(effect|receive_obj_advcl) = 6/18 = 0.3333333333333333
P(null|receive_obj_advcl) = 12/18 = 0.6666666666666666
P(mechanism|affect_nsubj:pass_obl) = 2/11 = 0.18181818181818182
P(null|affect_nsubj:pass_obl) = 9/11 = 0.8181818181818182
P(mechanism|produce_nsubj_conj) = 1/3 = 0.3333333333333333
P(effect|produce_nsubj_conj) = 2/3 = 0.6666666666666666
P(advise|give_obl_obl) = 1/3 = 0.3333333333333333
P(null|give_obl_obl) = 2/3 = 0.6666666666666666
P(null|use_advcl_nsubj:pass) = 2/2 = 1.0
P(null|use_advcl_obl) = 2/2 = 1.0
P(null|elevate_obj_conj) = 4/4 = 1.0
P(null|elevate_conj_conj) = 7/7 = 1.0
P(null|fibrate_nsubj_obj) = 2/2 = 1.0
P(effect|increase_obl_obl) = 1/5 = 0.2
P(null|increase_obl_obl) = 4/5 = 0.8
P(advise|determine_obl_obl) = 1/1 = 1.0
P(mechanism|result_nsubj_obl) = 6/137 = 0.043795620437956206
P(effect|result_nsubj_obl) = 6/137 = 0.043795620437956206
P(advise|result_nsubj_obl) = 1/137 = 0.0072992700729927005
P(null|result_nsubj_obl) = 124/137 = 0.9051094890510949
P(mechanism|be_obl_nsubj) = 1/8 = 0.125
P(null|be_obl_nsubj) = 7/8 = 0.875
P(mechanism|interact_nsubj_obl) = 2/126 = 0.015873015873015872
P(effect|interact_nsubj_obl) = 4/126 = 0.031746031746031744
P(int|interact_nsubj_obl) = 112/126 = 0.8888888888888888
P(advise|interact_nsubj_obl) = 2/126 = 0.015873015873015872
P(null|interact_nsubj_obl) = 6/126 = 0.047619047619047616
P(null|dose_nsubj_obl) = 1/1 = 1.0
P(null|dose_nsubj_obj) = 1/1 = 1.0
P(null|dose_obl_obj) = 1/1 = 1.0
P(null|treat_obl_parataxis) = 1/1 = 1.0
P(null|conduct_nsubj:pass_obl) = 9/9 = 1.0
P(null|have_obj_advcl) = 3/3 = 1.0
P(null|decrease_obj_conj) = 9/9 = 1.0
P(mechanism|coadminister_nsubj:pass_obl) = 6/31 = 0.1935483870967742
P(effect|coadminister_nsubj:pass_obl) = 2/31 = 0.06451612903225806
P(advise|coadminister_nsubj:pass_obl) = 17/31 = 0.5483870967741935
P(null|coadminister_nsubj:pass_obl) = 6/31 = 0.1935483870967742
P(null|require_csubj_obj) = 9/9 = 1.0
P(advise|give_obj_obl) = 2/2 = 1.0
P(mechanism|impair_nsubj:pass_obl) = 10/12 = 0.8333333333333334
P(null|impair_nsubj:pass_obl) = 2/12 = 0.16666666666666666
P(effect|render_nsubj_xcomp) = 1/9 = 0.1111111111111111
P(null|render_nsubj_xcomp) = 8/9 = 0.8888888888888888
P(mechanism|inhibit_nsubj_obj) = 35/54 = 0.6481481481481481
P(effect|inhibit_nsubj_obj) = 8/54 = 0.14814814814814814
P(null|inhibit_nsubj_obj) = 11/54 = 0.2037037037037037
P(effect|evaluate_obj_dep) = 3/3 = 1.0
P(null|examine_obj_obl) = 3/3 = 1.0
P(null|collect_nsubj:pass_obl) = 1/1 = 1.0
P(null|indicate_obl_ccomp) = 3/3 = 1.0
P(null|mean_obl_nsubj) = 2/2 = 1.0
P(null|mean_obl_ccomp) = 2/2 = 1.0
P(null|mean_nsubj_ccomp) = 1/1 = 1.0
P(null|recommend_nsubj:pass_obl) = 2/2 = 1.0
P(null|inhibit_obl_nsubj:pass) = 2/2 = 1.0
P(mechanism|inhibit_obl_obl) = 1/2 = 0.5
P(null|inhibit_obl_obl) = 1/2 = 0.5
P(mechanism|inhibit_nsubj:pass_obl) = 3/7 = 0.42857142857142855
P(effect|inhibit_nsubj:pass_obl) = 4/7 = 0.5714285714285714
P(mechanism|give_nsubj:pass_obl) = 3/40 = 0.075
P(effect|give_nsubj:pass_obl) = 14/40 = 0.35
P(advise|give_nsubj:pass_obl) = 7/40 = 0.175
P(null|give_nsubj:pass_obl) = 16/40 = 0.4
P(effect|give_nsubj:pass_advcl) = 1/3 = 0.3333333333333333
P(null|give_nsubj:pass_advcl) = 2/3 = 0.6666666666666666
P(null|give_obl_advcl) = 3/3 = 1.0
P(null|observe_advcl_xcomp) = 4/4 = 1.0
P(effect|add_nsubj_obl) = 3/3 = 1.0
P(mechanism|increase_nsubj_obl) = 5/17 = 0.29411764705882354
P(effect|increase_nsubj_obl) = 1/17 = 0.058823529411764705
P(null|increase_nsubj_obl) = 11/17 = 0.6470588235294118
P(effect|decrease_nsubj_obl) = 2/3 = 0.6666666666666666
P(null|decrease_nsubj_obl) = 1/3 = 0.3333333333333333
P(effect|augment_nsubj:pass_obl) = 4/4 = 1.0
P(null|result_nsubj_parataxis) = 2/2 = 1.0
P(null|result_obl_parataxis) = 3/3 = 1.0
P(advise|initiate_nsubj:pass_obl) = 2/3 = 0.6666666666666666
P(null|initiate_nsubj:pass_obl) = 1/3 = 0.3333333333333333
P(advise|monitor_advcl_conj) = 1/6 = 0.16666666666666666
P(null|monitor_advcl_conj) = 5/6 = 0.8333333333333334
P(int|interact_nsubj_parataxis) = 8/29 = 0.27586206896551724
P(null|interact_nsubj_parataxis) = 21/29 = 0.7241379310344828
P(effect|interact_nsubj_conj) = 2/10 = 0.2
P(int|interact_nsubj_conj) = 2/10 = 0.2
P(null|interact_nsubj_conj) = 6/10 = 0.6
P(null|interact_obl_parataxis) = 25/25 = 1.0
P(null|interact_obl_conj) = 30/30 = 1.0
P(null|interact_parataxis_conj) = 15/15 = 1.0
P(null|interact_conj_conj) = 18/18 = 1.0
P(mechanism|prolong_nsubj_obj) = 2/13 = 0.15384615384615385
P(effect|prolong_nsubj_obj) = 6/13 = 0.46153846153846156
P(null|prolong_nsubj_obj) = 5/13 = 0.38461538461538464
P(null|have_obj_obj) = 11/11 = 1.0
P(effect|experience_nsubj_obl) = 2/2 = 1.0
P(effect|discontinue_obj_conj) = 3/5 = 0.6
P(advise|discontinue_obj_conj) = 1/5 = 0.2
P(null|discontinue_obj_conj) = 1/5 = 0.2
P(advise|provide_advcl_obl) = 1/1 = 1.0
P(mechanism|reduce_nsubj:pass_obl) = 3/26 = 0.11538461538461539
P(effect|reduce_nsubj:pass_obl) = 9/26 = 0.34615384615384615
P(advise|reduce_nsubj:pass_obl) = 2/26 = 0.07692307692307693
P(null|reduce_nsubj:pass_obl) = 12/26 = 0.46153846153846156
P(mechanism|report_nsubj:pass_obl) = 2/38 = 0.05263157894736842
P(effect|report_nsubj:pass_obl) = 3/38 = 0.07894736842105263
P(int|report_nsubj:pass_obl) = 1/38 = 0.02631578947368421
P(advise|report_nsubj:pass_obl) = 1/38 = 0.02631578947368421
P(null|report_nsubj:pass_obl) = 31/38 = 0.8157894736842105
P(null|show_obj_advcl) = 4/4 = 1.0
P(null|coadminister_obl_conj) = 3/3 = 1.0
P(null|warrant_nsubj_advcl) = 2/2 = 1.0
P(advise|useda_nsubj_obj) = 1/1 = 1.0
P(advise|isrecommend_nsubj_obl) = 2/2 = 1.0
P(null|decrease_nsubj:pass_parataxis) = 4/4 = 1.0
P(null|decrease_parataxis_parataxis) = 5/5 = 1.0
P(advise|maintain_nsubj_obj) = 1/1 = 1.0
P(null|abase_obl_conj) = 2/2 = 1.0
P(mechanism|enhance_nsubj_obj) = 7/77 = 0.09090909090909091
P(effect|enhance_nsubj_obj) = 67/77 = 0.8701298701298701
P(null|enhance_nsubj_obj) = 3/77 = 0.03896103896103896
P(mechanism|show_obj_dep) = 2/5 = 0.4
P(null|show_obj_dep) = 3/5 = 0.6
P(advise|start_nsubj:pass_obl) = 1/1 = 1.0
P(effect|occur_nsubj_advcl) = 8/11 = 0.7272727272727273
P(null|occur_nsubj_advcl) = 3/11 = 0.2727272727272727
P(effect|administer_nsubj:pass_dep) = 9/16 = 0.5625
P(advise|administer_nsubj:pass_dep) = 2/16 = 0.125
P(null|administer_nsubj:pass_dep) = 5/16 = 0.3125
P(mechanism|receive_obj_obl) = 2/22 = 0.09090909090909091
P(effect|receive_obj_obl) = 11/22 = 0.5
P(advise|receive_obj_obl) = 2/22 = 0.09090909090909091
P(null|receive_obj_obl) = 7/22 = 0.3181818181818182
P(mechanism|reduce_obl_nsubj:pass) = 1/4 = 0.25
P(advise|reduce_obl_nsubj:pass) = 1/4 = 0.25
P(null|reduce_obl_nsubj:pass) = 2/4 = 0.5
P(mechanism|lead_nsubj_obl) = 1/14 = 0.07142857142857142
P(null|lead_nsubj_obl) = 13/14 = 0.9285714285714286
P(effect|have_advcl_obj) = 3/6 = 0.5
P(null|have_advcl_obj) = 3/6 = 0.5
P(null|contraindicate_advcl_nsubj:pass) = 4/4 = 1.0
P(mechanism|inhibit_nsubj_xcomp) = 1/1 = 1.0
P(null|monitor_obj_advcl) = 6/6 = 1.0
P(mechanism|alter_nsubj_obj) = 3/14 = 0.21428571428571427
P(effect|alter_nsubj_obj) = 3/14 = 0.21428571428571427
P(null|alter_nsubj_obj) = 8/14 = 0.5714285714285714
P(effect|monitor_nsubj:pass_advcl) = 2/15 = 0.13333333333333333
P(advise|monitor_nsubj:pass_advcl) = 3/15 = 0.2
P(null|monitor_nsubj:pass_advcl) = 10/15 = 0.6666666666666666
P(mechanism|reduce_nsubj:pass_advcl) = 1/12 = 0.08333333333333333
P(advise|reduce_nsubj:pass_advcl) = 2/12 = 0.16666666666666666
P(null|reduce_nsubj:pass_advcl) = 9/12 = 0.75
P(effect|show_nsubj_ccomp) = 2/10 = 0.2
P(null|show_nsubj_ccomp) = 8/10 = 0.8
P(null|induce_nsubj_obl) = 2/2 = 1.0
P(null|give_obj_dep) = 2/2 = 1.0
P(null|administer_nsubj_dep) = 2/2 = 1.0
P(mechanism|produce_nsubj_obj) = 10/34 = 0.29411764705882354
P(null|produce_nsubj_obj) = 24/34 = 0.7058823529411765
P(null|monitor_advcl_advcl) = 6/6 = 1.0
P(mechanism|take_nsubj:pass_obl) = 3/26 = 0.11538461538461539
P(effect|take_nsubj:pass_obl) = 1/26 = 0.038461538461538464
P(advise|take_nsubj:pass_obl) = 17/26 = 0.6538461538461539
P(null|take_nsubj:pass_obl) = 5/26 = 0.19230769230769232
P(effect|report_nsubj:pass_conj) = 2/4 = 0.5
P(null|report_nsubj:pass_conj) = 2/4 = 0.5
P(mechanism|potentiate_nsubj_obj) = 3/45 = 0.06666666666666667
P(effect|potentiate_nsubj_obj) = 36/45 = 0.8
P(null|potentiate_nsubj_obj) = 6/45 = 0.13333333333333333
P(effect|provoke_nsubj_dep) = 1/1 = 1.0
P(effect|report_obl_advcl) = 1/1 = 1.0
P(mechanism|administer_nsubj_obl) = 1/7 = 0.14285714285714285
P(advise|administer_nsubj_obl) = 1/7 = 0.14285714285714285
P(null|administer_nsubj_obl) = 5/7 = 0.7142857142857143
P(null|increase_obj_conj) = 8/8 = 1.0
P(mechanism|impair_nsubj_obj) = 3/3 = 1.0
P(effect|implicate_nsubj:pass_obl) = 1/1 = 1.0
P(effect|expect_ccomp_dep) = 1/1 = 1.0
P(null|test_conj_conj) = 1/1 = 1.0
P(effect|attenuate_nsubj_dep) = 3/5 = 0.6
P(null|attenuate_nsubj_dep) = 2/5 = 0.4
P(advise|suggest_nsubj_ccomp) = 1/15 = 0.06666666666666667
P(null|suggest_nsubj_ccomp) = 14/15 = 0.9333333333333333
P(null|change_obl_nsubj:pass) = 1/1 = 1.0
P(mechanism|stabilize_obl_obl) = 1/2 = 0.5
P(null|stabilize_obl_obl) = 1/2 = 0.5
P(mechanism|increase_obl_nsubj:pass) = 4/6 = 0.6666666666666666
P(null|increase_obl_nsubj:pass) = 2/6 = 0.3333333333333333
P(mechanism|indicate_nsubj_obj) = 3/3 = 1.0
P(mechanism|increase_obl_nsubj) = 1/4 = 0.25
P(effect|increase_obl_nsubj) = 1/4 = 0.25
P(null|increase_obl_nsubj) = 2/4 = 0.5
P(mechanism|add_nsubj:pass_obl) = 1/9 = 0.1111111111111111
P(effect|add_nsubj:pass_obl) = 4/9 = 0.4444444444444444
P(advise|add_nsubj:pass_obl) = 1/9 = 0.1111111111111111
P(null|add_nsubj:pass_obl) = 3/9 = 0.3333333333333333
P(mechanism|increase_advcl_nsubj) = 1/10 = 0.1
P(null|increase_advcl_nsubj) = 9/10 = 0.9
P(null|increase_advcl_advcl) = 2/2 = 1.0
P(null|increase_obj_obl) = 5/5 = 1.0
P(null|conduct_csubj:pass_ccomp) = 8/8 = 1.0
P(null|increase_csubj_obj) = 1/1 = 1.0
P(mechanism|inhibit_nsubj_dep) = 3/6 = 0.5
P(null|inhibit_nsubj_dep) = 3/6 = 0.5
P(mechanism|induce_nsubj_obj) = 7/11 = 0.6363636363636364
P(null|induce_nsubj_obj) = 4/11 = 0.36363636363636365
P(null|induce_obj_dep) = 2/2 = 1.0
P(null|use_nsubj:pass_dep) = 1/1 = 1.0
P(null|use_obl_dep) = 11/11 = 1.0
P(mechanism|antagonize_nsubj_obj) = 1/23 = 0.043478260869565216
P(effect|antagonize_nsubj_obj) = 14/23 = 0.6086956521739131
P(null|antagonize_nsubj_obj) = 8/23 = 0.34782608695652173
P(null|investigate_obj_dep) = 8/8 = 1.0
P(effect|combine_nsubj:pass_obl) = 9/10 = 0.9
P(advise|combine_nsubj:pass_obl) = 1/10 = 0.1
P(mechanism|affect_nsubj_obj) = 1/72 = 0.013888888888888888
P(effect|affect_nsubj_obj) = 7/72 = 0.09722222222222222
P(null|affect_nsubj_obj) = 64/72 = 0.8888888888888888
P(effect|diminish_obj_dep) = 1/1 = 1.0
P(effect|diminish_obj_advcl) = 23/23 = 1.0
P(effect|increase_obj_dep) = 1/8 = 0.125
P(null|increase_obj_dep) = 7/8 = 0.875
P(effect|increase_obj_parataxis) = 53/53 = 1.0
P(null|occur_advcl_nsubj) = 2/2 = 1.0
P(null|occur_advcl_advcl) = 4/4 = 1.0
P(null|result_nsubj_conj) = 49/49 = 1.0
P(null|increase_dep_nsubj:pass) = 1/1 = 1.0
P(null|inhibit_dep_nsubj) = 2/2 = 1.0
P(null|interfere_dep_nsubj) = 2/2 = 1.0
P(mechanism|interfere_dep_obl) = 1/3 = 0.3333333333333333
P(null|interfere_dep_obl) = 2/3 = 0.6666666666666666
P(null|conjugate_nsubj_obl) = 16/16 = 1.0
P(null|link_nsubj:pass_obl) = 1/1 = 1.0
P(null|improve_nsubj_iobj) = 3/3 = 1.0
P(null|decrease_obj_dep) = 3/3 = 1.0
P(null|improve_nsubj_obj) = 6/6 = 1.0
P(effect|counteract_nsubj_obj) = 7/7 = 1.0
P(null|enter_nsubj_obl) = 1/1 = 1.0
P(effect|block_nsubj_dep) = 3/4 = 0.75
P(null|block_nsubj_dep) = 1/4 = 0.25
P(null|block_nsubj_conj) = 1/1 = 1.0
P(null|block_dep_conj) = 1/1 = 1.0
P(mechanism|delay_nsubj_obj) = 7/11 = 0.6363636363636364
P(null|delay_nsubj_obj) = 4/11 = 0.36363636363636365
P(effect|potentiate_obl_nsubj:pass) = 1/1 = 1.0
P(effect|result_nsubj_advcl) = 2/8 = 0.25
P(null|result_nsubj_advcl) = 6/8 = 0.75
P(advise|extend_nsubj_obj) = 1/3 = 0.3333333333333333
P(null|extend_nsubj_obj) = 2/3 = 0.6666666666666666
P(null|reveal_nsubj_obj) = 1/1 = 1.0
P(advise|contraindicate_nsubj:pass_obl) = 1/2 = 0.5
P(null|contraindicate_nsubj:pass_obl) = 1/2 = 0.5
P(null|allow_advcl_xcomp) = 2/2 = 1.0
P(null|control_obj_obl) = 6/6 = 1.0
P(advise|prescribe_obl_obl) = 3/3 = 1.0
P(null|replace_obj_obl) = 1/1 = 1.0
P(null|metabolize_nsubj_parataxis) = 3/3 = 1.0
P(advise|monitor_obj_obl) = 1/1 = 1.0
P(null|average_obl_nsubj) = 2/2 = 1.0
P(null|report_advcl_obl) = 3/3 = 1.0
P(null|report_advcl_parataxis) = 2/2 = 1.0
P(null|report_nsubj:pass_parataxis) = 3/3 = 1.0
P(null|report_obl_parataxis) = 4/4 = 1.0
P(null|administer_nsubj:pass_conj) = 7/7 = 1.0
P(null|administer_nsubj:pass_parataxis) = 4/4 = 1.0
P(null|administer_obl_conj) = 5/5 = 1.0
P(null|administer_obl_parataxis) = 6/6 = 1.0
P(null|administer_conj_parataxis) = 6/6 = 1.0
P(mechanism|double_nsubj_ccomp) = 1/3 = 0.3333333333333333
P(null|double_nsubj_ccomp) = 2/3 = 0.6666666666666666
P(null|demonstrate_ccomp_dep) = 48/48 = 1.0
P(null|know_nsubj:pass_advcl) = 2/2 = 1.0
P(null|metabolize_nsubj:pass_obl) = 5/5 = 1.0
P(advise|require_nsubj:pass_conj) = 1/2 = 0.5
P(null|require_nsubj:pass_conj) = 1/2 = 0.5
P(mechanism|displace_nsubj_obj) = 3/3 = 1.0
P(null|displace_nsubj_dep) = 1/1 = 1.0
P(null|displace_obj_dep) = 1/1 = 1.0
P(null|mix_obj_obl) = 1/1 = 1.0
P(null|mix_obj_advcl) = 1/1 = 1.0
P(null|mix_obj_conj) = 1/1 = 1.0
P(null|mix_obl_advcl) = 1/1 = 1.0
P(null|mix_obl_conj) = 1/1 = 1.0
P(null|mix_advcl_conj) = 1/1 = 1.0
P(null|mix_nsubj:pass_obl) = 3/3 = 1.0
P(null|draw_advcl_nsubj:pass) = 2/2 = 1.0
P(null|mix_advcl_nsubj:pass) = 3/3 = 1.0
P(null|mix_advcl_obl) = 1/1 = 1.0
P(null|identify_nsubj:pass_ccomp) = 2/2 = 1.0
P(effect|experience_nsubj_advcl) = 1/2 = 0.5
P(null|experience_nsubj_advcl) = 1/2 = 0.5
P(effect|minimize_nsubj:pass_obl) = 1/7 = 0.14285714285714285
P(null|minimize_nsubj:pass_obl) = 6/7 = 0.8571428571428571
P(null|discontinue_obj_dep) = 1/1 = 1.0
P(null|discontinue_conj_dep) = 1/1 = 1.0
P(effect|increase_advcl_obj) = 1/2 = 0.5
P(null|increase_advcl_obj) = 1/2 = 0.5
P(mechanism|study_nsubj:pass_obl) = 1/5 = 0.2
P(null|study_nsubj:pass_obl) = 4/5 = 0.8
P(null|use_advcl_advmod) = 4/4 = 1.0
P(advise|take_obj_advmod) = 1/1 = 1.0
P(null|interrupt_obl_nsubj) = 2/2 = 1.0
P(null|interrupt_obl_obl:npmod) = 2/2 = 1.0
P(advise|interrupt_nsubj_obl:npmod) = 1/1 = 1.0
P(null|decrease_obj_obj) = 12/12 = 1.0
P(mechanism|bind_nsubj_obj) = 4/5 = 0.8
P(null|bind_nsubj_obj) = 1/5 = 0.2
P(null|intensify_nsubj_nsubj) = 1/1 = 1.0
P(effect|reduce_nsubj_conj) = 1/2 = 0.5
P(null|reduce_nsubj_conj) = 1/2 = 0.5
P(null|reduce_obj_conj) = 7/7 = 1.0
P(advise|refer_obl_obl) = 1/3 = 0.3333333333333333
P(null|refer_obl_obl) = 2/3 = 0.6666666666666666
P(null|interfere_obl_nsubj) = 2/2 = 1.0
P(advise|reduce_nsubj:pass_conj) = 1/6 = 0.16666666666666666
P(null|reduce_nsubj:pass_conj) = 5/6 = 0.8333333333333334
P(null|reduce_obl_conj) = 3/3 = 1.0
P(null|observe_nsubj:pass_conj) = 6/6 = 1.0
P(effect|reverse_nsubj:pass_obl) = 1/4 = 0.25
P(null|reverse_nsubj:pass_obl) = 3/4 = 0.75
P(null|administer_obj_obl) = 1/1 = 1.0
P(null|administer_obj_obl:npmod) = 1/1 = 1.0
P(effect|occur_obl_obl) = 1/2 = 0.5
P(null|occur_obl_obl) = 1/2 = 0.5
P(mechanism|displace_nsubj:pass_obl) = 1/2 = 0.5
P(advise|displace_nsubj:pass_obl) = 1/2 = 0.5
P(null|reduce_obj_dep) = 3/3 = 1.0
P(null|assess_nsubj:pass_advmod) = 18/18 = 1.0
P(null|be_nsubj_obl) = 8/8 = 1.0
P(null|give_advcl_advcl) = 2/2 = 1.0
P(null|document_obj_obl) = 1/1 = 1.0
P(null|coadminister_nsubj:pass_advcl) = 2/2 = 1.0
P(mechanism|occur_nsubj_punct) = 1/1 = 1.0
P(null|prepare_nsubj:pass_obl) = 1/1 = 1.0
P(effect|reduce_nsubj_dep) = 1/1 = 1.0
P(mechanism|blunt_nsubj_dep) = 1/1 = 1.0
P(effect|blunt_nsubj_conj) = 1/1 = 1.0
P(null|blunt_dep_conj) = 1/1 = 1.0
P(null|show_obj_xcomp) = 1/1 = 1.0
P(effect|inhibit_nsubj_conj) = 4/7 = 0.5714285714285714
P(null|inhibit_nsubj_conj) = 3/7 = 0.42857142857142855
P(effect|modify_advcl_obj) = 4/6 = 0.6666666666666666
P(null|modify_advcl_obj) = 2/6 = 0.3333333333333333
P(effect|stimulate_nsubj_conj) = 1/1 = 1.0
P(effect|regulate_nsubj_obl) = 8/8 = 1.0
P(effect|diminish_nsubj_obl) = 1/1 = 1.0
P(advise|withdraw_nsubj:pass_obl) = 1/1 = 1.0
P(effect|require_advcl_nsubj:pass) = 1/2 = 0.5
P(advise|require_advcl_nsubj:pass) = 1/2 = 0.5
P(null|enhance_nsubj_dep) = 1/1 = 1.0
P(null|enhance_obj_dep) = 1/1 = 1.0
P(null|enhance_nsubj_conj) = 4/4 = 1.0
P(null|enhance_obj_conj) = 1/1 = 1.0
P(mechanism|have_nsubj_ccomp) = 3/11 = 0.2727272727272727
P(int|have_nsubj_ccomp) = 1/11 = 0.09090909090909091
P(null|have_nsubj_ccomp) = 7/11 = 0.6363636363636364
P(effect|exhibit_nsubj_obj) = 2/2 = 1.0
P(effect|potentiate_nsubj_ccomp) = 1/1 = 1.0
P(advise|defer_nsubj:pass_advcl) = 1/1 = 1.0
P(effect|use_obj_obl) = 1/7 = 0.14285714285714285
P(null|use_obj_obl) = 6/7 = 0.8571428571428571
P(mechanism|decrease_nsubj_conj) = 2/12 = 0.16666666666666666
P(effect|decrease_nsubj_conj) = 3/12 = 0.25
P(null|decrease_nsubj_conj) = 7/12 = 0.5833333333333334
P(effect|reduce_obl_nsubj) = 5/6 = 0.8333333333333334
P(null|reduce_obl_nsubj) = 1/6 = 0.16666666666666666
P(null|reduce_obl_advcl) = 7/7 = 1.0
P(null|reduce_nsubj_advcl) = 2/2 = 1.0
P(null|fail_nsubj_xcomp) = 4/4 = 1.0
P(effect|increase_advcl_nsubj:pass) = 1/1 = 1.0
P(effect|prevent_nsubj:pass_obl) = 2/2 = 1.0
P(effect|provide_nsubj_dep) = 2/2 = 1.0
P(mechanism|modify_nsubj_obj) = 1/2 = 0.5
P(null|modify_nsubj_obj) = 1/2 = 0.5
P(effect|attenuate_nsubj_obj) = 2/2 = 1.0
P(null|use_obl_iobj) = 2/2 = 1.0
P(null|treat_obl_advcl) = 1/1 = 1.0
P(advise|treat_obl_obl) = 1/10 = 0.1
P(null|treat_obl_obl) = 9/10 = 0.9
P(null|associate_nsubj:pass_parataxis) = 9/9 = 1.0
P(mechanism|interfere_nsubj_conj) = 4/7 = 0.5714285714285714
P(int|interfere_nsubj_conj) = 1/7 = 0.14285714285714285
P(null|interfere_nsubj_conj) = 2/7 = 0.2857142857142857
P(null|neutralize_nsubj_dep) = 1/1 = 1.0
P(null|neutralize_nsubj_obl) = 1/1 = 1.0
P(mechanism|delay_nsubj_conj) = 7/14 = 0.5
P(null|delay_nsubj_conj) = 7/14 = 0.5
P(null|delay_obj_conj) = 28/28 = 1.0
P(null|interfere_nsubj_parataxis) = 10/10 = 1.0
P(mechanism|pose_nsubj_advcl) = 1/6 = 0.16666666666666666
P(null|pose_nsubj_advcl) = 5/6 = 0.8333333333333334
P(null|filtrate_nsubj:pass_advcl) = 2/2 = 1.0
P(null|interfere_advcl_nsubj) = 2/2 = 1.0
P(null|interfere_advcl_conj) = 1/1 = 1.0
P(advise|consider_advcl_nsubj:pass) = 6/11 = 0.5454545454545454
P(null|consider_advcl_nsubj:pass) = 5/11 = 0.45454545454545453
P(null|recommend_advcl_ccomp) = 14/14 = 1.0
P(null|alter_nsubj_dep) = 4/4 = 1.0
P(null|investigate_obj_xcomp) = 1/1 = 1.0
P(null|find_obj_obl) = 2/2 = 1.0
P(mechanism|become_nsubj_obl) = 1/1 = 1.0
P(null|decrease_nsubj_parataxis) = 2/2 = 1.0
P(null|decrease_dep_parataxis) = 2/2 = 1.0
P(effect|accentuate_nsubj_obj) = 1/1 = 1.0
P(effect|administer_nsubj_parataxis) = 4/4 = 1.0
P(null|prolong_obj_conj) = 5/5 = 1.0
P(mechanism|include_nsubj_obj) = 5/80 = 0.0625
P(effect|include_nsubj_obj) = 42/80 = 0.525
P(int|include_nsubj_obj) = 28/80 = 0.35
P(null|include_nsubj_obj) = 5/80 = 0.0625
P(effect|demonstrate_nsubj:pass_obl) = 4/4 = 1.0
P(null|expect_advcl_xcomp) = 1/1 = 1.0
P(mechanism|decrease_nsubj:pass_nmod) = 1/1 = 1.0
P(null|titrate_advcl_nsubj:pass) = 1/1 = 1.0
P(null|lower_advcl_obj) = 4/4 = 1.0
P(null|treat_obl_dep) = 10/10 = 1.0
P(null|observe_obl_parataxis) = 12/12 = 1.0
P(mechanism|return_nsubj_obl) = 1/2 = 0.5
P(null|return_nsubj_obl) = 1/2 = 0.5
P(null|observe_parataxis_parataxis) = 12/12 = 1.0
P(null|return_obl_obl) = 1/1 = 1.0
P(null|monitor_advcl_nsubj:pass) = 4/4 = 1.0
P(mechanism|potentiate_nsubj:pass_obl) = 1/35 = 0.02857142857142857
P(effect|potentiate_nsubj:pass_obl) = 33/35 = 0.9428571428571428
P(advise|potentiate_nsubj:pass_obl) = 1/35 = 0.02857142857142857
P(null|observe_obl_nsubj:pass) = 4/4 = 1.0
P(null|find_obl_obl) = 4/4 = 1.0
P(advise|initiate_advcl_obl) = 1/1 = 1.0
P(mechanism|result_obl_nsubj) = 1/3 = 0.3333333333333333
P(effect|result_obl_nsubj) = 1/3 = 0.3333333333333333
P(null|result_obl_nsubj) = 1/3 = 0.3333333333333333
P(effect|diminish_nsubj_obj) = 6/6 = 1.0
P(null|compare_nsubj:pass_obl) = 8/8 = 1.0
P(null|associate_advcl_nsubj:pass) = 3/3 = 1.0
P(mechanism|appear_nsubj_xcomp) = 3/18 = 0.16666666666666666
P(effect|appear_nsubj_xcomp) = 3/18 = 0.16666666666666666
P(null|appear_nsubj_xcomp) = 12/18 = 0.6666666666666666
P(null|warrant_advcl_nsubj:pass) = 3/3 = 1.0
P(mechanism|show_obl_dep) = 1/1 = 1.0
P(advise|monitor_nsubj:pass_dep) = 4/5 = 0.8
P(null|monitor_nsubj:pass_dep) = 1/5 = 0.2
P(mechanism|result_csubj_obl) = 1/5 = 0.2
P(effect|result_csubj_obl) = 2/5 = 0.4
P(null|result_csubj_obl) = 2/5 = 0.4
P(mechanism|lower_nsubj_obj) = 1/7 = 0.14285714285714285
P(null|lower_nsubj_obj) = 6/7 = 0.8571428571428571
P(null|interact_nsubj_dep) = 2/2 = 1.0
P(null|contraindicate_nsubj:pass_conj) = 2/2 = 1.0
P(mechanism|expect_nsubj:pass_xcomp) = 6/7 = 0.8571428571428571
P(null|expect_nsubj:pass_xcomp) = 1/7 = 0.14285714285714285
P(mechanism|b._nsubj_obl) = 1/1 = 1.0
P(null|b._nsubj_dep) = 1/1 = 1.0
P(null|b._obl_dep) = 1/1 = 1.0
P(advise|have_csubj_ccomp) = 1/2 = 0.5
P(null|have_csubj_ccomp) = 1/2 = 0.5
P(null|initiate_nsubj:pass_xcomp) = 1/1 = 1.0
P(null|involve_obj_advcl) = 1/1 = 1.0
P(null|occur_obl_conj) = 1/1 = 1.0
P(null|increase_nsubj:pass_advcl) = 8/8 = 1.0
P(effect|contain_obj_advcl) = 2/5 = 0.4
P(advise|contain_obj_advcl) = 3/5 = 0.6
P(mechanism|administer_nsubj:pass_advcl) = 2/15 = 0.13333333333333333
P(advise|administer_nsubj:pass_advcl) = 2/15 = 0.13333333333333333
P(null|administer_nsubj:pass_advcl) = 11/15 = 0.7333333333333333
P(mechanism|observe_nsubj:pass_advcl) = 1/7 = 0.14285714285714285
P(null|observe_nsubj:pass_advcl) = 6/7 = 0.8571428571428571
P(null|administer_obl_advcl) = 13/13 = 1.0
P(mechanism|decrease_nsubj:pass_advcl) = 6/10 = 0.6
P(null|decrease_nsubj:pass_advcl) = 4/10 = 0.4
P(null|determine_nsubj:pass_advcl) = 1/1 = 1.0
P(mechanism|occur_nsubj_obl) = 2/2 = 1.0
P(advise|avoid_obj_dep) = 2/2 = 1.0
P(mechanism|elevate_nsubj_obj) = 2/3 = 0.6666666666666666
P(null|elevate_nsubj_obj) = 1/3 = 0.3333333333333333
P(null|elevate_nsubj_dep) = 1/1 = 1.0
P(mechanism|elevate_obj_dep) = 1/2 = 0.5
P(null|elevate_obj_dep) = 1/2 = 0.5
P(null|elevate_obl_conj) = 3/3 = 1.0
P(effect|blunt_nsubj:pass_obl) = 2/2 = 1.0
P(null|combine_nsubj_obl) = 2/2 = 1.0
P(null|evaluate_obj_advcl) = 2/2 = 1.0
P(null|bind_nsubj_dep) = 1/1 = 1.0
P(null|bind_obj_dep) = 2/2 = 1.0
P(mechanism|decrease_obl_advcl) = 1/2 = 0.5
P(null|decrease_obl_advcl) = 1/2 = 0.5
P(null|start_nsubj:pass_dep) = 1/1 = 1.0
P(effect|cause_advcl_nsubj) = 1/4 = 0.25
P(null|cause_advcl_nsubj) = 3/4 = 0.75
P(null|appear_csubj_advcl) = 2/2 = 1.0
P(null|decrease_nsubj_advcl) = 8/8 = 1.0
P(null|tolerate_nsubj:pass_advcl) = 1/1 = 1.0
P(mechanism|receive_obl:tmod_ccomp) = 1/2 = 0.5
P(null|receive_obl:tmod_ccomp) = 1/2 = 0.5
P(null|affect_nsubj_nsubj) = 4/4 = 1.0
P(advise|exercise_advcl_advcl) = 1/14 = 0.07142857142857142
P(null|exercise_advcl_advcl) = 13/14 = 0.9285714285714286
P(effect|associate_dep_nsubj:pass) = 1/1 = 1.0
P(null|associate_dep_advcl) = 1/1 = 1.0
P(null|associate_nsubj:pass_advcl) = 1/1 = 1.0
P(null|consider_advcl_obl) = 1/1 = 1.0
P(null|consider_obl_nsubj:pass) = 3/3 = 1.0
P(null|decrease_advcl_obj) = 4/4 = 1.0
P(null|be_nsubj_dep) = 7/7 = 1.0
P(null|coadminister_obl_dep) = 4/4 = 1.0
P(null|investigate_nsubj:pass_obl) = 6/6 = 1.0
P(advise|exceed_obj_obl) = 3/3 = 1.0
P(advise|exceed_nsubj:pass_advcl) = 2/2 = 1.0
P(null|have_obl_nsubj) = 3/3 = 1.0
P(mechanism|take_nsubj_obl) = 1/1 = 1.0
P(null|take_nsubj_conj) = 1/1 = 1.0
P(null|take_obl_conj) = 1/1 = 1.0
P(null|evaluate_nsubj:pass_conj) = 5/5 = 1.0
P(effect|give_nsubj:pass_dep) = 1/3 = 0.3333333333333333
P(null|give_nsubj:pass_dep) = 2/3 = 0.6666666666666666
P(effect|experience_obl_nsubj) = 1/1 = 1.0
P(effect|separate_nsubj:pass_obl) = 1/1 = 1.0
P(null|experience_advcl_nsubj) = 2/2 = 1.0
P(null|dose_obl_obl) = 2/2 = 1.0
P(effect|produce_nsubj_advcl) = 12/12 = 1.0
P(null|administer_obl_dep) = 13/13 = 1.0
P(null|have_obl_conj) = 4/4 = 1.0
P(null|treat_csubj:pass_obl) = 2/2 = 1.0
P(null|conduct_obl_parataxis) = 2/2 = 1.0
P(null|enhance_nsubj_parataxis) = 3/3 = 1.0
P(null|enhance_obj_parataxis) = 3/3 = 1.0
P(null|interfere_nsubj_advcl) = 1/1 = 1.0
P(null|interfere_obl_advcl) = 1/1 = 1.0
P(effect|depress_nsubj_obj) = 1/1 = 1.0
P(mechanism|alter_nsubj_ccomp) = 6/6 = 1.0
P(advise|require_nsubj_obj) = 2/8 = 0.25
P(null|require_nsubj_obj) = 6/8 = 0.75
P(mechanism|increase_obj_advcl) = 1/9 = 0.1111111111111111
P(effect|increase_obj_advcl) = 4/9 = 0.4444444444444444
P(null|increase_obj_advcl) = 4/9 = 0.4444444444444444
P(null|inhibit_obl_conj) = 2/2 = 1.0
P(null|inhibit_nsubj:pass_conj) = 1/1 = 1.0
P(null|cause_obl_advcl) = 2/2 = 1.0
P(advise|alert_obl_obl) = 1/1 = 1.0
P(null|coadminister_nsubj:pass_dep) = 4/4 = 1.0
P(null|follow_obl_dep) = 3/3 = 1.0
P(null|be_advcl_nsubj) = 4/4 = 1.0
P(advise|cause_nsubj_conj) = 5/5 = 1.0
P(null|cause_obj_conj) = 1/1 = 1.0
P(effect|potentiate_nsubj:pass_obj) = 10/10 = 1.0
P(null|potentiate_obl_obj) = 8/8 = 1.0
P(null|bind_conj_conj) = 42/42 = 1.0
P(null|bind_nsubj_advmod) = 1/1 = 1.0
P(null|bind_nsubj_conj) = 2/2 = 1.0
P(null|bind_advmod_conj) = 2/2 = 1.0
P(null|receive_obj_conj) = 7/7 = 1.0
P(null|observe_obl_ccomp) = 4/4 = 1.0
P(null|find_nsubj:pass_obl) = 1/1 = 1.0
P(null|treat_advcl_obl) = 2/2 = 1.0
P(null|treat_dep_obl) = 1/1 = 1.0
P(null|display_obj_dep) = 2/2 = 1.0
P(advise|avoid_advcl_nsubj:pass) = 4/4 = 1.0
P(null|reduce_advcl_nsubj:pass) = 8/8 = 1.0
P(null|induce_obj_parataxis) = 1/1 = 1.0
P(advise|consider_nsubj:pass_obl) = 1/8 = 0.125
P(null|consider_nsubj:pass_obl) = 7/8 = 0.875
P(null|inhibit_obj_parataxis) = 2/2 = 1.0
P(null|alter_obj_parataxis) = 1/1 = 1.0
P(null|metabolize_nsubj:pass_dep) = 1/1 = 1.0
P(null|metabolize_advcl_nsubj:pass) = 1/1 = 1.0
P(effect|use_nsubj_obl) = 5/6 = 0.8333333333333334
P(null|use_nsubj_obl) = 1/6 = 0.16666666666666666
P(null|include_obj_obl) = 3/3 = 1.0
P(null|monitor_advcl_obl) = 3/3 = 1.0
P(effect|potentiate_nsubj:pass_conj) = 1/1 = 1.0
P(effect|potentiate_nsubj:pass_dep) = 9/9 = 1.0
P(null|potentiate_obl_conj) = 5/5 = 1.0
P(null|potentiate_obl_dep) = 17/17 = 1.0
P(null|potentiate_conj_dep) = 2/2 = 1.0
P(mechanism|report_obl_conj) = 1/2 = 0.5
P(null|report_obl_conj) = 1/2 = 0.5
P(mechanism|list_obl_obl) = 21/21 = 1.0
P(effect|need_nsubj_nsubj) = 1/1 = 1.0
P(null|measure_obj_obl) = 1/1 = 1.0
P(advise|stop_nsubj:pass_obl) = 1/1 = 1.0
P(advise|take_advcl_obj) = 1/2 = 0.5
P(null|take_advcl_obj) = 1/2 = 0.5
P(null|take_advcl_conj) = 1/1 = 1.0
P(effect|take_obj_conj) = 3/7 = 0.42857142857142855
P(advise|take_obj_conj) = 1/7 = 0.14285714285714285
P(null|take_obj_conj) = 3/7 = 0.42857142857142855
P(effect|allow_obj_xcomp) = 1/1 = 1.0
P(mechanism|administer_advcl_obl) = 4/5 = 0.8
P(advise|administer_advcl_obl) = 1/5 = 0.2
P(null|couple_nsubj:pass_obl) = 1/1 = 1.0
P(null|sterilize_nsubj_conj) = 1/1 = 1.0
P(advise|require_nsubj:pass_advcl) = 3/3 = 1.0
P(effect|counteract_nsubj:pass_obl) = 1/1 = 1.0
P(null|limit_obj_obl) = 1/1 = 1.0
P(advise|avoid_nsubj:pass_obl) = 5/5 = 1.0
P(null|measure_nsubj:pass_obl) = 3/3 = 1.0
P(null|alter_obl_nsubj:pass) = 3/3 = 1.0
P(mechanism|enhance_advcl_obl) = 1/1 = 1.0
P(null|enhance_advcl_nsubj:pass) = 1/1 = 1.0
P(null|enhance_obl_nsubj:pass) = 1/1 = 1.0
P(null|report_xcomp_conj) = 1/1 = 1.0
P(advise|use_obl_nsubj:pass) = 1/2 = 0.5
P(null|use_obl_nsubj:pass) = 1/2 = 0.5
P(null|reduce_obj_obj) = 6/6 = 1.0
P(advise|receive_nsubj_obj) = 1/18 = 0.05555555555555555
P(null|receive_nsubj_obj) = 17/18 = 0.9444444444444444
P(mechanism|demonstrate_obj_advcl) = 2/4 = 0.5
P(null|demonstrate_obj_advcl) = 2/4 = 0.5
P(mechanism|increase_nsubj_conj) = 5/11 = 0.45454545454545453
P(effect|increase_nsubj_conj) = 4/11 = 0.36363636363636365
P(null|increase_nsubj_conj) = 2/11 = 0.18181818181818182
P(null|lead_obl_conj) = 2/2 = 1.0
P(effect|be_nsubj_advcl) = 1/6 = 0.16666666666666666
P(null|be_nsubj_advcl) = 5/6 = 0.8333333333333334
P(null|study_advcl_nsubj:pass) = 2/2 = 1.0
P(null|expect_nsubj:pass_obl) = 2/2 = 1.0
P(null|reduce_obj_parataxis) = 9/9 = 1.0
P(null|control_obj_advcl) = 30/30 = 1.0
P(advise|consider_csubj:pass_obl) = 1/1 = 1.0
P(null|induce_nsubj_advmod) = 2/2 = 1.0
P(null|involve_nsubj:pass_obl) = 2/2 = 1.0
P(null|involve_nsubj:pass_conj) = 2/2 = 1.0
P(null|involve_obl_conj) = 4/4 = 1.0
P(effect|associate_obl_advcl) = 1/4 = 0.25
P(null|associate_obl_advcl) = 3/4 = 0.75
P(null|take_obj_obj) = 2/2 = 1.0
P(null|observe_advcl_obl) = 6/6 = 1.0
P(effect|have_nsubj_dep) = 3/6 = 0.5
P(null|have_nsubj_dep) = 3/6 = 0.5
P(null|have_obj_dep) = 9/9 = 1.0
P(mechanism|administer_nsubj_advcl) = 2/6 = 0.3333333333333333
P(null|administer_nsubj_advcl) = 4/6 = 0.6666666666666666
P(mechanism|administer_dep_obl) = 1/1 = 1.0
P(null|administer_dep_dep) = 1/1 = 1.0
P(null|continue_nsubj:pass_advcl) = 2/2 = 1.0
P(mechanism|produce_nsubj_obl) = 1/6 = 0.16666666666666666
P(effect|produce_nsubj_obl) = 1/6 = 0.16666666666666666
P(null|produce_nsubj_obl) = 4/6 = 0.6666666666666666
P(null|produce_obl_obj) = 1/1 = 1.0
P(null|consider_nsubj:pass_advcl) = 3/3 = 1.0
P(null|consider_nsubj:pass_conj) = 2/2 = 1.0
P(advise|require_obj_advmod) = 1/1 = 1.0
P(null|convert_obj_obl) = 1/1 = 1.0
P(null|give_obl_conj) = 8/8 = 1.0
P(null|increase_dep_obj) = 1/1 = 1.0
P(null|reduce_advcl_advcl) = 6/6 = 1.0
P(null|reflect_csubj_obj) = 2/2 = 1.0
P(advise|reduce_nsubj:pass_advmod) = 1/3 = 0.3333333333333333
P(null|reduce_nsubj:pass_advmod) = 2/3 = 0.6666666666666666
P(null|achieve_nsubj_obj) = 2/2 = 1.0
P(null|determine_advcl_parataxis) = 2/2 = 1.0
P(mechanism|accompany_nsubj_dep) = 1/1 = 1.0
P(advise|monitor_obl_obl) = 1/1 = 1.0
P(null|decrease_obj_obl) = 3/3 = 1.0
P(null|decrease_advcl_conj) = 3/3 = 1.0
P(mechanism|increase_nsubj_dep) = 4/9 = 0.4444444444444444
P(null|increase_nsubj_dep) = 5/9 = 0.5555555555555556
P(null|metabolize_nsubj_obl) = 7/7 = 1.0
P(advise|metabolize_nsubj_dep) = 2/2 = 1.0
P(advise|metabolize_obl_dep) = 2/2 = 1.0
P(null|give_obl_nsubj:pass) = 1/1 = 1.0
P(effect|give_obl_dep) = 2/5 = 0.4
P(null|give_obl_dep) = 3/5 = 0.6
P(null|give_nsubj:pass_conj) = 1/1 = 1.0
P(null|give_conj_dep) = 1/1 = 1.0
P(null|decrease_obj_advmod) = 1/1 = 1.0
P(null|result_nsubj_ccomp) = 4/4 = 1.0
P(null|result_obl_ccomp) = 1/1 = 1.0
P(null|administer_conj_conj) = 1/1 = 1.0
P(null|indicate_ccomp_parataxis) = 2/2 = 1.0
P(null|make_advcl_obl) = 4/4 = 1.0
P(null|see_advcl_nsubj:pass) = 4/4 = 1.0
P(advise|require_obj_advcl) = 1/1 = 1.0
P(null|delay_obl_nsubj:pass) = 1/1 = 1.0
P(advise|take_nsubj:pass_advcl) = 2/2 = 1.0
P(null|potentiate_nsubj:pass_ccomp) = 1/1 = 1.0
P(mechanism|potentiate_obl_ccomp) = 1/1 = 1.0
P(null|inhibit_obj_conj) = 1/1 = 1.0
P(effect|exacerbate_nsubj_advcl) = 3/3 = 1.0
P(null|give_nsubj:pass_obj) = 1/1 = 1.0
P(null|deliver_nsubj:pass_obl) = 4/4 = 1.0
P(effect|improve_nsubj:pass_obl) = 2/2 = 1.0
P(null|reduce_nsubj_obl) = 2/2 = 1.0
P(null|display_obl_advcl) = 2/2 = 1.0
P(null|occur_advcl_advmod) = 6/6 = 1.0
P(mechanism|use_nsubj:pass_advcl) = 4/22 = 0.18181818181818182
P(advise|use_nsubj:pass_advcl) = 9/22 = 0.4090909090909091
P(null|use_nsubj:pass_advcl) = 9/22 = 0.4090909090909091
P(null|reduce_obl_obj) = 1/1 = 1.0
P(null|reduce_nsubj:pass_obj) = 1/1 = 1.0
P(null|give_obl_parataxis) = 1/1 = 1.0
P(null|do_advcl_nsubj:pass) = 6/6 = 1.0
P(null|study_nsubj:pass_conj) = 4/4 = 1.0
P(null|alter_obl_obl) = 1/1 = 1.0
P(mechanism|form_nsubj_obl) = 5/6 = 0.8333333333333334
P(null|form_nsubj_obl) = 1/6 = 0.16666666666666666
P(null|precede_obj_conj) = 1/1 = 1.0
P(mechanism|demonstrate_nsubj_xcomp) = 1/1 = 1.0
P(null|demonstrate_nsubj_dep) = 1/1 = 1.0
P(null|demonstrate_xcomp_dep) = 1/1 = 1.0
P(mechanism|demonstrate_nsubj:pass_xcomp) = 1/1 = 1.0
P(null|observe_obl_punct) = 1/1 = 1.0
P(null|test_nsubj:pass_obl) = 1/1 = 1.0
P(null|produce_nsubj_parataxis) = 1/1 = 1.0
P(null|focus_advcl_obl) = 1/1 = 1.0
P(effect|give_obj_conj) = 1/1 = 1.0
P(null|persist_nsubj_conj) = 1/1 = 1.0
P(mechanism|compete_nsubj_obl) = 2/2 = 1.0
P(mechanism|compete_nsubj_conj) = 1/2 = 0.5
P(null|compete_nsubj_conj) = 1/2 = 0.5
P(null|compete_obl_conj) = 1/1 = 1.0
P(null|reduce_obj_obl) = 1/1 = 1.0
P(advise|allow_obl_advcl) = 1/1 = 1.0
P(mechanism|metabolize_nsubj:pass_conj) = 3/8 = 0.375
P(null|metabolize_nsubj:pass_conj) = 5/8 = 0.625
P(null|halve_advcl_nsubj:pass) = 2/2 = 1.0
P(null|derive_nsubj:pass_obl) = 2/2 = 1.0
P(null|derive_nsubj:pass_dep) = 2/2 = 1.0
P(null|derive_obl_dep) = 1/1 = 1.0
P(mechanism|reduce_nsubj:pass_dep) = 1/3 = 0.3333333333333333
P(null|reduce_nsubj:pass_dep) = 2/3 = 0.6666666666666666
P(null|reduce_advcl_obl) = 2/2 = 1.0
P(null|increase_obl_dep) = 3/3 = 1.0
P(effect|use_nsubj:pass_obl:tmod) = 1/1 = 1.0
P(effect|condition_obl_conj) = 1/1 = 1.0
P(null|maintain_nsubj_obl) = 1/1 = 1.0
P(null|maintain_nsubj_parataxis) = 4/4 = 1.0
P(null|maintain_obl_parataxis) = 4/4 = 1.0
P(mechanism|fall_obl_nsubj) = 1/1 = 1.0
P(effect|inhibit_nsubj_iobj) = 2/2 = 1.0
P(effect|antagonize_nsubj_conj) = 1/1 = 1.0
P(null|antagonize_obj_conj) = 1/1 = 1.0
P(null|include_obj_dep) = 5/5 = 1.0
P(null|involve_obl_obj) = 1/1 = 1.0
P(null|need_nsubj_xcomp) = 5/5 = 1.0
P(null|decrease_obl_nsubj) = 3/3 = 1.0
P(null|decrease_obl_conj) = 1/1 = 1.0
P(effect|associate_nsubj:pass_advmod) = 1/1 = 1.0
P(null|associate_advmod_obl) = 1/1 = 1.0
P(null|produce_obj_obl) = 2/2 = 1.0
P(mechanism|give_nsubj_obl) = 2/4 = 0.5
P(effect|give_nsubj_obl) = 2/4 = 0.5
P(null|report_csubj:pass_xcomp) = 2/2 = 1.0
P(null|use_nsubj:pass_parataxis) = 2/2 = 1.0
P(effect|attribute_nsubj:pass_obl) = 1/1 = 1.0
P(effect|prevent_nsubj_obj) = 3/6 = 0.5
P(null|prevent_nsubj_obj) = 3/6 = 0.5
P(null|replace_obl_nsubj:pass) = 1/1 = 1.0
P(null|replace_obl_obl) = 1/1 = 1.0
P(null|replace_nsubj:pass_obl) = 1/1 = 1.0
P(null|underlie_csubj_obj) = 2/2 = 1.0
P(null|inhibit_csubj_obj) = 2/2 = 1.0
P(null|increase_obj_punct) = 1/1 = 1.0
P(null|misuse_nsubj:pass_obl) = 1/1 = 1.0
P(effect|prescribe_nsubj:pass_obl) = 1/3 = 0.3333333333333333
P(advise|prescribe_nsubj:pass_obl) = 2/3 = 0.6666666666666666
P(advise|warn_obl_advmod) = 2/2 = 1.0
P(null|change_obj_advcl) = 1/1 = 1.0
P(null|affect_nsubj_conj) = 2/2 = 1.0
P(null|affect_obj_conj) = 2/2 = 1.0
P(null|affect_obj_obj) = 1/1 = 1.0
P(null|require_obj_obl) = 1/1 = 1.0
P(null|affect_conj_obj) = 2/2 = 1.0
P(null|absorb_nsubj_advcl) = 1/1 = 1.0
P(null|change_nsubj_obl) = 2/2 = 1.0
P(null|suggest_obl_ccomp) = 3/3 = 1.0
P(null|expect_advcl_nsubj:pass) = 4/4 = 1.0
P(advise|expect_advcl_advcl) = 3/4 = 0.75
P(null|expect_advcl_advcl) = 1/4 = 0.25
P(null|expect_nsubj:pass_advcl) = 1/1 = 1.0
P(null|add_nsubj:pass_dep) = 2/2 = 1.0
P(mechanism|know_nsubj:pass_xcomp) = 14/16 = 0.875
P(null|know_nsubj:pass_xcomp) = 2/16 = 0.125
P(advise|discontinue_nsubj:pass_advcl) = 1/2 = 0.5
P(null|discontinue_nsubj:pass_advcl) = 1/2 = 0.5
P(null|coadminister_obl_obl) = 1/1 = 1.0
P(null|demonstrate_obl_nsubj) = 7/7 = 1.0
P(null|enhance_nsubj_obl) = 1/1 = 1.0
P(null|enhance_obj_obl) = 1/1 = 1.0
P(null|dose_obl_dep) = 1/1 = 1.0
P(null|see_nsubj_obl) = 2/2 = 1.0
P(null|inhibit_obj_obl) = 3/3 = 1.0
P(null|decrease_obj_advcl) = 2/2 = 1.0
P(null|cause_obj_dep) = 5/5 = 1.0
P(null|potentiate_obj_conj) = 1/1 = 1.0
P(null|increase_dep_dep) = 4/4 = 1.0
P(null|collect_obl_obl) = 1/1 = 1.0
P(effect|drink_obj_obl) = 1/1 = 1.0
P(null|receive_obj_parataxis) = 2/2 = 1.0
P(effect|mask_nsubj_obj) = 1/1 = 1.0
P(null|cause_nsubj_parataxis) = 6/6 = 1.0
P(null|cause_obj_parataxis) = 2/2 = 1.0
P(effect|amplify_nsubj_obj) = 1/1 = 1.0
P(null|observe_obl_conj) = 3/3 = 1.0
P(null|increase_nsubj_advmod) = 1/1 = 1.0
P(null|increase_obj_advmod) = 1/1 = 1.0
P(null|perform_nsubj:pass_obl) = 3/3 = 1.0
P(effect|exacerbate_obl_advcl) = 1/1 = 1.0
P(null|characterize_obj_dep) = 2/2 = 1.0
P(null|exhibit_nsubj_advmod) = 1/1 = 1.0
P(null|change_advcl_obj) = 1/1 = 1.0
P(null|recommend_nsubj:pass_obj) = 6/6 = 1.0
P(null|indicate_advcl_ccomp) = 4/4 = 1.0
P(null|indicate_advcl_obj) = 2/2 = 1.0
P(null|indicate_ccomp_obj) = 2/2 = 1.0
P(advise|consider_obl_obl) = 2/2 = 1.0
P(null|affect_advmod_obj) = 2/2 = 1.0
P(mechanism|influence_csubj_obj) = 1/1 = 1.0
P(effect|exacerbate_nsubj:pass_obl) = 5/5 = 1.0
P(null|exercise_nsubj:pass_advcl) = 2/2 = 1.0
P(null|take_advcl_obl:tmod) = 1/1 = 1.0
P(mechanism|take_obj_obl:tmod) = 1/1 = 1.0
P(null|decrease_punct_conj) = 1/1 = 1.0
P(null|alter_nsubj:pass_advcl) = 2/2 = 1.0
P(mechanism|administer_nsubj:pass_obj) = 1/3 = 0.3333333333333333
P(advise|administer_nsubj:pass_obj) = 1/3 = 0.3333333333333333
P(null|administer_nsubj:pass_obj) = 1/3 = 0.3333333333333333
P(effect|diminish_nsubj:pass_advcl) = 1/1 = 1.0
P(advise|alter_nsubj:pass_obl) = 1/1 = 1.0
P(null|contribute_nsubj_iobj) = 1/1 = 1.0
P(null|isolate_obj_conj) = 2/2 = 1.0
P(advise|initiate_nsubj:pass_advcl) = 1/1 = 1.0
P(null|ascertain_obj_advmod) = 1/1 = 1.0
P(advise|treat_nsubj:pass_obl) = 4/4 = 1.0
P(null|show_nsubj_dep) = 6/6 = 1.0
P(advise|avoid_obj_advcl) = 3/5 = 0.6
P(null|avoid_obj_advcl) = 2/5 = 0.4
P(null|contain_nsubj_obj) = 2/2 = 1.0
P(null|contain_nsubj_obl) = 1/1 = 1.0
P(effect|contain_obj_obl) = 4/5 = 0.8
P(null|contain_obj_obl) = 1/5 = 0.2
P(null|coadminister_nsubj:pass_parataxis) = 2/2 = 1.0
P(null|metabolize_advcl_nsubj) = 2/2 = 1.0
P(mechanism|increase_nsubj_ccomp) = 5/7 = 0.7142857142857143
P(null|increase_nsubj_ccomp) = 2/7 = 0.2857142857142857
P(advise|administer_nsubj:pass_ccomp) = 3/4 = 0.75
P(null|administer_nsubj:pass_ccomp) = 1/4 = 0.25
P(null|use_obl_advcl) = 4/4 = 1.0
P(null|study_nsubj:pass_parataxis) = 2/2 = 1.0
P(null|metabolize_nsubj:pass_parataxis) = 1/1 = 1.0
P(null|breed_nsubj_obl) = 1/1 = 1.0
P(advise|use_nsubj:pass_xcomp) = 3/4 = 0.75
P(null|use_nsubj:pass_xcomp) = 1/4 = 0.25
P(null|occur_advcl_parataxis) = 49/49 = 1.0
P(null|change_nsubj_csubj) = 2/2 = 1.0
P(null|change_nsubj_obj) = 8/8 = 1.0
P(null|change_csubj_obj) = 5/5 = 1.0
P(null|know_nsubj:pass_conj) = 3/3 = 1.0
P(null|slow_obj_conj) = 1/1 = 1.0
P(advise|know_xcomp_conj) = 1/6 = 0.16666666666666666
P(null|know_xcomp_conj) = 5/6 = 0.8333333333333334
P(null|know_conj_conj) = 2/2 = 1.0
P(null|show_ccomp_dep) = 3/3 = 1.0
P(mechanism|inhibit_nsubj_ccomp) = 1/1 = 1.0
P(null|examine_obj_xcomp) = 2/2 = 1.0
P(null|analyze_obl_conj) = 3/3 = 1.0
P(null|permit_nsubj_obj) = 1/1 = 1.0
P(null|give_advcl_nsubj:pass) = 2/2 = 1.0
P(null|give_advcl_obl) = 12/12 = 1.0
P(null|indicate_nsubj_conj) = 3/3 = 1.0
P(null|see_obl_obl) = 2/2 = 1.0
P(null|associate_obl_obl) = 2/2 = 1.0
P(effect|protect_nsubj_obl) = 1/2 = 0.5
P(null|protect_nsubj_obl) = 1/2 = 0.5
P(null|employ_advcl_advcl) = 1/1 = 1.0
P(null|affect_nsubj_parataxis) = 1/1 = 1.0
P(null|study_obl_nsubj:pass) = 4/4 = 1.0
P(mechanism|cause_nsubj_xcomp) = 1/1 = 1.0
P(null|employ_obj_advcl) = 1/1 = 1.0
P(null|cause_obl_obl) = 1/1 = 1.0
P(null|contraindicate_nsubj:pass_parataxis) = 7/7 = 1.0
P(null|add_nsubj_dep) = 1/1 = 1.0
P(null|add_obl_dep) = 1/1 = 1.0
P(null|accelerate_obj_dep) = 1/1 = 1.0
P(null|monitor_obj_dep) = 2/2 = 1.0
P(effect|antagonize_nsubj:pass_obl) = 9/10 = 0.9
P(null|antagonize_nsubj:pass_obl) = 1/10 = 0.1
P(mechanism|diminish_dep_obl) = 1/1 = 1.0
P(null|diminish_dep_advcl) = 5/5 = 1.0
P(mechanism|diminish_obl_advcl) = 1/5 = 0.2
P(null|diminish_obl_advcl) = 4/5 = 0.8
P(advise|require_advcl_nsubj) = 1/4 = 0.25
P(null|require_advcl_nsubj) = 3/4 = 0.75
P(effect|prolong_nsubj_advcl) = 3/3 = 1.0
P(null|influence_nsubj_obj) = 6/6 = 1.0
P(null|prolong_advcl_obj) = 1/1 = 1.0
P(effect|antagonize_csubj:pass_obl) = 1/1 = 1.0
P(effect|suppress_nsubj_dep) = 3/3 = 1.0
P(null|result_nsubj_nsubj) = 19/19 = 1.0
P(null|report_nsubj_dep) = 1/1 = 1.0
P(advise|monitor_nsubj:pass_conj) = 1/3 = 0.3333333333333333
P(null|monitor_nsubj:pass_conj) = 2/3 = 0.6666666666666666
P(null|demonstrate_dep_obl) = 1/1 = 1.0
P(null|exercise_nsubj:pass_obl) = 1/1 = 1.0
P(null|use_nsubj:pass_conj) = 1/1 = 1.0
P(null|depend_nsubj_obl) = 6/6 = 1.0
P(advise|indicate_obl_obl) = 3/3 = 1.0
P(null|give_advcl_dep) = 10/10 = 1.0
P(mechanism|decrease_obl_dep) = 1/2 = 0.5
P(null|decrease_obl_dep) = 1/2 = 0.5
P(null|have_nsubj_nsubj) = 1/1 = 1.0
P(null|result_obl_obl) = 1/1 = 1.0
P(null|see_advcl_conj) = 4/4 = 1.0
P(null|see_nsubj:pass_conj) = 2/2 = 1.0
P(mechanism|increase_advmod_obl) = 1/1 = 1.0
P(advise|titrate_nsubj:pass_obl) = 4/4 = 1.0
P(effect|report_obl_dep) = 1/1 = 1.0
P(null|report_dep_advcl) = 2/2 = 1.0
P(null|form_nsubj:pass_obl) = 2/2 = 1.0
P(advise|stop_obj_advcl) = 1/1 = 1.0
P(advise|stop_obj_obl) = 1/1 = 1.0
P(null|receive_obl_obj) = 3/3 = 1.0
P(null|reduce_csubj_obj) = 3/3 = 1.0
P(null|reduce_csubj_conj) = 9/9 = 1.0
P(mechanism|depress_nsubj:pass_obj) = 1/1 = 1.0
P(null|correlate_obl_obj) = 1/1 = 1.0
P(null|evaluate_nsubj:pass_parataxis) = 6/6 = 1.0
P(int|suggest_nsubj_obj) = 10/25 = 0.4
P(null|suggest_nsubj_obj) = 15/25 = 0.6
P(null|administer_nsubj:pass_obl:tmod) = 1/1 = 1.0
P(null|administer_obl_obl:tmod) = 1/1 = 1.0
P(null|maximize_obj_parataxis) = 1/1 = 1.0
P(null|help_csubj_xcomp) = 1/1 = 1.0
P(null|augment_obj_dep) = 1/1 = 1.0
P(mechanism|expect_obl_xcomp) = 4/5 = 0.8
P(null|expect_obl_xcomp) = 1/5 = 0.2
P(effect|result_nsubj_dep) = 1/4 = 0.25
P(null|result_nsubj_dep) = 3/4 = 0.75
P(null|result_obl_dep) = 1/1 = 1.0
P(null|undergo_nsubj_conj) = 1/1 = 1.0
P(null|monitor_advcl_parataxis) = 2/2 = 1.0
P(advise|discontinue_nsubj:pass_obl) = 1/1 = 1.0
P(advise|tell_obl_advcl) = 12/12 = 1.0
P(null|interact_obl_dep) = 1/1 = 1.0
P(null|take_dep_parataxis) = 4/4 = 1.0
P(advise|use_csubj:pass_obl) = 4/6 = 0.6666666666666666
P(null|use_csubj:pass_obl) = 2/6 = 0.3333333333333333
P(null|increase_obj_obj) = 7/7 = 1.0
P(null|denote_obl_dep) = 2/2 = 1.0
P(mechanism|lower_obl_nsubj:pass) = 1/1 = 1.0
P(null|invalidate_nsubj_obj) = 6/6 = 1.0
P(null|increase_conj_obj) = 1/1 = 1.0
P(null|coadminister_nsubj_obl) = 2/2 = 1.0
P(null|note_obl_advcl) = 6/6 = 1.0
P(null|show_nsubj:pass_obl) = 3/3 = 1.0
P(null|show_obl_obl) = 2/2 = 1.0
P(mechanism|evaluate_obj_obl:npmod) = 1/1 = 1.0
P(advise|use_advcl_advcl) = 1/1 = 1.0
P(effect|worsen_nsubj:pass_obl) = 3/3 = 1.0
P(null|worsen_nsubj:pass_advcl) = 3/3 = 1.0
P(null|worsen_obl_advcl) = 1/1 = 1.0
P(advise|advise_obl_obl) = 1/1 = 1.0
P(advise|administer_obl_obl) = 1/2 = 0.5
P(null|administer_obl_obl) = 1/2 = 0.5
P(effect|administer_obl_obj) = 1/4 = 0.25
P(advise|administer_obl_obj) = 1/4 = 0.25
P(null|administer_obl_obj) = 2/4 = 0.5
P(effect|block_nsubj_obj) = 3/3 = 1.0
P(null|see_iobj_dep) = 2/2 = 1.0
P(effect|observe_nsubj:pass_xcomp) = 1/1 = 1.0
P(effect|increase_obl_advcl) = 9/12 = 0.75
P(int|increase_obl_advcl) = 1/12 = 0.08333333333333333
P(null|increase_obl_advcl) = 2/12 = 0.16666666666666666
P(null|show_ccomp_punct) = 2/2 = 1.0
P(effect|produce_obl_dep) = 2/2 = 1.0
P(null|advise_xcomp_dep) = 6/6 = 1.0
P(null|affect_obl_obj) = 8/8 = 1.0
P(effect|experience_nsubj_obj) = 3/3 = 1.0
P(effect|reverse_nsubj_obj) = 1/1 = 1.0
P(null|avoid_nsubj:pass_conj) = 2/2 = 1.0
P(effect|tend_nsubj_xcomp) = 1/2 = 0.5
P(null|tend_nsubj_xcomp) = 1/2 = 0.5
P(null|exhibit_nsubj_advcl) = 6/6 = 1.0
P(null|reduce_advcl_nsubj) = 1/1 = 1.0
P(effect|reduce_advcl_obj) = 1/1 = 1.0
P(null|advise_nsubj:pass_obj) = 2/2 = 1.0
P(null|rationalize_nsubj:pass_obl) = 2/2 = 1.0
P(null|inhibit_nsubj:pass_advcl) = 1/1 = 1.0
P(null|result_advcl_nsubj) = 2/2 = 1.0
P(null|result_advcl_obl) = 2/2 = 1.0
P(null|administer_nsubj:pass_advmod) = 1/1 = 1.0
P(null|require_nsubj:pass_obl) = 2/2 = 1.0
P(advise|take_advcl_nsubj:pass) = 1/4 = 0.25
P(null|take_advcl_nsubj:pass) = 3/4 = 0.75
P(null|take_advcl_advmod) = 2/2 = 1.0
P(advise|take_nsubj:pass_advmod) = 1/1 = 1.0
P(null|inhibit_obl_nsubj) = 1/1 = 1.0
P(mechanism|inhibit_obl_obj) = 1/1 = 1.0
P(null|inhibit_obl_dep) = 1/1 = 1.0
P(null|fortify_nsubj_obl) = 6/6 = 1.0
P(mechanism|fortify_obl_obl) = 2/12 = 0.16666666666666666
P(null|fortify_obl_obl) = 10/12 = 0.8333333333333334
P(null|occur_advcl_dep) = 1/1 = 1.0
P(null|find_parataxis_advcl) = 10/10 = 1.0
P(null|find_parataxis_parataxis) = 10/10 = 1.0
P(null|find_advcl_parataxis) = 1/1 = 1.0
P(null|inhibit_nsubj_obl) = 1/1 = 1.0
P(null|require_obl_nsubj) = 4/4 = 1.0
P(null|require_obl_obj) = 8/8 = 1.0
P(null|associate_nsubj:pass_conj) = 2/2 = 1.0
P(null|contribute_nsubj_obl) = 2/2 = 1.0
P(mechanism|prolong_nsubj:pass_obl) = 1/3 = 0.3333333333333333
P(null|prolong_nsubj:pass_obl) = 2/3 = 0.6666666666666666
P(null|prolong_obl_obl) = 2/2 = 1.0
P(mechanism|occur_obl_nsubj) = 1/1 = 1.0
P(effect|compromise_nsubj:pass_advcl) = 1/1 = 1.0
P(effect|fail_obl_nsubj) = 1/1 = 1.0
P(effect|apply_nsubj:pass_obl) = 1/1 = 1.0
P(null|abolish_advcl_nsubj:pass) = 2/2 = 1.0
P(null|potentiate_obl_advcl) = 1/1 = 1.0
P(null|reduce_obl_parataxis) = 2/2 = 1.0
P(advise|determine_nsubj:pass_obl) = 2/2 = 1.0
P(advise|advise_nsubj:pass_obl) = 1/1 = 1.0
P(mechanism|follow_nsubj_obl) = 1/1 = 1.0
P(advise|have_nsubj_iobj) = 2/2 = 1.0
P(null|metabolize_nsubj:pass_punct) = 1/1 = 1.0
P(null|decrease_obl_obj) = 5/5 = 1.0
P(null|ameliorate_nsubj_obj) = 2/2 = 1.0
P(null|induce_dep_conj) = 1/1 = 1.0
P(null|attenuate_obj_obl) = 1/1 = 1.0
P(null|have_advcl_nsubj) = 2/2 = 1.0
P(null|sequester_nsubj:pass_conj) = 4/4 = 1.0
P(null|require_advcl_xcomp) = 1/1 = 1.0
P(null|require_nsubj_xcomp) = 3/3 = 1.0
P(mechanism|increase_nsubj_iobj) = 4/5 = 0.8
P(effect|increase_nsubj_iobj) = 1/5 = 0.2
P(null|develop_obl_nsubj) = 2/2 = 1.0
P(effect|find_nsubj:pass_conj) = 1/1 = 1.0
P(effect|add_obj_obl) = 1/1 = 1.0
P(null|be_obl_obl) = 1/1 = 1.0
P(null|observe_obl_advmod) = 1/1 = 1.0
P(null|offer_obl_dep) = 1/1 = 1.0
P(null|fluoroquinolone_nsubj_obj) = 4/4 = 1.0
P(mechanism|react_nsubj_obl) = 4/4 = 1.0
P(mechanism|react_nsubj_advmod) = 4/4 = 1.0
P(null|react_obl_advmod) = 4/4 = 1.0
P(null|potentiate_nsubj:pass_advcl) = 1/1 = 1.0
P(effect|treat_nsubj_obl) = 1/1 = 1.0
P(null|avoid_obj_conj) = 1/1 = 1.0
P(effect|exaggerate_nsubj_dep) = 3/3 = 1.0
P(mechanism|accelerate_nsubj_obj) = 1/1 = 1.0
P(null|prescribe_advcl_nsubj:pass) = 1/1 = 1.0
P(mechanism|accelerate_nsubj_obl) = 1/1 = 1.0
P(effect|report_nsubj:pass_dep) = 2/5 = 0.4
P(null|report_nsubj:pass_dep) = 3/5 = 0.6
P(effect|associate_csubj:pass_advcl) = 2/2 = 1.0
P(advise|require_obl_nsubj:pass) = 1/1 = 1.0
P(advise|require_obl_conj) = 1/1 = 1.0
P(effect|produce_advcl_obl) = 1/1 = 1.0
P(mechanism|modify_nsubj_obl) = 1/1 = 1.0
P(null|modify_obj_obl) = 1/1 = 1.0
P(advise|change_obj_obl) = 1/1 = 1.0
P(advise|evaluate_nsubj:pass_obl) = 1/2 = 0.5
P(null|evaluate_nsubj:pass_obl) = 1/2 = 0.5
P(effect|antagonize_dep_dep) = 1/1 = 1.0
P(null|depend_nsubj_conj) = 2/2 = 1.0
P(null|suggest_obl_advcl) = 1/1 = 1.0
P(null|induce_obl_obl) = 1/1 = 1.0
P(effect|induce_obl_dep) = 4/4 = 1.0
P(null|report_xcomp_dep) = 4/4 = 1.0
P(null|anticipate_obl_obl) = 1/1 = 1.0
P(mechanism|increase_dep_conj) = 2/6 = 0.3333333333333333
P(null|increase_dep_conj) = 4/6 = 0.6666666666666666
P(mechanism|increase_conj_conj) = 2/2 = 1.0
P(advise|elapse_obl_obl) = 1/1 = 1.0
P(null|appear_nsubj_obl) = 1/1 = 1.0
P(null|appear_nsubj_conj) = 2/2 = 1.0
P(null|appear_obl_conj) = 2/2 = 1.0
P(null|lead_nsubj_obj) = 1/1 = 1.0
P(null|lead_obl_obj) = 1/1 = 1.0
P(null|emerge_nsubj_obl) = 4/4 = 1.0
P(null|emerge_obl_obl) = 1/1 = 1.0
P(effect|give_advcl_nsubj) = 1/1 = 1.0
P(effect|block_nsubj:pass_obl) = 1/1 = 1.0
P(null|wear_nsubj_advcl) = 1/1 = 1.0
P(null|query_obl_obl) = 3/3 = 1.0
P(effect|prolong_obl_nsubj) = 1/1 = 1.0
P(null|indicate_obl_nsubj) = 2/2 = 1.0
P(null|generate_nsubj:pass_obl) = 1/1 = 1.0
P(null|lead_dep_dep) = 3/3 = 1.0
P(null|lead_dep_nsubj) = 6/6 = 1.0
P(null|lead_dep_obl) = 3/3 = 1.0
P(null|follow_advcl_nsubj:pass) = 1/1 = 1.0
P(null|prevent_obj_obl) = 4/4 = 1.0
P(effect|modulate_nsubj_obj) = 1/1 = 1.0
P(null|suggest_obl_conj) = 4/4 = 1.0
P(null|compete_advcl_nsubj) = 2/2 = 1.0
P(null|compete_advcl_conj) = 2/2 = 1.0
P(null|switch_obl_obl) = 1/1 = 1.0
